Citrus Sinensis ID: 041907

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380
Protein Sequence
ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHHccccccccEEcEEccccEEEEEEEEEccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEcccccccccccccccccEEEEccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEcEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEccccccHHHEEEEHHHEEEEccccHHHHcccHcccccEEEEEEEccccccHHHHHccccccHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccccEccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
adstdhstesntkssrkssrsyvsssspksgqattiNFSFEEIYKAtenfspankigeggsgtvykgklkdgsIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFgflehgdeRIIVVEYVGngtlrehldgrggnglELAERLDIAIDVAHALTYlhtysdppiihrdvkasNILITEKLRAKVTDfgfarmseedsavshistqvkgtagyldpdylrtyqlteksdvYSFGVLLVEMMtgrypieskkpikeRVTIRWAMQCLKAGdailvmdprlrrtpasnMAVEKILGLAdvclaptrqsrptmKKCAEILWKIRKDfrekapssfssssspasaseshypigdakkksrhisfgndegdsykftsa
Flexible Loop (DISEMBL)
adstdhstesntkssrkssrsyvsssspksgqattINFSFEEIYKATEnfspankigeggsgtvykgklKDGSIVAVkrarknkhdkclLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARmseedsavshistqvkgtagyldPDYLRTYQLTEKSDVYSFGVLLVEMMtgrypieskkpikerVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVclaptrqsrptmkKCAEILWKIRKDFREKApssfssssspasaseshypigdakkksrhisfgndegdsykftsa
Low Complexity Region (SEG)
ADSTDHstesntkssrkssrsyvsssspksGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKapssfssssspasasesHYPIGDAKKKSRHISFGNDEGDSYKFTSA
Disordered region (IsUnstruct)
***********************************INFSFEEIYKATENF**********SGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM*****AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK***************************************************
Disordered Region (DISOPRED)
*************************************FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAV****************KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES*KPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR****************************************************
Disordered Region (DISEMBL)
********************************ATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS*************KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR**********************IGDAKKKSRHISFGNDEGDSYKFTSA
Disordered Region (DISPRO)
*********************************TTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPS*******************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	380	2.2.26 [Sep-21-2011]
Q9FIL7	470	Calmodulin-binding recept	yes	no	0.813	0.657	0.676	1e-122
Q8VZJ9	411	Calmodulin-binding recept	no	no	0.778	0.720	0.635	1e-113
Q9ASQ5	510	Calmodulin-binding recept	no	no	0.807	0.601	0.508	3e-88
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.828	0.443	0.396	3e-59
C0LGD7	953	Probable LRR receptor-lik	no	no	0.734	0.292	0.414	8e-59
C0LGI2	929	Probable LRR receptor-lik	no	no	0.739	0.302	0.43	7e-58
Q9SA72	849	Probable receptor-like pr	no	no	0.807	0.361	0.413	1e-57
Q9LK35	855	Receptor-like protein kin	no	no	0.860	0.382	0.410	1e-56
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.771	0.406	0.396	1e-56
Q9SGY7	718	Putative proline-rich rec	no	no	0.805	0.426	0.388	4e-56

>sp|Q9FIL7|CRCK1_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 1 OS=Arabidopsis thaliana GN=CRCK1 PE=1 SV=1

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 209/309 (67%), Positives = 252/309 (81%)

Query: 25  SSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNK 84
           SSS KS     + FSF E+ +AT NFS  ++IGEGG GTV+KGKL DG+IVA+KRARKN 
Sbjct: 122 SSSSKSWHQGPVIFSFGELQRATANFSSVHQIGEGGFGTVFKGKLDDGTIVAIKRARKNN 181

Query: 85  HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG 144
           + K  LLEFKNEI T SKIEH+NLVKL+GFLEHGDE++IVVEYV NG LREHLDG  GN 
Sbjct: 182 YGKSWLLEFKNEIYTLSKIEHMNLVKLYGFLEHGDEKVIVVEYVANGNLREHLDGLRGNR 241

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           LE+AERL+IAIDVAHALTYLHTY+D PIIHRD+KASNILIT KLRAKV DFGFAR+  ED
Sbjct: 242 LEMAERLEIAIDVAHALTYLHTYTDSPIIHRDIKASNILITNKLRAKVADFGFARLVSED 301

Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
              +HISTQVKG+AGY+DPDYLRT+QLT+KSDVYSFGVLLVE++TGR PIE K+P K+R+
Sbjct: 302 LGATHISTQVKGSAGYVDPDYLRTFQLTDKSDVYSFGVLLVEILTGRRPIELKRPRKDRL 361

Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           T++WA++ LK  +A+L+MDP L+R  A+    EK+L LA  C+ PTR +RP MK  AE L
Sbjct: 362 TVKWALRRLKDDEAVLIMDPFLKRNRAAIEVAEKMLRLASECVTPTRATRPAMKGIAEKL 421

Query: 325 WKIRKDFRE 333
           W IR++ +E
Sbjct: 422 WAIRREMKE 430

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8VZJ9|CRCK2_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 2 OS=Arabidopsis thaliana GN=CRCK2 PE=2 SV=1

 Score =  409 bits (1052), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 190/299 (63%), Positives = 243/299 (81%), Gaps = 3/299 (1%)

Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD--KCLLLEFKN 95
           F+F+EIY AT+NFSP+ +IG+GG GTVYK KL+DG   AVKRA+K+ HD  +    EF +
Sbjct: 107 FTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTFAVKRAKKSMHDDRQGADAEFMS 166

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           EI T +++ HL+LVK +GF+ H DE+I+VVEYV NGTLR+HLD + G  L++A RLDIA 
Sbjct: 167 EIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTLRDHLDCKEGKTLDMATRLDIAT 226

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS-EEDSAVSHISTQV 214
           DVAHA+TYLH Y+ PPIIHRD+K+SNIL+TE  RAKV DFGFAR++ + DS  +H+STQV
Sbjct: 227 DVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVADFGFARLAPDTDSGATHVSTQV 286

Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
           KGTAGYLDP+YL TYQLTEKSDVYSFGVLLVE++TGR PIE  +  KER+TIRWA++   
Sbjct: 287 KGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRRPIELSRGQKERITIRWAIKKFT 346

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE 333
           +GD I V+DP+L +  A+N+A+EK+L +A  CLAP R+SRP+MKKC+EILW IRKD+RE
Sbjct: 347 SGDTISVLDPKLEQNSANNLALEKVLEMAFQCLAPHRRSRPSMKKCSEILWGIRKDYRE 405

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ASQ5|CRCK3_ARATH Calmodulin-binding receptor-like cytoplasmic kinase 3 OS=Arabidopsis thaliana GN=CRCK3 PE=2 SV=1

 Score =  325 bits (834), Expect = 3e-88,   Method: Compositional matrix adjust.
 Identities = 157/309 (50%), Positives = 213/309 (68%), Gaps = 2/309 (0%)

Query: 27  SPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD 86
           SP+  +   +N +  +I  AT NF+ +++IGEGG G V+KG L DG +VA+KRA+K +H 
Sbjct: 202 SPRPSRLGPLNLTMSQINTATGNFADSHQIGEGGFGVVFKGVLDDGQVVAIKRAKK-EHF 260

Query: 87  KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLE 146
           + L  EFK+E+   SKI H NLVKL G+++ GDER+I+ EYV NGTLR+HLDG  G  L 
Sbjct: 261 ENLRTEFKSEVDLLSKIGHRNLVKLLGYVDKGDERLIITEYVRNGTLRDHLDGARGTKLN 320

Query: 147 LAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
             +RL+I IDV H LTYLH+Y++  IIHRD+K+SNIL+T+ +RAKV DFGFAR    DS 
Sbjct: 321 FNQRLEIVIDVCHGLTYLHSYAERQIIHRDIKSSNILLTDSMRAKVADFGFARGGPTDSN 380

Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI 266
            +HI TQVKGT GYLDP+Y++TY LT KSDVYSFG+LLVE++TGR P+E+K+   ER+T+
Sbjct: 381 QTHILTQVKGTVGYLDPEYMKTYHLTAKSDVYSFGILLVEILTGRRPVEAKRLPDERITV 440

Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK 326
           RWA      G    ++DP  R        + K+  LA  C APT++ RP M+   + LW 
Sbjct: 441 RWAFDKYNEGRVFELVDPNARER-VDEKILRKMFSLAFQCAAPTKKERPDMEAVGKQLWA 499

Query: 327 IRKDFREKA 335
           IR  +  ++
Sbjct: 500 IRSSYLRRS 508

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  229 bits (584), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 132/333 (39%), Positives = 198/333 (59%), Gaps = 18/333 (5%)

Query: 2   DSTDHSTESNTKSSRKSSRSYV-SSSSPKS---GQATTINFSFEEIYKATENFSPANKIG 57
           +S   S   N+  S++    Y  S S+P S   G   T +F++EE+   TE FS  N +G
Sbjct: 302 NSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQT-HFTYEELTDITEGFSKHNILG 360

Query: 58  EGGSGTVYKGKLKDGSIVAVKRAR--KNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           EGG G VYKGKL DG +VAVK+ +    + D+    EFK E+   S++ H +LV L G+ 
Sbjct: 361 EGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDR----EFKAEVEIISRVHHRHLVSLVGYC 416

Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
               ER+++ EYV N TL  HL G+G   LE A R+ IAI  A  L YLH    P IIHR
Sbjct: 417 IADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHR 476

Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+K++NIL+ ++  A+V DFG A+++  DS  +H+ST+V GT GYL P+Y ++ +LT++S
Sbjct: 477 DIKSANILLDDEFEAQVADFGLAKLN--DSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRS 534

Query: 236 DVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA----MQCLKAGDAILVMDPRLRRTPA 291
           DV+SFGV+L+E++TGR P++  +P+ E   + WA     + ++ GD   ++D RL +   
Sbjct: 535 DVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYV 594

Query: 292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            N  V +++  A  C+  +   RP M +    L
Sbjct: 595 EN-EVFRMIETAAACVRHSGPKRPRMVQVVRAL 626

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2

 Score =  228 bits (580), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 124/299 (41%), Positives = 184/299 (61%), Gaps = 20/299 (6%)

Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKN--KHDKCLLLEFKN 95
           F++ E+  AT+NF+ + +IG+GG G VYKG L  G++VA+KRA++   + +K    EF  
Sbjct: 613 FTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEK----EFLT 668

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           EI   S++ H NLV L GF +   E+++V EY+ NGTLR+++  +    L+ A RL IA+
Sbjct: 669 EIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIAL 728

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE----EDSAVSHIS 211
             A  + YLHT ++PPI HRD+KASNIL+  +  AKV DFG +R++     E  +  H+S
Sbjct: 729 GSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVS 788

Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ 271
           T VKGT GYLDP+Y  T+QLT+KSDVYS GV+L+E+ TG  PI   K I   + I +   
Sbjct: 789 TVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAY--- 845

Query: 272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA---EILWKI 327
             ++G  +  +D R+   P  +  +EK   LA  C      +RP+M +     EI+W++
Sbjct: 846 --ESGSILSTVDKRMSSVP--DECLEKFATLALRCCREETDARPSMAEVVRELEIIWEL 900

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score =  224 bits (571), Expect = 7e-58,   Method: Compositional matrix adjust.
 Identities = 129/300 (43%), Positives = 184/300 (61%), Gaps = 19/300 (6%)

Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVK-RARKNKHDKCLLLEFKNE 96
            S   + +AT+NFS   K+G G  G+VY G++KDG  VAVK  A  + H   L  +F  E
Sbjct: 596 ISLPVLEEATDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKITADPSSH---LNRQFVTE 650

Query: 97  ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAI 155
           +   S+I H NLV L G+ E  D RI+V EY+ NG+L +HL G      L+   RL IA 
Sbjct: 651 VALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQ 710

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           D A  L YLHT  +P IIHRDVK+SNIL+   +RAKV+DFG +R +EED  ++H+S+  K
Sbjct: 711 DAAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEED--LTHVSSVAK 768

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA 275
           GT GYLDP+Y  + QLTEKSDVYSFGV+L E+++G+ P+ ++    E   + WA   ++ 
Sbjct: 769 GTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRK 828

Query: 276 GDAILVMDPRLRRTPASNMAVEKILGLADV---CLAPTRQSRPTMKKCAEILWKIRKDFR 332
           GD   ++DP +    ASN+ +E +  +A+V   C+     +RP M+   E++  I+   R
Sbjct: 829 GDVCGIIDPCI----ASNVKIESVWRVAEVANQCVEQRGHNRPRMQ---EVIVAIQDAIR 881

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  224 bits (570), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 133/322 (41%), Positives = 184/322 (57%), Gaps = 15/322 (4%)

Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
           F+  EI  AT+NF     IG GG G VY+G+L+DG+++A+KRA    H +  L EF+ EI
Sbjct: 508 FTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRA--TPHSQQGLAEFETEI 565

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
           +  S++ H +LV L GF +  +E I+V EY+ NGTLR HL G     L   +RL+  I  
Sbjct: 566 VMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGS 625

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           A  L YLHT S+  IIHRDVK +NIL+ E   AK++DFG ++        +H+ST VKG+
Sbjct: 626 ARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDH-THVSTAVKGS 684

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
            GYLDP+Y R  QLTEKSDVYSFGV+L E +  R  I    P  +     WA+   K  +
Sbjct: 685 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRN 744

Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF------ 331
              ++D  LR    S  ++EK   +A+ CLA   ++RP M    E+LW +          
Sbjct: 745 LESIIDSNLRGN-YSPESLEKYGEIAEKCLADEGKNRPMM---GEVLWSLEYVLQIHEAW 800

Query: 332 --REKAPSSFSSSSSPASASES 351
             ++   +SFSSS +   A ES
Sbjct: 801 LRKQNGENSFSSSQAVEEAPES 822

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  220 bits (561), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 142/346 (41%), Positives = 194/346 (56%), Gaps = 19/346 (5%)

Query: 12  TKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD 71
           T S + ++ S +S +S   G+     F F+EI  AT  F  ++ +G GG G VYKG L+D
Sbjct: 476 TASHKSATASCISLASTHLGRC----FMFQEIMDATNKFDESSLLGVGGFGRVYKGTLED 531

Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG 131
           G+ VAVKR   N   +  + EF+ EI   SK+ H +LV L G+ +   E I+V EY+ NG
Sbjct: 532 GTKVAVKRG--NPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANG 589

Query: 132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK 191
            LR HL G     L   +RL+I I  A  L YLHT +   IIHRDVK +NIL+ E L AK
Sbjct: 590 PLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAK 649

Query: 192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           V DFG ++        +H+ST VKG+ GYLDP+Y R  QLTEKSDVYSFGV+L+E++  R
Sbjct: 650 VADFGLSKTGPSLDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCR 708

Query: 252 YPIESKKPIKERVTI-RWAMQCLKAGDAILVMDPRL--RRTPASNMAVEKILGLADVCLA 308
             +    P +E+V I  WAM   K G    +MD  L  +  PAS   ++K    A+ CLA
Sbjct: 709 PALNPVLP-REQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPAS---LKKFGETAEKCLA 764

Query: 309 PTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESHYP 354
                RP+M    ++LW +    + +  S  S+   P   S +H P
Sbjct: 765 EYGVDRPSM---GDVLWNLEYALQLEETS--SALMEPDDNSTNHIP 805

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  220 bits (561), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 123/310 (39%), Positives = 190/310 (61%), Gaps = 17/310 (5%)

Query: 24  SSSSPKS---GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVK-- 78
           SS +P S   G   T +FS+EE+ + T+ F+  N +GEGG G VYKG L+DG +VAVK  
Sbjct: 343 SSGTPDSAILGSGQT-HFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQL 401

Query: 79  RARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLD 138
           +A   + D+    EFK E+   S++ H +LV L G+      R+++ EYV N TL  HL 
Sbjct: 402 KAGSGQGDR----EFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLH 457

Query: 139 GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA 198
           G+G   LE ++R+ IAI  A  L YLH    P IIHRD+K++NIL+ ++  A+V DFG A
Sbjct: 458 GKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLA 517

Query: 199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
           R++  D+  +H+ST+V GT GYL P+Y  + +LT++SDV+SFGV+L+E++TGR P++  +
Sbjct: 518 RLN--DTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQ 575

Query: 259 PIKERVTIRWA----MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSR 314
           P+ E   + WA    ++ ++ GD   ++D RL +    +  V +++  A  C+  +   R
Sbjct: 576 PLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEH-EVFRMIETAAACVRHSGPKR 634

Query: 315 PTMKKCAEIL 324
           P M +    L
Sbjct: 635 PRMVQVVRAL 644

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  219 bits (557), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 126/324 (38%), Positives = 190/324 (58%), Gaps = 18/324 (5%)

Query: 14  SSRKSSRSYVSSSSPKSGQATT---------INFSFEEIYKATENFSPANKIGEGGSGTV 64
           S++ SS    S  +PK G+ T          I+F++EE+ + TE F  +  +GEGG G V
Sbjct: 325 SAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCV 384

Query: 65  YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV 124
           YKG L +G  VA+K+ +    +     EFK E+   S++ H +LV L G+      R ++
Sbjct: 385 YKGILFEGKPVAIKQLKSVSAEG--YREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLI 442

Query: 125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI 184
            E+V N TL  HL G+    LE + R+ IAI  A  L YLH    P IIHRD+K+SNIL+
Sbjct: 443 YEFVPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILL 502

Query: 185 TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
            ++  A+V DFG AR++  D+A SHIST+V GT GYL P+Y  + +LT++SDV+SFGV+L
Sbjct: 503 DDEFEAQVADFGLARLN--DTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVL 560

Query: 245 VEMMTGRYPIESKKPIKERVTIRWA----MQCLKAGDAILVMDPRLRRTPASNMAVEKIL 300
           +E++TGR P+++ +P+ E   + WA    ++ ++ GD   V+DPRL      +  V K++
Sbjct: 561 LELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVES-EVYKMI 619

Query: 301 GLADVCLAPTRQSRPTMKKCAEIL 324
             A  C+  +   RP M +    L
Sbjct: 620 ETAASCVRHSALKRPRMVQVVRAL 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
359478876	439	PREDICTED: probable leucine-rich repeat	0.965	0.835	0.701	1e-148
224104327	344	predicted protein [Populus trichocarpa]	0.889	0.982	0.696	1e-140
388490972	466	unknown [Lotus japonicus]	0.934	0.761	0.655	1e-134
356551844	458	PREDICTED: probable leucine-rich repeat	0.931	0.772	0.665	1e-133
356566128	453	PREDICTED: probable leucine-rich repeat	0.902	0.757	0.661	1e-132
357490559	456	Nodulation receptor kinase [Medicago tru	0.894	0.745	0.667	1e-132
49781338	456	calcium/calmodulin-regulated receptor-li	0.894	0.745	0.667	1e-132
356500845	458	PREDICTED: probable leucine-rich repeat	0.884	0.733	0.674	1e-132
388501664	392	unknown [Medicago truncatula]	0.894	0.867	0.667	1e-131
356539551	452	PREDICTED: probable leucine-rich repeat	0.915	0.769	0.644	1e-130

>gi|359478876|ref|XP_002280660.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Vitis vinifera] gi|297745952|emb|CBI16008.3| unnamed protein product [Vitis vinifera]

 Score =  530 bits (1365), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 263/375 (70%), Positives = 308/375 (82%), Gaps = 8/375 (2%)

Query: 7   STESNTKSSR-KSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVY 65
           S  +N +SSR K S SY  SS+  SGQ  T NFS EEI KAT+NFS ANKIGEGG GTVY
Sbjct: 72  SCSNNKRSSRFKYSDSY-GSSNAASGQLVTENFSIEEINKATQNFSQANKIGEGGFGTVY 130

Query: 66  KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV 125
           KG+L +GS+VA+KRA+KN +DK L  EFKNEILT S+IEHLNLVKL G+LEH DERII++
Sbjct: 131 KGRLGNGSLVAIKRAKKNMYDKRLSQEFKNEILTLSRIEHLNLVKLLGYLEHKDERIIII 190

Query: 126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT 185
           EY+GNGTLREHLDG    GLE+AERLDIAIDVAHA+ YLH Y+D PIIHRD+KASNILIT
Sbjct: 191 EYIGNGTLREHLDG--TQGLEIAERLDIAIDVAHAVAYLHMYTDTPIIHRDIKASNILIT 248

Query: 186 EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLV 245
           EKLRAKV DFGFAR++ ED   +HISTQ+KGTAGYLDP+YLRTYQLTEKSDVYSFGVLLV
Sbjct: 249 EKLRAKVADFGFARLAAEDPGATHISTQIKGTAGYLDPEYLRTYQLTEKSDVYSFGVLLV 308

Query: 246 EMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADV 305
           EM+TGR+PIESK+P+ ERVT RWAM+ LK GDA+L MDP+LRR PASN AVE++L LA  
Sbjct: 309 EMVTGRHPIESKRPLSERVTTRWAMERLKEGDAVLAMDPKLRRNPASNQAVERVLKLARQ 368

Query: 306 CLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHI 365
           CLAP RQSRP+M+KCAE+LW IRKDFREKA   FS S  P+S    ++   DA +K+RH 
Sbjct: 369 CLAPLRQSRPSMRKCAEVLWGIRKDFREKA---FSYSPCPSSHRSDNFLNKDA-RKNRHH 424

Query: 366 SFGNDEGDSYKFTSA 380
           +FG ++ D+YKF SA
Sbjct: 425 AFGLEDCDNYKFVSA 439

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104327|ref|XP_002313398.1| predicted protein [Populus trichocarpa] gi|222849806|gb|EEE87353.1| predicted protein [Populus trichocarpa]

 Score =  503 bits (1295), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 239/343 (69%), Positives = 286/343 (83%), Gaps = 5/343 (1%)

Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
           FS +EI+K T+NFSPANKIG+G   TVYKG+L+DGS VAVKRA+KN +DK LLLEF+NE 
Sbjct: 7   FSIQEIFKMTDNFSPANKIGDGSFSTVYKGRLRDGSFVAVKRAQKNTYDKRLLLEFQNEA 66

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
           +T SKIEHLNLV+ +G++E GDERI+VVEYVGNG LREHLDG+ G+ LE+AERLDIAIDV
Sbjct: 67  ITLSKIEHLNLVRFYGYVEQGDERILVVEYVGNGNLREHLDGKKGSILEIAERLDIAIDV 126

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           AHA+TYLHTY+DPPIIHRD+KASN+LITEKLRAKV DFGFAR++ E S  +HISTQVKGT
Sbjct: 127 AHAVTYLHTYTDPPIIHRDIKASNVLITEKLRAKVADFGFARLTTEGSDATHISTQVKGT 186

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
            GYLDP+YLRTYQLTEKSDVYSFGVLLVE+MTGR+PIE K+ +KERVTI+WAMQ LK GD
Sbjct: 187 TGYLDPEYLRTYQLTEKSDVYSFGVLLVELMTGRHPIEQKRSLKERVTIKWAMQSLKGGD 246

Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPS 337
           AI VMDP LRR+P S MA+EK+L LA  CLAP++QSRP+MK C+E+LW IRKD R   P 
Sbjct: 247 AIFVMDPLLRRSPGSTMAMEKVLKLARHCLAPSKQSRPSMKDCSEVLWGIRKDLRASGP- 305

Query: 338 SFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
              SSS+  S   + +P  + +KKSR  +FG ++G  YKF SA
Sbjct: 306 ---SSSAFISHQSADFPRRN-EKKSREAAFGIEDGGGYKFISA 344

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388490972|gb|AFK33552.1| unknown [Lotus japonicus]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 240/366 (65%), Positives = 292/366 (79%), Gaps = 11/366 (3%)

Query: 17  KSSRSYVSSSSPKSG--QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSI 74
           K S SY S+S+  +   Q   +NFSFEEIYK+T  FSP N+IGEGG GTVYKGKL DGS+
Sbjct: 104 KFSYSYPSASTATTSEQQLGIVNFSFEEIYKSTAKFSPDNQIGEGGFGTVYKGKLSDGSL 163

Query: 75  VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLR 134
           VAVKRA+K+      L EFKNEI T SKIEH+NLV+L+G+LEHGDE++I++EYVGNGTLR
Sbjct: 164 VAVKRAKKDVL-HSHLFEFKNEINTLSKIEHMNLVRLYGYLEHGDEKMIIIEYVGNGTLR 222

Query: 135 EHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD 194
           EHL+G  G+GLE+ ERLDIAIDVAHA+TYLH Y+D PIIHRD+KASNILIT+  RAKV D
Sbjct: 223 EHLNGIRGDGLEIGERLDIAIDVAHAVTYLHMYTDNPIIHRDIKASNILITDNFRAKVAD 282

Query: 195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           FGFAR+S+ D   +HISTQVKGTAGY+DP+YLRTYQLTEKSDVYSFGVLLVEM+TGR PI
Sbjct: 283 FGFARLSD-DPGATHISTQVKGTAGYMDPEYLRTYQLTEKSDVYSFGVLLVEMITGRNPI 341

Query: 255 ESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSR 314
           E K+P  ERVTIRWAMQ ++ GD +  MDPRLRR+PAS  AV+K+L LA  CLA  R+SR
Sbjct: 342 EQKRPPNERVTIRWAMQMVRKGDVVFAMDPRLRRSPASIDAVKKVLKLASQCLASLRESR 401

Query: 315 PTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDS 374
           P+MKKCAE+LW IRK FR++A         P+  SE+ +P    ++K++H+SFG ++ DS
Sbjct: 402 PSMKKCAEVLWGIRKSFRDEA---IPHPPLPSHLSEN-FP---QREKNKHMSFGIEDDDS 454

Query: 375 YKFTSA 380
           YKF SA
Sbjct: 455 YKFASA 460

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551844|ref|XP_003544283.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Glycine max]

 Score =  481 bits (1237), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 245/368 (66%), Positives = 290/368 (78%), Gaps = 14/368 (3%)

Query: 14  SSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGS 73
           S  K S SY SS +  SGQ    NFSFEEIYK+T  FSPAN+IG+GG GTVYKGKL DGS
Sbjct: 98  SKWKFSYSYASSIT-ASGQLGIGNFSFEEIYKSTAKFSPANEIGQGGFGTVYKGKLNDGS 156

Query: 74  IVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGT 132
           IVAVKRA+K+  H+   L EFKNEI T S+IEH NLV+L+G+LEHGDE+IIVVEYVGNG 
Sbjct: 157 IVAVKRAKKDVIHNH--LHEFKNEIYTLSQIEHRNLVRLYGYLEHGDEKIIVVEYVGNGN 214

Query: 133 LREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKV 192
           LREHL+G  G GLE+ ERLDIAIDVAHA+TYLH Y+D PIIHRD+KASNILITE L+AKV
Sbjct: 215 LREHLNGIRGEGLEIGERLDIAIDVAHAVTYLHMYTDNPIIHRDIKASNILITENLKAKV 274

Query: 193 TDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRY 252
            DFGFAR+S++ +A +HISTQVKGTAGY+DP+YLRTYQLTEKSDVYSFGVLLVEM+TGR+
Sbjct: 275 ADFGFARLSDDPNA-THISTQVKGTAGYMDPEYLRTYQLTEKSDVYSFGVLLVEMVTGRH 333

Query: 253 PIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQ 312
           PIE K+P+ ERVTIRWAM+ LK GDA+  MDPRLRR PAS  AV+++L LA  C+AP++Q
Sbjct: 334 PIEPKRPVDERVTIRWAMKMLKQGDAVFAMDPRLRRNPASIKAVKQVLKLALQCVAPSKQ 393

Query: 313 SRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEG 372
           SRP MK CAE+LW IRK FR++A S      S  SA+   +P  +  K      FG ++ 
Sbjct: 394 SRPPMKNCAEVLWDIRKSFRDEANSDHPPLPSHHSAN---FPQREKNK------FGIEDD 444

Query: 373 DSYKFTSA 380
           DSYKF S 
Sbjct: 445 DSYKFVSV 452

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566128|ref|XP_003551287.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Glycine max] gi|299882742|gb|ADJ57306.1| calcium-dependent/calmodulin-binding receptor-like kinase [Glycine soja]

 Score =  478 bits (1230), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 233/352 (66%), Positives = 279/352 (79%), Gaps = 9/352 (2%)

Query: 29  KSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC 88
           +S Q    NF+FEEIYKAT  FS  NKIGEG  GTVYKGKL DGS+VAVKRA+K+  +  
Sbjct: 111 RSSQLGMGNFTFEEIYKATAKFSLDNKIGEGAFGTVYKGKLNDGSLVAVKRAKKDLPNNN 170

Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA 148
           L  EFKNEI T SKIEH+NLVK +G+LEHG E+IIVVEYV NGTLREHLDG  G+ LE+ 
Sbjct: 171 LA-EFKNEINTLSKIEHINLVKWYGYLEHGHEKIIVVEYVSNGTLREHLDGIRGDVLEIG 229

Query: 149 ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
           ERLDIAID+AHA+TYLH Y+D PIIHRD+KASNILIT+KLRAKV DFGFAR+  ED   +
Sbjct: 230 ERLDIAIDIAHAITYLHMYTDHPIIHRDIKASNILITDKLRAKVADFGFARLGPEDPGAT 289

Query: 209 HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW 268
           HISTQ+KGTAGY+DPDY+RT  L+EKSDVYSFGVLLVEMMTGR+PIE ++P+ ERVTI+W
Sbjct: 290 HISTQIKGTAGYMDPDYMRTQHLSEKSDVYSFGVLLVEMMTGRHPIEPQRPLSERVTIKW 349

Query: 269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
           AMQ LK  + ++ MDPRLRR PASN AV+K+L LA  CLAP RQ RP+MK CAE+LW+IR
Sbjct: 350 AMQLLKQAEVVMAMDPRLRRNPASNKAVQKVLKLAFQCLAPGRQPRPSMKSCAEVLWEIR 409

Query: 329 KDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
           KDFREKA      S  P  +++  +P  D  +K+RH ++G ++G  YKF SA
Sbjct: 410 KDFREKA-----FSHPPHHSAD--FPQRDG-RKNRHKTYGIEDGKGYKFVSA 453

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357490559|ref|XP_003615567.1| Nodulation receptor kinase [Medicago truncatula] gi|355516902|gb|AES98525.1| Nodulation receptor kinase [Medicago truncatula]

 Score =  478 bits (1230), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 233/349 (66%), Positives = 282/349 (80%), Gaps = 9/349 (2%)

Query: 32  QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLL 91
           Q  T NF+FEEIYK+T  FS  N+IGEGG GTVY+GKL DG+IVAVKRA+K    +  L 
Sbjct: 111 QLGTGNFTFEEIYKSTAKFSQDNQIGEGGFGTVYRGKLNDGTIVAVKRAKKEAL-QSHLY 169

Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL 151
           EFKNEI T SKIEHLNLV+L+G+LEHGDE++I+VEYVGNG LREHLDG  G+GLE+ ERL
Sbjct: 170 EFKNEIYTLSKIEHLNLVRLYGYLEHGDEKLIIVEYVGNGNLREHLDGIRGDGLEIGERL 229

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
           DIAID+AHA+TYLH Y+D PIIHRD+KASNILI+E LRAKV DFGFAR+SE D   +HIS
Sbjct: 230 DIAIDIAHAITYLHMYTDNPIIHRDIKASNILISENLRAKVADFGFARLSE-DPGATHIS 288

Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ 271
           TQVKGTAGY+DP+YLRTYQLTEKSDVYSFGVLLVEMMTGR+P+E KK I ERVTIRWAM+
Sbjct: 289 TQVKGTAGYMDPEYLRTYQLTEKSDVYSFGVLLVEMMTGRHPVEPKKKIDERVTIRWAMK 348

Query: 272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
            LK G+A+  MDPRLRR+PAS   V+K+  LA  CLAP+  SRP MK CAE+LW IRKDF
Sbjct: 349 MLKNGEAVFAMDPRLRRSPASIKVVKKVFKLAFQCLAPSIHSRPPMKNCAEVLWGIRKDF 408

Query: 332 REKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
           +++        + P+  SE+ +P    ++K++HI+FG ++ DSYKF+SA
Sbjct: 409 KDETT---PLPTLPSHQSEN-FP---QREKNKHITFGIEDDDSYKFSSA 450

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|49781338|gb|AAT68475.1| calcium/calmodulin-regulated receptor-like kinase [Medicago sativa]

 Score =  478 bits (1229), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 233/349 (66%), Positives = 281/349 (80%), Gaps = 9/349 (2%)

Query: 32  QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLL 91
           Q  T NF+FEEIYK+T  FS  N+IGEGG GTVY+GKL DG+IVAVKRA+K    +  L 
Sbjct: 111 QLGTGNFTFEEIYKSTAKFSSDNQIGEGGFGTVYRGKLNDGTIVAVKRAKKEAL-QSHLY 169

Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL 151
           EFKNEI T SKIEHLNLV+L+G+LEHGDE++I+VEYVGNG L EHLDG  G+GLE+ ERL
Sbjct: 170 EFKNEIYTLSKIEHLNLVRLYGYLEHGDEKLIIVEYVGNGNLTEHLDGIRGDGLEIGERL 229

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
           DIAID+AHA+TYLH Y+D PIIHRD+KASNILI+E LRAKV DFGFAR+SE D   +HIS
Sbjct: 230 DIAIDIAHAITYLHMYTDNPIIHRDIKASNILISENLRAKVADFGFARLSE-DPGATHIS 288

Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ 271
           TQVKGTAGY+DP+YLRTYQLTEKSDVYSFGVLLVEMMTGR+P+E KK I ERVTIRWAM+
Sbjct: 289 TQVKGTAGYMDPEYLRTYQLTEKSDVYSFGVLLVEMMTGRHPVEPKKKIDERVTIRWAMK 348

Query: 272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
            LK GDA+  MDPRLRR+PAS   V+K+  LA  CLAP+  SRP MK CAE+LW IRKDF
Sbjct: 349 MLKNGDAVFAMDPRLRRSPASIKVVKKVFKLAFQCLAPSIHSRPAMKNCAEVLWGIRKDF 408

Query: 332 REKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
           +++        + P+  SE+ +P    ++K++HI+FG ++ DSYKF+SA
Sbjct: 409 KDETT---PLPTLPSHQSEN-FP---QREKNKHITFGIEDDDSYKFSSA 450

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500845|ref|XP_003519241.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Glycine max]

 Score =  477 bits (1227), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 238/353 (67%), Positives = 281/353 (79%), Gaps = 17/353 (4%)

Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARK---NKHDK 87
           GQ    NFSFEEIYK+T  FSP N+IG+GG GTVYKGKL DGSIVAVKRA+K     H  
Sbjct: 114 GQLGIGNFSFEEIYKSTAKFSPVNEIGQGGFGTVYKGKLNDGSIVAVKRAKKAVIQNH-- 171

Query: 88  CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLEL 147
             L EFKNEI T S+IEH NLV+L+G+LEHGDE+IIVVEYVGNG LREHLDG  G GLE+
Sbjct: 172 --LHEFKNEIYTLSQIEHRNLVRLYGYLEHGDEKIIVVEYVGNGNLREHLDGIRGEGLEI 229

Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
            ERLDIAIDVAHA+TYLH Y+D PIIHRD+KASNILITE L+AKV DFGFAR+S++ +A 
Sbjct: 230 GERLDIAIDVAHAITYLHMYTDNPIIHRDIKASNILITENLKAKVADFGFARLSDDPNA- 288

Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
           +HISTQVKGTAGY+DP+YLRTYQLTEKSDVYSFGVLLVEMMTGR+PIE K+P+ ERVTIR
Sbjct: 289 THISTQVKGTAGYMDPEYLRTYQLTEKSDVYSFGVLLVEMMTGRHPIEPKRPVDERVTIR 348

Query: 268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
           WAM+ LK GDA+  MDPRLRR  AS  AV+++L LA  C+AP++QSRP MK CAE+LW I
Sbjct: 349 WAMKMLKQGDAVFAMDPRLRRNSASIKAVKQVLKLALQCIAPSKQSRPPMKNCAEVLWDI 408

Query: 328 RKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
           RK FR++A S  +   S  SA+   +P    ++K+   +FG +E DSYKF S 
Sbjct: 409 RKSFRDEANSDHAPLPSHHSAN---FP---QREKN---TFGMEEDDSYKFVSV 452

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388501664|gb|AFK38898.1| unknown [Medicago truncatula]

 Score =  473 bits (1218), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 233/349 (66%), Positives = 282/349 (80%), Gaps = 9/349 (2%)

Query: 32  QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLL 91
           Q  T NF+FEEIYK+T  FS  N+IGEGG GTVY+GKL DG+IVAVKRA+K    +  L 
Sbjct: 47  QLGTGNFTFEEIYKSTAKFSQDNQIGEGGFGTVYRGKLNDGTIVAVKRAKKEAL-QSHLY 105

Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL 151
           EFKNEI T SKIEHLNLV+L+G+LEHGDE++I+VEYVGNG LREHLDG  G+GLE+ ERL
Sbjct: 106 EFKNEIYTLSKIEHLNLVRLYGYLEHGDEKLIIVEYVGNGNLREHLDGIRGDGLEIGERL 165

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
           DIAID+AHA+TYLH Y+D PIIHRD+KASNILI+E LRAKV DFGFAR+SE D   +HIS
Sbjct: 166 DIAIDIAHAITYLHMYTDNPIIHRDIKASNILISENLRAKVADFGFARLSE-DPGATHIS 224

Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ 271
           TQVKGTAGY DP+YLRTYQLTEKSDVYSFGVLLVEMMTGR+P+E KK I ERVTIRWAM+
Sbjct: 225 TQVKGTAGYTDPEYLRTYQLTEKSDVYSFGVLLVEMMTGRHPVEPKKKIDERVTIRWAMK 284

Query: 272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
            LK G+A+  MDPRLRR+PAS   V+K+  LA  CLAP+  SRP MK CAE+LW IRKDF
Sbjct: 285 MLKNGEAVFAMDPRLRRSPASIKVVKKVFKLAFQCLAPSIHSRPPMKNCAEVLWGIRKDF 344

Query: 332 REKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
           +++   +    + P+  SE+ +P    ++K++HI+FG ++ DSYKF+SA
Sbjct: 345 KDE---TTPLPTLPSHQSEN-FP---QREKNKHITFGIEDDDSYKFSSA 386

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356539551|ref|XP_003538261.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At4g00330-like [Glycine max]

 Score =  472 bits (1215), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 230/357 (64%), Positives = 281/357 (78%), Gaps = 9/357 (2%)

Query: 24  SSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKN 83
           +SS   S +    NF+FEEIYKAT  FS  NKIGEG  GTVYKGKL DG++VAVKRA+K+
Sbjct: 105 ASSGTASSKLGMGNFTFEEIYKATAKFSLENKIGEGAFGTVYKGKLNDGTLVAVKRAKKD 164

Query: 84  KHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN 143
             +K L  EFKNEI T SKIEH+NLV+ +G+LEHG E+IIVVEY+ NGTLREHLDG  G+
Sbjct: 165 LLNKNLA-EFKNEINTLSKIEHINLVRWYGYLEHGHEKIIVVEYISNGTLREHLDGIRGD 223

Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
           GLE+ ERLDIAID+AHA+TYLH Y+D PIIHRDVKASNILIT+KLRAKV DFGFAR+  E
Sbjct: 224 GLEIGERLDIAIDIAHAITYLHMYTDHPIIHRDVKASNILITDKLRAKVADFGFARLGPE 283

Query: 204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER 263
           D   +HISTQ+KGTAGY+DPDY+RT  L+EKSDVYSFGVLLVEMMTGRYP+E ++P  ER
Sbjct: 284 DPGATHISTQIKGTAGYMDPDYMRTRHLSEKSDVYSFGVLLVEMMTGRYPVEPQRPPNER 343

Query: 264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEI 323
           VTI+WAMQ L+  + ++ MDPRLRR P SN AV+K+L LA  CLAP R+SRP+MK CAE+
Sbjct: 344 VTIKWAMQLLRQKEVVIAMDPRLRRNPTSNKAVQKVLKLAFQCLAPVRRSRPSMKSCAEV 403

Query: 324 LWKIRKDFREKAPSSFSSSSSPASASESHYPIGDAKKKSRHISFGNDEGDSYKFTSA 380
           LW+IRKDF+EKA      S  P  +++  +P  DA +K+RH ++G ++   YKF  A
Sbjct: 404 LWEIRKDFKEKA-----FSHPPHHSAD--FPQRDA-RKNRHKTYGIEDSKGYKFVFA 452

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
TAIR|locus:2154563	470	CRCK1 "calmodulin-binding rece	0.778	0.629	0.689	2.4e-108
TAIR|locus:2126011	411	CRCK2 "calmodulin-binding rece	0.778	0.720	0.635	4.9e-101
TAIR|locus:2041735	510	CRCK3 "calmodulin-binding rece	0.773	0.576	0.523	2.2e-80
TAIR|locus:2156992	946	AT5G49770 [Arabidopsis thalian	0.752	0.302	0.431	3.5e-57
TAIR|locus:2157002	857	AT5G49780 [Arabidopsis thalian	0.731	0.324	0.438	8.5e-57
TAIR|locus:2157042	953	AT5G49760 [Arabidopsis thalian	0.726	0.289	0.439	1.7e-56
TAIR|locus:2019863	971	AT1G79620 [Arabidopsis thalian	0.723	0.283	0.449	3.1e-56
UNIPROTKB|O24585	901	CR4 "Putative receptor protein	0.742	0.312	0.422	2.4e-55
TAIR|locus:2084425	639	AT3G53840 [Arabidopsis thalian	0.736	0.438	0.445	3.7e-55
TAIR|locus:2008565	929	AT1G67720 [Arabidopsis thalian	0.710	0.290	0.440	1.1e-54

TAIR|locus:2154563 CRCK1 "calmodulin-binding receptor-like cytoplasmic kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
 Identities = 204/296 (68%), Positives = 246/296 (83%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             FSF E+ +AT NFS  ++IGEGG GTV+KGKL DG+IVA+KRARKN + K  LLEFKNEI
Sbjct:   135 FSFGELQRATANFSSVHQIGEGGFGTVFKGKLDDGTIVAIKRARKNNYGKSWLLEFKNEI 194

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
              T SKIEH+NLVKL+GFLEHGDE++IVVEYV NG LREHLDG  GN LE+AERL+IAIDV
Sbjct:   195 YTLSKIEHMNLVKLYGFLEHGDEKVIVVEYVANGNLREHLDGLRGNRLEMAERLEIAIDV 254

Query:   158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
             AHALTYLHTY+D PIIHRD+KASNILIT KLRAKV DFGFAR+  ED   +HISTQVKG+
Sbjct:   255 AHALTYLHTYTDSPIIHRDIKASNILITNKLRAKVADFGFARLVSEDLGATHISTQVKGS 314

Query:   218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
             AGY+DPDYLRT+QLT+KSDVYSFGVLLVE++TGR PIE K+P K+R+T++WA++ LK  +
Sbjct:   315 AGYVDPDYLRTFQLTDKSDVYSFGVLLVEILTGRRPIELKRPRKDRLTVKWALRRLKDDE 374

Query:   278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE 333
             A+L+MDP L+R  A+    EK+L LA  C+ PTR +RP MK  AE LW IR++ +E
Sbjct:   375 AVLIMDPFLKRNRAAIEVAEKMLRLASECVTPTRATRPAMKGIAEKLWAIRREMKE 430

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=IDA

GO:0005516 "calmodulin binding" evidence=IDA

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0042542 "response to hydrogen peroxide" evidence=IEP

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2126011 CRCK2 "calmodulin-binding receptor-like cytoplasmic kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 190/299 (63%), Positives = 243/299 (81%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD--KCLLLEFKN 95
             F+F+EIY AT+NFSP+ +IG+GG GTVYK KL+DG   AVKRA+K+ HD  +    EF +
Sbjct:   107 FTFDEIYDATKNFSPSFRIGQGGFGTVYKVKLRDGKTFAVKRAKKSMHDDRQGADAEFMS 166

Query:    96 EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
             EI T +++ HL+LVK +GF+ H DE+I+VVEYV NGTLR+HLD + G  L++A RLDIA 
Sbjct:   167 EIQTLAQVTHLSLVKYYGFVVHNDEKILVVEYVANGTLRDHLDCKEGKTLDMATRLDIAT 226

Query:   156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE-DSAVSHISTQV 214
             DVAHA+TYLH Y+ PPIIHRD+K+SNIL+TE  RAKV DFGFAR++ + DS  +H+STQV
Sbjct:   227 DVAHAITYLHMYTQPPIIHRDIKSSNILLTENYRAKVADFGFARLAPDTDSGATHVSTQV 286

Query:   215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
             KGTAGYLDP+YL TYQLTEKSDVYSFGVLLVE++TGR PIE  +  KER+TIRWA++   
Sbjct:   287 KGTAGYLDPEYLTTYQLTEKSDVYSFGVLLVELLTGRRPIELSRGQKERITIRWAIKKFT 346

Query:   275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE 333
             +GD I V+DP+L +  A+N+A+EK+L +A  CLAP R+SRP+MKKC+EILW IRKD+RE
Sbjct:   347 SGDTISVLDPKLEQNSANNLALEKVLEMAFQCLAPHRRSRPSMKKCSEILWGIRKDYRE 405

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

TAIR|locus:2041735 CRCK3 "calmodulin-binding receptor-like cytoplasmic kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 807 (289.1 bits), Expect = 2.2e-80, P = 2.2e-80
 Identities = 155/296 (52%), Positives = 207/296 (69%)

Query:    36 INFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKN 95
             +N +  +I  AT NF+ +++IGEGG G V+KG L DG +VA+KRA+K +H + L  EFK+
Sbjct:   211 LNLTMSQINTATGNFADSHQIGEGGFGVVFKGVLDDGQVVAIKRAKK-EHFENLRTEFKS 269

Query:    96 EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
             E+   SKI H NLVKL G+++ GDER+I+ EYV NGTLR+HLDG  G  L   +RL+I I
Sbjct:   270 EVDLLSKIGHRNLVKLLGYVDKGDERLIITEYVRNGTLRDHLDGARGTKLNFNQRLEIVI 329

Query:   156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
             DV H LTYLH+Y++  IIHRD+K+SNIL+T+ +RAKV DFGFAR    DS  +HI TQVK
Sbjct:   330 DVCHGLTYLHSYAERQIIHRDIKSSNILLTDSMRAKVADFGFARGGPTDSNQTHILTQVK 389

Query:   216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA 275
             GT GYLDP+Y++TY LT KSDVYSFG+LLVE++TGR P+E+K+   ER+T+RWA      
Sbjct:   390 GTVGYLDPEYMKTYHLTAKSDVYSFGILLVEILTGRRPVEAKRLPDERITVRWAFDKYNE 449

Query:   276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
             G    ++DP  R        + K+  LA  C APT++ RP M+   + LW IR  +
Sbjct:   450 GRVFELVDPNARER-VDEKILRKMFSLAFQCAAPTKKERPDMEAVGKQLWAIRSSY 504

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)]

 Score = 594 (214.2 bits), Expect = 3.5e-57, P = 3.5e-57
 Identities = 125/290 (43%), Positives = 179/290 (61%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             F+FEE+ K T NFS AN +G GG G VYKG L +G ++A+KRA++         EFK EI
Sbjct:   622 FTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAF--EFKTEI 679

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                S++ H N+VKL GF     E+++V EY+ NG+LR+ L G+ G  L+   RL IA+  
Sbjct:   680 ELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGS 739

Query:   158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
                L YLH  +DPPIIHRDVK++NIL+ E L AKV DFG +++   D   +H++TQVKGT
Sbjct:   740 GKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVG-DPEKAHVTTQVKGT 798

Query:   218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
              GYLDP+Y  T QLTEKSDVY FGV+++E++TG+ PI+    + + V  +   +     D
Sbjct:   799 MGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMD-KSRNLYD 857

Query:   278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
                ++D  + +   +    EK + +A  C+ P   +RPTM +  + L  I
Sbjct:   858 LQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELESI 907

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 8.5e-57, P = 8.5e-57
 Identities = 124/283 (43%), Positives = 177/283 (62%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             F+FEE+ K   NFS AN +G GG G VYKG L  G ++A+KRA+       L  EFK EI
Sbjct:   522 FTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGAL--EFKTEI 579

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                S++ H N+VKL GF     E+++V EY+ NG+LR+ L G+ G  L+   RL IA+  
Sbjct:   580 ELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIALGS 639

Query:   158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
                L YLH  +DPPIIHRDVK+SN+L+ E L AKV DFG +++ E D+  ++++ QVKGT
Sbjct:   640 GKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQLVE-DAEKANVTAQVKGT 698

Query:   218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
              GYLDP+Y  T QLTEKSDVY FGV+++E++TG+ PIE+ K + + + ++   +     D
Sbjct:   699 MGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMN-KSKNLYD 757

Query:   278 AILVMDPRLRRTPASNM-AVEKILGLADVCLAPTRQSRPTMKK 319
                 +D  +  T   N+   EK + +A  C+ P    RP+M +
Sbjct:   758 LQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNE 800

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)]

 Score = 588 (212.0 bits), Expect = 1.7e-56, P = 1.7e-56
 Identities = 123/280 (43%), Positives = 177/280 (63%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             F+FEE+ K T+NFS AN +G GG G VY+G L +G ++A+KRA++      L  EFK EI
Sbjct:   619 FTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRAQQGSLQGGL--EFKTEI 676

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                S++ H N+V+L GF    +E+++V EY+ NG+L++ L G+ G  L+   RL IA+  
Sbjct:   677 ELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSGIRLDWTRRLKIALGS 736

Query:   158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
                L YLH  +DPPIIHRD+K++NIL+ E L AKV DFG +++   D   +H++TQVKGT
Sbjct:   737 GKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVG-DPEKTHVTTQVKGT 795

Query:   218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
              GYLDP+Y  T QLTEKSDVY FGV+L+E++TGR PIE  K +   V  +   +     D
Sbjct:   796 MGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVREVKTKMN-KSRSLYD 854

Query:   278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM 317
                ++D  +  +  +    EK + LA  C+     +RP+M
Sbjct:   855 LQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSM 894

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0044242 "cellular lipid catabolic process" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)]

 Score = 586 (211.3 bits), Expect = 3.1e-56, P = 3.1e-56
 Identities = 128/285 (44%), Positives = 179/285 (62%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             FS+EE+ K T NFS ++++G GG G VYKG L+DG +VA+KRA++      L  EFK EI
Sbjct:   626 FSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQGSTQGGL--EFKTEI 683

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                S++ H NLV L GF     E+I+V EY+ NG+L++ L GR G  L+   RL +A+  
Sbjct:   684 ELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGITLDWKRRLRVALGS 743

Query:   158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
             A  L YLH  +DPPIIHRDVK++NIL+ E L AKV DFG +++   D    H+STQVKGT
Sbjct:   744 ARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS-DCTKGHVSTQVKGT 802

Query:   218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
              GYLDP+Y  T +LTEKSDVYSFGV+++E++T + PIE  K I   + +   M   K+ D
Sbjct:   803 LGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIKL--VMN--KSDD 858

Query:   278 AILVMDPRLRRTPASNMAVEKI---LGLADVCLAPTRQSRPTMKK 319
                 +  ++ R+      + ++   + LA  C+  T   RPTM +
Sbjct:   859 DFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADERPTMSE 903

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0042546 "cell wall biogenesis" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)]

 Score = 576 (207.8 bits), Expect = 2.4e-55, P = 2.4e-55
 Identities = 123/291 (42%), Positives = 183/291 (62%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             FS+EE+ +AT  FS  +++G+G    V+KG L+DG++VAVKRA K    K    EF NE+
Sbjct:   493 FSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNEL 552

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN---GLELAERLDIA 154
                S++ H +L+ L G+ E G ER++V E++ +G+L +HL G+  N    L  A R+ IA
Sbjct:   553 DLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIA 612

Query:   155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             +  A  + YLH Y+ PP+IHRD+K+SNILI E   A+V DFG + +   DS    +S   
Sbjct:   613 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTP-LSELP 671

Query:   215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
              GT GYLDP+Y R + LT KSDVYSFGV+L+E+++GR  I+ +   +E   + WA+  +K
Sbjct:   672 AGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQ--FEEGNIVEWAVPLIK 729

Query:   275 AGDAILVMDPRLRRTPASNM-AVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
             AGD   ++DP L  +P S++ A++KI  +A  C+    + RP+M K    L
Sbjct:   730 AGDIFAILDPVL--SPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTAL 778

GO:0042803 "protein homodimerization activity" evidence=IDA

TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)]

 Score = 569 (205.4 bits), Expect = 3.7e-55, P = 3.7e-55
 Identities = 131/294 (44%), Positives = 184/294 (62%)

Query:    38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
             F+ +EI KAT+NF+ +N +G GG G V+KG L DG+ VAVKRA+   ++K +  +  NE+
Sbjct:   342 FTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLG-NEKSIY-QIVNEV 399

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG------LELAERL 151
                 ++ H NLVKL G     +  ++V E+V NGTL EH+ G GG G      L L  RL
Sbjct:   400 QILCQVSHKNLVKLLGCCIELEMPVLVYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRRL 459

Query:   152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
              IA   A  L YLH+ S PPI HRDVK+SNIL+ E L  KV DFG +R+   D  VSH++
Sbjct:   460 MIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSD--VSHVT 517

Query:   212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ 271
             T  +GT GYLDP+Y   +QLT+KSDVYSFGV+L E++T +  I+  +  ++   + +  +
Sbjct:   518 TCAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRK 577

Query:   272 CLKAGDAILVMDPRLRRTPASNMAVE--KILG-LADVCLAPTRQSRPTMKKCAE 322
              LK G  + V+DP +    A+   +E  K LG LA++C+  TRQ RPTM+  A+
Sbjct:   578 ALKEGRLMDVIDPVIG-IGATEKEIESMKALGVLAELCVKETRQCRPTMQVAAK 630

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)]

 Score = 571 (206.1 bits), Expect = 1.1e-54, P = 1.1e-54
 Identities = 126/286 (44%), Positives = 179/286 (62%)

Query:    39 SFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVK-RARKNKHDKCLLLEFKNEI 97
             S   + +AT+NFS   K+G G  G+VY G++KDG  VAVK  A  + H   L  +F  E+
Sbjct:   597 SLPVLEEATDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKITADPSSH---LNRQFVTEV 651

Query:    98 LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAID 156
                S+I H NLV L G+ E  D RI+V EY+ NG+L +HL G      L+   RL IA D
Sbjct:   652 ALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQD 711

Query:   157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
              A  L YLHT  +P IIHRDVK+SNIL+   +RAKV+DFG +R +EED  ++H+S+  KG
Sbjct:   712 AAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEED--LTHVSSVAKG 769

Query:   217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG 276
             T GYLDP+Y  + QLTEKSDVYSFGV+L E+++G+ P+ ++    E   + WA   ++ G
Sbjct:   770 TVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKG 829

Query:   277 DAILVMDPRLRRTPASNMAVEKILGLADV---CLAPTRQSRPTMKK 319
             D   ++DP +    ASN+ +E +  +A+V   C+     +RP M++
Sbjct:   830 DVCGIIDPCI----ASNVKIESVWRVAEVANQCVEQRGHNRPRMQE 871

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FIL7	CRCK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.6763	0.8131	0.6574	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00024165001 SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (374 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	380
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-38
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-28
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-24
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-23
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-23
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	6e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-20
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-19
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-19
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	9e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-04

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  167 bits (426), Expect = 9e-50
 Identities = 87/278 (31%), Positives = 131/278 (47%), Gaps = 33/278 (11%)

Query: 55  KIGEGGSGTVYKGKLKDGSI-----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           K+GEG  G VYKG LK         VAVK  +++  ++  + EF  E     K++H N+V
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ-QIEEFLREARIMRKLDHPNIV 64

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           KL G     +  +IV+EY+  G L ++L       L L++ L  A+ +A  + YL     
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLR 227
              IHRD+ A N L+ E L  K++DFG +R   +D        +  ++  A    P+ L+
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA----PESLK 177

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
             + T KSDV+SFGVLL E+ T G  P       +        ++ LK G        RL
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------VLEYLKKGY-------RL 223

Query: 287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            + P +     ++  L   C A   + RPT  +  EIL
Sbjct: 224 PK-PPN--CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (423), Expect = 2e-49
 Identities = 88/278 (31%), Positives = 130/278 (46%), Gaps = 34/278 (12%)

Query: 55  KIGEGGSGTVYKGKLKDGSI-----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           K+GEG  G VYKGKLK         VAVK  +++  ++  + EF  E     K++H N+V
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ-QIEEFLREARIMRKLDHPNVV 64

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           KL G     +   IV+EY+  G L  +L       L L++ L  A+ +A  + YL     
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLE---S 120

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLR 227
              IHRD+ A N L+ E L  K++DFG +R   +D        +  ++  A    P+ L+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMA----PESLK 176

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
             + T KSDV+SFGVLL E+ T G  P       +        ++ LK G        RL
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLEYLKNGY-------RL 222

Query: 287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            + P +     ++  L   C A   + RPT  +  EIL
Sbjct: 223 PQ-PPN--CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  164 bits (417), Expect = 5e-49
 Identities = 69/195 (35%), Positives = 101/195 (51%), Gaps = 11/195 (5%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +GEGG GTVY  +  K G  VA+K  +K      LL E   EI    K+ H N+VKL+G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGV 59

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E  +   +V+EY   G+L++ L       L   E L I + +   L YLH+     IIH
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115

Query: 175 RDVKASNILITEK-LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-LT 232
           RD+K  NIL+     + K+ DFG +++   D     +   + GT  Y+ P+ L      +
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD---KSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 233 EKSDVYSFGVLLVEM 247
           EKSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (411), Expect = 2e-47
 Identities = 87/279 (31%), Positives = 128/279 (45%), Gaps = 35/279 (12%)

Query: 55  KIGEGGSGTVYKGKLKDGS-----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           K+GEG  G VYKG LK         VAVK  ++   ++    EF  E     K+ H N+V
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE-EREEFLEEASIMKKLSHPNIV 64

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L G    G+   IV EY+  G L + L   G   L L + L +A+ +A  + YL     
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE---S 120

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ--VKGTAGYLDPDYL 226
              +HRD+ A N L+TE L  K++DFG +R + E+D        +  +K  A    P+ L
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA----PESL 176

Query: 227 RTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           +  + T KSDV+SFGVLL E+ T G  P       +        ++ L+ G        R
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDG-------YR 222

Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           L R       + +++     C A   + RPT  +  E L
Sbjct: 223 LPRPENCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (410), Expect = 2e-47
 Identities = 70/201 (34%), Positives = 102/201 (50%), Gaps = 11/201 (5%)

Query: 54  NKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            K+GEG  G VY  + K  G +VA+K  +K K  K        EI    K++H N+V+L+
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRLY 63

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
              E  D+  +V+EY   G L + L  RG   L   E       +  AL YLH+     I
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSKG---I 118

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+K  NIL+ E    K+ DFG AR  +       ++T V GT  Y+ P+ L      
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPG---EKLTTFV-GTPEYMAPEVLLGKGYG 174

Query: 233 EKSDVYSFGVLLVEMMTGRYP 253
           +  D++S GV+L E++TG+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (408), Expect = 3e-47
 Identities = 88/273 (32%), Positives = 121/273 (44%), Gaps = 26/273 (9%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           K+G G  GTVYK K K  G IVAVK  +K           + EI    ++ H N+V+L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
             E  D   +V+EY   G L ++L    G  L   E   IA+ +   L YLH+     II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNG---II 120

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-T 232
           HRD+K  NIL+ E    K+ DFG A+   +    S   T   GT  Y+ P+ L       
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLK---SSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR-TPA 291
            K DV+S GV+L E++TG+ P   +  + +   IR             ++ P L    P 
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR------------RILGPPLEFDEPK 225

Query: 292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            +   E+   L   CL      RPT     EIL
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPT---AEEIL 255

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (397), Expect = 2e-45
 Identities = 71/215 (33%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
            K+GEG  G VYKGKLK        VAVK   K    +    +F  E     K+ H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGR-------GGNGLELAERLDIAIDVAHALT 162
           +L G     +   +V+EY+  G L ++L            + L L + L  AI +A  + 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ--VKGTAG 219
           YL        +HRD+ A N L+ E L  K++DFG +R + ++D        +  ++  A 
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA- 175

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
              P+ L+    T KSDV+SFGVLL E+ T G  P
Sbjct: 176 ---PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  139 bits (353), Expect = 4e-39
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)

Query: 54  NKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +G G  G+VY    KD G ++AVK    +   +  L   + EI   S ++H N+V+ +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 113 GFLEHGDERI--IVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYS 168
           G     ++    I +EYV  G+L   L   G     L E +       +   L YLH+  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAYLHSNG 121

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
              I+HRD+K +NIL+      K+ DFG A+    D      +  V+GT  ++ P+ +R 
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYP 253
            +    +D++S G  ++EM TG+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (350), Expect = 1e-38
 Identities = 70/223 (31%), Positives = 113/223 (50%), Gaps = 21/223 (9%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR-KNKHDKCLLLEFKNEILTWSKIEHLN 107
           F    KIG+GG G VYK +  + G  VA+K  + ++K  K  ++   NEI    K +H N
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---NEIQILKKCKHPN 58

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA---IDVAHALTYL 164
           +VK +G     DE  IV+E+   G+L++ L         L E   IA    ++   L YL
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ---TLTES-QIAYVCKELLKGLEYL 114

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDP 223
           H+     IIHRD+KA+NIL+T     K+ DFG + ++S+  +  + +     GT  ++ P
Sbjct: 115 HSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAP 166

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI 266
           + +       K+D++S G+  +E+  G+ P     P+K    I
Sbjct: 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 2e-36
 Identities = 78/220 (35%), Positives = 115/220 (52%), Gaps = 16/220 (7%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V  G  + G  VAVK     K D      F  E    + + H NLV+L G +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVK---CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
             G+   IV EY+  G+L ++L  RG   + LA++L  A+DV   + YL   +    +HR
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126

Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+ A N+L++E L AKV+DFG A+ + +      +   VK TA    P+ LR  + + KS
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP--VKWTA----PEALREKKFSTKS 180

Query: 236 DVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           DV+SFG+LL E+ + GR  YP    K +   V   + M+ 
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA 220

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 4e-35
 Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 15/209 (7%)

Query: 49  NFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+   + IG G  G VYKG  L+ G  VA+K+    K  +  L     EI     ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA---HALTYL 164
           +VK  G +E  D   I++EY  NG+LR+ +   G       E L +A+ V      L YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESL-VAVYVYQVLQGLAYL 115

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H      +IHRD+KA+NIL T+    K+ DFG A      + VS     V GT  ++ P+
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPYWMAPE 169

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
            +     +  SD++S G  ++E++TG  P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  127 bits (321), Expect = 2e-34
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 9/209 (4%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            +IG+G  G VY  +   DG +  +K    +   +    +  NE+    K+ H N++K +
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDP 170
              E   +  IV+EY   G L + +  +   G    E   LD  + +  AL YLH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SR 122

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            I+HRD+K  NI +T     K+ DFG +++      ++   T V GT  YL P+  +   
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVV-GTPYYLSPELCQNKP 179

Query: 231 LTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
              KSD++S G +L E+ T ++P E +  
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  122 bits (309), Expect = 1e-32
 Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 11/210 (5%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E F+   K+G G  G V++G  K+   VA+K  + +  D     +F+ E+    ++ H +
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKH 63

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           L+ LF     G+   I+ E +  G+L   L    G  L +A  +D+A  VA  + YL   
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE-- 121

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST-QVKGTAGYLDPDYL 226
            +   IHRD+ A NIL+ E L  KV DFG AR+ +ED  +S       K TA    P+  
Sbjct: 122 -EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTA----PEAA 176

Query: 227 RTYQLTEKSDVYSFGVLLVEMMT-GRYPIE 255
                + KSDV+SFG+LL EM T G+ P  
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 3e-32
 Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 13/202 (6%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G G  G V+ G     + VAVK  +         L+   E     K+ H  LV+L+  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ---EAQIMKKLRHDKLVQLYAV 69

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
               +   IV EY+  G+L + L    G  L L + +D+A  +A  + YL + +    IH
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD+ A NIL+ E L  K+ DFG AR+ E+D   +    +  +K TA    P+     + T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFT 182

Query: 233 EKSDVYSFGVLLVEMMT-GRYP 253
            KSDV+SFG+LL E++T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 87/318 (27%), Positives = 129/318 (40%), Gaps = 20/318 (6%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKI-EHLNLVKLF 112
           K+GEG  G VY  + +   +VA+K   K    K   +E F  EI   + +    N+VKL+
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDVAHALTYLHTYSDPP 171
            F +      +V+EYV  G+L + L   G  G L  +E L I   +  AL YLH+     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 172 IIHRDVKASNILITEKL-RAKVTDFGFARMSEEDSAVSHISTQVK---GTAGYLDPDYLR 227
           IIHRD+K  NIL+       K+ DFG A++  +  + S I        GT GY+ P+ L 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 228 TYQL---TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
              L   +  SD++S G+ L E++TG  P E +K              L+     L    
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL--KIILELPTPSLASPL 239

Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSS 344
                   + A   +L      LA   ++R +               +E   S       
Sbjct: 240 SPSNPELISKAASDLL---KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDD 296

Query: 345 PASASESHYPIGDAKKKS 362
            A    S  P  +A   S
Sbjct: 297 SAPLRLSLPPSLEALISS 314

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 1e-30
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G G  G V++G   + + VAVK  +    D     +F  E     K+ H  L++L+  
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAV 69

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL--HTYSDPPI 172
               +   IV E +  G+L E+L G  G  L+L + +D+A  VA  + YL    Y     
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY----- 124

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N+L+ E    KV DFG AR+ +ED   +    +  +K TA    P+     +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA----PEAALYNR 180

Query: 231 LTEKSDVYSFGVLLVEMMT-GRYP 253
            + KSDV+SFG+LL E++T GR P
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (292), Expect = 6e-30
 Identities = 79/260 (30%), Positives = 127/260 (48%), Gaps = 31/260 (11%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E +    KIGEG SG VYK      G  VA+K+ R  K +K L+    NEIL     +H
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKH 74

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALT 162
            N+V  +     GDE  +V+EY+  G+L + +     N + + E   IA    +V   L 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEP-QIAYVCREVLQGLE 130

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYL 221
           YLH+     +IHRD+K+ NIL+++    K+ DFGF A++++E    S  ++ V GT  ++
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE---KSKRNSVV-GTPYWM 183

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR------------WA 269
            P+ ++      K D++S G++ +EM  G  P   + P++    I             W+
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS 243

Query: 270 MQCLKAGDAILVMDPRLRRT 289
            +     +  LV DP  R +
Sbjct: 244 PEFKDFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 2e-29
 Identities = 75/226 (33%), Positives = 112/226 (49%), Gaps = 19/226 (8%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           KIG+G  G VYKG LK  + VAVK  R       L  +F  E     + +H N+VKL G 
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD-LKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   IV+E V  G+L   L  +  N L + + L +++D A  + YL + +    IH
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ-----VKGTAGYLDPDYLRTY 229
           RD+ A N L+ E    K++DFG +R  EE+  +  +S       +K TA    P+ L   
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTA----PEALNYG 170

Query: 230 QLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVTIRWAMQC 272
           + T +SDV+S+G+LL E  +     YP  S +  +ER+   + M  
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  112 bits (282), Expect = 8e-29
 Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 29/256 (11%)

Query: 49  NFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKC----LLLEFKNEILTWSKI 103
           +F     IG+G  G V   + +D   + A+K   K K  +      +L   NE     ++
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQEL 57

Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H  LV L+   +  +   +VV+ +  G LR HL  +     E   +  I  ++  AL Y
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWIC-EIVLALEY 115

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           LH+     IIHRD+K  NIL+ E+    +TDF  A     D+    ++T   GT GY+ P
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----LTTSTSGTPGYMAP 168

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGR--YPIESKKPIKERVTIR----------WAMQ 271
           + L     +   D +S GV   E + G+  Y   S+    +    +          W+ +
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTE 228

Query: 272 CLKAGDAILVMDPRLR 287
            + A + +L  DP+ R
Sbjct: 229 AIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  112 bits (282), Expect = 9e-29
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)

Query: 54  NKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           NKIG G  G VY    L  G ++AVK  R   +D   + E  +E+     ++H NLVK +
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G   H ++  I +EY   GTL E L    G  L+        + +   L YLH++    I
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG---YLDPDYLRTY 229
           +HRD+K +NI +      K+ DFG A   + ++       +V+  AG   Y+ P+ +   
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGG 178

Query: 230 QLTEK---SDVYSFGVLLVEMMTGRYP 253
           +       +D++S G +++EM TG+ P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  110 bits (278), Expect = 3e-28
 Identities = 68/209 (32%), Positives = 101/209 (48%), Gaps = 17/209 (8%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
            +G+G SG VYK + K  G I A+K+       +  K LL     E+ T    E   +VK
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL----RELKTLRSCESPYVVK 63

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSD 169
            +G      E  IV+EY+  G+L + L   G      LA    IA  +   L YLHT   
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHTKRH 120

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRD+K SN+LI  K   K+ DFG +++ E      +  T V GT  Y+ P+ ++  
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGE 175

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
             +  +D++S G+ L+E   G++P     
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPG 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  109 bits (274), Expect = 7e-28
 Identities = 81/222 (36%), Positives = 117/222 (52%), Gaps = 22/222 (9%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE--FKNEILTWSKIEHLNLVKLF 112
            IGEG  G V +G+   G  VAVK        KC +    F  E    +K+ H NLV+L 
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNI------KCDVTAQAFLEETAVMTKLHHKNLVRLL 65

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G + H +   IV+E +  G L   L  RG   + + + L  ++DVA  + YL +     +
Sbjct: 66  GVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKL 121

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A NIL++E   AKV+DFG AR+      V +    VK TA    P+ L+  + +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWTA----PEALKHKKFS 175

Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQ 271
            KSDV+S+GVLL E+ + GR  YP  S K +KE V   + M+
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME 217

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  108 bits (272), Expect = 3e-27
 Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 26/288 (9%)

Query: 54  NKIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++GEG  G V   +        G  VAVK    +  ++    +F+ EI     ++H N+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ-HRSDFEREIEILRTLDHENI 68

Query: 109 VKLFGFLE--HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G  E   G    +++EY+ +G+LR++L       + L   L  +  +   + YL +
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYLGS 127

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+ A NIL+  +   K++DFG A++  ED    ++    +    +  P+ L
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM---- 282
           RT + +  SDV+SFGV L E+ T  Y   S+ P  E       +   +    +  +    
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT--YGDPSQSPPAE---FLRMIGIAQGQMIVTRLLELL 239

Query: 283 --DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
               RL R P+    V  ++ L   C     Q RP+      I+ ++R
Sbjct: 240 KEGERLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (270), Expect = 5e-27
 Identities = 77/271 (28%), Positives = 122/271 (45%), Gaps = 29/271 (10%)

Query: 54  NKIGEGGSGTVYKGKLK-DGSIVAVKRAR---KNKHDKCLLLEFKNEILTWSKIEHLNLV 109
            ++G G SG V K   +  G I+AVK  R        K +L E    IL   K     +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD--IL--HKCNSPYIV 62

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLD-GRGGNGLELAERLDIAIDVAHALTYLHTYS 168
             +G   +  +  I +EY+  G+L + L   +G     +  +  IA+ V   LTYLH   
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
              IIHRDVK SNIL+  + + K+ DFG +       A + +     GT+ Y+ P+ ++ 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQG 173

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR 288
              + KSD++S G+ L+E+ TGR+P            I   +Q +          PRL  
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPY--PPENDPPDGIFELLQYIVNEPP-----PRLPS 226

Query: 289 TPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
              S    + +    ++CL    + RP+ K+
Sbjct: 227 GKFSPDFQDFV----NLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  106 bits (265), Expect = 2e-26
 Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 54  NKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K     VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 125

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 181

Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 9e-26
 Identities = 72/210 (34%), Positives = 104/210 (49%), Gaps = 18/210 (8%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNK-HDKCLLLEFKNE--ILTWSKIEHLNLVKL 111
           +G+G  G V   + KD G + A+K  +K K   +  +     E  IL  S+I H  +VKL
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNIL--SRINHPFIVKL 58

Query: 112 -FGFLEHGDERIIVV-EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            + F    +E++ +V EY   G L  HL   G    E A R   A ++  AL YLH+   
Sbjct: 59  HYAF--QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-RFYAA-EIVLALEYLHSLG- 113

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  NIL+      K+TDFG A+    +   S  +T   GT  YL P+ L   
Sbjct: 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC-GTPEYLAPEVLLGK 168

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
              +  D +S GVLL EM+TG+ P  ++  
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (261), Expect = 1e-25
 Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 43/235 (18%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRA------RKNKHDKCLLLEFKNEILTW 100
           ++F     IGEG   TV   K K      A+K        ++ K         K E    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK-----YVKIEKEVL 55

Query: 101 SKIE-HLNLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLD--IAI 155
           +++  H  ++KL+  F    +E +  V+EY  NG L +++   G     L E+     A 
Sbjct: 56  TRLNGHPGIIKLYYTF--QDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAA 109

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM--------SEEDSAV 207
           ++  AL YLH+     IIHRD+K  NIL+ + +  K+TDFG A++        S +  A 
Sbjct: 110 EILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 208 SHISTQVK---------GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           +  S   K         GTA Y+ P+ L      + SD+++ G ++ +M+TG+ P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  103 bits (259), Expect = 1e-25
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      K+G G  G V+ G     + VA+K  ++        L   N +    +++H  
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLM---KQLQHPR 62

Query: 108 LVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           LV+L+  +    E I I+ EY+ NG+L + L    G  L + + +D+A  +A  + ++  
Sbjct: 63  LVRLYAVVTQ--EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER 120

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPD 224
            +    IHRD++A+NIL++E L  K+ DFG AR+ E++   +    +  +K TA    P+
Sbjct: 121 KN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PE 173

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            +     T KSDV+SFG+LL E++T GR P
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (252), Expect = 9e-25
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 69

Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 70  VS--EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 124

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 180

Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (251), Expect = 1e-24
 Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 26/269 (9%)

Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +F   NKIG+G  G V+K   K D  + A+K+   +K ++    E  +E    +K++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 108 LVKLF-GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           +++ +  FL+ G +  IV+EY  NG L + L  + G  L   +     I +   L +LH+
Sbjct: 61  IIRYYESFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                I+HRD+K+ N+ +      K+ D G A++    S  ++ +  + GT  YL P+  
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
                 EKSDV++ GV+L E  TG++P ++     +   I   +              R 
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALILKII--------------RG 216

Query: 287 RRTPASNMAVEKILGLADVCLAPTRQSRP 315
              P S M  +++  L D CL    + RP
Sbjct: 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  101 bits (254), Expect = 3e-24
 Identities = 75/248 (30%), Positives = 113/248 (45%), Gaps = 38/248 (15%)

Query: 18  SSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVA 76
           SS S  SSSS  SG A +   S  E+ +        N+IG G  GTVYK   +  G + A
Sbjct: 51  SSSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYA 103

Query: 77  VKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREH 136
           +K    N H+  +  +   EI     + H N+VK     +H  E  +++E++  G+L   
Sbjct: 104 LKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT 162

Query: 137 LDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG 196
                 +   LA   D+A  +   + YLH      I+HRD+K SN+LI      K+ DFG
Sbjct: 163 ---HIADEQFLA---DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFG 213

Query: 197 FAR-----MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE------KSDVYSFGVLLV 245
            +R     M   +S+V        GT  Y+ P+ + T  L          D++S GV ++
Sbjct: 214 VSRILAQTMDPCNSSV--------GTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSIL 264

Query: 246 EMMTGRYP 253
           E   GR+P
Sbjct: 265 EFYLGRFP 272

Length = 353

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 99.7 bits (248), Expect = 4e-24
 Identities = 75/233 (32%), Positives = 118/233 (50%), Gaps = 18/233 (7%)

Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
             E+     K+G G  G V+ G     + VAVK  +         LE   E     K+ H
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRH 60

Query: 106 LNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
             LV+L+  +   +E I IV EY+  G+L + L    G  L+L   +D+A  VA  + Y+
Sbjct: 61  DKLVQLYAVVS--EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLD 222
              +    IHRD++++NIL+ + L  K+ DFG AR+ E++   +    +  +K TA    
Sbjct: 119 ERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA---- 171

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           P+     + T KSDV+SFG+LL E++T GR  YP  + + + E+V   + M C
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 35/230 (15%)

Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKN 95
           EI  +   F     +GEG  G VYKG+L         + VA+K  ++N  +  +  EF+ 
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQ 57

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRG 141
           E    S ++H N+V L G         ++ EY+ +G L E L              D   
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117

Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
            + L+ ++ L IAI +A  + YL   S    +HRD+ A N L+ E L  K++DFG +R  
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR-- 172

Query: 202 EEDSAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEM 247
                 S    +V+  +     ++ P+ +   + T +SD++SFGV+L E+
Sbjct: 173 ---DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 14/204 (6%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E     K+ H  LV+L+G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   IV EY+ NG L  +L    G   + ++ L++  DV   + YL +      IH
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIH 123

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD+ A N L+ ++   KV+DFG +R   +D   S + ++  V+ +     P+ L   + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLLYSKFS 179

Query: 233 EKSDVYSFGVLLVEMMT-GRYPIE 255
            KSDV++FGVL+ E+ + G+ P E
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 13/209 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     K+G G  G V+ G   + + VAVK  +         LE  N + T   ++H  
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKT---LQHDK 62

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+  G+L + L    G  + L + +D +  +A  + Y+   
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+N+L++E L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 123 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEA 175

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T G+ P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 97.7 bits (243), Expect = 2e-23
 Identities = 78/223 (34%), Positives = 117/223 (52%), Gaps = 22/223 (9%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V  G  + G+ VAVK     K+D      F  E    +++ H NLV+L G +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI---KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVI 68

Query: 116 -EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E      IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL   +    +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST-QVKGTAGYLDPDYLRTYQLTE 233
           RD+ A N+L++E   AKV+DFG   +++E S+        VK TA    P+ LR  + + 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTA----PEALREKKFST 178

Query: 234 KSDVYSFGVLLVEMMT-GRYPIESKKPIKE---RVTIRWAMQC 272
           KSDV+SFG+LL E+ + GR P   + P+K+   RV   + M  
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEKGYKMDA 220

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 3e-23
 Identities = 79/291 (27%), Positives = 118/291 (40%), Gaps = 36/291 (12%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
            +GEG  G V K + K  G IVA+K+   +  ++  K   L    E+    ++ H N+V 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L           +V EYV   TL E L+     GL           +  A+ Y H+++  
Sbjct: 65  LKEAFRRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            IIHRD+K  NIL++E    K+ DFGFAR      A S ++  V  T  Y  P+ L    
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYV-ATRWYRAPELLVGDT 177

Query: 231 LTEKS-DVYSFGVLLVEMMTGR--YPIESK-----------KPIKERVTIRWAMQCLKAG 276
              K  DV++ G ++ E++ G   +P +S             P+       ++     AG
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 277 DA---ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            A       +   RR P         L     CL    + R T   C E+L
Sbjct: 238 VAFPEPSQPESLERRYP--GKVSSPALDFLKACLRMDPKERLT---CDELL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 97.1 bits (242), Expect = 5e-23
 Identities = 67/222 (30%), Positives = 116/222 (52%), Gaps = 14/222 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
                  KIGEG +G V        G  VAVK+    K  +  LL F NE++     +H 
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-F-NEVVIMRDYQHP 76

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V+++     GDE  +V+E++  G L + +     N  ++A    + + V  AL++LH 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLAVLKALSFLHA 133

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                +IHRD+K+ +IL+T   R K++DFGF A++S+E   V    + V GT  ++ P+ 
Sbjct: 134 QG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLV-GTPYWMAPEV 186

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
           +       + D++S G++++EM+ G  P  ++ P++    IR
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 96.3 bits (239), Expect = 6e-23
 Identities = 72/224 (32%), Positives = 117/224 (52%), Gaps = 18/224 (8%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV L+  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ---EAQIMKKLRHDKLVPLYAV 69

Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV E++G G+L + L    G  L+L + +D+A  +A  + Y+   +    I
Sbjct: 70  VS--EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YI 124

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ + L  K+ DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 180

Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E++T GR  YP    + + E+V   + M C
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 97.0 bits (241), Expect = 7e-23
 Identities = 84/277 (30%), Positives = 139/277 (50%), Gaps = 30/277 (10%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    +K  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 84

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQG---VI 138

Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E   V    + V GT  ++ P+ +      
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---VPRRKSLV-GTPYWMAPELISRLPYG 194

Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR----------WAMQCLKAG--DAIL 280
            + D++S G++++EM+ G  P  ++ P+K    IR            +     G  D +L
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254

Query: 281 VMDPRLRRTPASNMAVEKILGLAD--VCLAP-TRQSR 314
           V DP  R T A+ +     L  A    C+ P  RQ+R
Sbjct: 255 VRDPAQRAT-AAELLKHPFLAKAGPPSCIVPLMRQNR 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 9e-23
 Identities = 70/204 (34%), Positives = 98/204 (48%), Gaps = 10/204 (4%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G G  G V+ GK +    VA+K  R+    +    +F  E     K+ H NLV+L+G  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
                  IV EY+ NG L  +L  R G  L     LD+  DV  A+ YL +      IHR
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+ A N L+ E    KV+DFG AR   +D   S  S   K    +  P+     + + KS
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS--SQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 236 DVYSFGVLLVEMMT-GRYPIESKK 258
           DV+SFGVL+ E+ + G+ P E   
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 89/291 (30%), Positives = 122/291 (41%), Gaps = 48/291 (16%)

Query: 56  IGEGGSGTVYKGKLKD------GSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +G G  G VY+G   D      G I VAVK  RK   D+    EF  E    S   H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDG-----RGGNGLELAERLDIAIDVAHALTY 163
           VKL G     + + I++E +  G L  +L        G   L L E LDI +DVA    Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRA-----KVTDFGFARMSEEDSAVSHISTQVKGT- 217
           L        IHRD+ A N L++EK        K+ DFG AR             + +G  
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEGEG 173

Query: 218 ---AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCL 273
                ++ P+ L   + T +SDV+SFGVL+ E++T G+ P  +    +        +Q +
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHV 226

Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            AG           R        +KI  L   C A     RPT  +  EIL
Sbjct: 227 TAGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 94.2 bits (234), Expect = 3e-22
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 12/205 (5%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+G 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPPII 173
                   +V E++ +G L ++L  R   G    E L  + +DV   + YL + +   +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + + 
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS--STGTKFPVKWSSPEVFSFSKYSS 180

Query: 234 KSDVYSFGVLLVEMMT-GRYPIESK 257
           KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENR 205

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.8 bits (233), Expect = 5e-22
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKR-------ARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           IG G  G+VY G     G ++AVK+       A      + +L     EI    +++H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +V+  G     D   I +EYV  G++   L+  G    E     +    +   L YLH  
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ---VKGTAGYLDPD 224
               IIHRD+K +NIL+  K   K++DFG ++  E +S  +  +     ++G+  ++ P+
Sbjct: 126 G---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
            ++    T K+D++S G L+VEM+TG++P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.8 bits (233), Expect = 9e-22
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 14/209 (6%)

Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G SGTVY    +  G  VA+K+    +  K  L+   NEIL   + +H N+V    
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI--INEILVMRENKHPNIVNYLD 83

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+EY+  G+L    D      ++  +   +  +   AL +LH+     +I
Sbjct: 84  SYLVGDELWVVMEYLAGGSLT---DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VI 137

Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ NIL+      K+TDFGF A+++ E S     ST V GT  ++ P+ +      
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMV-GTPYWMAPEVVTRKAYG 193

Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            K D++S G++ +EM+ G  P  ++ P++
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 20/220 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK---RARKNKHDKCLLLEFKNEILTWSKI 103
           E     +++GEG  G+V K +LK+ G I A+K           K +L E   EI      
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILREL--EIN--KSC 56

Query: 104 EHLNLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAH 159
           +   +VK +G FL+     I I +EY   G+L          G  + E+    IA  V  
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L+YLH+     IIHRD+K SNIL+T K + K+ DFG   +S E   V+ ++    GT+ 
Sbjct: 117 GLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG---VSGE--LVNSLAGTFTGTSF 168

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
           Y+ P+ ++    +  SDV+S G+ L+E+   R+P   +  
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 32/221 (14%)

Query: 56  IGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +GEG  G V+ G+        D  +VAVK   K         +F+ E    +  +H N+V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVK-TLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRG-------GNG-----LELAERLDIAIDV 157
           K +G    GD  I+V EY+ +G L + L   G               L L++ L IA+ +
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           A  + YL   +    +HRD+   N L+   L  K+ DFG +R        +    +V G 
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVGGH 183

Query: 218 A----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
                 ++ P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 72/281 (25%), Positives = 132/281 (46%), Gaps = 39/281 (13%)

Query: 56  IGEGGSGTVYKGKLKDG--SIVAVKRA-------RKNKHDKCLLLE-FKNEI-LTWSKIE 104
           +G G  G VYK + K+   +++A+K          K+K ++   +    +E+ +   ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREH---LDGRGGNGLELAERL-DIAIDVAHA 160
           H N+V+ +      D   IV++ +    L EH   L  +     E  ER+ +I + +  A
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE--ERIWNIFVQMVLA 125

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L YLH   +  I+HRD+  +NI++ E  +  +TDFG A+  + +S +    T V GT  Y
Sbjct: 126 LRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL----TSVVGTILY 179

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL 280
             P+ ++     EK+DV++FG +L +M T + P  S         +  A + ++A     
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVEA----- 228

Query: 281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA 321
           V +P         M  E +  +   CL P  ++RP + + +
Sbjct: 229 VYEPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 65/220 (29%), Positives = 101/220 (45%), Gaps = 24/220 (10%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKC--LLLEFKNEILTWSKIEHLNLVK 110
             IG G +  VY    L +   VA+KR      +KC   + E + E+   S+  H N+VK
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 111 LFG-FLEHGDERIIVVEYVGNGTLRE---HLDGRGGNGLELAERLDIAI---DVAHALTY 163
            +  F+  GDE  +V+ Y+  G+L +       RGG      +   IA    +V   L Y
Sbjct: 64  YYTSFVV-GDELWLVMPYLSGGSLLDIMKSSYPRGGL-----DEAIIATVLKEVLKGLEY 117

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS-TQVKGTAGYLD 222
           LH+      IHRD+KA NIL+ E    K+ DFG +    +    +        GT  ++ 
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 223 PDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           P+ +        K+D++SFG+  +E+ TG  P     P+K
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 28/207 (13%)

Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V +G+LK        VA+K  +    DK   L+F  E     + +H N+++L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK-QRLDFLTEASIMGQFDHPNIIRL 70

Query: 112 FGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
            G +      +I+ EY+ NG+L    RE+ DG+      + + + +   +A  + YL   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKFLREN-DGK----FTVGQLVGMLRGIASGMKYL--- 122

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ-----VKGTAGYLD 222
           S+   +HRD+ A NIL+   L  KV+DFG +R  E+  A    +T+     ++ TA    
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT--YTTKGGKIPIRWTA---- 176

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           P+ +   + T  SDV+SFG+++ E+M+
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 10/220 (4%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G+G  G V+KG LKD + VAVK  +++   + L ++F +E     + +H N+VKL G  
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE-LKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
                  IV+E V  G     L  +  + L+  + +  A+D A  + YL + +    IHR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+ A N L+ E    K++DFG +R  +ED  +   S   +    +  P+ L   + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 236 DVYSFGVLLVEMMT---GRYPIESKKPIKERVTIRWAMQC 272
           DV+S+G+LL E  +     YP  + +  +E+V   + M C
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC 215

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 68/220 (30%), Positives = 95/220 (43%), Gaps = 36/220 (16%)

Query: 56  IGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNL 108
           +GEG  G V K +          S VAVK  + +  +K  L +  +E+     I +H N+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNI 78

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI--------------A 154
           + L G         +VVEY  +G LR+ L  R   G   +                   A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             VA  + +L   +    IHRD+ A N+L+TE    K+ DFG AR       + HI    
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------DIHHIDYYR 189

Query: 215 KGTAGYLD-----PDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           K T G L      P+ L     T +SDV+SFGVLL E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 91.4 bits (227), Expect = 5e-21
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 36/283 (12%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
            N      +G G  G V+  K K        ++V VK  +K K D+ L  EF+ E+  + 
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFR 63

Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-------DGRGGNGLELAERLDIA 154
           K+ H N+V+L G     +   +++EY   G L++ L       +      L   +++ + 
Sbjct: 64  KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             +A  + +L        +HRD+ A N L++ +   KV+    ++           +  +
Sbjct: 124 TQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180

Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCL 273
                +L P+ ++    + KSDV+SFGVL+ E+ T G  P          ++    +  L
Sbjct: 181 P--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-------LSDEEVLNRL 231

Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT 316
           +AG         L           ++  L   C A   + RP+
Sbjct: 232 QAGK--------LELPVPEGCP-SRLYKLMTRCWAVNPKDRPS 265

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.0 bits (226), Expect = 5e-21
 Identities = 59/227 (25%), Positives = 110/227 (48%), Gaps = 14/227 (6%)

Query: 49  NFSPANKIGEG--GSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ++ P   +G+G  G  T+Y+ + +D S+V  K     +  +    +  NEI+  S ++H 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N++  +      +  +I +EY   GTL + +  + G   E    L     +  A++Y+H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDY 225
                I+HRD+K  NI +T+    K+ DFG ++ +  E    S   T V GT  Y+ P+ 
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE---YSMAETVV-GTPYYMSPEL 172

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC 272
            +  +   KSD+++ G +L E++T +   ++  P+   V I   +Q 
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI---VQG 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 91.6 bits (227), Expect = 6e-21
 Identities = 72/255 (28%), Positives = 127/255 (49%), Gaps = 20/255 (7%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V     K  G  VAVK+    K  +  LL   NE++      H N+V ++ 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHENVVDMYN 86

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+YLH      +I
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG---VI 140

Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK----RKSLVGTPYWMAPEVISRLPYG 196

Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM----QCLKAGDAIL--VMDPRL 286
            + D++S G++++EM+ G  P  ++ P++    IR  +    +      ++L   +D  L
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256

Query: 287 RRTPASNMAVEKILG 301
            R P+     +++L 
Sbjct: 257 VREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 6e-21
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRA------RKNKHDKCLLLEFKNEILTWS 101
           +F    K+G+G  G+VYK K L D    A+K        +K + D        NEI   +
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV------NEIRILA 54

Query: 102 KIEHLNLVKLF-GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVA 158
            + H N++     FL+ G++  IV+EY   G L + +  R      + E+    I I + 
Sbjct: 55  SVNHPNIISYKEAFLD-GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
             L  LH   +  I+HRD+K++NIL+      K+ D G +++ +++ A     TQ+ GT 
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA----KTQI-GTP 165

Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
            Y+ P+  +    + KSD++S G LL EM T   P E++
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 89.6 bits (222), Expect = 1e-20
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 8/210 (3%)

Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            +    KIGEG  G +Y  K K D     +K     K         K E++  +K++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +V  F   +      IV+EY   G L + ++ + G      + L   + ++  L ++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH-- 118

Query: 168 SDPPIIHRDVKASNILITEK-LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
            D  I+HRD+K+ NI +++  + AK+ DFG AR   +   +++      GT  YL P+  
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV---GTPYYLSPEIC 174

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           +      K+D++S G +L E+ T ++P E 
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 90.2 bits (223), Expect = 2e-20
 Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 14/216 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + ++   KIG+G SGTV+    +  G  VA+K+    K  K  L+   NEIL   ++++ 
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI--INEILVMKELKNP 76

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V        GDE  +V+EY+  G+L    D      ++ A+   +  +   AL +LH 
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLT---DVVTETCMDEAQIAAVCRECLQALEFLHA 133

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                +IHRD+K+ N+L+      K+TDFGF A+++ E S  S +     GT  ++ P+ 
Sbjct: 134 NQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 186

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           +       K D++S G++ +EM+ G  P  ++ P++
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.0 bits (231), Expect = 2e-20
 Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 31/292 (10%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           N I  G  G  YKGK     +  V +   N  +        +EI    K++H N+VKL G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVK-EINDVNSIPS----SEIADMGKLQHPNIVKLIG 750

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
                    ++ EY+    L E L       L    R  IAI +A AL +LH    P ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
             ++    I+I         D    R+S          T+   ++ Y+ P+   T  +TE
Sbjct: 806 VGNLSPEKIII------DGKDEPHLRLSLPGLLC--TDTKCFISSAYVAPETRETKDITE 857

Query: 234 KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           KSD+Y FG++L+E++TG+ P +++  +   + + WA  C       + +DP +R   + N
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHGSI-VEWARYCYSDCHLDMWIDPSIRGDVSVN 916

Query: 294 M-AVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSS 344
              + +++ LA  C A    +RP    CA        D  +   S+  SSSS
Sbjct: 917 QNEIVEVMNLALHCTATDPTARP----CA-------NDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 44/259 (16%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           K+GEG  G+VYK   K+ G +VA+K     +     L E   EI    + +   +VK +G
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYG 65

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHTYSDP 170
                 +  IV+EY G G++ + +         L E  +IA         L YLH+    
Sbjct: 66  SYFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEE-EIAAILYQTLKGLEYLHSNK-- 119

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
             IHRD+KA NIL+ E+ +AK+ DFG +    +  A  +    V GT  ++ P+ ++   
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN---TVIGTPFWMAPEVIQEIG 175

Query: 231 LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI------------RWA-------MQ 271
              K+D++S G+  +EM  G+ P     P++    I            +W+        +
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235

Query: 272 CLKAGDAILVMDPRLRRTP 290
           C       LV DP  R + 
Sbjct: 236 C-------LVKDPEERPSA 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 68/233 (29%), Positives = 112/233 (48%), Gaps = 20/233 (8%)

Query: 56  IGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V++G LK        VA+K  +    +K    +F +E     +  H N+++L
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-QRQDFLSEASIMGQFSHHNIIRL 71

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGG--NGLELAERLDIAIDVAHALTYLHTYSD 169
            G +      +I+ EY+ NG L ++L    G  +  +L   L     +A  + YL   SD
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---SD 125

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ ++  K    +  P+ +   
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYPI------ESKKPIKERVTIRWAMQCLKA 275
           + T  SDV+SFG+++ E+M+ G  P       E  K I +   +   M C  A
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSA 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +IGEG  G V+K K  + G  VA+K+    + +  +  +   EI      +H  +VKL  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
              HG   ++V+EY+    L E L       L  A+       +   + Y+H      I+
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121

Query: 174 HRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQVKGTAGYLDPDYL---RT 228
           HRD+K +N+LI+     K+ DFG AR+   EE    SH   QV  T  Y  P+ L   R 
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH---QV-ATRWYRAPELLYGARK 177

Query: 229 YQLTEKSDVYSFGVLLVEMMTGR 251
           Y      D+++ G +  E++ G 
Sbjct: 178 Y--DPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 87.6 bits (217), Expect = 7e-20
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 10/204 (4%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V+ GK +    VA+K   +    +    +F  E     K+ H  LV+L+G 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE---EDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   IV E++ NG L  +L  R G  L     L +  DV   + YL   S    IH
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNS---FIH 123

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L++     KV+DFG  R   +D   S  S+  K    +  P+     + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS--SSGAKFPVKWSPPEVFNFSKYSSK 181

Query: 235 SDVYSFGVLLVEMMT-GRYPIESK 257
           SDV+SFGVL+ E+ T G+ P E K
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 16/214 (7%)

Query: 54  NKIGEGGSGTVYKGKLK-DGSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             IG+G  GTV K + K DG I+  K        + +K  L+   +E+    +++H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62

Query: 110 KLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLH 165
           + +   ++  ++ + IV+EY   G L + +         + E     I   +  AL   H
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
             +     ++HRD+K +NI +      K+ DFG A++   DS+ +   T V GT  Y+ P
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK--TYV-GTPYYMSP 179

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + L      EKSD++S G L+ E+     P  ++
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 88.4 bits (220), Expect = 8e-20
 Identities = 64/219 (29%), Positives = 94/219 (42%), Gaps = 35/219 (15%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFK------NEILTWSKIEHLNL 108
           +G G  G V   + K  G   A+K   K K     +++ K      NE      I H  L
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAK-----IVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI------AIDVAHALT 162
           V L+G  +      +V+EYV  G L  HL   G        R         A  V  AL 
Sbjct: 64  VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--------RFPEPVARFYAAQVVLALE 115

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH+     I++RD+K  N+L+      K+TDFGFA+  +         T + GT  YL 
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYT-LCGTPEYLA 166

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           P+ + +    +  D ++ G+L+ EM+ G  P     PI+
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 87.0 bits (215), Expect = 1e-19
 Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 15/197 (7%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI----EHLNLV 109
           +IG G  G V+ G+L+ D + VAVK  R+      L  + K + L  ++I     H N+V
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRET-----LPPDLKAKFLQEARILKQYSHPNIV 56

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L G         IV+E V  G     L   G   L++ E + +  + A  + YL +   
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKH- 114

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N L+TEK   K++DFG +R  EED   +      +    +  P+ L   
Sbjct: 115 --CIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 230 QLTEKSDVYSFGVLLVE 246
           + + +SDV+SFG+LL E
Sbjct: 172 RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 16/207 (7%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRA---RKNKHDKCLLLE-FKNEILTWSKIEHLNLVK 110
           +G G   + Y+ + +K G+++AVK+    R    ++  ++E  + EI   +++ H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA--IDVAHALTYLHTYS 168
           + G         + VE++  G++   L   G       E + I     +   L+YLH   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA----FKEAVIINYTEQLLRGLSYLH--- 120

Query: 169 DPPIIHRDVKASNILI-TEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +  IIHRDVK +N+LI +   R ++ DFG A R++ + +       Q+ GT  ++ P+ L
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           R  Q     DV+S G +++EM T + P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 12/214 (5%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V   + K  G  VAVK     K  +  LL   NE++     +H N+V+++ 
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHQNVVEMYK 85

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               G+E  +++E++  G L + +     N  ++A    +   V  AL YLH+     +I
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT---VCESVLQALCYLHSQG---VI 139

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+K+ +IL+T   R K++DFGF     +D  V    + V GT  ++ P+ +       
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLV-GTPYWMAPEVISRTPYGT 196

Query: 234 KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
           + D++S G++++EM+ G  P  S  P++    +R
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 79/274 (28%), Positives = 114/274 (41%), Gaps = 40/274 (14%)

Query: 55  KIGEGGSGTVYKGKLKDGSI----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           K+G+G  G V +G+          VAVK  + +K    +  +F  E      ++H NL++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIR 60

Query: 111 LFGF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           L+G  L H    ++V E    G+L + L         ++   D A+ +A+ + YL +   
Sbjct: 61  LYGVVLTH--PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR- 117

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVSHISTQVKGTAGYLDPDYLR 227
              IHRD+ A NIL+    + K+ DFG  R     ED  V      +K    +  P+ LR
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM--EEHLKVPFAWCAPESLR 173

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWA----MQCLKAGDAILVM 282
           T   +  SDV+ FGV L EM T G  P              WA     Q LK  D     
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP--------------WAGLSGSQILKKIDKEG-- 217

Query: 283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT 316
             RL R  A     + I  +   C A     RPT
Sbjct: 218 -ERLERPEACP---QDIYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 87.1 bits (215), Expect = 2e-19
 Identities = 64/216 (29%), Positives = 113/216 (52%), Gaps = 14/216 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + ++   KIG+G SGTVY    +  G  VA+K+    +  K  L+   NEIL   + ++ 
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI--INEILVMRENKNP 76

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V        GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALDFLHS 133

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                +IHRD+K+ NIL+      K+TDFGF A+++ E S  S +     GT  ++ P+ 
Sbjct: 134 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 186

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           +       K D++S G++ +EM+ G  P  ++ P++
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.1 bits (215), Expect = 2e-19
 Identities = 63/216 (29%), Positives = 113/216 (52%), Gaps = 14/216 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + ++   KIG+G SGTVY    +  G  VA+++    +  K  L+   NEIL   + ++ 
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNP 77

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V        GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHS 134

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                +IHRD+K+ NIL+      K+TDFGF A+++ E S  S     + GT  ++ P+ 
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----TMVGTPYWMAPEV 187

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           +       K D++S G++ +EM+ G  P  ++ P++
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 14/202 (6%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G G  G V+       + VAVK  +         L   N +     ++H  LVKL   
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM---KTLQHDKLVKLHAV 69

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   I+ E++  G+L + L    G+   L + +D +  +A  + ++   +    IH
Sbjct: 70  VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL++  L  K+ DFG AR+ E++   +    +  +K TA    P+ +     T
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFT 181

Query: 233 EKSDVYSFGVLLVEMMT-GRYP 253
            KSDV+SFG+LL+E++T GR P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 35/216 (16%)

Query: 56  IGEGGSGTVYKGKLKD------GSIVAVK--RARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +G+G  G VY+G  K        + VA+K      +  ++   +EF NE     +    +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER---IEFLNEASVMKEFNCHH 70

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGR--------GGNGLELAERLDIAIDVAH 159
           +V+L G +  G   ++V+E +  G L+ +L  R        G     L + + +A ++A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTA 218
            + YL        +HRD+ A N ++ E L  K+ DFG  R + E D          KG  
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD-------YYRKGGK 180

Query: 219 GYL-----DPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           G L      P+ L+    T KSDV+SFGV+L EM T
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 17/209 (8%)

Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKR----ARKNKHDKCLLLE----FKNEILTWSKIEHL 106
           IG+G  G VY    +  G ++AVK+    A           +     ++EI T   ++HL
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V+  GF    +   I +EYV  G++   L   G    +L         V   L YLH+
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQVLEGLAYLHS 126

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                I+HRD+KA N+L+      K++DFG ++ S +D   +  +  ++G+  ++ P+ +
Sbjct: 127 KG---ILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 227 RTYQ--LTEKSDVYSFGVLLVEMMTGRYP 253
            +Y    + K D++S G +++EM  GR P
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 7e-19
 Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 46/289 (15%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARK---NKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +G G  GTVYKG    +G  V +  A K    +       E  +E    + ++H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 112 FGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
            G +    +  ++ + +  G L    R H D  G   L     L+  + +A  ++YL   
Sbjct: 75  LG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYL-----LNWCVQIAKGMSYL--- 125

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLD 222
            +  ++HRD+ A N+L+      K+TDFG A++ + D        +     G     ++ 
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD------EKEYHAEGGKVPIKWMA 179

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV 281
            + +     T KSDV+S+GV + E+MT G  P E   P  E          L+ G+    
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAVE------IPDLLEKGE---- 228

Query: 282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              RL + P   + V  +L     C     +SRPT K+      K+ +D
Sbjct: 229 ---RLPQPPICTIDVYMVL---VKCWMIDAESRPTFKELINEFSKMARD 271

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.9 bits (213), Expect = 8e-19
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 42/222 (18%)

Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            F   N+IGEG  G VY+ +    G IVA+K+ R +     + +    EI     + H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 108 LVKLFGFL--EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------------- 152
           +V+L   +  +H D   +V+EY       E          +LA  LD             
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYC------EQ---------DLASLLDNMPTPFSESQVKC 112

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           + + +   L YLH   +  IIHRD+K SN+L+T+K   K+ DFG AR          ++ 
Sbjct: 113 LMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG--LPAKPMTP 167

Query: 213 QVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
           +V  T  Y  P+ L    TY  T   D+++ G +L E++  +
Sbjct: 168 KVV-TLWYRAPELLLGCTTY--TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.8 bits (211), Expect = 1e-18
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDK-----CLLLEFKNEILTWSKI 103
           +    K+GEG  G VYK +  K G IVA+K+ R +  ++      L      EI    ++
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-----REISLLKEL 55

Query: 104 EHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H N+VKL   + H + ++ +V EY     L+++LD R G  L       I   +   L 
Sbjct: 56  KHPNIVKLLDVI-HTERKLYLVFEYCDM-DLKKYLDKRPG-PLSPNLIKSIMYQLLRGLA 112

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           Y H++    I+HRD+K  NILI      K+ DFG AR       +   + +V  T  Y  
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG--IPLRTYTHEVV-TLWYRA 166

Query: 223 PDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
           P+ L   + Y      D++S G +  EM+TG+
Sbjct: 167 PEILLGSKHYSTA--VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 29/217 (13%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F    ++G G  G V K   +   ++    ARK  H     LE K    N+I+   K+
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIM---ARKLIH-----LEIKPAIRNQIIRELKV 52

Query: 104 EHL----NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDV 157
            H      +V  +G      E  I +E++  G+L + L   G     + E +   I+I V
Sbjct: 53  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAV 108

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
              LTYL       I+HRDVK SNIL+  +   K+ DFG +    +  A S +     GT
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GT 161

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
             Y+ P+ L+    T +SD++S G+ LVEM  GRYPI
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           I E    ++YKG   +   V ++  +K     K L+   +NEI    +I+  N++K++GF
Sbjct: 28  IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86

Query: 115 -LEHGDE--RIIVV-EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
            ++  D+  R+ ++ EY   G LRE LD      L    +LD+AID    L  L+ Y++ 
Sbjct: 87  IIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY- 229
           P  ++++ + + L+TE  + K+   G      E    S     V     Y     L    
Sbjct: 145 P--YKNLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNFMV-YFSYKMLNDIF 196

Query: 230 -QLTEKSDVYSFGVLLVEMMTGRYPIE 255
            + T K D+YS GV+L E+ TG+ P E
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 9/198 (4%)

Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V  G+LK        VA+K  +    +K    +F +E     + +H N++ L
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNIIHL 70

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G +      +IV EY+ NG+L   L    G    + + + +   +A  + YL   SD  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
            +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ +   K    +  P+ +   + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 232 TEKSDVYSFGVLLVEMMT 249
           T  SDV+S+G+++ E+M+
Sbjct: 187 TSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 22/222 (9%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR------KNKHDKCLLLEFKNEILT 99
             NF    KIG+G    VYK   L DG +VA+K+ +            CL      EI  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCL-----KEIDL 55

Query: 100 WSKIEHLNLVK-LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAID 156
             +++H N++K L  F+E+ +E  IV+E    G L   +         + ER      + 
Sbjct: 56  LKQLDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +  AL ++H+     I+HRD+K +N+ IT     K+ D G  R     +  +H    + G
Sbjct: 115 LCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVG 168

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
           T  Y+ P+ +       KSD++S G LL EM   + P    K
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 42/212 (19%)

Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI----EHLNLVK 110
           +G G  GTVYK   L    I+AVK    +     + +E + +I++  +I    +   ++ 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLD-----ITVELQKQIMSELEILYKCDSPYIIG 63

Query: 111 LFG--FLEHGDERI-IVVEYVGNGTLR------EHLDGRGGNGLELAERLDIAIDVAHAL 161
            +G  F+E+   RI I  E++  G+L       EH+ GR            IA+ V   L
Sbjct: 64  FYGAFFVEN---RISICTEFMDGGSLDVYRKIPEHVLGR------------IAVAVVKGL 108

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
           TYL +     I+HRDVK SN+L+  + + K+ DFG +        V+ I+    GT  Y+
Sbjct: 109 TYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVST-----QLVNSIAKTYVGTNAYM 160

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
            P+ +   Q    SDV+S G+  +E+  GR+P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 83.2 bits (206), Expect = 2e-18
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +G G  G+VY+G  L DG   AVK    A   +  +  + + + EI   SK++H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G     D   I +E V  G+L   L  + G+  E   RL     +   L YLH   D  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRL-YTRQILLGLEYLH---DRN 122

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-RTYQ 230
            +HRD+K +NIL+      K+ DFG A+   E S         KG+  ++ P+ + +   
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK----SFKGSPYWMAPEVIAQQGG 178

Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
               +D++S G  ++EM TG+ P
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFG 113
           IGEG  G VYK +  K G +VA+K       D+    E K E     K   H N+   +G
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDE--EEEIKEEYNILRKYSNHPNIATFYG 70

Query: 114 -FLE-----HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYL 164
            F++     + D+  +V+E  G G++ + + G    G  L E   IA    +    L YL
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYILRETLRGLAYL 129

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP- 223
           H   +  +IHRD+K  NIL+T+    K+ DFG +     DS +   +T + GT  ++ P 
Sbjct: 130 H---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFI-GTPYWMAPE 183

Query: 224 ----DYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
               D         +SDV+S G+  +E+  G+ P
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 23/205 (11%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRAR---KNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +G G  G+V K K +  G+++A K      K+   K +L E   +I+   +  ++  V  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILREL--QIMHECRSPYI--VSF 68

Query: 112 FG-FLEHGDERIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYS 168
           +G FL   +   + +E++  G     LD   + G  + +     IA+ V   LTYL  Y+
Sbjct: 69  YGAFLNENN-ICMCMEFMDCG----SLDRIYKKGGPIPVEILGKIAVAVVEGLTYL--YN 121

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
              I+HRD+K SNIL+  + + K+ DFG   +S E   ++ I+    GT+ Y+ P+ ++ 
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFG---VSGE--LINSIADTFVGTSTYMSPERIQG 176

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYP 253
            + T KSDV+S G+ ++E+  G++P
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 4e-18
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 19/204 (9%)

Query: 54  NKIGEGGSGTVYKG--KLKDGSIVAVK-RARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
            ++G G  G+V KG   +K G  V V  +  K +H      EF  E    ++++H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSD 169
           L G  + G+  ++V+E    G L ++L  R      +L E   +A  VA  + YL +   
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH- 115

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARM----SEEDSAVSHISTQVKGTAGYLDPDY 225
              +HRD+ A N+L+  + +AK++DFG +R     S+   A +     +K  A    P+ 
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA----PEC 169

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT 249
           +   + + KSDV+S+GV L E  +
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)

Query: 48  ENFSPANKIGEGGSGTVYKG---KLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           E+ +    IGEG  G VY+G     ++  I VAVK   KN     +  +F  E     + 
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIMRQF 64

Query: 104 EHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H ++VKL G +   +  + IV+E    G LR +L       L+LA  +  +  ++ AL 
Sbjct: 65  DHPHIVKLIGVIT--ENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALA 121

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YL +      +HRD+ A N+L++     K+ DFG +R  E++S   + +++ K    ++ 
Sbjct: 122 YLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY--YKASKGKLPIKWMA 176

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVE-MMTGRYP 253
           P+ +   + T  SDV+ FGV + E +M G  P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 20/204 (9%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHD---KCLLLEFKNEILTWSKIEHLNLVK 110
           KIGEG  G VYK +    G IVA+K+ +            L    EI    ++ H N++K
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR---EIKLLKELNHPNIIK 62

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI--DVAHALTYLHTYS 168
           L     H  +  +V E++ +  L + +  R      L E L  +    +   L + H++ 
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-R 227
              I+HRD+K  N+LI  +   K+ DFG AR     S V   +  V  T  Y  P+ L  
Sbjct: 119 ---ILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYV-VTRWYRAPELLLG 172

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGR 251
               +   D++S G +  E+++ R
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 11/198 (5%)

Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +G G  G + +G LK  S     VA+   R    DK     F  E LT  + +H N+V+L
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-QRRGFLAEALTLGQFDHSNIVRL 71

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G +  G+  +IV EY+ NG L   L    G  L   + + +   +A  + YL   S+  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEMG 127

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
            +H+ + A  +L+   L  K++  GF R+ E+ S   + +   K    +  P+ ++ +  
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 232 TEKSDVYSFGVLLVEMMT 249
           +  SDV+SFG+++ E+M+
Sbjct: 186 SSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 19/205 (9%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL---NLVKL 111
           IG G  G VY+GK +  G +VA+K    +  D   + + + E+   S++      N+ K 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD-DVSDIQREVALLSQLRQSQPPNITKY 67

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI--DVAHALTYLHTYSD 169
           +G    G    I++EY   G++R  +  + G    +AE+    I  +V  AL Y+H    
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLM--KAG---PIAEKYISVIIREVLVALKYIHK--- 119

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+KA+NIL+T     K+ DFG A  +  +   S  ST V GT  ++ P+ +   
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFV-GTPYWMAPEVITEG 176

Query: 230 QLTE-KSDVYSFGVLLVEMMTGRYP 253
           +  + K+D++S G+ + EM TG  P
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 16/276 (5%)

Query: 56  IGEGGSGTV----YKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +GEG  G V    Y       G +VAVK   K +  +     +K EI     + H N+VK
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVK-TLKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 111 LFGFLEHGDERII--VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
             G       + +  ++EYV  G+LR++L     + L LA+ L  A  +   + YLH+  
Sbjct: 71  YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
               IHRD+ A N+L+      K+ DFG A+   E      +         +   + L+ 
Sbjct: 128 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR 288
            + +  SDV+SFGV L E++T     +S  P K+   +    Q       ++ +  R  R
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQS--PPKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 289 TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            P      +++  L   C     + RPT +    IL
Sbjct: 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 2e-17
 Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 34/251 (13%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-----KCLLLEFKNEILTWSKIEHLNLV 109
           I +G  G+VY  K +  G   A+K  +K+          +  E    I+     E   + 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE--RAIMMIQG-ESPYVA 60

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           KL+   +  D   +V+EY+  G     +   GG   + A++     +V   +  LH    
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---Q 115

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRD+K  N+LI +    K+TDFG +R   E+           GT  YL P+ +   
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILGV 168

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK-----ERVTIRWAMQCLK-----AGDAI 279
              + SD +S G ++ E + G  P  ++ P           I W  +  +     A D I
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228

Query: 280 ---LVMDPRLR 287
              L MDP  R
Sbjct: 229 NRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 12/203 (5%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG  GTV+K K ++   IVA+KR R +  D+ +      EI    +++H N+V+L+ 
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 114 FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
            L H D+++ +V EY  +  L+++ D   G+ ++          +   L + H+++   +
Sbjct: 67  VL-HSDKKLTLVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHN---V 120

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+K  N+LI +    K+ DFG AR       V   S +V  T  Y  PD L   +L 
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177

Query: 233 EKS-DVYSFGVLLVEMMTGRYPI 254
             S D++S G +  E+     P+
Sbjct: 178 STSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE---H 105
           +    +IGEG  GTVYK + L  G  VA+K+ R    ++ + L    EI    ++E   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 106 LNLVKLFG-FLEHGDERII----VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
            N+V+L         +R +    V E+V +  L  +L      GL      D+   +   
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           + +LH++    I+HRD+K  NIL+T   + K+ DFG AR+   + A+    T V  T  Y
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL----TSVVVTLWY 172

Query: 221 LDPDYLRTYQLTEKS--DVYSFGVLLVEM 247
             P+ L   Q +  +  D++S G +  E+
Sbjct: 173 RAPEVL--LQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           NF    K+GEG   TVYKG+ +  G IVA+K    +  +       + EI    +++H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDVAHALTYLHT 166
           +V+L   +   ++ ++V EY+ +  L++++D  G  G L+          +   + + H 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
             +  ++HRD+K  N+LI ++   K+ DFG AR       V+  S +V  T  Y  PD L
Sbjct: 118 --ENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVV-TLWYRAPDVL 172

Query: 227 ---RTYQLTEKSDVYSFGVLLVEMMTGR 251
              RTY  +   D++S G ++ EM+TGR
Sbjct: 173 LGSRTY--STSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 41/226 (18%)

Query: 56  IGEGGSGTVYKG-----KLKDG-SIVAVKRARKNKHD---KCLLLEFKNEILTWSKIEHL 106
           +GEG  G V K      K + G + VAVK  ++N      + LL EF        ++ H 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LLKQVNHP 63

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLD----------GRGGN------------G 144
           +++KL+G        +++VEY   G+LR  L           G  GN             
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEE 203
           L + + +  A  ++  + YL   ++  ++HRD+ A N+L+ E  + K++DFG +R + EE
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           DS V    ++ +    ++  + L  +  T +SDV+SFGVLL E++T
Sbjct: 181 DSYVKR--SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.4 bits (196), Expect = 6e-17
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 35/212 (16%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG+G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 113 G--------------FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
           G              +++HGD R  +     N T+++ +    G GL+          VA
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI----GFGLQ----------VA 108

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGT 217
             + YL   +    +HRD+ A N ++ E    KV DFG AR + +++    H  T  K  
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             ++  + L+T + T KSDV+SFGVLL E+MT
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 78/281 (27%), Positives = 117/281 (41%), Gaps = 54/281 (19%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKN---KHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  GTV K   K  G+I+AVKR R     K  K LL++  + ++  S      +VK 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL-DVVMRSSDCP--YIVKF 68

Query: 112 FGFLEH-GDERIIV-------------VEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
           +G L   GD  I +             V  V    + E + G+            IA+  
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK------------IAVAT 116

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
             AL YL    +  IIHRDVK SNIL+      K+ DFG +    +  A     T+  G 
Sbjct: 117 VKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA----KTRDAGC 170

Query: 218 AGYLDPDYLRTYQLTE---KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
             Y+ P+ +          +SDV+S G+ L E+ TG++P      + +++T     Q +K
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT-----QVVK 225

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP 315
            GD      P L  +     +    +   ++CL      RP
Sbjct: 226 -GDP-----PILSNSEEREFSPS-FVNFINLCLIKDESKRP 259

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.5 bits (196), Expect = 6e-17
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 9/204 (4%)

Query: 55  KIGEG--GSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           KIGEG  G   + K K +DG    +K    +K       E + E+   S ++H N+V+  
Sbjct: 7   KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
              E      IV++Y   G L + ++ + G      + LD  + +  AL ++H   D  I
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKI 122

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+K+ NI +T+    K+ DFG AR+   +S V    T + GT  YL P+        
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCI-GTPYYLSPEICENRPYN 179

Query: 233 EKSDVYSFGVLLVEMMTGRYPIES 256
            KSD+++ G +L EM T ++  E+
Sbjct: 180 NKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 73/254 (28%), Positives = 114/254 (44%), Gaps = 33/254 (12%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   ++    ARK  H     LE K    N+I+   ++
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIM---ARKLIH-----LEIKPAIRNQIIRELQV 56

Query: 104 EHL----NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDV 157
            H      +V  +G      E  I +E++  G+L + L   G     + E++   ++I V
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAV 112

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
              LTYL       I+HRDVK SNIL+  +   K+ DFG +    +  A S +     GT
Sbjct: 113 IKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GT 165

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
             Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GD
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMFGCPVEGD 221

Query: 278 AILVMDPRLRRTPA 291
                     R P 
Sbjct: 222 PAESETSPRPRPPG 235

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 74/289 (25%), Positives = 132/289 (45%), Gaps = 50/289 (17%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           F     +G G  G VYKG+ +K G + A+K     + ++    E K EI    K   H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE---EEIKLEINMLKKYSHHRN 74

Query: 108 LVKLFG-FLE-----HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
           +   +G F++     H D+  +V+E+ G G++ + +    GN L+      I  ++   L
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
            +LH +    +IHRD+K  N+L+TE    K+ DFG +  ++ D  V   +T + GT  ++
Sbjct: 135 AHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWM 188

Query: 222 DPDYL-------RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
            P+ +        TY    +SD++S G+  +EM  G  P+    P++             
Sbjct: 189 APEVIACDENPDATYDY--RSDIWSLGITAIEMAEGAPPLCDMHPMR------------- 233

Query: 275 AGDAILVM----DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
              A+ ++     P+L+    S    +K +   + CL     SRP+ ++
Sbjct: 234 ---ALFLIPRNPPPKLKSKKWS----KKFIDFIEGCLVKNYLSRPSTEQ 275

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 44/227 (19%)

Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVK-------RARKNKHDKCLLLEFKNEILTWS 101
           ++GEG  G V+  +       +D  +VAVK        ARK+ H +  LL         +
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL---------T 62

Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE-----------R 150
            ++H ++VK +G    GD  I+V EY+ +G L + L   G + + +AE            
Sbjct: 63  NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR---MSEEDSAV 207
           L IA  +A  + YL +      +HRD+   N L+ E L  K+ DFG +R    ++     
Sbjct: 123 LHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            H    ++    ++ P+ +   + T +SDV+S GV+L E+ T G+ P
Sbjct: 180 GHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 87/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)

Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 81

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 82  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               VA  + YL   +    IHRD+ A N+L+TE    K+ DFG AR       V++I  
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR------DVNNIDY 192

Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 247

Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 248 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAIPSHRPTFKQLVEDL 293

Query: 325 WKI 327
            +I
Sbjct: 294 DRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 11/203 (5%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRA---RKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +G+G  G VY     D G  +AVK+      +   K  +   + EI     ++H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           +G L   +   I +EY+  G++++ L   G     +  +    I     + YLH+     
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI--LEGVEYLHSNM--- 124

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
           I+HRD+K +NIL       K+ DFG + R+    S+ + + + V GT  ++ P+ +    
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGEG 183

Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
              K+DV+S G  +VEM+T + P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 14/215 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE-----FKNEILTWSKIEHLNL 108
             +G+G  GTVY G    G ++AVK+   +  +  L  E      + E+     ++H+N+
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV-LAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           V+  G     +   I +E+V  G++   L+ R G   E          +   + YLH   
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFC-KYTKQILDGVAYLH--- 119

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFAR---MSEEDSAVSHISTQVKGTAGYLDPDY 225
           +  ++HRD+K +N+++      K+ DFG AR           S++   + GT  ++ P+ 
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI 260
           +       KSD++S G  + EM TG+ P+ S   +
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 25/216 (11%)

Query: 56  IGEGGSGTVYKGKLK--DGSI--VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +GEG  G+V +G+L   DGS   VAVK  + + H    + EF +E       +H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 112 FGFLEHGDER------IIVVEYVGNGTLREHL----DGRGGNGLELAERLDIAIDVAHAL 161
            G              ++++ ++ +G L   L     G     L L   L   +D+A  +
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVSHISTQ-VKGTA 218
            YL   S+   IHRD+ A N ++ E +   V DFG ++   S +      I+   VK  A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             ++    R Y  T KSDV++FGV + E+ T G+ P
Sbjct: 184 --IESLADRVY--TSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 13/207 (6%)

Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           NF    KIGEG  G VYK +    G +VA+K+ R +   + +      EI    ++ H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKL   +   ++  +V E++ +  L++ +D    +G+ L         +   L + H++
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL- 226
               ++HRD+K  N+LI  +   K+ DFG AR       V   + +V  T  Y  P+ L 
Sbjct: 120 R---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVV-TLWYRAPEILL 173

Query: 227 --RTYQLTEKSDVYSFGVLLVEMMTGR 251
             + Y  +   D++S G +  EM+T R
Sbjct: 174 GCKYY--STAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 73/234 (31%), Positives = 103/234 (44%), Gaps = 54/234 (23%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DG-----SIVAVKR-ARKNKHDKCLLLEFKNEILTW 100
           E+    + IGEG  G V +  +K DG     +I  +K  A +N H      +F  E+   
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-----DFAGELEVL 56

Query: 101 SKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTL-----------------REHLDGRGG 142
            K+  H N++ L G  E+     I +EY   G L                 +EH     G
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH-----G 111

Query: 143 NGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM 200
               L  +  L  A DVA  + YL   S+   IHRD+ A N+L+ E L +K+ DFG +R 
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG 168

Query: 201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT 249
            E           VK T G L   ++    L     T KSDV+SFGVLL E+++
Sbjct: 169 EE---------VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 44/221 (19%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEF----KNEILTWSKIEHLNL 108
            +IGEG  G VYK +  K G +VA+K+ R  +++K     F      EI    K+ H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKE---GFPITAIREIKLLQKLRHPNI 60

Query: 109 VKLFGFL-EHGDERIIVV-EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH------- 159
           V+L   +   G   I +V EY+      +H D  G     L +  ++    +        
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYM------DH-DLTG-----LLDSPEVKFTESQIKCYMKQ 108

Query: 160 ---ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
               L YLH+     I+HRD+K SNILI      K+ DFG AR   + ++  + +  +  
Sbjct: 109 LLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-- 163

Query: 217 TAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           T  Y  P+ L     Y    + D++S G +L E+  G+ PI
Sbjct: 164 TLWYRPPELLLGATRY--GPEVDMWSVGCILAELFLGK-PI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 26/224 (11%)

Query: 42  EIYKAT-ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARK--NKHD-KCLLLEFKNE 96
           + Y A   +     +IG G  G VYK +  K G ++AVK+ R+  NK + K +L++   +
Sbjct: 8   QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--D 65

Query: 97  ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIA 154
           ++  S  +   +VK +G+     +  I +E +   T  + L  R    +   E +   + 
Sbjct: 66  VVLKSH-DCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPI--PEDILGKMT 120

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQ 213
           + +  AL YL       +IHRDVK SNIL+      K+ DFG + R+ +     S   T+
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-----SKAKTR 173

Query: 214 VKGTAGYLDPDYLRTYQLTEK----SDVYSFGVLLVEMMTGRYP 253
             G A Y+ P+ +       K    +DV+S G+ LVE+ TG++P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 47/230 (20%)

Query: 55  KIGEGGSGTVYKGK------LKDGSIVAVK-------RARKNKHDKCLLLEFKNEILTWS 101
           ++GEG  G V+  +       KD  +VAVK        ARK         +F+ E    +
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---------DFQREAELLT 62

Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG-------------GNG-LEL 147
            ++H ++VK +G    GD  I+V EY+ +G L + L   G               G L L
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR---MSEED 204
           ++ L IA  +A  + YL +      +HRD+   N L+   L  K+ DFG +R    ++  
Sbjct: 123 SQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
               H    ++    ++ P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 180 RVGGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 11/200 (5%)

Query: 56  IGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V +G+LK        VA+K  +    +K    +F +E     + +H N++ L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNIIHL 70

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G +      +I+ E++ NG L   L    G    + + + +   +A  + YL   S+  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEMN 126

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT--AGYLDPDYLRTY 229
            +HRD+ A NIL+   L  KV+DFG +R  E+D++    ++ + G     +  P+ +   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 230 QLTEKSDVYSFGVLLVEMMT 249
           + T  SDV+S+G+++ E+M+
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 76/285 (26%), Positives = 129/285 (45%), Gaps = 42/285 (14%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           F     +G G  G VYKG+ +K G + A+K       ++    E K EI    K   H N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 64

Query: 108 LVKLFG-FLEHG-----DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
           +   +G F++       D+  +V+E+ G G++ + +    GN L+      I  ++   L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
           ++LH +    +IHRD+K  N+L+TE    K+ DFG +  ++ D  V   +T + GT  ++
Sbjct: 125 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWM 178

Query: 222 DPDYL-------RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
            P+ +        TY    KSD++S G+  +EM  G  P+    P++       A+  + 
Sbjct: 179 APEVIACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIP 229

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
              A     PRL+    S    +K     + CL      RPT ++
Sbjct: 230 RNPA-----PRLKSKKWS----KKFQSFIESCLVKNHSQRPTTEQ 265

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 91/303 (30%), Positives = 127/303 (41%), Gaps = 60/303 (19%)

Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 84

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------ERLDI----- 153
           N++ L G         ++VEY   G LRE+L  R   G+E          E+L       
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 154 -AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL   +    IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 195

Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 250

Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 251 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 296

Query: 325 WKI 327
            +I
Sbjct: 297 DRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 27/221 (12%)

Query: 50  FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE--------FKNEILTW 100
           F+    IG+G  G VYK   K    +VA+K          + LE         + EI   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIK---------VIDLEEAEDEIEDIQQEIQFL 53

Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
           S+     + K +G    G +  I++EY G G+  + L     +   +A    I  +V   
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---ILREVLLG 110

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L YLH       IHRD+KA+NIL++E+   K+ DFG +   +  S +S  +T V GT  +
Sbjct: 111 LEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFV-GTPFW 164

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           + P+ ++     EK+D++S G+  +E+  G  P+    P++
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 21/220 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E F+   +IG+G  G V+KG   +   +VA+K     + +   + + + EI   S+ +  
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSP 62

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            + K +G    G +  I++EY+G G+  + L     +  ++A  L    ++   L YLH+
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHS 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYL 221
                 IHRD+KA+N+L++E+   K+ DFG A    +        TQ+K     GT  ++
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--------TQIKRNTFVGTPFWM 168

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+ ++      K+D++S G+  +E+  G  P     P++
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 69/221 (31%), Positives = 97/221 (43%), Gaps = 44/221 (19%)

Query: 56  IGEGGSGTVYKGKLKDGSI---VAVKR----ARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           IGEG  G V K ++K   +    A+KR    A K+ H      +F  E+    K+  H N
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 69

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLD--------------GRGGNGLELAERLDI 153
           ++ L G  EH     + +EY  +G L + L                   + L   + L  
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           A DVA  + YL   S    IHRD+ A NIL+ E   AK+ DFG +R  E           
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VY 177

Query: 214 VKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT 249
           VK T G L   ++    L     T  SDV+S+GVLL E+++
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 10/198 (5%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            +GEG  G V K K K+ G IVA+K+  +++ DK +      EI    ++ H NLV L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
                    +V E+V + T+ + L+ +  NGL+ +        +   + + H+++   II
Sbjct: 68  VFRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---II 122

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-RTYQLT 232
           HRD+K  NIL+++    K+ DFGFAR     +A   + T    T  Y  P+ L    +  
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTL---AAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 233 EKSDVYSFGVLLVEMMTG 250
              D+++ G L+ EM+TG
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 84/311 (27%), Positives = 122/311 (39%), Gaps = 60/311 (19%)

Query: 48  ENFSPANKIGEGGSGTVYKGKL--------KDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           +       +GEG  G V + +              VAVK  + N  DK L  +  +E+  
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA-DLISEMEL 70

Query: 100 WSKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---------- 148
              I +H N++ L G         ++VEY   G LRE L  R   G +            
Sbjct: 71  MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130

Query: 149 ----ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
               + +  A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR     
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR----- 182

Query: 205 SAVSHISTQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIES 256
             V  I    K + G     ++ P+ L     T +SDV+SFG+L+ E+ T     YP   
Sbjct: 183 -GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-- 239

Query: 257 KKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT 316
             P++E   +      L+ G          R    SN   E +  L   C       RPT
Sbjct: 240 -IPVEELFKL------LREGH---------RMDKPSNCTHE-LYMLMRECWHAVPTQRPT 282

Query: 317 MKKCAEILWKI 327
            K+  E L K+
Sbjct: 283 FKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 77.2 bits (190), Expect = 4e-16
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 56  IGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF-G 113
           +G G  G V+  + K    +V +K+    +  K   L  +NE      + H N+++ +  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           FLE     +IV+EY   GTL E++  R  + L+    L   + +  AL ++HT     I+
Sbjct: 68  FLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---IL 123

Query: 174 HRDVKASNILITE-KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K  NIL+ + K+  K+ DFG   +S+  S+ S   T V GT  Y+ P+        
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFG---ISKILSSKSKAYT-VVGTPCYISPELCEGKPYN 179

Query: 233 EKSDVYSFGVLLVEMMT 249
           +KSD+++ G +L E+ +
Sbjct: 180 QKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 67/243 (27%), Positives = 114/243 (46%), Gaps = 32/243 (13%)

Query: 55  KIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           ++GE   G +YKG L         +VA+K   K+ ++     EF+ E    +++ H N+V
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIK-TLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHL---------------DGRGGNGLELAERLDIA 154
            L G +       ++ EY+  G L E L               DG   + L+  + L IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
           I +A  + YL ++     +H+D+ A NILI E+L  K++D G +R   E  +  +   Q 
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR---EIYSADYYRVQP 184

Query: 215 KG--TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIE--SKKPIKERVTIRWA 269
           K      ++ P+ +   + +  SD++SFGV+L E+ + G  P    S + + E V  R  
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Query: 270 MQC 272
           + C
Sbjct: 245 LPC 247

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.9 bits (192), Expect = 4e-16
 Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVK-----RARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           IG+G  G V   K K DG   AVK        K K  K ++ E +N +L    ++H  LV
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE-RNVLL--KNVKHPFLV 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    +  D+   V++YV  G L  HL  R  +  E   R   A ++A AL YLH+ + 
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHSLN- 116

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  NIL+  +    +TDFG  +   E    S  ++   GT  YL P+ LR  
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESK 257
                 D +  G +L EM+ G  P  S+
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V K + K   ++    ARK  H     LE K    N+I+   ++
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIM---ARKLIH-----LEIKPAIRNQIIRELQV 56

Query: 104 EHL----NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L        E+  ++ IA  V  
Sbjct: 57  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLR 114

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L YL       I+HRDVK SNIL+  +   K+ DFG +    +  A S +     GT  
Sbjct: 115 GLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRS 167

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           Y+ P+ L+    + +SD++S G+ LVE+  GRYPI
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            +IG G  G VYK + +  G +VA+K  +    D       + EI    +  H N+V  F
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKECRHPNIVAYF 66

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHTYSD 169
           G     D+  IV+EY G G+L++      G    L+E   IA    +    L YLH    
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQ-IAYVCRETLKGLAYLHETG- 121

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFG-----FARMSEEDSAVSHISTQVKGTAGYLDPD 224
              IHRD+K +NIL+TE    K+ DFG      A +++  S +        GT  ++ P+
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI--------GTPYWMAPE 171

Query: 225 YL---RTYQLTEKSDVYSFGVLLVEMMTGRYP 253
                R      K D+++ G+  +E+   + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 40/226 (17%)

Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++GEG  G V+  +       +D  +VAVK  ++         + + E+LT   ++H ++
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT--VLQHQHI 69

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-------------LELAERLDIAI 155
           V+ +G    G   ++V EY+ +G L   L   G +              L L + L IA 
Sbjct: 70  VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +A  + YL +      +HRD+   N L+ + L  K+ DFG +R           ST   
Sbjct: 130 QIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR--------DIYSTDYY 178

Query: 216 GTAG-------YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
              G       ++ P+ +   + T +SD++SFGV+L E+ T G+ P
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 18/214 (8%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL-- 106
           + P  +IG G  GTVYK +    G  VA+K  R   ++  L L    E+    ++E    
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 107 -NLVKLFGFLE--HGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
            N+V+L         D      +V E+V +  LR +LD     GL      D+       
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L +LH      I+HRD+K  NIL+T   + K+ DFG AR+     A+    T V  T  Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL----TPVVVTLWY 173

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
             P+ L         D++S G +  EM   R P+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG  G V+K + ++ G IVA+K+  +++ D  +      EI    +++H NLV L  
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
                 +  +V EY  +  L E L+ +   G+       I      A+ + H ++    I
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNE-LE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CI 122

Query: 174 HRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQVKGTAGYLDPDYL-RTYQ 230
           HRDVK  NILIT++ + K+ DFGFAR+     D    +++T+      Y  P+ L    Q
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVGDTQ 177

Query: 231 LTEKSDVYSFGVLLVEMMTG 250
                DV++ G +  E++TG
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 22/284 (7%)

Query: 56  IGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+VK
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--LRDFEREIEILKSLQHDNIVK 69

Query: 111 LFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
             G       R   +V+EY+  G+LR++L  +    L+  + L  A  +   + YL +  
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
               +HRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L  
Sbjct: 129 ---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL-- 286
            + +  SDV+SFGV+L E+ T  Y  +S  P  E + +   M   K G  I+     L  
Sbjct: 186 SKFSVASDVWSFGVVLYELFT--YSDKSCSPPAEFMRM---MGNDKQGQMIVYHLIELLK 240

Query: 287 --RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
              R PA      +I  +   C       RP+  + A  +  IR
Sbjct: 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 75/241 (31%), Positives = 106/241 (43%), Gaps = 30/241 (12%)

Query: 46  ATENFSPANKIGEGGSGTVYKGKL--KDGSIVAVKRARKNKHDKCLL---LEFKNEILTW 100
             ++ +    +G G  G VY+G    +DG  V ++ A K   + C      +F  E L  
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-DGRGGNG----LELAERLDIAI 155
           SK  H N+V+L G       R I++E +  G L+  L + R        L + + L  A 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSHIST 212
           DVA    YL        IHRD+ A N L+T K     AK+ DFG AR       +   S 
Sbjct: 124 DVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR------DIYRASY 174

Query: 213 QVKGTAGYL-----DPDYLRTYQLTEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERV 264
             KG    L      P+       T K+DV+SFGVLL E+ + G   YP  + + + E V
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Query: 265 T 265
           T
Sbjct: 235 T 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 68/258 (26%), Positives = 119/258 (46%), Gaps = 31/258 (12%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E F+   +IG+G  G VYKG   +   +VA+K     + +   + + + EI   S+ +  
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSP 62

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            + + +G    G +  I++EY+G G+    LD      LE      I  ++   L YLH+
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKGLDYLHS 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYL 221
                 IHRD+KA+N+L++E+   K+ DFG A    +        TQ+K     GT  ++
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--------TQIKRNTFVGTPFWM 168

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI----------RWAMQ 271
            P+ ++      K+D++S G+  +E+  G  P     P++    I          +++  
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP 228

Query: 272 CLKAGDAILVMDPRLRRT 289
             +  +A L  DPR R T
Sbjct: 229 FKEFVEACLNKDPRFRPT 246

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 69/222 (31%), Positives = 99/222 (44%), Gaps = 38/222 (17%)

Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K      VAVK  + +  DK L  +  +E+     I +H 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS-DLVSEMEMMKMIGKHK 78

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G++ +              + + 
Sbjct: 79  NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL   +    IHRD+ A N+L+TE    K+ DFG AR       V +I  
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR------DVHNIDY 189

Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 18/214 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIE- 104
           + +    +IGEG  G V+K + LK+G   VA+KR R    ++ + L    E+     +E 
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 105 --HLNLVKLFGF-----LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
             H N+V+LF        +   +  +V E+V +  L  +LD     G+      D+   +
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
              L +LH++    ++HRD+K  NIL+T   + K+ DFG AR+     A++ +      T
Sbjct: 120 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV----T 172

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
             Y  P+ L         D++S G +  EM   +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 68/214 (31%), Positives = 95/214 (44%), Gaps = 39/214 (18%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNE---------ILTWSKIE 104
           ++G+GG G V+  K KD G IVA+KR +K+      LL   NE         ILT +K E
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKS------LLFKLNEVRHVLTERDILTTTKSE 61

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLE-----LAERLDIAIDVAH 159
            L  VKL    +  +   + +EYV  G  R  L+  G    +     +AE    A+D  H
Sbjct: 62  WL--VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF-EAVDALH 118

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y         IHRD+K  N LI      K+TDFG +        +   +  V G+  
Sbjct: 119 ELGY---------IHRDLKPENFLIDASGHIKLTDFGLS------KGIVTYANSVVGSPD 163

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           Y+ P+ LR        D +S G +L E + G  P
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 17/204 (8%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN-----KHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   +LK  G   AVK  +K+        +C ++E +   L W   E+  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW---ENPFLT 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L+   +  +    V+E++  G L  H+  +G    +L      A ++   L +LH+   
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+++      K+ DFG   M +E+    + ++   GT  Y+ P+ L+  
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFG---MCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
           + T   D +SFGVLL EM+ G+ P
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 72/236 (30%), Positives = 110/236 (46%), Gaps = 32/236 (13%)

Query: 48  ENFSPANKIGEGGSGTVYK----GKLKDGSI--VAVKRARKNKH---DKCLLLEFKNEIL 98
            N S    +G G  G V +    G  K  ++  VAVK  +   H    + L+ E K  I+
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK--IM 92

Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
           +     H N+V L G    G   +++ EY   G L   L  +  + L L + L  +  VA
Sbjct: 93  SHLG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
             + +L + +    IHRD+ A N+L+T     K+ DFG AR    DS     +  VKG A
Sbjct: 152 KGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS-----NYVVKGNA 203

Query: 219 ----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYP---IESK--KPIKE 262
                ++ P+ +     T +SDV+S+G+LL E+ +     YP   ++SK  K IKE
Sbjct: 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 68/226 (30%), Positives = 96/226 (42%), Gaps = 54/226 (23%)

Query: 56  IGEGGSGTVYKGKLKDGSI---VAVKR----ARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           IGEG  G V K ++K   +    A+KR    A K+ H      +F  E+    K+  H N
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 57

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTL-----------------REHLDGRGGNGLELAER 150
           ++ L G  EH     + +EY  +G L                   +          L+ +
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN-----STASTLSSQ 112

Query: 151 --LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
             L  A DVA  + YL   S    IHRD+ A NIL+ E   AK+ DFG +R  E      
Sbjct: 113 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------ 163

Query: 209 HISTQVKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT 249
                VK T G L   ++    L     T  SDV+S+GVLL E+++
Sbjct: 164 ---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 74.9 bits (184), Expect = 5e-15
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN---KHD--KCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   +LK  G + AVK  +K+   + D  +C + E    IL+ ++  H  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFLT 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTY 163
           +L+   +  D    V+E+V  G L  H+        + + R D       A ++  AL +
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHI--------QKSRRFDEARARFYAAEITSALMF 111

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           LH   D  II+RD+K  N+L+  +   K+ DFG   M +E       ++   GT  Y+ P
Sbjct: 112 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTSTFCGTPDYIAP 165

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + L+        D ++ GVLL EM+ G  P E++
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.9 bits (181), Expect = 6e-15
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 29/223 (13%)

Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 62

Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLE---LAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L     +           L + +
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R   E        
Sbjct: 123 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR--- 176

Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 177 ---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + +   N+I EG  G VY+ + K  G IVA+K+ +  K  +   +    EI    K++H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 107 NLVKL----FGFLEHGDERIIVVEYVGNG--TLREHLDGRGGNGLELAERLDIAIDVAHA 160
           N+V +     G   + D+  +V+EYV +   +L E +          +E   + + +   
Sbjct: 65  NIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQP----FLQSEVKCLMLQLLSG 118

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           + +LH   D  I+HRD+K SN+L+  +   K+ DFG AR   E  +     TQ+  T  Y
Sbjct: 119 VAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQLVVTLWY 172

Query: 221 LDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
             P+ L   + Y  +   D++S G +  E++T +
Sbjct: 173 RAPELLLGAKEY--STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 12/202 (5%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARK-NKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           I +G  G V+  K K  G I A+K  +K +   K  + +   E    S+ +   +VKL+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
             +      +V+EY+  G L   L+  G    ++A R+ IA ++  AL YLH+     II
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-RIYIA-EIVLALEYLHSNG---II 115

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYLDPDYLRT 228
           HRD+K  NILI      K+TDFG +++      ++    + +     GT  Y+ P+ +  
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 229 YQLTEKSDVYSFGVLLVEMMTG 250
              ++  D +S G +L E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 11/223 (4%)

Query: 44  YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           +   +++    K+GEG   TVYKGK K +G +VA+K  R  + +       +   L    
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL-KG 59

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           ++H N+V L   +   +   +V EYV +  L +++D   G GL           +   L+
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLS 117

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           Y+H      I+HRD+K  N+LI++    K+ DFG AR     S  SH  +    T  Y  
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAK---SVPSHTYSNEVVTLWYRP 171

Query: 223 PD-YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
           PD  L + + +   D++  G + VEM+ G       K I++++
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.0 bits (187), Expect = 7e-15
 Identities = 70/244 (28%), Positives = 112/244 (45%), Gaps = 25/244 (10%)

Query: 72  GSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV-EYVG 129
           G  VA+K  R +   ++     F+ E    +++ H N+V L    E     +  V EYV 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE--- 186
             TLRE L   G   L   E   + + V  AL   H   +  I+HRD+K  NI++++   
Sbjct: 63  GRTLREVLAADGA--LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117

Query: 187 KLRAKVTDFGFARM----SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGV 242
           +  AKV DFG   +     + D A    +T+V GT  Y  P+ LR   +T  SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 243 LLVEMMTGRYPIE--SKKPIKER------VTIRWAMQCLKAGDAI---LVMDPRLRRTPA 291
           + +E +TG+  ++  S   I  +      V++   +     G  +   L  DPR R   A
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASA 237

Query: 292 SNMA 295
             +A
Sbjct: 238 PALA 241

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 49/229 (21%)

Query: 56  IGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           IG+G  G V++ +       +  ++VAVK  ++      +  +F+ E    ++ +H N+V
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDHPNIV 71

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGR------------------GGNGLEL--AE 149
           KL G    G    ++ EY+  G L E L  R                  G N L L   E
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR---------M 200
           +L IA  VA  + YL   S+   +HRD+   N L+ E +  K+ DFG +R          
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           SE D+    I  +      ++ P+ +   + T +SDV+++GV+L E+ +
Sbjct: 189 SENDA----IPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 72/236 (30%), Positives = 111/236 (47%), Gaps = 23/236 (9%)

Query: 40  FEEIYKATENFSPANKIGEGGSGTVYK-GKLKDGSIVAVKRARKNKHDKCLLLEFKNEIL 98
            E +   T+ +     IG+G  G VYK    KDGS+ AVK       D    +E +  IL
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNIL 72

Query: 99  TWSKIEHLNLVKLFGFLEHGDERI-----IVVEYVGNGTLREHLDGRGGNGLELAERLD- 152
             S   H N+VK +G     D+ +     +V+E    G++ E + G     L   +RLD 
Sbjct: 73  Q-SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LICGQRLDE 127

Query: 153 --IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
             I+  +  AL  L    +  IIHRDVK +NIL+T +   K+ DFG +  ++  S     
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRR 185

Query: 211 STQVKGTAGYLDPDYLRTYQLTEKS-----DVYSFGVLLVEMMTGRYPIESKKPIK 261
           +T V GT  ++ P+ +   Q  + S     DV+S G+  +E+  G  P+    P+K
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.5 bits (180), Expect = 9e-15
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 12/219 (5%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E +   +K+GEG   TV+KG+ K   ++VA+K  R  +H++        E+     ++H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKNLKHA 63

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V L   +       +V EY+ +  L+++LD   GN + +         +   L+Y H 
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD-Y 225
                I+HRD+K  N+LI EK   K+ DFG AR     S  +   +    T  Y  PD  
Sbjct: 122 RK---ILHRDLKPQNLLINEKGELKLADFGLARAK---SVPTKTYSNEVVTLWYRPPDVL 175

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
           L + + +   D++  G +L EM TGR P+     +KE +
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEEL 213

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 18/225 (8%)

Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKC---LLLEFKNEIL 98
           I K TE       +G G  GTV+KG  + +G  + +  A K   D+       E  + +L
Sbjct: 3   ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61

Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
               ++H  +V+L G    G    +V +    G+L +H+     + L+    L+  + +A
Sbjct: 62  AMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIA 119

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA---VSHISTQVK 215
             + YL  +    ++HR++ A NIL+      ++ DFG A +   D      S   T +K
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKP 259
             A  L+      Y  T +SDV+S+GV + EMM+ G  P    +P
Sbjct: 177 WMA--LESILFGRY--THQSDVWSYGVTVWEMMSYGAEPYAGMRP 217

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 7/180 (3%)

Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII--VVEYVG 129
           G  VAVK + K +     + + K EI     + H N+VK  G         I  ++E++ 
Sbjct: 33  GEQVAVK-SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR 189
           +G+L+E+L  R  N + L ++L  A+ +   + YL +      +HRD+ A N+L+  + +
Sbjct: 92  SGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147

Query: 190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            K+ DFG  +  E D     +   +     +  P+ L   +    SDV+SFGV L E++T
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 35/223 (15%)

Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKC---LLLEFKNEIL 98
           I K TE       +G G  GTVYKG  + +G  V +  A K  ++       +EF +E L
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 99  TWSKIEHLNLVKLFG------------FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLE 146
             + ++H +LV+L G             + HG     +++YV      EH D  G   L 
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHG----CLLDYV-----HEHKDNIGSQLL- 111

Query: 147 LAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
               L+  + +A  + YL    +  ++HRD+ A N+L+      K+TDFG AR+ E D  
Sbjct: 112 ----LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             + +   K    ++  + +   + T +SDV+S+GV + E+MT
Sbjct: 165 -EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 17/152 (11%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARK--NKHDKCLLLEFKNEILTWSKI-EHLNLVK 110
           ++G+G  G+VY  + K+ G +VA+K+ +K     ++C+ L    E+ +  K+ EH N+VK
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNEHPNIVK 62

Query: 111 LFG-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT--Y 167
           L   F E+ DE   V EY+  G L + +  R G     +    I   +   L ++H   +
Sbjct: 63  LKEVFREN-DELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
                 HRD+K  N+L++     K+ DFG AR
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 17/213 (7%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G+G  G VYK + K+ G   A K  +    ++  L +F  EI   S+ +H N+V L+  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMVEIDILSECKHPNIVGLYEA 70

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
             + ++  I++E+   G L   +      GL   +   +   +  AL +LH++    +IH
Sbjct: 71  YFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHK---VIH 126

Query: 175 RDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           RD+KA NIL+T     K+ DFG  A+            T + GT  ++ P+ +      +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFI-GTPYWMAPEVVACETFKD 182

Query: 234 -----KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                K+D++S G+ L+E+     P     P++
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 21/220 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E F+   KIG+G  G V+KG   +   +VA+K     + +   + + + EI   S+ +  
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSP 62

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            + K +G      +  I++EY+G G+  + L+    +  ++A    I  ++   L YLH+
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLHS 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYL 221
                 IHRD+KA+N+L++E    K+ DFG A    +        TQ+K     GT  ++
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------TQIKRNTFVGTPFWM 168

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+ ++      K+D++S G+  +E+  G  P     P+K
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK---NKHD--KCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   +LK    + AVK  +K    + D  +C + E +   L     +H  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG---KHPFLT 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +L    +  D    V+EYV  G L  H+   GR     +       A ++   L +LH  
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLH-- 113

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +  II+RD+K  N+L+  +   K+ DFG   M +E       ++   GT  Y+ P+ L 
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFG---MCKEGILGGVTTSTFCGTPDYIAPEILS 169

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
                   D ++ GVLL EM+ G+ P E
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)

Query: 56  IGEGGSGTVYKGKLKDGS-IVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   +LK  +   A+K  +K     +   +C ++E +   L W   EH  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW---EHPFLT 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            LF   +  +    V+EY+  G L  H+   G    + A     A ++   L +LH    
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKG- 116

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+ +    K+ DFG   M +E+      ++   GT  Y+ P+ L+  
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFG---MCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
           +  E  D +SFGVLL EM+ G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARK----NKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           IG+G  G V   K K DG   AVK  +K    N+ ++  ++  +N +L    ++H  LV 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL--KNVKHPFLVG 60

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L    +  ++   V+++V  G L  HL  R  +  E   R   A ++A AL YLH+ +  
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHSIN-- 116

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            I++RD+K  NIL+  +    +TDFG  +   E  A S  +T   GT  YL P+ +R   
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 231 LTEKSDVYSFGVLLVEMMTGRYPIESK 257
                D +  G +L EM+ G  P   +
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 19/209 (9%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN----KHDKCLLLEFKNEILTWSKIEHLNLVK 110
           IG+G  G V   K K DGS  AVK  +K     K ++  ++  +N +L    ++H  LV 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL--KNLKHPFLVG 60

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L    +  ++   V++YV  G L  HL  R    LE   R   A +VA A+ YLH+ +  
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVASAIGYLHSLN-- 116

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
            II+RD+K  NIL+  +    +TDFG  +  +  E++     ++   GT  YL P+ LR 
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-----TSTFCGTPEYLAPEVLRK 170

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
                  D +  G +L EM+ G  P  S+
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 35/225 (15%)

Query: 48  ENFSPANKIGEGGSGTVYKGK---------LKDGSIVAVKRARKNKHDKCLLLEFKNEIL 98
           ++      +G G  G V+  +         LK  +I  V R ++ +H         NE  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-------VHNEKR 53

Query: 99  TWSKIEHLNLVKLFGFLEHGDERII--VVEYVGNGTLREHLDGRG--GNGLELAERLDIA 154
              ++ H  +++LF      D+R +  ++EYV  G L  +L   G   N   L      A
Sbjct: 54  VLKEVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF----YA 107

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++  AL YLH+     I++RD+K  NIL+ ++   K+TDFGFA+       +   +  +
Sbjct: 108 SEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTL 158

Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
            GT  YL P+ +++    +  D ++ G+L+ EM+ G  P     P
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 70/303 (23%), Positives = 136/303 (44%), Gaps = 37/303 (12%)

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE---- 149
           ++E+   +  +H  +VK F   +  D+ ++++EY   G L + +  R    L   E    
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 150 ----RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS 205
               ++ +A+D  H+           ++HRD+K++NI +      K+ DFGF++    DS
Sbjct: 173 LLFYQIVLALDEVHSRK---------MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DS 222

Query: 206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE--SKKPIKER 263
               +++   GT  YL P+     + ++K+D++S GV+L E++T   P +  S++ I ++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282

Query: 264 VT----------IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQS 313
           V           +   M+ L   D +L  +P LR T    +  E +  +A++     R S
Sbjct: 283 VLYGKYDPFPCPVSSGMKALL--DPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRHS 340

Query: 314 RPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASESH----YPIG-DAKKKSRHISFG 368
                   E + +  ++  E+AP   S      ++  +H    Y    D + K R+   G
Sbjct: 341 ETISPHDREEILRQLQESGERAPPPSSIRYGVVTSDVTHGGYLYKYSSDMRWKKRYFYIG 400

Query: 369 NDE 371
           N +
Sbjct: 401 NGQ 403

Length = 478

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN-----KHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V+  +LK      A+K  +K+        +C ++E +   L W   EH  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW---EHPFLT 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L+   +  +    V+EY+  G L  H+  +  +  +L      A ++   L +LH+   
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKG- 116

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I++RD+K  NIL+      K+ DFG   M +E+      +    GT  Y+ P+ L   
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFG---MCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
           +     D +SFGVLL EM+ G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 17/214 (7%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVK-----RARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V   ++K  G + A K     R +K K ++  L E   +IL   K+    +V
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNE--KKIL--EKVSSRFIV 56

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E  D+  +V+  +  G L+ H+   G  G   A  +  A  +   L +LH    
Sbjct: 57  SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I++RD+K  N+L+ +    +++D G A   +    +        GT GY+ P+ L+  
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI----KGRAGTPGYMAPEVLQGE 169

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER 263
                 D ++ G  L EM+ GR P   +K   E+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)

Query: 55  KIGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG     K    VAVK  + + +D  L  E   E     ++++  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L + L         N  EL  +      V+  + YL   
Sbjct: 62  IGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQ------VSMGMKYLEET 114

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
           +    +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P +  K
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 71/278 (25%), Positives = 114/278 (41%), Gaps = 38/278 (13%)

Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR-------KNKHDKCLLLEFKNEILTW 100
           NF    KIG G    VY+   L DG  VA+K+ +       K + D C+      EI   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CI-----KEIDLL 56

Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVA 158
            ++ H N++K +      +E  IV+E    G L   +         + E+      + + 
Sbjct: 57  KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            AL ++H+     ++HRD+K +N+ IT     K+ D G  R     +  +H    + GT 
Sbjct: 117 SALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTP 170

Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
            Y+ P+ +       KSD++S G LL EM   + P    K           M        
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKK 219

Query: 279 ILVMD-PRLRRTPASNMAVEKILGLADVCLAPTRQSRP 315
           I   D P L     S+   E++  L ++C+ P  + RP
Sbjct: 220 IEQCDYPPL----PSDHYSEELRQLVNMCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.6 bits (173), Expect = 9e-14
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 26/216 (12%)

Query: 56  IGEGGSGTVYKGKLKDGSI-VAVKR-ARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G+G  G VY  +     + +A+K    ++      L E   EI   S ++H N+V+  G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI----DVAHALTYLHTYSD 169
                    I +E V  G+L   L  + G    L +     I     +   L YLH   D
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLH---D 126

Query: 170 PPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-- 226
             I+HRD+K  N+L+ T     K++DFG    S+  + ++  +    GT  Y+ P+ +  
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFG---TSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 227 --RTYQLTEKSDVYSFGVLLVEMMTGRYP-IESKKP 259
             R Y     +D++S G  +VEM TG+ P IE  +P
Sbjct: 184 GPRGY--GAPADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E +   +K+GEG   TVYKG+ K   ++VA+K  R  +H++        E+     ++H 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 64

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V L   +       +V EY+ +  L+++LD   GN + +         +   L Y H 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD-Y 225
                ++HRD+K  N+LI E+   K+ DFG AR     S  +   +    T  Y  PD  
Sbjct: 123 RK---VLHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYSNEVVTLWYRPPDIL 176

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGR 251
           L +   + + D++  G +  EM TGR
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 35/233 (15%)

Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE----HLNLV 109
            IG+GG G VY          VA+K+ R++  +  LL   K   L  +KI     H  +V
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL---KKRFLREAKIAADLIHPGIV 65

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDG-RGGNGL--ELAER------LDIAIDVAHA 160
            ++     GD     + Y+   TL+  L        L  ELAE+      L I   +   
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA---RMSEEDSAVSHIST----- 212
           + Y+H+     ++HRD+K  NIL+       + D+G A   ++ EED     +       
Sbjct: 126 IEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 213 -------QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
                  ++ GT  Y+ P+ L     +E +D+Y+ GV+L +M+T  +P   KK
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235

Length = 932

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 6/163 (3%)

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           + E +  +K++H N+V      E      IV+EY   G L + +  + G        L  
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            + +   + ++H   +  ++HRD+K+ NI +T+  + K+ DFG AR+    S  ++  T 
Sbjct: 106 FVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTY 160

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           V GT  Y+ P+         KSD++S G +L E+ T ++P ++
Sbjct: 161 V-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 29/213 (13%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN---KHD--KCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   +LK    + A+K  +K+   + D   C + E    IL  +  +H  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KHPFLT 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTY 163
            L    +  D    V+EYV  G L   +        + + + D       A +V  AL +
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQI--------QRSRKFDEPRSRFYAAEVTLALMF 111

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           LH +    +I+RD+K  NIL+  +   K+ DFG   M +E       +T   GT  Y+ P
Sbjct: 112 LHRHG---VIYRDLKLDNILLDAEGHCKLADFG---MCKEGILNGVTTTTFCGTPDYIAP 165

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + L+  +     D ++ GVL+ EMM G+ P E+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 20/216 (9%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVK-----RARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V   ++K+ G + A K     R +K   +K  LLE   EIL   K+    +V
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLE--KEIL--EKVNSPFIV 56

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E      +V+  +  G L+ H+   G  GLE+   +  +  +   + +LH+   
Sbjct: 57  NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD- 115

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I++RD+K  N+L+ ++   +++D G A   ++   +    TQ  GT GY+ P+ L+  
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI----TQRAGTNGYMAPEILKEE 169

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT 265
             +   D ++ G  + EM+ GR P    K  KE+V 
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVA 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G+G  G VYK K K+   +A  +  + K ++  L ++  EI   +   H  +VKL G 
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 115 LEHGDERIIVVEYVGNGTLRE---HLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
                +  I++E+   G +      LD     GL   +   I   +  AL YLH+     
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK--- 130

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           IIHRD+KA N+L+T     K+ DFG   +S ++           GT  ++ P+ +    +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 232 TE-----KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +     K+D++S G+ L+EM     P     P++
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 53/235 (22%)

Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +F     +G G  G V   K K  G   A+K         CL    K EIL   +++H+ 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK---------CLK---KREILKMKQVQHVA 66

Query: 108 LVK--------------LFGFLEHGDERI-IVVEYVGNGTLREHLD--GRGGNGLELAER 150
             K              +  F +  + R+  ++E+V  G L  HL   GR  N       
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPN------- 117

Query: 151 LDIA----IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
            D+A     ++  A  YLH+     II+RD+K  N+L+  K   KVTDFGFA+       
Sbjct: 118 -DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK------K 167

Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           V   +  + GT  YL P+ +++    +  D ++ GVLL E + G  P     P +
Sbjct: 168 VPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 29/220 (13%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G+G  G VYK + K+  ++A  +    K ++  L ++  EI   +  +H N+VKL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHTYS 168
             + +   I++E+   G +   +       LEL   L       +      AL YLH   
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVM-------LELERPLTEPQIRVVCKQTLEALNYLH--- 120

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-- 226
           +  IIHRD+KA NIL T     K+ DFG   +S +++          GT  ++ P+ +  
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 227 -----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                R Y    K+DV+S G+ L+EM     P     P++
Sbjct: 178 ETSKDRPYDY--KADVWSLGITLIEMAQIEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +G G  G V K +    G+I+AVKR R     +  K LL++    + +   ++    V  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS---VDCPYTVTF 65

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSD 169
           +G L    +  I +E V + +L +        GL + E +   IA+ +  AL YLH  S 
Sbjct: 66  YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SK 122

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL-----DPD 224
             +IHRDVK SN+LI    + K+ DFG +    +  A     T   G   Y+     +P+
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA----KTIDAGCKPYMAPERINPE 178

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
            L       KSDV+S G+ ++E+ TGR+P +S
Sbjct: 179 -LNQKGYDVKSDVWSLGITMIELATGRFPYDS 209

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 17/212 (8%)

Query: 56  IGEGGSGTV-YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G G +GTV    ++ DG   AVK        +      + E+      +  ++VK    
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99

Query: 115 LEHGDER--------IIVVEYVGNGTLREHLDGRGGNGLELAERLD--IAIDVAHALTYL 164
               D R         +V++Y   G LR+ +  R        E     + I V  A+ ++
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS-HISTQVKGTAGYLDP 223
           H+     +IHRD+K++NIL+      K+ DFGF++M    + VS  +     GT  Y+ P
Sbjct: 160 HSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVAP 214

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           +  R    ++K+D++S GVLL E++T + P +
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 35/223 (15%)

Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGS----IVAVKRARKNKHDKCLLLEFKNEI 97
           I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    E  +E 
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEA 60

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERII--------VVEYVGNGTLREHLDGRGGNGLELAE 149
              + +++ ++ +L G       ++I        +++YV     REH D  G   L    
Sbjct: 61  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV-----REHKDNIGSQYL---- 111

Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            L+  + +A  + YL    +  ++HRD+ A N+L+      K+TDFG A++   D    H
Sbjct: 112 -LNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 210 I---STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                  +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 168 AEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 56  IGEGGSGTV------YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V        GK+     +  KR +K K +   L    NE     K+    +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL----NEKQILEKVNSRFVV 63

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E  D   +V+  +  G L+ H+   G  G E    +  A ++   L  LH    
Sbjct: 64  SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER- 122

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I++RD+K  NIL+ +    +++D G A    E      I  +V GT GY+ P+ ++  
Sbjct: 123 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV-GTVGYMAPEVVKNE 176

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
           + T   D ++ G LL EM+ G+ P + +K
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 55  KIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++G+G  G VY+G  +D       + VAVK   ++   +   +EF NE          ++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHV 71

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGL---ELAERLDIAIDVAHA 160
           V+L G +  G   ++V+E + +G L+ +L     +     G     L E + +A ++A  
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG- 219
           + YL+       +HRD+ A N ++      K+ DFG  R   E           KG  G 
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR------KGGKGL 182

Query: 220 ----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 16/183 (8%)

Query: 76  AVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLR 134
           A +R RK    +  LL         S+++H N+V      E  D  + IV+ +   G L 
Sbjct: 38  ASRRERKAAEQEAQLL---------SQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLY 88

Query: 135 EHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD 194
             L  + G  L   + ++  + +A AL YLH   +  I+HRD+K  N+ +T     KV D
Sbjct: 89  HKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGD 145

Query: 195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            G AR+ E    ++  ST + GT  Y+ P+         KSDV++ G  + EM T ++  
Sbjct: 146 LGIARVLENQCDMA--STLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202

Query: 255 ESK 257
            +K
Sbjct: 203 NAK 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 66/245 (26%), Positives = 113/245 (46%), Gaps = 21/245 (8%)

Query: 28  PKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYK-GKLKDGSIVAVKRARKNKHD 86
           P SG+       F+     ++ +     IG+G  G V+K    K+GS  AVK      HD
Sbjct: 2   PLSGKTII----FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHD 56

Query: 87  KCLLLEFKNEILTWSKIEHLNLVKLFGF-----LEHGDERIIVVEYVGNGTLREHLDGRG 141
               +E +  IL  +  +H N+VK +G      +++GD+  +V+E    G++ + + G  
Sbjct: 57  IDEEIEAEYNILK-ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115

Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
             G  + E + IA  +  AL  L        IHRDVK +NIL+T +   K+ DFG   +S
Sbjct: 116 KRGERMEEPI-IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VS 171

Query: 202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPIES 256
            + ++         GT  ++ P+ +   Q        + DV+S G+  +E+  G  P+  
Sbjct: 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Query: 257 KKPIK 261
             P++
Sbjct: 232 LHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 22/216 (10%)

Query: 56  IGEGGSGTV------YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V        GK+     +  KR +K K +   L    NE     K+    +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL----NEKQILEKVNSQFVV 63

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E  D   +V+  +  G L+ H+   G  G E    L  A ++   L  LH  + 
Sbjct: 64  NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN- 122

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
              ++RD+K  NIL+ +    +++D G A ++ E +S    +     GT GY+ P+ L  
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEVLNN 175

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
            + T   D +  G L+ EM+ G+ P   +   KE+V
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGR---KEKV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 22/220 (10%)

Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR-------KNKHDKCLLLEFKNEILTW 100
           NF    KIG G    VY+   L D   VA+K+ +       K + D C+      EI   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD-CV-----KEIDLL 56

Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVA 158
            ++ H N++K        +E  IV+E    G L + +         + ER      + + 
Sbjct: 57  KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            A+ ++H+     ++HRD+K +N+ IT     K+ D G  R     +  +H    + GT 
Sbjct: 117 SAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---SLVGTP 170

Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            Y+ P+ +       KSD++S G LL EM   + P    K
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 7/147 (4%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG  G VYK +    G IVA+K+ R    D+ +      EI    ++ H N+V+L  
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 114 FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
            + H + ++ +V E++ +  L++++D     GL+          +   + Y H++    +
Sbjct: 66  VV-HSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---V 120

Query: 173 IHRDVKASNILITEKLRAKVTDFGFAR 199
           +HRD+K  N+LI  +   K+ DFG AR
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 18/220 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E+F    +IG G  G VYK + +  G + A+K  +    +   +++   EI+     +H 
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKDCKHS 66

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLRE--HLDGRGGNGLELAERLDIAIDVAHALTYL 164
           N+V  FG     D+  I +E+ G G+L++  H+ G     L  ++   ++ +    L YL
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYL 122

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H+      +HRD+K +NIL+T+    K+ DFG   +S + +A         GT  ++ P+
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPE 176

Query: 225 YL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                R     +  D+++ G+  +E+   + P+    P++
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 25/209 (11%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVKRARKN--KHDKC-----LLLEFKNEILTWSKIEH 105
            K+GEG    VYK +  + G IVA+K+ +    K  K       L E K  +L   +++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK--LLQ--ELKH 61

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N++ L     H     +V E++   T  E +       L  A+     +     L YLH
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +     I+HRD+K +N+LI      K+ DFG AR     S    ++ QV  T  Y  P+ 
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTHQVV-TRWYRAPEL 173

Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMTGR 251
           L   R Y      D++S G +  E++   
Sbjct: 174 LFGARHY--GVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 63/220 (28%), Positives = 110/220 (50%), Gaps = 22/220 (10%)

Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHL 106
           +G+GG G V++ +   G+    I A+K  +K     N+ D       +N IL    ++H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN-IL--EAVKHP 60

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            +V L    + G +  +++EY+  G L  HL+ R G  +E      ++ +++ AL +LH 
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLS-EISLALEHLHQ 118

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                II+RD+K  NIL+  +   K+TDFG  + S  +  V+H      GT  Y+ P+ L
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEIL 172

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV 264
                 +  D +S G L+ +M+TG  P   E++K   +++
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)

Query: 59  GGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK-LFGFLEH 117
                + K K    ++VAVK+   +   K  L   + EI+T  +++H N++  +  F+  
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV- 70

Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGL-ELAERLDIAIDVAHALTYLHTYSDPPIIHRD 176
             E  +V   +  G+  + L      GL ELA    I  DV +AL Y+H+      IHR 
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSKG---FIHRS 126

Query: 177 VKASNILITEKLRAKVTDFGFAR-MSEE--------DSAVSHISTQVKGTAGYLDPDYLR 227
           VKAS+IL++   +  ++   ++  M +         D   S +         +L P+ L+
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL-----PWLSPEVLQ 181

Query: 228 TYQL--TEKSDVYSFGVLLVEMMTGRYP 253
                  EKSD+YS G+   E+  G  P
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 60/232 (25%), Positives = 110/232 (47%), Gaps = 35/232 (15%)

Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKN 95
           EI  +T  F    ++GE   G VYKG L      +    VA+K   K+K +  L  EFK+
Sbjct: 1   EINLSTVRF--MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKH 57

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRG 141
           E +  S+++H N+V L G +       ++  Y  +  L E L              D   
Sbjct: 58  EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
            + LE A+ + I   +A  + +L ++    ++H+D+   N+L+ +KL  K++D G  R  
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFR-- 172

Query: 202 EEDSAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            E  A  +   ++ G +     ++ P+ +   + +  SD++S+GV+L E+ +
Sbjct: 173 -EVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            ++    ++G G  G VYK   L  G + AVK  +    D   L++   EI    + +H 
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKECKHC 66

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLRE--HLDGRGGNGLELAERLDIAI---DVAHAL 161
           N+V  FG     ++  I +EY G G+L++  H+ G       L+E L IA    +    L
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG------PLSE-LQIAYVCRETLQGL 119

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
            YLH+      +HRD+K +NIL+T+    K+ DFG A    + +A         GT  ++
Sbjct: 120 AYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA---AKITATIAKRKSFIGTPYWM 173

Query: 222 DPDYLRTYQ---LTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+     +     +  D+++ G+  +E+   + P+    P++
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E +    K+GEG   TV+KG+ K   ++VA+K  R  +H++        E+     ++H 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 64

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V L   +       +V EY+ +  L++++D   GN + +         +   L Y H 
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                ++HRD+K  N+LI E+   K+ DFG AR     S  +   +    T  Y  PD L
Sbjct: 123 RK---VLHRDLKPQNLLINERGELKLADFGLARAK---SVPTKTYSNEVVTLWYRPPDVL 176

Query: 227 R-TYQLTEKSDVYSFGVLLVEMMTGR 251
             + + + + D++  G +  EM +GR
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 17/213 (7%)

Query: 44  YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           +   E +   +K+GEG   TVYKG+ K  G +VA+K  R   H++        E      
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE-HEEGAPFTAIREASLLKD 59

Query: 103 IEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
           ++H N+V L   + H  + + +V EY+ +  L++++D   G GL +         +   L
Sbjct: 60  LKHANIVTLHDII-HTKKTLTLVFEYL-DTDLKQYMD-DCGGGLSMHNVRLFLFQLLRGL 116

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
            Y H      ++HRD+K  N+LI+E+   K+ DFG AR     S  S   +    T  Y 
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAK---SVPSKTYSNEVVTLWYR 170

Query: 222 DPDYLRTYQLTEKS---DVYSFGVLLVEMMTGR 251
            PD L     TE S   D++  G +  EM TGR
Sbjct: 171 PPDVL--LGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 22/224 (9%)

Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGS----IVAVKRARKNKHDKCLLLEFKNEI 97
           I K TE       +G G  GTVYKG  + DG      VA+K  R+N   K    E  +E 
Sbjct: 3   ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK-EILDEA 60

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLELAERLDI 153
              + +    + +L G       ++ V + +  G L    RE+ D  G   L     L+ 
Sbjct: 61  YVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL-----LNW 114

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            + +A  ++YL    +  ++HRD+ A N+L+      K+TDFG AR+ + D    H +  
Sbjct: 115 CVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH-ADG 170

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIES 256
            K    ++  + +   + T +SDV+S+GV + E+MT G  P + 
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 10/105 (9%)

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L YLH+     I+HRD+K  N+L+      K+ DFG AR+ E D   S   TQ   T  Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYY 170

Query: 221 LDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE 262
             P+ L   R Y  T   D++S G +  E++  R   +++ PI++
Sbjct: 171 RAPEILMGSRHY--TSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 19/176 (10%)

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           +ILT++  E+  +V +F   E      +V+EYV  G     L   G   +++A R+  A 
Sbjct: 53  DILTFA--ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFAE 109

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM------------SEE 203
            V  AL YLH Y    I+HRD+K  N+LIT     K+TDFG +++              E
Sbjct: 110 TVL-ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165

Query: 204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
                 +  QV GT  Y+ P+ +      +  D ++ G++L E + G  P     P
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 64.9 bits (159), Expect = 7e-12
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 39/214 (18%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN--------KHDKCLLLEFKNEILTWSKIEHL 106
           +G GG G V   K+K      A+K  +K         +H        + EIL   +  H 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-----EKEIL--EECNHP 53

Query: 107 NLVKLFGFLEHGDERII--VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
            +VKL+   +  D++ I  ++EY   G L   L  RG      A R  IA  V  A  YL
Sbjct: 54  FIVKLYRTFK--DKKYIYMLMEYCLGGELWTILRDRGLFDEYTA-RFYIAC-VVLAFEYL 109

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAG 219
           H      II+RD+K  N+L+      K+ DFGFA+          + +  K     GT  
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK---------KLKSGQKTWTFCGTPE 157

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           Y+ P+ +         D +S G+LL E++TGR P
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 72/255 (28%), Positives = 116/255 (45%), Gaps = 31/255 (12%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKN-----KHDKCLLLEFKNEILTWSKIEHLNLV 109
           IG+G  G V   + K +    AVK  +K      K +K ++ E +N +L    ++H  LV
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE-RNVLL--KNVKHPFLV 59

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    +  D+   V++Y+  G L  HL  R    LE   R   A ++A AL YLH+ + 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHSLN- 116

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I++RD+K  NIL+  +    +TDFG  + + E +     ++   GT  YL P+ L   
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAPEVLHKQ 171

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESK-----------KPIKERVTIRWAMQCLKAGDA 278
                 D +  G +L EM+ G  P  S+           KP++ +  I  + + L  G  
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG-- 229

Query: 279 ILVMDPRLRRTPASN 293
            L+   R +R  A +
Sbjct: 230 -LLQKDRTKRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 63/210 (30%), Positives = 92/210 (43%), Gaps = 25/210 (11%)

Query: 56  IGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIE---------H 105
           IG G    V   +LK    I A+K  +K        L   +E + W + E         H
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKE-------LVNDDEDIDWVQTEKHVFEQASNH 55

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             LV L    +       V+EYV  G L  H+  R     E   R   A +++ AL YLH
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNYLH 113

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
              +  II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT  Y+ P+ 
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEI 167

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           LR        D ++ GVL+ EMM GR P +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 49/300 (16%)

Query: 48  ENFSPANKIGEGGSGTVY-KGKLKDGSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKI 103
           E F   ++IG G  G VY         +VAVK+   + K  ++K    +   E+    ++
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK--WQDIIKEVKFLQQL 78

Query: 104 EHLNLVKLFGFLEHGDERIIVVEY-VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H N ++  G         +V+EY +G+ +    +  +    +E+A    I       L 
Sbjct: 79  KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLA 135

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH+++   +IHRD+KA NIL+TE  + K+ DFG A       + S  +    GT  ++ 
Sbjct: 136 YLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA-------SKSSPANSFVGTPYWMA 185

Query: 223 PDYLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI 279
           P+ +      Q   K DV+S G+  +E+       E K P+       + M  + A   I
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELA------ERKPPL-------FNMNAMSALYHI 232

Query: 280 LVMD-PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF--REKAP 336
              D P L+    SN   +   G  D CL    Q RP     AE+L   R DF  R++  
Sbjct: 233 AQNDSPTLQ----SNEWTDSFRGFVDYCLQKIPQERPA---SAELL---RHDFVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 37/102 (36%), Positives = 60/102 (58%), Gaps = 6/102 (5%)

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           ++A AL +LH+     II+RD+K  NIL+ E+   K+TDFG ++ S +    ++      
Sbjct: 106 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFC 159

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           GT  Y+ P+ +     T+ +D +SFGVL+ EM+TG  P + K
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 25/210 (11%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLN------ 107
           IG G    V   +LK +  I A+K  +K        L   +E + W + E H+       
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKE-------LVHDDEDIDWVQTEKHVFEQASSN 55

Query: 108 --LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             LV L    +      +V+EYV  G L  H+  R     E   R   A ++  AL +LH
Sbjct: 56  PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLH 113

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
              +  II+RD+K  N+L+      K+TD+G   M +E       ++   GT  Y+ P+ 
Sbjct: 114 ---ERGIIYRDLKLDNVLLDADGHIKLTDYG---MCKEGLGPGDTTSTFCGTPNYIAPEI 167

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           LR  +     D ++ GVL+ EMM GR P +
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 11/211 (5%)

Query: 49  NFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIE 104
           N+     +G+G  G VY     D G  +AVK+ + +        E    + EI     + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 105 HLNLVKLFGFLEHGDERI--IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           H  +V+ +G L    ER   I +E++  G++++ L   G     +  +    I     ++
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI--LEGVS 120

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH+     I+HRD+K +NIL       K+ DFG ++  +           V GT  ++ 
Sbjct: 121 YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           P+ +       K+D++S G  +VEM+T + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 53/232 (22%)

Query: 55  KIGEGGSGTVY----------------KGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEI 97
           K+GEG  G V+                +    D   +VAVK  R +        +F  E+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEV 70

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGR---------GGNGLELA 148
              S++   N+ +L G         +++EY+ NG L + L                L  +
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 149 ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
             L +A  +A  + YL + +    +HRD+   N L+ +    K+ DFG +R     +  S
Sbjct: 131 TLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYS 182

Query: 209 HISTQVKGTAG-----------YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               +V+G A             L        + T KSDV++FGV L E++T
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLG-------KFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)

Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +++   KIGEG  G VYKG+  K G IVA+K+ R    ++ +      EI    +++H N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDG-RGGNGLELAERLDIAIDVAHALTYLHT 166
           +V L   L       ++ E++ +  L+++LD    G  ++          +   + + H+
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS---HISTQVKGTAGYLDP 223
                ++HRD+K  N+LI  K   K+ DFG AR      A      + T    T  Y  P
Sbjct: 120 RR---VLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVTLWYRAP 170

Query: 224 DYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
           + L      +   D++S G +  EM T +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 54  NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL----NL 108
           +++G+G  G+VYK   +  G  +A+K  R    +        N+I+    I H      +
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-----NQIIMELDILHKAVSPYI 61

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTY 167
           V  +G         + +EY+  G+L +   G         + L  I   V   L +L   
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK-- 119

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +  IIHRDVK +N+L+    + K+ DFG +       A ++I  Q      Y+ P+ ++
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ-----SYMAPERIK 174

Query: 228 --------TYQLTEKSDVYSFGVLLVEMMTGRYP 253
                   TY  T +SDV+S G+ ++EM  GRYP
Sbjct: 175 SGGPNQNPTY--TVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 32/223 (14%)

Query: 56  IGEGGSGTVYKGKLK-------DGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLN 107
           +G+G    +YKG L+        G    V    K    D    L F       S++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LVKL+G +   DE I+V EYV  G L   L  R  N + L  +LD+A  +A AL YL   
Sbjct: 63  LVKLYG-VCVRDENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 168 SDPPIIHRDVKASNILITE-------KLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAG 219
            D  ++H +V   NIL+             K++D G    +   +  V  I         
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-------- 169

Query: 220 YLDPDYLRTYQ--LTEKSDVYSFGVLLVEMMT-GRYPIESKKP 259
           ++ P+ +R  Q  LT  +D +SFG  L+E+ + G  P+ +   
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 62/247 (25%), Positives = 93/247 (37%), Gaps = 59/247 (23%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILT-- 99
           ++F     IG G  G V+  + KD G + A+K  RK           +  E   +IL   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE--RDILADA 58

Query: 100 ---WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE----RLD 152
              W       +VKL+   +  +   +V+EY+  G L   L  +     E A      L 
Sbjct: 59  DSPW-------IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV 111

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVS--- 208
           +A+D  H L +         IHRD+K  NILI      K+ DFG   +M++         
Sbjct: 112 LALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 209 ----------------------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
                                   +    GT  Y+ P+ LR      + D +S GV+L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 247 MMTGRYP 253
           M+ G  P
Sbjct: 223 MLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 29/210 (13%)

Query: 58  EGGSGTVYKGKLKDGSI-----VAVKRARKNKHD---KCLLLEFKNEILTWSKIEHLNLV 109
           EG  G ++ G L D        V VK  + +  +     LL     E      + H N++
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL----QESCLLYGLSHQNIL 71

Query: 110 KLFGF-LEHGDERIIVVEYVGNGTLREHL----DGRGGNGLELAER--LDIAIDVAHALT 162
            +    +E G+   ++  Y+  G L+  L     G   N   L+ +  + +AI +A  ++
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR---MSEEDSAVSHISTQVKGTAG 219
           YLH      +IH+D+ A N +I E+L+ K+TD   +R     +      + +  VK    
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           ++  + L   + +  SDV+SFGVLL E+MT
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 24/214 (11%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + +    KIGEG  G VYK + +     +A+K+ R  + D+ +      EI    +++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 107 NLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIA----IDVAHAL 161
           N+V+L   + H ++R+ +V EY+ +  L++H+D    +  + A+   +       +   +
Sbjct: 62  NIVRLQDVV-HSEKRLYLVFEYL-DLDLKKHMD----SSPDFAKNPRLIKTYLYQILRGI 115

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRA-KVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
            Y H++    ++HRD+K  N+LI  +  A K+ DFG AR       V   + +V  T  Y
Sbjct: 116 AYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVV-TLWY 169

Query: 221 LDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
             P+ L   R Y  +   D++S G +  EM+  +
Sbjct: 170 RAPEILLGSRHY--STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.8 bits (152), Expect = 6e-11
 Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 37/287 (12%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKR-ARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           F+   +IG G  G VY  + ++   +VA+K+ +   K       +   E+    +I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 108 LVKLFGFLEHGDERIIVVEY-VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++  G         +V+EY +G+ +    +  +    +E+A    I       L YLH+
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS 143

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQVKGTAGYLDPDY 225
           ++   +IHRD+KA NIL+TE  + K+ DFG A + S  +S V        GT  ++ P+ 
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV--------GTPYWMAPEV 192

Query: 226 LRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM 282
           +      Q   K DV+S G+  +E+       E K P+            + A  A+  +
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELA------ERKPPLFN----------MNAMSALYHI 236

Query: 283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
                 T  SN   +      D CL    Q RPT ++  + ++ +R+
Sbjct: 237 AQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 35/210 (16%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL------------LLEFKNEILTWSK 102
           ++G+G  GTVY        +V  K+A   +  K L             ++   E    SK
Sbjct: 7   RLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58

Query: 103 IEHLNLVKLFG-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAH 159
           ++H  +VK    FLE  D   I+ EY     L   L+     G  L+E    +  I +  
Sbjct: 59  LDHPAIVKFHASFLER-DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVSHISTQVKGT 217
            + Y+H      I+HRD+KA NI +   L  K+ DFG +R  M   D     ++T   GT
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD-----LATTFTGT 168

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEM 247
             Y+ P+ L+      KSD++S G +L EM
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 76/290 (26%), Positives = 118/290 (40%), Gaps = 61/290 (21%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           F+   +IG G  G VY  + ++   +VA+K+         +    K     W  I  +  
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKK---------MSYSGKQSNEKWQDI--IKE 65

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLD--------GRGGNGLELAER----LDIAI- 155
           V+    L H +     +EY G   LREH          G   + LE+ ++    ++IA  
Sbjct: 66  VRFLQQLRHPN----TIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI 120

Query: 156 --DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
                  L YLH++     IHRD+KA NIL+TE    K+ DFG A +     A S +   
Sbjct: 121 CHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV--SPANSFV--- 172

Query: 214 VKGTAGYLDPDYLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM 270
             GT  ++ P+ +      Q   K DV+S G+  +E+       E K P+       + M
Sbjct: 173 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA------ERKPPL-------FNM 217

Query: 271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
             + A   I   D     T +SN   +      D CL    Q RP+ ++ 
Sbjct: 218 NAMSALYHIAQNDS---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 18/212 (8%)

Query: 56  IGEGGSGTVYKGKL-KDGSI--VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +GEG  G+V +G+L +D SI  VAVK  +     +  + +F +E +   + +H N+++L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 113 GFLEHGDER------IIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAI--DVAHALT 162
           G      E       ++++ ++ +G L   L     G     L  ++ +    D+A  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YL + S    IHRD+ A N ++ E +   V DFG ++               K    ++ 
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ-GRIAKMPVKWIA 182

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            + L     T KSDV+SFGV + E+ T G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 43/293 (14%)

Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKR-ARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           FS   +IG G  G VY  + +++  +VA+K+ +   K       +   E+    K+ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 108 LVKLFGFLEHGDERIIVVEY-VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++  G         +V+EY +G+ +    +  +    +E+A    +       L YLH+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHS 133

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDY 225
           ++   +IHRDVKA NIL++E    K+ DFG A  M+  +  V        GT  ++ P+ 
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV--------GTPYWMAPEV 182

Query: 226 LRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM 282
           +      Q   K DV+S G+  +E+       E K P+       + M  + A   I   
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELA------ERKPPL-------FNMNAMSALYHIAQN 229

Query: 283 D-PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
           + P L+    S    E      D CL    Q RPT    +E+L K R   RE+
Sbjct: 230 ESPALQ----SGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRER 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.8 bits (150), Expect = 9e-11
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 15/208 (7%)

Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNK----HDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G+GG G V   +++  G + A K+  K +      + + L   NE     K+    +V 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVS 64

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L    E  D   +V+  +  G L+ H+   G  G +    +  A ++   L  LH     
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER-- 122

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            I++RD+K  NIL+ +    +++D G A    E      I  +V GT GY+ P+ ++  +
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRV-GTVGYMAPEVVKNER 177

Query: 231 LTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            T   D +  G L+ EM+ G+ P   +K
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.6 bits (149), Expect = 9e-11
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 7/160 (4%)

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERI--IVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           EI     ++H  +V+ +G L    E+   I +EY+  G++++ L   G     +  +   
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            I     ++YLH+     I+HRD+K +NIL       K+ DFG ++  +           
Sbjct: 114 QI--LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           V GT  ++ P+ +       K+DV+S G  +VEM+T + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 41/126 (32%), Positives = 65/126 (51%), Gaps = 13/126 (10%)

Query: 133 LREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKV 192
            ++  D      L+L + L  +  VA  + +L   +    IHRDV A N+L+T+   AK+
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKI 253

Query: 193 TDFGFARMSEEDSAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            DFG AR    DS     +  VKG A     ++ P+ +     T +SDV+S+G+LL E+ 
Sbjct: 254 CDFGLARDIMNDS-----NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308

Query: 249 T-GRYP 253
           + G+ P
Sbjct: 309 SLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 56  IGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIE---------H 105
           IG G    V   +LK    I A+K  +K        L   +E + W + E         H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKE-------LVNDDEDIDWVQTEKHVFETASNH 55

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             LV L    +       V+E+V  G L  H+  R     E   R   + +++ AL +LH
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-RQRKLPEEHARF-YSAEISLALNFLH 113

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT  Y+ P+ 
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYG---MCKEGIRPGDTTSTFCGTPNYIAPEI 167

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           LR        D ++ GVL+ EMM GR P +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 42/219 (19%)

Query: 54  NKIGEGGSGTVYKG-KLKDGSIVAVKR---ARKNKHDK-------CLLLEFKNEILTWSK 102
            K+G+G  G V+K    +   +VA+K+   A +N  D          L E  +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 103 IEHLNLVKLFGFLEHGDERII--VVEYVG---NGTLREHLDGRGGNGLELAERLDIAIDV 157
             H N+VKL   ++  +++ I  V EY+    +  +R ++       LE   +  I   +
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-------LEDVHKRYIMYQL 116

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQVK 215
             AL Y+H+ +   +IHRD+K SNIL+    R K+ DFG AR     E++  + + T   
Sbjct: 117 LKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 216 GTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ L     Y  T+  D++S G +L EM+ G+
Sbjct: 174 ATRWYRAPEILLGSTRY--TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 55/232 (23%), Positives = 97/232 (41%), Gaps = 28/232 (12%)

Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEIL 98
           F  +++ T  +     +G G  G V   +    G  VA+K+  K      L      E+ 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 99  TWSKIEHLNLVKLFG-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD----- 152
               + H N++ L   F+   ++   V E +G    R          L  +  L+     
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHR----------LLTSRPLEKQFIQ 111

Query: 153 -IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
                +   L Y+H+     ++HRD+K SNILI E    K+ DFG AR+ ++     ++S
Sbjct: 112 YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTGYVS 167

Query: 212 TQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE 262
           T+      Y  P+ + T+Q    + D++S G +  EM+ G+     K  + +
Sbjct: 168 TRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 52/190 (27%), Positives = 90/190 (47%), Gaps = 23/190 (12%)

Query: 74  IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL 133
           +VAVK  R +   K    +F  EI   S++++ N+++L G     D   ++ EY+ NG L
Sbjct: 46  LVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 134 REHLDGR--------GGN--GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL 183
            + L  R          N   + +A  L +A+ +A  + YL + +    +HRD+   N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161

Query: 184 ITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYS 239
           +      K+ DFG +R     +  S    +++G A     ++  + +   + T  SDV++
Sbjct: 162 VGNHYTIKIADFGMSR-----NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWA 216

Query: 240 FGVLLVEMMT 249
           FGV L EM T
Sbjct: 217 FGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 42/221 (19%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKR-----ARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G G +G V+     D    VAVK+      +  KH    L E K  I+   +++H N+V
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKH---ALREIK--II--RRLDHDNIV 65

Query: 110 KLFGFLEHGDERI--------------IVVEYVGNGTLREHLDGRGGNGLELAERLDI-A 154
           K++  L      +              IV EY+    L   L+     G    E   +  
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLE----QGPLSEEHARLFM 120

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
             +   L Y+H+ +   ++HRD+K +N+ I TE L  K+ DFG AR+ +   +     ++
Sbjct: 121 YQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 214 VKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
              T  Y  P  L     Y  T+  D+++ G +  EM+TG+
Sbjct: 178 GLVTKWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 36/228 (15%)

Query: 50  FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           F    +IGEG  G VYK + KD G +VA+K+ R +   +   +    EI    ++ H N+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 109 VKL----------FGFLEHGDERIIVVEYVGNGTLREH-LDGRGGNGLELAERLDIAIDV 157
           V L            F +      +V EY+      +H L G   +GL       I   +
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSEDHIKSFM 122

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
              L  L+       +HRD+K SNIL+  K + K+ DFG AR+   + +  + +  +  T
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--T 180

Query: 218 AGYLDPDYLRTYQLTEKS-----DVYSFGVLLVEMMTGRYPIESKKPI 260
             Y  P+ L    L E+      DV+S G +L E+ T       KKPI
Sbjct: 181 LWYRPPELL----LGEERYGPAIDVWSCGCILGELFT-------KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 66/245 (26%), Positives = 99/245 (40%), Gaps = 60/245 (24%)

Query: 46  ATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKN--------E 96
              ++    K+GEG  G VYK  ++K G +VA+K        K L+   K+        E
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK--------KILMHNEKDGFPITALRE 57

Query: 97  ILTWSKIEHLNLVKLFG-FLEHGDER-------IIVVEYVGNGTLREH-LDGRGGN---G 144
           I    K++H N+V L    +E  D+         +V  Y+      +H L G   N    
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSVK 111

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L  ++     + +   + YLH   +  I+HRD+KA+NILI  +   K+ DFG AR  +  
Sbjct: 112 LTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 205 SAVSHISTQVKGTAGYLDPDY-----LRTY----------QLTEKSDVYSFGVLLVEMMT 249
                     KG  G     Y      R Y          + T   D++  G +  EM T
Sbjct: 169 ------PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222

Query: 250 GRYPI 254
            R PI
Sbjct: 223 RR-PI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 37/235 (15%)

Query: 50  FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN---KHDKCLLLEFKNEILTWSKIEH 105
           F     +G+G  G V+  +LK  G + A+K   K    K +K   +  + EIL  + ++H
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLDH 60

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL-ELAERLDIAIDVAHALTYL 164
             L  L+   +      +V++Y   G L   L  + G  L E   R   A +V  AL YL
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYL 119

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS--------------EEDSAVSHI 210
           H      I++RD+K  NIL+ E     ++DF  ++ S                 S+V+ I
Sbjct: 120 HLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 211 STQVK------------GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
            ++              GT  Y+ P+ +         D ++ G+LL EM+ G  P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 48/207 (23%), Positives = 104/207 (50%), Gaps = 8/207 (3%)

Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           ++G G  G V KG  K++   I    +  KN+++K +  E   E     ++++  +V++ 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G  E  +  ++V+E    G L + L G+  + + ++  +++   V+  + YL   +    
Sbjct: 62  GVCE-AEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---F 116

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A N+L+  +  AK++DFG ++    D +     +  K    +  P+ +   + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 233 EKSDVYSFGVLLVEMMT-GRYPIESKK 258
            +SDV+S+G+ + E  + G+ P +  K
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMK 203

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 65/251 (25%), Positives = 94/251 (37%), Gaps = 55/251 (21%)

Query: 69  LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV 128
           LK G I+A          + L+ E K    T +   H  LV LF   +  D    V+EY 
Sbjct: 32  LKKGDIIA------RDEVESLMCE-KRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84

Query: 129 GNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHTYSDPPIIHRDVKASNI 182
             G L  H+           +          A  V   L YLH   +  I++RD+K  N+
Sbjct: 85  AGGDLMMHIH---------TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNL 132

Query: 183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGV 242
           L+  +   K+ DFG  +   E       ++   GT  +L P+ L     T   D +  GV
Sbjct: 133 LLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGV 189

Query: 243 LLVEMMTGRYP------------IESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP 290
           L+ EM+ G  P            I + +    R   R         +AI +M   LRR P
Sbjct: 190 LIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSR---------EAISIMRRLLRRNP 240

Query: 291 ASNMAVEKILG 301
                 E+ LG
Sbjct: 241 ------ERRLG 245

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 53  ANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN---- 107
             K+G   +G +Y  K LK  +IV  ++A+  +H +      + ++L     E +     
Sbjct: 19  VRKVGGHDAGKLYAMKVLKKATIV--QKAKTAEHTRT-----ERQVL-----EAVRRCPF 66

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV L    +   +  ++++YV  G L  HL  R  +  E   R+ IA ++  AL +LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIA-EIVLALDHLHQL 124

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARM---SEEDSAVSHISTQVKGTAGYLDPD 224
               II+RD+K  NIL+  +    +TDFG ++     EE+ A S       GT  Y+ P+
Sbjct: 125 G---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-----GTIEYMAPE 176

Query: 225 YLRTYQLTEKS--DVYSFGVLLVEMMTGRYP 253
            +R          D +S GVL  E++TG  P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 9/160 (5%)

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           +N +L  S+   L  +K + F  H D    V+EY   G L  HL  R     E   R   
Sbjct: 45  ENRVLQNSRHPFLTALK-YSFQTH-DRLCFVMEYANGGELFFHLS-RERVFSEDRARF-Y 100

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
             ++  AL YLH  S+  +++RD+K  N+++ +    K+TDFG  +   +D A       
Sbjct: 101 GAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC- 157

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
             GT  YL P+ L         D +  GV++ EMM GR P
Sbjct: 158 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 36/235 (15%)

Query: 45  KATENFSPANK-IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN------- 95
             +E +      +GEG  G V K      G IVA+K+ +  +    +  + +        
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 96  -----EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
                E+   ++I+H N++ L      GD   +V++ +    L++ +D +    + L E 
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK----IRLTES 119

Query: 151 LD--IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               I + + + L  LH +     +HRD+  +NI I  K   K+ DFG AR         
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 209 HISTQVKG-----------TAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
            +S                T  Y  P+ L    +     D++S G +  E++TG+
Sbjct: 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 9/146 (6%)

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R   A ++  AL YLH+     
Sbjct: 62  YSFQTH-DRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGA-EIVSALGYLHSCD--- 115

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +   E  +         GT  YL P+ L     
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)

Query: 56  IGEGGSGTV------YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V        GK+     +  KR +K K +   L    NE     K+    +V
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL----NEKRILEKVNSRFVV 63

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E  D   +V+  +  G L+ H+   G  G +    +  A ++   L  L     
Sbjct: 64  SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER- 122

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I++RD+K  NIL+ ++   +++D G A    E      +  +V GT GY+ P+ +   
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRV-GTVGYMAPEVINNE 176

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
           + T   D +  G L+ EM+ G+ P   +   KERV
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKR---KERV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 7/160 (4%)

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           EI     + H  +V+ +G L   +E+   I VEY+  G++++ L   G     +  R   
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            I     ++YLH+     I+HRD+K +NIL       K+ DFG ++  +           
Sbjct: 114 QI--LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           V GT  ++ P+ +       K+DV+S    +VEM+T + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 10/149 (6%)

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           L +L    +  D    V+EYV  G L  H+   G    +    +  A ++A  L +LH+ 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK 120

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               II+RD+K  N+++  +   K+ DFG   M +E+      +    GT  Y+ P+ + 
Sbjct: 121 G---IIYRDLKLDNVMLDAEGHIKIADFG---MCKENIFGGKTTRTFCGTPDYIAPEII- 173

Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIE 255
            YQ   KS D ++FGVLL EM+ G+ P +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           L +L    +  D    V+EYV  G L   +   G    +    +  A ++A  L +LH+ 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK 120

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               II+RD+K  N+++  +   K+ DFG   M +E+      +    GT  Y+ P+ + 
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFCGTPDYIAPEIIA 174

Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIESK 257
            YQ   KS D ++FGVLL EM+ G+ P E +
Sbjct: 175 -YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 11/199 (5%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           K+GEG   TVYKG  + +G +VA+K       +       +   L    ++H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLL-KGLKHANIVLLHD 70

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +   +    V EY+ +  L +++    G GL           +   L Y+H      I+
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQH---IL 125

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR-TYQLT 232
           HRD+K  N+LI+     K+ DFG AR     S     S++V  T  Y  PD L      +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVV-TLWYRPPDVLLGATDYS 182

Query: 233 EKSDVYSFGVLLVEMMTGR 251
              D++  G + +EM+ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 64/244 (26%), Positives = 96/244 (39%), Gaps = 50/244 (20%)

Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN 95
            F F +     E      KIG+G  G V+K +  K   IVA+K+       +   +    
Sbjct: 4   EFPFCDEVSKYEKL---AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60

Query: 96  EILTWSKIEHLNLVKL---------------------FGFLEHGDERIIVVEYVGNGTLR 134
           EI     ++H N+V L                     F F EH    ++  + V      
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK----- 115

Query: 135 EHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD 194
                       L+E   +   + + L Y+H      I+HRD+KA+NILIT+    K+ D
Sbjct: 116 ----------FTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162

Query: 195 FGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTG 250
           FG AR  S   ++  +  T    T  Y  P+ L   R Y      D++  G ++ EM T 
Sbjct: 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY--GPPIDMWGAGCIMAEMWT- 219

Query: 251 RYPI 254
           R PI
Sbjct: 220 RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 30/196 (15%)

Query: 74  IVAVK--RARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG 131
           +VAVK  R   NK+ +    +F  E+   S+++  N+++L G     D   ++ EY+ NG
Sbjct: 48  LVAVKILRPDANKNARN---DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104

Query: 132 TLRE-----HLDGRGGNGLELAER------------LDIAIDVAHALTYLHTYSDPPIIH 174
            L +     HLD +  NG +                L +A+ +A  + YL + +    +H
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG--YLDPDYLRTYQLT 232
           RD+   N L+ E L  K+ DFG   MS    A  +   Q +      ++  + +   + T
Sbjct: 162 RDLATRNCLVGENLTIKIADFG---MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218

Query: 233 EKSDVYSFGVLLVEMM 248
             SDV++FGV L E++
Sbjct: 219 TASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 29/251 (11%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +GEG  G V K + K+   IVA+K+ + ++ ++ +      E+     ++  N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL-------HTY 167
                +  +V EYV              N LEL E +   +      +Y+       H  
Sbjct: 69  FRRRGKLYLVFEYVEK------------NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+K  N+LI+     K+ DFGFAR   E S  ++  T+   T  Y  P+ L 
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRSPELLL 174

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGR--YPIESKKPIKERVTIRWAMQCLKAGDAILVM-DP 284
                +  D++S G +L E+  G+  +P ES+  I +  TI+  +  L A    L   +P
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFYSNP 232

Query: 285 RLR--RTPASN 293
           R    R PA N
Sbjct: 233 RFHGLRFPAVN 243

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 29/96 (30%), Positives = 54/96 (56%), Gaps = 5/96 (5%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ +   +   T+   T  
Sbjct: 118 GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 220 YLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPI 254
           Y  P+ +   +   K+ D++S G +L EM++ R P+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y+H+     IIHRD+K SNI + E    K+ DFG AR ++++       T    T  
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------MTGYVATRW 180

Query: 220 YLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           Y  P+  L      +  D++S G ++ E++TG+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 61/235 (25%)

Query: 55  KIGEGGSGTVYKGKLKDGS---IVAVKRARKNKHDK-------CLLLEFKNEILTWSKIE 104
            IG G  G VYK K K+G      A+K+ + +K          C       EI    +++
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC------REIALLRELK 60

Query: 105 HLNLVKLFG-FLEHGDERI-IVVEYVGNGTLREH------LDGRGGNGLELAERL--DIA 154
           H N+V L   FLEH D+ + ++ +Y       EH         R    + +   +   + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYA------EHDLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT----EKLRAKVTDFGFAR--------MSE 202
             + + + YLH+     ++HRD+K +NIL+     E+   K+ D G AR        +++
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 203 EDSAVSHISTQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            D  V         T  Y  P+ L   R Y  T+  D+++ G +  E++T   PI
Sbjct: 172 LDPVVV--------TIWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTLE-PI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 21/217 (9%)

Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKN---KHD--KCLLLEFKNEILTWSK 102
           +F+    +G+G  G V   + K    + A+K  +K+   + D  +C ++E K  +    K
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVE-KRVLALQDK 59

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
              L   +L    +  D    V+EYV  G L  H+   G    +  + +  A +++  L 
Sbjct: 60  PPFLT--QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLF 115

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV-KGTAGYL 221
           +LH      II+RD+K  N+++  +   K+ DFG  +    +  V  ++T+   GT  Y+
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCGTPDYI 168

Query: 222 DPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPIESK 257
            P+ +  YQ   KS D +++GVLL EM+ G+ P + +
Sbjct: 169 APEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 4/93 (4%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L YLH+ +   +IHRD+K SNIL+      K+ DFG AR  + D       T+   T  
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 220 YLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGR 251
           Y  P+ L +    T+  D++S G +  E++T +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 58/199 (29%), Positives = 87/199 (43%), Gaps = 20/199 (10%)

Query: 67  GKLKDGSIVAVKRARKNKHDKCLLLE-----FKNEI---LTWSKI----EHLNLVKLFGF 114
           GK   G ++ V+     K+    +L+      K+E+   LT S++     H  L  L   
Sbjct: 4   GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            +  D    V+EYV  G L  HL  R     E   R     ++  AL YLH+     I++
Sbjct: 64  FQTKDRLCFVMEYVNGGELFFHLS-RERVFSEDRTRF-YGAEIVSALDYLHS---GKIVY 118

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+K  N+++ +    K+TDFG  +    D+A         GT  YL P+ L        
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---GTPEYLAPEVLEDNDYGRA 175

Query: 235 SDVYSFGVLLVEMMTGRYP 253
            D +  GV++ EMM GR P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 29/224 (12%)

Query: 50  FSPANKIGEGGSGTVYKGKLK--DGSI--VAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
           F+    +G+G  G+V + +LK  DGS   VAVK  + +      + EF  E     + +H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 106 LNLVKLFGFLEHGDER------IIVVEYVGNGTLREHL----DGRGGNGLELAERLDIAI 155
            N++KL G       +      ++++ ++ +G L   L     G     L L   +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           D+A  + YL   S    IHRD+ A N ++ E +   V DFG ++       +       +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK------KIYSGDYYRQ 171

Query: 216 GTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT-GRYP 253
           G A  L   +L    L     T  SDV++FGV + E+MT G+ P
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 20/130 (15%)

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L+  + L  +  VA  +++L + +    IHRD+ A NIL+T     K+ DFG AR    D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 205 SAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT------GRYPI 254
           S     +  VKG A     ++ P+ +     T +SDV+S+G+LL E+ +         P+
Sbjct: 268 S-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322

Query: 255 ESK--KPIKE 262
           +SK  K IKE
Sbjct: 323 DSKFYKMIKE 332

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 12/155 (7%)

Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
           S++ H +LV  +G    GDE I+V EYV  G+L  +L  +  N + ++ +L++A  +A A
Sbjct: 54  SQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWA 112

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT--- 217
           L +L    D  + H +V A N+L+  +   K  +  F ++S  D  +S I+   K     
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS--DPGIS-ITVLPKEILLE 166

Query: 218 -AGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTG 250
              ++ P+ +   Q L+  +D +SFG  L E+ +G
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 45/146 (30%), Positives = 66/146 (45%), Gaps = 9/146 (6%)

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R   A ++  AL YLH+     
Sbjct: 62  YAFQTH-DRLCFVMEYANGGELFFHLS-RERVFTEERARFYGA-EIVSALEYLHSRD--- 115

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 172

Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 14/204 (6%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKN----KHDKCLLLEFKNEILTWSKIEHLNLVK 110
           IG+G  G VY+ + KD   I A+K   K     K +    +  +N ++     E   +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L    +   +  +V +Y+  G L  HL  + G   E   +  IA ++  AL +LH Y   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLHKYD-- 116

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            I++RD+K  NIL+       + DFG ++ +  D+  ++      GT  YL P+ L   +
Sbjct: 117 -IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLDEK 172

Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             T+  D +S GVL+ EM  G  P
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 22/220 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSI--VAVKRARKNKHDKCLLLEF---KNEILTWSK 102
           E+F+    +G G  G V     K+     VA+KR  K+K  K   ++    + +IL +  
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-- 87

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHA 160
           I H   V L+G  +      +V+E+V  G     L  + R  N +        A  +   
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----YAAQIVLI 143

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             YL + +   I++RD+K  N+L+ +    K+TDFGFA++ +  +        + GT  Y
Sbjct: 144 FEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT------LCGTPEY 194

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI 260
           + P+ L      + +D ++ G+ + E++ G  P  + +P+
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 51/200 (25%), Positives = 93/200 (46%), Gaps = 10/200 (5%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH--DKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           IG+G  G V + + +D   +   +  +  H   +  +     E    +++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
             +  ++  +V+ ++  G L  HL  R G       R   A ++  AL  LH ++   +I
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTA-ELLCALENLHKFN---VI 115

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           +RD+K  NIL+  +    + DFG  +++ +D   ++      GT  YL P+ L  +  T+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHGYTK 172

Query: 234 KSDVYSFGVLLVEMMTGRYP 253
             D ++ GVLL EM+TG  P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)

Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 8   LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 64

Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120

Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 121 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 173

Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 174 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLRE--HLDGRGGNGLELAERLDIAIDVAHAL 161
           ++ N +KL+  +      +++++Y+ +G L +    +G+    L  AE   I   +  AL
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKIIRQLVEAL 122

Query: 162 TYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             LH ++   IIH D+K  N+L    K R  + D+G  ++      +   S    GT  Y
Sbjct: 123 NDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPSCY-DGTLDY 172

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
             P+ ++ +      D ++ GVL  E++TG++P +
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 11/158 (6%)

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           E +    + H +++++   L  G    +V+ +  +  L  +L  R    L + + L I  
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRP-LPIDQALIIEK 164

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   L YLH      IIHRDVK  NI I +  +  + D G A+      A   ++  V+
Sbjct: 165 QILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVE 221

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
             A    P+ L   +   K+D++S G++L EM+   YP
Sbjct: 222 TNA----PEVLARDKYNSKADIWSAGIVLFEMLA--YP 253

Length = 357

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 51/158 (32%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKH-DKCLLLEFKNE--ILTWSKI 103
           E F     I  G  G VY G K  +  + AVK  +K    +K ++ + + E   L  SK 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
             +  V L+  L+  +   +V+EY+  G ++  L   G    E+A    I+ +VA AL Y
Sbjct: 64  PFI--VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-VKYIS-EVALALDY 119

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
           LH +    IIHRD+K  N+LI+ +   K+TDFG ++++
Sbjct: 120 LHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 9/102 (8%)

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           +V  AL  +H+      IHRDVK  N+L+ +    K+ DFG     + +  V    T V 
Sbjct: 150 EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAV- 204

Query: 216 GTAGYLDPDYLRTY----QLTEKSDVYSFGVLLVEMMTGRYP 253
           GT  Y+ P+ L++         + D +S GV L EM+ G  P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 45/228 (19%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEI-LTWSKIEH 105
           + +    KIGEG  G VYK +    G +VA+K+ R    ++ +      EI L     E 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 106 LNLVKLFGFLEHGDERI------IVVEYVGNGTLREHLDG-RGGNGLELAERL------D 152
           + +V+L   +EH +E+       +V EY+ +  L++ +D    G G  L  +        
Sbjct: 61  IYIVRLLD-VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHIS 211
           +   VAH     H +    ++HRD+K  N+L+  +K   K+ D G  R           S
Sbjct: 119 LLKGVAH----CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR---------AFS 162

Query: 212 TQVKG------TAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTG 250
             VK       T  Y  P+ L     Y  +   D++S G +  EM   
Sbjct: 163 IPVKSYTHEIVTLWYRAPEVLLGSTHY--STPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 52.6 bits (126), Expect = 8e-08
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVA---VK--RARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++IG G  G V  G+   G   A   VK  RA     ++ L L+   E+  + ++ H N+
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ---EVQPYRELNHPNV 57

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER---LDIAIDVAHALTYLH 165
           ++  G        ++V+E+   G L+ +L    G   ++A++     +A +VA  L +LH
Sbjct: 58  LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS-EEDSAVSHISTQVKGTAGYLDP- 223
                  IH D+   N  +T  L  K+ D+G A     ED  ++           +L P 
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT--KDCHAVPLRWLAPE 172

Query: 224 ------DYLRTYQLTEKSDVYSFGVLLVEMMT 249
                   L     T+KS+++S GV + E+ T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 36/264 (13%)

Query: 9   ESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKA-TENFSPANKIGEGGSGTVYKG 67
           E N K   +  RS+ +++     +   I+    +I ++  +++   N IG G  G VY+ 
Sbjct: 29  EMNDKKLDEEERSHNNNAGEDEDEEKMID---NDINRSPNKSYKLGNIIGNGSFGVVYEA 85

Query: 68  KLKDGS-IVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKLFGF-----LEHGDE 120
              D S  VA+K+  ++        ++KN E+L    + H+N++ L  +      +  ++
Sbjct: 86  ICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138

Query: 121 RI---IVVEYVGNGTLREHLD--GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
            I   +V+E++   T+ +++    R  + L L      +  +  AL Y+H+     I HR
Sbjct: 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHR 194

Query: 176 DVKASNILITEKLRA-KVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPD-YLRTYQLT 232
           D+K  N+LI       K+ DFG A+ +     +VS+I ++      Y  P+  L     T
Sbjct: 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYT 249

Query: 233 EKSDVYSFGVLLVEMMTGRYPIES 256
              D++S G ++ EM+ G YPI S
Sbjct: 250 THIDLWSLGCIIAEMILG-YPIFS 272

Length = 440

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 6/96 (6%)

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAG 219
           L Y+H+ +   +IHRD+K SN+L+ E    ++ DFG AR +S   +   +  T+   T  
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 220 YLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPI 254
           Y  P+ L +  + T   D++S G +  EM+ GR  +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 51/157 (32%), Positives = 70/157 (44%), Gaps = 26/157 (16%)

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA----GYLDPDYLRT 228
           IHRD+ A NIL++E    K+ DFG AR   +D          KG+A     ++ P+ +  
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-----KGSARLPLKWMAPESIFD 250

Query: 229 YQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
              T +SDV+SFGVLL E+ + G  P    + I E    R     LK G        R+R
Sbjct: 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-INEEFCQR-----LKDGT-------RMR 297

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
              A   A  +I  +   C     + RPT     EIL
Sbjct: 298 ---APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           AL Y+HT +   + HRD+K  NIL     + K+ DFG AR++  D+  +   T    T  
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 220 YLDPDYLRTY--QLTEKSDVYSFGVLLVEMMTGR 251
           Y  P+   ++  + T   D++S G +  E++TG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 48/169 (28%), Positives = 79/169 (46%), Gaps = 25/169 (14%)

Query: 123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI 182
           ++++YV  G +  HL  R  N  E   R     ++  AL +LH      I++RD+K  NI
Sbjct: 82  LILDYVSGGEMFTHLYQRD-NFSEDEVRFYSG-EIILALEHLHKLG---IVYRDIKLENI 136

Query: 183 LITEKLRAKVTDFGFAR--MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS-DVYS 239
           L+  +    +TDFG ++  +SEE            GT  Y+ P+ +R      K+ D +S
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLSEEKERTYSFC----GTIEYMAPEIIRGKGGHGKAVDWWS 192

Query: 240 FGVLLVEMMTGRYP--IESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
            G+L+ E++TG  P  +E ++  +  V+ R           IL  DP  
Sbjct: 193 LGILIFELLTGASPFTLEGERNTQSEVSRR-----------ILKCDPPF 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 45/185 (24%), Positives = 87/185 (47%), Gaps = 31/185 (16%)

Query: 96  EILTWSKIEHLNLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDG--RGGNGLELAERL 151
           E+    +++H N+V+    FL   ++++ I++E+   G L  ++    +    +E    +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 152 DIAIDVAHALTYLHTYSDPP----IIHRDVKASNILITEKLR-----------------A 190
           DI   + HAL Y H   D P    ++HRD+K  NI ++  +R                 A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQLTEKSDVYSFGVLLVEMM 248
           K+ DFG ++    +  +  ++    GT  Y  P+ L   T    +KSD+++ G ++ E+ 
Sbjct: 182 KIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 249 TGRYP 253
           +G+ P
Sbjct: 238 SGKTP 242

Length = 1021

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 43/228 (18%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIV----------AVKRARKN--KHDKCLLLEFKN 95
           E+F     IG G  G V   KLK+   V           +KRA     + ++ +L+   N
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG--TLREHLDGRGGNGLE---LAER 150
           +   W    H      + F +  +  +++  YVG    TL    + R    +    LAE 
Sbjct: 61  Q---WITTLH------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           + IAID  H L Y         +HRD+K  NIL+      ++ DFG      ED  V   
Sbjct: 112 V-IAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-- 159

Query: 211 STQVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYP 253
           S+   GT  Y+ P+ L+  +        + D +S GV + EM+ G  P
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 6/97 (6%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTA 218
            L Y+H+ +   ++HRD+K  N+L+      K+ DFG AR  SE     +   T+   T 
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 219 GYLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPI 254
            Y  P+ + ++Q   K+ DV+S G +L E++ GR P+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 64/280 (22%), Positives = 102/280 (36%), Gaps = 80/280 (28%)

Query: 50  FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN-----------KHDKCLLLEFKNEI 97
           F     +G G  G V   +  D  ++ A+K  RK            K ++ +L E  NE 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE- 61

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE----RLDI 153
             W       +V+L+   +  D    V++Y+  G +   L   G    +LA      L  
Sbjct: 62  --W-------VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTC 112

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA--------------- 198
           A++  H + +         IHRD+K  NILI      K+TDFG                 
Sbjct: 113 AVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163

Query: 199 ----------RMSEEDSAVSHISTQVK-------------------GTAGYLDPDYLRTY 229
                          D A      ++K                   GT  Y+ P+ L   
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV-TIRW 268
             T+  D +S GV+L EM+ G+ P  ++ P++ ++  I W
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 38/226 (16%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN----LV 109
           K+    SG +Y  K LK  +IV  ++A+  +H +      + ++L     EH+     LV
Sbjct: 21  KVSGHDSGKLYAMKVLKKATIV--QKAKTTEHTRT-----ERQVL-----EHIRQSPFLV 68

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHT 166
            L    +   +  ++++Y+  G L  HL  R     E  +  ++ I   ++  AL +LH 
Sbjct: 69  TLHYAFQTDTKLHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHK 123

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                II+RD+K  NIL+       +TDFG ++   ED      S    GT  Y+ PD +
Sbjct: 124 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEYMAPDIV 178

Query: 227 RTYQLTEKS--DVYSFGVLLVEMMTGRYPI------ESKKPIKERV 264
           R          D +S GVL+ E++TG  P        S+  I  R+
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI 224

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 37/122 (30%), Positives = 52/122 (42%), Gaps = 38/122 (31%)

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L L + +  +  VA  + +L   +    IHRD+ A NIL++E    K+ DFG AR     
Sbjct: 170 LTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI--- 223

Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQ-----------------LTEKSDVYSFGVLLVEM 247
                          Y DPDY+R                     T +SDV+SFGVLL E+
Sbjct: 224 ---------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Query: 248 MT 249
            +
Sbjct: 269 FS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 66/262 (25%), Positives = 96/262 (36%), Gaps = 67/262 (25%)

Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIV-AVKRARKN-----------KHDKCLLLEFKNEI 97
           F     IG G  G V   +  D + + A+K  RK            K ++ +L E  NE 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE- 61

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
             W       +VKL+   +  D    V++Y+  G +   L   G    +LA R  IA ++
Sbjct: 62  --W-------VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIA-EL 110

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG--------------------- 196
             A+  +H       IHRD+K  NILI      K+TDFG                     
Sbjct: 111 TCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 197 ------FARMSEEDSA------VSHISTQVK-------GTAGYLDPDYLRTYQLTEKSDV 237
                     SE D                +       GT  Y+ P+ L     T+  D 
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227

Query: 238 YSFGVLLVEMMTGRYPIESKKP 259
           +S GV+L EM+ G+ P  +  P
Sbjct: 228 WSVGVILYEMLVGQPPFLADTP 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 61/258 (23%), Positives = 104/258 (40%), Gaps = 41/258 (15%)

Query: 56  IGEGGSGTVY------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V        GKL     +  KR +K K  +  ++E +  IL  +K+    +V
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR--IL--AKVHSRFIV 56

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN--GLELAERLDIAIDVAHALTYLHTY 167
            L    +   +  +V+  +  G LR H+        G            +   L +LH  
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYLD 222
               II+RD+K  N+L+      +++D G A        V     Q K     GT G++ 
Sbjct: 117 R---IIYRDLKPENVLLDNDGNVRISDLGLA--------VELKDGQSKTKGYAGTPGFMA 165

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES------KKPIKERV-------TIRWA 269
           P+ L+  +     D ++ GV L EM+  R P  +       K +K+R+         +++
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFS 225

Query: 270 MQCLKAGDAILVMDPRLR 287
                  +A+L  DP  R
Sbjct: 226 PASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 43/227 (18%)

Query: 55  KIGEGGSGTVY----KGKLK-------------DGSIVAVK--RARKNKHDKCLLLEFKN 95
           K+GEG  G V+    +G  K                +VAVK  R   NK+ +    +F  
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN---DFLK 68

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG-RGGNGLELAERLDI- 153
           EI   S+++  N+++L       D   ++ EY+ NG L + L         E A+ + I 
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 154 -------AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
                  A  +A  + YL + +    +HRD+   N L+ +    K+ DFG +R     + 
Sbjct: 129 YSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSR-----NL 180

Query: 207 VSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            S    +++G A     ++  + +   + T  SDV++FGV L E++T
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 48.9 bits (117), Expect = 3e-07
 Identities = 32/148 (21%), Positives = 53/148 (35%), Gaps = 16/148 (10%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV--KLF 112
            +  G +  VY    KD   V +K     +       E    IL    +    L   K+ 
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADREREV--AILQL--LARKGLPVPKVL 59

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
              E      +++E++   TL E         +   E+ DIA  +A  L  LH      +
Sbjct: 60  ASGESDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLVL 110

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARM 200
            H D+   NIL+ +     + D+ +A  
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 16/95 (16%)

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG---T 217
           L Y+H      IIHRD+K  N+ + E    K+ DFG AR            +++ G   T
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---------QTDSEMTGYVVT 178

Query: 218 AGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
             Y  P+ +  +   T+  D++S G ++ EM+TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 40/128 (31%), Positives = 53/128 (41%), Gaps = 15/128 (11%)

Query: 141 GGNGLELAERLDIAIDVAHALTYL-------HTYSDPPIIHRDVKASNILITEKLRAKVT 193
           GG+ L L  R +   D   A  YL       H+      +HRD+K  N+LI      K+ 
Sbjct: 85  GGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA 144

Query: 194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS------DVYSFGVLLVEM 247
           DFG A     +  V   S    GT  Y+ P+ L T     K       D +S GV+  EM
Sbjct: 145 DFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202

Query: 248 MTGRYPIE 255
           + GR P  
Sbjct: 203 IYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 28/158 (17%)

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI--------AIDVAH 159
           +V+LF   +      +V+EY+            GG+ + L    D+          +V  
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYM-----------PGGDLVNLMSNYDVPEKWAKFYTAEVVL 153

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           AL  +H+     +IHRDVK  N+L+ +    K+ DFG   M  +++ +    T V GT  
Sbjct: 154 ALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAV-GTPD 208

Query: 220 YLDPDYLRTY----QLTEKSDVYSFGVLLVEMMTGRYP 253
           Y+ P+ L++         + D +S GV L EM+ G  P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 47/167 (28%), Positives = 87/167 (52%), Gaps = 9/167 (5%)

Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
           S++ H++L  + G    G E I+V E+V +G L   L    G  + +A ++ +A  +A A
Sbjct: 71  SQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR-VPVAWKITVAQQLASA 129

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-GTAG 219
           L+YL    D  ++H +V A NIL+     A+ T   F ++S+   + + +S + +     
Sbjct: 130 LSYLE---DKNLVHGNVCAKNILLARLGLAEGTS-PFIKLSDPGVSFTALSREERVERIP 185

Query: 220 YLDPDYLRTY-QLTEKSDVYSFGVLLVEM-MTGRYPIESKKPI-KER 263
           ++ P+ +     L+  +D +SFG  L+E+   G  P++ + P  KER
Sbjct: 186 WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 21/210 (10%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG- 113
           K+G G  G VYK K KDG     + A K      + +    EI    +++H N++ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKD-EKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 114 FLEHGDERI-IVVEYVGNG---TLREHLDGRGGNG-LELAERL--DIAIDVAHALTYLHT 166
           FL H D ++ ++ +Y  +     ++ H   +     ++L   +   +   +   + YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 167 YSDPPIIHRDVKASNILIT----EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
                ++HRD+K +NIL+     E+ R K+ D GFAR+             V  T  Y  
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 223 PDYL---RTYQLTEKSDVYSFGVLLVEMMT 249
           P+ L   R Y  T+  D+++ G +  E++T
Sbjct: 184 PELLLGARHY--TKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 15/207 (7%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG- 113
           K+G G  G VYK K KDG       A K      + +    EI    +++H N++ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDR-DYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 114 FLEHGDERI-IVVEYVGNG---TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           FL H D ++ ++ +Y  +     ++ H   +         R  +   +   L  +H    
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 170 PPIIHRDVKASNILIT----EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
             ++HRD+K +NIL+     E+ R K+ D GFAR+             V  T  Y  P+ 
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMT 249
           L   R Y  T+  D+++ G +  E++T
Sbjct: 187 LLGARHY--TKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 36/120 (30%), Positives = 59/120 (49%), Gaps = 6/120 (5%)

Query: 131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA 190
             ++  L   G  GL   + L     VA  + +L + +    +HRD+ A N+L+ +    
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIV 276

Query: 191 KVTDFGFARMSEEDSA-VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           K+ DFG AR    DS  VS  ST +     ++ P+ +     T  SDV+S+G+LL E+ +
Sbjct: 277 KICDFGLARDIMHDSNYVSKGSTFLP--VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 32/81 (39%), Positives = 46/81 (56%), Gaps = 9/81 (11%)

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA----GYLDPDYLRT 228
           +HRD+ A N+LI E    K+ DFG AR    DS  ++IS   KG+      ++ P+ +  
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDS--NYIS---KGSTFLPLKWMAPESIFN 315

Query: 229 YQLTEKSDVYSFGVLLVEMMT 249
              T  SDV+SFG+LL E+ T
Sbjct: 316 NLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLN--- 107
           IG GG G VY  +  D G + A+K    +  K K  + L L   NE +  S +   +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NERIMLSLVSTGDCPF 58

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +V +       D+   +++ +  G L  HL   G       E    A ++   L ++H  
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNR 116

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               +++RD+K +NIL+ E    +++D G A   +      H S    GT GY+ P+ L+
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV---GTHGYMAPEVLQ 168

Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIESKK 258
                + S D +S G +L +++ G  P    K
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 12/119 (10%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST-QVKGTA 218
           AL YLH      IIHRDVK  NI + E   A + DFG A   +      H  T Q  G +
Sbjct: 197 ALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA-----HPDTPQCYGWS 248

Query: 219 GYLD---PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
           G L+   P+ L       K+D++S G++L EM      +  K+       +R  ++C++
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307

Length = 392

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 61/259 (23%), Positives = 102/259 (39%), Gaps = 62/259 (23%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEH 105
           ++F     IG G  G V   + KD G I A+K+ RK++  +K  +   + E    ++ ++
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNG----------TLREHLDGRGGNGLELAERLDIAI 155
             +VKL+   +  +   +++EY+  G          T  E           +AE + +AI
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIAETI-LAI 114

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG------------FARMSEE 203
           D  H L Y         IHRD+K  N+L+  K   K++DFG            F R+   
Sbjct: 115 DSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 204 DSAVSHISTQVK-----------------------GTAGYLDPDYLRTYQLTEKSDVYSF 240
               + +    K                       GT  Y+ P+        ++ D +S 
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225

Query: 241 GVLLVEMMTGRYPIESKKP 259
           GV++ EM+ G  P  S  P
Sbjct: 226 GVIMYEMLVGYPPFCSDNP 244

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR + E        T+   T  Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK---GDFMTEYVVTRWY 174

Query: 221 LDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
             P+  L   + T   DV+S G +  E++ GR P+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 19/113 (16%)

Query: 147 LAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDS 205
           LAE + +AID  H L Y         +HRD+K  N+L+ +    ++ DFG   R+  + +
Sbjct: 108 LAEMV-LAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157

Query: 206 AVSHISTQVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYP 253
             S+++    GT  Y+ P+ L+  +        + D +S GV + EM+ G  P
Sbjct: 158 VQSNVAV---GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 31/81 (38%), Positives = 44/81 (54%), Gaps = 9/81 (11%)

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA----GYLDPDYLRT 228
           IHRD+ A NIL++E    K+ DFG AR   +D          KG A     ++ P+ +  
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-----KGDARLPLKWMAPETIFD 255

Query: 229 YQLTEKSDVYSFGVLLVEMMT 249
              T +SDV+SFGVLL E+ +
Sbjct: 256 RVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 46/190 (24%), Positives = 76/190 (40%), Gaps = 9/190 (4%)

Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG 131
           G++V V+        +  L   +NE++      H N++  +     G    ++  ++  G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---- 187
           +    L      G+  A   +I       L YLH       IHR++KAS+ILI+      
Sbjct: 85  SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVS 141

Query: 188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLV 245
           L      +   R  ++   V            +L P+ LR   Y    KSD+YS G+   
Sbjct: 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITAC 201

Query: 246 EMMTGRYPIE 255
           E+ TGR P +
Sbjct: 202 ELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLN--- 107
           IG GG G VY  +  D G + A+K    +  K K  + L L   NE +  S +   +   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NERIMLSLVSTGDCPF 58

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +V +       D+   +++ +  G L  HL   G      AE    A ++   L ++H  
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNR 116

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               +++RD+K +NIL+ E    +++D G A   +      H S    GT GY+ P+ L+
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV---GTHGYMAPEVLQ 168

Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIESKK 258
                + S D +S G +L +++ G  P    K
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T    T  
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRY 182

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           Y  P+ +      E  D++S G ++ EM+ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 47.6 bits (113), Expect = 4e-06
 Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 16/95 (16%)

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG---T 217
           L Y+H+     IIHRD+K  N+ + E    K+ DFG AR         H   ++ G   T
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVT 177

Query: 218 AGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
             Y  P+ +  +    +  D++S G ++ EM+TG+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVA---VKRARKNKHDKCLLLEFKNEILT----WSKIEHLN 107
           +IG G  G V   ++   + VA   VK  + N   K      +NE L     +  ++H N
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK-----EQNEFLQQGDPYRILQHPN 56

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL----DGRGGNGLELAERLDIAIDVAHALTY 163
           +++  G        ++V EY   G L+ +L      R  + L L +R+  A ++A  +T+
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTH 114

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDF--GFARMSEEDSAVSHISTQVKGTAG-- 219
           +H ++    +H D+   N  +T  L  KV D+  G +R  E+     +I T+        
Sbjct: 115 MHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-----YIETEDDKCVPLR 166

Query: 220 YLDP-------DYLRTYQLTEKSDVYSFGVLLVEM 247
           +L P         L T + T+ S+V++ GV L E+
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 26/92 (28%), Positives = 48/92 (52%), Gaps = 10/92 (10%)

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L Y+H+     IIHRD+K SN+ + E    ++ DFG AR ++++       T    T  Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE------MTGYVATRWY 181

Query: 221 LDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
             P+ +  +    +  D++S G ++ E++ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           + + + L I   V  A+ YLH      IIHRD+KA NI I       + DFG A    + 
Sbjct: 179 IAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235

Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           +A  +      GT     P+ L         D++S G++L EM T  
Sbjct: 236 NANKYYGW--AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 49/251 (19%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARK-NKHDKCLLLEFKNEILTWSKIEH 105
           E+F     IG G  G V   + KD G + A+K  RK +  +K  +   + E     + + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG-----GNGLELAERLDIAIDVAHA 160
           L +VK+F   +      +++E++  G +   L  +           +AE + +AID  H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV-LAIDSIHQ 119

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG------------------------ 196
           L +         IHRD+K  N+L+  K   K++DFG                        
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170

Query: 197 --FARMSEEDSAVS------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
             F  M+ +  A +       ++    GT  Y+ P+        +  D +S GV++ EM+
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 249 TGRYPIESKKP 259
            G  P  S+ P
Sbjct: 231 IGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            + +LH+     IIHRD+K SNI++      K+ DFG AR     +  + + T    T  
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----ACTNFMMTPYVVTRY 187

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
           Y  P+ +      E  D++S G ++ E++ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 18/153 (11%)

Query: 108 LVKLFGFLEHGDERIIVVEYVGNG---TLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           +V+LF   +      +V+EY+  G    L  + D            + +A+D  H++ + 
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF- 163

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
                   IHRDVK  N+L+ +    K+ DFG      ++  V    T V GT  Y+ P+
Sbjct: 164 --------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAV-GTPDYISPE 213

Query: 225 YLRTY----QLTEKSDVYSFGVLLVEMMTGRYP 253
            L++         + D +S GV L EM+ G  P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 16/106 (15%)

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           +AI   H L Y         +HRD+K  N+L+      ++ DFG      +D  V   S+
Sbjct: 113 LAIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SS 161

Query: 213 QVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYP 253
              GT  Y+ P+ L+  +        + D +S GV + EM+ G  P
Sbjct: 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 41/235 (17%)

Query: 37  NFSFEEIYKAT-------ENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHD 86
           NF   EI  +T       +N  P   IG G  G V   Y   L+    VA+K+  +   +
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQN 63

Query: 87  KCLLLEFKNEILTWSKIEHLNLVKLFGF------LEHGDERIIVVEYVGNG---TLREHL 137
           +        E++    + H N++ L         LE   +  IV+E +       ++  L
Sbjct: 64  QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123

Query: 138 DGRGGNGLELAERLDIAI-DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG 196
           D          ER+   +  +   + +LH+     IIHRD+K SNI++      K+ DFG
Sbjct: 124 D---------HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171

Query: 197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
            AR     +  S + T    T  Y  P+ +      E  D++S G ++ EM+ G 
Sbjct: 172 LART----AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 64/280 (22%), Positives = 102/280 (36%), Gaps = 80/280 (28%)

Query: 50  FSPANKIGEGGSGTV-YKGKLKDGSIVAVKRARKN-----------KHDKCLLLEFKNEI 97
           F     +G G  G V    K+   ++ A+K  RK            K ++ +L E  NE 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE- 61

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE----RLDI 153
             W       +VKL+   +  D    V++Y+  G +   L         LA      L +
Sbjct: 62  --W-------VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL 112

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA--------------- 198
           AI+  H + +         IHRD+K  NILI      K+TDFG                 
Sbjct: 113 AIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163

Query: 199 --------------------------RMSEEDSAVSH---ISTQVKGTAGYLDPDYLRTY 229
                                     +  E+ +   H   ++  + GT  Y+ P+ L   
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV-TIRW 268
             T+  D +S GV+L EM+ G+ P  +  P + ++  I W
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V L  ++   D   +V+++   G L  H+        E  +R   A ++  AL  LH 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRW--AAEMVVALDALHR 103

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE-EDS----AVSHISTQVKGTAGYL 221
                I+ RD+  +NIL+ ++   ++T F   R SE EDS    AV ++         Y 
Sbjct: 104 EG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM---------YC 149

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
            P+     + TE  D +S G +L E++TG+  +E 
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.5 bits (107), Expect = 2e-05
 Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 7/89 (7%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T    T  
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYVVTRY 183

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
           Y  P+ +      E  D++S G ++ EM+
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 53/253 (20%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           ++F     IG G  G V   + KD G I A+K  RK    + ++   +  + +IL   + 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV--EA 58

Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLE-----LAERLDIAIDVA 158
           +   +VK+F   +      +++E++  G +   L  +     E     +AE + +AID  
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV-LAIDAI 117

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG---------------------- 196
           H L +         IHRD+K  N+L+  K   K++DFG                      
Sbjct: 118 HQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168

Query: 197 ----FARMSEEDSAVS------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
               F  M+ +  A +       ++    GT  Y+ P+        +  D +S GV++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 247 MMTGRYPIESKKP 259
           M+ G  P  S+ P
Sbjct: 229 MLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 34/210 (16%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKL 111
            KIGEG    V K +  K G   A+K  +K+      +     EI    ++  H N+++L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 112 FGFL---EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
              L   + G  R+ +V  + +  L E + GR     E   +      +  +L ++H   
Sbjct: 64  IEVLFDRKTG--RLALVFELMDMNLYELIKGRKRPLPEKRVKS-YMYQLLKSLDHMHRNG 120

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH------ISTQVKGTAGYLD 222
              I HRD+K  NILI + +  K+ DFG  R        S       IST+      Y  
Sbjct: 121 ---IFHRDIKPENILIKDDI-LKLADFGSCR-----GIYSKPPYTEYISTR-----WYRA 166

Query: 223 PDYLRT---YQLTEKSDVYSFGVLLVEMMT 249
           P+ L T   Y    K D+++ G +  E+++
Sbjct: 167 PECLLTDGYY--GPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 55  KIGEGGSGTVYKGKLKDG---SIVAVKRARKNK--HDKCLLLEFKNEILTWSKIEHLNLV 109
           +IG G  G V  G++  G   + V VK  R +    ++   ++F  E   +  ++H NL+
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ---MKFLEEAQPYRSLQHSNLL 58

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDG-RGGNGL--ELAERLDIAIDVAHALTYLHT 166
           +  G        ++V+E+   G L+ +L   R    +  +      +A ++A  L +LH 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS-EEDSAVSHISTQVKGTAGYLDPDY 225
            +    IH D+   N L+T  L  K+ D+G +    +ED  V+    Q+     ++ P+ 
Sbjct: 119 NN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT--PDQLWVPLRWIAPEL 173

Query: 226 -------LRTYQLTEKSDVYSFGVLLVEM 247
                  L     T++S+V+S GV + E+
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 51/186 (27%), Positives = 74/186 (39%), Gaps = 49/186 (26%)

Query: 48  ENFSPANKIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEF-KNEILTW 100
           ++F    K+GEG  G VYK  L      K+G  V +K+A           E+   EI   
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT----------EYGAVEIWMN 180

Query: 101 SKIEHLNLVK----LFGFLEH-----GDERIIVVEYVGNGTL-------------REHLD 138
            ++           ++GFLE       DE  +V  Y G  TL               +L 
Sbjct: 181 ERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLL 240

Query: 139 GRGGNGLELAERLDIAI-----DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA-KV 192
           G+  +  +  ER +  I      +  AL  LH      I+HRDVK  NI+ +E   + K+
Sbjct: 241 GKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKI 297

Query: 193 TDFGFA 198
            D G A
Sbjct: 298 IDLGAA 303

Length = 566

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 22/224 (9%)

Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLL-----------LEFKNEILTWSKIE 104
           +G G    +Y G L              K  K +L           L F        ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H ++V L+G      E I+V E+V  G L   +  R  + L    +  +A  +A AL+YL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPWKFKVAKQLASALSYL 121

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFG-FARMSEEDSAVSHISTQVK-GTAGYLD 222
               D  ++H +V   NIL+  +      + G F ++S+    ++ +S Q       ++ 
Sbjct: 122 E---DKDLVHGNVCTKNILLARE--GIDGECGPFIKLSDPGIPITVLSRQECVERIPWIA 176

Query: 223 PDYLR-TYQLTEKSDVYSFGVLLVEM-MTGRYPIESKKPI-KER 263
           P+ +  +  L+  +D +SFG  L E+   G  P++ K    KER
Sbjct: 177 PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER 220

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 33/166 (19%)

Query: 48  ENFSPANKIGEGGSGTV-YKGKLKDGSIVAVKRARKN---KHDKCLLLEFKNEILT---- 99
           E+F     IG+G  G V    K   G I A+K   K+   K D+   ++ + ++L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 100 -------WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
                  +S  +   L  +  FL  GD   ++++Y    T  E +         +AE + 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY---DTFSEDV-----TRFYMAECV- 111

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA 198
           +AI+  H L +         IHRD+K  NILI      K++DFG +
Sbjct: 112 LAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	380
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.86
PRK10345	210	hypothetical protein; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
smart00090	237	RIO RIO-like kinase.	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
KOG1243	690	consensus Protein kinase [General function predict	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
KOG3087	229	consensus Serine/threonine protein kinase [General	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
COG4248	637	Uncharacterized protein with protein kinase and he	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.29
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.14
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.08
PRK09902	216	hypothetical protein; Provisional	98.99
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.96
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.96
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.91
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.73
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.72
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.63
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.45
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.43
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.34
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.21
PRK10593	297	hypothetical protein; Provisional	98.2
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.13
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.09
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.05
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.01
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.92
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.9
PRK05231	319	homoserine kinase; Provisional	97.86
KOG2270	520	consensus Serine/threonine protein kinase involved	97.82
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.8
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.72
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.69
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.63
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.47
PLN02756	418	S-methyl-5-thioribose kinase	97.3
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.16
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	97.15
PLN02236	344	choline kinase	97.15
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.07
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.98
PRK12396	409	5-methylribose kinase; Reviewed	96.94
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.71
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.7
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.67
PRK11768	325	serine/threonine protein kinase; Provisional	96.62
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.55
PRK06148	1013	hypothetical protein; Provisional	96.44
COG2334	331	Putative homoserine kinase type II (protein kinase	96.29
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.09
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.88
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.81
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.73

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-54  Score=403.45  Aligned_cols=290  Identities=47%  Similarity=0.765  Sum_probs=253.1

Q ss_pred             ccccccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEE
Q 041907           34 TTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG  113 (380)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  113 (380)
                      +...|++.++..++++|.....||+|+||.||+|...+|..||||++.......  ..+|.+|+.++.+++|||+|+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence            677899999999999999999999999999999999988999999887654432  456999999999999999999999


Q ss_pred             EEEeCC-EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 041907          114 FLEHGD-ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKV  192 (380)
Q Consensus       114 ~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl  192 (380)
                      ||.+.+ ..+||+||+++|+|.++|......+++|..+++|+.++|+||+|||....++|+|||||++|||+|+++.+||
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            999988 5999999999999999998876436999999999999999999999977778999999999999999999999


Q ss_pred             ccccccccccC-CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 041907          193 TDFGFARMSEE-DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ  271 (380)
Q Consensus       193 ~Dfg~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  271 (380)
                      +|||+++.... ...   ......||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+...+........|...
T Consensus       219 sDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             cCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            99999965443 211   11111799999999999999999999999999999999999999887665556667888888


Q ss_pred             hhccCCcccccccCCCCCCCCH-HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPASN-MAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .+..+....++|+.+....... .....+..+..+|++.+|.+||+|.+|++.|..+.
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            8888888899999986433332 57777999999999999999999999988885443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-53  Score=377.72  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=216.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-EEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-ERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  126 (380)
                      +.+..+.||+|..|+||+++++ +++.+|+|++... .++...+++.+|++++++.+||+||.+||.|..++ .++|+||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            4566789999999999999998 5899999999544 44567788999999999999999999999999998 5999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++|+|++++...+.  +++...-+++.+|++||.|||+ ++   ||||||||+||||+..|.|||||||.+..+..  
T Consensus       159 YMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--  231 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--  231 (364)
T ss_pred             hcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh--
Confidence            9999999999988754  8999999999999999999996 77   99999999999999999999999999986553  


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCC--cchhhHHHHHHHhhccCCcccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP--IKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                         ....+..||..|||||.+.+..|+.++||||||++++|+.+|++||....+  .....++.++            .+
T Consensus       232 ---S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I------------v~  296 (364)
T KOG0581|consen  232 ---SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI------------VD  296 (364)
T ss_pred             ---hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH------------hc
Confidence               256778899999999999999999999999999999999999999976522  1222222211            11


Q ss_pred             cCCCCCCCCH-HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          284 PRLRRTPASN-MAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       284 ~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ...  ...+. .++.++..+|..||++||.+||+++|+++|.|-..
T Consensus       297 ~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  297 EPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             CCC--CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            111  11233 48889999999999999999999999999999653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-52  Score=387.51  Aligned_cols=266  Identities=33%  Similarity=0.500  Sum_probs=221.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCE-EEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-EEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-ERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~l  123 (380)
                      ....+.+.+.||.|+||+||+|.|+ |+. ||||++............|.+|+.+|.+++|||||+++|+|.... ..+|
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            3445556667999999999999998 555 999999877665555778999999999999999999999999887 7999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  202 (380)
                      ||||+++|+|.+++.......+++..+++++.+|++||.|||+++.  ||||||||+|||++.++ ++||+|||+++...
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            9999999999999988544559999999999999999999998652  99999999999999998 99999999998755


Q ss_pred             CCCcceeeeecccCCccccChhhhh--hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLR--TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ...   ...+...||+.|||||+++  ...|+.|+||||||+++|||+||..||....+......      ....     
T Consensus       196 ~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~------v~~~-----  261 (362)
T KOG0192|consen  196 ISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA------VVVG-----  261 (362)
T ss_pred             ccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhc-----
Confidence            421   1233467999999999999  66999999999999999999999999998766221111      1101     


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhc
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE  333 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~  333 (380)
                          . .+...+..++..+..|+..||+.||..||++.+|+..+..+......
T Consensus       262 ----~-~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  262 ----G-LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             ----C-CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                1 11223344778899999999999999999999999999998776654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-53  Score=379.17  Aligned_cols=259  Identities=27%  Similarity=0.397  Sum_probs=216.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchH-----HHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-----LLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..+.|.+.+.||+|+||.|-+|..+ +|+.||||++........     ......+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4577889999999999999999986 699999999976543321     1233679999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEcccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFG  196 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg  196 (380)
                      ..|+||||+.||+|.+++...+.  +.+.....++.|++.||.|||+.|   |+||||||+|||+..+   ..+||+|||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            99999999999999999987765  677777889999999999999999   9999999999999876   679999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCC--C-CccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHh
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL--T-EKSDVYSFGVLLVEMMTGRYPIESKKPIK-ERVTIRWAMQC  272 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~~~DiwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~  272 (380)
                      +|+..+.    ...+.+.|||+.|.|||++.+..+  . .++|||||||+||-+|+|.+||....... ...++      
T Consensus       325 lAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI------  394 (475)
T KOG0615|consen  325 LAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI------  394 (475)
T ss_pred             hhhcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH------
Confidence            9998663    345678999999999999976553  3 48899999999999999999997654332 22221      


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ..|..       ....+.+....++..+||.+||..||++|||+.|+++|+|.-
T Consensus       395 -~~G~y-------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  395 -LKGRY-------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             -hcCcc-------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence             11111       112346677889999999999999999999999999999965

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-52  Score=386.41  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=221.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEe-CCCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKL-KDGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+|...+.||+|||+.||.+++ ..|+.||+|++.+... +......+.+|+++++.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999998 6799999999987533 3345667889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |+|..++|..++.+.+  .+++.+++.+++||+.||.|||+++   |+|||||..|+|++++.+|||+|||+|..+..+.
T Consensus        98 ELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999998544  4999999999999999999999999   9999999999999999999999999999887542


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .   ...+.|||+.|.|||++.+...+..+||||+||++|.||+|++||+...-.+.       ...+...+        
T Consensus       173 E---rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~~--------  234 (592)
T KOG0575|consen  173 E---RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLNE--------  234 (592)
T ss_pred             c---ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhcC--------
Confidence            2   24578999999999999999999999999999999999999999987543222       22222211        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         ...+..++.+..+||.++|+.+|.+|||+++|+.|.+....
T Consensus       235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence               12333667789999999999999999999999999987433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=367.64  Aligned_cols=255  Identities=28%  Similarity=0.447  Sum_probs=214.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|.||+||+|+++ ++..||||.+.+........+.+..|+.+|+.++|||||.+++++...+.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            478999999999999999999987 5899999999888766666777899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC------CceEEccccccc
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK------LRAKVTDFGFAR  199 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~------~~~kl~Dfg~~~  199 (380)
                      |||.||+|.++|+..+.  +++..++..+.||+.||++||+++   ||||||||+|||++..      -.+||+|||+++
T Consensus        89 EyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999875  999999999999999999999998   9999999999999865      458999999999


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .+...    ....+.+|++.|||||+++.+.|+.|+|+||+|+|||++++|..||....+.+....++....      . 
T Consensus       164 ~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------~-  232 (429)
T KOG0595|consen  164 FLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------I-  232 (429)
T ss_pred             hCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc------c-
Confidence            88753    345678999999999999999999999999999999999999999987766554332221111      0 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                              ....+......+.+|+...++.+|.+|-++.+-..+..
T Consensus       233 --------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~  270 (429)
T KOG0595|consen  233 --------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPF  270 (429)
T ss_pred             --------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence                    11223334445567777778888888877776665544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-50  Score=370.48  Aligned_cols=257  Identities=33%  Similarity=0.497  Sum_probs=221.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +.+.+++.||+|.||.||+|.++....||+|.++.....   ...|.+|+.+|++|+|+|||+++++|..+..++|||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            444567899999999999999997779999999876443   35688999999999999999999999998899999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      ++.|+|.++|+...+..+...+.+.++.|||+|++||.+++   +|||||...||||++++.+||+|||+++...++  .
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~  357 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD--E  357 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC--c
Confidence            99999999999866667999999999999999999999988   999999999999999999999999999955443  2


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                      +.......-...|.|||.+..+.++.|+|||||||+||||+| |+.||......+.       .+.++.|.         
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------~~~le~Gy---------  421 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------LELLERGY---------  421 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------HHHHhccC---------
Confidence            333444456778999999999999999999999999999999 9999987765443       23333332         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                       +.+.+..|+..+.+++..||+.+|++|||++.+...+..+..
T Consensus       422 -Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  422 -RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             -cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence             255677799999999999999999999999988888876644

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-51  Score=346.82  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=214.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEE-EEEeCCE-EEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG-FLEHGDE-RIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv  124 (380)
                      .+|+++++||+|.||.||++... +|..||.|.+.-...+......+..|+.+|++|+|||||++++ .+.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            34677889999999999999975 7999999999977777777788999999999999999999998 4444444 8999


Q ss_pred             EEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCC-CCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYS-DPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ||+|.+|+|..+|+..+  .+.+++..+|+++.|++.||.++|+.- ...|.||||||.||+++.+|.|||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999997533  345999999999999999999999832 133999999999999999999999999999987


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....   .......||+.||+||.+...+|+.|+||||+||++|||..-+.||.+.+-..       ....++.++.   
T Consensus       179 ~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~---  245 (375)
T KOG0591|consen  179 SSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDY---  245 (375)
T ss_pred             cchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCC---
Confidence            6542   23456789999999999999999999999999999999999999999874322       2333444432   


Q ss_pred             cccCCCCCCCC-HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPAS-NMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                             .+.+ .-.+..+..||..|+..||+.||+.-.++..+.
T Consensus       246 -------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  246 -------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                   2234 567889999999999999999999644444433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3e-50  Score=345.76  Aligned_cols=270  Identities=27%  Similarity=0.355  Sum_probs=222.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|+.+.++|+|+||.||++++++ |+.||||++..+..++...+-..+|+++|++++|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            567888999999999999999985 9999999999887777666668899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ||+. ++.+.++... .+++...+.+++.|++.|+.|+|+++   ++||||||+|||++.+|.+||||||+|+.+.... 
T Consensus        82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg-  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG-  155 (396)
T ss_pred             ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence            9977 6667676654 34899999999999999999999998   9999999999999999999999999999877432 


Q ss_pred             ceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC--------C
Q 041907          207 VSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG--------D  277 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~  277 (380)
                        ...+....|.+|.|||.+.| .+|...+|||++||++.||++|.+.|.+....++...++.....+.+.        .
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              23467789999999999988 689999999999999999999999999999888777664332222111        1


Q ss_pred             c-ccccccCCC-CCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 A-ILVMDPRLR-RTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~-~~~~~~~~~-~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      . ..+.-+... ..+   .......-+.+|+..||+.||.+|++-++++.|..
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence            1 111111110 011   12334567889999999999999999999998743

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-49  Score=348.67  Aligned_cols=256  Identities=28%  Similarity=0.371  Sum_probs=216.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchH-HHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++++.||+|+||+||.++.++ ++.||+|++++...-.. ..+....|..+|.+++||.||+++..|.+...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            45789999999999999999999874 99999999987643322 35567899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |+||+.||.|+..|++++.  +++..++-++..|+.||.|||++|   ||||||||+|||+|++|+++|+|||+++....
T Consensus       103 Vld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999999998776  899999999999999999999999   99999999999999999999999999986443


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   ...+.+||+.|||||++.+..|+..+|-|||||++|||++|..||...+.......       +..+.      
T Consensus       178 ~~~---~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~-------I~~~k------  241 (357)
T KOG0598|consen  178 DGD---ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK-------ILKGK------  241 (357)
T ss_pred             CCC---ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH-------HhcCc------
Confidence            322   23457999999999999999999999999999999999999999987664432221       11111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC----ChHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRP----TMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP----t~~eil~~l~~  326 (380)
                          ....+.-...+.++++.+.|..+|++|.    ++++|.+|.+-
T Consensus       242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF  284 (357)
T KOG0598|consen  242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF  284 (357)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence                1122333567789999999999999995    57777777653

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-49  Score=365.40  Aligned_cols=281  Identities=27%  Similarity=0.415  Sum_probs=230.4

Q ss_pred             CCCCCccccccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce
Q 041907           29 KSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL  108 (380)
Q Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  108 (380)
                      ..+.......+.+++....+++.+...||+|.||+||+|.|. |. ||||++......+...+.|++|+..+++-+|.||
T Consensus       373 ~~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-Gd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI  450 (678)
T KOG0193|consen  373 ISGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-GD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI  450 (678)
T ss_pred             cccccccCCccccccccCHHHhhccceeccccccceeecccc-cc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh
Confidence            344444444556888888899999999999999999999997 44 9999999998888889999999999999999999


Q ss_pred             eceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      +-++|+|...+. .||+.||+|.+|+.+|+.... .++....+.|+.||++|+.|||.++   |||+|||..||++.+++
T Consensus       451 lLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  451 LLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             eeeehhhcCCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCC
Confidence            999999998777 999999999999999987764 3999999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhc---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT  265 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~  265 (380)
                      .|||+|||++........ ..-.....|...|||||+++.+   +|+..+||||||+++|||++|..||......+....
T Consensus       526 kVkIgDFGLatvk~~w~g-~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm  604 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWSG-EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM  604 (678)
T ss_pred             cEEEecccceeeeeeecc-ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE
Confidence            999999999976543311 1112334578899999999854   588999999999999999999999984333221111


Q ss_pred             HHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          266 IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                             ...|..      ..+.......+++++.+|+..||..++++||.+.+|+..|..+...
T Consensus       605 -------VGrG~l------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  605 -------VGRGYL------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -------eccccc------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                   111110      0111223456778999999999999999999999999988877664

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=360.40  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=215.7

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc---hHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCC
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD---KCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGD  119 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  119 (380)
                      ...++|.+.+.||+|.||+|++|.+. +|+.||+|++......   ......+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            35679999999999999999999876 6899999977664221   123445668999999998 999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEcccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFA  198 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  198 (380)
                      ..++||||+.||+|+++|.+.+.  +.+.++.+++.||+.||+|||++|   |+||||||+|+|++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999998443  888999999999999999999999   9999999999999999 99999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcC-CC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-LT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .....   ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.........       .+..+
T Consensus       169 ~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~-------ki~~~  238 (370)
T KOG0583|consen  169 AISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR-------KIRKG  238 (370)
T ss_pred             cccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH-------HHhcC
Confidence            97731   122346788999999999999987 87 78999999999999999999998744322111       11111


Q ss_pred             CcccccccCCCCCCCCHHH-HHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMA-VEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .           ...+..+ +.++..|+.+||..+|..|+++.+|+.+.|...
T Consensus       239 ~-----------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 E-----------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             C-----------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            1           1122223 678999999999999999999999999999765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=349.15  Aligned_cols=261  Identities=26%  Similarity=0.420  Sum_probs=212.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC--EEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD--ERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  123 (380)
                      ..++...+.||+|.||.||++.+.+ |+..|||.+.......  ...+.+|+.+|.+++|||||+++|......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            3456778899999999999999874 8999999987663222  566889999999999999999999754444  6899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~  202 (380)
                      +|||+++|+|.+++...++ .+++..+.++..||++||.|||++|   |+|+||||+|||++. ++.+||+|||++....
T Consensus        94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999999887 6999999999999999999999999   999999999999999 7999999999998766


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCC-CCcchhhHHHHHHHhhccCCccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESK-KPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .............||+.|||||++..+. ...++|||||||++.||+||..||... .....      .......     
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~------~~~ig~~-----  238 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA------LLLIGRE-----  238 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH------HHHHhcc-----
Confidence            3222222234577999999999999633 345999999999999999999999863 11111      1111100     


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         .  .....+..++.+..+++.+|++.+|+.|||+.++++|++....
T Consensus       239 ---~--~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  239 ---D--SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             ---C--CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence               0  1123455577889999999999999999999999999987654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-48  Score=353.51  Aligned_cols=259  Identities=25%  Similarity=0.323  Sum_probs=217.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|.+++.||+|.|++|++|+.. +++.||||++.+...- +...+.+..|-..|.+| .||.|++++..|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            4578999999999999999999987 5999999999765321 22234467888888888 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +|+||+++|+|.++|...+.  +++..++.++.+|+.||+|||++|   ||||||||+|||+|.+++++|+|||.|+.+.
T Consensus       151 FvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            99999999999999999875  999999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCcc----------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          203 EDSAV----------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       203 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      .....          ......+.||..|.+||++..+..++.+|||+||||||+|+.|.+||.+.+++-....+   +..
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI---~~l  302 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI---QAL  302 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH---HHh
Confidence            43221          01114478999999999999999999999999999999999999999887654321111   111


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                                +     ...+...++.+.+||++.|..||.+|+|.++|.+|++--
T Consensus       303 ----------~-----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~  342 (604)
T KOG0592|consen  303 ----------D-----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE  342 (604)
T ss_pred             ----------c-----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence                      1     123444557899999999999999999999999987643

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=343.60  Aligned_cols=271  Identities=25%  Similarity=0.347  Sum_probs=223.7

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ...+.|++...||.|..++||+|+.. .++.||||++..+..... ...+.+|+..+..++||||++++..|.....+|+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            36689999999999999999999975 589999999987766554 6789999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||.||.+|++.+++...-..++++..+..|++++++||.|||++|   .||||||+.||||+.+|.|||+|||.+..+..
T Consensus       102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            999999999999999887777999999999999999999999999   99999999999999999999999998766544


Q ss_pred             CCcceeee-ecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          204 DSAVSHIS-TQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       204 ~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ........ .+..||++|||||+++.  ..|+.|+||||||++..||.+|..||...-+......  ..     .+....
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~--tL-----qn~pp~  251 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL--TL-----QNDPPT  251 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH--Hh-----cCCCCC
Confidence            33333333 66789999999999653  4689999999999999999999999987766543211  11     111100


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .. -..............+.++|..||+.||.+|||+.+++.+.|.-
T Consensus       252 ~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk  297 (516)
T KOG0582|consen  252 LL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK  297 (516)
T ss_pred             cc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence            00 00111123344566899999999999999999999999997754

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-48  Score=362.55  Aligned_cols=253  Identities=24%  Similarity=0.379  Sum_probs=219.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEcccc-CcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +-|++++.||.|+.|.|.+|++. +|+.+|||++... .........+.+|+.+|+.+.||||+++|+++++..++|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45788999999999999999986 6999999999765 333334556889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++||.|++++..++.  +.+.++.+.+.||+.|+.|+|..+   |+||||||+|+|+|..+++||+|||+|.+-..  
T Consensus        92 Eyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            99999999999998876  899999999999999999999999   99999999999999999999999999987544  


Q ss_pred             cceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                        .....+.||.+.|.+||+++|.+|+ .++||||.|||||.||+|..||++.+.       +.....+..|.+      
T Consensus       165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------r~LLlKV~~G~f------  229 (786)
T KOG0588|consen  165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------RVLLLKVQRGVF------  229 (786)
T ss_pred             --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------HHHHHHHHcCcc------
Confidence              3445778999999999999999997 689999999999999999999985442       223333333322      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ..+...+.++.+|+.+||..||++|.|++||++|+|-.
T Consensus       230 -----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  230 -----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             -----cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence                 12345667889999999999999999999999999965

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=354.66  Aligned_cols=272  Identities=23%  Similarity=0.321  Sum_probs=222.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCC-EEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGD-ERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~  122 (380)
                      ..++|.+.++||.|.||.||+|+.. .|+.||||.++..... +....-.+|+.-|++++ ||||+++.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            5678999999999999999999976 5999999999876544 33334569999999998 999999999998888 999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +|||||+. +|++++..+ +..+++..++.|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+|+.+.
T Consensus        87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            99999955 999999988 567999999999999999999999999   9999999999999988899999999999765


Q ss_pred             CCCcceeeeecccCCccccChhhh-hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc--
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI--  279 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  279 (380)
                      ...    ..+.+..|.+|+|||++ +.+-|+.+.|||++|||++|+.+-++.|.+.++.++...+-.+..-.....+.  
T Consensus       162 Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  162 SKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             cCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            432    34678899999999976 56789999999999999999999999999998888776654332221111111  


Q ss_pred             ----cccc---cCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 ----LVMD---PRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ----~~~~---~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          ..+.   +.....+   .-..++.++.+||.+||+.||.+|||+.++++++.-.
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence                1111   1111111   1123678899999999999999999999999997643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-47  Score=348.29  Aligned_cols=271  Identities=24%  Similarity=0.310  Sum_probs=221.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  124 (380)
                      +.|+..++||+|.||.||+|++. +|+.||+|+++.+..++....-..+|+.+|++|.||||+++.+.....  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45778899999999999999976 699999999998887777777788999999999999999999988776  789999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      +|||+. +|..++...+ ..|+..++..++.||+.||.|||.+|   |+|||||.+|||||++|.+||+|||+|+.+...
T Consensus       197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999987 9999987654 34999999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...  ..+...-|++|.|||++.|. .|+.++|+||.||||.||++|++.|.+....++...+-.......+..+. +.+
T Consensus       272 ~~~--~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~k  348 (560)
T KOG0600|consen  272 GSA--PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSK  348 (560)
T ss_pred             CCc--ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-ccc
Confidence            322  24566789999999999875 59999999999999999999999999988877665553332222222221 111


Q ss_pred             c-----CCCCCC-------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 P-----RLRRTP-------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~-----~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      -     .....+       ....++....+|+..+|..||.+|.|+.++++.-+.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            0     011111       123345667789999999999999999999988764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.4e-47  Score=319.19  Aligned_cols=272  Identities=22%  Similarity=0.279  Sum_probs=223.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .+|...+.||+|.||.||+|++. +|+.||||+++.....+-......+|+..|+.++|+||+.++++|.+.+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999976 69999999999877665555667899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++. +|...|+... ..++..++..++.++++||+|||.+.   |+||||||.|+|++.+|.+||+|||+++.+.....
T Consensus        82 fm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             eccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9977 9999998775 34999999999999999999999998   99999999999999999999999999998875433


Q ss_pred             ceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc---c
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV---M  282 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  282 (380)
                      .   .....-|.+|.|||.+.|. .|+..+||||.|||+.||+.|.+-|.+..+.++...+-....-..+.++...   -
T Consensus       157 ~---~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  157 I---QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             c---cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            2   2233689999999988764 5899999999999999999999999988887766555433332222222211   0


Q ss_pred             -------ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 -------DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 -------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                             -+.......-..++.++.+|+..+|..||.+|+++.|++++.+-.
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence                   111111112234567789999999999999999999999998744

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-47  Score=340.72  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=219.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchH-HHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ...+|++.+.||+|.||+|-+|..+ .|+.||||.++++...+. -...+++|+++|..|+||||+.+|++|+..+.+.|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            4468889999999999999999974 699999999998765443 35568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||..+|.|+++|.+.+.  +++.++++++.||+.|+.|+|.++   ++|||||.+|||+|+++++||+|||++.++..
T Consensus       131 vMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            9999999999999998765  999999999999999999999998   99999999999999999999999999998876


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .    .+..++||.+.|.+||+..|.+|. +.+|-|||||+||.|+.|..||++.+-.....       .+..|..    
T Consensus       206 ~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr-------QIs~GaY----  270 (668)
T KOG0611|consen  206 K----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR-------QISRGAY----  270 (668)
T ss_pred             c----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH-------Hhhcccc----
Confidence            4    345778999999999999999997 78999999999999999999999865433221       2222211    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          +..    ..+.....||++||..+|++|.|+++|..|.|--
T Consensus       271 ----rEP----~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 ----REP----ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ----cCC----CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                111    1224567899999999999999999999999953

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-47  Score=350.02  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=219.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ..|....+||+|.-|.||.|... +++.||||.+.......  ..-+.+|+.+|+..+|+|||++++.|...+.+++|||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            46888899999999999999875 58899999997765443  2346799999999999999999999988899999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++||+|.+.+....   +++.++..|+..+++||+|||.+|   |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       351 ym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             ecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999999998755   899999999999999999999999   99999999999999999999999999987665332


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ...+..||+.|||||+.....|++|+||||||++++||+-|++||-..++.....++.               +...
T Consensus       425 ---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa---------------~ng~  486 (550)
T KOG0578|consen  425 ---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------------TNGT  486 (550)
T ss_pred             ---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh---------------hcCC
Confidence               3456789999999999999999999999999999999999999998766655433321               1122


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ........++..+.+|+.+||+.|+.+|+++.|+|+|.+..
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence            22345566788999999999999999999999999998864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.6e-47  Score=348.37  Aligned_cols=252  Identities=28%  Similarity=0.427  Sum_probs=220.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+....+...+.+.+|++++++++||||+.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            67889999999999999999987 58899999998887777778889999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+.| +|+.+|..-+.  +++..+..++.+++.||.|||+.+   |+|||+||.|||++.+|.+|+||||+++.+..+  
T Consensus        82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--  153 (808)
T ss_pred             hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC--
Confidence            9977 99999987655  999999999999999999999988   999999999999999999999999999987653  


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                       ..+.+.+.||+.|||||+..+++|+..+|+||||||+||+++|++||.......       ....+..       |+  
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-------Lv~~I~~-------d~--  216 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-------LVKSILK-------DP--  216 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-------HHHHHhc-------CC--
Confidence             345677899999999999999999999999999999999999999997533211       1111111       11  


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ...+...+..+..++...|..||..|.+..+++.|.+-
T Consensus       217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~  254 (808)
T KOG0597|consen  217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW  254 (808)
T ss_pred             --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence              12233677789999999999999999999999999653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-46  Score=344.35  Aligned_cols=262  Identities=22%  Similarity=0.286  Sum_probs=218.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.++..||+|+||.||+|+-+ +|..||+|+++++..- ......++.|-.+|....+|+||++|..|.+..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4568999999999999999999977 5999999999887543 2345568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||++||++..+|...+.  |++..++.++.+++.||..||+.|   +|||||||+|+|||..|++||+|||++.-+..
T Consensus       219 iMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence            9999999999999988765  899999999999999999999999   99999999999999999999999999863321


Q ss_pred             C----------------------Ccc-----eee-----------------eecccCCccccChhhhhhcCCCCccchhh
Q 041907          204 D----------------------SAV-----SHI-----------------STQVKGTAGYLDPDYLRTYQLTEKSDVYS  239 (380)
Q Consensus       204 ~----------------------~~~-----~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  239 (380)
                      .                      ...     ...                 .....||+-|+|||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                      000     000                 01146999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC---C
Q 041907          240 FGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP---T  316 (380)
Q Consensus       240 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t  316 (380)
                      ||||+||||.|.+||....+......+......+.              .|....+..+..+||.+||. ||++|.   .
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            99999999999999999888776555543322221              12233344789999999999 999996   4


Q ss_pred             hHHHHHHHHHH
Q 041907          317 MKKCAEILWKI  327 (380)
Q Consensus       317 ~~eil~~l~~~  327 (380)
                      ++||.+|+|--
T Consensus       439 ~~EIK~HPfF~  449 (550)
T KOG0605|consen  439 AEEIKKHPFFK  449 (550)
T ss_pred             HHHHhcCCccc
Confidence            99999998864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=320.22  Aligned_cols=251  Identities=27%  Similarity=0.391  Sum_probs=216.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchH-HHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|+..+.||.|.||.|.+++.+ +|..||+|++.+...-+. ......+|-.+|+.+.||+++++++.+.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56788999999999999999987 589999999987654332 3445779999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++||.|+.++++.+.  +++..++-++.+|+.||+|||+.+   |++|||||+|||+|.+|.+||+|||.|+..... 
T Consensus       124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999998765  999999999999999999999999   999999999999999999999999999976642 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           ..+.|||+.|+|||++...+|..++|=|+|||++|||+.|..||...++..       ..+.+..++        
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~--------  257 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGK--------  257 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCc--------
Confidence                 457889999999999999999999999999999999999999999887743       223333322        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCC-----CChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSR-----PTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~R-----Pt~~eil~~l~~~  327 (380)
                         ...+.-....+.+|+...|+.|-.+|     +...+|..|.|--
T Consensus       258 ---v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  258 ---VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             ---ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence               12344456778999999999999999     3566888888754

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-45  Score=336.01  Aligned_cols=258  Identities=22%  Similarity=0.311  Sum_probs=209.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .|++.+.||+|+||.||+|.+. +|+.||+|.+....... .....+.+|+.++.+++|+||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999976 69999999987543222 223457789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999999887655556899999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.   ......          
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~----------  220 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKED----------  220 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhcc----------
Confidence               1234568999999999999999999999999999999999999998655432211111   111000          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~  327 (380)
                       ........+..+.+|+.+||+.+|.+||+     ++++++|.|-.
T Consensus       221 -~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~  265 (285)
T cd05631         221 -QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK  265 (285)
T ss_pred             -cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence             01122234567889999999999999997     89999998854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2e-45  Score=344.11  Aligned_cols=263  Identities=27%  Similarity=0.384  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||+++.... ......+.+|+.++.++ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            4578999999999999999999742      356899999975432 23345688999999999 899999999988764


Q ss_pred             -CEEEEEEEeCCCCCHHHHhccCC--------------------------------------------------------
Q 041907          119 -DERIIVVEYVGNGTLREHLDGRG--------------------------------------------------------  141 (380)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------------------------  141 (380)
                       ...+++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             46899999999999999987532                                                        


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCC
Q 041907          142 ----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT  217 (380)
Q Consensus       142 ----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt  217 (380)
                          ..++++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++........ .......++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~  239 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP  239 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence                123778888999999999999999988   999999999999999999999999999865332211 111234467


Q ss_pred             ccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHH
Q 041907          218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAV  296 (380)
Q Consensus       218 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (380)
                      ..|+|||++.+..++.++|||||||++|||++ |..||.........      ......+..          ...+..++
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~------~~~~~~~~~----------~~~~~~~~  303 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF------CQRLKDGTR----------MRAPENAT  303 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH------HHHHhcCCC----------CCCCCCCC
Confidence            88999999999999999999999999999997 99999765432211      111111110          11122345


Q ss_pred             HHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          297 EKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       297 ~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ..+.+++.+||+.+|.+||++.++++.|..+..
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            678999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=338.26  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=208.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999987 5899999998654321 123455789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++...+  .+++..++.++.|++.||.|||++|   ++||||||+|||++.++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999997654  3889999999999999999999998   999999999999999999999999998765432 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........       .....+.        
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~--------  214 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY-------EKILAGK--------  214 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCC--------
Confidence                 12346899999999999999999999999999999999999999765432211       1111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~  327 (380)
                         ...+......+.+||.+||+.||.+||+     ++++++|.|-.
T Consensus       215 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         215 ---LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             ---cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence               0111223567889999999999999995     99999999864

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-47  Score=347.66  Aligned_cols=248  Identities=27%  Similarity=0.460  Sum_probs=209.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +....++-||.|+-|-||+|+.+ ++.||||+++.-+         ..+++-|++|+||||+.|.|+|.....+||||||
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            34445667999999999999998 8889999886422         2678899999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      |..|.|...|....  .+.......|..+|+.|+.|||.+.   |||||||.-||||+.+..|||+|||-++.....   
T Consensus       194 Ca~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---  265 (904)
T KOG4721|consen  194 CAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---  265 (904)
T ss_pred             cccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence            99999999998754  3888888899999999999999988   999999999999999999999999998876543   


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                       .+...++||..|||||+++..+.+.|+|||||||+|||||||..||...+....    .|.            +....-
T Consensus       266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwG------------VGsNsL  328 (904)
T KOG4721|consen  266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWG------------VGSNSL  328 (904)
T ss_pred             -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEe------------ccCCcc
Confidence             223467899999999999999999999999999999999999999976443211    010            111112


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      ..+.+..+++.+.-|+++||+-.|.+||++++|+.||.-...+
T Consensus       329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            2456777889999999999999999999999999999765443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-46  Score=311.65  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=217.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|.+++.||+|.||.||+|+.+ ++-.||+|++.++.. ......++.+|+++-..|+||||+++|++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999976 588899999976532 223345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      +||.++|.|+..++......+++.....++.|++.|+.|+|.++   ++||||||+|+|++..+.+||+|||.+....  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999999877777999999999999999999999888   9999999999999999999999999886533  


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                         .....+.+||.-|+|||...+..++..+|+|++|++.||++.|..||+.....+.   +..+...            
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---YkrI~k~------------  237 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKRIRKV------------  237 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHHHHHc------------
Confidence               2234678899999999999999999999999999999999999999987652221   1111110            


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ....+...+....++|.+|+..+|.+|....|+++|+|-.
T Consensus       238 ---~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  238 ---DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             ---cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence               1112345667889999999999999999999999999943

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.5e-45  Score=336.91  Aligned_cols=271  Identities=23%  Similarity=0.289  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||+|.++ +++.||+|++............+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999987 58899999997655444445567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++++.+..+....  ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            99987666554332  34889999999999999999999988   99999999999999999999999999986543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh---------ccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL---------KAGD  277 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~  277 (380)
                        .......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.......         ....
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         156 --ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             --ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence              11234568999999999999999999999999999999999999998765433222221110000         0000


Q ss_pred             cccccccCCCCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 AILVMDPRLRRT-----PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ......+.....     ......+..+.+|+.+||+.||++|||++++++|.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            000000000000     001124567999999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-45  Score=339.73  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=227.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE-EEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE-RIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv  124 (380)
                      .++|.+++.+|+|+||.+++++++ ++..|++|.+..............+|+.+++++.|||||.+.+.+..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367899999999999999999987 58899999999887776667778999999999999999999999988888 9999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |+||+||+|.+.|.++++..+++..+++|+.|++.|+.|||+.+   |+|||||+.||+++.++.|+|+|||+++.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999999988778999999999999999999999888   999999999999999999999999999988764


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .   .......||+.||.||++.+.+|..|+|||||||++|||++-+.+|...+.......+   .+..           
T Consensus       160 ~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki---~~~~-----------  222 (426)
T KOG0589|consen  160 D---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI---NRGL-----------  222 (426)
T ss_pred             h---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH---hhcc-----------
Confidence            3   1345678999999999999999999999999999999999999999876654322221   1111           


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ..+.+...+.++..+|..||+.+|+.||++.+++.++...
T Consensus       223 ---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  223 ---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL  262 (426)
T ss_pred             ---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence               2456677888999999999999999999999999985544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3e-45  Score=341.47  Aligned_cols=252  Identities=25%  Similarity=0.343  Sum_probs=208.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367899999999999999999987 589999999875432 122345678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...+.  +++..+..++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++......
T Consensus        97 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             EcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            999999999999987543  788889999999999999999988   999999999999999999999999999865432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .      ....||+.|+|||++.+..++.++|||||||++|+|++|..||....+....       ..+..+.       
T Consensus       172 ~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i~~~~-------  231 (329)
T PTZ00263        172 T------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY-------EKILAGR-------  231 (329)
T ss_pred             c------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------HHHhcCC-------
Confidence            1      2346999999999999999999999999999999999999999765432211       1111111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~  327 (380)
                       .   ..+......+.+||.+||+.||.+||+     +++++.|.|-.
T Consensus       232 -~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        232 -L---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             -c---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence             0   111223466889999999999999987     79999998753

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-44  Score=337.46  Aligned_cols=271  Identities=23%  Similarity=0.345  Sum_probs=211.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||++.+. +|..||+|.+..... ......+.+|+.++++++||||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            478999999999999999999987 588999999876532 334567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||+++++|.+++.....  +++..+..++.+++.||.|||+. +   ++|+||||+|||++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999999976543  88999999999999999999974 5   999999999999999999999999998755332


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc-----
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI-----  279 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  279 (380)
                           ......||..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.........+...     
T Consensus       158 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             -----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence                 1234568999999999999999999999999999999999999997544322111100000000000000     


Q ss_pred             -------------------------cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          280 -------------------------LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       280 -------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                                               ..+.............+.++.+||.+||+.||++|||+++++++.|-..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~  306 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKR  306 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhh
Confidence                                     0000000000011134567999999999999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.1e-45  Score=337.79  Aligned_cols=247  Identities=23%  Similarity=0.282  Sum_probs=202.6

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      +.||+|+||.||+|.++ +|+.||+|++..... .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999986 589999999975432 2223455778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|.+++....  .+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++......   ...
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~---~~~  152 (323)
T cd05571          81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG---ATM  152 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC---Ccc
Confidence            9999997654  3899999999999999999999998   9999999999999999999999999987532211   112


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||.........       .....+.           ...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~-----------~~~  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEE-----------IRF  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcCC-----------CCC
Confidence            3456999999999999999999999999999999999999999764322111       1111110           111


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                      +...+.++.+|+.+||+.||++||     ++.++++|.|-
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f  254 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF  254 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence            223457789999999999999999     89999999774

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-45  Score=340.46  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=210.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47899999999999999999987 4899999999764322 123456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999997654  3889999999999999999999998   99999999999999999999999999875433  


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+.....         .+...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE---------TLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc---------cccCC
Confidence                22345699999999999999999999999999999999999999986554332111111000         00000


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .. .......+.++.+++.+||+.+|.+||++++++++.|-.
T Consensus       221 ~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~  261 (333)
T cd05600         221 VY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK  261 (333)
T ss_pred             CC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence            00 000123457789999999999999999999999998754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.3e-44  Score=337.00  Aligned_cols=255  Identities=24%  Similarity=0.385  Sum_probs=200.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|+..+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            45667789999999999999986 589999999865432 3345668899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+..      ......+..++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++.......
T Consensus       153 ~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        153 FMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             cCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            99999986532      2566778889999999999999988   99999999999999999999999999886543211


Q ss_pred             ceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          207 VSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                         ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+.......    ....     
T Consensus       224 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~----~~~~-----  291 (353)
T PLN00034        224 ---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA----ICMS-----  291 (353)
T ss_pred             ---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhcc-----
Confidence               1234568999999998743     2344689999999999999999999974332221111110    0000     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                           ........++.++.+||.+||+.+|++||++.|+++|.|....
T Consensus       292 -----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        292 -----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             -----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                 0011223455779999999999999999999999999986543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=334.71  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=217.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ....|+..+.||+|.||.||+|.+. .++.||+|++......+ ...++.+|+.+|..++++||.++|+.+..+..++++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d-eIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED-EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcch-hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            3456788899999999999999986 59999999998776543 467789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||||.||++.+++...+.  +++..+.-++++++.|+.|||..+   .+|||||+.|||+...|.+||+|||.+......
T Consensus        90 Mey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence            999999999999987553  577788889999999999999988   999999999999999999999999999866543


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..   ...++.||+.|||||++++..|+.|+||||||++.+||.+|.+|+....+......+                -+
T Consensus       165 ~~---rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk  225 (467)
T KOG0201|consen  165 VK---RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PK  225 (467)
T ss_pred             hh---ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cC
Confidence            21   225678999999999999999999999999999999999999999988775432221                11


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      . ........++..+++||..||+.+|+.||++.+++.|-+-
T Consensus       226 ~-~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FI  266 (467)
T KOG0201|consen  226 S-APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFI  266 (467)
T ss_pred             C-CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHH
Confidence            1 1122333677889999999999999999999999988654

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-44  Score=331.63  Aligned_cols=270  Identities=24%  Similarity=0.309  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC--CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEE-----e
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK--DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLE-----H  117 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  117 (380)
                      ++|++.+.||+|+||.||+|.+.  +|+.||+|.++...........+.+|+.+++.+   .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999874  468899999876543332233455666666554   7999999999885     3


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      ....++||||++ ++|.+++.......+++..++.++.|++.||.|||+.|   ++||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 59999998766566899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...........
T Consensus       157 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCCc----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            98654321    22345689999999999999999999999999999999999999987655433222211100000000


Q ss_pred             ccccc---ccCCC---CCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 AILVM---DPRLR---RTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~~~~~---~~~~~---~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .....   .....   ..+   .....+..+.+|+.+||+.+|++|||+.++++|.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence            00000   00000   000   01124467789999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9e-45  Score=339.59  Aligned_cols=273  Identities=22%  Similarity=0.280  Sum_probs=204.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----CEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----DERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  122 (380)
                      +|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999986 589999999875433333345678999999999999999999987543     3579


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+. ++|.+++.....  +++..+..++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 589999876543  899999999999999999999998   9999999999999999999999999997643


Q ss_pred             CCCcceeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------Hh
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM--------QC  272 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~~  272 (380)
                      .............||..|+|||++.+  ..++.++|||||||++|+|++|+.||...........+....        ..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            32221122234569999999999876  678999999999999999999999997654322111110000        00


Q ss_pred             hccCCc---ccccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 LKAGDA---ILVMDPRLRR--TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~---~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ......   ...+......  .......+..+.+++.+||+.+|.+||++++++++.|-.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~  294 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK  294 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence            000000   0000000000  000011345678999999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-44  Score=335.68  Aligned_cols=248  Identities=23%  Similarity=0.282  Sum_probs=202.4

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      +.||+|+||.||++.+. +|..||+|+++.... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999986 589999999976432 2223455778999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|..++....  .+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++.......   ...
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~~  152 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATM  152 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC---Ccc
Confidence            9999887654  3899999999999999999999998   9999999999999999999999999987532211   112


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .....        .   ...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-------~~~~~--------~---~~~  214 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILME--------E---IRF  214 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcC--------C---CCC
Confidence            34569999999999999999999999999999999999999997654322111       11000        0   011


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                      +...+..+.+++.+||+.+|.+||     ++.+++++.|..
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence            223456788999999999999998     899999988754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7e-44  Score=325.32  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=202.1

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEe----CCEEEEEEEeC
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GDERIIVVEYV  128 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  128 (380)
                      ..||+|+++.||+|.+. |+.||||.+....... .....+.+|+.+|.+++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            67999999999999985 8899999997654332 234568899999999999999999999876    45789999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      ++|+|.+++....  .+++.....++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999998754  388899999999999999999974 6   8899999999999999999999999988654321  


Q ss_pred             eeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          208 SHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                          ....|+..|+|||++.+  ..++.++|||||||++|||++|..||......+.   .    .......        
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~----~~i~~~~--------  238 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---Y----DLIINKN--------  238 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHhcC--------
Confidence                23458899999999976  6899999999999999999999999986543221   1    1110000        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      . ..+.+..++..+.+++.+||+.||.+|||++++++.|..++.
T Consensus       239 ~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 N-SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             C-CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0 011222356789999999999999999999999999987653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2e-45  Score=355.63  Aligned_cols=261  Identities=27%  Similarity=0.459  Sum_probs=220.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..+....+.||+|.||+||+|...      +-..||||.++..... ....+|++|+.++..++|||||+++|+|.+++.
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            345677899999999999999854      2457999999876544 357889999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCC--------CCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          121 RIIVVEYVGNGTLREHLDGRG--------GNG----LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~--------~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      .++|+||+..|+|.++|....        +.+    ++..+.+.|+.|||.|+.||-++.   +|||||-..|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            999999999999999996532        223    888999999999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIR  267 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  267 (380)
                      .|||+|||+++..-. .+.++......-.++|||||.+..++++.++|||||||+|||+++ |..||.+....+..    
T Consensus       641 ~VKIsDfGLsRdiYs-sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI----  715 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYS-SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----  715 (774)
T ss_pred             EEEecccccchhhhh-hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH----
Confidence            999999999985432 122333333445689999999999999999999999999999999 99999987765432    


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         +.+..+.          ..+.++.++.++..|+..||+..|.+||+++||-..|....+
T Consensus       716 ---e~i~~g~----------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  716 ---ECIRAGQ----------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ---HHHHcCC----------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence               3333332          255778899999999999999999999999999999987644

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-45  Score=317.84  Aligned_cols=272  Identities=25%  Similarity=0.276  Sum_probs=217.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  124 (380)
                      ++|+.+..|++|.||.||+|+++ +++.||+|+++.+....-.-.-..+|+.+|.+++|||||.+-++.+.  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            46788899999999999999987 69999999999876544333445799999999999999999998765  4679999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||||+. +|..++...+ .++...++.-+..|+++|++|||.+.   |+||||||+|+|++..|.+||+|||+|+.++..
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999988 9999999877 45999999999999999999999988   999999999999999999999999999988754


Q ss_pred             CcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                         ....+...-|++|.|||++.+. .|+...|+||+|||+.||+++.+.|.+....++...+-....-..+..+.....
T Consensus       231 ---~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  231 ---LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             ---cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence               2234566789999999999875 589999999999999999999999999887776555432211111111111000


Q ss_pred             --------------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 --------------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 --------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                                    ..++.........+.-++|+...|..||.+|.|+.+.|+|-|-.
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~  365 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR  365 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence                          00110101111446778999999999999999999999998854

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.2e-44  Score=328.67  Aligned_cols=264  Identities=23%  Similarity=0.327  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-----------------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCcee
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-----------------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV  109 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  109 (380)
                      .++|.+.+.||+|+||.||+|.+.+                 +..||+|.+..... .....++.+|+.++.+++||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCee
Confidence            4688999999999999999998642                 33699999876533 33456788999999999999999


Q ss_pred             ceEEEEEeCCEEEEEEEeCCCCCHHHHhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 041907          110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRG-----------------GNGLELAERLDIAIDVAHALTYLHTYSDPPI  172 (380)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  172 (380)
                      ++++++...+..++||||+++++|.+++....                 ...+++..+++++.||+.||.|||+.|   +
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence            99999999999999999999999999986532                 123677889999999999999999988   9


Q ss_pred             eeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh--C
Q 041907          173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT--G  250 (380)
Q Consensus       173 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--g  250 (380)
                      +|+||||+|||++.++.+||+|||+++....... ........++..|+|||++.++.++.++||||||+++|+|++  +
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999986543221 122234456889999999999999999999999999999987  5


Q ss_pred             CCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          251 RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       251 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..||..........   ............ .     . ...+..++..+.+|+.+||+.+|.+|||+++|.+.|.
T Consensus       239 ~~p~~~~~~~~~~~---~~~~~~~~~~~~-~-----~-~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQVIE---NAGEFFRDQGRQ-V-----Y-LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHHHHH---HHHHHhhhcccc-c-----c-ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            67776544322111   111111110000 0     0 0011234567899999999999999999999988774

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-44  Score=335.14  Aligned_cols=247  Identities=24%  Similarity=0.284  Sum_probs=202.3

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      +.||+|+||.||++.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999986 589999999975432 2233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|..++....  .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......   ...
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~---~~~  152 (328)
T cd05593          81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA---ATM  152 (328)
T ss_pred             CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc---ccc
Confidence            9999987654  3899999999999999999999998   9999999999999999999999999987532211   112


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.........       .....+.           ...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-------~~~~~~~-----------~~~  214 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMED-----------IKF  214 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-------HHhccCC-----------ccC
Confidence            3456999999999999999999999999999999999999999765432211       1111000           111


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                      +...+.++.+|+.+||+.+|.+||     ++.+++++.|.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  254 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF  254 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence            223456788999999999999997     89999999775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=318.89  Aligned_cols=279  Identities=22%  Similarity=0.320  Sum_probs=222.4

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe---
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH---  117 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---  117 (380)
                      +.......|...+.||+|+||.|..|.++ +|+.||||++..........++..+|+.+|+.++|+||+.+++++.-   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            44556677888899999999999999987 69999999998666666667788899999999999999999998754   


Q ss_pred             --CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          118 --GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       118 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                        -..+|+|+|+++ .+|...|.....  ++...+..++.||++||.|+|+.+   ++||||||+|+|++.+..+||+||
T Consensus        96 ~~f~DvYiV~elMe-tDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   96 DKFNDVYLVFELME-TDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             cccceeEEehhHHh-hHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccc
Confidence              456899999994 499999987654  899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhh-hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-----
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA-----  269 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-----  269 (380)
                      |+|+..... ......+....|.+|.|||++ ....|+...||||.|||+.||++|+..|.+.+...+...+...     
T Consensus       170 GLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  170 GLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             cceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            999987643 223334677899999999976 5678999999999999999999999999988876655544221     


Q ss_pred             ---HHhhccCCcccccc--cCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 ---MQCLKAGDAILVMD--PRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 ---~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ...+........+.  +.....+   .-........+|+.+||..||.+|+|++|+++|+...
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~  314 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA  314 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence               11111111111111  1111111   1123446788999999999999999999999998744

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-44  Score=330.00  Aligned_cols=270  Identities=25%  Similarity=0.331  Sum_probs=205.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||.|+||.||+|.++ +++.||+|.++...... ....+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            367999999999999999999987 58999999987543221 2335678999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++ +|.+++...+ ..+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          83 EYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             eCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            99975 9999887654 23788999999999999999999988   9999999999999999999999999987543221


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC-------
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD-------  277 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  277 (380)
                      .   ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...........       
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         158 K---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             c---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            1   1233458999999999875 5688999999999999999999999976654332222111100000000       


Q ss_pred             --cccccccCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 --AILVMDPRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 --~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        ......+.....+   .......++.+|+.+||+.||.+|||++|+++|.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence              0000000000000   01123456889999999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-45  Score=329.88  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch------------HHHHHHHHHHHHHhcCCCCceeceE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK------------CLLLEFKNEILTWSKIEHLNLVKLF  112 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~  112 (380)
                      .-++|.+.+.||+|.||.|-+|++. +++.||||++.+.....            .-.....+|+.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999999987 59999999997543211            1134678999999999999999999


Q ss_pred             EEEEe--CCEEEEEEEeCCCCCHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          113 GFLEH--GDERIIVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       113 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      ++..+  ...+|||+|||..|.+...   ....+ ++..++++++..++.||+|||.+|   |+||||||+|+|++++|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence            99865  5689999999988765433   22333 899999999999999999999999   999999999999999999


Q ss_pred             eEEccccccccccCCCc--ceeeeecccCCccccChhhhhhcC---C-CCccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 041907          190 AKVTDFGFARMSEEDSA--VSHISTQVKGTAGYLDPDYLRTYQ---L-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKER  263 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~  263 (380)
                      +||+|||.+........  .........||+.|+|||...++.   + +.+.||||+||+||.|+.|+.||.+.......
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~  328 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF  328 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence            99999999886632211  111123467999999999987633   3 36789999999999999999999875543321


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ..       +        +...+. .+......+.+.+||.++|++||+.|.++.+|..|+|..+.
T Consensus       329 ~K-------I--------vn~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  329 DK-------I--------VNDPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HH-------H--------hcCccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            11       1        111221 23333566789999999999999999999999999997644

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-44  Score=337.56  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=208.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC--CCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD--GSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|.+.+.||+|+||.||+|.++.  +..||+|.+..... .......+.+|+.++..++||||+++++++...+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            34679999999999999999998653  46899999865432 2223456789999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++|+|.+++.....  +++..+..++.|++.||.|||+.|   ++||||||+|||++.++.+||+|||++....
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999986543  889999999999999999999998   9999999999999999999999999997654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ..      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....+...       ...+..+.     
T Consensus       183 ~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~-----  244 (340)
T PTZ00426        183 TR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGI-----  244 (340)
T ss_pred             CC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCC-----
Confidence            21      1245699999999999999999999999999999999999999986543221       11111111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                         .   ..+...+..+.++|.+||+.+|.+|+     +++++++|+|-.
T Consensus       245 ---~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        245 ---I---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             ---C---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence               0   01122345688999999999999995     899999998753

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=331.59  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=223.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+-|.+++.||+|.|+.|-+|++- +|+.||||++.+...++.....+.+|++.|+.++|||||++|++......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            356888999999999999999875 7999999999998887777777899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~  204 (380)
                      |+-.+|+|+++|-... .++.+..+.+++.||+.||.|+|+..   +|||||||+||.+.+ -|-|||+|||++..+.++
T Consensus        97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999997664 34999999999999999999999999   999999999998875 478999999999887765


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..    ..+.+|.+.|.|||++.|..|+ +++||||||||||.|++|+.||+..+..+....               ++|
T Consensus       173 ~k----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImD  233 (864)
T KOG4717|consen  173 KK----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMD  233 (864)
T ss_pred             ch----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhc
Confidence            43    3567899999999999999998 788999999999999999999987665443332               223


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..   ...+...+.+.++||..||..||.+|.+.+||..+.|..
T Consensus       234 CK---YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  234 CK---YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             cc---ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            22   335667888999999999999999999999999999853

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.5e-44  Score=335.61  Aligned_cols=259  Identities=23%  Similarity=0.273  Sum_probs=208.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||++.+. +|+.||+|+++.... .......+.+|+.+++.++|+||+++++++......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999987 589999999976533 2223456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999998753 24899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cceeeeecccCCccccChhhhh------hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR------TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ..  ......||+.|+|||++.      +..++.++|||||||++|+|++|..||...........+      .....  
T Consensus       157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~~--  226 (330)
T cd05601         157 MV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------MNFQR--  226 (330)
T ss_pred             ce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH------HcCCC--
Confidence            21  223456999999999987      456789999999999999999999999765443221111      00000  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ....+.....+..+.+|+..||+ +|.+||++++++.|.|-.
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         227 ------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             ------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence                  00011112345678899999998 999999999999998743

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-44  Score=330.17  Aligned_cols=269  Identities=26%  Similarity=0.364  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++....... ....+.+|+.++++++||||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            478999999999999999999987 58999999987543322 2234678999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++ ++|.+++.... ..++...+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          83 EYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             ECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9996 58888876543 33888999999999999999999998   9999999999999999999999999987543221


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC---cc--
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD---AI--  279 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~--  279 (380)
                         .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........  +...........   ..  
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         158 ---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             ---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccch
Confidence               11234568999999999875 45788999999999999999999999875443221  111111110000   00  


Q ss_pred             ---cccccC-CCC-CCC-------CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 ---LVMDPR-LRR-TPA-------SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 ---~~~~~~-~~~-~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..+.+. ... .+.       .......+.+|+.+||+.||.+|||++++++|.|-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f  291 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF  291 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence               000000 000 000       00123567899999999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-44  Score=332.01  Aligned_cols=246  Identities=22%  Similarity=0.294  Sum_probs=201.0

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999987 488999999875422 223345677899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++...+  .+++..+..++.||+.||.|||+++   ++||||||+|||++.++.++|+|||+++......   .....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~  152 (312)
T cd05585          81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---DKTNT  152 (312)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC---Ccccc
Confidence            99997654  3899999999999999999999998   9999999999999999999999999987543221   11234


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCH
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN  293 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (380)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||........       ......+        .   ...+.
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-------~~~~~~~--------~---~~~~~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-------YRKILQE--------P---LRFPD  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-------HHHHHcC--------C---CCCCC
Confidence            5699999999999999999999999999999999999999976433211       1111111        0   11222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHHH
Q 041907          294 MAVEKILGLADVCLAPTRQSRP---TMKKCAEILWKI  327 (380)
Q Consensus       294 ~~~~~l~~li~~cl~~~p~~RP---t~~eil~~l~~~  327 (380)
                      ..+..+.+++.+||+.||.+||   ++.+++.|.|-.
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            3456788999999999999997   578899988744

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=340.31  Aligned_cols=260  Identities=24%  Similarity=0.304  Sum_probs=211.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++....... .....+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999987 59999999997543221 33456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            9999999999998763  4899999999999999999999988   9999999999999999999999999988654322


Q ss_pred             c--------------------------ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 041907          206 A--------------------------VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP  259 (380)
Q Consensus       206 ~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~  259 (380)
                      .                          .........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            0                          00112345699999999999999999999999999999999999999987653


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-MKKCAEILWKI  327 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~eil~~l~~~  327 (380)
                      ......+.   ...          .... .+.....+..+.+||.+||+ +|.+||+ ++++++++|-.
T Consensus       236 ~~~~~~i~---~~~----------~~~~-~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         236 QETYNKII---NWK----------ESLR-FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             HHHHHHHh---ccC----------Cccc-CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence            32211110   000          0000 11111246778999999998 9999999 99999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-43  Score=337.46  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=204.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .|.+.+.||+|+||+||+|.+. +++.||||++..... .......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999986 589999999976432 23345568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|.+++.....  +++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            9999999999976543  888899999999999999999988   99999999999999999999999999754311000


Q ss_pred             --------------------------------------------ceeeeecccCCccccChhhhhhcCCCCccchhhHHH
Q 041907          207 --------------------------------------------VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGV  242 (380)
Q Consensus       207 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  242 (380)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                        000112356999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHH--hcCCCCCCCCChHHH
Q 041907          243 LLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADV--CLAPTRQSRPTMKKC  320 (380)
Q Consensus       243 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ei  320 (380)
                      ++|||++|..||....+......+      ....       ... ..+.....+.++.+||.+  |+..++..||+++++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i------~~~~-------~~~-~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKV------INWE-------NTL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHH------Hccc-------ccc-CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999865543221111      0000       000 011112244677888888  555666679999999


Q ss_pred             HHHHHH
Q 041907          321 AEILWK  326 (380)
Q Consensus       321 l~~l~~  326 (380)
                      +.|.|-
T Consensus       303 l~hp~f  308 (381)
T cd05626         303 KAHPFF  308 (381)
T ss_pred             hcCccc
Confidence            999885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-43  Score=330.28  Aligned_cols=268  Identities=26%  Similarity=0.406  Sum_probs=209.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||++.+. +|..+|+|.+..... ......+.+|+.++++++|+||+++++++...+..++|
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            3578999999999999999999987 588899998876532 33456688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||+++++|.+++...+.  +++..+..++.+++.||.|||+ .+   ++|+||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999999976543  8889999999999999999997 36   99999999999999999999999999875432


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc---
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL---  280 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  280 (380)
                      .     ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+    .....+....   
T Consensus       157 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~  227 (333)
T cd06650         157 S-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF----GCPVEGDPAESET  227 (333)
T ss_pred             h-----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh----cCcccCCcccccc
Confidence            2     123356899999999999989999999999999999999999999754432111100    0000000000   


Q ss_pred             ------------ccccC-----------------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          281 ------------VMDPR-----------------LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       281 ------------~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                                  ...+.                 ............++.+|+.+||+.||++|||+.|++.+.|...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~  304 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  304 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence                        00000                 0000000113467889999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=324.62  Aligned_cols=259  Identities=23%  Similarity=0.312  Sum_probs=210.6

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +|++.+.||+|+||.||++.+. +++.||+|.+....... .....+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999986 58999999987543322 223446789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999999987655556899999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                          .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.   ......          
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~~----------  220 (285)
T cd05605         158 ----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKED----------  220 (285)
T ss_pred             ----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhhc----------
Confidence                123468999999999999999999999999999999999999998654322111111   111110          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKIR  328 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~~  328 (380)
                       ........+..+.+|+.+||+.||.+||     ++++++++.|...
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence             0112233567789999999999999999     8999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-44  Score=339.45  Aligned_cols=260  Identities=21%  Similarity=0.310  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999987 589999999975432 2233455788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+  .+++..++.++.||+.||.|||+.|   ++||||||+|||++.++.++|+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999997654  3899999999999999999999998   9999999999999999999999999987543211


Q ss_pred             ccee-----------------------------------eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhC
Q 041907          206 AVSH-----------------------------------ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG  250 (380)
Q Consensus       206 ~~~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  250 (380)
                      ....                                   ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            0000                                   01124699999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHHH
Q 041907          251 RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT---MKKCAEILWKI  327 (380)
Q Consensus       251 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~eil~~l~~~  327 (380)
                      ..||...........   ....   .       .... .+.....+..+.+||.+|+. +|.+|++   ++++++|.|..
T Consensus       236 ~~Pf~~~~~~~~~~~---i~~~---~-------~~~~-~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~  300 (364)
T cd05599         236 YPPFCSDNPQETYRK---IINW---K-------ETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK  300 (364)
T ss_pred             CCCCCCCCHHHHHHH---HHcC---C-------CccC-CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence            999986654322111   1100   0       0000 11111245678899999997 9999998   99999998753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=349.68  Aligned_cols=263  Identities=25%  Similarity=0.373  Sum_probs=215.6

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCCC-CEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEE-EEe---
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGF-LEH---  117 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~---  117 (380)
                      ..+..+++|.+.|.+|||+.||+|.+..+ ..||+|++...  ++.....+.+|+.+|++|+ |+|||.+++. ...   
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            34778899999999999999999998765 99999999776  4455778899999999996 9999999993 211   


Q ss_pred             ---CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          118 ---GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       118 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                         .-.++|+||||+||.|.+++..+....|++.++++|+.++++||.+||... ++|||||||-+||||+.+|..||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence               235789999999999999998776666999999999999999999999985 8899999999999999999999999


Q ss_pred             ccccccccCCCcc-eee---e--ecccCCccccChhhh---hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 041907          195 FGFARMSEEDSAV-SHI---S--TQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT  265 (380)
Q Consensus       195 fg~~~~~~~~~~~-~~~---~--~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~  265 (380)
                      ||.+.-....... ..+   .  -....|+.|++||.+   ++.++++|+|||+|||+||-|+....||+.....     
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----  264 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----  264 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence            9988643222110 000   0  013479999999976   6788999999999999999999999999865322     


Q ss_pred             HHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          266 IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                                    .+++.... .|.....+..+.+||..||+.+|.+||++-+++..+..++.
T Consensus       265 --------------aIlng~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 --------------AILNGNYS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --------------eEEecccc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                          12222222 33445778899999999999999999999999999998854

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-44  Score=340.15  Aligned_cols=260  Identities=20%  Similarity=0.260  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||++.+. +|+.||||++..... .......+.+|+.++.+++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999986 589999999865432 2234556889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++....  .+++..++.++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9999999999997654  3888999999999999999999998   9999999999999999999999999986432110


Q ss_pred             cce--------------------------------------------eeeecccCCccccChhhhhhcCCCCccchhhHH
Q 041907          206 AVS--------------------------------------------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFG  241 (380)
Q Consensus       206 ~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  241 (380)
                      ...                                            .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            000                                            000124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC---CChH
Q 041907          242 VLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSR---PTMK  318 (380)
Q Consensus       242 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~  318 (380)
                      |++|||++|..||...........   ....   ..       .+. .+.....+.++.+||.+||+ +|.+|   +++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~---i~~~---~~-------~~~-~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRK---IINW---RE-------TLY-FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHH---HHcc---CC-------ccC-CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999976554321111   1100   00       000 11111234678899999998 66665   5999


Q ss_pred             HHHHHHHHH
Q 041907          319 KCAEILWKI  327 (380)
Q Consensus       319 eil~~l~~~  327 (380)
                      +++.+.|..
T Consensus       301 ~~l~hp~~~  309 (377)
T cd05629         301 EIKSHPFFR  309 (377)
T ss_pred             HHhcCCCcC
Confidence            999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.4e-44  Score=332.31  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=204.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCc--chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKH--DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  121 (380)
                      +|++.+.||+|+||.||++...    +|+.||+|++.....  .......+..|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999863    588999999875422  122344577899999999 589999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++|+|.+++.....  +++..+..++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            999999999999999976543  889999999999999999999988   999999999999999999999999998765


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..   ....     
T Consensus       156 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~-----  225 (332)
T cd05614         156 LSEEKE--RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILK-----  225 (332)
T ss_pred             cccCCC--ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhc-----
Confidence            332211  12245699999999999875 478899999999999999999999975433222111111   1110     


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                       .+     .+.+...+..+.+++.+||+.||.+||     +++++++|.|-
T Consensus       226 -~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  270 (332)
T cd05614         226 -CD-----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF  270 (332)
T ss_pred             -CC-----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence             01     111223456788999999999999999     78899999874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.6e-44  Score=336.16  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=202.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||+||+|.+. +|+.||+|++..... .......+..|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999986 589999999975432 2223456788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+  .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            9999999999998754  3899999999999999999999988   9999999999999999999999999987543211


Q ss_pred             cc--------------------------------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC
Q 041907          206 AV--------------------------------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP  253 (380)
Q Consensus       206 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  253 (380)
                      ..                                ........||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                0001235799999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcC--CCCCCCCChHHHHHHHHH
Q 041907          254 IESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLA--PTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~eil~~l~~  326 (380)
                      |...........+   ..    ...      .+. .+.......++.++|.+++.  .++..||+++||++|.|-
T Consensus       236 f~~~~~~~~~~~i---~~----~~~------~~~-~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f  296 (363)
T cd05628         236 FCSETPQETYKKV---MN----WKE------TLI-FPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFF  296 (363)
T ss_pred             CCCCCHHHHHHHH---Hc----CcC------ccc-CCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCC
Confidence            9865543221111   10    000      000 01111234567777777544  233456999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-43  Score=318.06  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=207.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++..... .....+.+|+..+.+++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            467899999999999999999864    3568999999865432 33456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++++|||.+....
T Consensus        83 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999997653 24899999999999999999999988   9999999999999999999999999876432


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....  .......++..|+|||.+.+..++.++|||||||++||+++ |..||.........       .....+.    
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~-------~~~~~~~----  225 (266)
T cd05064         159 SEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDGF----  225 (266)
T ss_pred             ccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCC----
Confidence            2111  11112335678999999999999999999999999999875 99999765433211       1111110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ..+.+..++..+.+++.+||+.+|.+||++++|++.+..+
T Consensus       226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                  1122334567899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-43  Score=330.03  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=200.2

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHH---hcCCCCceeceEEEEEeCCEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTW---SKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      |++.+.||+|+||.||+|.+. +|+.||||+++.... .......+..|..++   ..++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999986 589999999975431 112234455665544   567899999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|..++...   .+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            9999999999988653   3899999999999999999999988   999999999999999999999999998643221


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .   .......|++.|+|||++.+..++.++|||||||++|+|++|..||..........       .+..+.       
T Consensus       155 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~-------~i~~~~-------  217 (324)
T cd05589         155 G---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------SIVNDE-------  217 (324)
T ss_pred             C---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhCC-------
Confidence            1   11234669999999999999999999999999999999999999997654322111       111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                          ...+...+..+.++|.+||+.||.+||     ++.+++++.|.
T Consensus       218 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f  260 (324)
T cd05589         218 ----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF  260 (324)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence                011123456788999999999999999     68899888764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7e-44  Score=331.84  Aligned_cols=248  Identities=23%  Similarity=0.272  Sum_probs=201.3

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      +.||+|+||.||++.+. +|+.||+|++..... .......+..|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999986 589999999976432 2223455678999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      +|..++....  .+++..+..++.||+.||.|||+ .|   ++||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---~~  152 (325)
T cd05594          81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---AT  152 (325)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---cc
Confidence            9999887654  38999999999999999999997 67   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........       ......           ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~-------~i~~~~-----------~~  214 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE-------LILMEE-----------IR  214 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH-------HHhcCC-----------CC
Confidence            234569999999999999999999999999999999999999997654321111       111000           01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                      .+...+.++.+++.+||+.||.+|+     +++++++|.|..
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            1122456788999999999999996     899999998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.3e-43  Score=334.38  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+.      ++..||||+++..... .....+.+|+.++..+ +||||+++++++...
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3467999999999999999999742      3568999999754332 2345678999999999 899999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCC--------------------------------------------------------
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGG--------------------------------------------------------  142 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~--------------------------------------------------------  142 (380)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999999865321                                                        


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          143 -----------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       143 -----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                                       ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                             23678889999999999999999988   9999999999999999999999999998654322


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      . ........++..|+|||++.+..++.++|||||||++|+|++ |..||.........      ......+..      
T Consensus       269 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~------~~~~~~~~~------  335 (375)
T cd05104         269 N-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF------YKMIKEGYR------  335 (375)
T ss_pred             c-ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH------HHHHHhCcc------
Confidence            1 111223345678999999999999999999999999999998 88998754322111      111111100      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ...+...+.++.+|+.+||+.+|++||++.+|++.|++
T Consensus       336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                01111234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-43  Score=318.86  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=210.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.++||+|+||.||+|.+.++..||+|.+.....   ....+.+|+.++++++|+||+++++++......+++|
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            3578899999999999999999988788899999865432   2456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.......+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999999999998765556889999999999999999999988   9999999999999999999999999998754322


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  .......++..|+|||++.+..++.++|||||||++|+|++ |..||..........       ....+.       
T Consensus       158 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-------~~~~~~-------  221 (261)
T cd05072         158 Y--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-------ALQRGY-------  221 (261)
T ss_pred             e--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH-------HHHcCC-------
Confidence            1  11223346778999999999899999999999999999998 999997544322111       111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..+....++..+.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 ---RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               011122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.4e-45  Score=308.84  Aligned_cols=261  Identities=23%  Similarity=0.330  Sum_probs=219.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc------chHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH------DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      ....|.-.+.||+|..++|.++.++ +|..+|+|++.....      ....+..-.+|+.+|+++ .||+|+.+.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            4567888899999999999999887 588899999864321      122334466899999997 79999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      +..+++|+|.++.|.|++++.+...  +++.+.++|++|+..|+.|||.++   ||||||||+|||++++.+++|+|||.
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence            9999999999999999999998765  999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhh------cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRT------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ  271 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  271 (380)
                      ++.+..+..    .+..+||++|+|||.++.      ..|+..+|+|++|||+|.||.|.+||......-..       .
T Consensus       170 a~~l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML-------R  238 (411)
T KOG0599|consen  170 ACQLEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML-------R  238 (411)
T ss_pred             eeccCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-------H
Confidence            998876543    367889999999998853      34788899999999999999999999764432221       2


Q ss_pred             hhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .+.+|..       ....+.+.+.+....+||.+||+.||.+|.|++|++.|+|.++-
T Consensus       239 ~ImeGky-------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  239 MIMEGKY-------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHHhccc-------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            2222221       12356777888999999999999999999999999999998644

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-43  Score=334.21  Aligned_cols=263  Identities=26%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      ...++|++.+.||+|+||.||+|.+.      ++..||+|++...... .....+.+|+.+++.+ +|+||+++++++..
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            34568999999999999999999853      2357999999765433 2345688999999999 89999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCC--------------------------------------------------------
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRG--------------------------------------------------------  141 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------------------------  141 (380)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999985421                                                        


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          142 ------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       142 ------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                                  ..++++..+++++.||+.||.|||++|   ++||||||+|||+++++.++|+|||+++....... ..
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-~~  269 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YV  269 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-ee
Confidence                        123678889999999999999999988   99999999999999999999999999876543221 11


Q ss_pred             eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||..........      .....+.     .     
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~------~~~~~~~-----~-----  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY------KMVKRGY-----Q-----  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH------HHHHccc-----C-----
Confidence            2223345678999999999999999999999999999997 999997644322111      1111100     0     


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ...+...+.++.+++.+||+.+|.+||++.++++.|.++.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0111123467899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=346.21  Aligned_cols=263  Identities=24%  Similarity=0.362  Sum_probs=212.4

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-  119 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  119 (380)
                      +.....++|.+.+.||+|+||+||+|.+. +|+.||||++............+.+|+..+..++|+|++++++.+.... 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            33445689999999999999999999976 5999999999776555555667889999999999999999988765432 


Q ss_pred             -------EEEEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 041907          120 -------ERIIVVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA  190 (380)
Q Consensus       120 -------~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~  190 (380)
                             .+++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence                   3689999999999999997542  345889999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  270 (380)
                      ||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......       ..
T Consensus       183 kL~DFGls~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~  254 (496)
T PTZ00283        183 KLGDFGFSKMYAATVS-DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VM  254 (496)
T ss_pred             EEEecccCeecccccc-ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HH
Confidence            9999999986543211 112345679999999999999999999999999999999999999997643221       11


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .....+.          ..+.+...+..+.+++.+||+.+|.+||++.+++++.+
T Consensus       255 ~~~~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~  299 (496)
T PTZ00283        255 HKTLAGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI  299 (496)
T ss_pred             HHHhcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence            1111111          01122335577999999999999999999999998765

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=330.62  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=220.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcch-HHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  122 (380)
                      ..+.|.+.+.||+|.||.||++..+. |+.+|+|.+.+..... .....+.+|+.+|+++. |||||.++++|+....++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            55789999999999999999999885 9999999998765432 23456889999999998 999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC----CceEEcccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK----LRAKVTDFGFA  198 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~  198 (380)
                      +|||++.||.|++.|...  . +++..+..++.|++.++.|||+.|   ++||||||+|+|+...    +.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999887  2 999999999999999999999998   9999999999999643    47999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ......    ......+||+.|+|||++....|+..+||||+||++|.|++|..||.+.........       +..++.
T Consensus       187 ~~~~~~----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~  255 (382)
T KOG0032|consen  187 KFIKPG----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF  255 (382)
T ss_pred             eEccCC----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC
Confidence            987652    234678899999999999999999999999999999999999999998765443221       111111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                             ....+........+.++|..||..||..|+|+.++++|+|
T Consensus       256 -------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  256 -------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             -------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                   1123455567888999999999999999999999999999

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-43  Score=328.03  Aligned_cols=247  Identities=24%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             CeeeccCceEEEEEEeC----CCCEEEEEEccccCc--chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           54 NKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKH--DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +.||+|+||.||++...    .++.||+|++.....  .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863    478999999875422  112234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++...+.  +.+..+..++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          82 LSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            999999999976543  788888899999999999999988   99999999999999999999999999875332211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||........       ......+.          
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------~~~~~~~~----------  216 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------IDKILKGK----------  216 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC----------
Confidence              12345699999999999998999999999999999999999999976543221       11111111          


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                       ...+...+..+.++|.+||+.+|++||     ++++++++.|.
T Consensus       217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~  259 (323)
T cd05584         217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF  259 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence             011222456788999999999999999     89999999874

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=302.42  Aligned_cols=265  Identities=25%  Similarity=0.341  Sum_probs=210.8

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-----
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-----  117 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  117 (380)
                      ....++|++.+.||+|||+.||++..- +++.||+|++......  ..+...+|++..++++||||++++++...     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~--~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE--DIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH--HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            346689999999999999999999954 6889999999877633  35678899999999999999999987543     


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                      ....||+++|+..|+|.+.|+...  +..+++.++++|+.+|++||++||... ++++||||||.|||+.+.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            345899999999999999997654  335999999999999999999999875 67999999999999999999999999


Q ss_pred             cccccccCCCcceeee------ecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 041907          196 GFARMSEEDSAVSHIS------TQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI  266 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~------~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~  266 (380)
                      |.+....-.-....-.      ....-|..|.|||.+.   +...+.++|||||||+||+|+.|..||+..-.       
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-------  246 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-------  246 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence            9987543110000000      1234688999999985   55678999999999999999999999973211       


Q ss_pred             HHHHHhhccCCcc--cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          267 RWAMQCLKAGDAI--LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       267 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                              .|...  .+...... .|.....++.+.++|++||+.||.+||++.+++.++..+
T Consensus       247 --------~GgSlaLAv~n~q~s-~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  247 --------QGGSLALAVQNAQIS-IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------cCCeEEEeeeccccc-cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    12111  12222222 223334788999999999999999999999999998765

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-44  Score=334.22  Aligned_cols=268  Identities=30%  Similarity=0.452  Sum_probs=222.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCC--C---CEEEEEEccc-cCcchHHHHHHHHHHHHHhcCCCCceeceEEE
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKD--G---SIVAVKRARK-NKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF  114 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~-~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  114 (380)
                      +.|+...++..+.++||+|+||.||+|.++.  +   ..||+|..+. .........++.+|++++++++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3455566777788999999999999999752  2   2389999886 33556678899999999999999999999999


Q ss_pred             EEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                      +.....++||||+|+||+|.++|+..+. .++..+...++.+.+.||+|||+++   ++||||-..|+|++.++.+||+|
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence            9999999999999999999999998765 4999999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcceeeee-cccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHh
Q 041907          195 FGFARMSEEDSAVSHIST-QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      ||+++.-.    ...... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+.     
T Consensus       306 FGLs~~~~----~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-----  376 (474)
T KOG0194|consen  306 FGLSRAGS----QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-----  376 (474)
T ss_pred             cccccCCc----ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-----
Confidence            99987532    112222 2235688999999999999999999999999999999 888998877654333221     


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                       ..+          .+.+.+...+..+..++.+||..+|++||+|.++.+.+..+.+...
T Consensus       377 -~~~----------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 -KNG----------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -hcC----------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence             111          1123344667788899999999999999999999999998877654

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.2e-43  Score=319.47  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=208.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-C-----CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-G-----SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ++|++.+.||+|+||.||+|.+.. +     ..|++|.+..... ......+.+|+..+.+++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            578899999999999999998653 2     5799999875433 33455688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          122 IIVVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      +++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            999999999999999975421              34788899999999999999999988   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |..||......+..   
T Consensus       161 ~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~---  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---  236 (283)
T ss_pred             CcEEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---
Confidence            9999999999876533221 112233456889999999998899999999999999999998 99999765443211   


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ..+..+.          ....+..++..+.+|+.+||+.+|.+||++.+|+++|..
T Consensus       237 ----~~i~~~~----------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 ----EMIRSRQ----------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHHcCC----------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                1111110          112234566889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4e-43  Score=327.18  Aligned_cols=255  Identities=23%  Similarity=0.306  Sum_probs=201.8

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||+|+++..... ......+..|..++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999987 5889999999765332 22345577899999888 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|.+++...+  .+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---~~  152 (329)
T cd05588          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---DT  152 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC---Cc
Confidence            99999887653  3899999999999999999999998   9999999999999999999999999987422111   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHhhccCCcccccccCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK--ERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+..+.....        ..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~--  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QI--  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CC--
Confidence            234579999999999999999999999999999999999999996432111  000111111111111        11  


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCC------hHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPT------MKKCAEILWKI  327 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~eil~~l~~~  327 (380)
                       ..+...+..+.+++.+||+.+|.+||+      ++++++|.|-.
T Consensus       223 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             -CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence             112234567889999999999999987      78999998763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-43  Score=334.75  Aligned_cols=264  Identities=20%  Similarity=0.218  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +++.||+|....        ..+.+|+.++++++||||+++++++......++||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            367999999999999999999986 589999997532        23568999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |++. ++|..++....  .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus       163 e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        163 PRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             ecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            9995 58998887654  3889999999999999999999988   9999999999999999999999999987533211


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc----hhhHHHHHHHhhcc--CCc-
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK----ERVTIRWAMQCLKA--GDA-  278 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~-  278 (380)
                        ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......    ....+.........  ... 
T Consensus       237 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        237 --ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             --ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence              111234579999999999999999999999999999999999998875432211    01111111111000  000 


Q ss_pred             -------ccc---------cccCCCCC-CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          279 -------ILV---------MDPRLRRT-PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       279 -------~~~---------~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                             ...         ..+..... ......+.++.+||.+||+.||.+|||++|++++.|-
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence                   000         00000000 0112345678999999999999999999999999985

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.4e-43  Score=326.84  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||+|++...... ......+..|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999987 5889999999765322 22344577888888776 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|..++....  .+++..++.++.+|+.||.|||+++   ++||||||+||+++.++.+||+|||+++......   ..
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---~~  152 (329)
T cd05618          81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---DT  152 (329)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---Cc
Confidence            99999887654  3899999999999999999999998   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHhhccCCcccccccCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK--ERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||.......  ......+.........           
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------  221 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------  221 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------
Confidence            234569999999999999999999999999999999999999996322111  0011111111111110           


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCC------hHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPT------MKKCAEILWK  326 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~eil~~l~~  326 (380)
                      ...+...+..+.+++.+||+.||.+||+      +.++++|.|-
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f  265 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF  265 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence            1122234567889999999999999998      5799998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=312.43  Aligned_cols=272  Identities=24%  Similarity=0.311  Sum_probs=212.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc-eeceEEEEEeCC-----
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-LVKLFGFLEHGD-----  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-----  119 (380)
                      ...|...++||+|+||+||+|+.+ +|+.||+|+++.....+-.-....+|+.+|++++|+| |+.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            344566678999999999999987 6999999999876543212223569999999999999 999999998877     


Q ss_pred             -EEEEEEEeCCCCCHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          120 -ERIIVVEYVGNGTLREHLDGRGG--NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       120 -~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                       .+++|+||+.. +|..++...+.  ..++...+..++.||+.||.|||+++   |+||||||+||||++.|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             88999999965 99999988663  35777889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      +|+.+....   ...+...+|.+|.|||++.+. .|+...||||+|||+.||++++..|.+....++...+-....-..+
T Consensus       166 lAra~~ip~---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e  242 (323)
T KOG0594|consen  166 LARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE  242 (323)
T ss_pred             hHHHhcCCc---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence            999665322   224556799999999999887 7999999999999999999999999988876655444322222222


Q ss_pred             CCcccc-----cccCCCCCCCCHHH-------HHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          276 GDAILV-----MDPRLRRTPASNMA-------VEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       276 ~~~~~~-----~~~~~~~~~~~~~~-------~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..+..+     .+............       .....+++.+||+.+|.+|.+++.++.|..
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y  304 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY  304 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence            222211     11111111111111       137789999999999999999999999865

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=353.58  Aligned_cols=264  Identities=30%  Similarity=0.462  Sum_probs=219.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC--CC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD--GS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++....+.||+|.||.||.|...+  |.    .||||.++..... ....+|.+|..+|++++|||||+++|++-....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~-~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE-QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            3456678899999999999998653  44    3999999876443 456789999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRG-----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                      .+|++|||++|+|..+|++..     ...+...+.+.++.+||+|+.||++++   +|||||...|+|+++...|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence            999999999999999998762     345899999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      |+|+...... .+.......-...|||||.+..+.++.|+|||||||+|||+++ |..||...++.+....      ...
T Consensus       847 GlArDiy~~~-yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~~  919 (1025)
T KOG1095|consen  847 GLARDIYDKD-YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VLE  919 (1025)
T ss_pred             chhHhhhhch-heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HHh
Confidence            9999443322 2222222234578999999999999999999999999999999 8999987766543221      111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .+           +.+.+..|+..+.++|..||+.+|++||++..|++.+..+...+.
T Consensus       920 gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  920 GG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             CC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            11           244566788999999999999999999999999999888766543

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-43  Score=316.40  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=209.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|++|.||+|.+.+++.||+|.++.....   ..++.+|+.++++++|+||+++++++...+..+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            45678999999999999999999877788999998765432   356789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....+..+++..+..++.+++.||.+||+.|   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999998766556899999999999999999999988   9999999999999999999999999998765321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  ........+..|+|||++.+..++.++||||||+++|+|++ |+.||..........       ......       
T Consensus       158 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~-------  221 (261)
T cd05068         158 Y--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-------QVDQGY-------  221 (261)
T ss_pred             c--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCC-------
Confidence            1  11111223468999999999999999999999999999999 999997654322111       111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..+.....+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               011222345779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.8e-43  Score=313.36  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=211.5

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|.+.+.||+|++|.||+|.++ +|+.|++|.+............+.+|+.++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999986 589999999876554455566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++.......+++..++.++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            99999999998765556899999999999999999999988   99999999999999999999999999886543221 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|..||........   ..    ....+.          
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~----------  217 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL----KIIRGV----------  217 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH----HHHcCC----------
Confidence              12334688999999999999999999999999999999999999976542211   11    111110          


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..+.....+..+.+++.+||+.+|++||++.+++++.|
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence            01122245677999999999999999999999998754

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.2e-44  Score=337.99  Aligned_cols=260  Identities=22%  Similarity=0.272  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+|++.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+|++++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999986 589999999865422 1223455779999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+.  ++...+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++..+....
T Consensus        81 E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRLGI--FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            99999999999977543  788888999999999999999998   9999999999999999999999999975321000


Q ss_pred             c----------------------------------------ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHH
Q 041907          206 A----------------------------------------VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLV  245 (380)
Q Consensus       206 ~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  245 (380)
                      .                                        .........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                        000112356999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC---ChHHHHH
Q 041907          246 EMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP---TMKKCAE  322 (380)
Q Consensus       246 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~eil~  322 (380)
                      +|++|..||....+......+.       ...      .... .+.....+..+.++|.+|+ .+|.+|+   ++.++++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~-------~~~------~~~~-~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVI-------NWE------TTLH-IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHh-------ccC------cccc-CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999998765433211110       000      0000 1111224456778888876 5999999   9999999


Q ss_pred             HHHHH
Q 041907          323 ILWKI  327 (380)
Q Consensus       323 ~l~~~  327 (380)
                      |.|..
T Consensus       301 h~~~~  305 (376)
T cd05598         301 HPFFK  305 (376)
T ss_pred             CCCcC
Confidence            98853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-43  Score=318.34  Aligned_cols=256  Identities=32%  Similarity=0.478  Sum_probs=212.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ...+|++.+.||.|+||.||+|.+.++..+++|.+......  ....+..|+.+++.++|+||+++++++......++||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh--hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            34578889999999999999999988899999998765432  2456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.......+++..++.++.+|+.||.|||+.|   ++|+||+|+||++++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999998766666899999999999999999999988   9999999999999999999999999997654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .   ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.   +...    ..+.       
T Consensus       159 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~-------  221 (261)
T cd05148         159 Y---LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQI----TAGY-------  221 (261)
T ss_pred             c---cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHH----HhCC-------
Confidence            1   1123346778999999998899999999999999999998 8999976542211   1111    1110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..+.+..++..+.++|.+||+.+|.+|||++++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 ---RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               012223455778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-43  Score=328.01  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.++ +++.||+|++..... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999987 588999999875422 122344566788888766 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|.+++....  .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.......   ..
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---~~  152 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KT  152 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---Cc
Confidence            99999987654  3889999999999999999999988   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........       ..+..+.           ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~-----------~~  214 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-------EAILNDE-----------VV  214 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHhcCC-----------CC
Confidence            23456999999999999999999999999999999999999999865432211       1111110           01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM------KKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~------~eil~~l~~  326 (380)
                      .+...+..+.+++.+||+.||.+||++      ++++.|.|-
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence            122245678999999999999999998      889998774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=334.23  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=209.8

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  121 (380)
                      ..-++|.+.+.||+|.||+|+++..+ +++.||||++++... ........+.|-+++... +||.+++++..|....++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            35578999999999999999999988 489999999987643 223355567787777766 599999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      |+||||+.||++...++..   .+++..++-++..|+.||.|||++|   ||+||||.+|||+|.+|++||+|||+++.-
T Consensus       445 ~fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999844444333   3999999999999999999999999   999999999999999999999999999853


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      -..   .....+++||+.|||||++.+..|+.++|=|+|||+|||||.|+.||.+.+..+.-.       .+..+     
T Consensus       519 m~~---g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------sI~~d-----  583 (694)
T KOG0694|consen  519 MGQ---GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------SIVND-----  583 (694)
T ss_pred             CCC---CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHhcC-----
Confidence            321   223567899999999999999999999999999999999999999999876543211       11111     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~  325 (380)
                            ....+..++.+..++++++|..+|++|..+     .+|..|++
T Consensus       584 ------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF  626 (694)
T KOG0694|consen  584 ------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF  626 (694)
T ss_pred             ------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence                  123556677889999999999999999875     56666653

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.1e-43  Score=327.19  Aligned_cols=247  Identities=28%  Similarity=0.335  Sum_probs=195.8

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHH-HHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEIL-TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||+||+|.+. +|+.||+|++...... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999987 5899999998754321 112233444544 56789999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|..++....  .+++..+..++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++.......   ..
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~  152 (323)
T cd05575          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---KT  152 (323)
T ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---Cc
Confidence            99999997654  3889999999999999999999998   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+..       .....+        ...   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~--------~~~---  214 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY-------DNILNK--------PLR---  214 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcC--------CCC---
Confidence            23456999999999999999999999999999999999999999765432211       111110        001   


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh----HHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM----KKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~----~eil~~l~~  326 (380)
                      .....+..+.+++.+||+.+|.+||++    .+++++.|-
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~  254 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF  254 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence            111235678899999999999999997    588887663

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-43  Score=337.30  Aligned_cols=259  Identities=21%  Similarity=0.277  Sum_probs=204.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999986 588999999875432 22334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999997654  3788889999999999999999988   99999999999999999999999999753211000


Q ss_pred             --------------------------------------------ceeeeecccCCccccChhhhhhcCCCCccchhhHHH
Q 041907          207 --------------------------------------------VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGV  242 (380)
Q Consensus       207 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  242 (380)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000112346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---hHH
Q 041907          243 LLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT---MKK  319 (380)
Q Consensus       243 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e  319 (380)
                      ++|||++|..||....+......+.   .   .       ..... .+.....+.++.++|.+++ .+|.+|++   +++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~---~---~-------~~~~~-~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVI---N---W-------QTSLH-IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHH---c---c-------CCCcC-CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999998765432211110   0   0       00000 1112234566778887765 59999987   999


Q ss_pred             HHHHHHHH
Q 041907          320 CAEILWKI  327 (380)
Q Consensus       320 il~~l~~~  327 (380)
                      +++|.|..
T Consensus       302 i~~hp~f~  309 (382)
T cd05625         302 IKAHPFFK  309 (382)
T ss_pred             HhcCCCcC
Confidence            99998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-43  Score=334.32  Aligned_cols=260  Identities=22%  Similarity=0.274  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++......++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4568999999999999999999987 488999999865322 12223457789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++....   ++...+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~~---~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         121 VMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999997543   788899999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQ----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ...  .......||+.|+|||++.+..    ++.++|||||||++|+|++|..||...........   .   .....  
T Consensus       195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~---i---~~~~~--  264 (370)
T cd05621         195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK---I---MDHKN--  264 (370)
T ss_pred             CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH---H---HhCCc--
Confidence            221  1123567999999999997643    78899999999999999999999976543221111   1   10000  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~~  327 (380)
                           .. ..+.....+..+.+++..||+.++.+  |++++++++|.|-.
T Consensus       265 -----~~-~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         265 -----SL-NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             -----cc-CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence                 00 01122234567889999999865543  89999999999854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-43  Score=342.23  Aligned_cols=255  Identities=22%  Similarity=0.325  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-C-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-D-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..|.+.+.||+|+||.||+|... + ++.||+|.+.....  .....+..|+.+|+.++||||+++++++...+..+|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34899999999999999999865 3 67899997754432  23456778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||+++|+|.+++...  ...++++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999988642  2335889999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ... ........||+.|+|||++.+..++.++|||||||++|+|++|..||........       ......+..     
T Consensus       222 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-------~~~~~~~~~-----  288 (478)
T PTZ00267        222 SVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-------MQQVLYGKY-----  288 (478)
T ss_pred             ccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC-----
Confidence            221 1123456799999999999999999999999999999999999999976443211       111111110     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .+.+..++..+.++|.+||+.+|++||++++++.+.+
T Consensus       289 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~  325 (478)
T PTZ00267        289 -----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF  325 (478)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence                 1122234567899999999999999999999987654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=308.96  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=215.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++-+.||+|.|+.|+++.+. +|+.+|+|++..........+++.+|+.+-+.|+||||+++.+.+...+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467788889999999999999876 5999999999766555555677899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEcccccccccc
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSE  202 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~  202 (380)
                      |++.|++|..-|-.+-  -+++..+-..+.||+.+|.|+|.++   |||||+||+|+|+-..   --+||+|||++..+.
T Consensus        90 e~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999988776542  2788888899999999999999988   9999999999999643   359999999999877


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .+.    ..-...||++|||||+++..+|+..+|||+.||+||-||.|.+||.+.....       ..+.+..+..    
T Consensus       165 ~g~----~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~y----  229 (355)
T KOG0033|consen  165 DGE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAY----  229 (355)
T ss_pred             Ccc----ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhcccc----
Confidence            321    2345679999999999999999999999999999999999999998744322       2223333321    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      |   ...+......++.++||++||..||.+|.|+.|.++|+|--
T Consensus       230 d---~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  230 D---YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             C---CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence            1   11335556778899999999999999999999999999964

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.6e-44  Score=330.61  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             CeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           54 NKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      +.||+|+||.||++...    +|+.||+|++............+.+|+.++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998752    58899999997654333334456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      +++|.+++....  .+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.......   .
T Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~  153 (318)
T cd05582          82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---K  153 (318)
T ss_pred             CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC---C
Confidence            999999997643  3899999999999999999999988   9999999999999999999999999987644321   1


Q ss_pred             eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT  289 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .+....           .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-------~i~~~~-----------~  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT-------MILKAK-----------L  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH-------HHHcCC-----------C
Confidence            1234569999999999999899999999999999999999999997654322111       111110           1


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          290 PASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       290 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                      ..+...+..+.+|+.+||+.||.+||+     +++++.+.|.
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~  257 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF  257 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence            112234567889999999999999999     6667777653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5e-43  Score=324.71  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=195.9

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhc-CCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSK-IEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||+|+++..... ......+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 4889999999764321 1223334556666654 4899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|..++....  .++...+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......   ..
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---~~  152 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GK  152 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---Cc
Confidence            99999997654  3889999999999999999999988   9999999999999999999999999987543221   12


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .+...           ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~-------~i~~~-----------~~~  214 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILND-----------RPH  214 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHcC-----------CCC
Confidence            234569999999999999999999999999999999999999998654322111       11100           011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMK-KCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~l~~  326 (380)
                      .+...+.++.+++.+||+.+|.+||++. +++++.|.
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF  251 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence            1223456788999999999999999875 67777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3e-43  Score=327.45  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=202.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCC-ceeceEEEEEeCCEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHL-NLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  125 (380)
                      +|++.+.||+|+||.||+|.+. +++.||||++..... .......+..|..++..+.|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788999999999999999987 478999999975432 122345577889999988765 6888999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            99999999999976543  889999999999999999999988   9999999999999999999999999986432211


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........       ....        .
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~-------i~~~--------~  217 (324)
T cd05587         156 ---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS-------IMEH--------N  217 (324)
T ss_pred             ---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcC--------C
Confidence               112345699999999999999999999999999999999999999976543221111       1110        0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~~  326 (380)
                         ...+...+..+.+++.+||+.+|.+|++.     ++++++.|-
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~  260 (324)
T cd05587         218 ---VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF  260 (324)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence               11122345678899999999999999986     788888663

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-43  Score=316.94  Aligned_cols=257  Identities=31%  Similarity=0.473  Sum_probs=208.7

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      |++.+.||+|+||+||++.+.. ++.||+|.+..............+|+..+++++||||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999874 678999999887666555545567999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++++|.+++....  .++...++.++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||.+......   .
T Consensus        81 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---N  152 (260)
T ss_dssp             TTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST---T
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc---c
Confidence            9999999998333  3899999999999999999999998   999999999999999999999999998754211   1


Q ss_pred             eeeecccCCccccChhhhh-hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          209 HISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||......+....+..........        .  
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~--  222 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------S--  222 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------H--
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------c--
Confidence            2234566899999999998 8889999999999999999999999998763333222222211110000        0  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       ..........+.+++.+||+.+|++||++.+++++.|
T Consensus       223 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  223 -SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             -TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             -ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence             0000011277999999999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.8e-44  Score=336.25  Aligned_cols=260  Identities=21%  Similarity=0.252  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||++.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4568999999999999999999987 589999999865322 12223447789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++....   ++...+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~~---l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999997643   788888899999999999999988   99999999999999999999999999876543


Q ss_pred             CCcceeeeecccCCccccChhhhhhc----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTY----QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ...  .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||..........       .+..... 
T Consensus       195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-------~i~~~~~-  264 (370)
T cd05596         195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-------KIMDHKN-  264 (370)
T ss_pred             CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH-------HHHcCCC-
Confidence            211  112345699999999998754    47889999999999999999999998655422111       1111000 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~~  327 (380)
                           ... .+.....+..+.+||.+||+.+|.+  |++++++++|.|-.
T Consensus       265 -----~~~-~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         265 -----SLT-FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             -----cCC-CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence                 000 1112234577899999999999987  99999999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.8e-43  Score=327.22  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=200.1

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +|+.||+|++..... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999987 488999999876432 222334566788888765 899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|...+....  .+++..+..++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++.......   ..
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---~~  152 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VT  152 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC---cc
Confidence            99999987654  3889999999999999999999998   9999999999999999999999999987533211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.........       ..+..+.           ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-------~~i~~~~-----------~~  214 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF-------ESILHDD-----------VL  214 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC-----------CC
Confidence            23456999999999999999999999999999999999999999865532211       1111111           01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCC-------ChHHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRP-------TMKKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RP-------t~~eil~~l~~  326 (380)
                      .+...+.++.+++.+||+.+|.+||       ++++++++.|-
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            1122446788999999999999999       89999999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.6e-43  Score=313.13  Aligned_cols=251  Identities=28%  Similarity=0.412  Sum_probs=203.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      ++|++.+.||+|+||.||++.++++..+|+|.+......   ...+.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            468888999999999999999987788999998754332   34678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++|+|.+++..... .+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          81 MENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            999999999976443 3889999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                       .......++..|+|||++.+..++.++||||||+++|+|++ |..||......+...       ....+..        
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~-------~i~~~~~--------  219 (256)
T cd05114         156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE-------MISRGFR--------  219 (256)
T ss_pred             -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHCCCC--------
Confidence             11122335678999999998899999999999999999999 899997654322111       1111110        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                        ...+...+..+.+++.+||+.+|.+||+++++++.|
T Consensus       220 --~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 --LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              011112345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=313.75  Aligned_cols=257  Identities=21%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch---HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK---CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ++|.+.+.||+|++|.||+|... +++.|++|.+.......   .....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999976 58999999987543221   224568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ++||+++++|.+++...+.  ++...+..++.+++.||.|||+.|   ++|+||+|+||++++++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            9999999999999976543  788999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ............++..|+|||++.+..++.++||||||+++|+|++|..||..........      ......       
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~-------  223 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIATQP-------  223 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH------HHhccC-------
Confidence            2111111123457889999999999999999999999999999999999997654322111      100000       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                         .....+......+.+++.+||+.+|.+||++.+++++.|
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence               001122335567889999999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.8e-43  Score=323.85  Aligned_cols=247  Identities=22%  Similarity=0.320  Sum_probs=197.0

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhc-CCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSK-IEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.++ +|+.||+|+++..... ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999987 5899999999764321 1123345667777765 4899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|..++....  .+++..+..++.||+.||.|||+.|   ++||||||+|||++.++.++|+|||+++......   ..
T Consensus        81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~  152 (316)
T cd05620          81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---NR  152 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC---Cc
Confidence            99999987654  3889999999999999999999988   9999999999999999999999999987432111   12


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||.........       ......      .     ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~-------~~~~~~------~-----~~  214 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF-------ESIRVD------T-----PH  214 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhC------C-----CC
Confidence            24467999999999999999999999999999999999999999765432111       111100      0     01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh-HHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM-KKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~-~eil~~l~~  326 (380)
                      .+.....++.+++.+||+.||.+||++ +++++|.|.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f  251 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF  251 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence            112245678899999999999999998 578877764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-43  Score=318.23  Aligned_cols=251  Identities=34%  Similarity=0.547  Sum_probs=197.9

Q ss_pred             CCCeeeccCceEEEEEEeC-----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           52 PANKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.+.||.|.||.||+|.+.     .+..|+||.+.... ......++.+|+..+++++||||++++|++...+..++|||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeeccccccccccccccccccccccccccccccc
Confidence            4578999999999999987     25679999996533 33346778999999999999999999999998888999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|.++|.......+++..++.|+.||+.||.|||+++   ++|+||+++||+++.++.+||+|||++........
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999999885556999999999999999999999988   99999999999999999999999999987632211


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                       ........+...|+|||.+.+..++.++||||||+++|||++ |+.||......+..       ..+..+..       
T Consensus       159 -~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~-------~~~~~~~~-------  223 (259)
T PF07714_consen  159 -YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII-------EKLKQGQR-------  223 (259)
T ss_dssp             -EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH-------HHHHTTEE-------
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------cccccccc-------
Confidence             222334557889999999999999999999999999999999 78998765332211       11111110       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                         .+.+..++..+.++|..||+.+|.+||++++|++.|
T Consensus       224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               112333567789999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-42  Score=317.14  Aligned_cols=252  Identities=20%  Similarity=0.275  Sum_probs=201.8

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||+|+||+||++.+. +|+.||+|.+....... .....+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999986 58999999987543222 2234567899999999999999999999999999999999999999


Q ss_pred             HHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          134 REHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       134 ~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      ..++...  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~  154 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KT  154 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---cc
Confidence            9887542  2335899999999999999999999988   99999999999999999999999999876543221   12


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+   .....        ...   ...
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~--------~~~---~~~  220 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQRIL--------NDS---VTY  220 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH---HHhhc--------ccC---CCC
Confidence            3456899999999999999999999999999999999999999764332111111   01000        000   112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                      +...+..+.+++.+||+.+|++||     +++++++|.|--
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~  261 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR  261 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence            234567789999999999999999     789999998853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5e-43  Score=320.42  Aligned_cols=269  Identities=25%  Similarity=0.307  Sum_probs=200.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEEe-----CC
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLEH-----GD  119 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  119 (380)
                      +|++.+.||+|+||.||+|.+. +|+.||+|.++...........+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999987 589999999875433222223345666666554   79999999998764     34


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..+++|||+++ +|.+++.......+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            57999999975 8999988766556899999999999999999999998   9999999999999999999999999988


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ......    ......||..|+|||++.+..++.++|||||||++|+|++|..||......+....+.............
T Consensus       157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            654321    1233468999999999999999999999999999999999999997654432221111100000000000


Q ss_pred             c-------ccccCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          280 L-------VMDPRLR--RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       280 ~-------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .       .+.+...  ...........+.+++.+||+.||.+|||+.+++.|.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            0       0000000  00011234567889999999999999999999998876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1e-42  Score=322.82  Aligned_cols=260  Identities=23%  Similarity=0.370  Sum_probs=206.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.+..... .....++.+|+.+++.++||||+++++++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            457999999999999999999875 343    489999875432 23456788999999999999999999998765 56


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++++||+++|+|.+++..... .+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            799999999999999986542 3888999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+.       ......+..  
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--  229 (316)
T cd05108         160 GADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER--  229 (316)
T ss_pred             cCCCcce-eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCC--
Confidence            5432211 1122335678999999999999999999999999999998 9999976432211       111111110  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                              .+....+...+.+++.+||+.+|.+||++.+++..+..+...
T Consensus       230 --------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         230 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                    111223445788999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-42  Score=315.92  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||+|+||.||++..+ +|+.||+|.+....... .....+..|+.++++++||||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999986 59999999986543221 1223456799999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++.......+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......    ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~  153 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQ  153 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----eeec
Confidence            99987766666899999999999999999999988   9999999999999999999999999987654321    1233


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCH
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN  293 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (380)
                      ..|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.   ......        ...  ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~---~~~~~~--------~~~--~~~~  220 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTLED--------EVK--FEHQ  220 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH---HHhhcc--------ccc--cccc
Confidence            568999999999999999999999999999999999999997543321111111   111100        000  0112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCChH----HHHHHHHH
Q 041907          294 MAVEKILGLADVCLAPTRQSRPTMK----KCAEILWK  326 (380)
Q Consensus       294 ~~~~~l~~li~~cl~~~p~~RPt~~----eil~~l~~  326 (380)
                      ..+.++.+|+.+||+.+|.+||+++    +++.|.|.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f  257 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF  257 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence            3456789999999999999999995    45566554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-42  Score=328.81  Aligned_cols=272  Identities=22%  Similarity=0.280  Sum_probs=207.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----EEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----ERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  122 (380)
                      +|++.+.||+|+||.||++.+. +|+.||||++............+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999986 6899999998755444344567889999999999999999999998776     789


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+. ++|.+.+....  .+++..++.++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 58888886543  3899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh--------h
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC--------L  273 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~  273 (380)
                      ....  .......+|..|+|||++.+. .++.++|||||||++|+|++|+.||....+......+......        .
T Consensus       155 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         155 PDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            3221  112334578999999999874 4789999999999999999999999876654322221110000        0


Q ss_pred             ccCCcccccccCCCCC------CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRT------PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ..+....+........      ........++.+||.+||+.||.+|||+.+++++.|-..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence            0000000000000000      011123567889999999999999999999999998543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-42  Score=314.30  Aligned_cols=256  Identities=28%  Similarity=0.402  Sum_probs=208.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..+|.+.+.||+|+||.||+|.+. .++.|++|.+.....   ...++.+|+..+++++|+||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            346788899999999999999986 488899999875432   2456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999999999998765556899999999999999999999988   9999999999999999999999999988654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........       ......+.       
T Consensus       159 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~-------  222 (263)
T cd05052         159 Y--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGY-------  222 (263)
T ss_pred             e--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCC-------
Confidence            1  11112234668999999999999999999999999999998 9999875433211       11111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ....+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       223 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 ---RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               0112223457799999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-42  Score=316.57  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=208.6

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      |++.+.||+|+||.||++.+. +++.||+|.+....... .....+.+|+.++++++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999987 58999999987543322 2234467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++...+...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999997665556899999999999999999999988   99999999999999999999999999875443211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|..||....................             
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------  221 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------  221 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-------------
Confidence               1234689999999999999999999999999999999999999976443211111111100000             


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKIR  328 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~~  328 (380)
                       ..........+.+|+.+||+.+|.+|||     ++|+++|.|-..
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence             0011234466889999999999999999     899999998654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5e-43  Score=331.44  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=208.3

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEe
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH  117 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  117 (380)
                      +.++....++|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556689999999999999999999987 588999999865322 12223447789999999999999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      ....++||||+++|+|.+++....   ++...+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999999997643   788888999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      +........  .......||+.|+|||++.+..    ++.++|||||||++|+|++|..||..........      ...
T Consensus       189 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~  260 (371)
T cd05622         189 CMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIM  260 (371)
T ss_pred             eeEcCcCCc--ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHH
Confidence            986543221  1123456999999999997643    7889999999999999999999998654322111      111


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWK  326 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~  326 (380)
                      ....       .. ..+.....+..+.++|.+||..++.+  |++++++++|+|-
T Consensus       261 ~~~~-------~~-~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         261 NHKN-------SL-TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             cCCC-------cc-cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            0000       00 01122245677889999999844433  7899999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.7e-43  Score=324.94  Aligned_cols=251  Identities=21%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +|.+.+.||+|+||.||+|.+. +++.||+|++...... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999987 4789999998764321 22234456777777776 5899999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+.  +++..++.++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            99999999999976543  889999999999999999999988   9999999999999999999999999987533211


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........   .    .+....        
T Consensus       156 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~----~i~~~~--------  217 (323)
T cd05616         156 ---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---Q----SIMEHN--------  217 (323)
T ss_pred             ---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCC--------
Confidence               1123456999999999999999999999999999999999999999865432211   1    111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILW  325 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~  325 (380)
                         ...+...+.++.+++.+||+.+|.+|++.     ++++++.|
T Consensus       218 ---~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~  259 (323)
T cd05616         218 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  259 (323)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence               11122345678899999999999999984     78877755

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.8e-43  Score=324.67  Aligned_cols=247  Identities=26%  Similarity=0.305  Sum_probs=194.3

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHH-HHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEIL-TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999986 589999999875432 1122334445544 57889999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|...+....  .+....+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   ..
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~  152 (321)
T cd05603          81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---ET  152 (321)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---Cc
Confidence            99999887643  3888899999999999999999988   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........   .    ......        .   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~----~~i~~~--------~---~~  214 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y----DNILHK--------P---LQ  214 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H----HHHhcC--------C---CC
Confidence            2345689999999999999999999999999999999999999976542211   1    111110        0   11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh----HHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM----KKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~----~eil~~l~~  326 (380)
                      .+......+.+++.+||+.+|.+||+.    .++++++|-
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~  254 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence            112234678899999999999999875    477776653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.9e-43  Score=322.67  Aligned_cols=247  Identities=22%  Similarity=0.312  Sum_probs=196.7

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhc-CCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSK-IEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||||+++..... ......+..|..++.. ++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999987 4889999999764321 1123345567777765 5999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.......   ..
T Consensus        81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~  152 (316)
T cd05619          81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AK  152 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---Cc
Confidence            99999997643  3888999999999999999999988   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||...........       ....      .     ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~-------i~~~------~-----~~  214 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-------IRMD------N-----PC  214 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhC------C-----CC
Confidence            2345689999999999999999999999999999999999999976543221111       1100      0     01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMK-KCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~l~~  326 (380)
                      .+......+.+++.+||+.+|.+||++. +++++.|-
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF  251 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence            1122456788999999999999999997 78887663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.9e-43  Score=323.06  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=200.4

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||||+++.... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999987 488999999976432 122334566788888877 799999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|..++....  .+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   .
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~  152 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T  152 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence            99999987654  3899999999999999999999988   99999999999999999999999999864322111   1


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||..|+|||++.+..++.++|||||||++|+|++|..||........       ........           ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-------~~~i~~~~-----------~~  214 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-------FQSILEDE-----------VR  214 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCC-----------CC
Confidence            2335689999999999999999999999999999999999999976543211       11111110           01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILWKI  327 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~~~  327 (380)
                      .+...+..+.+||.+||+.||.+||++     .+++++.|-.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~  256 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR  256 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            122345678999999999999999999     9999987653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-42  Score=311.89  Aligned_cols=249  Identities=25%  Similarity=0.423  Sum_probs=200.5

Q ss_pred             eeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           55 KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .||+|+||.||+|.++   ++..+|+|++...........++.+|+.+++++.||||+++++++.. ...++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   47889999987665555566778999999999999999999998864 4678999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|.+++....  .+++..+..++.|++.||.|||++|   ++|+||||.||+++.++.++|+|||++.............
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            9999997654  3889999999999999999999988   9999999999999999999999999998665432211111


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||........       ...+..+..          .+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~i~~~~~----------~~  218 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------TQMIESGER----------ME  218 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCC----------CC
Confidence            22334678999999998889999999999999999998 9999976543211       111111110          11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .+..++.++.++|.+||+.+|.+||++.+|.+.|..
T Consensus       219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            222355778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-42  Score=312.01  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=208.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|++.+.||+|+||.||+|.+..    ...||+|.+..... ......+.+|+..+++++||||+++++++......+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            3678999999999999999999752    35799999876543 334556889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ++|||+++++|.+++....+ .+++..++.++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++....
T Consensus        82 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999999976543 4899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........       ......+.    
T Consensus       158 ~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~----  225 (266)
T cd05033         158 DSEATY-TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------IKAVEDGY----  225 (266)
T ss_pred             ccccce-eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcCC----
Confidence            222111 1122345678999999999999999999999999999998 9999965432211       11111110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ..+....++..+.+++.+||+.+|.+||++.+|+++|..+
T Consensus       226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  0111223456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.3e-43  Score=339.88  Aligned_cols=272  Identities=21%  Similarity=0.289  Sum_probs=198.7

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC------CCceeceEEE
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE------HLNLVKLFGF  114 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~  114 (380)
                      ++....++|++.+.||+|+||+||+|.+. .++.||||+++....   ....+..|+.++.+++      |.++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            34445688999999999999999999986 488899999864321   2233455666666554      4568889988


Q ss_pred             EEeC-CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCC----
Q 041907          115 LEHG-DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKL----  188 (380)
Q Consensus       115 ~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~----  188 (380)
                      +... ...++||+++ +++|.+++...+  .+++..+..++.||+.||.|||+ .|   |+||||||+|||++.++    
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            8764 5789999988 668999887654  38999999999999999999997 47   99999999999998765    


Q ss_pred             ------------ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041907          189 ------------RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES  256 (380)
Q Consensus       189 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  256 (380)
                                  .+||+|||.+.....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                        499999998754221      12346799999999999999999999999999999999999999987


Q ss_pred             CCCcchhhHHHHHHHhhcc--------CCcccccc------cCCC----------CCCCCHHHHHHHHHHHHHhcCCCCC
Q 041907          257 KKPIKERVTIRWAMQCLKA--------GDAILVMD------PRLR----------RTPASNMAVEKILGLADVCLAPTRQ  312 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~------~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~  312 (380)
                      ....+....+.........        ......++      +...          ...........+.+||.+||+.||.
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            6554332222111000000        00000000      0000          0000011235677999999999999


Q ss_pred             CCCChHHHHHHHHHHH
Q 041907          313 SRPTMKKCAEILWKIR  328 (380)
Q Consensus       313 ~RPt~~eil~~l~~~~  328 (380)
                      +|||++|+++|.|-..
T Consensus       428 ~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        428 KRLNARQMTTHPYVLK  443 (467)
T ss_pred             hCCCHHHHhcCccccc
Confidence            9999999999999653

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.7e-43  Score=329.70  Aligned_cols=270  Identities=18%  Similarity=0.255  Sum_probs=205.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  119 (380)
                      ..++|++.+.||+|+||.||++.+. +|+.||+|++............+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4589999999999999999999986 5899999999765444444566789999999999999999999886443     


Q ss_pred             -EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          120 -ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       120 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                       ..|+||||+++ +|.+.+..    .++...+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999965 67777643    2788889999999999999999998   999999999999999999999999998


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH----------
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW----------  268 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~----------  268 (380)
                      +......    ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+..          
T Consensus       171 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         171 RTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             cccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            7543221    12345689999999999999999999999999999999999999986543221111000          


Q ss_pred             ------HHHhhccC-Ccc-----cccccCC--CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          269 ------AMQCLKAG-DAI-----LVMDPRL--RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       269 ------~~~~~~~~-~~~-----~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ........ ...     .......  ............+.+|+.+||+.||.+|||++|+++|.|..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  319 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT  319 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhh
Confidence                  00000000 000     0000000  00001112345688999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-42  Score=329.43  Aligned_cols=270  Identities=21%  Similarity=0.241  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ...+|.+.+.||+|+||.||++...   .+..|++|.+....       ...+|+.+|++++||||+++++++......+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            3467999999999999999999754   36789999886432       2458999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ++||++. ++|.+++...  ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.++|+|||++....
T Consensus       163 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             EEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            9999995 5899988543  34899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc---
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI---  279 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  279 (380)
                      .... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.............   
T Consensus       237 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        237 AHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             cccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            3221 111234569999999999999999999999999999999999999997765433222222222211110000   


Q ss_pred             ----------cccccCCCC-CCC-----CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          280 ----------LVMDPRLRR-TPA-----SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       280 ----------~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                                ..+....+. ...     ......++.++|.+||..+|.+||++.|++.+.|-...
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                      000000000 000     11234567889999999999999999999999986543

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.6e-42  Score=328.56  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=208.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  118 (380)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||||++..... ......+.+|+.+|.++. ||||+++++++...
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            4578999999999999999999863      134699999975433 233456889999999996 99999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCC---------------------------------------------------------
Q 041907          119 DERIIVVEYVGNGTLREHLDGRG---------------------------------------------------------  141 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~---------------------------------------------------------  141 (380)
                      +..+|||||+++|+|.++|....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999886421                                                         


Q ss_pred             -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 041907          142 -------------------------------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI  184 (380)
Q Consensus       142 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~  184 (380)
                                                           ...+++..+..++.||+.||.|||+.+   ++|+||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                 123677888999999999999999988   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchh
Q 041907          185 TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKER  263 (380)
Q Consensus       185 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~  263 (380)
                      +.++.+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.........
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            99999999999998865432211 11223446788999999999999999999999999999997 99999754322111


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                            ......+.          ..+....++..+.+++.+||+.+|.+||++.+|.+.+..+.+
T Consensus       350 ------~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 ------YNKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ------HHHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                  11111110          011223456789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-42  Score=323.06  Aligned_cols=253  Identities=23%  Similarity=0.309  Sum_probs=200.4

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999986 5889999999865332 22345577899998888 699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|..++...+  .+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++.......   ..
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~  152 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DT  152 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC---Cc
Confidence            99999887654  3899999999999999999999998   9999999999999999999999999987432211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............+..+.....        .   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~---~~  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------P---IR  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------C---CC
Confidence            234569999999999999999999999999999999999999996533221111111111111111        0   11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCC------hHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPT------MKKCAEILW  325 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~eil~~l~  325 (380)
                      .+...+..+.+++.+||+.||.+|++      ++++++|.|
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~  262 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF  262 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence            22234467889999999999999998      568888875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-42  Score=314.86  Aligned_cols=271  Identities=26%  Similarity=0.354  Sum_probs=205.2

Q ss_pred             cCC-CCCCeeeccCceEEEEEEe-----CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--C
Q 041907           48 ENF-SPANKIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--D  119 (380)
Q Consensus        48 ~~~-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  119 (380)
                      ++| ++.+.||+|+||+||++..     .++..||+|.+..... ......+.+|+.++++++||||+++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence            344 8899999999999988653     2478899999876532 23345678999999999999999999987653  4


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..+++|||+++++|.+++....   +++..++.++.+++.||.|||+++   ++|+||||+||++++++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            6899999999999999997643   899999999999999999999988   9999999999999999999999999988


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ................++..|+|||.+.+..++.++||||||+++|+|++|..||......... .+.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  234 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLI  234 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hhcccccccchhhhh
Confidence            6654322111222334667899999999889999999999999999999999998654321100 000000000000000


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...+... ..+.+..++..+.+++.+||+.+|.+||+++++++.+..+
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         235 ELLERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111111 1122334567899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.1e-42  Score=309.69  Aligned_cols=261  Identities=24%  Similarity=0.336  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.+. +++.||||.+.... ........+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999986 68999999886532 23334456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||+++++|.+++....  ...++...++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999886422  234788999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........     .........      
T Consensus       159 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-----~~~~~~~~~------  224 (267)
T cd08228         159 KTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-----LCQKIEQCD------  224 (267)
T ss_pred             hhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-----HHHHHhcCC------
Confidence            221   112345888999999999888999999999999999999999999654321111     111111110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                         .........+..+.+++.+||+.+|.+||++.+|++.+..++
T Consensus       225 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 ---YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence               001112345577999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-42  Score=311.37  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=208.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..+.|++.+.||+|+||.||+|..++++.||+|.+......   ...+.+|+.++++++|+|++++++++. ....+++|
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            45789999999999999999999888899999998765443   346789999999999999999999874 45689999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....+..+++..++.++.+++.||.|||+.|   ++|+||||+||++++++.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999999998766666899999999999999999999988   9999999999999999999999999987655322


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  .......++..|+|||++.+..++.++||||||+++|+|++ |..||..........       ....+.       
T Consensus       157 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~-------  220 (260)
T cd05067         157 Y--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-------NLERGY-------  220 (260)
T ss_pred             c--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH-------HHHcCC-------
Confidence            1  11123346778999999999999999999999999999999 999997654322111       111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..+.....+.++.+++.+||+.+|++||++++++..|..
T Consensus       221 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 ---RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               011223345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.2e-43  Score=329.00  Aligned_cols=271  Identities=18%  Similarity=0.240  Sum_probs=206.1

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----  118 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  118 (380)
                      ...++|++.+.||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999976 588999999976554444556678899999999999999999987543     


Q ss_pred             -CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          119 -DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                       ...++||||+++ +|.+.+..    .++...+..++.|++.||.|||+.|   ++||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             357999999965 77777753    2788899999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA--------  269 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------  269 (380)
                      ++......    ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+...        
T Consensus       166 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         166 ARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            97644321    123456899999999999999999999999999999999999999865533221111000        


Q ss_pred             --------HHhhccC-Ccccc-----cccCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 --------MQCLKAG-DAILV-----MDPRLR--RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 --------~~~~~~~-~~~~~-----~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                              ....... .....     ......  ...........+.+||.+||+.||++|||+.|++++.|..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~  315 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN  315 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence                    0000000 00000     000000  0001112345688999999999999999999999998853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3e-42  Score=310.05  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=204.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      ++|.+.+.||+|+||.||+|.+.++..+|+|.+......   ...+.+|+.++.+++||||+++++++......+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            467888999999999999999887677999998754332   34688999999999999999999999998899999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++..... .+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++.+||+|||.++....... 
T Consensus        81 ~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          81 MSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            999999999976543 4899999999999999999999988   99999999999999999999999999876543221 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                       .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   .    .....+..        
T Consensus       156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~----~~~~~~~~--------  219 (256)
T cd05113         156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---V----EKVSQGLR--------  219 (256)
T ss_pred             -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H----HHHhcCCC--------
Confidence             11122346678999999998899999999999999999998 9999975443211   1    11111110        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                        .......+..+.+++.+||+.+|.+||++.+++..+
T Consensus       220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence              011112356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=327.51  Aligned_cols=270  Identities=23%  Similarity=0.297  Sum_probs=216.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-C-----CceeceEEEEEeCCEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-H-----LNLVKLFGFLEHGDER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~  121 (380)
                      +|.+.+.||+|.||.|.+|.+. +++.||||+++...   ....+...|+.+|..|+ |     -|+|+++++|...++.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            4788999999999999999987 59999999998753   34556678999999986 4     3899999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC--ceEEccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL--RAKVTDFGFAR  199 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~  199 (380)
                      |||+|.+.. +|+++|......+++...++.++.||+.||.+||+.+   |||+||||+|||+.+.+  .+||+|||.++
T Consensus       264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999955 9999999988888999999999999999999999998   99999999999998654  69999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh------
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL------  273 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------  273 (380)
                      .....     .. ..+.+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.++.++...+.......      
T Consensus       340 ~~~q~-----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~  413 (586)
T KOG0667|consen  340 FESQR-----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD  413 (586)
T ss_pred             ccCCc-----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            65532     22 5668899999999999999999999999999999999999999888877665553211110      


Q ss_pred             ---------cc-CCccc--c--------------------cccCCCC------CC-CCHHHHHHHHHHHHHhcCCCCCCC
Q 041907          274 ---------KA-GDAIL--V--------------------MDPRLRR------TP-ASNMAVEKILGLADVCLAPTRQSR  314 (380)
Q Consensus       274 ---------~~-~~~~~--~--------------------~~~~~~~------~~-~~~~~~~~l~~li~~cl~~~p~~R  314 (380)
                               .. .....  .                    .+.....      .. ........+.+++.+||..||..|
T Consensus       414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R  493 (586)
T KOG0667|consen  414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER  493 (586)
T ss_pred             hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence                     00 00000  0                    0000000      00 111334678899999999999999


Q ss_pred             CChHHHHHHHHHHHhhh
Q 041907          315 PTMKKCAEILWKIRKDF  331 (380)
Q Consensus       315 Pt~~eil~~l~~~~~~~  331 (380)
                      +|..++++|.|--...+
T Consensus       494 ~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  494 ITPAQALNHPFLTGTSL  510 (586)
T ss_pred             CCHHHHhcCcccccccc
Confidence            99999999999764433

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.1e-42  Score=313.76  Aligned_cols=257  Identities=27%  Similarity=0.450  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++|.+.+.||+|+||.||+|.+.+      ++.||+|.+...... .....+.+|+.++++++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-HHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4568889999999999999998642      478999998765433 245678899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          121 RIIVVEYVGNGTLREHLDGRG------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      .+++|||+++++|.+++...+            ...+++..+..++.+++.||.+||+.|   ++|+||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence            999999999999999997543            134788899999999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIR  267 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  267 (380)
                      .++|+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||........   + 
T Consensus       160 ~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~-  234 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---I-  234 (280)
T ss_pred             eEEECCcccceecccCcc-eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H-
Confidence            999999999875432211 111223346788999999999999999999999999999998 9999975543221   1 


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                         .....+..          .......+..+.+++.+||+.+|.+||+++||++.+.
T Consensus       235 ---~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ---ECITQGRL----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               11111110          1112235577899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.7e-42  Score=308.78  Aligned_cols=254  Identities=29%  Similarity=0.466  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|++.+.||+|+||.||+|.+.++..+|+|.+......   ...+.+|+.++++++|+|++++++++. ....+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence            4678999999999999999999888888999998765443   245789999999999999999999875 456799999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.......+++..++.++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999999998765556899999999999999999999988   99999999999999999999999999986543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                        .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.   ..    ....+.        
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~----~~~~~~--------  220 (260)
T cd05070         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LE----QVERGY--------  220 (260)
T ss_pred             --ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHHcCC--------
Confidence              11122335678999999999899999999999999999999 8999976443221   11    111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ..+.+...+..+.+++.+||+.+|.+|||++++++.|..
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              112223445679999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.7e-42  Score=314.35  Aligned_cols=259  Identities=24%  Similarity=0.311  Sum_probs=208.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .|+..+.||.|+||+||+|.+. +|+.||+|.+....... .....+.+|+.++++++|+|++++++.+...+..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3677889999999999999986 58999999986543322 223446789999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++...+...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            999999999987665556999999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..   ......         
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~---~~~~~~---------  221 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR---RVLETE---------  221 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---hhhccc---------
Confidence               11334689999999999999999999999999999999999999986543222111111   111100         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKIR  328 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~~  328 (380)
                        .......+..+.+|+..||+.+|.+||+     +++++.+.|-..
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05632         222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN  266 (285)
T ss_pred             --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence              0111234466889999999999999999     889999877543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-42  Score=320.73  Aligned_cols=260  Identities=20%  Similarity=0.268  Sum_probs=202.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||++.+. +++.||+|++..... .......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999986 589999999875322 2223455788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++.... ..+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            9999999999997643 23889999999999999999999998   9999999999999999999999999987654322


Q ss_pred             cceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .  .......||+.|+|||++..     ..++.++|||||||++|+|++|..||......+....       +....   
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-------i~~~~---  224 (331)
T cd05597         157 T--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-------IMNHK---  224 (331)
T ss_pred             C--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH-------HHcCC---
Confidence            1  11123458999999999973     4578899999999999999999999976543221111       10000   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCC--CCCChHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQ--SRPTMKKCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~eil~~l~~  326 (380)
                         ............+..+.+++.+||..++.  .||+++++++|.|-
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~  269 (331)
T cd05597         225 ---EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF  269 (331)
T ss_pred             ---CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence               00111111122556788899988765443  37899999999885

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-42  Score=320.79  Aligned_cols=272  Identities=22%  Similarity=0.304  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||.||+|.++ +++.||+|.+....... ....+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            367999999999999999999987 58889999987543322 2334678999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++ +|.+++...+. .+++..+..++.||+.||.|||+.|   ++||||||+||+++.++.+||+|||++.......
T Consensus        84 e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          84 EYLDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             eCCCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            99975 88888866543 3788999999999999999999988   9999999999999999999999999987543321


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc-----
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI-----  279 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  279 (380)
                      .   ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.............     
T Consensus       159 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         159 K---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             c---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            1   1223457899999998865 467899999999999999999999997665433222221110000000000     


Q ss_pred             ---cccc-cCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 ---LVMD-PRLRR---TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ---~~~~-~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ...+ +....   .......+.++.+||.+||+.||.+|||++|++++.|-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence               0000 00000   001112456788999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=310.38  Aligned_cols=251  Identities=31%  Similarity=0.442  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      .+|++.+.||+|+||.||++.++++..+|+|++......   ...+.+|+.++++++|+||+++++++...+..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            457889999999999999999887778999998654332   23577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++..... .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-  155 (256)
T cd05059          81 MANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-  155 (256)
T ss_pred             CCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence            999999999976543 4899999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                       .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...       ....+.         
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~---------  218 (256)
T cd05059         156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE-------SVSAGY---------  218 (256)
T ss_pred             -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH-------HHHcCC---------
Confidence             11112234568999999999999999999999999999999 899997654322111       111110         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                       ....+...+..+.+++.+||+.+|++||++.++++.+
T Consensus       219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 -RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             0111123466799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4e-42  Score=310.28  Aligned_cols=255  Identities=30%  Similarity=0.463  Sum_probs=206.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|++.++||+|+||.||+|.+.++..||+|++......   ...+.+|+.++++++|+||+++++++.. ...++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            4679999999999999999999876667999999764432   2467899999999999999999998754 56799999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.......+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999999998755555889999999999999999999988   99999999999999999999999999976543321


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .  ......++..|+|||+..+..++.++||||||+++|+|++ |..||.........       .....+.        
T Consensus       158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~~--------  220 (262)
T cd05071         158 T--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY--------  220 (262)
T ss_pred             c--cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcCC--------
Confidence            1  1123446778999999999999999999999999999999 88898765432211       1111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        ..+.....+..+.+++.+||+.+|.+||++.++++.++..
T Consensus       221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              0112334567789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6e-42  Score=316.47  Aligned_cols=270  Identities=25%  Similarity=0.378  Sum_probs=208.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||++.+. +|..||+|.+..... ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            46899999999999999999986 588899998875432 3345568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+ .+   ++|+||||+|||++.++.++|+|||++...... 
T Consensus        80 y~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          80 HMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999997653  38889999999999999999997 46   999999999999999999999999998754321 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc------
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI------  279 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  279 (380)
                          ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.............      
T Consensus       154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence                1234568899999999998889999999999999999999999996544221111110000000000000      


Q ss_pred             -----------c----ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          280 -----------L----VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       280 -----------~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                                 .    ..... .........+.++.+++.+||+.+|.+||+++++++++|-...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                       0    00000 0000011245678999999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-42  Score=309.14  Aligned_cols=262  Identities=24%  Similarity=0.317  Sum_probs=219.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||.|.-|+||++..++ +..+|+|++.+.... .....+...|-++|..+.||.++.+|..++.....|+
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            44578889999999999999999884 799999999766432 3345667889999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      +||||+||+|..+.+.+.+..+++..++.++..|+-||+|||..|   ||.|||||+||||-++|++.|+||.++.....
T Consensus       155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999999999999999999999999999999999999998   99999999999999999999999998764321


Q ss_pred             CCc------------------------------cee-----------------------eeecccCCccccChhhhhhcC
Q 041907          204 DSA------------------------------VSH-----------------------ISTQVKGTAGYLDPDYLRTYQ  230 (380)
Q Consensus       204 ~~~------------------------------~~~-----------------------~~~~~~gt~~y~aPE~~~~~~  230 (380)
                      ...                              ...                       ....+.||-.|+|||+++|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence            000                              000                       011256899999999999999


Q ss_pred             CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCC
Q 041907          231 LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPT  310 (380)
Q Consensus       231 ~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  310 (380)
                      .+.++|=|+|||+|||||.|..||.+....+....+               +...+. -+.....+..+.+||++.|.+|
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~-Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLK-FPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCc-CCCCCcchhHHHHHHHHHhccC
Confidence            999999999999999999999999988765543332               112222 1222356678999999999999


Q ss_pred             CCCCCC----hHHHHHHHHH
Q 041907          311 RQSRPT----MKKCAEILWK  326 (380)
Q Consensus       311 p~~RPt----~~eil~~l~~  326 (380)
                      |.+|..    +.||.+|.+-
T Consensus       376 P~kRlg~~rGA~eIK~HpFF  395 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFF  395 (459)
T ss_pred             hhhhhccccchHHhhcCccc
Confidence            999998    9999998754

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-42  Score=321.92  Aligned_cols=246  Identities=25%  Similarity=0.314  Sum_probs=193.6

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHH-HHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEI-LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +++.||+|++...... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999987 4788999998754321 11222334444 456788999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|.+++.....  +....+..++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 ~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---~~  152 (325)
T cd05602          81 GELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---GT  152 (325)
T ss_pred             CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC---CC
Confidence            999999976543  788888899999999999999998   9999999999999999999999999987532211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........   ....    ..        .   ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~----~~--------~---~~  214 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---DNIL----NK--------P---LQ  214 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---HHHH----hC--------C---cC
Confidence            23456999999999999999999999999999999999999999765432211   1110    00        0   01


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChH----HHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMK----KCAEILW  325 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~----eil~~l~  325 (380)
                      .....+..+.+++.+||+.+|.+||++.    ++++++|
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~  253 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF  253 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence            1123456788999999999999999876    6666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.9e-42  Score=319.70  Aligned_cols=271  Identities=19%  Similarity=0.233  Sum_probs=203.7

Q ss_pred             CCCeeecc--CceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           52 PANKIGEG--GSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        52 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      +.+.||+|  +|++||++..+ +|+.||+|.+............+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  67899999986 6899999999766544445556788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||||+|||++.++.++++||+............
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999997654445899999999999999999999988   9999999999999999999999998654332111100


Q ss_pred             e----eeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc--------
Q 041907          209 H----ISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK--------  274 (380)
Q Consensus       209 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  274 (380)
                      .    ......++..|+|||++.+  ..++.++|||||||++|+|++|..||.........  .........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccch
Confidence            0    1122346788999999976  46889999999999999999999999754322110  000000000        


Q ss_pred             -cCCc-----ccccc----------------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          275 -AGDA-----ILVMD----------------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       275 -~~~~-----~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ....     ....+                ......+........+.+|+.+||+.||++|||+++++++.|-.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence             0000     00000                00000112233456789999999999999999999999998864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.3e-42  Score=313.30  Aligned_cols=261  Identities=26%  Similarity=0.433  Sum_probs=209.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+....  ......+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            467899999999999999999852      24569999886543  2335568899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGG-----------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      .++||||+++++|.+++...+.           ..+++..++.++.|++.||.|||+.|   ++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999999975431           23899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  268 (380)
                      ++|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|++ |..||........   +  
T Consensus       159 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~--  232 (288)
T cd05093         159 VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---I--  232 (288)
T ss_pred             EEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--
Confidence            99999999876543211 112233446788999999999999999999999999999998 8999876543221   1  


Q ss_pred             HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                        .....+..          .......+..+.+++.+||+.+|.+|||+++++..+..+.+.
T Consensus       233 --~~i~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         233 --ECITQGRV----------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             --HHHHcCCc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence              11111111          001112346789999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.9e-42  Score=321.37  Aligned_cols=263  Identities=27%  Similarity=0.408  Sum_probs=206.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe-
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH-  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  117 (380)
                      ..++|++.+.||.|+||.||+|.+.      +++.||+|+++..... .....+..|+.++.++ +|+||+++++++.. 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            3468999999999999999999642      2578999998754332 2345677899999999 89999999998764 


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCC-------------------------------------------------------
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGG-------------------------------------------------------  142 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~-------------------------------------------------------  142 (380)
                      ....+++|||+++++|.++|.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4578899999999999999864321                                                       


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCc
Q 041907          143 ----NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA  218 (380)
Q Consensus       143 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~  218 (380)
                          ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+++.+...... .......++.
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~  239 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL  239 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence                24788999999999999999999988   999999999999999999999999999865432211 1122344677


Q ss_pred             cccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHH
Q 041907          219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVE  297 (380)
Q Consensus       219 ~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (380)
                      .|+|||++.+..++.++|||||||++|+|++ |..||......+.   +.   .....+..          .........
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~---~~~~~~~~----------~~~~~~~~~  303 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FC---RRLKEGTR----------MRAPEYATP  303 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HH---HHHhccCC----------CCCCccCCH
Confidence            8999999999999999999999999999998 9999976433221   10   11111100          011223446


Q ss_pred             HHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          298 KILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       298 ~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .+.+++.+||+.+|++||++.+++++|..+..
T Consensus       304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            78999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.4e-42  Score=312.39  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ..|++.+.||+|+||.||+|.+.     .+..|++|.+..... ......+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            56788999999999999999852     467899999975433 334467889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          123 IVVEYVGNGTLREHLDGRG---------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      ++|||+++++|.+++....               ...+++..+..++.+++.||.|||+++   ++|+||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            9999999999999985322               123788888999999999999999988   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....+...    
T Consensus       161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~----  235 (283)
T cd05090         161 LHVKISDLGLSREIYSADY-YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV----  235 (283)
T ss_pred             CcEEeccccccccccCCcc-eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence            9999999999986543221 112233446778999999998899999999999999999998 9999976543211    


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                         ........          ..+....++..+.+++.+||+.+|.+||++.+|++++.
T Consensus       236 ---~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         236 ---IEMVRKRQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             ---HHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence               11111110          01122234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.5e-42  Score=314.16  Aligned_cols=258  Identities=23%  Similarity=0.389  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+...... ....++.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            5678999999999999999999854      2567999998654322 23456889999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG--------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                      ..++||||+++++|.+++.....        ..+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999999975321        23577888999999999999999988   99999999999999999999


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  270 (380)
                      |+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||........   +    
T Consensus       160 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~----  231 (277)
T cd05062         160 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---L----  231 (277)
T ss_pred             ECCCCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----
Confidence            999999875543211 111122345788999999999999999999999999999999 7889876543211   1    


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .....+..          ......++..+.+++.+||+.+|.+||++.|+++.+.
T Consensus       232 ~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         232 RFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111110          0111234467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.1e-42  Score=306.85  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=206.8

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|+||.||++.+. +++.||+|.++..... .....+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            5788999999999999999987 5889999998654332 2345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++.......++...++.++.+++.||.+||+.|   ++|+||||+||++++++.++|+|||++........ 
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999999987655556889999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|..||.........       .....+..         
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~---------  217 (255)
T cd08219         156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-------LKVCQGSY---------  217 (255)
T ss_pred             --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-------HHHhcCCC---------
Confidence              123456889999999999999999999999999999999999999764432111       11111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEI  323 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~  323 (380)
                       .+.+...+..+.+++.+||+.+|.+||++.+++..
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             11223345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-42  Score=308.66  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=208.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  126 (380)
                      +|++.+.||.|++|.||++.++ +++.|++|.+............+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999986 47889999997655444455668899999999999999999988764 446899999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.......+++..++.++.+++.||.+||+.|   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999998765556899999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......+++.|+|||++.+..++.++||||||+++++|++|..||........   .    .....+..        
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~----~~~~~~~~--------  219 (257)
T cd08223         158 ---MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---V----YRIIEGKL--------  219 (257)
T ss_pred             ---ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H----HHHHhcCC--------
Confidence               22345688999999999999999999999999999999999999975432211   0    11111100        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        .......+..+.+++.+||+.+|.+||++.+++.+.|
T Consensus       220 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         220 --PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             --CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence              1122345577999999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-42  Score=335.97  Aligned_cols=267  Identities=19%  Similarity=0.257  Sum_probs=198.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  118 (380)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++.....      ...+|+.+++.++||||+++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3467999999999999999999986 589999998865322      234799999999999999999876432      


Q ss_pred             --CEEEEEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEc
Q 041907          119 --DERIIVVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVT  193 (380)
Q Consensus       119 --~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~  193 (380)
                        ..+++||||+++ +|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence              246799999975 787776532  2345899999999999999999999998   99999999999999665 69999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      |||+++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+......
T Consensus       214 DFGla~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        214 DFGSAKNLLAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             ccccchhccCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999986543221    1235689999999998764 6899999999999999999999999876554332222111000


Q ss_pred             hc-------cCCcccccccCCCC----CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          273 LK-------AGDAILVMDPRLRR----TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       273 ~~-------~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ..       ........-+....    ...+...+.++.+||.+||+.+|.+|||+.++++|.|-
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence            00       00000000000000    00111234678999999999999999999999999984

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-41  Score=310.29  Aligned_cols=256  Identities=25%  Similarity=0.378  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+..... ......+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            46888999999999999999975 588999999865432 2344568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|..+.      .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  
T Consensus        80 ~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          80 FMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             cCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            99999986552      2678888999999999999999988   999999999999999999999999998765432  


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......||..|+|||++.+..++.++||||||+++|+|++|..||.......................     .+. 
T Consensus       149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~-  219 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPV-  219 (279)
T ss_pred             ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCC-
Confidence               12345689999999999999999999999999999999999999975432221111111111111100     000 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ......+..+.+++.+||+.+|.+||++++++++.|..
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~  257 (279)
T cd06619         220 ---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV  257 (279)
T ss_pred             ---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence               01112345688999999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.1e-42  Score=310.88  Aligned_cols=256  Identities=23%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.......  ...+.+|+.++++++||||+++++++......++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~--~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD--FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch--HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            467999999999999999999985 58899999987543322  345778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        86 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          86 EYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999999987544  3889999999999999999999988   9999999999999999999999999988653221


Q ss_pred             cceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .   ......|+..|+|||.+.   ...++.++|||||||++|+|++|..||....+......+       ...    ..
T Consensus       161 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~----~~  226 (267)
T cd06646         161 A---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKS----NF  226 (267)
T ss_pred             c---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecC----CC
Confidence            1   112345889999999884   445778999999999999999999999654332211000       000    00


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+  .........+..+.+++.+||+.+|++||+++++++++|
T Consensus       227 ~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         227 QP--PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CC--CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            00  001111234567899999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.1e-42  Score=320.40  Aligned_cols=252  Identities=20%  Similarity=0.301  Sum_probs=201.0

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999986 589999999875432 1223345677888888775 577888999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++.....  +++..++.++.||+.||.|||++|   ++||||||+|||++.++.++|+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            99999999999976543  899999999999999999999998   9999999999999999999999999987533221


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...    +....        
T Consensus       156 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~----i~~~~--------  217 (323)
T cd05615         156 V---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQS----IMEHN--------  217 (323)
T ss_pred             c---cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHH----HHhCC--------
Confidence            1   12345699999999999999999999999999999999999999986543221   111    11110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~~  326 (380)
                         ...+...+..+.+++.+||+.+|.+|++.     +++++|.|-
T Consensus       218 ---~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f  260 (323)
T cd05615         218 ---VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF  260 (323)
T ss_pred             ---CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence               01122345678899999999999999974     677777553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8e-43  Score=329.25  Aligned_cols=259  Identities=22%  Similarity=0.304  Sum_probs=204.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||++.+. +|+.||+|++..... .......+.+|+.++..++|+||+++++.+......++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999987 589999999975322 2233456788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++.....  +++..+..++.|++.||.|||+.|   |+||||||+|||++.++.++|+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999999976543  889999999999999999999998   9999999999999999999999999987543211


Q ss_pred             cc--------------------------------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC
Q 041907          206 AV--------------------------------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP  253 (380)
Q Consensus       206 ~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  253 (380)
                      ..                                ........||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                0001234699999999999999999999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHHH
Q 041907          254 IESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP---TMKKCAEILWK  326 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~eil~~l~~  326 (380)
                      |....+......+   .    ...      .... .+.....+.++.+||.+++ .+|.+|+   +++++++|.|-
T Consensus       236 f~~~~~~~~~~~i---~----~~~------~~~~-~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f  296 (360)
T cd05627         236 FCSETPQETYRKV---M----NWK------ETLV-FPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF  296 (360)
T ss_pred             CCCCCHHHHHHHH---H----cCC------Ccee-cCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCC
Confidence            9876543221111   0    000      0000 0111123456788888876 4999998   47999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-42  Score=309.48  Aligned_cols=256  Identities=30%  Similarity=0.473  Sum_probs=209.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|.+.+.||.|+||.||+|.++++..||||.+......   ..++.+|+..+++++|+|++++++++......+++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            56789999999999999999999887888999998765433   356889999999999999999999999988999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.......+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999998766566899999999999999999999988   9999999999999999999999999987654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                        ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||........   +..    ...+.       
T Consensus       158 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~----~~~~~-------  221 (261)
T cd05034         158 --YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQ----VERGY-------  221 (261)
T ss_pred             --hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCC-------
Confidence              111112235678999999999899999999999999999998 9999965433211   111    11100       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..+.+...+..+.+++.+||+.+|.+||+++++++.++.
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               011122235678999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-41  Score=327.06  Aligned_cols=266  Identities=20%  Similarity=0.204  Sum_probs=199.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..+|.+.+.||+|+||.||+|.+.. ++.||||....        ..+.+|+.+|++++|+||+++++++...+..++||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            3479999999999999999999874 88999996432        23468999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |++. ++|.+++.... ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.++|+|||+++......
T Consensus       240 e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        240 PKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             EccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            9995 68988886543 24899999999999999999999998   9999999999999999999999999998654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc----hhhHHHHHHHhhcc--CCcc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK----ERVTIRWAMQCLKA--GDAI  279 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~~  279 (380)
                      . ........||..|+|||++.+..++.++|||||||+||||++|..|+.......    ....+.........  ....
T Consensus       315 ~-~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        315 S-TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             c-cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            1 112234569999999999999999999999999999999999887653322110    00111111110000  0000


Q ss_pred             c--------ccc----cCCC---CCCCC---HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 L--------VMD----PRLR---RTPAS---NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 ~--------~~~----~~~~---~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .        .+.    ....   ..+..   ......+.+||.+||+.||.+|||+.|++++.|-
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            0        000    0000   00000   1223468899999999999999999999999874

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-42  Score=326.89  Aligned_cols=269  Identities=19%  Similarity=0.259  Sum_probs=205.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  118 (380)
                      ..++|++.+.||+|+||.||++.+. .++.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4588999999999999999999986 588999999976544444456678999999999999999999987543      


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ...|+||||+++ +|.+.+..    .++...+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999965 78877753    2788899999999999999999988   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------H
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA--------M  270 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~  270 (380)
                      +......    ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+...        .
T Consensus       174 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         174 RTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             cccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            7654321    123456899999999999999999999999999999999999999765543221111000        0


Q ss_pred             H--------hhccC-Ccc-----cccccCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 Q--------CLKAG-DAI-----LVMDPRLR--RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 ~--------~~~~~-~~~-----~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .        ..... ...     ........  ...........+.+||.+||+.||.+|||++++++|.|-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            0        00000 000     00000000  000111123568899999999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.1e-42  Score=321.48  Aligned_cols=264  Identities=22%  Similarity=0.264  Sum_probs=197.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ...+|.+.+.||+|+||.||+|.+. +++.||+|+.....        ...|+.++++++|+||+++++++......++|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            4568999999999999999999987 47889999854322        24689999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||++. ++|.+++.... ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.++|+|||+++.....
T Consensus       136 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            99995 58888886543 34899999999999999999999998   999999999999999999999999998753321


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-------hHHHHHHHhhc--c
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER-------VTIRWAMQCLK--A  275 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~--~  275 (380)
                      .    ......||..|+|||++.+..++.++|||||||++|||+++..|+....+....       ..+........  .
T Consensus       211 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  286 (357)
T PHA03209        211 P----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP  286 (357)
T ss_pred             c----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence            1    123456899999999999999999999999999999999865554322211100       00111111000  0


Q ss_pred             CCcc---------cccc-cCCCCCC-------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          276 GDAI---------LVMD-PRLRRTP-------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       276 ~~~~---------~~~~-~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ....         ..++ ......+       .....+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        287 EEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             hhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence            0000         0000 0000000       011223456679999999999999999999999884

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.4e-41  Score=305.38  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=211.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|+||.||.+... +++.+++|.+............+.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999876 588999999876655555566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++.......+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999998765556899999999999999999999988   99999999999999999999999999886544321 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......++..|+|||.+.+..++.++||||||+++|+|++|..||......+...       ....+..         
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~-------~~~~~~~---------  218 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-------KIVQGNY---------  218 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHcCCC---------
Confidence              1234568999999999998889999999999999999999999997644322111       1111110         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       .+.....+.++.+++.+||+.+|.+||++++++++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         219 -TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             -CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence             1122344577899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-41  Score=307.72  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=201.5

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-CC--EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------CE
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-GS--IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------DE  120 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  120 (380)
                      |.+.+.||+|+||.||+|.+.. +.  .||+|.++...........+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999999764 33  699999876654455567788999999999999999999987432      24


Q ss_pred             EEEEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGR----GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      .+++|||+++|+|.+++...    ....+++..++.++.|++.||.|||+++   ++|+||||+|||+++++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999987432    1234789999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      +++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||........       ......
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~  229 (272)
T cd05075         158 LSKKIYNGDY-YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI-------YDYLRQ  229 (272)
T ss_pred             cccccCcccc-eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHc
Confidence            9987643221 111223346778999999999999999999999999999999 8899975433211       111111


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      +..          ......++..+.+++.+||+.+|.+|||+.++++.+..+
T Consensus       230 ~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111          011123456789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.7e-42  Score=307.35  Aligned_cols=254  Identities=29%  Similarity=0.472  Sum_probs=205.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|.+.+.||+|++|.||+|.+..+..+|+|.+......   ...+.+|+.++++++|+|++++++++.. ...+++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence            3568999999999999999999887778999998754332   3457789999999999999999998754 56789999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.......+++..+..++.+++.||.|||+.|   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999999998765555889999999999999999999988   99999999999999999999999999976543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                        .......++..|+|||...+..++.++||||||+++|+|++ |..||........   ...    ...+.        
T Consensus       158 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~--------  220 (260)
T cd05069         158 --TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ----VERGY--------  220 (260)
T ss_pred             --cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCC--------
Confidence              11122346778999999999999999999999999999999 8999976443221   111    11110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ..+.....+..+.+++.+||+.+|.+||+++++++.|..
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 --RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence              011223456789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.8e-41  Score=305.15  Aligned_cols=261  Identities=24%  Similarity=0.351  Sum_probs=211.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.++.... .......+.+|+.++++++|+|++++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67999999999999999999987 699999999875332 2233566889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||+++++|.+++...  ....++...++.++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642  2344889999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   ......++..|+|||.+.+..++.++|||||||++|+|++|..||........     ........+.      
T Consensus       159 ~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~------  224 (267)
T cd08224         159 KTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKIEKCD------  224 (267)
T ss_pred             CCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----HHHhhhhcCC------
Confidence            221   11234588899999999998999999999999999999999999965432100     0111111110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                         .........+..+.++|.+||..+|.+||++.+|++.+..+.
T Consensus       225 ---~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 ---YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence               101112245678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.3e-42  Score=309.00  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-C---CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-D---GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|++.+.||+|+||.||+|.+. +   +..+|+|.+...... .....+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357889999999999999999874 2   337999998764432 34567889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++..... .+++..++.++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        82 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999999976543 4899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .............++..|+|||.+.+..++.++||||||+++|++++ |..||......+.   .    .....+.    
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~~~----  226 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I----KAIEEGY----  226 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H----HHHhCCC----
Confidence            43221111122234568999999999899999999999999999887 9999976543221   1    1111110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ..+.....+..+.+++.+||+.+|.+||++.++++.+..+
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  0112223456788999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-42  Score=322.55  Aligned_cols=247  Identities=26%  Similarity=0.322  Sum_probs=194.6

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHH-HHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEIL-TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+. +|+.||+|++..... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999986 589999999975422 1122334445554 46778999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|..++....  .+++..+..++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||+++......   ..
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---~~  152 (325)
T cd05604          81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---DT  152 (325)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---CC
Confidence            99999887644  3899999999999999999999988   9999999999999999999999999987432211   11


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........       ......        ...   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~-------~~~~~~--------~~~---  214 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY-------DNILHK--------PLV---  214 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH-------HHHHcC--------Ccc---
Confidence            23456999999999999999999999999999999999999999765432211       111111        000   


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChH----HHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMK----KCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~----eil~~l~~  326 (380)
                      .....+..+.+++.+||+.+|.+||+++    +++++.|-
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f  254 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF  254 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence            1112345678999999999999999874    77776553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.8e-42  Score=311.88  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=204.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC-----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG-----  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----  118 (380)
                      ..+.|++.+.||+|+||.||+|.+. +++.||+|.+......   ...+.+|+.++.++ +|+||+++++++...     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            5678888999999999999999986 5889999998754332   34577899999988 799999999998653     


Q ss_pred             -CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          119 -DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                       ...+++|||+++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence             46899999999999999998765556899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      +.......   .......|+..|+|||++.     +..++.++|||||||++|+|++|..||....+.......      
T Consensus       158 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------  228 (272)
T cd06637         158 SAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------  228 (272)
T ss_pred             ceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH------
Confidence            87653321   1123456899999999986     345788999999999999999999999754432211110      


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       ....         ........++..+.+|+.+||+.+|.+||++++++.+.|
T Consensus       229 -~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         229 -PRNP---------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             -hcCC---------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence             0000         001111234567899999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=307.39  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=204.5

Q ss_pred             CCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE-----
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE-----  120 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  120 (380)
                      |.+.+.||+|+||.||+|.+..    +..||+|+++...........+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5778999999999999998652    3679999998665544456678899999999999999999998866544     


Q ss_pred             -EEEEEEeCCCCCHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          121 -RIIVVEYVGNGTLREHLDGRG----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       121 -~~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                       .+++|||+++++|..++....    ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999999985432    234889999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      |+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.   +    ....
T Consensus       158 g~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~----~~~~  229 (273)
T cd05035         158 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---Y----DYLR  229 (273)
T ss_pred             cceeeccccccc-cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHH
Confidence            998865432211 11112335678999999999999999999999999999999 8899976443221   1    1111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+..          ...+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       230 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 HGNR----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCCC----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110          112234556899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-41  Score=311.67  Aligned_cols=260  Identities=26%  Similarity=0.458  Sum_probs=209.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ++|.+.+.||+|+||.||+|.+.      ++..+++|.+.....  .....+.+|+..+++++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence            56888899999999999999853      245689998865433  2345688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          122 IIVVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      ++||||+++++|.+++.....              ..+++..++.++.+|+.||.|||+++   ++|+||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            999999999999999975431              23788999999999999999999988   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.++|+|||++....... .........++..|+|||.+.+..++.++|||||||++|+|++ |..||........    
T Consensus       160 ~~~~l~dfg~a~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----  234 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV----  234 (291)
T ss_pred             CcEEECCCCcccccCCCc-eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence            999999999987554321 1122234457889999999999999999999999999999999 9999876543221    


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                         ......+...          .....++..+.+++.+||+.+|.+||++++|++.+..+.+.
T Consensus       235 ---~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 ---IECITQGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---HHHHhCCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence               1111111110          11223456789999999999999999999999999988663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-41  Score=312.20  Aligned_cols=255  Identities=24%  Similarity=0.406  Sum_probs=208.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..+|++.+.||.|+||.||+|.+. +++.|++|.+.......  ...+.+|+.+++.++|+||+++++.+......++||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            358899999999999999999976 58899999987654433  355789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++...   .+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......
T Consensus        97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            999999999998653   3788999999999999999999988   9999999999999999999999999987644321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .   ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+.....      .....+.        
T Consensus       171 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~------~~~~~~~--------  233 (296)
T cd06654         171 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT--------  233 (296)
T ss_pred             c---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH------HHhcCCC--------
Confidence            1   1123458899999999999889999999999999999999999997654422111      0000000        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ............+.+++.+||+.+|.+||++.+++++.|..
T Consensus       234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~  274 (296)
T cd06654         234 -PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (296)
T ss_pred             -CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence             01112234556788999999999999999999999998854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.9e-41  Score=308.68  Aligned_cols=259  Identities=23%  Similarity=0.385  Sum_probs=204.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++|++.+.||+|+||.||+|.+. +|+    .+++|.+..... .....++..|+..+.++.||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            357888999999999999999975 354    478888754322 2334567888889999999999999998764 457


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++++||+++|+|.+++..... .+++..++.++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||+++..
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            889999999999999976543 4899999999999999999999988   999999999999999999999999999865


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..... ........++..|+|||.+.++.++.++|||||||++|||++ |..||.+..+....       .....+..  
T Consensus       160 ~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~--  229 (279)
T cd05111         160 YPDDK-KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-------DLLEKGER--  229 (279)
T ss_pred             cCCCc-ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCc--
Confidence            43221 111234557789999999999999999999999999999998 99999765432211       11111111  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                              .+....+...+..++.+||..+|.+||++.|+++.+..+..
T Consensus       230 --------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 --------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                    01111234567889999999999999999999998877643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-41  Score=304.80  Aligned_cols=250  Identities=22%  Similarity=0.405  Sum_probs=198.3

Q ss_pred             eeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           55 KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .||+|+||.||+|.+.   .+..||+|++..... ......+.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999999864   355799999876533 3345668899999999999999999998864 5789999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|.+++.... ..+++..+++++.+++.||.|||++|   ++|+||||+||+++.++.+||+|||++.............
T Consensus        80 ~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          80 PLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9999997543 34899999999999999999999988   9999999999999999999999999987654332222212


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.........       .....+..          ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~----------~~  218 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGKR----------LD  218 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCCC----------CC
Confidence            22334678999999998889999999999999999996 99999765432211       11111110          11


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+..++.++.+++.+||+.+|++||++.+|.+.+...
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            2223457888999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-41  Score=305.33  Aligned_cols=249  Identities=29%  Similarity=0.465  Sum_probs=198.8

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGT  132 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  132 (380)
                      +.||+|+||.||+|.+. +|+.||+|.+..... ......+.+|+.++++++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            46999999999999986 689999998865432 3345668899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeee
Q 041907          133 LREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST  212 (380)
Q Consensus       133 L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  212 (380)
                      |.+++.... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........ .....
T Consensus        80 L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~  154 (252)
T cd05084          80 FLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-ASTGG  154 (252)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccc-cccCC
Confidence            999997543 34889999999999999999999988   99999999999999999999999999875442211 01011


Q ss_pred             cccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       213 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ...++..|+|||.+.++.++.++|||||||++|+|++ |..||..........       .....         . ..+.
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~~---------~-~~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQG---------V-RLPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHcC---------C-CCCC
Confidence            1223467999999999999999999999999999998 889986543321111       11110         0 0112


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ....+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2234567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-42  Score=325.16  Aligned_cols=272  Identities=19%  Similarity=0.289  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC---
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG---  118 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---  118 (380)
                      .....++|++.+.||.|+||.||+|.+. +++.||||.+............+.+|+.++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3345689999999999999999999976 588999999876543333445677899999999999999999887533   


Q ss_pred             ---CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          119 ---DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       119 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                         ...+++++++ +++|.+++...   .+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence               3568999988 67998888643   3899999999999999999999998   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH---
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ---  271 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~---  271 (380)
                      |+++.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.....   
T Consensus       163 g~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         163 GLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             ccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            998865432      233468999999999877 5688999999999999999999999976543322111110000   


Q ss_pred             -----hhccCCcccccccCCCCCCC------CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          272 -----CLKAGDAILVMDPRLRRTPA------SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       272 -----~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                           ..........+ ..+...+.      .......+.+|+.+||+.||.+|||+.|+++|.|-..
T Consensus       237 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~  303 (343)
T cd07878         237 PEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ  303 (343)
T ss_pred             HHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence                 00000000000 00000000      0112345789999999999999999999999998653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.5e-42  Score=312.13  Aligned_cols=270  Identities=27%  Similarity=0.352  Sum_probs=207.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||+|.++ +|+.||+|++............+.+|+.++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47889999999999999999987 58999999987654333334457899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++++.|..++....  .+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            999988887775543  3899999999999999999999988   99999999999999999999999999987654321


Q ss_pred             ceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh--------ccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL--------KAGD  277 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~  277 (380)
                         ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+.......        ....
T Consensus       156 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         156 ---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             ---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence               1123457889999999876 457889999999999999999999998665443322211110000        0000


Q ss_pred             cc-cccccCCCCC-C---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 AI-LVMDPRLRRT-P---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~~-~~~~~~~~~~-~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .. ....+..... +   .....+..+.+|+.+||+.+|++||++.+++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence            00 0000000000 0   01123567889999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.5e-42  Score=314.37  Aligned_cols=262  Identities=29%  Similarity=0.408  Sum_probs=208.9

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ....++|++.+.||+|+||.||++.+..      ...+|+|.+...... .....+.+|+.++.++ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-KDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            3455788999999999999999998642      367999998765333 2345688999999999 8999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGR--------------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      ..+..+++|||+++++|.+++...              ....+++..++.++.|++.||.|||+.+   ++|+||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            999999999999999999999652              2345889999999999999999999988   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      ++++++.++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999986553221 111122335678999999999999999999999999999998 999987544322


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..       .....+.          ....+..++..+.+|+.+||+.+|.+|||++++++.+..+
T Consensus       243 ~~-------~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 LF-------KLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HH-------HHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            11       1111110          0111223456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=304.86  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=200.1

Q ss_pred             CeeeccCceEEEEEEeCC-C---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           54 NKIGEGGSGTVYKGKLKD-G---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      +.||+|+||.||+|.+.. +   ..||+|.+...... ....++.+|+.+++++.|+||+++++++.. ...++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence            469999999999998642 2   68999999866543 345668899999999999999999998764 46799999999


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      +++|.+++....  .+++..++.++.|++.||.|||..+   ++|+||||+||+++.++.++|+|||+++..........
T Consensus        79 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          79 LGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999998755  4899999999999999999999988   99999999999999999999999999987654332211


Q ss_pred             eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.   ....    ....          .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~----~~~~----------~  216 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAML----ESGE----------R  216 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH----HcCC----------c
Confidence            1122234578999999999999999999999999999998 9999976543211   1111    1111          0


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+.+..++..+.+++.+||..+|.+||++.++++.|..+
T Consensus       217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            112223456789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-41  Score=317.86  Aligned_cols=260  Identities=20%  Similarity=0.253  Sum_probs=202.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||++.++ +++.||+|++..... .......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999987 478899999864322 2222344778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++..... .+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            99999999999976432 3889999999999999999999998   9999999999999999999999999987543221


Q ss_pred             cceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .  .......||+.|+|||++.     ...++.++|||||||++|||++|..||...........       +....   
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~-------i~~~~---  224 (332)
T cd05623         157 T--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-------IMNHK---  224 (332)
T ss_pred             c--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH-------HhCCC---
Confidence            1  1123356999999999986     34678999999999999999999999976543322111       11100   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~  326 (380)
                         ...........++..+.+|+.+||..++..  |++++++++|.|-
T Consensus       225 ---~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f  269 (332)
T cd05623         225 ---ERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF  269 (332)
T ss_pred             ---ccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence               000011112234577889999988664444  6899999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.5e-42  Score=319.79  Aligned_cols=260  Identities=19%  Similarity=0.250  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||++.+. +++.||+|++..... .......+.+|..++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57899999999999999999987 588999999865321 2223345778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++.... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999997643 23888999999999999999999998   9999999999999999999999999987654322


Q ss_pred             cceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .  .......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||......+...       .+....   
T Consensus       157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-------~i~~~~---  224 (331)
T cd05624         157 T--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------KIMNHE---  224 (331)
T ss_pred             c--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH-------HHHcCC---
Confidence            1  11223569999999999876     567889999999999999999999997654322111       110000   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~  326 (380)
                         ............+..+.+++.+||+.++.+  |++++++++|.|.
T Consensus       225 ---~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         225 ---ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             ---CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence               000111111234577889999999876544  5689999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9e-43  Score=307.92  Aligned_cols=263  Identities=23%  Similarity=0.327  Sum_probs=204.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----EEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----ERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  122 (380)
                      .|...+.+|.|.||.||.|... +++.||||+.-.+..-.      ..|+.+|+++.|||||++..+|....     ...
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4667889999999999999976 47899999987664432      38999999999999999998875432     346


Q ss_pred             EEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccccc
Q 041907          123 IVVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFAR  199 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~  199 (380)
                      +||||++. +|.+.++..  .+..++...+.-+..||++||.|||+.|   |+||||||+|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence            99999987 999999853  2334888888889999999999999988   9999999999999976 899999999999


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC-
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD-  277 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  277 (380)
                      .+..+...    ....-|..|+|||.+.|. .|+.+.||||.||++.||+-|++.|.+.+..++...+-....-....+ 
T Consensus       175 ~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            87665432    234568899999988764 699999999999999999999999999887766555432211111100 


Q ss_pred             ------cccccccCCCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 ------AILVMDPRLRRTP----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ------~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                            ......+.....+    .....+.++.+|+.++|+.+|.+|.++.|++.|..
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence                  0011111122111    23345678999999999999999999999999864

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.8e-42  Score=312.78  Aligned_cols=265  Identities=25%  Similarity=0.369  Sum_probs=203.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CC
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GD  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~  119 (380)
                      .++|++.+.||+|+||.||++...     +++.||+|.+.....  .....+.+|+.++++++||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            357899999999999999999742     478999999875532  335678899999999999999999998754  34


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            68999999999999999976432 3889999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh---------hHHHHHH
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER---------VTIRWAM  270 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~---------~~~~~~~  270 (380)
                      ................++..|+|||++.+..++.++|||||||++|||++|..|+.........         .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            7654322211112223455699999999989999999999999999999988776433211000         0000000


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...         ... ...+....++..+.+|+.+||+.+|++|||+++|++.|..+
T Consensus       237 ~~~---------~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELL---------KNN-GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHH---------hcC-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000         000 01122233456799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-41  Score=307.38  Aligned_cols=259  Identities=27%  Similarity=0.439  Sum_probs=206.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CC---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DG---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|...+.||+|+||.||+|.+. ++   ..+++|.+...... .....+.+|+.++++++|+|++++.+++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            357888999999999999999975 23   37999998765332 23556889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++.... ..+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          83 IITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999997643 34889999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..............+..|+|||++.+..++.++|||||||++|+|++ |..||........       ...+..+.    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~-------~~~i~~~~----  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------MKAINDGF----  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-------HHHHhcCC----
Confidence            32221111112224567999999998899999999999999999998 9999965443211       11111110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ..+....++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       228 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  1122223457789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.1e-42  Score=313.79  Aligned_cols=270  Identities=24%  Similarity=0.300  Sum_probs=204.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||+|++|.||+|.+. +|..||+|.+............+.+|+.++.+++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788999999999999999986 589999999876543333345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          128 VGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ++ ++|.+++..... ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 589888866442 45899999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC--------
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD--------  277 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------  277 (380)
                        .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.......................        
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              112233578899999988754 478899999999999999999999986544322111100000000000        


Q ss_pred             -cccccccCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 -AILVMDPRLR--RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 -~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       ..........  ........+.++.++|.+||+.||.+|||+.+|+.+.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence             0000000000  00011124567889999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-41  Score=307.22  Aligned_cols=257  Identities=23%  Similarity=0.387  Sum_probs=206.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcc----hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD----KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +|.+.+.||.|+||.||+|...+|+.+|+|.+......    ......+.+|+.++++++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            57889999999999999999888999999998754321    22334588999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.+..  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999997654  3788999999999999999999988   999999999999999999999999998764321


Q ss_pred             Cc---ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          205 SA---VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       205 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..   .........|+..|+|||++.+..++.++|||||||++|+|++|..||...........+   ..  ...     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~--~~~-----  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI---GA--HRG-----  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh---hh--ccC-----
Confidence            11   111123456899999999999999999999999999999999999999754432211100   00  000     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .........+..+.++|.+||+.+|.+||++.+++.+.|
T Consensus       226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence                 001122234567899999999999999999999998765

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.1e-41  Score=306.23  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||.|+||.||+|.+. +|+.|+||.+..... ......++.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57888999999999999999975 689999998865432 2233456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||+++++|.+++...  ....+++..++.++.+|+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998642  2234889999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   ......|+..|+|||++.+..++.++||||||+++|+|++|..||........ .    ........       
T Consensus       159 ~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~~~-------  223 (267)
T cd08229         159 KTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S----LCKKIEQC-------  223 (267)
T ss_pred             CCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-H----HhhhhhcC-------
Confidence            221   11234588999999999998999999999999999999999999965432110 0    00111100       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        ..........+..+.+++.+||+.+|.+|||+.+|++.+.++
T Consensus       224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence              000111234567899999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-41  Score=314.56  Aligned_cols=264  Identities=28%  Similarity=0.388  Sum_probs=208.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ..++|.+.+.||+|+||.||+|.+.        .+..+|+|.+...... ....++..|+.++.++ +|+||+++++++.
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-HHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            3467999999999999999999853        1356999999765332 2345678899999999 7999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      ..+..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+.|   ++|+||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence            99999999999999999999976432              24788999999999999999999988   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      +++.++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999998755421111 11112234568999999999999999999999999999998 888986543211


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .       ......+.          ....+...+.++.+++.+||+.+|.+||++.++++.+..+....
T Consensus       251 ~-------~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         251 L-------FKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             H-------HHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            1       11111110          01122234568889999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=318.67  Aligned_cols=267  Identities=23%  Similarity=0.314  Sum_probs=219.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ......+.++||+|.||.|.++....+.+||||.++..... ..+.+|..|+++|.+++||||++++|+|...+.+++|+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            34567789999999999999999987899999999876544 45688999999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++..............+|+.||+.|++||.+.+   +|||||.+.|+|++.++++||+|||+++.+-.+ 
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg-  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG-  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC-
Confidence            9999999999998875444566777889999999999999988   999999999999999999999999999854432 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT--GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...+......-.+.|||||.+..++++.++|||+||+++||+++  ...||......+....   ..... .+.      
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven---~~~~~-~~~------  760 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN---AGEFF-RDQ------  760 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh---hhhhc-CCC------
Confidence            23444555667889999999999999999999999999999765  7889876554332111   11111 110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ........+..++..+.+++..||+.+-++||+++++..+|.+.
T Consensus       761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            01112345566888999999999999999999999999888753

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.4e-41  Score=311.32  Aligned_cols=259  Identities=27%  Similarity=0.427  Sum_probs=206.5

Q ss_pred             CCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +|++.+.||+|+||.||+|.+.      ....+++|.+...... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            4788999999999999999863      2356999988755432 33456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 041907          123 IVVEYVGNGTLREHLDGRG----------------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKAS  180 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  180 (380)
                      ++|||+.+++|.+++....                      ...+++..++.++.|++.||.|||+.+   ++|+||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence            9999999999999986421                      124788899999999999999999988   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 041907          181 NILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKP  259 (380)
Q Consensus       181 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~  259 (380)
                      |||+++++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....+
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSY-VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccch-hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999998765432211 11122345778999999998899999999999999999998 9999976543


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ...       ......+.          ........+..+.+++.+||+.+|.+||+++++++.|.++..
T Consensus       236 ~~~-------~~~~~~~~----------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ERL-------FNLLKTGY----------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHH-------HHHHhCCC----------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            221       11111110          011122345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.8e-42  Score=315.05  Aligned_cols=271  Identities=23%  Similarity=0.314  Sum_probs=205.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||.|+||.||+|.+. +++.||+|.+....... ....+.+|+.++++++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            367999999999999999999986 58899999987543322 2334678999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++ ++|.+++..... .+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        84 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          84 EYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             eccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9997 489998876533 4889999999999999999999988   9999999999999999999999999987543221


Q ss_pred             cceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc-
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD-  283 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  283 (380)
                      .   ......++..|+|||++.+. .++.++|||||||++|+|++|..||......+....+...............+. 
T Consensus       159 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         159 K---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             C---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence            1   11234578899999998754 578899999999999999999999976554322111111000000000000000 


Q ss_pred             --------cCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 --------PRLRR---TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 --------~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                              +....   .......+..+.+||.+||+.||.+|||++|++++.|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                    00000   00111235678899999999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-41  Score=309.33  Aligned_cols=262  Identities=23%  Similarity=0.373  Sum_probs=210.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  119 (380)
                      ..++|.+.+.||+|+||.||+|.+..     +..|++|.+.... .......+.+|+.++++++|+||+++++++.. ..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            45789999999999999999999865     6789999886443 33445668899999999999999999998765 56


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                      ..+++++|+++++|.+++.....      ..+++..++.++.+++.||.|||+.+   ++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            78999999999999999976432      34889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHh
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      |||+++.+..... ........++..|+|||++.+..++.++|||||||++|++++ |..||....+.+..       ..
T Consensus       160 d~g~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~  231 (280)
T cd05043         160 DNALSRDLFPMDY-HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-------AY  231 (280)
T ss_pred             CCCCcccccCCce-EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-------HH
Confidence            9999986543221 112233456788999999999999999999999999999999 99999765432211       11


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ...+.         . ......++..+.+++.+||+.+|++|||+.++++.|..+.+
T Consensus       232 ~~~~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         232 LKDGY---------R-LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHcCC---------C-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11110         0 01122345678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.8e-41  Score=310.29  Aligned_cols=264  Identities=22%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-----------------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCcee
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-----------------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV  109 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  109 (380)
                      .++|++.+.||+|+||.||++.+.                 ++..||+|++..... ......+.+|+.++++++|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcc
Confidence            467999999999999999998643                 234699999875532 33456788999999999999999


Q ss_pred             ceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCC---------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 041907          110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG---------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKAS  180 (380)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  180 (380)
                      ++++++...+..+++|||+++++|.+++.....         ..+++..++.++.+++.||.|||+.|   ++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence            999999999999999999999999999976432         23667889999999999999999988   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 041907          181 NILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT--GRYPIESKK  258 (380)
Q Consensus       181 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--g~~p~~~~~  258 (380)
                      |||++.++.++|+|||++..+..... ........++..|++||...++.++.++|||||||++|||++  |..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcc-eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            99999999999999999876543221 111222345678999999988899999999999999999998  778887544


Q ss_pred             CcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          259 PIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..+......   ........ ..      ..+.+..++..+.+|+.+||+.+|.+||++.+|++.|.
T Consensus       239 ~~~~~~~~~---~~~~~~~~-~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 DEQVIENTG---EFFRDQGR-QV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hHHHHHHHH---HHHhhccc-cc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            322111110   00000000 00      01112234577899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-43  Score=320.84  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=211.6

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ......|+++++||+||-+.||++...+.+.||+|++.....+......|.+|+.+|.+| .|.+||++|+|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            345678999999999999999999998888899999887777778888899999999999 5899999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||= ..+|...|.+.......| .++.+..|++.++.++|++|   |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            999986 459999998877654444 67789999999999999999   99999999999987 4699999999999877


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcC-----------CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQ-----------LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ  271 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  271 (380)
                      .+. +.-.....+||+.||+||.+....           .++++||||||||||+|+.|+.||..-..         .+.
T Consensus       511 ~DT-TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~a  580 (677)
T KOG0596|consen  511 PDT-TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIA  580 (677)
T ss_pred             ccc-cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHH
Confidence            643 233445688999999999985432           56889999999999999999999974321         111


Q ss_pred             hhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+     ..+.++........-....++.++++.||+.||.+||+..|+|++.+..
T Consensus       581 Kl-----~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~  631 (677)
T KOG0596|consen  581 KL-----HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ  631 (677)
T ss_pred             HH-----HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence            11     1233442211100000112288999999999999999999999998743

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-41  Score=314.03  Aligned_cols=265  Identities=20%  Similarity=0.262  Sum_probs=191.6

Q ss_pred             CCeeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEEEEEe
Q 041907           53 ANKIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERIIVVEY  127 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  127 (380)
                      ..+||+|+||.||+|.++   +++.||+|.+......    ..+.+|+.++++++||||+++++++..  ....+++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999865   4678999998754332    345689999999999999999998854  4568999999


Q ss_pred             CCCCCHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEcccc
Q 041907          128 VGNGTLREHLDGRG-------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI----TEKLRAKVTDFG  196 (380)
Q Consensus       128 ~~~~~L~~~i~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg  196 (380)
                      +.+ +|.+++....       ...++...+..++.||+.||.|||+.|   |+||||||+|||+    +..+.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            965 8888875321       224888999999999999999999988   9999999999999    456789999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcch------hhHHHHH
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE------RVTIRWA  269 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~------~~~~~~~  269 (380)
                      +++................||+.|+|||++.+. .++.++|||||||++|+|++|..||........      ...+...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            998765332211222346789999999999774 588999999999999999999999975432110      0111111


Q ss_pred             HHhhccC------------Cccccc---ccC-CCCCC-------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          270 MQCLKAG------------DAILVM---DPR-LRRTP-------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       270 ~~~~~~~------------~~~~~~---~~~-~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .......            .....+   ... .....       ........+.+||.+||+.||.+|||++|+++|.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            1100000            000000   000 00000       00011245789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-41  Score=309.98  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=204.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..|++.+.||+|+||.||+|.+.      .+..||+|++..... ......+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            34677889999999999999864      257899999975543 23445688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          122 IIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      ++++||+++++|.+++....              ...+++..++.++.|++.||.|||++|   ++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            99999999999999985321              123788889999999999999999988   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.+||+|||+++....... ........+++.|+|||.+.++.++.++|||||||++|||++ |..||......+.    
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----  235 (283)
T cd05091         161 LNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----  235 (283)
T ss_pred             CceEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence            9999999999886543221 122233456789999999998899999999999999999998 8888875433211    


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                         ......+.          ..+....++..+.+++..||+.+|.+||++++|+..|.
T Consensus       236 ---~~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         236 ---IEMIRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             ---HHHHHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence               11111111          11223346677999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.6e-42  Score=306.47  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=209.6

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|+||.||++... +|+.|++|.+...........++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999986 589999999876544444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999998765555889999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......|+..|+|||++.+..++.++|||||||++++|++|..||........   +    .....+..         
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~----~~~~~~~~---------  218 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL---V----LKIIRGSY---------  218 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH---H----HHHhcCCC---------
Confidence              11234588899999999998999999999999999999999999975432211   1    11111110         


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       .+.....+..+.++|.+||+.+|.+||++.+|+++.|
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         219 -PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             -CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence             1122344567899999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-41  Score=308.10  Aligned_cols=266  Identities=25%  Similarity=0.387  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--C
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--D  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  119 (380)
                      ...|++.+.||+|+||.||++.+.     ++..||+|.+..... ......+.+|+.++++++|||++++++++...  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            346789999999999999999742     478899999875533 23445688999999999999999999998775  5


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++++|.+++.... ..+++..++.++.+++.||.|||++|   ++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            6899999999999999997643 24899999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--------hhhHHHHHHH
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK--------ERVTIRWAMQ  271 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~--------~~~~~~~~~~  271 (380)
                      ................++..|+|||++.+..++.++|||||||++|+|++++.|+.......        ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76543322222234557788999999998899999999999999999999877653321100        0000111111


Q ss_pred             hhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....+.          ..+....++..+.+|+.+||+.+|.+||+++++++.+..+
T Consensus       238 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111110          1112233567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.3e-41  Score=310.65  Aligned_cols=264  Identities=24%  Similarity=0.355  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-----------------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCcee
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-----------------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV  109 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  109 (380)
                      .++|++.+.||+|+||.||+|.+..                 +..||+|.+...... .....+.+|+.++++++||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEe
Confidence            4689999999999999999998652                 245899998765433 3456788999999999999999


Q ss_pred             ceEEEEEeCCEEEEEEEeCCCCCHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 041907          110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRG---------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKAS  180 (380)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  180 (380)
                      ++++++...+..+++|||+++++|.+++....         ...+++..++.++.+++.||.|||+.+   ++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99999999999999999999999999997654         124889999999999999999999988   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 041907          181 NILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT--GRYPIESKK  258 (380)
Q Consensus       181 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--g~~p~~~~~  258 (380)
                      ||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|++  |..||....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999876543221 122234456789999999999899999999999999999998  778886543


Q ss_pred             CcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          259 PIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ....   +............      . ...+....++.++.+++.+||+.+|.+||++.+|++.|.
T Consensus       239 ~~~~---~~~~~~~~~~~~~------~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQV---IENAGHFFRDDGR------Q-IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHHH---HHHHHhccccccc------c-ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2221   1111111111000      0 001112234467999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.5e-41  Score=303.94  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=203.4

Q ss_pred             CeeeccCceEEEEEEeCC--CC--EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           54 NKIGEGGSGTVYKGKLKD--GS--IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      +.||+|++|.||+|.+.+  ++  .||+|.+...... .....+.+|+..+++++||||+++++++.. ...+++|||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999999753  33  6999999876553 456678899999999999999999999988 88999999999


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      +++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...........
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999998765345899999999999999999999988   99999999999999999999999999987654332222


Q ss_pred             eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....   ...   ..          ..
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~---~~----------~~  219 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK---IDK---EG----------ER  219 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHh---cC----------Cc
Confidence            2233557889999999999999999999999999999998 9999975543321111   100   00          00


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .......+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1112234567999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-41  Score=311.24  Aligned_cols=260  Identities=28%  Similarity=0.381  Sum_probs=205.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CC--EEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GS--IVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ++|++.+.||+|+||.||+|.++. +.  .+++|.++.... ......+.+|+.++.++ +||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            679999999999999999998763 43  478888764322 23345688999999999 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          124 VVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      +|||+++++|.+++.....              ..+++..++.++.|++.||.|||++|   ++|+||||+|||+++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            9999999999999965321              24788999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  268 (380)
                      +||+|||++......    ........+..|+|||++.+..++.++|||||||++|+|++ |..||......+..     
T Consensus       158 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~-----  228 (297)
T cd05089         158 SKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY-----  228 (297)
T ss_pred             EEECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999998643211    00111223567999999999899999999999999999997 99999765432211     


Q ss_pred             HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                        .....+         .. ...+..++..+.+|+.+||+.+|.+||+++++++.|..+....+
T Consensus       229 --~~~~~~---------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         229 --EKLPQG---------YR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             --HHHhcC---------CC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence              111111         00 11122345678999999999999999999999999988866543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.4e-41  Score=307.74  Aligned_cols=258  Identities=28%  Similarity=0.373  Sum_probs=203.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|.+.+.||+|++|.||+|.+..      +..|++|.+...... .....+.+|+.++++++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34678999999999999999998753      567999988654332 23456888999999999999999999999888


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceE
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG-----NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAK  191 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~k  191 (380)
                      ..++||||+++++|.+++.....     ..+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            99999999999999999976532     24889999999999999999999988   99999999999998765   599


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  270 (380)
                      |+|||+++....... .........+..|+|||++.+..++.++|||||||++|+|++ |..||.........       
T Consensus       160 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~-------  231 (277)
T cd05036         160 IADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-------  231 (277)
T ss_pred             eccCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------
Confidence            999999986532211 111112234568999999999999999999999999999997 99999765432211       


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ........          ...+..++..+.+++.+||+.+|.+||++.+|++++.
T Consensus       232 ~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 EFVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111100          0112234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-41  Score=310.14  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|.+.+.||+|+||.||++.+.      .+..||+|.++.... ......+.+|+.+++++ +|+||+++++++...
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            4467999999999999999999752      245799999876533 23345688999999999 799999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      +..+++|||+++++|.+++.......+++..+..++.+++.||.|||+.+   ++|+||||+|||++.++.++|+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999998655445899999999999999999999988   999999999999999999999999998


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........ ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.........      ......+.
T Consensus       189 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~------~~~~~~~~  261 (302)
T cd05055         189 RDIMNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF------YKLIKEGY  261 (302)
T ss_pred             ccccCCCc-eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH------HHHHHcCC
Confidence            86543221 111223446788999999999999999999999999999998 99998754432211      11111110


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .          .......+..+.+++.+||+.+|++||++.++++.+.++
T Consensus       262 ~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 R----------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             c----------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0          011112346789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.7e-41  Score=311.74  Aligned_cols=254  Identities=25%  Similarity=0.419  Sum_probs=209.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|++|.||+|.+. +|+.|++|.+......  ....+.+|+..++.++|||++++++++......++|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            46999999999999999999975 5899999998754433  24567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|..++...   .+++..+..++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........
T Consensus        97 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          97 YLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             ecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999999998754   3899999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+......+      ....         .
T Consensus       171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~~~---------~  232 (296)
T cd06655         171 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG---------T  232 (296)
T ss_pred             ---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcC---------C
Confidence               123346889999999999988999999999999999999999999776543221111      0000         0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .....+...+..+.++|.+||+.+|.+||++.+++.+.|-.
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence            01112233456788999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=310.93  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=204.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC---------------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceece
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD---------------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL  111 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  111 (380)
                      .++|++.+.||+|+||.||++.+..               ...||+|.+..... ......+.+|+.++++++|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            4689999999999999999987642               23589999876533 3345568899999999999999999


Q ss_pred             EEEEEeCCEEEEEEEeCCCCCHHHHhccCCC----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 041907          112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGG----------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN  181 (380)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  181 (380)
                      ++++......++||||+++++|.+++.....          ..+++..++.++.+++.||.|||+.+   ++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence            9999999999999999999999999865321          13678889999999999999999988   9999999999


Q ss_pred             eeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh--CCCCCCCCCC
Q 041907          182 ILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT--GRYPIESKKP  259 (380)
Q Consensus       182 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--g~~p~~~~~~  259 (380)
                      |+++.++.+||+|||++........ ........++..|+|||++.++.++.++|||||||++|+|++  |..||.....
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999999876543221 112223445788999999999999999999999999999998  6678765443


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ......   .............       .......+..+.+|+.+||+.+|.+||++++|++.|.
T Consensus       239 ~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIEN---TGEFFRNQGRQIY-------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHH---HHHhhhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            221111   1111110000000       0111224467999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-41  Score=313.19  Aligned_cols=260  Identities=28%  Similarity=0.397  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCC--EEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGS--IVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|++.+.||+|+||.||+|.++ +|.  .+++|.+.... .......+.+|+.++.++ +|+||+++++++...+..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            468899999999999999999976 354  46777765432 233456788999999999 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          123 IVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      +||||+++++|.+++....              ...+++..++.++.|++.||.|||++|   ++||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCC
Confidence            9999999999999997543              124788999999999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIR  267 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~  267 (380)
                      .++|+|||++.......    ......++..|+|||++.+..++.++|||||||++|+|++ |..||......+.     
T Consensus       162 ~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----  232 (303)
T cd05088         162 VAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----  232 (303)
T ss_pred             cEEeCccccCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----
Confidence            99999999986422110    0111224567999999998889999999999999999998 9999975443211     


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                        ......+.          ........+..+.+|+.+||+.+|.+||++++++..+..+....
T Consensus       233 --~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         233 --YEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             --HHHHhcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence              11111110          00111224467889999999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-41  Score=305.03  Aligned_cols=249  Identities=29%  Similarity=0.446  Sum_probs=202.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE-eCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE-HGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||.||++... |..|++|.+....    ....+.+|+.++++++|+|++++++++. .....+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            467899999999999999999876 7889999986543    2346789999999999999999999754 456789999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.......+++..++.++.+++.||+|||++|   ++|+||||+||++++++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999998766556889999999999999999999988   9999999999999999999999999987543211


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                            ....++..|+|||++.+..++.++|||||||++|+|++ |..||........       ......+..      
T Consensus       157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~------  217 (256)
T cd05082         157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK------  217 (256)
T ss_pred             ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCC------
Confidence                  22335678999999999999999999999999999998 9999875432211       111111100      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ......++..+.+++.+||+.+|.+|||+.++++.|..
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                11122345778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.9e-41  Score=304.08  Aligned_cols=262  Identities=26%  Similarity=0.430  Sum_probs=211.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|+||.||+|.+. ++..+++|++....... ....+.+|+..++.++|+|++++++.+......+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            47899999999999999999976 58899999987654433 45678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          127 YVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ++++++|.+++..... ..+++..+..++.|++.||.+||+.|   ++|+||+|+||++++++.++|+|||++..+....
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999976432 45899999999999999999999988   9999999999999999999999999987665432


Q ss_pred             cce-eeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          206 AVS-HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       206 ~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ... .......|+..|+|||++... .++.++|+|||||++|+|++|..||...........      .....      .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~------~~~~~------~  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML------TLQND------P  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH------HhcCC------C
Confidence            221 122345689999999998877 788999999999999999999999976544321111      00000      0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ............+..+.+++.+||+.+|.+||++++++.|.|
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            011111112245677899999999999999999999999865

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=343.84  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=206.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDER  121 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  121 (380)
                      ...++|.+.+.||.|+||+||+|.+. .+..||+|++............+..|+.+|.+++||||+++++++..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            35578999999999999999999987 47889999987665555556678899999999999999999998854  4578


Q ss_pred             EEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeeeccCCCCceeeCCC--------
Q 041907          122 IIVVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSD----PPIIHRDVKASNILITEK--------  187 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~dlkp~Nil~~~~--------  187 (380)
                      ||||||+++++|.++|....  ...+++..++.|+.||+.||.|||+.+.    .+|+|+||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999997532  2348999999999999999999998432    349999999999999642        


Q ss_pred             ---------CceEEccccccccccCCCcceeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041907          188 ---------LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIES  256 (380)
Q Consensus       188 ---------~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~  256 (380)
                               +.+||+|||++.......    ......||+.|+|||++.+  ..++.++||||||||||+|++|..||..
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc----cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     348999999998654321    1234569999999999864  4588999999999999999999999975


Q ss_pred             CCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          257 KKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .......      ...+...       +.+    .....+..+.+||..||+.+|.+||++.+++.+.|..
T Consensus       246 ~~~~~ql------i~~lk~~-------p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        246 ANNFSQL------ISELKRG-------PDL----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             CCcHHHH------HHHHhcC-------CCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            4432211      1111110       011    1112346789999999999999999999999887643

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.1e-41  Score=310.14  Aligned_cols=255  Identities=24%  Similarity=0.391  Sum_probs=209.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||.|+||.||++.+. +|+.||+|.+.......  ...+.+|+.+++.++|+||+++++++......++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            478999999999999999999975 69999999987654332  345788999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....   +++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        96 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          96 EYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cccCCCCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999997543   788999999999999999999988   9999999999999999999999999987654322


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .   ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+......      .         ....
T Consensus       170 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~---------~~~~  231 (297)
T cd06656         170 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------I---------ATNG  231 (297)
T ss_pred             c---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------e---------ccCC
Confidence            1   12234588999999999998899999999999999999999999976543221100      0         0000


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ......+...+..+.+++.+||+.+|.+||++++++++.|-.
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence            011112334556788999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-41  Score=304.33  Aligned_cols=250  Identities=31%  Similarity=0.496  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|++.+.||.|+||.||+|... |+.||+|.+.....   ....+.+|+.++++++|+||+++++++......++|||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence            468899999999999999999986 88999999976543   35568899999999999999999999998999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999998766556899999999999999999999988   9999999999999999999999999988653221 


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           ....++..|+|||.+.+..++.++||||||+++|+|++ |..||........       ......+..       
T Consensus       157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-------  217 (256)
T cd05039         157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHVEKGYR-------  217 (256)
T ss_pred             -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhcCCC-------
Confidence                 12235678999999998899999999999999999997 9999975432211       111111100       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         .......+..+.+++.+||+.+|.+||+++++++.|..
T Consensus       218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 ---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               11122345778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.7e-42  Score=309.09  Aligned_cols=256  Identities=22%  Similarity=0.384  Sum_probs=203.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|.++.....  ....+.+|+.+++.++||||+++++++...+..+++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            357888899999999999999976 5889999998765332  2345778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++...+  .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......
T Consensus        86 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          86 EFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             eccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            9999999999997654  3899999999999999999999988   9999999999999999999999999987553221


Q ss_pred             cceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                         .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+.......       ....    .
T Consensus       161 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-------~~~~----~  226 (267)
T cd06645         161 ---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------TKSN----F  226 (267)
T ss_pred             ---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-------hccC----C
Confidence               1123456899999999984   556889999999999999999999998655432211110       0000    0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+.  ........+..+.+++.+||+.+|++||++++++++.|
T Consensus       227 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         227 QPP--KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCC--cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            000  00011123456889999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=323.95  Aligned_cols=264  Identities=27%  Similarity=0.379  Sum_probs=226.9

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      +.|+...-+.....+||-|.||.||.|.|+. .-.||||.++.+.   ....+|..|+.+|+.+.|||+|+++|+|..+.
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            6677777778888999999999999999985 6679999998764   34788999999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..|||+|||.+|+|.++|++.....++....+.++.||..|+.||..++   +|||||-..|+||.++..||++|||+++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999999988777888888999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ++..+..  .........+-|.|||-+....++.|+|||+|||+|||+.| |..||.+-+-.       ..+..++.+..
T Consensus       414 lMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LLEkgyR  484 (1157)
T KOG4278|consen  414 LMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLLEKGYR  484 (1157)
T ss_pred             hhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHHhcccc
Confidence            9875432  22223345678999999999999999999999999999999 89998764422       23333433322


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                                ...++.|++.+.+|+.+||+..|.+||++.|+.+.++.+..
T Consensus       485 ----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  485 ----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                      23566788999999999999999999999999999987743

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-41  Score=305.73  Aligned_cols=255  Identities=25%  Similarity=0.432  Sum_probs=205.6

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-------hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-------KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      +|.+...||.|+||.||+|.+. +++.||+|.+......       ......+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999986 5889999988654322       1223557899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++|||+++++|.+++...+  .++...+..++.+++.||.|||+.|   ++|+||+|+||++++++.++|+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            999999999999999997754  3788899999999999999999988   99999999999999999999999999886


Q ss_pred             ccCCCccee---eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          201 SEEDSAVSH---ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       201 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .........   ......|+..|+|||.+.+..++.++|||||||++|+|++|..||..........      .... . 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-~-  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF------KIGE-N-  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH------HHhc-c-
Confidence            653211111   1123458899999999999899999999999999999999999997643321111      1000 0 


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          .     ....+...+..+.+++.+||+.+|.+||++.+++++.|
T Consensus       228 ----~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         228 ----A-----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             ----C-----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence                0     01122235577899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-41  Score=303.01  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=208.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|+||.||+|.+.. ++.|++|.+.....    ...+.+|+.++++++|+||+++++++......++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            678999999999999999999875 88999999865422    5678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.... ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        79 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          79 YCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             cCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999997544 34899999999999999999999988   99999999999999999999999999886543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......++..|+|||++.+..++.++||||||+++|+|++|..||....+......       ...        ...
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~--------~~~  216 (256)
T cd06612         155 ---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPN--------KPP  216 (256)
T ss_pred             ---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hcc--------CCC
Confidence               12234578899999999999999999999999999999999999976543221110       000        000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ............+.+++.+||+.+|.+||++.+++.+.|
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         217 PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence            111122345567899999999999999999999998765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-41  Score=304.92  Aligned_cols=255  Identities=27%  Similarity=0.448  Sum_probs=207.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||.||++.+..+..+++|.+....   .....+.+|+.++++++|+||+++++++.. ...+++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            457899999999999999999998777889999887542   234568899999999999999999999887 6789999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.......+++..++.++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999999998765556888999999999999999999988   9999999999999999999999999987654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  .......++..|+|||++.+..++.++|||||||++|++++ |..||.........       .....+..      
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~------  221 (260)
T cd05073         157 Y--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGYR------  221 (260)
T ss_pred             c--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCC------
Confidence            1  11122345678999999999889999999999999999999 99999765432211       11111100      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          .+.....+..+.+++.+||+.+|++||++.++++.|..
T Consensus       222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                11122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-41  Score=333.25  Aligned_cols=275  Identities=17%  Similarity=0.215  Sum_probs=193.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC--CCEEEEEEc--------------c-ccCcchHHHHHHHHHHHHHhcCCCCce
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD--GSIVAVKRA--------------R-KNKHDKCLLLEFKNEILTWSKIEHLNL  108 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~-~~~~~~~~~~~~~~e~~~l~~l~h~ni  108 (380)
                      ..++|++.+.||+|+||+||++.++.  +..+++|.+              . ...........+.+|+.+|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987642  222222211              1 111112234557899999999999999


Q ss_pred             eceEEEEEeCCEEEEEEEeCCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 041907          109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG---GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~  185 (380)
                      +++++++...+..|++++++. ++|.+++....   ........++.++.||+.||.|||++|   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999995 47888775432   111345667889999999999999988   99999999999999


Q ss_pred             CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC-CCCCCCcchhh
Q 041907          186 EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP-IESKKPIKERV  264 (380)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p-~~~~~~~~~~~  264 (380)
                      .++.+||+|||+++.+.....  .......||..|+|||++.+..++.++|||||||++|||++|..+ |....... ..
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~-~~  378 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP-GK  378 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH-HH
Confidence            999999999999987653221  112345699999999999999999999999999999999998764 43322211 11


Q ss_pred             HHHHHHHhhc--cCCcc-------ccccc-CCCCC--CC-----CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          265 TIRWAMQCLK--AGDAI-------LVMDP-RLRRT--PA-----SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       265 ~~~~~~~~~~--~~~~~-------~~~~~-~~~~~--~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+........  .....       ..++. .....  ..     ....+..+.+++.+||+.||.+|||+.|++.+.|..
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            1111111100  00000       00000 00000  00     001234577889999999999999999999999854

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=311.45  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=212.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||.|++|.||+|.... ++.||+|.+....... .....+.+|+.+++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            478899999999999999999874 8999999997654432 34556889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+.+++|.+++.......+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999998765556899999999999999999999988   9999999999999999999999999987543221


Q ss_pred             cce--------------------------eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 041907          206 AVS--------------------------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP  259 (380)
Q Consensus       206 ~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~  259 (380)
                      ...                          .......||..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            100                          001124588899999999999999999999999999999999999976543


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC----hHHHHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT----MKKCAEILWKIR  328 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~eil~~l~~~~  328 (380)
                      ......      ..         ..... .+.....+..+.+++.+||+.+|++||+    +++++.+.|...
T Consensus       238 ~~~~~~------~~---------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~  294 (316)
T cd05574         238 DETFSN------IL---------KKEVT-FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG  294 (316)
T ss_pred             HHHHHH------Hh---------cCCcc-CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence            221110      00         00100 1112225678999999999999999999    999999987643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.1e-41  Score=303.17  Aligned_cols=256  Identities=21%  Similarity=0.345  Sum_probs=202.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc---hHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD---KCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  121 (380)
                      .+|++.+.||+|+||.||+|.+. +|..|++|.+......   ......+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999986 5899999998654321   2234568899999999999999999998865  3678


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++++||+++++|.+++.....  +++...+.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            899999999999999976543  888999999999999999999888   999999999999999999999999998765


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..............++..|+|||++.+..++.++|||||||++|+|++|+.||..........      ......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhcCC-----
Confidence            321111111223458899999999999899999999999999999999999997543322111      110000     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .....+......+..++ .||..+|.+||++++|+.|.|
T Consensus       226 -----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~  263 (266)
T cd06651         226 -----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF  263 (266)
T ss_pred             -----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence                 01112233456677777 688899999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.8e-41  Score=303.10  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=203.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc---chHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  121 (380)
                      .+|++.+.||+|+||.||++.+. +|+.|++|.+.....   .......+.+|+.++++++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999986 489999998864321   12334568899999999999999999998866  3567


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      +++|||+++++|.+++.....  +++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            899999999999999976543  788889999999999999999988   999999999999999999999999998765


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..............|+..|+|||++.+..++.++|||||||++|+|++|..||.........      ......      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~------  224 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQ------  224 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhcC------
Confidence            43211111122345889999999999888999999999999999999999999754322111      111100      


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        +  .....+......+.+++.+||. +|++||++++|+++.|
T Consensus       225 --~--~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         225 --P--TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             --C--CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence              0  0112234456678889999995 9999999999998876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.5e-41  Score=310.02  Aligned_cols=263  Identities=27%  Similarity=0.396  Sum_probs=208.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFL  115 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  115 (380)
                      ...++|.+.+.||+|+||.||+|.+.        ++..||+|.+..... ......+.+|+..+..+ +||||+++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            35678899999999999999999742        245799999875432 23356688999999999 899999999999


Q ss_pred             EeCCEEEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 041907          116 EHGDERIIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN  181 (380)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  181 (380)
                      ......+++|||+++++|.+++....              ...+++..++.++.||+.||.|||++|   ++|+||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence            99999999999999999999997642              123778889999999999999999988   9999999999


Q ss_pred             eeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 041907          182 ILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPI  260 (380)
Q Consensus       182 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~  260 (380)
                      |+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999865432211 11122346678999999999899999999999999999998 78888654322


Q ss_pred             chhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          261 KERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      +.       ......+..          ......++..+.+++.+||+.+|.+||++.++++.|..+..
T Consensus       247 ~~-------~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         247 EL-------FKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HH-------HHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            11       111111100          01122355778999999999999999999999999988755

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-41  Score=303.84  Aligned_cols=253  Identities=25%  Similarity=0.348  Sum_probs=208.8

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||+|+||.||++... +++.+|+|.+............+.+|+.++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999986 588999999976654445567788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccccccccCCCc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  206 (380)
                      +++++|.+++.......+++..++.++.+++.+|.|||+++   ++|+||+|+||+++++ +.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999998766566899999999999999999999988   9999999999999865 4589999999886543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                          .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........   .....    ..         
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~----~~---------  217 (256)
T cd08220         158 ----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LKIMS----GT---------  217 (256)
T ss_pred             ----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HHHHh----cC---------
Confidence                12345889999999999988999999999999999999999999765432211   11100    00         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       ..+.....+..+.+++.+||+.+|.+|||+.+++.+.+
T Consensus       218 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         218 -FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             -CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence             01112234567899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-41  Score=308.27  Aligned_cols=256  Identities=24%  Similarity=0.431  Sum_probs=204.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..+|.+.+.||+|+||.||++...      ++..+++|.+.....  .....+.+|+.++++++|+||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--HHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            467888999999999999999742      356799998865432  335578899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCC-------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          121 RIIVVEYVGNGTLREHLDGRGG-------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      .+++|||+++++|.+++.....             ..+++..++.++.|++.||.|||+.|   ++|+||||+|||++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence            9999999999999999976432             23788999999999999999999988   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.........   
T Consensus       159 ~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---  234 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---  234 (280)
T ss_pred             CCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---
Confidence            9999999999875543211 111223345788999999999999999999999999999998 99998654432211   


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          .....+.          ....+..++..+.+++.+||+.+|.+||++++|++.|.
T Consensus       235 ----~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ----ECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----HHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                1111110          01112234567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-41  Score=302.62  Aligned_cols=249  Identities=33%  Similarity=0.502  Sum_probs=205.3

Q ss_pred             CeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           54 NKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      +.||+|+||.||+|.+..    +..|++|.+....... ....+.+|+..+..++|+|++++++++......+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            469999999999999863    7889999998765443 45678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          130 NGTLREHLDGRG-------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       130 ~~~L~~~i~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +++|.+++....       ...+++..++.++.|++.||.+||+++   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            999999998752       244899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .... ........++..|+|||.+....++.++||||||+++|+|++ |..||......+..       .....+.    
T Consensus       157 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~----  224 (262)
T cd00192         157 DDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL-------EYLRKGY----  224 (262)
T ss_pred             cccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC----
Confidence            4322 112234557889999999998899999999999999999999 69999876432211       1111110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                            ....+..++..+.+++.+||+.+|.+||++.++++++
T Consensus       225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         225 ------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             ------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                  1112233467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=307.72  Aligned_cols=258  Identities=27%  Similarity=0.420  Sum_probs=206.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|.+.+.||+|+||.||+|.+..      +..||+|.+...... .....+.+|+.++..++|+||+++++++....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            45688999999999999999998752      367999998654322 23456789999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG--------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                      ..++||||+++++|.+++.....        ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence            99999999999999999975431        23678899999999999999999988   99999999999999999999


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  270 (380)
                      |+|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||........   ..   
T Consensus       160 l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~---  232 (277)
T cd05032         160 IGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LK---  232 (277)
T ss_pred             ECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HH---
Confidence            999999876543221 111223446789999999998899999999999999999998 9999975443221   11   


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       ....+..          ...+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       233 -~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 -FVIDGGH----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -HHhcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             1111110          1112223678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=306.25  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|++|.||+|.+. +|+.|++|.+...... .....+.+|+.+++.++|+|++++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc-hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            46888999999999999999987 5899999998755322 234567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++...   .+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          80 YCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            99999999999865   4899999999999999999999988   9999999999999999999999999998765321 


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                        .......++..|+|||++.+..++.++||||||+++|+|++|..||....+.....       .....         .
T Consensus       153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-------~~~~~---------~  214 (274)
T cd06609         153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-------LIPKN---------N  214 (274)
T ss_pred             --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-------Hhhhc---------C
Confidence              11233568889999999999899999999999999999999999997654322111       01110         0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .........+..+.+++.+||..+|.+||++++++++.|-.
T Consensus       215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~  255 (274)
T cd06609         215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK  255 (274)
T ss_pred             CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence            00001111556788999999999999999999999998864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=6.8e-41  Score=305.01  Aligned_cols=259  Identities=23%  Similarity=0.387  Sum_probs=204.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..+|++.+.||.|+||.||+|.+. +|+    .||+|.+..... .....++.+|+.++..+.|+||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            467889999999999999999865 344    489999875433 2345668899999999999999999999875 457


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++++||+++|+|.+++..... .+++..++.++.|++.||.|||+++   ++|+||||+|||+++++.+||+|||+++..
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            899999999999999976432 3899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........    .   ..+..+.   
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~---~~~~~~~---  228 (279)
T cd05109         160 DIDETEY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI----P---DLLEKGE---  228 (279)
T ss_pred             cccccee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----H---HHHHCCC---
Confidence            5322211 1122335678999999999999999999999999999998 8999875432211    1   1111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                             ..+....++..+.+++.+||+.+|+.||++.++++.+..+..
T Consensus       229 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 -------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                   011122345678899999999999999999999998876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.4e-41  Score=310.47  Aligned_cols=264  Identities=27%  Similarity=0.408  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      -.++|.+.+.||+|+||.||+|.+.        .+..+|+|.+..... ......+.+|+.+++++ +||||+++++++.
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            3467889999999999999999752        245699999875433 23455688999999999 6999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      .....+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||++|   ++|+||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            9999999999999999999997542              134788899999999999999999988   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      |++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999865432111 11112234567999999999999999999999999999999 889986543321


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .       ......+..          ......++..+.+++.+||+.+|.+||++.++++.++.+....
T Consensus       245 ~-------~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         245 L-------FKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             H-------HHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            1       111111110          1112234567889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.5e-41  Score=337.78  Aligned_cols=264  Identities=23%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999987 589999999976432 2334556889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          126 EYVGNGTLREHLDGRG---------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      ||++|++|.+++....         ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421         123566778899999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCcc---------------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 041907          197 FARMSEEDSAV---------------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK  261 (380)
Q Consensus       197 ~~~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~  261 (380)
                      +++........               ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99865211100               001123469999999999999999999999999999999999999997633221


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHHh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-TMKKCAEILWKIRK  329 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~eil~~l~~~~~  329 (380)
                      ..    .....         ..+. . .......+..+.+++.+||+.+|.+|| +++++++.+.....
T Consensus       239 i~----~~~~i---------~~P~-~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 IS----YRDVI---------LSPI-E-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh----hhhhc---------cChh-h-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            10    00000         0000 0 001123456788999999999999995 56777777776644

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=9.6e-42  Score=311.26  Aligned_cols=267  Identities=22%  Similarity=0.319  Sum_probs=202.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|+||.||+|.+. +|+.|++|.+............+.+|+.++++++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999986 589999999976543333344577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++ +|.+++.... ..+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            975 8888876543 23899999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc------cc
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA------IL  280 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  280 (380)
                        ......++..|+|||++.+.. ++.++|||||||++|+|++|..|+........  .+............      ..
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhh
Confidence              112345788999999987754 68999999999999999999998654332221  11111111100000      00


Q ss_pred             ccc--------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          281 VMD--------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       281 ~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..+        ............+..+.++|.+||+.+|.+|||+++++.+.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            000        000000111234577889999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-41  Score=308.07  Aligned_cols=261  Identities=23%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.+....... ....+.+|+..+++++||||+++++++...
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHH-HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            35678999999999999999999754      24579999987544322 334577899999999999999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGG--------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA  190 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~  190 (380)
                      ...++||||+++|+|.+++.....        ....+..+..++.|++.||.|||+++   ++|+||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence            999999999999999999975321        23566788899999999999999988   9999999999999999999


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  269 (380)
                      +|+|||+++....... ........++..|+|||.+.++.++.++|||||||++|||++ |..||......+.   .   
T Consensus       159 ~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~---  231 (288)
T cd05061         159 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---L---  231 (288)
T ss_pred             EECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---
Confidence            9999999876543221 111122335678999999999999999999999999999998 7889875433211   1   


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       .....+..          .......+..+.+++.+||+.+|.+||++.++++.+...
T Consensus       232 -~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         232 -KFVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -HHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             11111100          011122346799999999999999999999999888754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.7e-41  Score=298.86  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=199.6

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      +.||.|+||.||+|...++..||+|.+...... .....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            368999999999999888899999998765432 3344688999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++.... ..+++..++.++.+++.+|.|||+.|   ++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~  153 (250)
T cd05085          80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--YSSSGL  153 (250)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc--cccCCC
Confidence            99987654 34789999999999999999999988   9999999999999999999999999987543221  111112


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCC
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPAS  292 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (380)
                      ..++..|+|||++.+..++.++||||||+++|++++ |..||..........       ....+..          ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-------~~~~~~~----------~~~~  216 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-------QVEKGYR----------MSCP  216 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHHcCCC----------CCCC
Confidence            234677999999999899999999999999999998 999997654322111       1111100          0111


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          293 NMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       293 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..++..+.+++.+||+.+|++||++.++++.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            234567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-42  Score=318.76  Aligned_cols=247  Identities=25%  Similarity=0.318  Sum_probs=193.6

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC---CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI---EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      ||+|+||+||+|.+. +|+.||||++..... ..........|..++.+.   .||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999987 589999999865322 111223344566666554   699999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|..++...+.  +++..+..++.||+.||.|||+.|   |+||||||+|||++.++.++|+|||++.......   ..
T Consensus        81 g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---~~  152 (330)
T cd05586          81 GELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN---KT  152 (330)
T ss_pred             ChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---CC
Confidence            999999876543  899999999999999999999988   9999999999999999999999999987533211   11


Q ss_pred             eecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT  289 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                      .....||..|+|||++.+. .++.++|||||||++|+|++|..||........       ...+..+..      ..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~------~~---  216 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKV------RF---  216 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCC------CC---
Confidence            2345699999999998765 478999999999999999999999976543221       111111110      00   


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCC----ChHHHHHHHHHH
Q 041907          290 PASNMAVEKILGLADVCLAPTRQSRP----TMKKCAEILWKI  327 (380)
Q Consensus       290 ~~~~~~~~~l~~li~~cl~~~p~~RP----t~~eil~~l~~~  327 (380)
                       .....+..+.+++.+||+.+|.+||    ++.++++|.|..
T Consensus       217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence             0112456788999999999999998    688999988753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-41  Score=304.68  Aligned_cols=258  Identities=25%  Similarity=0.419  Sum_probs=205.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-C---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-G---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..|++.+.||+|+||.||+|.+.. +   ..||||.+.... ......++..|+.++++++||||+++++++......++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            457889999999999999999763 3   369999987543 23345678999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++++|.+++..... .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.....
T Consensus        83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          83 ITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999999976543 4899999999999999999999988   99999999999999999999999999876543


Q ss_pred             CCcceeeeeccc--CCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          204 DSAVSHISTQVK--GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       204 ~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ............  .+..|+|||.+.+..++.++|||||||++|||++ |..||.........       ......    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-------~~i~~~----  227 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------NAIEQD----  227 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcC----
Confidence            221111111111  2457999999999999999999999999999886 99999765432211       111111    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ...+....++..+.+++.+||+.+|.+||++++++..+..+
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  01112234456788999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-41  Score=309.37  Aligned_cols=267  Identities=23%  Similarity=0.345  Sum_probs=207.8

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|+||.||+|.+. +|+.|++|++............+.+|+.++++++|||++++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999986 589999999987654444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      + +++|.+++.... ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999987654 45899999999999999999999988   99999999999999999999999999886654321 


Q ss_pred             eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC----------
Q 041907          208 SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG----------  276 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  276 (380)
                       .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.........   ..........          
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccC
Confidence             112335689999999998654 4688999999999999999998888665432211   1111110000          


Q ss_pred             --CcccccccCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          277 --DAILVMDPRLRR---TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       277 --~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        +......+....   ..........+.+++.+||+.+|.+||++++++.|.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence              000000000000   0001123478899999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-40  Score=302.79  Aligned_cols=256  Identities=23%  Similarity=0.407  Sum_probs=211.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+..... ......+.+|+.+++++.|+||+++++++......++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            45778889999999999999986 588999999875432 2335678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++...   +++...+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          83 YLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999999998753   3888899999999999999999988   99999999999999999999999999876543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......++..|+|||++.+..++.++|||||||++|+|++|..||....+......       ...+          
T Consensus       157 ---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~----------  216 (277)
T cd06640         157 ---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IPKN----------  216 (277)
T ss_pred             ---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hhcC----------
Confidence               12234578899999999998999999999999999999999999976543221110       0000          


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      .........+..+.+++.+||+.+|.+||++++++.+.|-....
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            11223445678899999999999999999999999998865443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=319.32  Aligned_cols=259  Identities=27%  Similarity=0.397  Sum_probs=217.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC---CCC--EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK---DGS--IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..+.....++||.|.||.||+|.+.   .|+  .||||..+.+...+ ..+.|.+|+.+|++++||||++++|+|.+. .
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            4445567788999999999999854   233  59999998765443 366799999999999999999999999876 5


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+||||.++.|.|..+++..+.. ++......++.||+.||.|||+..   +|||||-..||||....-|||+|||+++.
T Consensus       465 ~WivmEL~~~GELr~yLq~nk~s-L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNKDS-LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eeEEEecccchhHHHHHHhcccc-chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            79999999999999999887654 888888899999999999999988   99999999999999999999999999999


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      +.+...  ...+...-..-|||||.+....++.++|||.|||.+||++. |..||.+....+..                
T Consensus       541 ~ed~~y--YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------------  602 (974)
T KOG4257|consen  541 LEDDAY--YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------------  602 (974)
T ss_pred             ccccch--hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----------------
Confidence            886542  22334445678999999999999999999999999999887 99999876654421                


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ..+..+ .+.|.+..|+..+..|+.+||+.+|.+||++.++...|..++.
T Consensus       603 ~~iEnG-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  603 GHIENG-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEecCC-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            122222 2356788899999999999999999999999999999988755

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-41  Score=307.43  Aligned_cols=257  Identities=24%  Similarity=0.359  Sum_probs=205.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..+.|++.+.||.|+||.||+|.+.. +..|++|.+....  ......+.+|+.+++.++|+||+++++.+......++|
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            34679999999999999999999874 8899999987543  23456688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|..++.+.. ..+++..++.++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999999988876543 34899999999999999999999988   999999999999999999999999988654321


Q ss_pred             CcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .   .......++..|+|||++.     ...++.++|||||||++|+|++|..||....+....      ......    
T Consensus       164 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~----  230 (292)
T cd06644         164 L---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKS----  230 (292)
T ss_pred             c---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH------HHHhcC----
Confidence            1   1122345888999999885     345678999999999999999999999765432211      111000    


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                           ...........+..+.+++.+||+.+|.+||++++++++.|-
T Consensus       231 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         231 -----EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             -----CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                 000111222345678899999999999999999999998773

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.7e-41  Score=319.19  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=207.3

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLE  116 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  116 (380)
                      ....++|.+.+.||+|+||.||+|.++      .+..||+|+++..... .....+.+|+.+|.++. ||||+++++++.
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            334567888999999999999999864      2467999999765433 23446889999999997 999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCC------------------------------------------------------
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGG------------------------------------------------------  142 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~------------------------------------------------------  142 (380)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999965321                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 041907          143 ------------------------------------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKAS  180 (380)
Q Consensus       143 ------------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  180 (380)
                                                                ..+++..++.++.||+.||.|||+.+   ++|+||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                      12567778899999999999999888   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 041907          181 NILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKP  259 (380)
Q Consensus       181 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~  259 (380)
                      |||++.++.++|+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999865332111 11123346788999999999899999999999999999998 8999865432


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .+...      .....+.         . .+.+..++.++.+++.+||+.+|.+||++++|++.|..+.
T Consensus       348 ~~~~~------~~~~~~~---------~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQFY------NAIKRGY---------R-MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHHHH------HHHHcCC---------C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            22111      1111110         0 1112234578999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.9e-41  Score=308.38  Aligned_cols=264  Identities=24%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             ccHHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEE
Q 041907           38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFL  115 (380)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  115 (380)
                      ..++.+..+.++|++.+.||+|+||.||++.+. +++.+|+|++......   ...+.+|+.++.++ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            445667778899999999999999999999986 4889999987643221   24567899999998 699999999987


Q ss_pred             E-----eCCEEEEEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          116 E-----HGDERIIVVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       116 ~-----~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      .     .....++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence            4     345789999999999999987642  2234888999999999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER  263 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~  263 (380)
                      .++|+|||++........   ......|+..|+|||++..     ..++.++|||||||++|+|++|..||....+....
T Consensus       162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~  238 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL  238 (286)
T ss_pred             CEEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence            999999999876543211   1223458999999999853     45788999999999999999999999765432211


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..       .....     .+.   ..........+.+++.+||+.+|.+||+++|+++++|
T Consensus       239 ~~-------~~~~~-----~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         239 FK-------IPRNP-----PPT---LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             hh-------ccccC-----CCc---ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            10       00000     000   0011123457889999999999999999999999876

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=307.09  Aligned_cols=257  Identities=23%  Similarity=0.348  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||.|+||.||++.+. ++..||+|.+....  ......+.+|+.++++++|+||+++++++......++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            467889999999999999999986 58899999987543  233456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          82 EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999999987643 34899999999999999999999988   9999999999999999999999999887543221


Q ss_pred             cceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .   ......++..|+|||.+.     ...++.++||||||+++|+|++|..||...........       ...+..  
T Consensus       158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~--  225 (280)
T cd06611         158 Q---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-------ILKSEP--  225 (280)
T ss_pred             c---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH-------HhcCCC--
Confidence            1   122345899999999985     34567899999999999999999999976543221111       111100  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            .....+..++..+.+++.+||+.+|.+||++.+++++.|-.
T Consensus       226 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (280)
T cd06611         226 ------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS  266 (280)
T ss_pred             ------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence                  00112233456788999999999999999999999998854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-41  Score=307.42  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      |++.+.||.|+||.||++.+.. +..+++|.+.....  .....+.+|+.+++.++|||++++++++......++||||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            5677889999999999999874 78899998865432  23556789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++++|..++.... .++++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---  157 (282)
T cd06643          85 AGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---  157 (282)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc---
Confidence            9999999876533 34899999999999999999999988   9999999999999999999999999987543211   


Q ss_pred             eeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          209 HISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .......++..|+|||++.     +..++.++|||||||++|+|++|..||....+......   ....    .     .
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~----~-----~  225 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKS----E-----P  225 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH---Hhhc----C-----C
Confidence            1123356899999999984     45577899999999999999999999976543221111   0000    0     0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      +   ....+...+..+.++|.+||+.+|.+||++.+++++.|..
T Consensus       226 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         226 P---TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             C---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            0   0111223456789999999999999999999999998843

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-41  Score=302.12  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=208.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|+||.||+|.+. +++.+++|.+......  ....+.+|+.++++++||||+++++++......+++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            67899999999999999999986 5788999999765433  35678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.... ..++...++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          81 YCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999999987652 34889999999999999999999988   9999999999999999999999999987654321 


Q ss_pred             ceeeeecccCCccccChhhhhhc---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                        .......++..|+|||.+.+.   .++.++||||||+++|+|++|..||....+......+.      ..+     +.
T Consensus       156 --~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~------~~~-----~~  222 (262)
T cd06613         156 --AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS------KSN-----FP  222 (262)
T ss_pred             --hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcc-----CC
Confidence              112335688899999999877   88899999999999999999999997654332211110      000     00


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .  .........+..+.+++.+||+.+|.+||++.+|+.+.|
T Consensus       223 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         223 P--PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             C--ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            0  001123345677999999999999999999999987643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.9e-41  Score=305.35  Aligned_cols=265  Identities=28%  Similarity=0.430  Sum_probs=209.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDE  120 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  120 (380)
                      +.|++.+.||+|+||.||+|.+.     .+..||||.+...... .....+.+|+..++.+.|+||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            56788899999999999999854     3678999999765543 345678999999999999999999999877  567


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++|||+++++|.+++..... .+++..++.++.+++.||.|||+.|   ++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            8999999999999999976543 3899999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHHHh
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--------VTIRWAMQC  272 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~~  272 (380)
                      ...............++..|+|||.+.+..++.++||||||+++|+|++|..|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            653322222222334567799999999889999999999999999999999998653321110        001111111


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...+         . ..+....++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       239 ~~~~---------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEG---------E-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcC---------C-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111         0 1112234457799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.1e-41  Score=313.86  Aligned_cols=263  Identities=27%  Similarity=0.384  Sum_probs=204.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe------CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe-
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH-  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  117 (380)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||.++..... .....+.+|+.++.++ +||||+++++++.. 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            346899999999999999999974      24788999999765433 2345678999999999 68999999998765 


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCC-------------------------------------------------------
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGG-------------------------------------------------------  142 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~-------------------------------------------------------  142 (380)
                      ....+++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            4567899999999999999865321                                                       


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeee
Q 041907          143 ----------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST  212 (380)
Q Consensus       143 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  212 (380)
                                ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++......... ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~  239 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKG  239 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch-hhcC
Confidence                      12677888899999999999999988   999999999999999999999999998765332111 1112


Q ss_pred             cccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       213 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.........      ......+..          ...
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~~----------~~~  303 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTR----------MRA  303 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH------HHHHhccCC----------CCC
Confidence            2345678999999999999999999999999999997 99998754332111      111111110          011


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      +......+.+++..||+.+|.+||++.+|+++|..+..
T Consensus       304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11234568899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9e-41  Score=301.32  Aligned_cols=258  Identities=27%  Similarity=0.418  Sum_probs=209.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||+|+||.||+|.+. +++.|++|.++...........+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999976 589999999987665545677899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++....  .+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999998653  3788899999999999999999988   999999999999999999999999998876543221


Q ss_pred             eee-eecccCCccccChhhhhhcC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          208 SHI-STQVKGTAGYLDPDYLRTYQ---LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       208 ~~~-~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ... .....++..|+|||++.+..   ++.++||||||+++|+|++|..||.......   ...+....   +       
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~~~---~-------  222 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHVGA---G-------  222 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHHhc---C-------
Confidence            111 12356889999999998766   8899999999999999999999997543211   11111010   0       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                       .....+........+.+++.+||+.+|.+||++.+++.+.|
T Consensus       223 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         223 -HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             -CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence             00011122234567889999999999999999999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=329.96  Aligned_cols=260  Identities=26%  Similarity=0.430  Sum_probs=224.6

Q ss_pred             CCCCCCeeeccCceEEEEEEeCC-C---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKD-G---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ...+++.||.|.||.|++|+++- |   ..||||.++..... ....+|..|+.+|.++.||||+++-|+......++||
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte-kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE-KQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH-HHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            45688999999999999999873 3   45999999877554 4577899999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      .|||++|+|+.+|+...++ +.+.+...++.+|+.|+.||-+.+   +|||||...||||+.+...|++|||+++.++++
T Consensus       709 TEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999999988766 999999999999999999999888   999999999999999999999999999988776


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .........-.-...|.|||.+....++.++|||||||++||.++ |..||......+..       ..++++       
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-------kaIe~g-------  850 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------KAIEQG-------  850 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-------HHHHhc-------
Confidence            533332233334578999999999999999999999999999888 99999877665432       222222       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                         .+.|.+.+|+..|.+|+..||++|-..||.+.+|+..|.++..+
T Consensus       851 ---yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  851 ---YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ---cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence               13567788999999999999999999999999999999988553

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.6e-41  Score=306.46  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|+..+.||.|+||.||+|.+. +++.||+|.+...... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            34566778999999999999976 4888999998754333 245678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++...   .+++..++.++.+++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          83 YLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             ccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999999998653   3889999999999999999999988   99999999999999999999999999876543211


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......++..|+|||++.+..++.++|||||||++|+|++|..||....+.....       ....+         .
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~---------~  217 (277)
T cd06642         157 ---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKN---------S  217 (277)
T ss_pred             ---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcC---------C
Confidence               1123457899999999999999999999999999999999999997544322111       00000         0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ........+..+.+++.+||+.+|.+||++.+++.+.|-.
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06642         218 -PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT  257 (277)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence             0111223456788999999999999999999999998854

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=309.42  Aligned_cols=271  Identities=24%  Similarity=0.329  Sum_probs=208.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||+|.+. +++.|++|+++...........+.+|+.++++++|+||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46889999999999999999987 58899999987654444445678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++++.+..++....  .++...++.++.+|+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            999877766655433  3899999999999999999999988   99999999999999999999999999887654321


Q ss_pred             ceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc-----c
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI-----L  280 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  280 (380)
                        .......++..|+|||++.+. .++.++||||||+++|+|++|..||......+....+.............     .
T Consensus       156 --~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         156 --SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             --ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence              122345678999999999888 88899999999999999999999997654433222211111000000000     0


Q ss_pred             cccc-CCCCC--------CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          281 VMDP-RLRRT--------PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       281 ~~~~-~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+.. .....        .....++.++.++|.+||..+|.+||++++++.+.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence            0000 00000        011123678999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.6e-41  Score=307.20  Aligned_cols=262  Identities=24%  Similarity=0.401  Sum_probs=208.2

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           39 SFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        39 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ++.++....+.|++.+.||.|+||.||+|.+. +++.||+|++....   .....+..|+.++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            44566667789999999999999999999986 58899999986542   2234577899999988 7999999999885


Q ss_pred             e------CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 041907          117 H------GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA  190 (380)
Q Consensus       117 ~------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~  190 (380)
                      .      ....+++|||+++++|.+++.......+++..++.++.||+.||.|||+.+   ++|+||+|+||++++++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence            3      467899999999999999998766556888889999999999999999988   9999999999999999999


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT  265 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~  265 (380)
                      +|+|||++.......   .......|+..|+|||.+.     +..++.++|||||||++|+|++|..||....+......
T Consensus       161 ~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         161 KLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             EEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence            999999987543211   1123356899999999886     34678899999999999999999999975443221111


Q ss_pred             HHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          266 IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +      ..          ..........++..+.++|.+||+.+|.+||++.|++++.|
T Consensus       238 ~------~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         238 I------PR----------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             H------hh----------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            0      00          00011112235578999999999999999999999998866

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-40  Score=311.60  Aligned_cols=262  Identities=28%  Similarity=0.392  Sum_probs=207.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC--------CCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ...+|.+.+.||+|+||.||+|.+..        +..||+|.+..... ......+.+|+.+++++ +||||+++++++.
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            44679999999999999999997531        23689998875432 33456788999999999 8999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      ..+..+++|||+++|+|.+++....              ...+++..+..++.|++.||.|||+.|   ++|+||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence            9999999999999999999997532              223788889999999999999999988   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      |++.++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  244 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  244 (334)
T ss_pred             EEcCCCcEEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999876543211 111122334578999999999999999999999999999998 888886543221


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .       ......+..          ......++..+.+++.+||+.+|.+||++.++++.|..+..
T Consensus       245 ~-------~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         245 L-------FKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             H-------HHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1       111111100          11122345678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.1e-41  Score=305.56  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|.+..... .....++.+|+.++++++||||+++++++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            467999999999999999999864      367899999875543 2334568899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 041907          121 RIIVVEYVGNGTLREHLDGRG--------------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKAS  180 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~  180 (380)
                      .+++|||+++++|.+++....                    ...+++..++.++.+++.||.|||+.+   ++|+||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999996432                    123778889999999999999999988   999999999


Q ss_pred             ceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 041907          181 NILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKP  259 (380)
Q Consensus       181 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~  259 (380)
                      ||+++.++.++|+|||++........ .........+..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADY-YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCcc-ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999875432211 111122234677999999999999999999999999999998 8889865433


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+.       ......+..          .+....++..+.+|+.+||+.+|.+||++.|+++.|+
T Consensus       239 ~~~-------~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 EEV-------IYYVRDGNV----------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHH-------HHHHhcCCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            211       111111111          1112234577999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-41  Score=310.13  Aligned_cols=270  Identities=26%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||+|.++ +|+.||+|++............+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47889999999999999999987 48999999987654443345567899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++++.|..++....  .+++..++.++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            999988888776543  3899999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc--------CC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA--------GD  277 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~  277 (380)
                         ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+.........        ..
T Consensus       156 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         156 ---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             ---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence               1233457899999999875 34678999999999999999999999765443221111111000000        00


Q ss_pred             cc-cccccCCCC----CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 AI-LVMDPRLRR----TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~~-~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .. ....+....    .......+..+.+|+.+||+.+|.+||++.+++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence            00 000000000    0011234577999999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-40  Score=300.93  Aligned_cols=259  Identities=22%  Similarity=0.380  Sum_probs=207.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc----hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD----KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      +|+..+.||+|++|.||++.+. +++.||+|.+......    ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5788899999999999999975 6899999998754321    1235668899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  202 (380)
                      ||||+++++|.+++...+  ++++..+..++.||+.||.|||++|   ++|+||+|+||+++.++ .++|+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            999999999999997654  4889999999999999999999988   99999999999998776 59999999987654


Q ss_pred             CCCcc-eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAV-SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..... ........++..|+|||.+.+..++.++||||||+++++|++|..||...........+.   ....       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~-------  225 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIAS-------  225 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhc-------
Confidence            32111 111223468899999999998899999999999999999999999997544322111111   1000       


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                         .......+......+.+++.+||+.+|.+||++.+++++.|
T Consensus       226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence               00112233456678999999999999999999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-40  Score=304.65  Aligned_cols=262  Identities=23%  Similarity=0.362  Sum_probs=209.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||+||++.+. +|+.||+|++..... ......+.+|+.+++.++||||+++++++......++||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            367888899999999999999986 588999998875433 334567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||+++++|.+++...+  .+++..+..++.+++.+|.|||+ .+   ++|+||+|+||++++++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999999987654  38899999999999999999996 46   999999999999999999999999988654321


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-----hhHHHHHHHhhccCCcc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE-----RVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~  279 (380)
                      .     .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     ........... ..   
T Consensus       158 ~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~---  228 (284)
T cd06620         158 I-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QE---  228 (284)
T ss_pred             c-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hc---
Confidence            1     1234689999999999888999999999999999999999999986543211     00111111111 00   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                           ... .......+..+.+|+.+||+.+|.+||+++|+++++|-+..
T Consensus       229 -----~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         229 -----PPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             -----cCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                 000 11112255678999999999999999999999999876644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.2e-41  Score=305.88  Aligned_cols=258  Identities=23%  Similarity=0.388  Sum_probs=206.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||.||++.+. +|..||+|.+..... ......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            46889999999999999999987 689999999875432 2334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          127 YVGNGTLREHLDGRG-GNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |+++++|..++.... ...+++..+..++.+++.||.|||+ .+   ++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            999999999887642 2248999999999999999999996 47   999999999999999999999999998755322


Q ss_pred             CcceeeeecccCCccccChhhhhhcC------CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQ------LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                           ......++..|+|||.+.+..      ++.++|||||||++|+|++|..||...........+    .....+  
T Consensus       157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~--  225 (286)
T cd06622         157 -----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL----SAIVDG--  225 (286)
T ss_pred             -----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----HHHhhc--
Confidence                 123345888999999986543      478999999999999999999999754322111111    111010  


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                            .  ....+..++..+.++|.+||+.+|.+||++++++++.|-..
T Consensus       226 ------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~  267 (286)
T cd06622         226 ------D--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK  267 (286)
T ss_pred             ------C--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence                  0  11123346678899999999999999999999999988553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9e-41  Score=300.15  Aligned_cols=251  Identities=27%  Similarity=0.455  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      .+|++.+.||.|+||.||++.+.++..+|+|.+......   ...+.+|+.++++++|||++++++++......+++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            468888999999999999999877889999998765433   24578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++..... .+++..++.++.+++.+|.+||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          81 MEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            999999999976543 3788999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                       .......++..|+|||.+.++.++.++||||||+++|+|++ |..||........       ......+.  ..     
T Consensus       156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~--~~-----  220 (256)
T cd05112         156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-------VETINAGF--RL-----  220 (256)
T ss_pred             -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHhCCC--CC-----
Confidence             11122335678999999998899999999999999999998 9999975432211       11111110  00     


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                         ..+...+..+.+|+.+||+.+|.+||+++++++.+
T Consensus       221 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 ---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence               01112346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=322.27  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=222.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC--CC--EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD--GS--IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ++.++.+.||+|.||.|++|.|..  |.  .||||.++...... ...+|.+|+..|.+|+|+|++++||+..+ ....+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            455677899999999999999873  44  49999998876654 56789999999999999999999999987 67889


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||+++.|+|.+.|+......|-......++.||+.|+.||..++   +|||||-..|+|+-..-.|||+|||+.+-+..
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999999855556888899999999999999999988   99999999999999998999999999999988


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      +...+.+.....-...|+|||.++...++.++|||+|||+||||++ |+.||-+....+...                .+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----------------~i  328 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----------------NI  328 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH----------------hc
Confidence            7777766555666788999999999999999999999999999999 899998877654221                22


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      | ...+.+.+..|++.+++++..||..+|++||++..|.+.+...
T Consensus       329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            3 1223566778999999999999999999999999998655443

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-40  Score=301.39  Aligned_cols=259  Identities=20%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +..++++.....||+|+||.||+|.+. ++..|++|.+......  ....+.+|+.++++++|+||+++++++..++..+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            345566666788999999999999976 5788999988755432  3456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEcccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGN-GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARM  200 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~  200 (380)
                      +++||+++++|.+++...... ..+...+..++.||+.||.|||+.+   ++|+||||+||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999999764321 1278888899999999999999988   999999999999986 67899999999876


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ......   ......|+..|+|||++.+..  ++.++||||||+++|+|++|..||..........   +.....     
T Consensus       159 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~-----  227 (268)
T cd06624         159 LAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF-----  227 (268)
T ss_pred             cccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh-----
Confidence            533211   122345889999999987654  7889999999999999999999996533211110   000000     


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          .   .....+.....++.+++.+||+.+|.+||++.+++.+.|
T Consensus       228 ----~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         228 ----K---IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             ----c---cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence                0   001122345577899999999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.9e-40  Score=307.52  Aligned_cols=265  Identities=20%  Similarity=0.249  Sum_probs=190.7

Q ss_pred             CCeeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEEEEEe
Q 041907           53 ANKIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERIIVVEY  127 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~  127 (380)
                      ..+||+|+||.||+|...   ++..||+|.+......    ..+.+|+.++++++||||+++++++..  ....++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            357999999999999975   3578999998754332    346789999999999999999998853  5678999999


Q ss_pred             CCCCCHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEcccc
Q 041907          128 VGNGTLREHLDGR-------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI----TEKLRAKVTDFG  196 (380)
Q Consensus       128 ~~~~~L~~~i~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg  196 (380)
                      +.+ +|.+++...       ....+++..++.++.||+.||.|||+.+   ++||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            965 888877532       1224788899999999999999999988   9999999999999    566789999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcch------hhHHHHH
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE------RVTIRWA  269 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~------~~~~~~~  269 (380)
                      +++................||..|+|||++.+. .++.++|||||||++|+|++|..||........      ...+...
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            998765432211222345689999999999764 578999999999999999999999975432110      0011110


Q ss_pred             HHhhccCC------------cccc---cccCCCC--------CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          270 MQCLKAGD------------AILV---MDPRLRR--------TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       270 ~~~~~~~~------------~~~~---~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ........            ....   .......        ..........+.+|+.+||+.||.+|||++|+++|.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            00000000            0000   0000000        0000112345788999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-40  Score=305.84  Aligned_cols=271  Identities=23%  Similarity=0.283  Sum_probs=206.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc---hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD---KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +|.+.+.||.|+||.||+|.+. +|+.|++|.+......   ......+..|+.++++++|+||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999986 5899999999765443   33344577899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+ +++|.+++.... ..+++..++.++.||++||.|||++|   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 889999997754 35899999999999999999999988   999999999999999999999999999866442


Q ss_pred             CcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC------
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD------  277 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------  277 (380)
                      ..   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...........      
T Consensus       156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         156 NR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             Cc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            21   1123346788999998865 4578899999999999999999888876554332111110000000000      


Q ss_pred             cccccccC----CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          278 AILVMDPR----LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       278 ~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ........    ..........+..+.++|.+||+.+|.+||++++++.+.|-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~  286 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS  286 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence            00000000    000001123356788999999999999999999999998744

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-40  Score=300.54  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-CC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-GS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..+|++.+.||+|+||.||+|.++. |+    .||+|.+..... ......+.+|+..+.+++||||+++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4678899999999999999998752 43    589998876543 3345668899999999999999999999987 788


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++..
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999999987543 3899999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ....... ......++..|+|||.+....++.++||||||+++||+++ |..||......+..       .....+.   
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~---  228 (279)
T cd05057         160 DVDEKEY-HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------DLLEKGE---  228 (279)
T ss_pred             cCcccce-ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhCCC---
Confidence            5322111 1112234678999999998899999999999999999998 99999765432211       1111111   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                             ..+.+..+...+.+++.+||..+|..||++.++++.+..+.+
T Consensus       229 -------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 -------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   011122234568899999999999999999999999988755

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.6e-41  Score=305.80  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=207.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||++.+. +++.||+|.+...... ......+.+|+.++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47889999999999999999987 5899999998754322 223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....  .++...+..++.|++.||.|||+.|   ++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999997764  3889999999999999999999988   999999999999999999999999998865432 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++|..||........   .    .....+.        
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~~--------  214 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---Y----EKILEGK--------  214 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHhcCC--------
Confidence                 2344689999999999888889999999999999999999999976542111   0    1111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                         ...+......+.+++.+||+.+|.+|+     ++++++++.|.
T Consensus       215 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         215 ---VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             ---ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence               111222356788999999999999999     89999999873

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=296.76  Aligned_cols=249  Identities=31%  Similarity=0.447  Sum_probs=201.4

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      +.||.|+||.||++.+.+++.|++|.+...... .....+.+|+.+++++.|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999877999999998765443 3456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++..... .+++..++.++.+++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus        80 ~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  154 (251)
T cd05041          80 LTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGL  154 (251)
T ss_pred             HHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eecccc
Confidence            999976432 4788999999999999999999988   99999999999999999999999999876542111 000112


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCC
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPAS  292 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (380)
                      ..++..|+|||.+.++.++.++|||||||++|+|++ |..||...........       .....          ..+.+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-------~~~~~----------~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-------IESGY----------RMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-------HhcCC----------CCCCC
Confidence            234567999999999899999999999999999999 8889876543221111       11100          01122


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          293 NMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       293 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ...+..+.+++.+||+.+|.+||++.|+++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            345568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.1e-40  Score=297.64  Aligned_cols=254  Identities=27%  Similarity=0.411  Sum_probs=195.0

Q ss_pred             CeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE-eCCEEEEEEEeC
Q 041907           54 NKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE-HGDERIIVVEYV  128 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  128 (380)
                      +.||+|+||.||+|.+.    .+..||+|.+..... ......+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999864    245799998854322 223456788999999999999999999775 455689999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      .+++|.+++..... ...+..+..++.+++.||.|||+.+   ++|+||||+|||+++++.+||+|||+++.........
T Consensus        80 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          80 KHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999976543 2677788899999999999999988   9999999999999999999999999987554321111


Q ss_pred             -eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          209 -HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG-RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       209 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                       .......++..|+|||.+.+..++.++|||||||++|||++| ..||........   ...    ...+.         
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~---~~~----~~~~~---------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI---TVY----LLQGR---------  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HhcCC---------
Confidence             111233467789999999988999999999999999999995 556654332211   111    11110         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                       ........+..+.+++.+||+.+|++||++.+|++.+..+..
T Consensus       220 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         220 -RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence             011122345678899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.2e-41  Score=307.82  Aligned_cols=267  Identities=25%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|++|.||+|.+. +|+.||||.+............+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999986 589999999876544333345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +. ++|.+++.......+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 58999987766566899999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc--------
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA--------  278 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  278 (380)
                        ......++..|+|||++.+.. ++.++|||||||++|+|++|..||...........+.   ........        
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF---RTLGTPDEVVWPGVTS  230 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---HHhCCCChhhhhhhhH
Confidence              112334688999999887654 5789999999999999999999997654332211111   00000000        


Q ss_pred             ----ccccccCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          279 ----ILVMDPRLR--RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       279 ----~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          ...+.....  ...........+.++|.+||+.||.+||++++++.+.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence                000000000  00001123456789999999999999999999998876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.9e-40  Score=300.56  Aligned_cols=258  Identities=27%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|.+.+.||.|+||.||+|.+.+    ...|++|....... ......+.+|+.++++++||||+++++++.. ...+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            4568899999999999999998753    24699998865543 2345578899999999999999999998876 4578


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++..... .+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++...
T Consensus        83 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999999976442 4899999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........       ...+.    
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-------~~~~~----  225 (270)
T cd05056         159 DESY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-------IENGE----  225 (270)
T ss_pred             cccc--eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHcCC----
Confidence            3311  11122334568999999988889999999999999999986 9999976543221111       11111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                            ..+....++..+.+++.+||..+|.+|||+.++++.|..+..
T Consensus       226 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 ------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  011223445679999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.8e-41  Score=307.07  Aligned_cols=253  Identities=26%  Similarity=0.433  Sum_probs=203.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      .|.....||.|+||.||++.+. ++..||||.+.....  .....+.+|+..++.++|+||+++++.+...+..++||||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            3444567999999999999976 588999999865432  2345588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++...   .+++..++.++.+|+.||.|||+.+   ++|+||||+||++++++.++|+|||++........ 
T Consensus       101 ~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         101 LEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            9999999988643   3889999999999999999999988   99999999999999999999999999875432211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|..||...........+   ...         +...  
T Consensus       174 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~---------~~~~--  237 (292)
T cd06658         174 --KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDN---------LPPR--  237 (292)
T ss_pred             --cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhc---------CCCc--
Confidence              112345889999999999989999999999999999999999999765433211111   000         0011  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       .......+..+.+++.+||+.+|.+|||+++++++.|..
T Consensus       238 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         238 -VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             -cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence             111223456788999999999999999999999997744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-40  Score=298.60  Aligned_cols=254  Identities=23%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERIIVV  125 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  125 (380)
                      +|++.+.||.|+||.||++.+. +|..||+|.+............+.+|+.++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788999999999999999976 58899999997665555556678899999999999999999997753  45689999


Q ss_pred             EeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          126 EYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLH-----TYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ||+++++|.+++....  ...+++..++.++.+|+.||.|||     +.+   ++|+||+|+||++++++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999999999997542  345899999999999999999999     666   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ........   ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......   ..    .....+. 
T Consensus       158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~-  226 (265)
T cd08217         158 KILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA----SKIKEGK-  226 (265)
T ss_pred             ccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH----HHHhcCC-
Confidence            87654321   1233468999999999999889999999999999999999999998654211   11    1111110 


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                               ........+..+.+++.+||+.+|.+||++++|+++.+
T Consensus       227 ---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~  264 (265)
T cd08217         227 ---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL  264 (265)
T ss_pred             ---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence                     01123345578899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-40  Score=297.16  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=205.8

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc---chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +|+..+.||+|+||.||+|.+. +++.|++|.+.....   .......+.+|+.++++++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999987 689999999865432   233456788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      +||+++++|.+++....  .+++..++.++.+|+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999997654  3788999999999999999999988   999999999999999999999999998765432


Q ss_pred             CcceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .    ......|+..|++||.+.... ++.++|+||||+++|+|++|..||...........      ......      
T Consensus       156 ~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~------~~~~~~------  219 (258)
T cd06632         156 S----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK------IGRSKE------  219 (258)
T ss_pred             c----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH------HHhccc------
Confidence            2    123456889999999998766 88999999999999999999999976542221111      000000      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          ....+......+.+++.+||+.+|.+||++.+++.+.|
T Consensus       220 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         220 ----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             ----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence                01112234567889999999999999999999998764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-40  Score=301.73  Aligned_cols=259  Identities=25%  Similarity=0.440  Sum_probs=203.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc--------hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD--------KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      +|.+.+.||.|+||.||+|... +|+.||+|.++.....        ......+.+|+.+++.++|+|++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778899999999999999876 5899999988643211        112345788999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++++|.+++...+  .++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999998764  4888999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ....... ........|+..|+|||.+....  ++.++|+||||+++|++++|..||..........      ...... 
T Consensus       157 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~-  228 (272)
T cd06629         157 KSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------KLGNKR-  228 (272)
T ss_pred             ccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------Hhhccc-
Confidence            6443211 11123355889999999988755  7899999999999999999999996443321111      000000 


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .    .... .......++..+.+++.+||+.+|.+||++++++++.|
T Consensus       229 ~----~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         229 S----APPI-PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             c----CCcC-CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence            0    0000 01111234678999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=318.67  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .|.-++.||.|.||-||.|++. +++.||||++.-+. .......++..|+..|++++|||++.+.|+|..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            5778899999999999999976 68899999996543 333456779999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      || -|+-.|++.-.. .++.+.++..|.++.+.||.|||+.+   .||||||..|||+++.|.|||+|||.+.+..+   
T Consensus       107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99 458888887654 45899999999999999999999999   99999999999999999999999999887554   


Q ss_pred             ceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          207 VSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                          ...++||+.|||||++.   .+.|+.|+||||||++..||.-.++|+-..+.....       ..+..++      
T Consensus       179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------YHIAQNe------  241 (948)
T KOG0577|consen  179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQNE------  241 (948)
T ss_pred             ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------HHHHhcC------
Confidence                34577999999999884   568999999999999999999999998665543221       1111111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         .+.-....++..+.+|+..||+.-|.+|||.++++.|.+-.
T Consensus       242 ---sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  242 ---SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             ---CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence               11223567889999999999999999999999999887654

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.4e-40  Score=298.77  Aligned_cols=254  Identities=21%  Similarity=0.318  Sum_probs=192.5

Q ss_pred             CeeeccCceEEEEEEeCC---CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLKD---GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+.+   +..+++|.++..... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            368999999999998653   467999998765432 2334688899999999999999999999998899999999999


Q ss_pred             CCHHHHhccCCC---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          131 GTLREHLDGRGG---NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       131 ~~L~~~i~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      |+|.+++.....   ...++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-  155 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-  155 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce-
Confidence            999999975432   23567778889999999999999988   99999999999999999999999999875432211 


Q ss_pred             eeeeecccCCccccChhhhhhc-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          208 SHISTQVKGTAGYLDPDYLRTY-------QLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ........++..|+|||++.+.       .++.++||||||+++|+|++ |..||......+...   ..    ..+...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~----~~~~~~  228 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT----VREQQL  228 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH----hhcccC
Confidence            1112234578889999998642       35789999999999999996 999997654332111   10    001111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ....+.     ........+.+++..|| .+|.+|||+++|+..|.
T Consensus       229 ~~~~~~-----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPR-----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCc-----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111     11123456788999999 68999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-40  Score=304.46  Aligned_cols=264  Identities=26%  Similarity=0.385  Sum_probs=206.6

Q ss_pred             ccHHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEE
Q 041907           38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFL  115 (380)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  115 (380)
                      +.+.++..+.++|.+.+.||+|+||.||++... +++.+|+|++.....   ....+.+|+.++.++ +|||++++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            344556667889999999999999999999986 588999999865422   234567889999988 899999999998


Q ss_pred             EeC-----CEEEEEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          116 EHG-----DERIIVVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       116 ~~~-----~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      ...     ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCC
Confidence            653     3589999999999999988642  2345899999999999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcC-----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchh
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER  263 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~  263 (380)
                      .++|+|||++........   ......|+..|+|||.+....     ++.++|||||||++|+|++|+.||....+....
T Consensus       166 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~  242 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL  242 (291)
T ss_pred             CEEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence            999999999876543211   112345889999999986543     678999999999999999999999765432221


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..       ......     +.   ..........+.++|.+||+.+|++||++.+++++.|
T Consensus       243 ~~-------~~~~~~-----~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         243 FK-------IPRNPP-----PT---LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             HH-------HhcCCC-----CC---CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence            11       000000     00   0112234457899999999999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-41  Score=315.81  Aligned_cols=256  Identities=23%  Similarity=0.361  Sum_probs=220.6

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      .....|.+.+.||+|.|+.|.+|++. ++..||||.+.+...+...+..+.+|+.+|..++|||||+++.+......+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            35678999999999999999999986 59999999999887777666778999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+.+|.+++++...+.  +....+..++.|+.+|++|||+++   |||||||++|||++.+.++||+|||++..+..
T Consensus       133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999998775  566888999999999999999998   99999999999999999999999999987664


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                          .....+.+|++.|.|||++.+..|+ +.+|+||+|++||.|+.|..||++..-...+..               ++
T Consensus       208 ----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r---------------vl  268 (596)
T KOG0586|consen  208 ----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR---------------VL  268 (596)
T ss_pred             ----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch---------------he
Confidence                2345678999999999999998886 899999999999999999999997654322111               01


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      -..   ...+.....+..++|+++|-++|.+|++++++..+-|.-
T Consensus       269 ~gk---~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  269 RGK---YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             eee---ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence            111   112333456677899999999999999999999998864

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=300.86  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCC----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGD----  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----  119 (380)
                      .+++|++.+.||.|++|.||+|.+. +++.|++|++.....   ....+.+|+.+++++ .|+||+++++++....    
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4689999999999999999999986 588999999876543   235688999999998 7999999999987644    


Q ss_pred             --EEEEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          120 --ERIIVVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       120 --~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                        ..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence              4899999999999999987643  345899999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  270 (380)
                      |++.......   .......|+..|+|||++..     ..++.++|||||||++|+|++|..||..........      
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------  228 (275)
T cd06608         158 GVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------  228 (275)
T ss_pred             ccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH------
Confidence            9987543221   11234568999999998854     346789999999999999999999997543322111      


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +. ...        ...........+..+.+++.+||..||.+|||+.+++++.|
T Consensus       229 ~~-~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         229 KI-PRN--------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             Hh-hcc--------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence            11 000        00011122335678999999999999999999999999876

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-40  Score=299.32  Aligned_cols=246  Identities=32%  Similarity=0.514  Sum_probs=200.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      ++|++.+.||.|+||.||++.. +++.||+|.+....    ....+.+|+.++++++|||++++++++... ..+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            5689999999999999999975 47889999986542    234678999999999999999999998765 47999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++.......+++..++.++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++......   
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999998766556899999999999999999999988   999999999999999999999999998754321   


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.........       .....+.         
T Consensus       154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~---------  214 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-------ECVEKGY---------  214 (254)
T ss_pred             ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-------HHHhCCC---------
Confidence               112234568999999998899999999999999999998 99999765432211       1111110         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      . .......+..+.+++.+||+.+|..||+++++++.+.
T Consensus       215 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         215 R-MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             C-CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            0 1112234577889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=299.41  Aligned_cols=250  Identities=29%  Similarity=0.403  Sum_probs=196.0

Q ss_pred             CeeeccCceEEEEEEeCC-CC--EEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           54 NKIGEGGSGTVYKGKLKD-GS--IVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      +.||+|+||.||+|.+.+ |.  .+++|.+..... ......+.+|+.++.++ +||||+++++++...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            358999999999999863 44  478888874332 23345688999999999 79999999999999999999999999


Q ss_pred             CCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          130 NGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       130 ~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                      +++|.+++....              ...+++..++.++.+++.||+|||+.|   ++|+||||+||+++.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            999999997532              123788999999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      |++.......    .......+..|+|||++.+..++.++|||||||++|+|++ |..||........       .....
T Consensus       157 gl~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~  225 (270)
T cd05047         157 GLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEKLP  225 (270)
T ss_pred             CCccccchhh----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------HHHHh
Confidence            9986322110    0111224567999999999899999999999999999997 9999965432211       11111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .+..          .......+..+.+++.+||+.+|.+||++.+++..|..+.
T Consensus       226 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         226 QGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCC----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1100          0111224467889999999999999999999999987663

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-40  Score=298.91  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=208.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|++|.||++.++ +++.|++|.+...... .....+.+|+.++++++||||+++++++......++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            46788899999999999999987 5899999998765433 345668899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |+++++|.+++.... ..++...+..++.+++.||.|||+ .+   ++|+||||+||++++++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          80 YMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             ecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            999999999998754 348899999999999999999998 77   9999999999999999999999999987553221


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           .....++..|+|||.+.+..++.++||||||+++|+|++|..||......... ... .........        
T Consensus       156 -----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~--------  220 (265)
T cd06605         156 -----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFE-LLQYIVNEP--------  220 (265)
T ss_pred             -----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHH-HHHHHhcCC--------
Confidence                 11256889999999999999999999999999999999999999754321110 011 111111110        


Q ss_pred             CCCCCCCH-HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASN-MAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .  ..... ..+..+.++|.+||..+|.+||++.+++.+.|-
T Consensus       221 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         221 P--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             C--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence            0  01111 156779999999999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3e-40  Score=304.70  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||.|+||.||++.+. .++.|++|.+...... ......+.+|+.+++.++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47889999999999999999987 4889999998765322 223456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++...+  .+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999997654  3889999999999999999999988   9999999999999999999999999886421100


Q ss_pred             c------------ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 041907          206 A------------VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       206 ~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .            .........++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+..       ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~-------~~~  228 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-------GQV  228 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHH
Confidence            0            000112245788999999999889999999999999999999999999754432111       111


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT---MKKCAEILWKI  327 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~eil~~l~~~  327 (380)
                      ..+..        .........+..+.++|.+||+.+|.+||+   +.+++++.|..
T Consensus       229 ~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~  277 (305)
T cd05609         229 ISDDI--------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL  277 (305)
T ss_pred             Hhccc--------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcccc
Confidence            11100        000111135567899999999999999998   67777777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-40  Score=299.47  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=207.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|.+.+.||.|+||.||++.++ +|..||+|.+............+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999987 488999999876543333345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-eEEccccccccccCCCc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR-AKVTDFGFARMSEEDSA  206 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~  206 (380)
                      +++++|.+++.......+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++. ++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999998765556899999999999999999999988   999999999999998864 69999999876543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......|+..|+|||++.+..++.++||||||+++|+|++|..||........      ..... .+.        .
T Consensus       158 ---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~--------~  219 (257)
T cd08225         158 ---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKIC-QGY--------F  219 (257)
T ss_pred             ---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-ccc--------C
Confidence               12234588999999999988899999999999999999999999975433221      11111 110        0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        .+.....+..+.+++.+||+.+|++||++++++.+.|
T Consensus       220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         220 --APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence              1111234467899999999999999999999998866

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-40  Score=297.68  Aligned_cols=239  Identities=21%  Similarity=0.346  Sum_probs=188.0

Q ss_pred             CeeeccCceEEEEEEeCC-------------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           54 NKIGEGGSGTVYKGKLKD-------------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      +.||+|+||.||+|.+..             ...|++|.+.....  .....+.+|+.++..++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            468999999999998532             23589998765432  234567889999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-------eEEc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR-------AKVT  193 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~-------~kl~  193 (380)
                      .+++|||+++++|..++.... ..+++..++.++.||+.||.|||+.+   ++|+||||+|||++.++.       ++++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999999887543 23899999999999999999999988   999999999999987654       8999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhh-hcCCCCccchhhHHHHHHHHH-hCCCCCCCCCCcchhhHHHHHHH
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMM-TGRYPIESKKPIKERVTIRWAMQ  271 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~  271 (380)
                      |||++.....       .....++..|+|||++. +..++.++|||||||++|+|+ +|..||......+...    .  
T Consensus       155 d~g~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~--  221 (262)
T cd05077         155 DPGIPITVLS-------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----F--  221 (262)
T ss_pred             CCCCCccccC-------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----H--
Confidence            9998865432       12345788999999886 567889999999999999998 5888886543221110    0  


Q ss_pred             hhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                        ..+..        .   ........+.+||.+||+.+|.+||++.+|++.+
T Consensus       222 --~~~~~--------~---~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 --YEGQC--------M---LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --HhcCc--------c---CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              00000        0   0111235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.7e-40  Score=295.51  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||.|++|.||+|.+.. |+.|++|++...... .....+.+|+..+.+++|+|++++++++......+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            468889999999999999999874 999999998766443 345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |+++++|.+++...  ..++...++.++.|++.|+.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          80 YMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             ecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            99999999999865  348999999999999999999998 88   9999999999999999999999999988654322


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      ..   .....++..|+|||.+.+..++.++||||||+++|+|++|..||................    ...        
T Consensus       155 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~--------  219 (264)
T cd06623         155 DQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGP--------  219 (264)
T ss_pred             Cc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCC--------
Confidence            11   123458899999999999999999999999999999999999997665311111111111    100        


Q ss_pred             CCCCCCCHH-HHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASNM-AVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ....... .+..+.+++.+||..+|.+||++.+++++.|.
T Consensus       220 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~  259 (264)
T cd06623         220 --PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI  259 (264)
T ss_pred             --CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence              0111222 55789999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=303.29  Aligned_cols=270  Identities=25%  Similarity=0.358  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||.|++|.||+|.++ +|+.||+|.+....... ....+.+|+.++++++|+||+++++++......++||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            368999999999999999999987 58999999987543221 1234568999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++ +|.+++..... .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++......
T Consensus        83 e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             ecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            99975 99998876543 4889999999999999999999988   9999999999999999999999999987543211


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-HhhccCCcccc--
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM-QCLKAGDAILV--  281 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--  281 (380)
                      .   ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.............+.. ...........  
T Consensus       158 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 K---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            1   1122346889999999876 457899999999999999999999997554221111110000 00000000000  


Q ss_pred             ----cc---cCCCCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 ----MD---PRLRRTP-----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ----~~---~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          ..   ......+     ........+.+++.+||+.+|.+||++.+++.+.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence                00   0000000     00011256789999999999999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.4e-40  Score=301.85  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=208.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|.+.+.||.|+||.||++... ++..|++|.+......  ....+.+|+.++++++||||+++++++......++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            68899999999999999999875 5888999998654332  23557889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++.+..   +++..+..++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........
T Consensus        97 ~~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          97 YLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             cCCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999999997643   788899999999999999999988   99999999999999999999999998875543221


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......+++.|+|||.+.+..++.++|||||||++|++++|..||...........+      .         ....
T Consensus       171 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~---------~~~~  232 (293)
T cd06647         171 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A---------TNGT  232 (293)
T ss_pred             ---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------h---------cCCC
Confidence               122345889999999999888999999999999999999999999765432211100      0         0000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .........+..+.++|.+||+.+|.+||++.+++.+.|...
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~  274 (293)
T cd06647         233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI  274 (293)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            111123345567889999999999999999999999988643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-40  Score=305.36  Aligned_cols=269  Identities=23%  Similarity=0.306  Sum_probs=205.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  124 (380)
                      ++|++.+.||.|+||.||+|.++ +++.+++|.++...........+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57889999999999999999987 588999999976554433344567899999999999999999998877  899999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++ +|.+++..... .+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999975 99998876543 4899999999999999999999988   999999999999999999999999998865542


Q ss_pred             CcceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh-----------
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC-----------  272 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------  272 (380)
                      ..   ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+......           
T Consensus       160 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         160 LK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            11   122345788999999987644 688999999999999999999999866543322211100000           


Q ss_pred             hcc---CCcccccccCCCCCCCCHH-HHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          273 LKA---GDAILVMDPRLRRTPASNM-AVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       273 ~~~---~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ...   ..........+. ...... ....+.++|.+||+.+|++|||++|++.+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             cchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence            000   000000000000 001111 3567889999999999999999999998865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-40  Score=300.89  Aligned_cols=258  Identities=25%  Similarity=0.386  Sum_probs=200.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHH-HhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILT-WSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||++.+. +|+.||+|.+........ ...+..|+.. ++.+.||||+++++++...+..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            47889999999999999999987 599999999876543322 2344455554 56679999999999999999999999


Q ss_pred             EeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          126 EYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       126 e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ||++ ++|.+++...  ....+++..++.++.|++.||.|||++ +   ++|+||||+||+++.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9996 5888887653  224589999999999999999999986 7   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhh----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRT----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ...    ......++..|+|||.+.+    ..++.++|||||||++|+|++|..||........  .+.   ......  
T Consensus       156 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~~---~~~~~~--  224 (283)
T cd06617         156 DSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--QLK---QVVEEP--  224 (283)
T ss_pred             ccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--HHH---HHHhcC--
Confidence            321    1123458889999998865    4568899999999999999999999964322111  111   111000  


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          .+.    ......+.++.++|.+||+.+|.+||++++++++.|-...
T Consensus       225 ----~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         225 ----SPQ----LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             ----CCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence                000    0112345779999999999999999999999999886644

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.3e-40  Score=294.13  Aligned_cols=252  Identities=34%  Similarity=0.526  Sum_probs=203.9

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-C----CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-G----SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +++.+.||.|+||.||++.+.. +    ..||+|.+...... .....+.+|+..+..++|+||+++++++...+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence            4677899999999999999864 3    88999999765433 2456788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.......+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999998755444899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ....  .....++..|+|||.+.+..++.++||||||+++++|++ |..||........   .    .....+..     
T Consensus       157 ~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~----~~~~~~~~-----  222 (258)
T smart00219      157 DYYK--KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---L----EYLKKGYR-----  222 (258)
T ss_pred             cccc--cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcCCC-----
Confidence            2111  112337789999999988889999999999999999998 7888875332211   1    11111110     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                           .......+..+.+++.+||..+|.+|||+.++++.+
T Consensus       223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                 111222567799999999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3e-40  Score=303.06  Aligned_cols=270  Identities=23%  Similarity=0.311  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|++|.||+|.+. +|+.||+|.+............+.+|+.++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999987 58999999987654333334567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEccccccccccCCC
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |+++ +|.+++.......+++..++.++.||+.||.|||+++   ++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9964 8888887655555788888899999999999999988   999999999999985 5679999999997654321


Q ss_pred             cceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC--Ccc---
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG--DAI---  279 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~---  279 (380)
                      .   ......++..|+|||++.+. .++.++|||||||++|+|++|..||......+....+   .......  ...   
T Consensus       158 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~  231 (294)
T PLN00009        158 R---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPGV  231 (294)
T ss_pred             c---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhcccc
Confidence            1   11234578899999998764 5789999999999999999999999865443222111   1100000  000   


Q ss_pred             -cccc-----cCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 -LVMD-----PRLRRT---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 -~~~~-----~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ...+     +.....   ......+..+.+++.+||+.+|++||++.+++++.|-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~  288 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK  288 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence             0000     000000   00112346688999999999999999999999988743

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.3e-40  Score=303.36  Aligned_cols=261  Identities=25%  Similarity=0.404  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|+..+.||+|+||.||+|.+. +|+    .||+|.+..... .....++.+|+.++++++||||+++++++... .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            3467888999999999999999875 344    578898865433 23344688999999999999999999998654 4


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .++++||+++|+|.+++..... .+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence            6789999999999999976542 3888999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........       ......+.. 
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~-  229 (303)
T cd05110         159 LEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGER-  229 (303)
T ss_pred             ccCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCC-
Confidence            5432211 11122345778999999999999999999999999999997 9999975432111       111111110 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                               .+....++..+.+++..||..+|++||+++++++.+..+...
T Consensus       230 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         230 ---------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                     111122345788999999999999999999999999987554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.9e-40  Score=308.95  Aligned_cols=271  Identities=19%  Similarity=0.259  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----  118 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  118 (380)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|.+............+.+|+.++++++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            35688999999999999999999986 589999999875443334445677899999999999999999987543     


Q ss_pred             -CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          119 -DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                       ...++||||+.+ +|.+.+...    ++...+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||+
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence             357999999965 888887643    788899999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH---------
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW---------  268 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------  268 (380)
                      +.......    ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+..         
T Consensus       165 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         165 ARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             ceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            98654321    12234578999999999999999999999999999999999999976543221111100         


Q ss_pred             ------HHH-hhccCC------cccccccCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          269 ------AMQ-CLKAGD------AILVMDPRLRRT---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       269 ------~~~-~~~~~~------~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ... ......      ....+.......   ......+..+.++|.+||+.||.+|||+.|++++.|..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence                  000 000000      000000000000   00123456788999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.3e-40  Score=296.98  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=190.3

Q ss_pred             CeeeccCceEEEEEEeCC---CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLKD---GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|....   ...+++|.+..... ......+.+|+..++.++|+||+++++.+......++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            369999999999997542   45688888765432 23345678899999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCC---CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          131 GTLREHLDGRGG---NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       131 ~~L~~~i~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      |+|.+++.....   ...++...+.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  155 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-  155 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh-
Confidence            999999976542   22467778899999999999999988   99999999999999999999999999865432211 


Q ss_pred             eeeeecccCCccccChhhhhh-------cCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          208 SHISTQVKGTAGYLDPDYLRT-------YQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ........++..|+|||++..       ..++.++|||||||++|+|++ |..||....+.+.   +...   .... ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~---~~~~-~~  228 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQV---VREQ-DI  228 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHHH---hhcc-Cc
Confidence            111123345778999999753       356789999999999999999 7888875543221   1111   1110 00


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                           ...........+..+.+++..|| .+|.+||++++|++.+
T Consensus       229 -----~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         229 -----KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             -----cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence                 11111122234566778888998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-39  Score=296.49  Aligned_cols=255  Identities=25%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +-|++.+.||.|+||.||+|.+. +++.||+|.+...... .....+.+|+..+.+++||||+++++++..+...++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            44677889999999999999876 5889999998654332 334568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|.+++...   .+++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          83 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            99999999998753   3889999999999999999999988   99999999999999999999999999876543211


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......++..|+|||.+.+..++.++|||||||++|+|++|..||..........       ......         
T Consensus       157 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~---------  217 (277)
T cd06641         157 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-------LIPKNN---------  217 (277)
T ss_pred             ---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-------HHhcCC---------
Confidence               1123458889999999998889999999999999999999999997544321111       111110         


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                       ........+..+.+++.+||+.+|.+||++.+++.+.|-...
T Consensus       218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence             011222345678899999999999999999999999876644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4e-40  Score=299.64  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=202.9

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||+|+||+||+|.+. +|+.||+|.+....... .....+..|+.++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999876 58999999987543222 2234467899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++.......+++..++.++.|++.||.|||+.|   ++|+||+|+||++++++.++|+|||++.......    ....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~  153 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KIKG  153 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cccc
Confidence            99998766556899999999999999999999988   9999999999999999999999999987654321    1223


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCH
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN  293 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (380)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|..||...........+..   ....           .....+.
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-----------~~~~~~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTLE-----------MAVEYPD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---cccc-----------ccccCCc
Confidence            4578899999999988899999999999999999999999976544221111110   0000           0111222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHHH
Q 041907          294 MAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKIR  328 (380)
Q Consensus       294 ~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~~  328 (380)
                      ..+..+.++|.+||+.+|.+||     ++.+++.+.|-..
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence            3467789999999999999999     8888999888643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.6e-40  Score=305.68  Aligned_cols=275  Identities=25%  Similarity=0.305  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  123 (380)
                      .++|++.+.||.|+||.||+|.+. +|+.||+|.+............+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999986 599999999875543332233456899999999999999999998754  56899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.....
T Consensus        86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999965 8988887643 34899999999999999999999998   99999999999999999999999999986653


Q ss_pred             CCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc----
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA----  278 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  278 (380)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+......+............    
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         161 PAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             ccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            221   1122345788999999875 45789999999999999999999999866544322221110000000000    


Q ss_pred             ----ccccccCCCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          279 ----ILVMDPRLRRTP----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       279 ----~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          ...+........    ........+.++|.+||+.||++|||+++++.|.|-...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence                000000000000    001135678899999999999999999999999986533

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.7e-40  Score=303.88  Aligned_cols=257  Identities=25%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ..|.....||.|+||.||+|.+. +++.||+|.+......  ....+.+|+..+..++|||++++++++..+...+++||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            34455668999999999999986 5899999998654332  24557899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++++|..++...   .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659          99 FLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             cCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            99999999988653   3889999999999999999999988   99999999999999999999999999875543211


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+......       ......     .. 
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~-----~~-  236 (297)
T cd06659         173 ---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-------LRDSPP-----PK-  236 (297)
T ss_pred             ---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhccCC-----CC-
Confidence               12335689999999999998999999999999999999999999976543221111       111000     00 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                        .......+..+.+++.+||+.+|.+||++++++++.|.....
T Consensus       237 --~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         237 --LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             --ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence              011112346688999999999999999999999998866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.8e-40  Score=299.12  Aligned_cols=250  Identities=34%  Similarity=0.449  Sum_probs=197.8

Q ss_pred             CeeeccCceEEEEEEeCC-------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           54 NKIGEGGSGTVYKGKLKD-------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.||.|+||.||+|.+.+       +..+++|.+..... ......+.+|+.+++.++||||+++++++......+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            368999999999998652       25799998865432 2234568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCC-----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-----ceEEcccc
Q 041907          127 YVGNGTLREHLDGRG-----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-----RAKVTDFG  196 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-----~~kl~Dfg  196 (380)
                      |+++++|.+++....     ...+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++     .++|+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999997532     233788999999999999999999988   99999999999999877     89999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ++........ ........++..|+|||++.++.++.++|||||||++|+|++ |..||......+..       .....
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~  228 (269)
T cd05044         157 LARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL-------QHVTA  228 (269)
T ss_pred             cccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH-------HHHhc
Confidence            9875533211 111122345788999999999999999999999999999998 99999754432211       11111


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +.          ........+..+.+++.+||+.+|.+||++++|++.|.
T Consensus       229 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 GG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            10          01122345678899999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-40  Score=305.52  Aligned_cols=275  Identities=22%  Similarity=0.256  Sum_probs=202.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||||.+............+.+|+.++++++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999987 5899999998654433323344568999999999999999999886654     


Q ss_pred             ---EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          120 ---ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       120 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                         ..++||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               45999999965 8888887653 24899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccccCCCcc-eeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          197 FARMSEEDSAV-SHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       197 ~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ++......... ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||...........+........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99765432211 11122345788999999887654 68899999999999999999999987654333222222111000


Q ss_pred             cCCc-----ccccccCCCCCCC---------CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          275 AGDA-----ILVMDPRLRRTPA---------SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       275 ~~~~-----~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ....     ....+........         .......+.++|.+||+.+|.+|||+++++++.|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence            0000     0000000000000         0011245678999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-40  Score=299.52  Aligned_cols=253  Identities=24%  Similarity=0.310  Sum_probs=208.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +|++.+.||.|+||.||+|.+. ++..||+|.+....... .....+.+|+.++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999987 58999999997653322 345678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+.+++|.+++...  .+++...+..++.+|+.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999775  34899999999999999999999988   9999999999999999999999999987654322 


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...........    ......           
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~-----------  216 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI----RAKQET-----------  216 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH----HHHhcc-----------
Confidence               12335588899999999998899999999999999999999999986654211111    111100           


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh--HHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTM--KKCAEILW  325 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~eil~~l~  325 (380)
                      .....+...+..+.++|.+||+.+|.+||++  ++++++.|
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~  257 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY  257 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence            0111223345789999999999999999999  88877654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=9.5e-40  Score=298.52  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=212.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..+.|++...||.|++|.||+|.+. ++..|++|++.....   ....+.+|+..+++++|+|++++++++......+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            5567889999999999999999987 588999999976543   345678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      +||+++++|.+++.... ..+++..+..++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999998765 34899999999999999999999988   999999999999999999999999988754432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..   ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+......+      . ..        
T Consensus       170 ~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~------~-~~--------  231 (286)
T cd06614         170 KS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI------T-TK--------  231 (286)
T ss_pred             hh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hc--------
Confidence            11   112345788999999999888999999999999999999999999765443211110      0 00        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ..........++..+.++|.+||+.+|.+||++.+++.+.|...
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence            01111122235677999999999999999999999999988665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.7e-40  Score=304.72  Aligned_cols=272  Identities=22%  Similarity=0.315  Sum_probs=203.6

Q ss_pred             Ceeecc--CceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEG--GSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      ..||+|  +||+||++.+. +|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999986 699999999876654444556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+.+............
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999998765556899999999999999999999988   999999999999999999999999865433221111100


Q ss_pred             ----eecccCCccccChhhhhhc--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------------H
Q 041907          211 ----STQVKGTAGYLDPDYLRTY--QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA--------------M  270 (380)
Q Consensus       211 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------------~  270 (380)
                          .....++..|+|||++.+.  .++.++|||||||++|+|++|..||...............              .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                1112356679999999764  4789999999999999999999999765422111000000              0


Q ss_pred             Hh-------hccCCcc---------cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          271 QC-------LKAGDAI---------LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       271 ~~-------~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ..       ...+...         ...+..+ ..+....+...+.+|+.+||+.||++|||+++++++.|-...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence            00       0000000         0000111 122334567889999999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.1e-40  Score=297.96  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=204.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ++|++.+.||.|+||.||+|+.+      +.+.|++|.+..... ......+.+|+.++++++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            67889999999999999999964      245799998865433 23456788999999999999999999999998999


Q ss_pred             EEEEEeCCCCCHHHHhccCCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          122 IIVVEYVGNGTLREHLDGRGG-------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                      ++||||+++++|.+++.....       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            999999999999999976552       14899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhh
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ||++.......  ........++..|+|||.+.+..++.++||||||+++|+|++ |..||........   +    ...
T Consensus       161 ~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~----~~~  231 (275)
T cd05046         161 LSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---L----NRL  231 (275)
T ss_pred             cccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---H----HHH
Confidence            99886433211  111123346778999999998889999999999999999999 8889865432211   1    111


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..+..         ..+....++..+.+++.+||+.+|.+||++.+++..++
T Consensus       232 ~~~~~---------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKL---------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCc---------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11110         01112234567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=298.09  Aligned_cols=262  Identities=26%  Similarity=0.371  Sum_probs=205.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  124 (380)
                      ++|...+.||.|++|.||++.+. +++.||+|.+...... .....+.+|++++++++||||+++++++..  .+..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            46788899999999999999986 5889999998755332 345668899999999999999999998865  3478999


Q ss_pred             EEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          125 VEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |||+++++|.+++...  ....++...+..++.+|+.||.|||+.+   ++|+||+|.||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            9999999999887542  2344888999999999999999999988   9999999999999999999999999986543


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCC--cchhhHHHHHHHhhccCCccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP--IKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ...     .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ........+...    .... 
T Consensus       157 ~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~-  226 (287)
T cd06621         157 NSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNP-  226 (287)
T ss_pred             ccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCch-
Confidence            211     1234578899999999999999999999999999999999999986532  111111111111    0000 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .+..   ........+..+.+++.+||+.+|.+|||+.|++.+.|-
T Consensus       227 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         227 ELKD---EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             hhcc---CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence            0000   011112345778999999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-40  Score=303.07  Aligned_cols=271  Identities=21%  Similarity=0.285  Sum_probs=202.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCE-----
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDE-----  120 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  120 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+............+.+|+.+++.+. |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47889999999999999999987 5899999998765433333456778999999995 6999999999877665     


Q ss_pred             EEEEEEeCCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRG---GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg  196 (380)
                      .+++|||+++ +|.+++....   ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 8988886543   235899999999999999999999988   999999999999998 8899999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ++........   ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.........
T Consensus       157 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9876533211   1122346888999998865 45789999999999999999999999865544322211110000000


Q ss_pred             CCcccccc-------cCCCC---CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          276 GDAILVMD-------PRLRR---TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       276 ~~~~~~~~-------~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ........       +....   .......+..+.++|.+||+.+|.+||++++++.+.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            00000000       00000   0001234577889999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=302.81  Aligned_cols=269  Identities=25%  Similarity=0.322  Sum_probs=204.1

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      |++.+.||.|++|.||+|.+. +|..||+|++............+.+|+.++++++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999986 6999999998765433333345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      + ++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 59999998766455899999999999999999999988   99999999999999999999999999876543211  


Q ss_pred             eeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC---------Cc
Q 041907          209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG---------DA  278 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  278 (380)
                       ......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+..........         ..
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             11223468899999988664 56889999999999999999999997665433221111000000000         00


Q ss_pred             cccccc--CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          279 ILVMDP--RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       279 ~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ...+..  ...........+..+.++|.+||+.+|.+||++++++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence            000000  00000011223467889999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=297.70  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=212.4

Q ss_pred             CCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           51 SPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      .++++||+|.||.||+|.++ .|..+|||.+....    -+.++..|+.+++++..++||++||.|-....++||||||.
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            44688999999999999987 59999999987653    35678899999999999999999998888889999999999


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      .|++.+.++.+. .++.+.++..++...++||+|||...   -+|||||..|||++.+|.+||+|||.+..+.+.   -.
T Consensus       112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT---MA  184 (502)
T KOG0574|consen  112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT---MA  184 (502)
T ss_pred             CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh---HH
Confidence            999999987664 45999999999999999999999877   899999999999999999999999998765431   11


Q ss_pred             eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT  289 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                      ...++.||+.|||||++..-.|+.++||||||++..||..|++||.+-.+....+.+.               .....-.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~PPPTF  249 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TKPPPTF  249 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CCCCCCC
Confidence            2346789999999999999999999999999999999999999998877654322211               0000011


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          290 PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       290 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ..++..+.++.++|+.||-..|++|-|+-++++|.+-
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi  286 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFI  286 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence            2356778899999999999999999999999998764

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=311.50  Aligned_cols=270  Identities=23%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----D  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|.+..... ......+.+|+.++++++|+||+++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            3578999999999999999999976 589999999864322 22345677899999999999999999987544     3


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++++||+.+ +|.+++...   .+++..++.++.|++.||.+||+.|   ++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            57999999965 888888654   3899999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC--
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG--  276 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  276 (380)
                      ................|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........   ........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCCH
Confidence            65432221112234568999999998754 5688999999999999999999999975432211110   00000000  


Q ss_pred             -Cc-----------ccccccCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 -DA-----------ILVMDPRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 -~~-----------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ..           ....... ...+   ........+.+++.+||+.+|.+|||+.+++++.|-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~  296 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFK-PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE  296 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcC-CcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence             00           0000000 0000   0012346788999999999999999999999998743

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.9e-40  Score=292.99  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=211.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|.+.+.||.|+||.||++.+. ++..|++|++............+.+|++.++.++|+|++++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999986 589999999987665555566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          128 VGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       128 ~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      +++++|.+++....  ...+++..+..++.+++.||.+||+.|   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998753  355899999999999999999999988   9999999999999999999999999988655432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                         .......|++.|+|||.+.+..++.++||||||+++++|++|..||.........       .......        
T Consensus       158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~--------  219 (258)
T cd08215         158 ---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-------LKILKGQ--------  219 (258)
T ss_pred             ---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-------HHHhcCC--------
Confidence               1233456889999999999999999999999999999999999999765422111       1111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        ..+.+...+..+.+++.+||..+|.+||++.+++++.|
T Consensus       220 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         220 --YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence              01112244567899999999999999999999998865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.2e-40  Score=298.47  Aligned_cols=238  Identities=24%  Similarity=0.396  Sum_probs=186.3

Q ss_pred             eeeccCceEEEEEEeCC-------------------------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCcee
Q 041907           55 KIGEGGSGTVYKGKLKD-------------------------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV  109 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  109 (380)
                      .||+|+||.||+|.+..                         ...|++|++.....  .....+.+|+.+++.++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence            59999999999997421                         13588998865432  2345678899999999999999


Q ss_pred             ceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-
Q 041907          110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-  188 (380)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-  188 (380)
                      ++++++......++||||+++++|..++.... ..+++..+..++.||+.||.|||+.+   ++||||||+|||++..+ 
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            99999999999999999999999999987543 24888999999999999999999988   99999999999997643 


Q ss_pred             ------ceEEccccccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHH-hCCCCCCCCCCc
Q 041907          189 ------RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMM-TGRYPIESKKPI  260 (380)
Q Consensus       189 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell-tg~~p~~~~~~~  260 (380)
                            .++++|||++......       ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+.
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             ccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence                  3899999987643221       12347788999998875 56889999999999999985 699999765433


Q ss_pred             chhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          261 KERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                      .....    ...            ...   .+......+.++|.+||+.+|.+||++++|++.|
T Consensus       229 ~~~~~----~~~------------~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         229 EKERF----YEK------------KHR---LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHH----HHh------------ccC---CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            21111    000            000   0111224688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=295.76  Aligned_cols=252  Identities=26%  Similarity=0.435  Sum_probs=203.6

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC---CCceeceEEEEEeCCEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE---HLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv  124 (380)
                      .|++.+.||.|+||.||+|.+. +++.|++|.+...... ....++.+|+.+++++.   |||++++++++......++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD-DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            5778899999999999999975 5899999998754332 23456788999998886   99999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...   .+++..++.++.+++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          81 MEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             EecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999999998654   4889999999999999999999988   999999999999999999999999998866543


Q ss_pred             CcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..   ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||..........       .....     ..
T Consensus       155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~-----~~  219 (277)
T cd06917         155 SS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKS-----KP  219 (277)
T ss_pred             cc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccC-----CC
Confidence            21   12334688999999998754 46889999999999999999999997644321100       00000     00


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      +.+    .....+..+.+++.+||+.+|.+||++.+++.+.|.
T Consensus       220 ~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         220 PRL----EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             CCC----CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence            000    111245678999999999999999999999998885

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.6e-39  Score=300.20  Aligned_cols=254  Identities=25%  Similarity=0.364  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .+.|++.+.||+|+||.||+|.+. +|+.||+|.+.... ........+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356889999999999999999986 58999999986443 2233445688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          94 MEYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HHhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            999974 7877776443 24899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CcceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                             ....++..|+|||++.   ...++.++||||||+++|+|++|..||...........       .....    
T Consensus       169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-------~~~~~----  230 (307)
T cd06607         169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IAQND----  230 (307)
T ss_pred             -------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-------HhcCC----
Confidence                   2345788999999874   45688999999999999999999999976543221111       00000    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                           ........++..+.+++.+||+.+|.+||++.+|+.+.|...
T Consensus       231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  272 (307)
T cd06607         231 -----SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR  272 (307)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                 011112345678999999999999999999999999988553

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.6e-39  Score=294.90  Aligned_cols=257  Identities=25%  Similarity=0.384  Sum_probs=201.5

Q ss_pred             CCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC------
Q 041907           50 FSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD------  119 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  119 (380)
                      |.+.+.||+|+||.||+|.+.    +++.||||++...........++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            667889999999999999864    3688999999876555555667889999999999999999999886532      


Q ss_pred             EEEEEEEeCCCCCHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRG----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                      ..+++++|+.+|+|.+++....    ...++...++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            3478899999999998875321    124788899999999999999999988   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      |+++....... ........++..|++||.+.+..++.++|||||||++|+|++ |..||........   ..+    ..
T Consensus       158 g~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~----~~  229 (273)
T cd05074         158 GLSKKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNY----LI  229 (273)
T ss_pred             cccccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHH----HH
Confidence            99886543221 111122345678999999999899999999999999999999 8889875433211   111    11


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....          .......+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       230 ~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 KGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1100          011123446799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=319.14  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=209.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|.+...||.|+||.||+|..++ +-..|.|++....  ...+.++.-|+.+|..+.||+||++++.|..++.++|+.|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            456778889999999999999885 5556677775433  3457789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ||.||-++..+-..+ ..+.+.++..++.+++.||.|||+.+   |||||||..|||++.+|.++|+|||.+.....   
T Consensus       110 FC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~---  182 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS---  182 (1187)
T ss_pred             ecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh---
Confidence            999999988887765 45999999999999999999999888   99999999999999999999999998764321   


Q ss_pred             ceeeeecccCCccccChhhh-----hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          207 VSHISTQVKGTAGYLDPDYL-----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .......++||+.|||||+.     ...+|+.++||||||++|.||..+.+|-...++......+.    .         
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia----K---------  249 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----K---------  249 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh----h---------
Confidence            11123467899999999986     45789999999999999999999999987666543322211    0         


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      -++..  .-.+..+...+.+++.+||..||..||++.++++|.|--
T Consensus       250 SePPT--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  250 SEPPT--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             cCCCc--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            11111  123456778899999999999999999999999998853

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.1e-41  Score=313.14  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             CCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC--cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE--EEEEE
Q 041907           51 SPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK--HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE--RIIVV  125 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  125 (380)
                      ++...||+|+|.+||+|.+. +|-.||--.++...  ..+.....|..|+.+|+.|+||||+++|+++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            56788999999999999987 48777765554332  233445779999999999999999999999877554  78999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~  204 (380)
                      |.+..|+|+.|+.+.+.  .+...+..|++||++||.|||.+. +||+|||||-+||+|+.+ |.|||+|+|+|......
T Consensus       123 EL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            99999999999998876  888899999999999999999984 899999999999999854 89999999999986643


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .     ...++||+.|||||++. ..|+..+||||||+.++||+|+.+||.--....  ..++.....+.+..+..+   
T Consensus       200 ~-----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV---  268 (632)
T KOG0584|consen  200 H-----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKV---  268 (632)
T ss_pred             c-----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhcc---
Confidence            2     34478999999999998 689999999999999999999999996332211  112222222222221111   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                                .-.+++++|.+||.. ..+|||+.|+|.+.+.-
T Consensus       269 ----------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~  300 (632)
T KOG0584|consen  269 ----------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFD  300 (632)
T ss_pred             ----------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence                      124688999999999 99999999999987754

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=289.22  Aligned_cols=262  Identities=24%  Similarity=0.331  Sum_probs=213.5

Q ss_pred             HhcCCCCC-CeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe----C
Q 041907           46 ATENFSPA-NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH----G  118 (380)
Q Consensus        46 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~  118 (380)
                      ++++|++. +.||-|--|.|-.+..+ +|+.+|+|++....       ..++|+++.-.. .|||||.++++|++    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            56677654 56899999999999987 69999999997542       345778776554 79999999998754    4


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDF  195 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Df  195 (380)
                      ..+.+|||.++||.|+..|++++...+++.++..|++||+.|+.|||+.+   |.||||||+|+|+...   -.+||+||
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence            56789999999999999999999999999999999999999999999988   9999999999999754   46999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      |+|+.....    ....+.+-|+.|.|||++....|+...|+||+||++|-||+|.+||.........-.++.   .+..
T Consensus       209 GFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~---rI~~  281 (400)
T KOG0604|consen  209 GFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKR---RIRT  281 (400)
T ss_pred             ccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHh---Hhhc
Confidence            999875532    234567899999999999999999999999999999999999999987654221111110   0111


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      +       .--...+.+...++...++|+..|..+|.+|.|+.+++++.|-.....
T Consensus       282 g-------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  282 G-------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             c-------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            1       111235567788999999999999999999999999999999665443

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=299.59  Aligned_cols=268  Identities=24%  Similarity=0.308  Sum_probs=208.3

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      |.+.+.||.|++|.||+|.+. +|+.+++|.+............+.+|+.++++++|+||+++++++......+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            677889999999999999986 6899999998766544444567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++ +|.+++.... ..+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~---  152 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV---  152 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence            76 8888887654 34899999999999999999999988   9999999999999999999999999987665432   


Q ss_pred             eeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc----
Q 041907          209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD----  283 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  283 (380)
                      .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+................+    
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            112234578899999999876 788999999999999999999999976654332221111000000000000000    


Q ss_pred             --------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 --------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 --------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                              ............+.++.++|.+||+.+|.+||++.+++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence                    000001112345678999999999999999999999999876

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-39  Score=289.83  Aligned_cols=252  Identities=28%  Similarity=0.448  Sum_probs=207.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      .|.+.+.||.|++|.||++.+. +++.+++|++.....  .....+.+|+..+++++|+|++++++++......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            4778899999999999999987 588999999976544  2356788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++.... ..+++..+..++.+++.+|.+||..|   ++|+||+|+||++++++.++|+|||.+........ 
T Consensus        79 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          79 CSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999999998763 34899999999999999999999988   99999999999999999999999999876654321 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|..||.............   .    ..        ..
T Consensus       154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~--------~~  215 (253)
T cd05122         154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T----NG--------PP  215 (253)
T ss_pred             ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h----cC--------CC
Confidence               234568899999999998889999999999999999999999997654322211110   0    00        00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ........+..+.+++.+||+.+|.+|||+.+++++.|
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            01111123567999999999999999999999998764

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2e-39  Score=293.59  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=202.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeCC--CCEEEEEEccccC--------cchHHHHHHHHHHHHHhc-CCCCceeceEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKD--GSIVAVKRARKNK--------HDKCLLLEFKNEILTWSK-IEHLNLVKLFGFLEH  117 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  117 (380)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+....        .......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999864  6889999886432        122334556788888865 799999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                      .+..+++|||+++++|.+++...  ....+++..++.++.|++.+|.|||. .+   ++|+||+|.||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542  23458899999999999999999995 66   99999999999999999999999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ||++.......    ......|+..|+|||.+.+..++.++||||||+++|+|++|..||..........       ...
T Consensus       158 fg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~-------~~~  226 (269)
T cd08528         158 FGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT-------KIV  226 (269)
T ss_pred             ccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH-------HHh
Confidence            99998654432    2234568999999999999889999999999999999999999997543321111       111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+..        . .......+..+.++|.+||+.||.+||++.|+..++.
T Consensus       227 ~~~~--------~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EAVY--------E-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hccC--------C-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1100        0 0011134567899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-41  Score=314.61  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=205.8

Q ss_pred             eeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           55 KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      .||+|.||+||-|++.+ ...+|||.+......  ...-+++|+.+.++|+|.|||+++|.+.+++..-|.||.++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr--~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR--EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch--hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            58999999999999875 667999999765432  345688999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEccccccccccCCCcceee
Q 041907          134 REHLDGRGGNGL--ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       134 ~~~i~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      .++++..=+ ++  ++..+-.+.+||++||.|||...   |||||||-.||||+ -.|.+||+|||-++.+..   .+..
T Consensus       660 SsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg---inP~  732 (1226)
T KOG4279|consen  660 SSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG---INPC  732 (1226)
T ss_pred             HHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc---CCcc
Confidence            999987533 24  77788889999999999999887   99999999999997 468899999998886543   2333


Q ss_pred             eecccCCccccChhhhhhcC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      ..++.||+.|||||++..++  |..++|||||||++.||.||++||.-....+.        .++.       +.--...
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFk-------VGmyKvH  797 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFK-------VGMYKVH  797 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhh-------hcceecC
Confidence            45677999999999998664  78899999999999999999999964433221        0111       1111223


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+.+...+.+...+|.+|+.++|.+||++.++++.++..
T Consensus       798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence            567888999999999999999999999999999987643

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-40  Score=297.48  Aligned_cols=239  Identities=23%  Similarity=0.365  Sum_probs=187.8

Q ss_pred             CeeeccCceEEEEEEeCC-C-------CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           54 NKIGEGGSGTVYKGKLKD-G-------SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.||.|+||.||+|.+.. +       ..|++|.+....  ......+.+|+.+++.+.||||+++++++......++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            469999999999998752 2       348888875432  223456788999999999999999999999989999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--------eEEccccc
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR--------AKVTDFGF  197 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~--------~kl~Dfg~  197 (380)
                      ||+++|+|.+++..... .+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.        ++++|||+
T Consensus        79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999976543 4889999999999999999999988   999999999999987765        69999998


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHhhcc
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGR-YPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      +......       ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||....+.....       ....
T Consensus       155 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~  220 (258)
T cd05078         155 SITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED  220 (258)
T ss_pred             ccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc
Confidence            7654321       23457889999999986 45789999999999999999985 5655433221110       0000


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                               ..   ..+.....++.+++.+||+.+|.+|||++++++.|
T Consensus       221 ---------~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         221 ---------RH---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---------cc---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     00   01112235688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.7e-40  Score=301.35  Aligned_cols=274  Identities=24%  Similarity=0.329  Sum_probs=205.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----  119 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  119 (380)
                      ...++|++.+.||.|+||.||+|.++ +|+.||+|+++...........+.+|+.++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999987 4899999999765433333445678999999999999999999887654    


Q ss_pred             ------EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          120 ------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       120 ------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                            ..++|+||+++ +|..++.... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence                  78999999976 7878776643 34899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      |||++........  .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus       159 dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         159 DFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             cccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999886644321  111223467789999988653 5688999999999999999999999765543322222111100


Q ss_pred             hccCCcccc--------cccCCC----CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          273 LKAGDAILV--------MDPRLR----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       273 ~~~~~~~~~--------~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .........        .+....    ........+..+.+++..||+.+|.+||++++++.+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            000000000        000000    00011123577899999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.4e-40  Score=300.40  Aligned_cols=269  Identities=23%  Similarity=0.292  Sum_probs=200.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +.++|.+.+.||+|+||.||+|... +|+.|++|.+....... ....+.+|+.+++.++|+||+++++++......++|
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3578999999999999999999976 58899999987553322 223466899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+. ++|.+++.... ..+.+..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.....
T Consensus        82 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             Eeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            99996 57877765443 23778888899999999999999988   999999999999999999999999998754322


Q ss_pred             CcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc--c------
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK--A------  275 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~------  275 (380)
                      ..   ......++..|+|||++.+. .++.++|||||||++|+|++|..||.........  +........  .      
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         157 SQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHHHHHHcCCCChhhhhh
Confidence            11   11234478999999998764 5788999999999999999999999765432111  111111000  0      


Q ss_pred             -----CCccccccc----CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          276 -----GDAILVMDP----RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       276 -----~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .........    ..............+.+++.+|++.||.+|||+++++.+.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence                 000000000    00000000012356789999999999999999999998765

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=300.59  Aligned_cols=273  Identities=20%  Similarity=0.272  Sum_probs=201.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeCC---CCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKD---GSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  122 (380)
                      +|++.+.||+|+||.||+|.+..   ++.||+|.+.... ........+.+|+.++.+++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999853   7899999998643 1122234567899999999999999999999888  8899


Q ss_pred             EEEEeCCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC----CCceEEccc
Q 041907          123 IVVEYVGNGTLREHLDGRG---GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE----KLRAKVTDF  195 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~----~~~~kl~Df  195 (380)
                      +||||+++ +|.+++....   ...++...++.++.|++.||.|||+.+   ++|+||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7877775332   235889999999999999999999988   999999999999999    899999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcch------hhHHHH
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE------RVTIRW  268 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~------~~~~~~  268 (380)
                      |++.................++..|+|||++.+. .++.++|||||||++++|++|..||........      ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            9988664432211122345678999999988764 578999999999999999999999976543320      011111


Q ss_pred             HHHhhccC------------Cccccccc-CCCCCC--CC-H------HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          269 AMQCLKAG------------DAILVMDP-RLRRTP--AS-N------MAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       269 ~~~~~~~~------------~~~~~~~~-~~~~~~--~~-~------~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ....+...            ......+. .....+  .. .      .....+.+++.+||+.+|++|||+.|++++.|
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            11111000            00000000 000000  00 0      23356889999999999999999999998865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.7e-39  Score=296.86  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=204.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|...+.||.|++|.||++.+. +++.+++|.+.....  .....+.+|+.+++.++||||+++++++...+..++++||
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            4555679999999999999975 588999998864432  2344578999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++...   .+++..++.++.+++.||.+||+.|   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648          98 LEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999999999872   3889999999999999999999988   99999999999999999999999998875443211 


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                        ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+......+       ..+..     +.  
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~-------~~~~~-----~~--  234 (285)
T cd06648         171 --RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI-------RDNLP-----PK--  234 (285)
T ss_pred             --ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH-------HhcCC-----CC--
Confidence              122345889999999999989999999999999999999999999764432211111       11000     00  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       .......+..+.+++.+||+.+|.+||++.+++++.|..
T Consensus       235 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  273 (285)
T cd06648         235 -LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA  273 (285)
T ss_pred             -CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence             011112446799999999999999999999999987743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-39  Score=292.84  Aligned_cols=237  Identities=27%  Similarity=0.403  Sum_probs=189.3

Q ss_pred             CeeeccCceEEEEEEeCC-C----------CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           54 NKIGEGGSGTVYKGKLKD-G----------SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +.||+|+||.||+|.+.+ +          ..+++|.+......   ...+.+|+.++++++||||+++++++.. ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            469999999999999874 3          25788877654322   4568899999999999999999999988 7789


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-------ceEEccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-------RAKVTDF  195 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-------~~kl~Df  195 (380)
                      +||||+++++|.+++..... .+++..++.++.||+.||.|||+++   ++|+||||+||+++.++       .++|+||
T Consensus        77 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999999987553 4889999999999999999999988   99999999999999887       7999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhc--CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHh
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY--QLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      |++.....       .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||...........   . . 
T Consensus       153 g~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~-~-  220 (259)
T cd05037         153 GIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---Y-Q-  220 (259)
T ss_pred             Cccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---H-h-
Confidence            99875432       1223467789999999876  78899999999999999999 5788866542211110   0 0 


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                        ..        .....+.    ...+.+++.+||+.+|.+||++.++++.|
T Consensus       221 --~~--------~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 --DQ--------HRLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             --cC--------CCCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              00        0000111    16788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6e-40  Score=306.58  Aligned_cols=276  Identities=21%  Similarity=0.281  Sum_probs=207.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe----CCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  121 (380)
                      .++|++.+.||.|+||.||+|... +|+.||+|++............+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999986 59999999987654333345567789999999999999999988753    3568


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+. ++|.+++.....  +++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999995 589999876543  899999999999999999999988   999999999999999999999999998765


Q ss_pred             cCCCcc-eeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------
Q 041907          202 EEDSAV-SHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ--------  271 (380)
Q Consensus       202 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------  271 (380)
                      ...... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.....        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            432211 111234568899999999865 4688999999999999999999999976544322111100000        


Q ss_pred             hhccCCcccccccCCCCCCC-----CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPA-----SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ...........+........     ....+..+.++|.+||+.+|.+||++.+++.+.|.-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence            00000000000000000001     1224678999999999999999999999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-39  Score=289.61  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=211.5

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERIIVV  125 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  125 (380)
                      +|.+.+.||+|++|.||+|.+. +++.|++|++............+.+|+..+++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999987 689999999977655445567789999999999999999999999988  8999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....  .+++..++.++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999998765  4899999999999999999999988   9999999999999999999999999988765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .. .......++..|+|||.+.+..++.++||||||+++++|++|..||........  .   ......          .
T Consensus       156 ~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~~----------~  219 (260)
T cd06606         156 TG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--A---LYKIGS----------S  219 (260)
T ss_pred             cc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--H---HHhccc----------c
Confidence            11 012345688999999999988899999999999999999999999976551110  0   000000          0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ......+...+..+.+++.+||+.+|.+||++.+++.+.|
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence            0111223344678999999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=292.02  Aligned_cols=256  Identities=21%  Similarity=0.317  Sum_probs=203.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC---cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK---HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  121 (380)
                      .+|++.+.||+|+||.||+|.+. +|..|++|.+....   ........+.+|+.++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999999986 58999999875431   1223455688999999999999999999988663  568


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      +++|||+++++|.+++...+.  +++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            899999999999999976543  788899999999999999999988   999999999999999999999999999865


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..............++..|+|||++.+..++.++|||||||++|+|++|..||.........      .+.....     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~-----  225 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FKIATQP-----  225 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HHHHcCC-----
Confidence            32111111122356889999999999988999999999999999999999999754332211      1111000     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .....+......+.+++.+||+ +|..||++.+++.|++
T Consensus       226 -----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         226 -----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             -----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence                 0112234456779999999999 5799999999988753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-39  Score=295.64  Aligned_cols=249  Identities=21%  Similarity=0.286  Sum_probs=193.4

Q ss_pred             eeeccCceEEEEEEeC-CCCEEEEEEccccCcchH-HHHHHHHHHHH---HhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           55 KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNEILT---WSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      .||+|+||.||++.+. +|+.||+|.+........ ....+.+|..+   +....|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999986 589999999876433211 11223344333   334479999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      +++|.+++...+.  +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----  151 (279)
T cd05633          81 GGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (279)
T ss_pred             CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence            9999999876543  899999999999999999999988   9999999999999999999999999987543221    


Q ss_pred             eeecccCCccccChhhhh-hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                       .....|+..|+|||.+. +..++.++|||||||++|+|++|..||.......... +.   .....      .     .
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~---~~~~~------~-----~  215 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID---RMTLT------V-----N  215 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HH---HHhhc------C-----C
Confidence             12345899999999986 4568899999999999999999999997544322111 11   10000      0     0


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKIR  328 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~~  328 (380)
                      ...+...+..+.++|.+||+.+|.+||     +++++++|+|...
T Consensus       216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            112234567889999999999999999     6999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.9e-40  Score=308.18  Aligned_cols=273  Identities=21%  Similarity=0.285  Sum_probs=205.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----D  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  119 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||.+............+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3468999999999999999999976 589999999875433333345667899999999999999999987644     3


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++++||+. ++|.+++...+  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            5799999996 68999887653  3899999999999999999999988   9999999999999999999999999988


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh------
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC------  272 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------  272 (380)
                      ......   .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+......      
T Consensus       157 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         157 TTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             ccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            654321   11233457889999998865 46889999999999999999999999765432211111100000      


Q ss_pred             --hccCCcccccc-----cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 --LKAGDAILVMD-----PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 --~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        .........+.     ...........++..+.++|.+||+.+|++|||+++++++.|..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~  295 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA  295 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence              00000000000     00000001123457789999999999999999999999998854

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.3e-39  Score=297.06  Aligned_cols=269  Identities=24%  Similarity=0.354  Sum_probs=203.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|++|.||+|.+. +|..||||.+...... .....+.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            5888999999999999999987 5899999998765432 2234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          128 VGNGTLREHLDGRG-GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       128 ~~~~~L~~~i~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      +++ +|.+++.... ...+++..+..++.|++.||.|||+.|   ++|+||+|+||++++++.++|+|||++........
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            985 8988886544 235899999999999999999999988   99999999999999999999999999875433211


Q ss_pred             ceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc-----cc
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA-----IL  280 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  280 (380)
                         ......++..|++||++.+. .++.++|||||||++|+|++|..||......+....+............     ..
T Consensus       156 ---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 ---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             ---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence               11234578899999998664 4688999999999999999999999866543322211100000000000     00


Q ss_pred             ccccCCCC------CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          281 VMDPRLRR------TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       281 ~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ........      .......+..+.+++.+||+.+|.+||++.+++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  283 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW  283 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            00000000      0001123567889999999999999999999998765

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.3e-39  Score=292.13  Aligned_cols=248  Identities=25%  Similarity=0.311  Sum_probs=202.6

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||.|++|.||+|.+. +++.|++|++...... ......+.+|+.++++++||||+++++++......+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999987 4899999999765432 23445688999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++.....  ++...+..++.+|+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......    ....
T Consensus        81 ~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----~~~~  151 (262)
T cd05572          81 WTILRDRGL--FDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----KTWT  151 (262)
T ss_pred             HHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----cccc
Confidence            999976543  889999999999999999999988   9999999999999999999999999988665422    1223


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCH
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN  293 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (380)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|..||.......... .   ..... +         ......+.
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~---~~~~~-~---------~~~~~~~~  217 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI-Y---NDILK-G---------NGKLEFPN  217 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH-H---HHHhc-c---------CCCCCCCc
Confidence            468899999999988889999999999999999999999997655311111 1   11110 0         00111222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          294 MAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       294 ~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                      ..+..+.++|.+||+.+|.+||+     ++|++++.|-
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            23678999999999999999999     9999999884

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.8e-40  Score=298.69  Aligned_cols=258  Identities=26%  Similarity=0.363  Sum_probs=199.5

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +|...+.||+|+||.||++.+. +|+.||+|.+...... .....+.+|+..+.++. |+||+++++++......+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4556788999999999999986 5899999998765433 33456789999999996 9999999999999999999999


Q ss_pred             eCCCCCHHHHh---ccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          127 YVGNGTLREHL---DGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       127 ~~~~~~L~~~i---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |+.. +|.++.   .......+++..+..++.+++.||.|||+. +   ++||||||+||+++.++.++|+|||++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 655543   333334589999999999999999999973 6   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhc---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ...    ......|+..|+|||++.+.   .++.++|||||||++|+|++|..||......     ........ .+.  
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~-~~~--  227 (288)
T cd06616         160 DSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVV-KGD--  227 (288)
T ss_pred             cCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhhc-CCC--
Confidence            321    11234588999999999876   6889999999999999999999999754311     00011110 000  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         .+.+. .......+..+.+|+.+||+.+|.+|||+++|+.+.|..
T Consensus       228 ---~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         228 ---PPILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             ---CCcCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence               01111 111233567899999999999999999999999998853

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=297.17  Aligned_cols=269  Identities=25%  Similarity=0.333  Sum_probs=204.8

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERIIVVE  126 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  126 (380)
                      |++.+.||.|++|.||+|.+.+ |+.||+|.+............+.+|+.++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6778999999999999999874 88999999987643333445678999999999999999999999888  89999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++ +|.+++.... ..+++..++.++.+|+.||.+||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8999887653 34899999999999999999999988   99999999999999999999999999986654321


Q ss_pred             ceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc--
Q 041907          207 VSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD--  283 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  283 (380)
                        .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+................+  
T Consensus       156 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         156 --ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             --ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence              11223456889999998765 4578999999999999999999999986654332222111100000000000000  


Q ss_pred             --cCCC-CCC--------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 --PRLR-RTP--------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 --~~~~-~~~--------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                        .... ...        ....++..+.+++.+||+.+|.+||++++++++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence              0000 000        00112567889999999999999999999998866

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.2e-39  Score=290.84  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=209.0

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||.|+||.||++.+. +++.+++|.+............+.+|+.++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788999999999999999876 588999999976554444556678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          128 VGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       128 ~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      +++++|.+++....  ...+++..++.++.+++.||.|||+.|   ++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986632  244889999999999999999999988   999999999999999999999999999876543 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                          ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........       ....+         
T Consensus       157 ----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-------~~~~~---------  216 (256)
T cd08530         157 ----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-------KVQRG---------  216 (256)
T ss_pred             ----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHhcC---------
Confidence                1223458889999999999999999999999999999999999997654321111       11111         


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                       ...........++.+++.+||+.+|.+||++.++++++
T Consensus       217 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         217 -KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             -CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence             01122335667899999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.6e-39  Score=296.98  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.|...+.||+|+||.||++.+. +|..||+|++..... .......+.+|+.++++++|+|++++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34778899999999999999976 589999999865432 2234456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++ +|.+.+.... .++++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....  
T Consensus       105 e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         105 EYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             eCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            99975 7877775443 34899999999999999999999988   99999999999999999999999998875432  


Q ss_pred             cceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                           .....|+..|+|||++.   .+.++.++|||||||++|+|++|..||...........      .....      
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~~~------  240 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNE------  240 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHhcc------
Confidence                 12345888999999974   45688999999999999999999999875432221111      00000      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          .........+..+.+++.+||+.+|.+||++.++++++|....
T Consensus       241 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         241 ----SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ----CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                0011122345678999999999999999999999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.4e-39  Score=298.80  Aligned_cols=270  Identities=21%  Similarity=0.257  Sum_probs=201.2

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      +.+.+|.|+++.|+++.. +|+.||||++............+.+|+..+++++|+||+++++++......+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555444 5899999999876444455677999999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc----
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV----  207 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----  207 (380)
                      +|.+++.......+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999998765555889999999999999999999988   999999999999999999999999988654321110    


Q ss_pred             eeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc----cC-----
Q 041907          208 SHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK----AG-----  276 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~-----  276 (380)
                      ........++..|+|||++.+  ..++.++|||||||++|+|++|..||.........  +........    ..     
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhh
Confidence            111123457889999999876  35889999999999999999999999865432211  111000000    00     


Q ss_pred             --Cccc----cccc---CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 --DAIL----VMDP---RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 --~~~~----~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        ....    ..+.   .............++.+++.+||+.+|.+|||+++++++.|-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~  299 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK  299 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence              0000    0000   0011223344567889999999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=294.58  Aligned_cols=268  Identities=25%  Similarity=0.301  Sum_probs=202.6

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEEeCCE-----
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLEHGDE-----  120 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  120 (380)
                      |++.+.||.|+||.||+|.++. ++.||+|+++...........+.+|+.++.++   .|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6778899999999999999874 89999999976544333334456677766655   69999999999988776     


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++|||+++ +|.+++.......+++..++.++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8999887755445899999999999999999999988   99999999999999999999999999877


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc-
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI-  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  279 (380)
                      ......    .....++..|+|||++.+..++.++|||||||++|+|++|..||......+....+............. 
T Consensus       157 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            543221    123347889999999999999999999999999999999999998655433221111000000000000 


Q ss_pred             ------cccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          280 ------LVMDPRLRR--TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       280 ------~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                            ..+......  ..........+.++|.+||+.+|.+||++++++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence                  000000000  0111234577889999999999999999999998765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.7e-39  Score=291.09  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=199.4

Q ss_pred             HHHHHHHhcCCCCCCee--eccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEE
Q 041907           40 FEEIYKATENFSPANKI--GEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFL  115 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  115 (380)
                      +.+.....++|.+.+.+  |.|+||.||++..+ +|..+|+|.+.......       .|+.....+ +|+|++++++.+
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEE
Confidence            34455556778887777  99999999999976 58899999986543221       122222212 799999999999


Q ss_pred             EeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEcc
Q 041907          116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTD  194 (380)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~D  194 (380)
                      ...+..++||||+++++|.+++....  .+++..++.++.|+++||.|||+.|   ++|+||||+||+++.++ .++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            99999999999999999999997754  4899999999999999999999988   99999999999999988 999999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ||++......       ....++..|+|||++.+..++.++||||||+++|+|++|..||........  ......... 
T Consensus       154 fg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~-  223 (267)
T PHA03390        154 YGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKRQ-  223 (267)
T ss_pred             CccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHhh-
Confidence            9998765422       223588999999999999999999999999999999999999985433211  111111110 


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-MKKCAEILW  325 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~eil~~l~  325 (380)
                      .           ...+.....+..+.++|.+||+.+|.+||+ +++++++.|
T Consensus       224 ~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~  264 (267)
T PHA03390        224 Q-----------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF  264 (267)
T ss_pred             c-----------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence            0           011222346678999999999999999996 699999877

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-40  Score=306.21  Aligned_cols=273  Identities=22%  Similarity=0.267  Sum_probs=209.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----EEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----ERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  122 (380)
                      +|++.+.||.|++|.||+|.+. +|+.|++|.+............+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999987 4899999998765433344566889999999999999999999987765     789


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ++|||+++ +|.+++....  .+++..++.++.+|+.||.+||+.|   ++|+||||.||+++.++.++|+|||++....
T Consensus        81 lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            99999975 8999887654  5899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc------
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA------  275 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  275 (380)
                      .............++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.........      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            432111112334578899999999887 7899999999999999999999999876543322111110000000      


Q ss_pred             --CCcccccc---cC--CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          276 --GDAILVMD---PR--LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       276 --~~~~~~~~---~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        ......+.   ..  ..........+..+.++|.+||+.+|.+||++++++.+.|--
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  293 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA  293 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence              00000000   00  000001122456789999999999999999999999998754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-39  Score=295.31  Aligned_cols=265  Identities=23%  Similarity=0.256  Sum_probs=198.5

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeC--CEEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHG--DERIIVV  125 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  125 (380)
                      |++.+.||+|+||.||+|.+. +++.||+|.++........ ....+|+..+.++. |+|++++++++.+.  +..++||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            677889999999999999976 5899999998765332222 23457888888885 99999999999887  8899999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++ +|.+.+.... ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++.......
T Consensus        80 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          80 ELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             ecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            99975 8888887643 34899999999999999999999988   999999999999999 999999999998654322


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HHhhccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA--------MQCLKAG  276 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~  276 (380)
                      .    .....++..|+|||++.. ..++.++|||||||++|+|++|..||......+....+...        .......
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         154 P----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             C----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            1    123457899999997654 55788999999999999999999999776543321111100        0000000


Q ss_pred             CcccccccCCC---CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          277 DAILVMDPRLR---RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       277 ~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .......+...   ........+..+.++|.+||+.+|.+||++++++++.|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            00000000000   00011234688999999999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-39  Score=287.55  Aligned_cols=252  Identities=29%  Similarity=0.462  Sum_probs=208.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|++.+.||+|++|.||++.+. +++.|++|.+............+.+|+.++.+++|+|++++++++......+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788999999999999999987 588999999987765445567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++++|.+++....  .+++..++.++.+++.+|.+||+.|   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999999997753  4899999999999999999999988   999999999999999999999999999876543221


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                         .....++..|+|||.+.+..++.++|||+||+++|+|++|..||..........    ..  . ...          
T Consensus       156 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~----~~--~-~~~----------  215 (254)
T cd06627         156 ---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF----RI--V-QDD----------  215 (254)
T ss_pred             ---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HH--h-ccC----------
Confidence               233458899999999988888999999999999999999999997554321111    10  0 000          


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ....+...+..+.+++.+||..+|++||++.+++.+.|
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  253 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW  253 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence            01122234567889999999999999999999987643

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.8e-39  Score=302.46  Aligned_cols=276  Identities=25%  Similarity=0.324  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC--CEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG--DER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  121 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++............+..|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578899999999999999999987 588999999865433333445677899999999 999999999988653  468


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++ +|..++...   .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            999999974 999998764   4888999999999999999999988   999999999999999999999999999865


Q ss_pred             cCCCcc--eeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh------
Q 041907          202 EEDSAV--SHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC------  272 (380)
Q Consensus       202 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------  272 (380)
                      ......  ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211  011233568999999998755 45788999999999999999999999765543322111111000      


Q ss_pred             --hccCCcccccc----cCCC-CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          273 --LKAGDAILVMD----PRLR-RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       273 --~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                        .........++    .... ........+..+.++|.+||+.+|.+|||+.+++++.|-..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence              00000000000    0000 00011114577899999999999999999999999977543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.2e-39  Score=290.44  Aligned_cols=253  Identities=20%  Similarity=0.302  Sum_probs=187.7

Q ss_pred             CeeeccCceEEEEEEeCCC---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLKDG---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||++...++   ..+++|.+...... .....+.+|+..++.++||||+++++.+......++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            3699999999999976533   34667766544322 2345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          131 GTLREHLDGRGG--NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       131 ~~L~~~i~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      |+|.+++.+...  ...+...++.++.||+.||.|||+.+   ++|+||||+|||++.++.++|+|||++........ .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~  155 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-I  155 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh-h
Confidence            999999976432  23566777889999999999999988   99999999999999999999999998764221111 1


Q ss_pred             eeeecccCCccccChhhhhh-------cCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          209 HISTQVKGTAGYLDPDYLRT-------YQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .......++..|+|||++..       ..++.++|||||||++|||++ |..||........   +...   . .+....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~~~---~-~~~~~~  228 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV---LNHV---I-KDQQVK  228 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---H-hhcccc
Confidence            11234567899999998753       245789999999999999997 5678865433211   1111   1 111111


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                      ..++...     ......+.+++..|| .+|.+||++++|++.|
T Consensus       229 ~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         229 LFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             cCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            1222211     123456788999999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-39  Score=301.22  Aligned_cols=274  Identities=24%  Similarity=0.278  Sum_probs=201.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-------  118 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  118 (380)
                      .++|++.+.||.|+||.||+|.+. +++.|++|++............+.+|+.++++++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999987 589999999875543332233567899999999999999999987543       


Q ss_pred             -CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          119 -DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                       ...++||||+.+ +|...+.... ..+++..+..++.|+++||.|||+.|   ++|+||||+||++++++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999965 7877776543 34899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcce--------eeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 041907          198 ARMSEEDSAVS--------HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       198 ~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~  268 (380)
                      +..........        .......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            97654322111        111234578889999988654 578999999999999999999999986655432222211


Q ss_pred             HHHhhccCCc------cc----ccccCCCCC--CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          269 AMQCLKAGDA------IL----VMDPRLRRT--PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       269 ~~~~~~~~~~------~~----~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ..........      ..    .........  .........+.+++.+||+.+|.+|||+.+++.+.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence            1110000000      00    000000000  000112356889999999999999999999998865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-38  Score=335.47  Aligned_cols=263  Identities=26%  Similarity=0.460  Sum_probs=206.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+.|...+.||+|+||.||+|.+. +|..||||.+.......      ..|+..+++++||||+++++++.+....++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            356778889999999999999985 68999999986543221      25688899999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++..     +++..+.+++.+++.||+|||....++++||||||+||+++.++..++. ||.......  
T Consensus       763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            99999999999963     7899999999999999999995534459999999999999998888775 665443221  


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           .....+|..|+|||++.+..++.++|||||||++|||++|+.||...... ......|.............+++.
T Consensus       835 -----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        835 -----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcc
Confidence                 12235789999999999999999999999999999999999999643322 112233333333222233344444


Q ss_pred             CCC-CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          286 LRR-TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       286 ~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ... .........++.+++.+||+.+|++||+|+|+++.++.+.+
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            432 22344566778899999999999999999999999987644

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.7e-39  Score=294.09  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=207.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  124 (380)
                      ++|.+.+.||.|+||.||+|.+. +|+.|++|++..... .......+..|+.++.+++ |+||+++++++......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999986 599999999876432 2223456788999999998 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...+  .+++..++.++.|++.||.+||+.|   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999998764  4899999999999999999999988   999999999999999999999999998865432


Q ss_pred             Ccc-----------------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 041907          205 SAV-----------------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR  267 (380)
Q Consensus       205 ~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~  267 (380)
                      ...                 ........++..|+|||.+.+..++.++||||||++++++++|..||........   +.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence            210                 0112234578999999999988899999999999999999999999986542211   11


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh----HHHHHHHH
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM----KKCAEILW  325 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~eil~~l~  325 (380)
                      ...    ..           ....+...+..+.+++.+||+.+|.+||++    ++++.+.|
T Consensus       233 ~~~----~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         233 KIL----KL-----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             HHH----hc-----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            110    00           011222335678999999999999999999    89888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-38  Score=290.03  Aligned_cols=249  Identities=22%  Similarity=0.278  Sum_probs=193.3

Q ss_pred             eeeccCceEEEEEEeC-CCCEEEEEEccccCcchH-HHHHHHHH---HHHHhcCCCCceeceEEEEEeCCEEEEEEEeCC
Q 041907           55 KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNE---ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      .||+|+||.||+|.+. +++.||+|.+........ ....+..|   +..++...||||+.+++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999976 588999999876432211 11112233   334445689999999999999999999999999


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCccee
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      |++|.+++...+  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            999999887643  4899999999999999999999988   9999999999999999999999999987543221    


Q ss_pred             eeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                       .....|+..|+|||++.++ .++.++|||||||++|+|++|..||........... .   .....      ..     
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~---~~~~~------~~-----  215 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D---RMTLT------MA-----  215 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-H---HHhhc------cC-----
Confidence             1234689999999999754 689999999999999999999999976533221110 0   00000      00     


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKIR  328 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~~  328 (380)
                      ...+...+..+.+++.+||..+|.+||     ++.+++++.|...
T Consensus       216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence            111222357799999999999999999     9999999988643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-39  Score=287.84  Aligned_cols=247  Identities=24%  Similarity=0.320  Sum_probs=193.2

Q ss_pred             CeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHH-HhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILT-WSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||.|+||.||+|.+. +|+.||+|.+...... ......+..|... .....|+|++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999986 5899999998754321 1122233445444 4456899999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      ++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....       
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-------  149 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-------  149 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence            99999997654  3889999999999999999999988   99999999999999999999999998875332       


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........       .....+..    .   ....
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~----~---~~~~  215 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-------DNILSRRI----N---WPEE  215 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhccc----C---CCCc
Confidence            22345888999999999888999999999999999999999999765432211       11111100    0   0011


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh---HHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM---KKCAEILWK  326 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~---~eil~~l~~  326 (380)
                      ....++..+.+++.+||+.+|.+||++   +|++.+.|-
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            122356779999999999999999955   688877764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.9e-39  Score=292.71  Aligned_cols=251  Identities=27%  Similarity=0.444  Sum_probs=201.9

Q ss_pred             CCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           53 ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      ...||+|+||.||++... +|+.||+|.+.....  .....+.+|+.+++.++|+|++++++++...+..+++|||++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            357999999999999986 589999998864332  23456889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|.+++...   .+++..++.++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++........   ..
T Consensus       103 ~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---~~  173 (292)
T cd06657         103 ALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RR  173 (292)
T ss_pred             cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc---cc
Confidence            999988643   3788999999999999999999988   99999999999999999999999998875433211   12


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA  291 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (380)
                      ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+.   ...         ....   ..
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~---------~~~~---~~  238 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNL---------PPKL---KN  238 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhC---------Cccc---CC
Confidence            23458899999999988889999999999999999999999997654332211111   000         0000   01


Q ss_pred             CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       292 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ....+..+.+++.+||+.+|.+||++.+++.+.|....
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~  276 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  276 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence            11234568899999999999999999999999885544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-39  Score=300.79  Aligned_cols=275  Identities=20%  Similarity=0.286  Sum_probs=206.2

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ..++....++|.+.+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++.+++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            4566668899999999999999999999875 689999999876543333345677899999999999999999987543


Q ss_pred             ------CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEE
Q 041907          119 ------DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKV  192 (380)
Q Consensus       119 ------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl  192 (380)
                            ...+++++++ +++|.+++...   .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                  3467888887 77998888654   3899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-
Q 041907          193 TDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM-  270 (380)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~-  270 (380)
                      +|||++......      .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.... 
T Consensus       162 ~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         162 LDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             eccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999998754321      123457899999999876 568899999999999999999999997654322111110000 


Q ss_pred             -------HhhccCCcc---cccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          271 -------QCLKAGDAI---LVMDPRLRR--TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       271 -------~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                             .........   ..+......  ..........+.++|.+||+.+|.+||++.+++.+.|-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~  304 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  304 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence                   000000000   000000000  000001345688999999999999999999999999844

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-40  Score=284.04  Aligned_cols=255  Identities=24%  Similarity=0.276  Sum_probs=211.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      -.++|..++.||+|.||+|.+++-+ +|+.||+|++++... .......-..|-++|+..+||.+..+...|...+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467888999999999999999987 599999999987632 22334445688999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+.||.|+-.+.+...  +++...+.+...|+.||.|||+++   ||.||||.+|+|+|.+|++||+|||+++.--.
T Consensus       246 VMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence            9999999999999987554  899999999999999999999988   99999999999999999999999999975322


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .   .....+.+||+.|+|||++....|..++|-|.+||++|||++|+.||...+....-.++.       -+       
T Consensus       321 ~---g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-------~e-------  383 (516)
T KOG0690|consen  321 Y---GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-------ME-------  383 (516)
T ss_pred             c---cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-------hh-------
Confidence            1   223567899999999999999999999999999999999999999998665433221111       00       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                          ....+..++++...|+...|..||.+|..     ++||.++-+-
T Consensus       384 ----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF  427 (516)
T KOG0690|consen  384 ----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF  427 (516)
T ss_pred             ----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence                11244456678889999999999999964     7787777543

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=277.24  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=199.4

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEEe
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      .+.+..||.|..|.|++++.+ +|...|||.++..... ...+++...+.++.+. .+|+||+.+|+|..+..++|.||.
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            445677999999999999987 4899999999876544 3456677777777665 489999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +.. -++.++.... .++++.-+-++...+++||.||-.+  .+|+|||+||+|||+|+.|.+||||||++..+-+.   
T Consensus       173 Ms~-C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---  245 (391)
T KOG0983|consen  173 MST-CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---  245 (391)
T ss_pred             HHH-HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc---
Confidence            843 4455555443 4588888889999999999999864  24999999999999999999999999998765432   


Q ss_pred             eeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          208 SHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                       ...+...|-+.|||||.+.   ...|+-++||||||++|+||.||+.||.+-+...+-  +..+            ++.
T Consensus       246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~--ltkv------------ln~  310 (391)
T KOG0983|consen  246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV--LTKV------------LNE  310 (391)
T ss_pred             -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH--HHHH------------Hhc
Confidence             2234566899999999985   346888999999999999999999999875433211  1111            111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .....+....++..+.+++..||+.|+.+||.+.++++|.+-.
T Consensus       311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            1122223334778899999999999999999999999987643

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.9e-39  Score=298.11  Aligned_cols=272  Identities=22%  Similarity=0.325  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CCE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GDE  120 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  120 (380)
                      +..++++|++.+.||.|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3457889999999999999999999977 68999999886543333345567799999999999999999998865 567


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++|||+ +++|..++...   +++...+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++..
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            89999998 56898888643   3788888899999999999999988   99999999999999999999999999875


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------HH
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA--------MQ  271 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~~  271 (380)
                      ....      .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...        ..
T Consensus       158 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         158 QDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4321      123457889999998765 56889999999999999999999999765432211111000        00


Q ss_pred             hhccCCcccccccCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPAS-----NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..........+.......+.+     ...+..+.++|.+||+.+|++||++++++.+.|..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~  292 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA  292 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence            000000000000000000001     12346789999999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-41  Score=334.88  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=212.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      -+++....||.|.||.||.|... +|+..|+|.++...........+.+|+.++..++|||+|++||+-.+.+..+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            36778889999999999999976 59999999998765555556678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC-
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS-  205 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  205 (380)
                      ||.+|+|.++++..+.  +++.....+..|++.|+.|||+.|   ||||||||.||+++.+|.+|++|||.|..+.... 
T Consensus      1315 yC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999986543  666777778999999999999999   9999999999999999999999999998876542 


Q ss_pred             cceeeeecccCCccccChhhhhhcC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQ---LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....-.....||+.|||||++.+..   ...++|||||||++.||+||+.||...+.   ...+.+-   ...|      
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~---V~~g------ 1457 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYH---VAAG------ 1457 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhH---Hhcc------
Confidence            1111223577999999999997644   44689999999999999999999975433   2222221   1111      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                          ...+.+...+.+-.+++..||..||+.|.++.|++++-+
T Consensus      1458 ----h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1458 ----HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred             ----CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence                123455668888999999999999999999998888755

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=281.15  Aligned_cols=270  Identities=24%  Similarity=0.325  Sum_probs=216.4

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEe-CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           39 SFEEIYKATENFSPANKIGEGGSGTVYKGKL-KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        39 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      .|+|++..+     .+.||+|+|+.|.-+.. .+|..||||++.+..  ...+..+.+|++++... .|+||+.++++|+
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            488998888     45699999999998874 579999999998763  34567788999999988 6999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAKVT  193 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~kl~  193 (380)
                      ++...|||||.+.||.|...|+++..  +++.++.++.+.|+.||.+||.+|   |.||||||+|||.....   -+|||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC  221 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC  221 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence            99999999999999999999998765  999999999999999999999999   99999999999997654   38999


Q ss_pred             cccccccccCCCcceee----eecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch--
Q 041907          194 DFGFARMSEEDSAVSHI----STQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE--  262 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~--  262 (380)
                      ||.+..-..........    ..+.+|...|||||+..     .-.|+.+.|.||||||||-||.|.+||.+.-..+-  
T Consensus       222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            99887654433222211    23577999999999763     23588999999999999999999999976543221  


Q ss_pred             ------hhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          263 ------RVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       263 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            +.-.......+.+|...       .....+...+.+..++|...|..++.+|.++.++++++|--
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYe-------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYE-------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCc-------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence                  12222233333333221       11223456778899999999999999999999999999954

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-38  Score=292.23  Aligned_cols=258  Identities=25%  Similarity=0.420  Sum_probs=200.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.+.+.||.|+||.||+|.+.. ++.||||.++...... ...++..|+..+.+. .|+||+++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            45788999999999999999999875 8999999997654332 344556677666666 59999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +|||+.+ +|.+++..... .+++..+..++.+++.||.|||+ .+   ++|+||+|+||++++++.++|+|||++....
T Consensus        92 v~e~~~~-~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          92 CMELMST-CLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EeeccCc-CHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            9999854 78777765433 58999999999999999999997 47   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQ----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ....    .....++..|+|||.+.+..    ++.++||||||+++|+|++|..||........  .+.   .....   
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~---~~~~~---  234 (296)
T cd06618         167 DSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLT---KILQE---  234 (296)
T ss_pred             CCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHH---HHhcC---
Confidence            3211    12234788999999987654    78899999999999999999999965322110  011   11111   


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            .....+.....+..+.+|+.+||+.+|.+||++++++.+.|..
T Consensus       235 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         235 ------EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             ------CCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence                  0011111113456789999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-39  Score=302.47  Aligned_cols=266  Identities=22%  Similarity=0.349  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------C
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------D  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  119 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999976 589999999876433333345678999999999999999999988654      3


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++|+||+.. +|..++.    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46899999964 7777653    23889999999999999999999988   9999999999999999999999999987


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM--------  270 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------  270 (380)
                      .....      .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+....        
T Consensus       166 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         166 HADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CCCCC------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            54321      123457889999999876 468899999999999999999999998654332211111100        


Q ss_pred             HhhccCCcccccc--cCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 QCLKAGDAILVMD--PRLRRT---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 ~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .............  +.....   .........+.+||.+||+.+|.+||++++++.+.|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f  300 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF  300 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence            0000000000000  000000   0001234568899999999999999999999999764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.1e-38  Score=289.70  Aligned_cols=261  Identities=18%  Similarity=0.216  Sum_probs=188.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHH---------HHHHHHHHHHHhcCCCCceeceE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCL---------LLEFKNEILTWSKIEHLNLVKLF  112 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~  112 (380)
                      ..++|++.+.||+|+||.||+|.+.+    +..+++|+..........         ......+...+..+.|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            44789999999999999999999763    455777764432211100         01122344556677999999999


Q ss_pred             EEEEeCC----EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          113 GFLEHGD----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       113 ~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      +.+....    ..+++++++.. ++.+.+.....  .++..++.++.|++.||.|||+.+   ++||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC--KNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhcc--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            8765443    44788888744 77777655432  567888899999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 041907          189 RAKVTDFGFARMSEEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV  264 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  264 (380)
                      .++|+|||+++.+.......    .......||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999999998664321111    11123469999999999999999999999999999999999999998663322111


Q ss_pred             HHHH--HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          265 TIRW--AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       265 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                      ....  ....+..+.        .    ....++..+.+++..||..+|.+||+++++++.+
T Consensus       244 ~~~~~~~~~~~~~~~--------~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGK--------I----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhh--------h----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1000  011111110        0    0112357789999999999999999999998865

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.3e-38  Score=292.59  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=201.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.|...+.||.|+||.||+|.+. +++.+++|.+..... .......+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777889999999999999986 588899999864322 2233456778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+. |+|.+.+.... ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9996 58888775443 34889999999999999999999988   999999999999999999999999998754321 


Q ss_pred             cceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                            ....++..|+|||.+.   ...++.++|||||||++|+|++|..||...........       ...+.     
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------~~~~~-----  230 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IAQNE-----  230 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-------HhhcC-----
Confidence                  2345788999999985   35678899999999999999999999865433221111       00000     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                          .........+..+.++|.+||+.+|.+||++++++.+.|...
T Consensus       231 ----~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         231 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ----CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                001112245567899999999999999999999999998664

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=294.32  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=216.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchH-HHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..+.|+.-+.||+||||.|+-+..+ +|+.||.|.+.+...+.. ......+|-.+|.+++.+.||.+-..|+..+.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3456889999999999999999877 599999999876544322 23336789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||..|+||+|.-+|-+.+...+++++++.++.+|+.||++||+.+   ||.|||||+|||+|+.|+++|+|+|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999998888999999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      +..    .....||.+|||||++.++.|+...|-|||||+||||+.|+.||...........+..   ....        
T Consensus       340 g~~----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~~~--------  404 (591)
T KOG0986|consen  340 GKP----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RTLE--------  404 (591)
T ss_pred             CCc----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HHhc--------
Confidence            432    2334799999999999999999999999999999999999999976554433222211   1100        


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~  325 (380)
                         .....+..+++++.+|.+..|+.||++|..     +++|.+|+.
T Consensus       405 ---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf  448 (591)
T KOG0986|consen  405 ---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF  448 (591)
T ss_pred             ---chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence               112345677889999999999999999975     567777764

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-38  Score=290.50  Aligned_cols=258  Identities=23%  Similarity=0.299  Sum_probs=202.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcc--hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHD--KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  121 (380)
                      +|++.+.||.|+||.||+|...    +|..||+|++......  ......+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999863    5889999998754321  12335577899999999 589999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999997654  3888899999999999999999988   999999999999999999999999998765


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhc--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTY--QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .....  .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........+.   ......   
T Consensus       156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~~~~~---  227 (290)
T cd05613         156 HEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKS---  227 (290)
T ss_pred             ccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH---HHhhcc---
Confidence            43221  112235588999999998753  46789999999999999999999997543322111111   111000   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                              ..+.+......+.+++.+||+.+|.+||     ++++++.+.|--
T Consensus       228 --------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  272 (290)
T cd05613         228 --------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ  272 (290)
T ss_pred             --------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccc
Confidence                    0112223456788999999999999997     889999987744

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-38  Score=287.29  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=200.1

Q ss_pred             eeccCceEEEEEEeCC-CCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLKD-GSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||.|+||.||++.+.. |+.|++|.+..... .......+.+|+.++++++|+||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 99999999875433 223455688999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc-----e
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV-----S  208 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~  208 (380)
                      .+++...+  .+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.++|+|||++.........     .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99998755  4899999999999999999999988   999999999999999999999999998754332110     0


Q ss_pred             eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          209 HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      .......++..|+|||...+..++.++||||||+++|+|++|..||.........       .....+..        . 
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~--------~-  219 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF-------QNILNGKI--------E-  219 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCc--------C-
Confidence            1123345788999999999888999999999999999999999999755432211       11111100        0 


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCCh---HHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPTM---KKCAEILWK  326 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~---~eil~~l~~  326 (380)
                      .+.....+..+.+++.+||+.+|.+|||+   .+++++.|-
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence            11111135778999999999999999999   777777663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.2e-39  Score=300.65  Aligned_cols=271  Identities=21%  Similarity=0.292  Sum_probs=200.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-------  118 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  118 (380)
                      ..+|.+.+.||.|+||.||+|.+. +|..||+|.+......  ....+.+|+.++++++||||+++++++...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~--~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ--SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc--hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            478999999999999999999986 5899999998665432  345678899999999999999999776543       


Q ss_pred             -------CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCce
Q 041907          119 -------DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRA  190 (380)
Q Consensus       119 -------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~  190 (380)
                             ...++||||++ ++|.+++...   .+++..++.++.||+.||.|||+.|   ++|+||||+||+++ +++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~  154 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence                   35789999997 4898888643   3889999999999999999999988   99999999999997 45678


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      +|+|||++.................++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+......+...
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999998765332111111123457889999998754 56788999999999999999999999766543322211100


Q ss_pred             HHhhcc---CCcc----cccc--cCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          270 MQCLKA---GDAI----LVMD--PRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       270 ~~~~~~---~~~~----~~~~--~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ......   ....    ..+.  ......+   .......++.+|+.+||+.+|.+||++.+++.+.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence            000000   0000    0000  0000000   011234678899999999999999999999999885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.1e-38  Score=290.37  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .|...+.||.|+||.||+|.+. +|+.|++|++..... .......+.+|+.++++++|||++++++++.+....++|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            3666788999999999999976 589999999865432 22334567889999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+.+ +|.+++.... .++++..++.++.|++.+|.|||+.|   ++|+||+|+||+++.++.++|+|||++.....   
T Consensus       102 ~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         102 YCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             cCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            9964 8888776543 34899999999999999999999988   99999999999999999999999998764322   


Q ss_pred             ceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          207 VSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                          .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...........+   .    ....     
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~----~~~~-----  237 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---A----QNDS-----  237 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---H----hcCC-----
Confidence                12345889999999984   456888999999999999999999999765433221111   0    0000     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          ........+..+.+++.+||+.+|.+||++.+++.+.|..
T Consensus       238 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         238 ----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence                0011122345688999999999999999999999987743

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=290.68  Aligned_cols=267  Identities=23%  Similarity=0.308  Sum_probs=201.3

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEEe
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      |.+.+.||.|++|.||+|... +++.|+||.+....... ......+|+..+.+++ |+|++++++++...+..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            677899999999999999987 48899999987553321 1223457899999998 99999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      + +++|.+++.......+++..+..++.|++.+|.|||+++   ++|+||+|.||+++.++.++|+|||++........ 
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence            9 779999988765455899999999999999999999988   99999999999999999999999999876543211 


Q ss_pred             eeeeecccCCccccChhhhh-hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH----------HHhhccC
Q 041907          208 SHISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA----------MQCLKAG  276 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~  276 (380)
                         .....++..|+|||++. +..++.++||||||+++++|++|..||......+....+...          .......
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence               12345788999999875 445789999999999999999999999766543321111100          0000000


Q ss_pred             CcccccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          277 DAILVMDPRLRR--TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       277 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .....+......  ..........+.+++.+||+.+|.+||+++|++.+.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            000000000000  0000111467889999999999999999999998865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-39  Score=300.71  Aligned_cols=270  Identities=21%  Similarity=0.332  Sum_probs=203.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----  119 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  119 (380)
                      ...++|++.+.||+|+||.||+|.+. +|..||||++............+.+|+.++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35688999999999999999999976 5899999998654444444556789999999999999999999886543    


Q ss_pred             --EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          120 --ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       120 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                        ..++||||+ +++|.+++...   .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence              458999999 67999888653   3899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-------
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA-------  269 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-------  269 (380)
                      +......      .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...       
T Consensus       165 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         165 ARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            8765432      123457889999999876 45788999999999999999999999765432211111000       


Q ss_pred             -HHhhccCCcccccc--cCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 -MQCLKAGDAILVMD--PRLRRT---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 -~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ...+..........  +.....   .........+.++|.+||+.+|.+|||+.+++.+.|.-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~  302 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE  302 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHh
Confidence             00000000000000  000000   00112345688999999999999999999999998854

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=296.34  Aligned_cols=273  Identities=22%  Similarity=0.264  Sum_probs=203.8

Q ss_pred             HhcCCC-CCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchH------------HHHHHHHHHHHHhcCCCCceece
Q 041907           46 ATENFS-PANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC------------LLLEFKNEILTWSKIEHLNLVKL  111 (380)
Q Consensus        46 ~~~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~~  111 (380)
                      ..++|. +.+.||.|+||.||+|.+. +|+.||||.+........            ....+.+|+.++++++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            346665 4577999999999999986 589999999865432210            01246789999999999999999


Q ss_pred             EEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 041907          112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                      ++++......+++|||+. ++|.+++.....  ++...+..++.|++.||.|||+.|   ++|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            999999999999999996 599999876443  889999999999999999999988   99999999999999999999


Q ss_pred             EccccccccccCCCcc-----------eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 041907          192 VTDFGFARMSEEDSAV-----------SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKP  259 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~  259 (380)
                      |+|||++.........           ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999998765411100           0111223468889999998764 468899999999999999999999987654


Q ss_pred             cchhhHHHHHHHhhccCC---cccc-----cccCCCCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGD---AILV-----MDPRLRRT-----PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .+...   ..........   ....     ..+.....     ......+..+.++|.+||+.+|.+||++++++.+.|.
T Consensus       240 ~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        240 IDQLG---RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHHH---HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            33221   1111111000   0000     00000000     0011235678899999999999999999999999986


Q ss_pred             H
Q 041907          327 I  327 (380)
Q Consensus       327 ~  327 (380)
                      .
T Consensus       317 ~  317 (335)
T PTZ00024        317 K  317 (335)
T ss_pred             C
Confidence            4

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=297.45  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=211.8

Q ss_pred             CCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           53 ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .+.||+|.||+||-|+++ +|+.||||++.+-+........+++|+.+|+++.||.||.+-..|+..+.++.|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            578999999999999987 699999999987776666667899999999999999999999999999999999999965 


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEccccccccccCCCcce
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      +..++|-......+++.....++.||+.||.|||-++   |+|+||||+|||+...   -.+||||||.|+.....    
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk----  720 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK----  720 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh----
Confidence            6666665544445888888889999999999999888   9999999999999754   46999999999988753    


Q ss_pred             eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCC
Q 041907          209 HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRR  288 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      ...+...||+.|+|||+++...|...-|+||.|||+|--|.|..||.-......+.+         ..       .....
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ---------NA-------aFMyP  784 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ---------NA-------AFMYP  784 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh---------cc-------ccccC
Confidence            245678899999999999999999999999999999999999999976554332211         10       01122


Q ss_pred             CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          289 TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       289 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...+.....+..+||...|+..-++|-+.+..+.|.|..
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence            334566778899999999999999999999999999864

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-38  Score=297.75  Aligned_cols=270  Identities=20%  Similarity=0.283  Sum_probs=204.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE---
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE---  120 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  120 (380)
                      ...++|.+.+.||+|++|.||+|.+. +++.||+|++............+.+|+.+++++.|+|++++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            35678999999999999999999987 58899999987643333344567789999999999999999988765554   


Q ss_pred             ---EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          121 ---RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       121 ---~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                         .++|+||+ +++|.+++...   .+++..++.++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 56999998763   3899999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH------
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM------  270 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------  270 (380)
                      +......      .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+....      
T Consensus       165 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         165 ARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            8765432      233457889999999865 367889999999999999999999997654432211110000      


Q ss_pred             --HhhccCCcccccccC-CCCC----CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          271 --QCLKAGDAILVMDPR-LRRT----PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       271 --~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        ...........+... ....    ......+..+.++|.+||+.+|.+|||+.+|+.+.|--
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence              000000000000000 0000    00012356789999999999999999999999998754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=289.34  Aligned_cols=268  Identities=25%  Similarity=0.332  Sum_probs=204.9

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      |++.+.||+|++|.||+|... +++.|++|.+............+..|+.++++++|+|++++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567788999999999999987 4899999999876433334456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++ +|.+++.... ..+++..+..++.+++.||.+||+.+   ++|+||+|+||++++++.++|+|||++........  
T Consensus        81 ~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 DM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             Cc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            75 9999998763 24899999999999999999999988   99999999999999999999999999876543211  


Q ss_pred             eeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc-----cccc
Q 041907          209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA-----ILVM  282 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  282 (380)
                       ......++..|+|||.+.+. .++.++|||||||++|+|++|..||...........+............     ....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             11233467889999998776 7889999999999999999999999775543322111110000000000     0000


Q ss_pred             ccCCCC---C---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          283 DPRLRR---T---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       283 ~~~~~~---~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +.....   .   .........+.+++.+||+.+|.+||++.+++.+.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            000000   0   001122567999999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.8e-38  Score=284.70  Aligned_cols=253  Identities=23%  Similarity=0.334  Sum_probs=199.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccC---cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNK---HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +|.+.+.||+|+||.||++.+.. +..+++|.++...   ........+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999998763 4556666654322   2222234566889999999999999999999998999999


Q ss_pred             EEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          125 VEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |||+++++|.+++...  ....+++..++.++.|++.||.|||+.|   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642  2345899999999999999999999988   999999999999985 569999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........      .. ...+.     
T Consensus       157 ~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~------~~-~~~~~-----  221 (260)
T cd08222         157 GSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV------LR-IVEGP-----  221 (260)
T ss_pred             CCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH------HH-HHcCC-----
Confidence            3221   122345788999999998888999999999999999999999999654322111      11 10110     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           ........+..+.++|.+||+.+|.+||++.+++++.|
T Consensus       222 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         222 -----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             -----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence                 11123456678999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.3e-38  Score=295.62  Aligned_cols=272  Identities=21%  Similarity=0.262  Sum_probs=198.8

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-C--CCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC----CE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-D--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG----DE  120 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~  120 (380)
                      +|.+.+.||+|+||.||++.+. .  +..||+|.+............+.+|+.+++++ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999976 3  77899999875433333445677899999998 599999999875432    45


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++++|+. ++|.+++....  .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.++|+|||++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899986 58999886543  4899999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCcc-eeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--------
Q 041907          201 SEEDSAV-SHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM--------  270 (380)
Q Consensus       201 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~--------  270 (380)
                      ....... ........||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+....        
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5432211 111123568999999998866 468899999999999999999999997654322111100000        


Q ss_pred             HhhccCCcc---cccc--cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 QCLKAGDAI---LVMD--PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 ~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .........   ....  +..............+.+++.+||+.+|.+|||+++++.+.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            000000000   0000  0000000011124678899999999999999999999999985

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.5e-39  Score=319.69  Aligned_cols=255  Identities=25%  Similarity=0.367  Sum_probs=190.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-------
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-------  119 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  119 (380)
                      .+|+....||+||||.||+++++ +|+.||||+++... .......+.+|+..|++|+|||||+++..+.+..       
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            45666788999999999999998 89999999998876 5566777889999999999999999987421110       


Q ss_pred             --------------------------------------------------------------------------------
Q 041907          120 --------------------------------------------------------------------------------  119 (380)
Q Consensus       120 --------------------------------------------------------------------------------  119 (380)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 041907          120 --------------------------------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY  167 (380)
Q Consensus       120 --------------------------------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  167 (380)
                                                      .+||-||||+..+|.++|..... .-.....++++.+|+.||.|+|+.
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            14899999998777777765432 125788899999999999999998


Q ss_pred             CCCCeeeccCCCCceeeCCCCceEEcccccccccc------C-----C----CcceeeeecccCCccccChhhhhhcC--
Q 041907          168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE------E-----D----SAVSHISTQVKGTAGYLDPDYLRTYQ--  230 (380)
Q Consensus       168 ~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~------~-----~----~~~~~~~~~~~gt~~y~aPE~~~~~~--  230 (380)
                      |   +|||||||.||++++++.|||+|||++....      .     .    .......+...||..|+|||++.+..  
T Consensus       717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            8   9999999999999999999999999998721      0     0    00011234568999999999997654  


Q ss_pred             -CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCC
Q 041907          231 -LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAP  309 (380)
Q Consensus       231 -~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  309 (380)
                       |+.|+|+|||||+|+||+.   ||...-   ++..   ....+..+....-       ..........-..+|.+++++
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsM---ERa~---iL~~LR~g~iP~~-------~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSM---ERAS---ILTNLRKGSIPEP-------ADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchH---HHHH---HHHhcccCCCCCC-------cccccccchHHHHHHHHHhcC
Confidence             9999999999999999985   454211   1111   1111111111100       001122223456899999999


Q ss_pred             CCCCCCChHHHHHH
Q 041907          310 TRQSRPTMKKCAEI  323 (380)
Q Consensus       310 ~p~~RPt~~eil~~  323 (380)
                      ||.+|||+.|+|+.
T Consensus       858 dP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  858 DPSKRPTATELLNS  871 (1351)
T ss_pred             CCccCCCHHHHhhc
Confidence            99999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6e-38  Score=316.46  Aligned_cols=148  Identities=30%  Similarity=0.454  Sum_probs=133.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|.+.+.||+|+||.||+|.+. +++.||||+++... ........+..|+.++..++|+||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999987 58999999997543 2333446688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      |||+.+++|.+++...+.  +++..++.++.||+.||.|||.++   |+||||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999976543  788899999999999999999988   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=291.60  Aligned_cols=267  Identities=25%  Similarity=0.381  Sum_probs=208.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHH-----HHHHHHHHHHHhcCCCCceeceEEEEE-eC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLVKLFGFLE-HG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~-~~  118 (380)
                      ..++|-++..||+|||+.||+|.+- .++.||||+-..+..+...     .+...+|.++.+.|.||.||++|+++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            4457888899999999999999975 5899999987655433222     233558999999999999999999985 56


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDF  195 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Df  195 (380)
                      +..|-|+|||+|.+|+-+|....-  +++.+++.|+.||+.||.||.... ++|+|-||||.|||+-++   |.+||+||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            778999999999999999987654  899999999999999999999885 889999999999999654   78999999


Q ss_pred             cccccccCCCcce----eeeecccCCccccChhhhhhc----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 041907          196 GFARMSEEDSAVS----HISTQVKGTAGYLDPDYLRTY----QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR  267 (380)
Q Consensus       196 g~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~  267 (380)
                      |+++++..+....    .......||.+|++||++.-+    ..+.|+||||.|||+|.++.|+.||.............
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN  697 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN  697 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence            9999987643221    223456799999999988543    35789999999999999999999998654433222111


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+...            .....|.......+...+|++||+..-++|....++..+...+
T Consensus       698 TIlkA------------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  698 TILKA------------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             chhcc------------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            11111            0011223334556788999999999999999988887776543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-37  Score=284.85  Aligned_cols=256  Identities=22%  Similarity=0.288  Sum_probs=198.4

Q ss_pred             CCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcc--hHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHD--KCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  121 (380)
                      +|++.+.||+|++|.||++.+.    +++.||||.++.....  ......+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999999853    4788999998754321  22334577899999999 599999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++....  .+++..+..++.|++.+|.|||+.+   ++|+||+|.||+++.++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            99999999999999987643  3889999999999999999999988   999999999999999999999999998765


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .....  .......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||...........+   .......   
T Consensus       156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~---  227 (288)
T cd05583         156 LAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI---SRRILKS---  227 (288)
T ss_pred             ccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH---HHHHHcc---
Confidence            43211  1112345889999999987765  788999999999999999999999643322111111   1111110   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHH---HHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC---AEILW  325 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei---l~~l~  325 (380)
                              ..+.+......+.+++.+||+.+|++|||+.++   ++++|
T Consensus       228 --------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         228 --------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             --------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence                    011222345678899999999999999996555   55554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=284.38  Aligned_cols=269  Identities=19%  Similarity=0.255  Sum_probs=210.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCC--CC----ceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--HL----NLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~~~~~~~~~  118 (380)
                      ..++|.+...+|+|.||.|-.+.++. +..||||+++.-.   .......-|+++|.++.  .|    -++.+.+||...
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            37899999999999999999999874 7899999997532   23444668899999983  23    367788899999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC------------
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE------------  186 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~------------  186 (380)
                      ++.|||+|.+ |-++++++...+..+++...++.|+.||++++++||+.+   ++|.||||+|||+.+            
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            9999999998 669999999988888999999999999999999999888   999999999999832            


Q ss_pred             --------CCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 041907          187 --------KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK  258 (380)
Q Consensus       187 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~  258 (380)
                              +..++|+|||.|+.....      ...+..|..|.|||++.+-.++.++||||+||||+|+.+|...|+...
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                    235899999999864432      245678999999999999999999999999999999999999998877


Q ss_pred             CcchhhHHHHHHHhhccCC-------------ccc------------ccccCCC---CCCCCHHHHHHHHHHHHHhcCCC
Q 041907          259 PIKERVTIRWAMQCLKAGD-------------AIL------------VMDPRLR---RTPASNMAVEKILGLADVCLAPT  310 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~-------------~~~------------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~  310 (380)
                      ..+....++.+...+....             ...            +.+....   ...........|++|+++||..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            5554333322211111000             000            0000000   01122334567999999999999


Q ss_pred             CCCCCChHHHHHHHHHH
Q 041907          311 RQSRPTMKKCAEILWKI  327 (380)
Q Consensus       311 p~~RPt~~eil~~l~~~  327 (380)
                      |.+|+|+.|++.|.+-.
T Consensus       394 P~~RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  394 PARRITLREALSHPFFA  410 (415)
T ss_pred             ccccccHHHHhcCHHhh
Confidence            99999999999998743

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=281.27  Aligned_cols=273  Identities=22%  Similarity=0.364  Sum_probs=211.7

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHh--cCCCCceeceEEEEEeC-
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWS--KIEHLNLVKLFGFLEHG-  118 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~-  118 (380)
                      -...+.++..+.+.||+|.||.||+|.|+ |+.||||++.......     ..+|.++.+  .|+|+||+.+++.-... 
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~S-----WfrEtEIYqTvmLRHENILgFIaaD~~~~  278 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERS-----WFRETEIYQTVMLRHENILGFIAADNKDN  278 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchhh-----hhhHHHHHHHHHhccchhhhhhhccccCC
Confidence            33456788899999999999999999999 8999999997654332     345555554  46999999999875433 


Q ss_pred             ---CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeeeccCCCCceeeCCCCce
Q 041907          119 ---DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-----YSDPPIIHRDVKASNILITEKLRA  190 (380)
Q Consensus       119 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dlkp~Nil~~~~~~~  190 (380)
                         ..++||.+|.+.|+|+|+|.+..   ++....++++..++.||++||.     +|.+.|.|||||..||||..++..
T Consensus       279 gs~TQLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  279 GSWTQLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             CceEEEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence               35799999999999999998743   9999999999999999999996     345779999999999999999999


Q ss_pred             EEccccccccccCCCcceee-eecccCCccccChhhhhhc----CCC--CccchhhHHHHHHHHHhC----------CCC
Q 041907          191 KVTDFGFARMSEEDSAVSHI-STQVKGTAGYLDPDYLRTY----QLT--EKSDVYSFGVLLVEMMTG----------RYP  253 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~----~~~--~~~DiwSlGvil~elltg----------~~p  253 (380)
                      -|+|+|+|-..........+ .....||..|||||++...    .+.  ..+||||||+++||+.-+          +.|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            99999999876654322222 2446799999999998542    122  468999999999998753          478


Q ss_pred             CCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          254 IESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      |.+..+.+......      ..-...+.+.+..........+...+.++++.||..+|..|.|+-.|...+.++..
T Consensus       436 yyd~Vp~DPs~eeM------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  436 YYDVVPSDPSFEEM------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cccCCCCCCCHHHH------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            87665544322211      11112233455555566677788899999999999999999999988888877753

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-38  Score=279.83  Aligned_cols=244  Identities=27%  Similarity=0.331  Sum_probs=199.4

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ||.|+||.||++.+. +++.|++|.+...... ......+..|+.++++++|+||+++++.+......+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999987 4899999998765432 22455688999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec
Q 041907          134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       134 ~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      .+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~  152 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---SRTNT  152 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC---CcccC
Confidence            99998764  3899999999999999999999988   9999999999999999999999999987654321   11234


Q ss_pred             ccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCH
Q 041907          214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN  293 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (380)
                      ..++..|++||.+.+...+.++|+||||+++|+|++|..||.......   .....    ...           ....+.
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~-----------~~~~~~  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKI----LKD-----------PLRFPE  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----hcC-----------CCCCCC
Confidence            558899999999998889999999999999999999999997544311   11111    000           011222


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCh---HHHHHHHH
Q 041907          294 MAVEKILGLADVCLAPTRQSRPTM---KKCAEILW  325 (380)
Q Consensus       294 ~~~~~l~~li~~cl~~~p~~RPt~---~eil~~l~  325 (380)
                      ..+..+.+++.+||..+|.+||++   ++++++.|
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence            235778999999999999999999   77777654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=297.26  Aligned_cols=244  Identities=26%  Similarity=0.339  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      .++.|.+...+|.|.|+.|..+.+. +++.+++|++.....+      ..+|+.++.+. +|||++++.+.+.+..+.|+
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeee
Confidence            4678889999999999999999876 5888999999776322      23666555554 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee-CCCCceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~-~~~~~~kl~Dfg~~~~~~  202 (380)
                      |||.+.|+-|.+.|.....  +. .++..|+.+|+.|+.|||.+|   +|||||||+|||+ ++.++++|+|||.++...
T Consensus       394 v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             eehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            9999999999999887663  23 677789999999999999999   9999999999999 689999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ..      ..+.+-|..|.|||+.....|++++|+||||++||+||+|+.||...-..   ..   ....+         
T Consensus       468 ~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e---i~~~i---------  526 (612)
T KOG0603|consen  468 RS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE---IHTRI---------  526 (612)
T ss_pred             hh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH---HHHhh---------
Confidence            43      33456789999999999999999999999999999999999999754332   11   11111         


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          .........+...++|+.+||+.||.+||++.++..+.|.
T Consensus       527 ----~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  527 ----QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ----cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                1122336677889999999999999999999999999997

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=253.91  Aligned_cols=269  Identities=23%  Similarity=0.296  Sum_probs=209.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +|.-.++||+|.||+||+|+.+ +++.||+|.++.+..++..-....+|+-+|+.+.|.|||+++++...+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556788999999999999977 489999999987766555555678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      |.. +|..+.....+. ++.+.++..+.|+++||.++|+++   +.||||||.|+|++.+|++||+|||+++.+.-.-  
T Consensus        83 cdq-dlkkyfdslng~-~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             hhH-HHHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            965 999998877654 899999999999999999999999   9999999999999999999999999999765431  


Q ss_pred             eeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc---c
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV---M  282 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  282 (380)
                       .......-|++|.+|.++.|.. |+...|+||-|||+.|+.. |++.|.+.+-.++.-.+-+......++++...   -
T Consensus       156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence             2234456799999999988765 7889999999999999998 66667666554444444443333333333211   1


Q ss_pred             ccCCC-CCC---CCHH----HHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          283 DPRLR-RTP---ASNM----AVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       283 ~~~~~-~~~---~~~~----~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      |.... ..+   ....    ....=++|+++.|.-+|..|.++++.+++..
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy  285 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY  285 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence            11110 011   1111    1223357888999999999999999988753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=285.17  Aligned_cols=268  Identities=23%  Similarity=0.350  Sum_probs=198.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHH--hcCCCCceeceEEEEEeCC----EE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTW--SKIEHLNLVKLFGFLEHGD----ER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~~~~~~~~~~----~~  121 (380)
                      ...++.+.||+|.||.||+|.+. ++.||||++....     ...+.+|-++.  -.+.|+||++++++-....    .+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            44566788999999999999997 6999999997643     23455555554  4579999999999876655    78


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------CCCeeeccCCCCceeeCCCCceEEccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS------DPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                      +||++|.+.|+|.++|....   .+|....+|+..+++||+|||...      .++|+|||||..||||.++++..|+||
T Consensus       284 wLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999998765   899999999999999999999743      357999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcC-CC-----CccchhhHHHHHHHHHhCCCCCC--CCCCcchhhH--
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-LT-----EKSDVYSFGVLLVEMMTGRYPIE--SKKPIKERVT--  265 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlGvil~elltg~~p~~--~~~~~~~~~~--  265 (380)
                      |+|..+.......... ...||.+|||||++.+.- +.     .+.||||+|.+||||+++..-+.  ...+++.-..  
T Consensus       361 GLAl~~~p~~~~~d~~-~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTH-GQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             ceeEEecCCCCCcchh-hhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999887543332222 367999999999997642 11     36899999999999999765442  1111111111  


Q ss_pred             ------HHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          266 ------IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       266 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                            +...+......    ...+.............-+.+.+..||.+||+.|.|+.=+-+.++.+..
T Consensus       440 vG~hPt~e~mq~~VV~k----K~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRK----KQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             hcCCCCHHHHHHHHHhh----ccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence                  01111111100    1111111111222345678899999999999999999988888887754

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=293.95  Aligned_cols=271  Identities=30%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------CEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------DER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  121 (380)
                      .+...+.||+|+||.||+|+++ +|+.||||.++...... -......|+++|++++|+|||+++++-+..      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r-~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR-PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc-hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3455678999999999999976 69999999998754322 244567999999999999999999976543      356


Q ss_pred             EEEEEeCCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC--C--ceEEcccc
Q 041907          122 IIVVEYVGNGTLREHLDGRG-GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK--L--RAKVTDFG  196 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~--~--~~kl~Dfg  196 (380)
                      .+|||||.||+|+..+++-. ..++++.+.+.++.+++.||.|||++|   |+||||||.||++-.+  |  .-||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            89999999999999998754 356999999999999999999999988   9999999999998533  3  37999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .|+-+.++.    ......||..|++||++-. +.|+.-+|.|||||++|++.||..||..........-+.|..--..+
T Consensus       170 ~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp  245 (732)
T KOG4250|consen  170 AARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP  245 (732)
T ss_pred             ccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence            999887654    4567789999999999984 78899999999999999999999999754433211112221111111


Q ss_pred             CCcccccccC----------C-CCCCCCHHHHHHHHHHHHHhcCCCCCCCC--ChHHHHHHHHHH
Q 041907          276 GDAILVMDPR----------L-RRTPASNMAVEKILGLADVCLAPTRQSRP--TMKKCAEILWKI  327 (380)
Q Consensus       276 ~~~~~~~~~~----------~-~~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~eil~~l~~~  327 (380)
                      ........+.          + ............+-.++..+|..+|++|-  .+.++...+..+
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            1110000000          0 01112233344455667778888888887  555555555444

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.9e-38  Score=270.49  Aligned_cols=277  Identities=21%  Similarity=0.243  Sum_probs=204.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  120 (380)
                      -..|++.+.||+|.||.||+|..++     ...+|||.++.....+-.....-+|+.+++.++||||+.+..++.. ...
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            3578999999999999999996432     2369999998774433333445689999999999999999998876 788


Q ss_pred             EEEEEEeCCCCCHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC----CceEEc
Q 041907          121 RIIVVEYVGNGTLREHLDGRG---GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK----LRAKVT  193 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~----~~~kl~  193 (380)
                      +++++||.+. +|+..|+-..   ...++...+..|+-||+.|+.|||++=   |+||||||.||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999988 9999885432   245888899999999999999999977   9999999999999876    899999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCc------chhhHH
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPI------KERVTI  266 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~------~~~~~~  266 (380)
                      |||+++++...-........+.-|.+|.|||++.|. .|+++.|||+.|||+.||++-.+.|.+....      -...++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999987543322233456789999999999875 5899999999999999999999988654321      111122


Q ss_pred             HHHHHhhccCCcccccc------------cCCCCCCCCH----------HHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMD------------PRLRRTPASN----------MAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~~----------~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                      ..+...+.-.....+-+            ........+.          ...+...+|+.++|..||.+|.|+++.+++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            22222211110000000            0000000000          0112366899999999999999999999987


Q ss_pred             HHH
Q 041907          325 WKI  327 (380)
Q Consensus       325 ~~~  327 (380)
                      .-.
T Consensus       339 yF~  341 (438)
T KOG0666|consen  339 YFT  341 (438)
T ss_pred             ccc
Confidence            654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-37  Score=273.78  Aligned_cols=227  Identities=20%  Similarity=0.193  Sum_probs=182.5

Q ss_pred             cCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHh
Q 041907           59 GGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL  137 (380)
Q Consensus        59 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i  137 (380)
                      |.+|.||++.+. +|+.||+|.++....       +..|...+....|||++++++++......+++|||+++++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            889999999986 589999999976432       234455555667999999999999999999999999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCC
Q 041907          138 DGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT  217 (380)
Q Consensus       138 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt  217 (380)
                      .....  +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+......      .....++
T Consensus        77 ~~~~~--l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~  145 (237)
T cd05576          77 SKFLN--IPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE  145 (237)
T ss_pred             HHhcC--CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence            76543  899999999999999999999988   999999999999999999999999987654432      1223467


Q ss_pred             ccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHH
Q 041907          218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVE  297 (380)
Q Consensus       218 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (380)
                      ..|+|||.+.+..++.++||||||+++|+|++|..|+.......            ...       ..   ...+...+.
T Consensus       146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-------~~---~~~~~~~~~  203 (237)
T cd05576         146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-------TT---LNIPEWVSE  203 (237)
T ss_pred             ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-------cc---cCCcccCCH
Confidence            78999999988889999999999999999999998875321100            000       00   011223456


Q ss_pred             HHHHHHHHhcCCCCCCCCCh-----HHHHHHHH
Q 041907          298 KILGLADVCLAPTRQSRPTM-----KKCAEILW  325 (380)
Q Consensus       298 ~l~~li~~cl~~~p~~RPt~-----~eil~~l~  325 (380)
                      .+.+++.+||+.||.+||++     +++++|.|
T Consensus       204 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~  236 (237)
T cd05576         204 EARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF  236 (237)
T ss_pred             HHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence            78899999999999999996     77776654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-38  Score=308.02  Aligned_cols=266  Identities=22%  Similarity=0.261  Sum_probs=215.3

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEe
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEH  117 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  117 (380)
                      ..++....++|.+.+.||+|+||.|.+++++ +++.||+|++.+-..- .....-|..|-.+|..-+.+-|+.+...|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4555666789999999999999999999997 4899999999762211 1123457889999998899999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      +.++|+||||++||+|-.++....  .+++.-++.++..|+.||.-||+.|   +|||||||+|||+|..|++||+|||.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999999887  4888999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhh----h-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLR----T-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      +-.+..++.  .......|||-|.+||+++    + +.|++.+|-||+||++|||+.|..||....-......|.   ..
T Consensus       222 Clkm~~dG~--V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm---~h  296 (1317)
T KOG0612|consen  222 CLKMDADGT--VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM---NH  296 (1317)
T ss_pred             HHhcCCCCc--EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh---ch
Confidence            887765432  2345678999999999995    3 578999999999999999999999998655443322221   11


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC---hHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT---MKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~eil~~l~~~  327 (380)
                      .          ..+. .|.....+.+..+||++.+. +|+.|..   ++++..|+|--
T Consensus       297 k----------~~l~-FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~  342 (1317)
T KOG0612|consen  297 K----------ESLS-FPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE  342 (1317)
T ss_pred             h----------hhcC-CCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence            0          0111 12234477888899988775 5677877   99999998753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=300.25  Aligned_cols=265  Identities=30%  Similarity=0.471  Sum_probs=214.3

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC----C----CCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK----D----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFG  113 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  113 (380)
                      ++...++..+.+.||+|.||.|++|...    .    ...||||.++..... .....+..|+.+|..+ .|+||+.++|
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            3334455567779999999999999743    1    346999999877665 5567899999999998 6999999999


Q ss_pred             EEEeCCEEEEEEEeCCCCCHHHHhccCC------C--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 041907          114 FLEHGDERIIVVEYVGNGTLREHLDGRG------G--------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKA  179 (380)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~------~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  179 (380)
                      +|...+..++|+||+..|+|.++++...      .        ..+...+.+.++.||+.|++||++..   ++||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999998765      0        12888899999999999999999888   99999999


Q ss_pred             CceeeCCCCceEEccccccccccCCCcceeeeecccC--CccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041907          180 SNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG--TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIES  256 (380)
Q Consensus       180 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~  256 (380)
                      .|||+..+..+||+|||+++...+.....  .....|  ...|||||.+....|+.++|||||||+||||++ |..||.+
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~--~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYR--TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceE--ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999655433221  122222  345999999999999999999999999999999 8899976


Q ss_pred             CCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          257 KKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ......      ..+.+..|..          ...+..+..++.+++..||+.+|++||++.++.+.+..+..
T Consensus       525 ~~~~~~------l~~~l~~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  525 IPPTEE------LLEFLKEGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCcHHH------HHHHHhcCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            332221      1223333322          33455567899999999999999999999999999998654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=294.49  Aligned_cols=264  Identities=24%  Similarity=0.421  Sum_probs=218.5

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           39 SFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        39 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      .++.+...++-|.+.+.||.|.+|.||+++.. +++..|+|++......+   .++..|.++|+.+ .|||++.+||+|.
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            34555556778899999999999999999976 68999999987765443   4567888888877 7999999999885


Q ss_pred             e-----CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 041907          117 H-----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       117 ~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                      .     .+.++||||||.+|+..|++....+..+.+..+..|++.++.|+.+||+..   ++|||||=.|||++.++.||
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence            4     568999999999999999999888888999999999999999999999888   99999999999999999999


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI  266 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~  266 (380)
                      |+|||++..+...   .....+..||+.|||||++..     ..|+.++|+||||++.+||--|.+|+-++.+....+.+
T Consensus       164 LvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I  240 (953)
T KOG0587|consen  164 LVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  240 (953)
T ss_pred             Eeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC
Confidence            9999998765432   122345789999999999854     34778999999999999999999999988876543321


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .       .       ++. ...-.+....+++.++|..||..|-++||++.++++|.+.
T Consensus       241 p-------R-------NPP-PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  241 P-------R-------NPP-PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             C-------C-------CCC-ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence            1       0       011 1122466788999999999999999999999999988653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-39  Score=269.47  Aligned_cols=275  Identities=22%  Similarity=0.270  Sum_probs=210.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--------C
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--------G  118 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------~  118 (380)
                      ..|.-..+||+|.||.||+|+.++ |+.||+|++.....+.-.-....+|+.+|..+.|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            445566789999999999999874 8889999887655444444456799999999999999999997743        3


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ..+|+||.+|+. +|..++..... .++..++.+++.++..||.|+|...   |+|||+|+.|+||+.+|.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v-r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV-RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc-cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence            457999999987 99999977643 3899999999999999999999888   999999999999999999999999999


Q ss_pred             ccccCCCc-ceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          199 RMSEEDSA-VSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       199 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      +.+..... .....+...-|++|++||.+.|. .|+++.|||.-|||+.||++|.+.+.+.........+.........+
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            87654322 12223445569999999988764 68999999999999999999999999887766655554333222222


Q ss_pred             CcccccccC----C--CCCC--C---CHH------HHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPR----L--RRTP--A---SNM------AVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~----~--~~~~--~---~~~------~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .+..+....    .  ...+  .   ..+      ..++..+|+.++|..||.+|++++++++|.|-.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            221110000    0  0000  0   001      123677899999999999999999999998765

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=293.16  Aligned_cols=256  Identities=26%  Similarity=0.393  Sum_probs=212.5

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CC----CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DG----SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .+..+.||+|+||+||+|.|- .|    -+||+|++...... ....++.+|+.+|.+++|||++++++++.... +.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            345788999999999999873 33    46999998765433 34567899999999999999999999998765 7899


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ++|+++|.|.++++..++ ++..+..+.|..||++|+.|||.++   +|||||-..||||.....+||.|||+++....+
T Consensus       776 tq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999999988664 4888999999999999999999888   999999999999999999999999999998776


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...... ....-.+.|||-|.++...|++++|||||||++||++| |..|+++....+..       ..++.+       
T Consensus       852 ~~ey~~-~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~g-------  916 (1177)
T KOG1025|consen  852 EKEYSA-PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKG-------  916 (1177)
T ss_pred             cccccc-cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhcc-------
Confidence            543332 23334577999999999999999999999999999999 99999875533221       122222       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                        .+ .+.+..++.++..++.+||-.|+..||+++++...+..+..
T Consensus       917 --eR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  917 --ER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             --cc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence              12 45666788999999999999999999999999998887643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=282.11  Aligned_cols=255  Identities=21%  Similarity=0.272  Sum_probs=218.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+++....||-||||.|-++..++ ...+|+|++++... +......+..|-.+|...+.|.||++|-.|.+..++|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            566777889999999999998874 33499999976543 3334455778999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |-|-||.|+..+..++.  ++...+..++.++++|+.|||.+|   ||.|||||+|++++.+|.+||.|||+|+.+..+.
T Consensus       500 EaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999999998876  888889999999999999999999   9999999999999999999999999999887654


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .    ..+++||+.|.|||++.+...+.++|.||||+++||||+|.+||.+.++......+-.....+            
T Consensus       575 K----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------------  638 (732)
T KOG0614|consen  575 K----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------------  638 (732)
T ss_pred             c----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh------------
Confidence            3    467889999999999999999999999999999999999999999998876555443333322            


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~  327 (380)
                          ..+........+||++.+..+|.+|..     +.+|..|-|-.
T Consensus       639 ----~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  639 ----EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             ----hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence                233455677889999999999999986     88999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=267.46  Aligned_cols=260  Identities=28%  Similarity=0.365  Sum_probs=196.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhc-CCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSK-IEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++.+-++.||.|.||+|++-.++ .|+..|||.++...... ...++..|.....+ -+.||||++||.+-.++..+|.|
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            34455678999999999999987 59999999998776643 34456677766555 47899999999988888999999


Q ss_pred             EeCCCCCHHHHhc---cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          126 EYVGNGTLREHLD---GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       126 e~~~~~~L~~~i~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |.+.- +|+.+-.   ......+++.-.-+|....+.||.||-.  ...|+|||+||+|||++..|.+||||||++..+.
T Consensus       143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence            99954 7766542   2233447888888889999999999987  4459999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhh--hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLR--TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..-    ..+.-.|-..|||||.+.  +..|+-++||||||++|||+.||..|+......-++     ..+. ..++...
T Consensus       220 ~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq-----l~~V-v~gdpp~  289 (361)
T KOG1006|consen  220 DSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ-----LCQV-VIGDPPI  289 (361)
T ss_pred             HHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-----HHHH-HcCCCCe
Confidence            321    123345888999999985  335889999999999999999999999876553221     1111 1111111


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                           +............+..+|..||-.|-.+||.+.+++.+..-
T Consensus       290 -----l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy  330 (361)
T KOG1006|consen  290 -----LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY  330 (361)
T ss_pred             -----ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence                 11111122355678999999999999999999999988653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.9e-35  Score=259.65  Aligned_cols=242  Identities=31%  Similarity=0.440  Sum_probs=196.9

Q ss_pred             CceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhc
Q 041907           60 GSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLD  138 (380)
Q Consensus        60 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~  138 (380)
                      +||.||+|.+.. |+.+++|++........ ...+.+|+..+++++|+|++++++++......++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            589999999874 89999999976654332 5678899999999999999999999999999999999999999999997


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCc
Q 041907          139 GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA  218 (380)
Q Consensus       139 ~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~  218 (380)
                      ....  +++..++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+.......    ......++.
T Consensus        80 ~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~  150 (244)
T smart00220       80 KRGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP  150 (244)
T ss_pred             hccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence            7554  889999999999999999999988   9999999999999999999999999988765432    223455888


Q ss_pred             cccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHH
Q 041907          219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEK  298 (380)
Q Consensus       219 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (380)
                      .|++||.+.+..++.++|||+||+++++|++|..||........      .......+.        ..........+..
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~~~~~~~~~--------~~~~~~~~~~~~~  216 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKPK--------PPFPPPEWKISPE  216 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHHhccC--------CCCccccccCCHH
Confidence            99999999988899999999999999999999999976322211      111111110        0001111114567


Q ss_pred             HHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          299 ILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       299 l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +.+++.+||..+|.+||++.+++++.|
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhhCCC
Confidence            899999999999999999999998654

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=268.58  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchH-HHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKC-LLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ...+|..+..||+|.||+|-+|..+. .+.||||+++++..-.. -..--..|-++|+.. +-|.++.+...|...+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            34578889999999999999999874 67899999987632111 111123566677665 4578899999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+.||+|--.|++.+.  +.+..+..++..|+-||-+||++|   |+.||||..||++|.+|++||+|||+++.--
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999999999998876  788888899999999999999999   9999999999999999999999999997422


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ..   ..+..+.+||+.|+|||++..++|+.++|-|||||+|||||.|++||++.+..+.-..       +.+       
T Consensus       502 ~~---~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a-------I~e-------  564 (683)
T KOG0696|consen  502 FD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA-------IME-------  564 (683)
T ss_pred             cC---CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHH-------
Confidence            22   1234678999999999999999999999999999999999999999998765432211       111       


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILW  325 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~  325 (380)
                       .   ....+..++.+...++...|...|.+|..     -++|-.|.+
T Consensus       565 -h---nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~F  608 (683)
T KOG0696|consen  565 -H---NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPF  608 (683)
T ss_pred             -c---cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcc
Confidence             1   13355667788889999999999999965     345555543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.9e-35  Score=288.63  Aligned_cols=266  Identities=21%  Similarity=0.225  Sum_probs=173.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-C----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEE------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-D----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF------  114 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------  114 (380)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||+|.+........    ...+  .+....+.++..++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~----~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI----WMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH----HHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            5678999999999999999999986 4    68999998764332211    1111  1112222222222211      


Q ss_pred             EEeCCEEEEEEEeCCCCCHHHHhccCCCC------------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 041907          115 LEHGDERIIVVEYVGNGTLREHLDGRGGN------------------GLELAERLDIAIDVAHALTYLHTYSDPPIIHRD  176 (380)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  176 (380)
                      .......++||||+++++|.+++......                  ......+..++.||+.||.|||+.+   |+|||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRD  280 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRD  280 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCc
Confidence            24566789999999999999998754310                  0122345679999999999999988   99999


Q ss_pred             CCCCceeeCC-CCceEEccccccccccCCCcceeeeecccCCccccChhhhhhc----------------------CCCC
Q 041907          177 VKASNILITE-KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY----------------------QLTE  233 (380)
Q Consensus       177 lkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~  233 (380)
                      |||+|||+++ ++.+||+|||+++......  ........+++.|+|||.+...                      .++.
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~--~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGI--NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCcccccccc--ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            9999999986 5789999999997654321  1223456789999999976432                      2345


Q ss_pred             ccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC--CcccccccCCCC-----CCCCHHHHHHHHHHHHHh
Q 041907          234 KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG--DAILVMDPRLRR-----TPASNMAVEKILGLADVC  306 (380)
Q Consensus       234 ~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~c  306 (380)
                      ++|||||||+||||+++..|+....     ..+..........  .+..........     ............+||.+|
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSNL-----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchHH-----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            6799999999999999877654211     0000000000000  000000000000     000001122455899999


Q ss_pred             cCCCCCCCCChHHHHHHHHHH
Q 041907          307 LAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       307 l~~~p~~RPt~~eil~~l~~~  327 (380)
                      |+.||.+|||++++++|.|-.
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~  454 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFD  454 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcC
Confidence            999999999999999999854

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=289.45  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=196.8

Q ss_pred             CCCCCCeeeccCceE-EEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGT-VYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      -|.-.+.+|.|.-|+ ||+|... |+.||||++.....     .-..+|+..|+.- .|||||++++.-.+.+..||..|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~-----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF-----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH-----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            455567789999885 8999997 89999999876432     2356999999987 69999999999999999999999


Q ss_pred             eCCCCCHHHHhccCC-C-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---C--CceEEccccccc
Q 041907          127 YVGNGTLREHLDGRG-G-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---K--LRAKVTDFGFAR  199 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~-~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~--~~~kl~Dfg~~~  199 (380)
                      .|.. +|.+++.... . ........+.++.|++.||++||+.+   ||||||||.||||+.   +  .+++|+|||+++
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9965 9999998841 1 11222455778999999999999988   999999999999976   2  479999999999


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG-RYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .+..+........+..||-+|+|||+++...-+.++|||||||++|+.++| .+||......+...        +.....
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--------l~~~~~  731 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--------LTGNYT  731 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--------hcCccc
Confidence            988765555556678899999999999999889999999999999999995 99998653322111        111100


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      ...      ..+.. ++  +..+||.+|++++|..||++.+|+.|+.
T Consensus       732 L~~------L~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPl  769 (903)
T KOG1027|consen  732 LVH------LEPLP-DC--EAKDLISRMLNPDPQLRPSATDVLNHPL  769 (903)
T ss_pred             eee------eccCc-hH--HHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence            000      11111 12  7889999999999999999999999853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=260.21  Aligned_cols=270  Identities=21%  Similarity=0.321  Sum_probs=221.3

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceE
Q 041907           39 SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF  112 (380)
Q Consensus        39 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  112 (380)
                      ..+++.....+++....+-+|.||.||.|+|++      .+.|.+|.++... .+.....+..|.-++..+.|||+..+.
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            356677777888989999999999999998752      2457778776553 345566788999999999999999999


Q ss_pred             EEEEe-CCEEEEEEEeCCCCCHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 041907          113 GFLEH-GDERIIVVEYVGNGTLREHLDGR------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       113 ~~~~~-~~~~~lv~e~~~~~~L~~~i~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~  185 (380)
                      +++.+ ....+.++.+..-|+|..++...      ..+.++..+...++.|++.|+.|||+++   +||.||-..|.+||
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceeh
Confidence            98755 45678889999999999999732      2334777888899999999999999999   99999999999999


Q ss_pred             CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 041907          186 EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERV  264 (380)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~  264 (380)
                      +...+||+|=.+++-+-+. +..+..........||+||.+....|+.++|||||||++|||+| |+.|+..-+|.+...
T Consensus       431 d~LqVkltDsaLSRDLFP~-DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~  509 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPG-DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH  509 (563)
T ss_pred             hheeEEeccchhccccCcc-cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence            9999999999999866543 33455556667889999999999999999999999999999999 999998877766544


Q ss_pred             HHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      .+.       .|.          +...+.+|+++++.++..||+..|++||++++++.-|.+.-..
T Consensus       510 ylk-------dGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  510 YLK-------DGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             HHh-------ccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            332       221          1234567899999999999999999999999999888765443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.9e-34  Score=275.77  Aligned_cols=268  Identities=20%  Similarity=0.255  Sum_probs=184.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe-----------------CCCCEEEEEEccccCcch--H----------HHHHHHHH
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL-----------------KDGSIVAVKRARKNKHDK--C----------LLLEFKNE   96 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~--~----------~~~~~~~e   96 (380)
                      ..++|.+.++||+|+||.||+|.+                 ..++.||||++.......  .          .......|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            357899999999999999999964                 235679999986543211  0          01123346


Q ss_pred             HHHHhcCCCCce-----eceEEEEEe--------CCEEEEEEEeCCCCCHHHHhccCCC---------------------
Q 041907           97 ILTWSKIEHLNL-----VKLFGFLEH--------GDERIIVVEYVGNGTLREHLDGRGG---------------------  142 (380)
Q Consensus        97 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~i~~~~~---------------------  142 (380)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.+++....+                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777766544     667777643        3567999999999999999875321                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCcccc
Q 041907          143 -NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL  221 (380)
Q Consensus       143 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~  221 (380)
                       ..+++..++.++.|++.+|.|||+.+   ++||||||+|||++.++.+||+|||++.........  ......+|+.|+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~  377 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYS  377 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCccee
Confidence             12456778889999999999999988   999999999999999999999999998754332111  111223578999


Q ss_pred             ChhhhhhcC--------------------C--CCccchhhHHHHHHHHHhCCC-CCCCCCCcchhhH----HHHHHHhhc
Q 041907          222 DPDYLRTYQ--------------------L--TEKSDVYSFGVLLVEMMTGRY-PIESKKPIKERVT----IRWAMQCLK  274 (380)
Q Consensus       222 aPE~~~~~~--------------------~--~~~~DiwSlGvil~elltg~~-p~~~~~~~~~~~~----~~~~~~~~~  274 (380)
                      |||.+....                    +  ..+.||||+||++++|++|.. ||...........    ....+....
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999875432                    1  235799999999999999886 7654322111000    000000000


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCC---CCCCChHHHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTR---QSRPTMKKCAEILWKI  327 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~eil~~l~~~  327 (380)
                      ..         ...............+|+.++|..+|   .+|+|++|+++|.|..
T Consensus       458 ~~---------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        458 GQ---------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             cc---------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            00         00111223345778899999999766   6899999999999853

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=257.02  Aligned_cols=268  Identities=23%  Similarity=0.305  Sum_probs=196.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-----C---CceeceEEEEEe-
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-----H---LNLVKLFGFLEH-  117 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~-  117 (380)
                      ++|.+.++||.|.|++||+|.+. +.+.||+|+.+...   ...+....|+.+|++++     |   ..||++++.|.. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            57889999999999999999986 57889999987542   23344678999999883     3   369999999865 


Q ss_pred             ---CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-------
Q 041907          118 ---GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-------  187 (380)
Q Consensus       118 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-------  187 (380)
                         +.++|+|+|++ |.+|..+|.....++++...+..|+.||+.||.|||.  ..+|||-||||+|||+..+       
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhh
Confidence               56899999999 6699999998888889999999999999999999997  4459999999999998100       


Q ss_pred             --------------------------------------------------------------------------------
Q 041907          188 --------------------------------------------------------------------------------  187 (380)
Q Consensus       188 --------------------------------------------------------------------------------  187 (380)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------------------------------C
Q 041907          188 -------------------------------------------------------------------------------L  188 (380)
Q Consensus       188 -------------------------------------------------------------------------------~  188 (380)
                                                                                                     .
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                           0


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCc------ch
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI------KE  262 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~------~~  262 (380)
                      ++||+|||-|+.+...      .+.-+.|..|+|||++.|..|++.+||||++|++|||+||...|+.....      +-
T Consensus       392 ~vKIaDlGNACW~~kh------FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKH------FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             eEEEeeccchhhhhhh------hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence            1344444444332210      12234688899999999999999999999999999999999999754321      11


Q ss_pred             hhHHHHHH-----HhhccCCcc-ccccc--------CCC----------CCCCCHHHHHHHHHHHHHhcCCCCCCCCChH
Q 041907          263 RVTIRWAM-----QCLKAGDAI-LVMDP--------RLR----------RTPASNMAVEKILGLADVCLAPTRQSRPTMK  318 (380)
Q Consensus       263 ~~~~~~~~-----~~~~~~~~~-~~~~~--------~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  318 (380)
                      ...+....     .....|... ..++.        .++          ....+.....++.+++.-||+.+|++|||+.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            11111100     001111110 11110        011          1223455667888999999999999999999


Q ss_pred             HHHHHHHHH
Q 041907          319 KCAEILWKI  327 (380)
Q Consensus       319 eil~~l~~~  327 (380)
                      ++++|+|.-
T Consensus       546 ~cl~hPwLn  554 (590)
T KOG1290|consen  546 QCLKHPWLN  554 (590)
T ss_pred             HHhcCcccc
Confidence            999999954

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=247.70  Aligned_cols=260  Identities=23%  Similarity=0.312  Sum_probs=201.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHH-HHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCL-LLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      .-++|.+++.||+|.|++|.+++++ +.+.||+|++++.-.++.. +.=.+.|-.+.... +||.+|-+...|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            3457999999999999999999986 5888999999876443321 11234555555544 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +|.||++||+|--.++++..  ++++.++.+...|+.||.|||++|   |+.||||..|||+|..|++||+|+|+++.--
T Consensus       328 fvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999999888877654  999999999999999999999999   9999999999999999999999999997532


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK-ERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...   ....+.+||+.|.|||++++..|...+|-|+|||+++||+.|+.||+...... ....-.+..+.+.+.+    
T Consensus       403 ~~g---d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq----  475 (593)
T KOG0695|consen  403 GPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ----  475 (593)
T ss_pred             CCC---cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc----
Confidence            222   23467899999999999999999999999999999999999999997432111 1111222333332221    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC------hHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT------MKKCAEIL  324 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~eil~~l  324 (380)
                          .+   .+...+-....+++.-|+.||.+|..      +.++..|.
T Consensus       476 ----ir---iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~  517 (593)
T KOG0695|consen  476 ----IR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA  517 (593)
T ss_pred             ----cc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence                11   22333445667788889999999964      55665554

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-33  Score=264.05  Aligned_cols=257  Identities=23%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      |..++.||-|+||.|.++.-- +...||+|.+++... ........+.|-.+|.....+-||++|..|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            667888999999999999743 477899999976532 233445578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc-----
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE-----  202 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-----  202 (380)
                      ++||++-.+|.+.+-  |.+..++.++..|..||++.|..|   +|||||||+|||||.+|++||+|||++.-+.     
T Consensus       711 IPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             cCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999988876  888889999999999999999999   9999999999999999999999999986431     


Q ss_pred             ----CCCcce------------------------------eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHH
Q 041907          203 ----EDSAVS------------------------------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM  248 (380)
Q Consensus       203 ----~~~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell  248 (380)
                          .++...                              ...-...||..|+|||++....|+..+|-||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                100000                              0001136999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHH-hcCCCCCCCC---ChHHHHHHH
Q 041907          249 TGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADV-CLAPTRQSRP---TMKKCAEIL  324 (380)
Q Consensus       249 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~RP---t~~eil~~l  324 (380)
                      .|+.||....+......+.....         .+     ..+....++.+..+||.+ |.  +++.|.   ..++|..|.
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~---------~l-----~~~~~~~ls~e~~~li~kLc~--sad~RLGkng~d~vKaHp  929 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRN---------FL-----HIPYQGNLSKEALDLIQKLCC--SADSRLGKNGADQVKAHP  929 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhh---------cc-----ccccccccCHHHHHHHHHHhc--ChhhhhcccchhhhhcCc
Confidence            99999988877654333211111         11     112222344555566544 43  345554   466788877


Q ss_pred             HHH
Q 041907          325 WKI  327 (380)
Q Consensus       325 ~~~  327 (380)
                      |..
T Consensus       930 fFk  932 (1034)
T KOG0608|consen  930 FFK  932 (1034)
T ss_pred             ccc
Confidence            653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-35  Score=247.55  Aligned_cols=272  Identities=22%  Similarity=0.308  Sum_probs=207.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----CEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----DERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  122 (380)
                      +.+-.+.||-|+||.||.+.+. +|+.|++|++..-...-...+.+.+|+.+|.-++|.|++..+++..-.     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4567889999999999999986 799999999876544444566788999999999999999988875432     2357


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      .++|.+.. +|.+.|..-  ..++...+.-.+.||++||.|||+.+   |.||||||.|+|++.+..+||||||+++..+
T Consensus       134 V~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            78888854 888887654  34888888888999999999999988   9999999999999999999999999999766


Q ss_pred             CCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH--------HHHHhh
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR--------WAMQCL  273 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~~~  273 (380)
                      .+...  -++...-|-.|.|||+++|. .|+.+.||||.|||+.||+.++..|....+.+....+.        ..+...
T Consensus       208 ~d~~~--hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  208 QRDRL--NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             hhhhh--hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            54322  12334568899999999875 58999999999999999999999999988887665542        122222


Q ss_pred             ccCCcccccccCCCCC--------CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRT--------PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .+|...-++....+..        ..+.....+...+..+++..+|.+|.+..+.+.++..-.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            2222211121111111        112233345667888999999999999999998876543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-34  Score=265.05  Aligned_cols=270  Identities=23%  Similarity=0.272  Sum_probs=209.7

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC------CceeceEEEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH------LNLVKLFGFLE  116 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~  116 (380)
                      +....+|.+....|+|-|++|..|.+.. |..||||+++.+...   .+.=..|+.+|++|+.      -++++++-.|.
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3355688899999999999999999874 889999999876433   2234589999999953      47899999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEcc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTD  194 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~D  194 (380)
                      +.+++|||+|-+.- +|.++|...+. .++....+..++.|+..||..|-.+|   |+|.||||.||||++. ..+||||
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD  580 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD  580 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence            99999999999954 99999988763 45888999999999999999999999   9999999999999976 4689999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH----
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM----  270 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----  270 (380)
                      ||.|.....+..     +.+.-...|.|||++.|-+|+...|+||.||+||||.||+..|.+....++..+.....    
T Consensus       581 fGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p  655 (752)
T KOG0670|consen  581 FGSASFASENEI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP  655 (752)
T ss_pred             Cccccccccccc-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence            999876655432     22334567999999999999999999999999999999999998877665543331110    


Q ss_pred             -HhhccCCcc-cccc--------------------------c----------CCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 041907          271 -QCLKAGDAI-LVMD--------------------------P----------RLRRTPASNMAVEKILGLADVCLAPTRQ  312 (380)
Q Consensus       271 -~~~~~~~~~-~~~~--------------------------~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~  312 (380)
                       .++..+.+. +.+|                          |          ..............|.+|+.+||..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence             000000000 0000                          0          0011223345567889999999999999


Q ss_pred             CCCChHHHHHHHH
Q 041907          313 SRPTMKKCAEILW  325 (380)
Q Consensus       313 ~RPt~~eil~~l~  325 (380)
                      +|.|..++|.|++
T Consensus       736 KRit~nqAL~HpF  748 (752)
T KOG0670|consen  736 KRITVNQALKHPF  748 (752)
T ss_pred             hcCCHHHHhcCCc
Confidence            9999999999876

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1e-33  Score=235.08  Aligned_cols=264  Identities=19%  Similarity=0.293  Sum_probs=198.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeC--CEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHG--DERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~  122 (380)
                      .++|++.+++|+|.++.||.|..- ++++++||+++.-.     .+.+.+|+.+|..|. ||||++++++..+.  ....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            468999999999999999999864 68999999997532     345789999999996 99999999998664  4568


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFARMS  201 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~  201 (380)
                      ||+||+++.+...+...     ++..+++.++.+++.||.|+|+.|   |.|||+||.|+++|.. -.++|+|+|+|..+
T Consensus       112 LiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999988666555433     777889999999999999999999   9999999999999965 46999999999988


Q ss_pred             cCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCC-CCCCcchhhHHHHHHHh-------
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIE-SKKPIKERVTIRWAMQC-------  272 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~-~~~~~~~~~~~~~~~~~-------  272 (380)
                      .++...+    -...+..|.-||++-. ..|+..-|+|||||+|..|+..+.||- +.+..++.+.+.....-       
T Consensus       184 Hp~~eYn----VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKEYN----VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCCceee----eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            7654322    1235667888998854 557889999999999999999999875 44555555544211100       


Q ss_pred             -----hccCCcccccccCCCC------CCCC-HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 -----LKAGDAILVMDPRLRR------TPAS-NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 -----~~~~~~~~~~~~~~~~------~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ........+++...+.      .... .....+..+|+.+.|..|-.+|||++|+..|++-.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                 0000001111111110      0111 11236788999999999999999999999998754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=229.67  Aligned_cols=203  Identities=29%  Similarity=0.416  Sum_probs=166.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.......||+|++|.|-+-++. +|...|+|.++..... ...+++.+|+.+..+. .+|.+|.+||.+..+..++|.|
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34445677999999999888875 6999999999876544 3455677888877665 7899999999998899999999


Q ss_pred             EeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |.+.. +|..+-.+.  .+...++.-.-+|+..+.+||.|||++  ..++|||+||+|||++.+|++|+||||++..+.+
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99965 887765432  234488888889999999999999984  4499999999999999999999999999987654


Q ss_pred             CCcceeeeec-ccCCccccChhhhhh----cCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 041907          204 DSAVSHISTQ-VKGTAGYLDPDYLRT----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKP  259 (380)
Q Consensus       204 ~~~~~~~~~~-~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltg~~p~~~~~~  259 (380)
                      .     +..+ -.|-..|||||.+..    ..|+-|+||||||++++||.++++||+....
T Consensus       202 S-----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  202 S-----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             h-----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            2     2222 457889999998853    3688999999999999999999999986654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=261.32  Aligned_cols=205  Identities=24%  Similarity=0.358  Sum_probs=175.2

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcc-hHHHHH-----HHHHHHHHhcCC---CCceec
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHD-KCLLLE-----FKNEILTWSKIE---HLNLVK  110 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~-----~~~e~~~l~~l~---h~niv~  110 (380)
                      +-.+.....|...+.+|+|+||.|++|.++. +..|+||.+.+.+.- +...++     +--|+.+|..++   |+||++
T Consensus       554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK  633 (772)
T KOG1152|consen  554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK  633 (772)
T ss_pred             eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence            3333445568999999999999999999984 667999999776431 111111     457999999996   999999


Q ss_pred             eEEEEEeCCEEEEEEEeC-CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          111 LFGFLEHGDERIIVVEYV-GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~-~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      ++++|++++++||+||.. +|.+|+++|.-++.  +++.++..|++|++.|+++||+.|   |||||||-+||.++.+|-
T Consensus       634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence            999999999999999965 57899999998765  999999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCC
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIE  255 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~  255 (380)
                      +||+|||.+.+...+.     ...+.||..|.|||++.|..|- ..-|||+||++||.++....||.
T Consensus       709 ~klidfgsaa~~ksgp-----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGP-----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcCCC-----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999998766432     3456799999999999999986 56799999999999999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=3.6e-31  Score=229.21  Aligned_cols=212  Identities=36%  Similarity=0.598  Sum_probs=184.3

Q ss_pred             eeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCHH
Q 041907           56 IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLR  134 (380)
Q Consensus        56 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  134 (380)
                      ||.|.+|.||++...+ |+.+++|++....... ....+.+|+..++.+.|++++++++++......++++|++++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            6899999999999874 8999999998765432 3456889999999999999999999999999999999999989999


Q ss_pred             HHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEccccccccccCCCcceeeeec
Q 041907          135 EHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSEEDSAVSHISTQ  213 (380)
Q Consensus       135 ~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~  213 (380)
                      +++.... ..++...++.++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........   ....
T Consensus        80 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~  152 (215)
T cd00180          80 DLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKT  152 (215)
T ss_pred             HHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhc
Confidence            9998653 24889999999999999999999988   999999999999999 89999999999886554321   1233


Q ss_pred             ccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCC
Q 041907          214 VKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPAS  292 (380)
Q Consensus       214 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (380)
                      ..+...|++||.+... .++.+.|+|+||+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4578899999999887 788999999999999998                                             


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          293 NMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       293 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                          ..+.+++..|++.+|.+||++.++++++
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                3477899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=238.46  Aligned_cols=267  Identities=20%  Similarity=0.255  Sum_probs=203.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  118 (380)
                      ...+|.-++.+|.|.- .|-.|.+. .++.||+|++..........+...+|..++..+.|+|+++++.++.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            4467888889999998 66666665 589999999876655555566778999999999999999999988433      


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ...|+|||++. .+|...+...    ++=..+..++.|++.|++|||+.|   |+||||||+||++..+..+||.|||++
T Consensus        94 ~e~y~v~e~m~-~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   94 QEVYLVMELMD-ANLCQVILME----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             HhHHHHHHhhh-hHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            35699999995 4999999832    666788899999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH---------H
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW---------A  269 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~---------~  269 (380)
                      +....    ....+.+..|..|.|||++.+..|.+.+||||+||++.||++|...|.+....++-..+..         .
T Consensus       166 r~e~~----~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  166 RTEDT----DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             cccCc----ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            86443    2345677899999999999998899999999999999999999999987655443222210         0


Q ss_pred             HHh-------hc---cCC---ccccc-ccCCCC-CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          270 MQC-------LK---AGD---AILVM-DPRLRR-TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       270 ~~~-------~~---~~~---~~~~~-~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+.       ..   ...   ....+ |..... ...+......+.+++.+||..+|++|-+++++|.|+-
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY  312 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY  312 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence            000       00   000   00000 111110 1111223355778999999999999999999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-32  Score=230.95  Aligned_cols=255  Identities=23%  Similarity=0.421  Sum_probs=190.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEE-EEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFG-FLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~  122 (380)
                      ..+.|.+.+.||+|.||.+-++.++ ++..+++|.++..-   ...++|.+|...--.| .|.||+..|+ .|...+..+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            4577889999999999999999998 47889999987653   3467889998876666 5899999887 477788889


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--CCCceEEcccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT--EKLRAKVTDFGFARM  200 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~  200 (380)
                      +++||++.|+|.+-+...+   +.+....+++.|++.||.|+|+++   +||||||.+||||-  +..++||||||+.+.
T Consensus        99 F~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            9999999999999988754   888888999999999999999988   99999999999995  345899999999875


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhc-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTY-----QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .+.      ......-+..|.+||.....     ...+.+|||.||+++|.+|||.+||+.....+ ....+|.  ....
T Consensus       173 ~g~------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~--~w~~  243 (378)
T KOG1345|consen  173 VGT------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWE--QWLK  243 (378)
T ss_pred             cCc------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHH--HHhc
Confidence            432      11223356789999977432     34678999999999999999999998433222 2222221  1111


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC---ChHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP---TMKKCAEILW  325 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~eil~~l~  325 (380)
                      +.-     +.+  ...-..+++.+..+.++-|.+++++|-   +.+.....+|
T Consensus       244 rk~-----~~~--P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  244 RKN-----PAL--PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             ccC-----ccC--chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            111     111  111233456788899999999999993   4444444444

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=259.14  Aligned_cols=257  Identities=24%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.....+|.|.||.||++++. .++..|+|+++....+.  ..-+.+|+-+++..+||||+.+++.+......+|+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            3468889999999999999999987 69999999998765544  34567999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||||.||+|.+.-+--+  ++++.++..+.+..++|+.|||+.|   -+|||||=.|||+++.|.+|++|||.+..+...
T Consensus        91 MEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999999876544  4899999999999999999999988   999999999999999999999999988755421


Q ss_pred             CcceeeeecccCCccccChhhh---hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                         -.......||+.|||||+.   +.+.|...+|||++|++..|+---+.|.....+.+...++.      ..     .
T Consensus       166 ---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------kS-----~  231 (829)
T KOG0576|consen  166 ---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------KS-----G  231 (829)
T ss_pred             ---hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------cc-----C
Confidence               1123467899999999976   56789999999999999999988888876666654333221      11     1


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +++..  ........+.+.+|++.||-.+|.+||+++.++.|..
T Consensus       232 ~qpp~--lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~f  273 (829)
T KOG0576|consen  232 FQPPT--LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF  273 (829)
T ss_pred             CCCCc--ccCCccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence            11111  1122345677889999999999999999999887644

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.4e-30  Score=225.50  Aligned_cols=200  Identities=38%  Similarity=0.573  Sum_probs=173.7

Q ss_pred             CCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           50 FSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      |.+.+.||.|++|.||++.... ++.+++|.+...... .....+.+|+..+++++|+|++++++++......++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            5678899999999999999875 899999999876543 23567889999999999999999999999989999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++++|.+++...... +++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+........  
T Consensus        80 ~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--  153 (225)
T smart00221       80 EGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--  153 (225)
T ss_pred             CCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence            999999999875432 788999999999999999999988   99999999999999999999999999887654320  


Q ss_pred             eeeecccCCccccChhhh-hhcCCCCccchhhHHHHHHHHHhCCCCCCC
Q 041907          209 HISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMTGRYPIES  256 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~~  256 (380)
                      .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            012334578899999999 677788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.3e-31  Score=239.21  Aligned_cols=272  Identities=26%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      +....+.|.++++||+|.|++||++.+.    .++.||+|.+......    ..+.+|+++|..+ .+.||+++.+.+..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            4456678999999999999999999864    3678999999765433    3477999999998 68999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEcccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFG  196 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg  196 (380)
                      ++...+||||++...-.++...     ++..++..+++.++.||.++|.+|   ||||||||+|+|++.. +.-.|.|||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            9999999999999888888865     678899999999999999999999   9999999999999854 678999999


Q ss_pred             ccccccCCC------c-------c------------------eee----------eecccCCccccChhhhhhc-CCCCc
Q 041907          197 FARMSEEDS------A-------V------------------SHI----------STQVKGTAGYLDPDYLRTY-QLTEK  234 (380)
Q Consensus       197 ~~~~~~~~~------~-------~------------------~~~----------~~~~~gt~~y~aPE~~~~~-~~~~~  234 (380)
                      ++.......      .       .                  ...          .-...||++|.|||++.+. ..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            998321000      0       0                  000          0123599999999998665 46789


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCCC-cchhhHHHH------HH-HhhccCC--ccc---------------ccc-----c
Q 041907          235 SDVYSFGVLLVEMMTGRYPIESKKP-IKERVTIRW------AM-QCLKAGD--AIL---------------VMD-----P  284 (380)
Q Consensus       235 ~DiwSlGvil~elltg~~p~~~~~~-~~~~~~~~~------~~-~~~~~~~--~~~---------------~~~-----~  284 (380)
                      .||||-|||++-++++++||-.... .+....+..      .. -....|.  ...               .++     +
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999854322 211111100      00 0000111  000               000     0


Q ss_pred             ----CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 ----RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ...........+..+.+|+.+||..||.+|.|+++.|.|.+-
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF  384 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF  384 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence                011111223334578899999999999999999999998763

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4e-30  Score=265.54  Aligned_cols=200  Identities=20%  Similarity=0.227  Sum_probs=142.1

Q ss_pred             CCC-CceeceEEEE-------EeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 041907          103 IEH-LNLVKLFGFL-------EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH  174 (380)
Q Consensus       103 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  174 (380)
                      ++| +||+++++++       .....++++||++ +++|.++|.... ..+++.+++.++.||+.||.|||++|   |+|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---IvH  103 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQG---IVV  103 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            445 5777788876       2334667888988 559999997543 44899999999999999999999998   999


Q ss_pred             ccCCCCceeeCCC-------------------CceEEccccccccccCCCc-----c--------eeeeecccCCccccC
Q 041907          175 RDVKASNILITEK-------------------LRAKVTDFGFARMSEEDSA-----V--------SHISTQVKGTAGYLD  222 (380)
Q Consensus       175 ~dlkp~Nil~~~~-------------------~~~kl~Dfg~~~~~~~~~~-----~--------~~~~~~~~gt~~y~a  222 (380)
                      |||||+||||+..                   +.+|++|||+++.......     .        ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999653                   4556666666653211000     0        000112458899999


Q ss_pred             hhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHH
Q 041907          223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGL  302 (380)
Q Consensus       223 PE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  302 (380)
                      ||++.+..++.++|||||||+||||++|..|+......     +.......        ..      +...........+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~~~~~~~--------~~------~~~~~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MSSLRHRV--------LP------PQILLNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HHHHHHhh--------cC------hhhhhcCHHHHHH
Confidence            99999999999999999999999999998886532111     00000000        00      0001112345678


Q ss_pred             HHHhcCCCCCCCCChHHHHHHHHH
Q 041907          303 ADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       303 i~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      +.+||+.+|.+||++.|++++.|-
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h~~~  268 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQSEFI  268 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhchhh
Confidence            899999999999999999998874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=2.1e-28  Score=207.24  Aligned_cols=170  Identities=22%  Similarity=0.317  Sum_probs=130.2

Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|.+++...+ ..+++..++.++.|++.||.|||+.+         ||+|||++.++.+++  ||++......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence            68999998643 34999999999999999999999865         999999999999999  9998765432      


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                        ...||+.|+|||++.+..++.++|||||||++|||++|..||.........  +..........      .+  ....
T Consensus        63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~------~~--~~~~  130 (176)
T smart00750       63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEILLNGMPAD------DP--RDRS  130 (176)
T ss_pred             --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHHHHHHhccC------Cc--cccc
Confidence              125899999999999999999999999999999999999999755432211  11111111110      00  0011


Q ss_pred             CCHHHHH--HHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          291 ASNMAVE--KILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       291 ~~~~~~~--~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      .......  .+.+++.+||+.+|.+||++.+++++++.+...
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            1223333  689999999999999999999999999987543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-28  Score=212.43  Aligned_cols=266  Identities=20%  Similarity=0.312  Sum_probs=213.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..-+|+++++||+|.||.++.|..- +|+.||||.-......+    +++.|.+..+.| ..++|..+|.+..++-+-.|
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            3468999999999999999999864 79999999987655444    466777777776 56999999988888888899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-----CceEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-----LRAKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-----~~~kl~Dfg~~  198 (380)
                      |+|.+ |-+|.|+..-.+ +.++...++.++.|++.-|+++|.+.   +|.|||||+|+||...     ..+.|+|||+|
T Consensus       102 VidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence            99999 779999887654 45999999999999999999999988   9999999999999743     35899999999


Q ss_pred             ccccCCCcceeee----ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          199 RMSEEDSAVSHIS----TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       199 ~~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      +.+-+.....++.    ....||..||+-..+.|.+.+.+.|+-|||-+++++|-|..||.+..........+    .+.
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe----KIG  252 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE----KIG  252 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH----Hhc
Confidence            9887655444432    45679999999999999999999999999999999999999999877554333222    221


Q ss_pred             cCCcccccccCCCCCCC---CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhc
Q 041907          275 AGDAILVMDPRLRRTPA---SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE  333 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~  333 (380)
                      +.         .+..+.   -..++.++..-+...-..+-.+-|.++-+...+..+......
T Consensus       253 e~---------Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  253 ET---------KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             cc---------cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            11         111111   123567888888888889999999999888887777665443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.4e-27  Score=217.44  Aligned_cols=263  Identities=24%  Similarity=0.284  Sum_probs=200.5

Q ss_pred             CCCCCCeeeccCceEEEEEEeCC--CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC----CceeceEEEE-EeCCEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH----LNLVKLFGFL-EHGDER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~  121 (380)
                      +|.+.+.||+|+||.||++.+..  ...+|+|..........  ..+..|..++..+..    .++..+++.. ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            89999999999999999999875  35799998876433221  145677788777762    5888999888 577889


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-----CceEEcccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-----LRAKVTDFG  196 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-----~~~kl~Dfg  196 (380)
                      ++||+.+ |.+|.++........++...+.+|+.|++.+|.+||+.|   ++||||||.|+++...     ..++|.|||
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            9999998 779999987766566999999999999999999999999   9999999999999865     359999999


Q ss_pred             ccc--cccCCCcce--ee---eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          197 FAR--MSEEDSAVS--HI---STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       197 ~~~--~~~~~~~~~--~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      +++  .+.......  ..   .....||..|+++.++.+.+.+.+.|+||++.++.+++.|..||...........+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            999  432222111  11   12355999999999999999999999999999999999999999766544332222111


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      ......       ..      .....+..+.++...+-..+...+|.+..+...+......
T Consensus       253 ~~~~~~-------~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  253 PRKLLT-------DR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hhhhcc-------cc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            111000       00      1122345566777777779999999999999998776554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3e-27  Score=198.04  Aligned_cols=266  Identities=17%  Similarity=0.256  Sum_probs=209.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC-CceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l  123 (380)
                      ..+.|.+.++||.|.||.+|+|..- +|+.||||+-......+    .+.-|..+...|++ ..|..+..+..+...-.+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            5578999999999999999999964 69999999987665554    35577888888865 688888888888999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEcccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARM  200 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~  200 (380)
                      ||+.+ |-+|.++..-.. +.++...++.++-|++.-|+|+|.++   ++||||||+|+|..-+   ..+.|+|||+++.
T Consensus        89 VMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            99999 779998876443 34999999999999999999999999   9999999999998744   4689999999998


Q ss_pred             ccCCCcceee----eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          201 SEEDSAVSHI----STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       201 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      +.+.....++    .+...||..|.+-..+.+.+.+.+.|+-|+|.+|.++.-|..||++..........+.+.+....-
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST  243 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence            7654433333    345779999999999999999999999999999999999999999887665444443332221110


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      - ..         ..=...+.++.-.+..|-...-++-|+..-+.+.+..+...
T Consensus       244 ~-ie---------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  244 P-IE---------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             C-HH---------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence            0 00         01122456788888999999999999988777766555443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.5e-26  Score=212.93  Aligned_cols=180  Identities=19%  Similarity=0.156  Sum_probs=137.1

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC--CCCEEEEEEccccCc---chHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK--DGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ....++|.+.+.||+|+||+||+|.++  +++.||||++.....   .+.....+.+|+.+|++++|+|+++.+..   .
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence            346688999999999999999999875  477789998753311   22335568999999999999999864322   2


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCceeeCCCCceEEccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV-KASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nil~~~~~~~kl~Dfg~  197 (380)
                      +..++||||++|++|.. +..     ..   ...++.+++++|.|||+.|   |+|||| ||+|||++.++.++|+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            45799999999999963 211     11   1457889999999999998   999999 99999999999999999999


Q ss_pred             cccccCCCcceeee-----ecccCCccccChhhhhhcC------CCCccchh
Q 041907          198 ARMSEEDSAVSHIS-----TQVKGTAGYLDPDYLRTYQ------LTEKSDVY  238 (380)
Q Consensus       198 ~~~~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~------~~~~~Diw  238 (380)
                      ++.+........+.     ....++..|+|||.+.-.+      .+..+|-|
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99776543322221     3566888899999885432      23446666

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=203.18  Aligned_cols=250  Identities=20%  Similarity=0.361  Sum_probs=198.2

Q ss_pred             CCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           51 SPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      .+.-+|.+...|..|+|+|+ |..+++|++..........++|..|.-.|+-+.||||+++++.|....++.++..|++.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34567889999999999998 44567799887766666667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc--cccccccccCCCcce
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT--DFGFARMSEEDSAVS  208 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~  208 (380)
                      |+|+..++++...-.+-.++.+.+..+++|+.|||+.. +-|.-.-|....|++|++.+.+|.  |--++.         
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---------  341 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------  341 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------
Confidence            99999999887766778889999999999999999864 334445689999999999887764  322111         


Q ss_pred             eeeecccCCccccChhhhhhcCCC---CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          209 HISTQVKGTAGYLDPDYLRTYQLT---EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                       ......-.+.||+||.+...+-+   .++|+|||+++||||.|...||....+.+....+      ..+         .
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------ale---------g  405 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------ALE---------G  405 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------hhc---------c
Confidence             11223357899999999876644   5789999999999999999999988776532211      111         1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ++ ...+...+..+.+|+.-|++.||.+||.++.|+-.|++++
T Consensus       406 lr-v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LR-VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cc-ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            11 2234455677889999999999999999999999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=8.1e-28  Score=236.86  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=198.1

Q ss_pred             CCCCeeeccCceEEEEEEeC-CCCEEEEEEcc----ccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           51 SPANKIGEGGSGTVYKGKLK-DGSIVAVKRAR----KNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .....+|.|++|.|+.+... .+..++.|.++    ...........+..|+.+-..+.|+|++..+..+.+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988877654 34445555544    22222222333667888888899999988877666655555569


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |||++ +|+.++...+.  +...++..+++|++.|+.|||..|   +.|||||++|++++.+|.+||+|||.+..+....
T Consensus       401 E~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 99999987633  788888999999999999999999   9999999999999999999999999998765432


Q ss_pred             c-ceeeeecccCCccccChhhhhhcCCCC-ccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          206 A-VSHISTQVKGTAGYLDPDYLRTYQLTE-KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       206 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      . ........+|...|+|||++.+..|++ ..||||.|++++.|++|+.||......+....     ...    ......
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~----~~~~~~  545 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNN----YSDQRN  545 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhc----cccccc
Confidence            1 124456788999999999999999996 57999999999999999999987665443220     000    000011


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...........++...+.+|.++|+++|.+|.|+++|++..|..
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~  589 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR  589 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence            11111224455677788999999999999999999999999954

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=5e-24  Score=196.94  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=202.0

Q ss_pred             CCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchH-HHHHHHHHHHHHhcCCCC-ceeceEEEEEeCCEEEEEEEe
Q 041907           50 FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHL-NLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  127 (380)
                      |.+.+.||.|+|+.||++.+.  ..+++|.+........ ....+.+|+..+..+.|+ +++++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999987  7799999987765543 566788999999999988 799999999888778999999


Q ss_pred             CCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEccccccccccCCC
Q 041907          128 VGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMSEEDS  205 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  205 (380)
                      +.+++|.+++..... ..+.......++.+++.++.++|..+   ++|||+||+||+++..+ .++++|||++.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765532 14888999999999999999999998   99999999999999988 79999999998654432


Q ss_pred             ccee---eeecccCCccccChhhhhh---cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhccCCc
Q 041907          206 AVSH---ISTQVKGTAGYLDPDYLRT---YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK-ERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       206 ~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  278 (380)
                      ....   ......||..|++||.+.+   ..+....|+|++|++++++++|..||....... ..............   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            2111   2356779999999999988   578899999999999999999999977655310 00111111110000   


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEI  323 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~  323 (380)
                        ......... ........+.+++..|+..+|..|.+..+....
T Consensus       234 --~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000000 002233568889999999999999999888776

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=229.04  Aligned_cols=259  Identities=21%  Similarity=0.257  Sum_probs=190.4

Q ss_pred             HHHHHHHhc-CCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHH--HhcCCCCceeceEEEEE
Q 041907           40 FEEIYKATE-NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT--WSKIEHLNLVKLFGFLE  116 (380)
Q Consensus        40 ~~~~~~~~~-~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~  116 (380)
                      ++.++..-. +|...+.||++.|=+|.+|++++|. |+||++-+.... .....+.+++.-  ...++|||++++..+-.
T Consensus        14 ~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   14 VEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             HHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHH
Confidence            344443333 7889999999999999999999888 889998665432 123334443333  44568999999998877


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      .....|+|-+|+.. +|+|.|..++.  +...+...|+.||+.||..+|..|   |+|||||.+||||+....+.|+||.
T Consensus        92 t~kAAylvRqyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             hhHHHHHHHHHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhccc
Confidence            77788999999976 99999987765  788888999999999999999999   9999999999999999999999999


Q ss_pred             ccccc--cC--CCcceeeeecccCCccccChhhhhhc----------C-CCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 041907          197 FARMS--EE--DSAVSHISTQVKGTAGYLDPDYLRTY----------Q-LTEKSDVYSFGVLLVEMMT-GRYPIESKKPI  260 (380)
Q Consensus       197 ~~~~~--~~--~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlGvil~ellt-g~~p~~~~~~~  260 (380)
                      ..+-.  ..  .........+...-.+|.|||.+...          . .+++.||||+||+++||++ |++||....  
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--  243 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--  243 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--
Confidence            77532  21  22233334455566789999988531          1 6789999999999999998 788885321  


Q ss_pred             chhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 041907          261 KERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEI  323 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~  323 (380)
                          ++.+...  ...+...++..-         ....+++||..|++.||.+|.++++.|+.
T Consensus       244 ----L~aYr~~--~~~~~e~~Le~I---------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 ----LLAYRSG--NADDPEQLLEKI---------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ----HHhHhcc--CccCHHHHHHhC---------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                1111000  000000111100         01247789999999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=3.8e-24  Score=184.90  Aligned_cols=174  Identities=14%  Similarity=0.169  Sum_probs=135.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHH-HHH------HHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-LLE------FKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||.|+||.||++.. ++..+|||+++........ ...      +.+|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            568999999999999999999766 5778999999765443322 122      57999999999999999999886533


Q ss_pred             --------CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 041907          119 --------DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA  190 (380)
Q Consensus       119 --------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~  190 (380)
                              +..+|+|||++|.+|.++..      ++.    ....+++.+|..||..|   ++|+|++|+||+++.+| +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence                    35789999999999988732      222    24669999999999999   99999999999999988 9


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT  249 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  249 (380)
                      +|+|||...........               ..+.....|..++|||+||+++..+..
T Consensus       174 ~liDfg~~~~~~e~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchhhH---------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            99999987654321110               113444456679999999999887653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1e-23  Score=180.03  Aligned_cols=142  Identities=14%  Similarity=0.162  Sum_probs=109.8

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHH------------------------HHHHHHHHHHHhcCCCCce
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL------------------------LLEFKNEILTWSKIEHLNL  108 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ni  108 (380)
                      .+.||+|+||.||+|.+.+|+.||||+++........                        ......|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5789999999999999888999999999765321100                        1123459999999988776


Q ss_pred             eceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeccCCCCceeeCCC
Q 041907          109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL-HTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      .....+...  ..+|||||++++++...+...  ..++...+..++.|++.+|.+| |+.|   |+||||||+|||++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence            443333222  238999999987776553322  2488899999999999999999 6888   99999999999998 4


Q ss_pred             CceEEcccccccccc
Q 041907          188 LRAKVTDFGFARMSE  202 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~  202 (380)
                      +.++|+|||++....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=5.3e-23  Score=183.04  Aligned_cols=234  Identities=20%  Similarity=0.287  Sum_probs=151.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCC----------CceeceEEEE-
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEH----------LNLVKLFGFL-  115 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~-  115 (380)
                      .+...+.||.|+++.||.+.+. +|+.+|||++..... .....+.+++|......+.+          -.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456788999999999999997 499999999865442 22245667777666555322          1222222221 


Q ss_pred             --------EeCC--------EEEEEEEeCCCCCHHHHhcc---CCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 041907          116 --------EHGD--------ERIIVVEYVGNGTLREHLDG---RGG--NGLELAERLDIAIDVAHALTYLHTYSDPPIIH  174 (380)
Q Consensus       116 --------~~~~--------~~~lv~e~~~~~~L~~~i~~---~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  174 (380)
                              ....        +.+++|+-+. ++|.+++..   ...  ..+....++.+..|+++.+++||..|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                    1111        2367888874 488888643   211  12344455667789999999999999   999


Q ss_pred             ccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhc--------CCCCccchhhHHHHHHH
Q 041907          175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY--------QLTEKSDVYSFGVLLVE  246 (380)
Q Consensus       175 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwSlGvil~e  246 (380)
                      +||+|+|++++.+|.++|+||+.....+..      ......+..|.|||.....        .++.+.|.|+||+++|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            999999999999999999999977654321      1113456889999977542        47889999999999999


Q ss_pred             HHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC
Q 041907          247 MMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSR  314 (380)
Q Consensus       247 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  314 (380)
                      |++|..||+...+......                     .-.... ..++.+..||..+|+.+|.+|
T Consensus       243 lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999986543221100                     112234 778899999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=1.9e-22  Score=172.77  Aligned_cols=143  Identities=19%  Similarity=0.217  Sum_probs=112.0

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEccccCcch------------------------HHHHHHHHHHHHHhcCCCCc
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK------------------------CLLLEFKNEILTWSKIEHLN  107 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~n  107 (380)
                      +.+.||+|+||.||+|.+.+|+.||||+++......                        .....+..|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            357899999999999998889999999998653210                        00122457899999999998


Q ss_pred             eeceEEEEEeCCEEEEEEEeCCCCCHHHH-hccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeC
Q 041907          108 LVKLFGFLEHGDERIIVVEYVGNGTLREH-LDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       108 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~  185 (380)
                      +.....+....  .++||||++|+++... +..   ..++......++.+++.++.+||. .|   |+|+||||+||+++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            75444433332  4899999998755443 332   237788899999999999999999 88   99999999999999


Q ss_pred             CCCceEEccccccccccC
Q 041907          186 EKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~  203 (380)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.1e-21  Score=166.01  Aligned_cols=191  Identities=14%  Similarity=0.116  Sum_probs=143.1

Q ss_pred             CCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchH--HHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEEe
Q 041907           51 SPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC--LLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      .+...|++|+||+||++.. .+.+++.+.+........  ....+.+|+++|+++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999998776 588888888776544211  1224789999999995 4789999886    346999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCceeeCCCCceEEccccccccccCCCc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV-KASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      +.|.+|...+..         ....++.+++.+|.++|.+|   |+|+|| ||+|||++.++.++|+|||++........
T Consensus        80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999988754421         11347889999999999999   999999 79999999999999999999986554321


Q ss_pred             ceeee----------ecccCCccccChhhhhhc-CCC-CccchhhHHHHHHHHHhCCCCCCCCC
Q 041907          207 VSHIS----------TQVKGTAGYLDPDYLRTY-QLT-EKSDVYSFGVLLVEMMTGRYPIESKK  258 (380)
Q Consensus       207 ~~~~~----------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlGvil~elltg~~p~~~~~  258 (380)
                      .....          -....++.|+.|+..+.- ..+ .+.+-++-|.-+|.++|+..+...+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            10000          012367888888866543 334 46688899999999999999876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.8e-23  Score=195.39  Aligned_cols=226  Identities=22%  Similarity=0.273  Sum_probs=182.8

Q ss_pred             eeccCceEEEEEEe----CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           56 IGEGGSGTVYKGKL----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        56 lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +|.|.||.|+++.-    ..|..||+|++++.............|..++..++ ||.++++...+......++++++..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            78999999998752    24788999998765433221223457778888886 99999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |.|...+.....  +.......+...++.++.++|+.+   ++|+|+|++||+++.+|++++.|||+++..-...     
T Consensus        82 g~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   82 GDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             chhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            999988877654  777777788899999999999999   9999999999999999999999999998643321     


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                        ..+||..|||||+++  .....+|-||||++.++|++|..||..    +....   + ..              ...+
T Consensus       152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~---I-l~--------------~~~~  205 (612)
T KOG0603|consen  152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR---I-LK--------------AELE  205 (612)
T ss_pred             --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH---H-hh--------------hccC
Confidence              127999999999999  567889999999999999999999986    11000   0 00              1234


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCCh
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTM  317 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~  317 (380)
                      .+......+..++..++..+|.+|...
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            566777888999999999999999764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=3.3e-21  Score=182.12  Aligned_cols=218  Identities=27%  Similarity=0.425  Sum_probs=162.2

Q ss_pred             HhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 041907          100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKA  179 (380)
Q Consensus       100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  179 (380)
                      |+.+.|.|+.+++|.+.+.+..++|.+||..|+|.+.+.... ..+++.-...+++.|+.||.|||+-  +-..|+.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeecc
Confidence            457899999999999999999999999999999999998744 3488888889999999999999973  3349999999


Q ss_pred             CceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcC-------CCCccchhhHHHHHHHHHhCCC
Q 041907          180 SNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-------LTEKSDVYSFGVLLVEMMTGRY  252 (380)
Q Consensus       180 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlGvil~elltg~~  252 (380)
                      .|+++|....+||+|||+........ .............|.|||.+++..       .+.++||||||++++|+++...
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999987664310 011112223456799999998642       4678999999999999999999


Q ss_pred             CCCCCCCcchh-hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          253 PIESKKPIKER-VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       253 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ||......... ..+.+    +.. .....+.+...   ......+++..++..||..+|..||+++.|-..+..+.+
T Consensus       157 ~~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~---~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILR----VKK-GGSNPFRPSIE---LLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHH----HHh-cCCCCcCcchh---hhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            99764332221 11111    111 01111111111   111344578899999999999999999999887776644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3e-21  Score=194.50  Aligned_cols=202  Identities=19%  Similarity=0.241  Sum_probs=163.7

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC---CCceeceEEEEEe
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE---HLNLVKLFGFLEH  117 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  117 (380)
                      .+.....+.|.|.+.||+|+||+||+|...+|+.||+|+-+....++-.+.     .+++.||+   -+.|..+...+..
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~-----~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC-----LQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh-----HHHHHhhchhhhcchHHHHHHHcc
Confidence            455667889999999999999999999998899999999987766543222     22333333   3456666666677


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-------CCce
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-------KLRA  190 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-------~~~~  190 (380)
                      .+..+||+||.+.|+|.++++..+  .+++..++.+..|++..|.+||..+   ||||||||+|+|+..       ...+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence            778899999999999999999544  4899999999999999999999998   999999999999942       3459


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP  253 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  253 (380)
                      +|+|||.+.-+.-.... .......+|-.+--+|...|.+++..+|.|.|+.+++-||.|++-
T Consensus       841 ~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99999988654322221 234556789999999999999999999999999999999998743

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-21  Score=173.43  Aligned_cols=196  Identities=20%  Similarity=0.245  Sum_probs=140.3

Q ss_pred             CCCceeceEEEEEe---------------------------CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHH
Q 041907          104 EHLNLVKLFGFLEH---------------------------GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAID  156 (380)
Q Consensus       104 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~  156 (380)
                      .|||||++.++|.+                           +..+|+||..++. +|..++-.+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999886532                           2246999998866 9999997654   666777789999


Q ss_pred             HHHHHHHHhhCCCCCeeeccCCCCceeeC--CCC--ceEEccccccccccCCCcce---eeeecccCCccccChhhhhhc
Q 041907          157 VAHALTYLHTYSDPPIIHRDVKASNILIT--EKL--RAKVTDFGFARMSEEDSAVS---HISTQVKGTAGYLDPDYLRTY  229 (380)
Q Consensus       157 i~~~l~~LH~~~~~~i~H~dlkp~Nil~~--~~~--~~kl~Dfg~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~  229 (380)
                      +++|+.|||++|   |.|||+|.+|||+.  +++  .+.|+|||.+-.-..-....   .-.-...|....||||+....
T Consensus       350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999999   99999999999984  333  57899999764322100000   001124577889999998654


Q ss_pred             C-----CC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHH
Q 041907          230 Q-----LT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLA  303 (380)
Q Consensus       230 ~-----~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  303 (380)
                      +     .+ .|+|.|+.|.+.||+++...||......-....- +.             ..  .....+..++..+.+|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yq-------------e~--qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQ-------------ES--QLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hh-------------hh--hCCCCcccCChHHHHHH
Confidence            3     22 5899999999999999999999863322111100 00             01  11334556778899999


Q ss_pred             HHhcCCCCCCCCChHHHHH
Q 041907          304 DVCLAPTRQSRPTMKKCAE  322 (380)
Q Consensus       304 ~~cl~~~p~~RPt~~eil~  322 (380)
                      ...|+.||.+|++..-..+
T Consensus       491 ~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HHHhcCCccccCCccHHHh
Confidence            9999999999998554433

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=7.1e-20  Score=157.83  Aligned_cols=134  Identities=18%  Similarity=0.220  Sum_probs=104.2

Q ss_pred             CCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-----CCCceeceEEEEEeCC---EE
Q 041907           51 SPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-----EHLNLVKLFGFLEHGD---ER  121 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~  121 (380)
                      .-.+.||+|+|+.||.  ++ ++.. +||++......  ....+.+|+.+++.+     .||||++++|++.++.   .+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            4467899999999995  54 3444 79988764332  245688999999999     5799999999998863   43


Q ss_pred             E-EEEEe--CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeeccCCCCceeeCC----CCceEEc
Q 041907          122 I-IVVEY--VGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL-TYLHTYSDPPIIHRDVKASNILITE----KLRAKVT  193 (380)
Q Consensus       122 ~-lv~e~--~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlkp~Nil~~~----~~~~kl~  193 (380)
                      + +|+||  +.+++|.+++.+..   +++.  ..++.+++.++ .|||+++   |+||||||+|||++.    ++.++|+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence            4 78999  55799999997632   5544  35677888777 9999998   999999999999974    3479999


Q ss_pred             cccc
Q 041907          194 DFGF  197 (380)
Q Consensus       194 Dfg~  197 (380)
                      ||+-
T Consensus       152 Dg~G  155 (210)
T PRK10345        152 DNIG  155 (210)
T ss_pred             ECCC
Confidence            9543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=2.3e-19  Score=154.81  Aligned_cols=148  Identities=20%  Similarity=0.217  Sum_probs=115.0

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcch--------------------HHHHHHHHHHHH
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK--------------------CLLLEFKNEILT   99 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~   99 (380)
                      +.++......|.+.+.||.|+||.||++.+.+|+.||||+++......                    .....+..|+..
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            455655666699999999999999999998889999999876532110                    011225678888


Q ss_pred             HhcCCCC--ceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 041907          100 WSKIEHL--NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV  177 (380)
Q Consensus       100 l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  177 (380)
                      +..+.|+  .++..++.    ...+++|||++|++|......        .....++.+++.++.++|+.|   ++|+||
T Consensus        87 l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl  151 (198)
T cd05144          87 LKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDL  151 (198)
T ss_pred             HHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence            8888777  44444442    345899999999998766431        234568899999999999988   999999


Q ss_pred             CCCceeeCCCCceEEcccccccccc
Q 041907          178 KASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       178 kp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +|.||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.1e-19  Score=156.67  Aligned_cols=136  Identities=21%  Similarity=0.371  Sum_probs=113.5

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcch------HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK------CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      +.||+|++|.||+|.+ .|..+++|+........      .....+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 47789999865432211      1123477899999999999988777777777788999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      ++|++|.+++....     . ....++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986532     2 77889999999999999988   99999999999999 78899999998764

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=4e-19  Score=156.83  Aligned_cols=148  Identities=18%  Similarity=0.194  Sum_probs=112.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEE--eCCCCEEEEEEccccCcc----------------------hHHHHHHHHHHHHHh
Q 041907           46 ATENFSPANKIGEGGSGTVYKGK--LKDGSIVAVKRARKNKHD----------------------KCLLLEFKNEILTWS  101 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~  101 (380)
                      ....|.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                      ......+..|+..+.
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            33458999999999999999998  457999999998754311                      001123568999999


Q ss_pred             cCCCC--ceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 041907          102 KIEHL--NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKA  179 (380)
Q Consensus       102 ~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp  179 (380)
                      ++.+.  .+.+++++   . ..++||||+++++|........  .+....+..++.+++.+|.+||..|  .++|+||||
T Consensus       106 ~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      106 RLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            99753  33444443   2 3489999999988876653322  2566677889999999999999643  299999999


Q ss_pred             CceeeCCCCceEEcccccccccc
Q 041907          180 SNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       180 ~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=5.2e-20  Score=182.64  Aligned_cols=211  Identities=24%  Similarity=0.349  Sum_probs=149.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..+|...+.|..|+||-||+++++. .+.+|+|+-+++..       +++   ++.....|.+|                
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-------lRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-------LRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccchh-------hhc---cccccCCccee----------------
Confidence            4678888999999999999999884 67788854322111       111   22222333333                


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                           |+-..++...+..+.+          ++.+++|||+.|   |+|||+||+|++|+.-|++|++|||+++.-....
T Consensus       136 -----gDc~tllk~~g~lPvd----------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVD----------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             -----chhhhhcccCCCCcch----------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                 4666666665543222          278899999988   9999999999999999999999999987532211


Q ss_pred             cc------------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 041907          206 AV------------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       206 ~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ..            .......+||+.|.|||++..+.|...+|=|++|+|+|+++.|+.||.+..+.+....+-..    
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----  273 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----  273 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----
Confidence            11            01123468999999999999999999999999999999999999999988776532221110    


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  316 (380)
                                 .....+.....+.++.++|.+.|+.+|..|.-
T Consensus       274 -----------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  274 -----------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -----------hccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                       00011112334467889999999999999943

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=7.7e-19  Score=151.64  Aligned_cols=132  Identities=20%  Similarity=0.346  Sum_probs=106.8

Q ss_pred             eeeccCceEEEEEEeCCCCEEEEEEccccCcc------hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           55 KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD------KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      .||+|+||.||+|.+. |..+++|........      ......+.+|+.++..+.|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3899999999999964 788999986543211      112345778999999999887655555555666778999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      +|++|.+++.....         .++.+++.+|.+||+.|   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998754321         68999999999999988   99999999999999 78999999998875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=4.7e-20  Score=171.40  Aligned_cols=180  Identities=28%  Similarity=0.426  Sum_probs=130.9

Q ss_pred             CEEEEEEEeCCCCCHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGR-GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      .++||.|++|.-.+|.++|... .....++...+.+++|++.++.|   ++   .+|+|+||.||++..+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999743 34557888899999999999999   77   99999999999999999999999999


Q ss_pred             cccccCCCcc---eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhh
Q 041907          198 ARMSEEDSAV---SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       198 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ..........   ..-.+...||..||+||.+.+..|+.|+||||||++|+||+. =..+|+...          ...-+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence            8766543311   111345679999999999999999999999999999999997 222222110          00001


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                      ..+    .+.+.     ...+. ..-..|+.+++.+.|.+||++.+..-+.
T Consensus       473 r~g----~ip~~-----~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~  513 (516)
T KOG1033|consen  473 RDG----IIPPE-----FLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHE  513 (516)
T ss_pred             hcC----CCChH-----HhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhh
Confidence            111    11100     01111 2234788999999999999665554443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=2.4e-18  Score=170.20  Aligned_cols=146  Identities=21%  Similarity=0.338  Sum_probs=115.1

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEc-cccCc-----chHHHHHHHHHHHHHhcCCCCceeceEE
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRA-RKNKH-----DKCLLLEFKNEILTWSKIEHLNLVKLFG  113 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~  113 (380)
                      +.........|...+.||+|+||.||++.+..+. +++|+. .....     .......+.+|+.++..++|++++..+.
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            3333444556677899999999999999886443 444432 21111     1122345789999999999999988877


Q ss_pred             EEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                      ++......++||||+++++|.+++.          ....++.+++.+|.+||+.+   ++||||||+|||+ .++.++|+
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence            7777777899999999999999885          34578999999999999988   9999999999999 57799999


Q ss_pred             ccccccc
Q 041907          194 DFGFARM  200 (380)
Q Consensus       194 Dfg~~~~  200 (380)
                      |||+++.
T Consensus       470 DFGla~~  476 (535)
T PRK09605        470 DFGLGKY  476 (535)
T ss_pred             eCccccc
Confidence            9999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=2.6e-20  Score=183.91  Aligned_cols=264  Identities=20%  Similarity=0.241  Sum_probs=203.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC--CCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..|.+.+.||+|.|+.|-+.....  ...+|+|.+...............|..+-..+. |.|++.+++...+....+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456667779999999998887642  455777776555433333444556777777776 99999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeeccCCCCceeeCCCC-ceEEcccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH-TYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMSE  202 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  202 (380)
                      +++..++++.+.+........+...+-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||++..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999994222223666677789999999999999 888   99999999999999999 99999999999877


Q ss_pred             CCCcceeeeecccC-CccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          203 EDSAVSHISTQVKG-TAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       203 ~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ............+| ++.|+|||...+..+ .+..|+||.|+++..+++|..||.........              ...
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------------~~~  242 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------------YSS  242 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------------cee
Confidence            63333344455667 999999999988544 57889999999999999999999866544321              111


Q ss_pred             ccccCCC-CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          281 VMDPRLR-RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       281 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ++..... .............+++.+++..+|..|.+.+++....|...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            2222111 12234445566788999999999999999999999988776

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=1.8e-17  Score=141.56  Aligned_cols=138  Identities=20%  Similarity=0.260  Sum_probs=98.7

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHH----------------------HHHHHHHHhcCCCC--ce
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE----------------------FKNEILTWSKIEHL--NL  108 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~--ni  108 (380)
                      .+.||+|+||.||+|.+.+|+.||||+++...........                      ...|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5789999999999999888999999998754322111111                      13455556555443  24


Q ss_pred             eceEEEEEeCCEEEEEEEeCCCCCHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCC
Q 041907          109 VKLFGFLEHGDERIIVVEYVGNGTLRE-HLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITE  186 (380)
Q Consensus       109 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~  186 (380)
                      .+.++.    ...++||||++++.+.. .+....   .. ..+..++.+++.++.++|. .+   ++|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            445543    23589999999854321 121111   11 5677899999999999998 87   99999999999999 


Q ss_pred             CCceEEcccccccccc
Q 041907          187 KLRAKVTDFGFARMSE  202 (380)
Q Consensus       187 ~~~~kl~Dfg~~~~~~  202 (380)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.4e-16  Score=139.43  Aligned_cols=137  Identities=17%  Similarity=0.165  Sum_probs=105.3

Q ss_pred             CCeee-ccCceEEEEEEeCCCCEEEEEEccccCc-----------chHHHHHHHHHHHHHhcCCCCce--eceEEEEEeC
Q 041907           53 ANKIG-EGGSGTVYKGKLKDGSIVAVKRARKNKH-----------DKCLLLEFKNEILTWSKIEHLNL--VKLFGFLEHG  118 (380)
Q Consensus        53 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  118 (380)
                      ...|| .||.|+||.+... +..++||.+.....           .......+.+|+.++.++.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 8999999999886 77899998854221           11223457789999999998775  6677664432


Q ss_pred             C----EEEEEEEeCCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          119 D----ERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       119 ~----~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                      .    ..++|||+++| .+|.+++....   ++..    .+.+|+.+|.+||+.|   |+|+||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~---l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP---LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC---CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 68998886532   4433    3678999999999999   9999999999999998899999


Q ss_pred             ccccccc
Q 041907          194 DFGFARM  200 (380)
Q Consensus       194 Dfg~~~~  200 (380)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.8e-16  Score=130.03  Aligned_cols=135  Identities=21%  Similarity=0.243  Sum_probs=112.4

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC--CceeceEEEEEeCCEEEEEEEeCC
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH--LNLVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      +.+.||.|.++.||++...+ ..+++|.......    ...+.+|+..+..++|  .++++++++....+..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            46789999999999999864 7799999866543    3457789999999976  588999998888788999999998


Q ss_pred             CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       130 ~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      ++.+..+         +......++.+++.++..||.....+++|+|++|.||++++.+.+++.|||.+..
T Consensus        77 g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8766544         4456667899999999999985334499999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.2e-14  Score=139.38  Aligned_cols=143  Identities=21%  Similarity=0.285  Sum_probs=100.3

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchH----------------------------H----------HHHHH
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC----------------------------L----------LLEFK   94 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------~----------~~~~~   94 (380)
                      .+.||.|++|.||+|+.++|+.||||+.+......-                            .          ..++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            468999999999999999999999999875421100                            0          01244


Q ss_pred             HHHHHHhcCC----CCceeceEEEE-EeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHhhCC
Q 041907           95 NEILTWSKIE----HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH-ALTYLHTYS  168 (380)
Q Consensus        95 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~  168 (380)
                      +|+..+.+++    |.+-+.+-.++ ......+|||||++|++|.++...... ..+   ...++..++. .+..+|..|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCC
Confidence            5666555552    32222222222 224457899999999999887653211 122   2345666665 468899888


Q ss_pred             CCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       169 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                         ++|+|++|.||+++.++.++|+|||++..+.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=8.4e-15  Score=139.04  Aligned_cols=254  Identities=22%  Similarity=0.239  Sum_probs=185.2

Q ss_pred             CCCCCCeeec--cCceEEEEEEe--C-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           49 NFSPANKIGE--GGSGTVYKGKL--K-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        49 ~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      .+.+.+.+|.  |.+|.||.+..  . ++..+|+|.-+.....+.....=.+|+...+++ .|+|.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4667888999  99999999987  4 588899998544333222222234677777777 5999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH----ALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGF  197 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~  197 (380)
                      +-+|++. .+|..+....... ++....+..+.+...    |+.++|..+   ++|-|+||.||+...+ ...+++|||+
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~-~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNF-LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeecccc-chhHHhhhccccc-CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence            9999995 6888888776543 677788888888888    999999888   9999999999999998 8899999999


Q ss_pred             cccccCCCcceee--eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          198 ARMSEEDSAVSHI--STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       198 ~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ...+.........  .....|...|++||..++ -++...|||+||.++.+..++..+........      |  ...  
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W--~~~--  338 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------W--SQL--  338 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------c--ccc--
Confidence            9887765422221  223468889999999887 56889999999999999988876653221000      0  000  


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                             +........-..-...+...+..+++.+|..|++.+.+..+-.
T Consensus       339 -------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~  381 (524)
T KOG0601|consen  339 -------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV  381 (524)
T ss_pred             -------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence                   0000000011111234455888999999999999988876543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=8.3e-15  Score=128.94  Aligned_cols=207  Identities=22%  Similarity=0.300  Sum_probs=143.7

Q ss_pred             HHHHhcCCCCceeceEEEEEe-----CCEEEEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 041907           97 ILTWSKIEHLNLVKLFGFLEH-----GDERIIVVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSD  169 (380)
Q Consensus        97 ~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~  169 (380)
                      ...|-.+-|.|||++..|+.+     .....++.||+..|+|..+|++..  ...+......+|+.||+.||.|||+. +
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            344556679999999988754     345789999999999999998643  33467777788999999999999998 4


Q ss_pred             CCeeeccCCCCceeeCCCCceEEccccccccccCC--CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHH
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEED--SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEM  247 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el  247 (380)
                      ++++|+++....|++..+|-+|+.--.-.. ....  .....-.....+-++|.+||.-.....+.++|||+||...++|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            889999999999999999888875321110 0000  0000001123467899999988887888899999999999999


Q ss_pred             HhCCCC-CCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          248 MTGRYP-IESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       248 ltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ..+..- -...........+.......+.         .            .-++++.+|++..|..||+|++++.|+-.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~len---------~------------lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGLEN---------G------------LQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeeccC---------c------------cccCcCcccccCCCCCCcchhhhhcCcee
Confidence            887654 2222222222221111111111         0            12257788999999999999999877543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=4.1e-14  Score=137.45  Aligned_cols=146  Identities=18%  Similarity=0.235  Sum_probs=95.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcc----------------------------h----HHHH---
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHD----------------------------K----CLLL---   91 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~~---   91 (380)
                      ..|.. +.||+|++|.||+|.+++ |+.||||+++.....                            .    ....   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999987 999999999755211                            0    0111   


Q ss_pred             ---HHHHHHHHHhcCC----CCceeceEEEEEe-CCEEEEEEEeCCCCCHHHH--hccCCCCCCCHHHHHHHHHHHHH-H
Q 041907           92 ---EFKNEILTWSKIE----HLNLVKLFGFLEH-GDERIIVVEYVGNGTLREH--LDGRGGNGLELAERLDIAIDVAH-A  160 (380)
Q Consensus        92 ---~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~--i~~~~~~~~~~~~~~~i~~~i~~-~  160 (380)
                         ++.+|+..+.+++    +.+.+.+-.++.+ ....+|||||+.|+.|.++  +...+   .+...   ++...+. -
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~---la~~~v~~~  272 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMKL---LAERGVEVF  272 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHHH---HHHHHHHHH
Confidence               1344554444442    3333443343332 4567899999999999874  33222   22222   1222111 2


Q ss_pred             HHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEccccccccccC
Q 041907          161 LTYLHTYSDPPIIHRDVKASNILITEKL----RAKVTDFGFARMSEE  203 (380)
Q Consensus       161 l~~LH~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~  203 (380)
                      +..+...|   ++|+|++|.||+++.++    .++++|||+...+..
T Consensus       273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33445567   99999999999999888    999999999886653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=5.3e-13  Score=113.15  Aligned_cols=139  Identities=13%  Similarity=0.181  Sum_probs=100.4

Q ss_pred             CCeeeccCceEEEEEEeCC-------CCEEEEEEccccCcc--------------------hHHHHH----HHHHHHHHh
Q 041907           53 ANKIGEGGSGTVYKGKLKD-------GSIVAVKRARKNKHD--------------------KCLLLE----FKNEILTWS  101 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~--------------------~~~~~~----~~~e~~~l~  101 (380)
                      ...||.|..+.||.|...+       +..+|||+.+.....                    ......    ..+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            5679999999999998653       478999997643210                    001122    238999999


Q ss_pred             cCCC--CceeceEEEEEeCCEEEEEEEeCCCCCHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeccC
Q 041907          102 KIEH--LNLVKLFGFLEHGDERIIVVEYVGNGTLRE-HLDGRGGNGLELAERLDIAIDVAHALTYL-HTYSDPPIIHRDV  177 (380)
Q Consensus       102 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~i~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dl  177 (380)
                      ++..  -++..++++    ...+|||||+.+..+.. .+...   .++......+..+++.+|..| |..|   ++|+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            8854  466677765    34589999997643322 23221   245556677889999999988 8888   999999


Q ss_pred             CCCceeeCCCCceEEcccccccccc
Q 041907          178 KASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       178 kp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ++.||+++ ++.+.|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.47  E-value=9.2e-13  Score=126.55  Aligned_cols=164  Identities=19%  Similarity=0.244  Sum_probs=125.7

Q ss_pred             CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHH
Q 041907           71 DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER  150 (380)
Q Consensus        71 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  150 (380)
                      ++.+|.|+.......  .......+.+..|+.++||||+++++.++..+..|||+|.+.  .|..++.+.+     ....
T Consensus        36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v  106 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV  106 (690)
T ss_pred             cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence            578888888876554  233446788999999999999999999999999999999983  6777887644     4566


Q ss_pred             HHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcC
Q 041907          151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ  230 (380)
Q Consensus       151 ~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  230 (380)
                      ..-+.||+.||.+||+  ++.++|++|.-..|+|+..|+.||++|.++........   ......---.|..|+.+....
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc
Confidence            6678999999999986  44499999999999999999999999998765432211   111112223456666554333


Q ss_pred             CCCccchhhHHHHHHHHHhC
Q 041907          231 LTEKSDVYSFGVLLVEMMTG  250 (380)
Q Consensus       231 ~~~~~DiwSlGvil~elltg  250 (380)
                        ...|.|-|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=2.7e-13  Score=113.72  Aligned_cols=131  Identities=18%  Similarity=0.248  Sum_probs=96.0

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCcee-ceEEEEEeCCEEEEEEEeCCCC
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV-KLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .+.|+.|.++.||++... +..|++|........   ...+..|+..+..+.+.+++ +++.+.  ....++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            356889999999999876 778999997654321   12356888888888655544 455443  23357999999998


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS--DPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      ++...    .   ..   ...++.+++++|..||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        77 ~l~~~----~---~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTE----D---FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc----c---cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            77543    0   11   1235789999999999876  12359999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=9.8e-14  Score=131.82  Aligned_cols=248  Identities=23%  Similarity=0.240  Sum_probs=179.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC--CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK--DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .+|..+..||.|.|+.|+....+  ++..|++|.+.+..........-..|+.+...+ .|.+++..+..+......|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            47889999999999999987643  588899999987765543333344566666655 688888888777777778899


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccccccccC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFARMSEE  203 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  203 (380)
                      .|||+++++...+.-.  ..++....+++..+++.++.++|+..   ++|+|++|+||++..+ +..++.|||....+..
T Consensus       345 ~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             hhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccce
Confidence            9999998887777322  23788888999999999999999888   9999999999999886 7889999998864221


Q ss_pred             CCcceeeeecccCCccc-cChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCC-CCCCcchhhHHHHHHHhhccCCcccc
Q 041907          204 DSAVSHISTQVKGTAGY-LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE-SKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ..     .....++..| .+++......+..++|++|||..+.+.+++..--. ......                    
T Consensus       420 ~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~--------------------  474 (524)
T KOG0601|consen  420 SS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT--------------------  474 (524)
T ss_pred             ec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee--------------------
Confidence            11     1112233344 36666677788899999999999999999865322 111100                    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      +  .....+........+..+.+.+...++..||.+.++..+....
T Consensus       475 i--~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  475 I--RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             e--ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            0  0011122222336677788889999999999998877665543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.43  E-value=2.4e-12  Score=105.08  Aligned_cols=145  Identities=20%  Similarity=0.245  Sum_probs=110.2

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEcccc-Ccc-----hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKN-KHD-----KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ....|-+|+.+.|+++.+. |+...||.-... -..     ........+|++.|.++.--.|.-..=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678899999999999997 888777754322 111     223445779999999987656654444555666667999


Q ss_pred             EeCCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEcccccccc
Q 041907          126 EYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAKVTDFGFARM  200 (380)
Q Consensus       126 e~~~~-~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~  200 (380)
                      ||++| .++.+++...............++..|-+.|.-||..+   ++||||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 58889988776544444444678999999999999888   99999999999997665   358999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=8.2e-12  Score=102.47  Aligned_cols=133  Identities=22%  Similarity=0.305  Sum_probs=99.7

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEcc-ccCcchH-----HHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRAR-KNKHDKC-----LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      ..+++|+-+.++.+.+. |..+++|.-. +.-..+.     ....-.+|+.++.++.--.|.-.+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999876 5456666432 2222221     223356899999988766665555455666777899999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      ++|..|.+.+....         ..++..+-.-+.-||..|   |+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEAR---------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhcc---------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998987651         346777777788999999   99999999999999764 99999999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.36  E-value=1.1e-10  Score=106.73  Aligned_cols=262  Identities=16%  Similarity=0.207  Sum_probs=166.6

Q ss_pred             CCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEE------EEeC-CEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGF------LEHG-DER  121 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~  121 (380)
                      ....+.||+|+.+.+|-.-.- +..|| |+.......-.     .+.+..|... .||-+-.-+.+      .-.. ...
T Consensus        13 i~~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             cCCCccccCCccceeeecchh-hchhh-eeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            355788999999999864322 22244 77765433211     1223334333 45543321111      1122 236


Q ss_pred             EEEEEeCCCCC-HHHHhc----cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          122 IIVVEYVGNGT-LREHLD----GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       122 ~lv~e~~~~~~-L~~~i~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      .++|..+++.. +..+..    ++......|.-.++++..|+.+...||..|   .+-+|+.++|+||++++.|.|.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccc
Confidence            78898887742 222222    122233789999999999999999999999   9999999999999999999998755


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhC-CCCCCCCCC-----cchhhH
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTG-RYPIESKKP-----IKERVT  265 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg-~~p~~~~~~-----~~~~~~  265 (380)
                      ...+...    ........|...|.+||.-+     +..-+...|.|.||+++|++|.| ++||.+-..     ......
T Consensus       163 sfqi~~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         163 SFQINAN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             ceeeccC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            4433221    22334567899999999765     44556789999999999999986 999965321     111101


Q ss_pred             HHHHHHhhccCCcccccc--cCCC---CCCCCHHHHHHHHHHHHHhcCCC--CCCCCChHHHHHHHHHHHhhhh
Q 041907          266 IRWAMQCLKAGDAILVMD--PRLR---RTPASNMAVEKILGLADVCLAPT--RQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~l~~li~~cl~~~--p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      +       ..+.....-+  ....   .......++..+..|..+|+...  +.-|||++.++..|..+..++.
T Consensus       239 I-------a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         239 I-------AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             h-------hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            1       1111111111  1111   12233556678888889998763  5689999999999988876554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=1.9e-11  Score=107.10  Aligned_cols=143  Identities=21%  Similarity=0.273  Sum_probs=109.2

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC--CceeceEEEEEeC---CEEEEEEEeC
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH--LNLVKLFGFLEHG---DERIIVVEYV  128 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~  128 (380)
                      +.|+.|..+.||++...+|+.+++|........ .....+..|+.++..+.+  .++.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999999876688999998654321 123457789999998865  3467777776654   2568999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS----------------------------------------  168 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  168 (380)
                      +|.++.+.+..   ..++......++.+++++|..||+..                                        
T Consensus        83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            99888776642   12667777778888888888888531                                        


Q ss_pred             -------------CCCeeeccCCCCceeeCC--CCceEEcccccccc
Q 041907          169 -------------DPPIIHRDVKASNILITE--KLRAKVTDFGFARM  200 (380)
Q Consensus       169 -------------~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~  200 (380)
                                   ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         134799999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.29  E-value=7.8e-13  Score=132.33  Aligned_cols=251  Identities=19%  Similarity=0.212  Sum_probs=171.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.+.+.+.+-+|.++.++.+.-.. |...+.|+......- .........+-.++-...+|-++....-+......+|++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            555666788899999998877542 433444433221100 000111222223333334566665554455567889999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC-
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED-  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  204 (380)
                      +|+.+++|...++..+.  .+..-++.....+..+.++||...   +.|+|++|.|.|...++..+++|||......-- 
T Consensus       884 ~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             HHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccccc
Confidence            99999999999988774  555555667778889999999877   899999999999999999999999843322100 


Q ss_pred             --Ccc-------------------------eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 041907          205 --SAV-------------------------SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK  257 (380)
Q Consensus       205 --~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~  257 (380)
                        ...                         ........||+.|.+||...+......+|.|++|++++|.++|..||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence              000                         00112246899999999999999999999999999999999999999887


Q ss_pred             CCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChH
Q 041907          258 KPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMK  318 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  318 (380)
                      .+.+..       +.+.        .........+.....+..+++...+..+|.+|..+.
T Consensus      1039 tpq~~f-------~ni~--------~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIF-------ENIL--------NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             chhhhh-------hccc--------cCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            664321       1111        111122334445566788899999999999998776

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.24  E-value=2.2e-10  Score=102.58  Aligned_cols=142  Identities=18%  Similarity=0.169  Sum_probs=100.9

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHH---------HHHHHHHHHHHhcCCCCc--eeceEEEEEe-----
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL---------LLEFKNEILTWSKIEHLN--LVKLFGFLEH-----  117 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~n--iv~~~~~~~~-----  117 (380)
                      +.+-......|+++.+ +|+.|.||...........         ...+.+|...+.++..-+  ++.++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4455444555777666 4888999977443321100         013668888888874433  3455555543     


Q ss_pred             CCEEEEEEEeCCCC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-------CCc
Q 041907          118 GDERIIVVEYVGNG-TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-------KLR  189 (380)
Q Consensus       118 ~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-------~~~  189 (380)
                      ....+||||++++. +|.+++......+.+......++.+++..+..||..|   ++|+|+++.|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            23468999999885 8999986433333566777789999999999999999   999999999999975       467


Q ss_pred             eEEccccccc
Q 041907          190 AKVTDFGFAR  199 (380)
Q Consensus       190 ~kl~Dfg~~~  199 (380)
                      +.|+||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999775

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=2.6e-10  Score=96.40  Aligned_cols=128  Identities=27%  Similarity=0.350  Sum_probs=83.5

Q ss_pred             EEEEEEeCCCCEEEEEEccccCc------------------------chHHHHHHHHHHHHHhcCCCC--ceeceEEEEE
Q 041907           63 TVYKGKLKDGSIVAVKRARKNKH------------------------DKCLLLEFKNEILTWSKIEHL--NLVKLFGFLE  116 (380)
Q Consensus        63 ~V~~~~~~~~~~vavK~~~~~~~------------------------~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  116 (380)
                      .||.|...+|..+|||+.+....                        .........+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999998899999998764311                        111123367899999999765  566676553 


Q ss_pred             eCCEEEEEEEeCC--CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          117 HGDERIIVVEYVG--NGTLREHLDGRGGNGLELAERLDIAIDVAHALTY-LHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       117 ~~~~~~lv~e~~~--~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                         ..+|||||++  |..+..+....    ++......++.+++..+.. +|..|   ++||||.+.||+++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence               2369999998  65554443322    1233445677788885554 67888   9999999999999987 99999


Q ss_pred             ccccccccc
Q 041907          194 DFGFARMSE  202 (380)
Q Consensus       194 Dfg~~~~~~  202 (380)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.14  E-value=1.6e-09  Score=101.64  Aligned_cols=167  Identities=20%  Similarity=0.299  Sum_probs=126.1

Q ss_pred             eEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE----eCCEEEEEEEeCCC-CCHHH
Q 041907           62 GTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE----HGDERIIVVEYVGN-GTLRE  135 (380)
Q Consensus        62 g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~~L~~  135 (380)
                      .+.|++... +|..|++|+++.....  .......-++.++++.|+|||++.+++.    ....+++|++|.++ ++|.+
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            578999865 7999999999432211  1111235578899999999999999876    34567999999986 67777


Q ss_pred             HhccC-C------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          136 HLDGR-G------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       136 ~i~~~-~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +-... .            +...++...|.++.||..||.++|+.|   +..+-|.|.+||++.+.+++|...|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            65321 1            223678899999999999999999999   9999999999999999899999999877655


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP  253 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  253 (380)
                      .+.          +       |-+.+   -.+-|.=.||.+++.|.||..-
T Consensus       445 ~d~----------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDP----------T-------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------C-------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            432          0       11111   2356889999999999999654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.08  E-value=8.8e-10  Score=95.96  Aligned_cols=140  Identities=22%  Similarity=0.186  Sum_probs=104.0

Q ss_pred             CCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCc--------------------chHHHHHHHHHHHHHhcCCCC--
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKH--------------------DKCLLLEFKNEILTWSKIEHL--  106 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h~--  106 (380)
                      -+.++.+||-|.-+.||.|.+..|.++|||.=+....                    -...+...++|...|.+|.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3567899999999999999999999999997442211                    011234467899999998655  


Q ss_pred             ceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC
Q 041907          107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE  186 (380)
Q Consensus       107 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~  186 (380)
                      .|.+.+++-    .-.+|||+++|..|...--       +....-.++..|+.-+..+-..|   +||+|+++-||++++
T Consensus       172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIAWN----RHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCccccc----cceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            777777653    4579999999866654431       22333445666666666666778   999999999999999


Q ss_pred             CCceEEcccccccccc
Q 041907          187 KLRAKVTDFGFARMSE  202 (380)
Q Consensus       187 ~~~~kl~Dfg~~~~~~  202 (380)
                      +|.+.++||-.+....
T Consensus       238 dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         238 DGDIVVIDWPQAVPIS  253 (304)
T ss_pred             CCCEEEEeCcccccCC
Confidence            9999999998765433

>PRK09902 hypothetical protein; Provisional

Probab=98.99  E-value=1.3e-08  Score=86.61  Aligned_cols=155  Identities=15%  Similarity=0.136  Sum_probs=111.0

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcc----hHHHHHHHHHHHHHhcCCCC--ceeceEE
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD----KCLLLEFKNEILTWSKIEHL--NLVKLFG  113 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~--niv~~~~  113 (380)
                      |+.+-.....+-..-.-|+||.+-|+..... |..+-+|........    +....-|.+|+..|.++..-  .+.+++ 
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-   87 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-   87 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-
Confidence            3444444444444455678999999998776 557999987521110    22345588899998888532  244544 


Q ss_pred             EEE-e----CCEEEEEEEeCCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          114 FLE-H----GDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       114 ~~~-~----~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      ++. .    ....+||+|-++| .+|.+++.+....+.+......++.+++.+|.-||..|   +.|+|+-+.||+++.+
T Consensus        88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~  164 (216)
T PRK09902         88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTE  164 (216)
T ss_pred             eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCC
Confidence            332 1    1235799997763 68988887765445677888899999999999999999   9999999999999866


Q ss_pred             Cc--eEEccccccc
Q 041907          188 LR--AKVTDFGFAR  199 (380)
Q Consensus       188 ~~--~kl~Dfg~~~  199 (380)
                      +.  +.++||.-++
T Consensus       165 g~~~v~lIDlEk~r  178 (216)
T PRK09902        165 GKAEAGFLDLEKSR  178 (216)
T ss_pred             CCeeEEEEEhhccc
Confidence            66  9999998665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.96  E-value=5.2e-09  Score=101.44  Aligned_cols=140  Identities=21%  Similarity=0.312  Sum_probs=95.9

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcch----------------------------HH----------HHHHHH
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK----------------------------CL----------LLEFKN   95 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------~~----------~~~~~~   95 (380)
                      ..|+.++-|.||+|.+++|+.||||+.+.+-...                            ..          ..++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            7899999999999999999999999987543210                            00          112445


Q ss_pred             HHHHHhcCC-----CCceeceEEEE-EeCCEEEEEEEeCCCCCHHHHh--ccCCCCCCCHHHHHHHHHHHHHH-HHHHhh
Q 041907           96 EILTWSKIE-----HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHA-LTYLHT  166 (380)
Q Consensus        96 e~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~i--~~~~~~~~~~~~~~~i~~~i~~~-l~~LH~  166 (380)
                      |+..+.+++     .+++ .+=.+| +......|+|||++|-.+.+..  ...+   .+...   ++..++++ +..+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k~---ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRKE---LAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHHH---HHHHHHHHHHHHHHh
Confidence            555555542     2333 222222 3356678999999998888874  4432   55433   33333333 334444


Q ss_pred             CCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       167 ~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      .|   ++|.|..|.||+++.+|++.+.|||+...+..
T Consensus       284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            56   99999999999999999999999999876654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=8.3e-09  Score=89.34  Aligned_cols=124  Identities=20%  Similarity=0.226  Sum_probs=90.2

Q ss_pred             CCEEEEEEccccCcch-----HHHHHHHHHHHHHhcCCC--CceeceEEEEEeC----CEEEEEEEeCCC-CCHHHHhcc
Q 041907           72 GSIVAVKRARKNKHDK-----CLLLEFKNEILTWSKIEH--LNLVKLFGFLEHG----DERIIVVEYVGN-GTLREHLDG  139 (380)
Q Consensus        72 ~~~vavK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~i~~  139 (380)
                      ++.|.+|.........     .......+|...+.++..  -.+++.+++.+..    ...+||+|++++ .+|.+++..
T Consensus        32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~  111 (206)
T PF06293_consen   32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ  111 (206)
T ss_pred             ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence            5667777543221111     122346677777777643  3356666666542    245899999988 479999987


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEcccccccc
Q 041907          140 RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAKVTDFGFARM  200 (380)
Q Consensus       140 ~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~  200 (380)
                      ...  .+......++.+++..+.-||..|   |+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       112 ~~~--~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  112 WEQ--LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hcc--cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            443  556677789999999999999999   99999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=2.6e-10  Score=110.40  Aligned_cols=156  Identities=20%  Similarity=0.315  Sum_probs=107.7

Q ss_pred             HHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeec------ccCCccccChhhhh
Q 041907          154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ------VKGTAGYLDPDYLR  227 (380)
Q Consensus       154 ~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~------~~gt~~y~aPE~~~  227 (380)
                      +.+++.|+.++|.  ...+||++|.|++|.++.++..||+.|+.+...............      ..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4455589999998  667999999999999999999999999987655442221111111      12356799999999


Q ss_pred             hcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHh
Q 041907          228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVC  306 (380)
Q Consensus       228 ~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  306 (380)
                      +...+.++|+|||||++|.+.. |..-+........     +.....       ..+.  .........+.++.+=+.++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~~-------~~~~--~~~~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSRN-------LLNA--GAFGYSNNLPSELRESLKKL  248 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhhc-------cccc--ccccccccCcHHHHHHHHHH
Confidence            9888899999999999999994 5544443321110     000000       0011  11223356778899999999


Q ss_pred             cCCCCCCCCChHHHHHHHH
Q 041907          307 LAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       307 l~~~p~~RPt~~eil~~l~  325 (380)
                      +..++..||++.++...+.
T Consensus       249 l~~~~~~rp~~~~l~~~~f  267 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLSIPF  267 (700)
T ss_pred             hcCCcccCcchhhhhcccc
Confidence            9999999998877766543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.91  E-value=1.4e-08  Score=87.60  Aligned_cols=152  Identities=21%  Similarity=0.257  Sum_probs=103.1

Q ss_pred             HHHHHHHhcCCCC---CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHH-----------------HHH-----HH
Q 041907           40 FEEIYKATENFSP---ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----------------LLE-----FK   94 (380)
Q Consensus        40 ~~~~~~~~~~~~~---~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-----------------~~~-----~~   94 (380)
                      .+.+.....+..+   ..+|+.|..+.||+|...++..+|+|+.+.....-..                 ...     ..
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            3444444444443   3456688889999999888999999998754321111                 000     24


Q ss_pred             HHHHHHhcCC--CCceeceEEEEEeCCEEEEEEEeCCCC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCC
Q 041907           95 NEILTWSKIE--HLNLVKLFGFLEHGDERIIVVEYVGNG-TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDP  170 (380)
Q Consensus        95 ~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~  170 (380)
                      +|+..|.++.  +-.+.+.+++.    ...|||||+... .-.-.|...   ++...++..+..++++.+.-|-. .+  
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~--  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAG--  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence            6777777763  44566666655    347999999653 111122222   23444677888899999988887 66  


Q ss_pred             CeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          171 PIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       171 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                       +||+||+.-|||+. ++.+.|+|||-+....
T Consensus       188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -cccccchhhheEEE-CCeEEEEECccccccC
Confidence             99999999999999 7899999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.73  E-value=2.5e-07  Score=81.17  Aligned_cols=138  Identities=17%  Similarity=0.200  Sum_probs=85.3

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc--eeceEEEEEeCCEEEEEEEeCCCC
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN--LVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      ..||.|..+.||+.   .|..+++|.......    .....+|.+.++.+..-+  +.+.+++....+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999984   245688898865432    234578999998885433  577788887788889999999986


Q ss_pred             C-HHHHh---------------------ccCCCCCCCHHHHH-HHHH----------HHHHH-HHHHhhC-CCCCeeecc
Q 041907          132 T-LREHL---------------------DGRGGNGLELAERL-DIAI----------DVAHA-LTYLHTY-SDPPIIHRD  176 (380)
Q Consensus       132 ~-L~~~i---------------------~~~~~~~~~~~~~~-~i~~----------~i~~~-l~~LH~~-~~~~i~H~d  176 (380)
                      + +...+                     +............. ++..          .+... ..+|... ....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 21111                     11100011111100 0000          01111 1222211 124579999


Q ss_pred             CCCCceeeCCCCceEEccccccc
Q 041907          177 VKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       177 lkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.72  E-value=9.3e-08  Score=81.79  Aligned_cols=139  Identities=17%  Similarity=0.214  Sum_probs=91.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHH-HH------HHHHHHHHHhcC---CCCceeceEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-LL------EFKNEILTWSKI---EHLNLVKLFGFL  115 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~------~~~~e~~~l~~l---~h~niv~~~~~~  115 (380)
                      ..++|.+.+.+-......|.+.... |..+++|..+......+. ..      ...+.+..+.++   ..-....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4567888888888887778777765 788999998765432211 11      122333333333   222333333222


Q ss_pred             -----EeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCce
Q 041907          116 -----EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA  190 (380)
Q Consensus       116 -----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~  190 (380)
                           ......+++|||++|..|.+...      ++.    .+...+.+++..||..|   ++|+|+.|.|+++++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence                 22344568999999987766532      221    24566778899999999   99999999999999654 9


Q ss_pred             EEccccccc
Q 041907          191 KVTDFGFAR  199 (380)
Q Consensus       191 kl~Dfg~~~  199 (380)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=1.7e-07  Score=90.81  Aligned_cols=140  Identities=20%  Similarity=0.324  Sum_probs=92.8

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcch-----------------------------HH------HHHHHHHH
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK-----------------------------CL------LLEFKNEI   97 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------------~~------~~~~~~e~   97 (380)
                      .+.||.-..|.||+|+.++|+.||||+.+..-...                             +.      ..+|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            47899999999999999999999999977543211                             00      11133444


Q ss_pred             HHHhcC----CCCc------eeceEEEEEeCCEEEEEEEeCCCCCHHHH--hccCCCCCCCHHHHHHHHHHHHHHH-HHH
Q 041907           98 LTWSKI----EHLN------LVKLFGFLEHGDERIIVVEYVGNGTLREH--LDGRGGNGLELAERLDIAIDVAHAL-TYL  164 (380)
Q Consensus        98 ~~l~~l----~h~n------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--i~~~~~~~~~~~~~~~i~~~i~~~l-~~L  164 (380)
                      +...++    .|-+      |.+++-  .......|+|||++|..+.+.  |.+.+   ++...+   +..+.++. ..+
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i---~~~l~~~~~~qI  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDI---LNKLVEAYLEQI  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHH---HHHHHHHHHHHH
Confidence            443333    3444      333332  224567899999999877665  44444   555544   44444432 233


Q ss_pred             hhCCCCCeeeccCCCCceeeCC----CCceEEccccccccccC
Q 041907          165 HTYSDPPIIHRDVKASNILITE----KLRAKVTDFGFARMSEE  203 (380)
Q Consensus       165 H~~~~~~i~H~dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~  203 (380)
                      =..|   ++|+|-.|.||++..    ++.+.+.|||+......
T Consensus       318 f~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 FKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            3445   999999999999994    56899999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=1.8e-06  Score=75.97  Aligned_cols=141  Identities=19%  Similarity=0.207  Sum_probs=82.6

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC--ceeceEEEE---EeCCEEEEEEEeC
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL--NLVKLFGFL---EHGDERIIVVEYV  128 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~---~~~~~~~lv~e~~  128 (380)
                      +.|+.|..+.||++...+ ..+++|.....    .....+..|..++..+...  .+.+++.+.   ......+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            578999999999999986 68999997654    2344566888887777432  356666644   3345678999999


Q ss_pred             CCCCHHH----------------Hh---ccC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHh
Q 041907          129 GNGTLRE----------------HL---DGR--GGNGLELAER---------LDI------------AIDVAH-ALTYLH  165 (380)
Q Consensus       129 ~~~~L~~----------------~i---~~~--~~~~~~~~~~---------~~i------------~~~i~~-~l~~LH  165 (380)
                      +|..+..                .+   +..  ...+......         ...            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   111  1111111000         000            111222 233333


Q ss_pred             h----CCCCCeeeccCCCCceeeC-CCCceEEccccccc
Q 041907          166 T----YSDPPIIHRDVKASNILIT-EKLRAKVTDFGFAR  199 (380)
Q Consensus       166 ~----~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~  199 (380)
                      .    .....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    1234599999999999999 56666799999765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.45  E-value=2.7e-06  Score=75.66  Aligned_cols=139  Identities=17%  Similarity=0.148  Sum_probs=84.4

Q ss_pred             eeeccCc-eEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEEeCCCCC
Q 041907           55 KIGEGGS-GTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEYVGNGT  132 (380)
Q Consensus        55 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~  132 (380)
                      .|..|.. +.||+.... +..+.||+.....     ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            4555665 689998765 5778889876542     123557888877773 3446677877776667899999999987


Q ss_pred             HHHHhc-------------------cCCC--CCCCHH--HHHHHHH--------------------HHHHHHHHHhh---
Q 041907          133 LREHLD-------------------GRGG--NGLELA--ERLDIAI--------------------DVAHALTYLHT---  166 (380)
Q Consensus       133 L~~~i~-------------------~~~~--~~~~~~--~~~~i~~--------------------~i~~~l~~LH~---  166 (380)
                      |.....                   ....  .++...  .......                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            764421                   1110  011100  0000000                    01111122211   


Q ss_pred             -CCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          167 -YSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       167 -~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                       .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             112459999999999999998778899999765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.43  E-value=1.8e-06  Score=70.79  Aligned_cols=131  Identities=19%  Similarity=0.299  Sum_probs=93.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceec-eEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK-LFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e  126 (380)
                      ...++.+.|++|++|.||++.|. |..+|+|+-+.+..    ...+..|+++|..+.-.++.+ +|.|..    -.+.||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me   92 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME   92 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeecc-CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence            34456788999999999999998 66899998776543    346788999998887666644 444432    245699


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC-C-CceeeCCCCceEEcccccccc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK-A-SNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-p-~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      |+.|..|.+.....     +    .+-+..+++.-.-|...|   |-|+.|. | .||++.+ +.+.|+||..|..
T Consensus        93 ~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            99998887765432     1    223455666666677667   9999987 4 4555554 4999999998873

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.34  E-value=8.3e-08  Score=92.48  Aligned_cols=185  Identities=19%  Similarity=0.162  Sum_probs=131.2

Q ss_pred             CCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc-eeceEEEEEeCCEEEEEEEeCC
Q 041907           51 SPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-LVKLFGFLEHGDERIIVVEYVG  129 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~  129 (380)
                      .....+++|+++++++.+...-+...++.+...       ....-++++|.+++||| .+..++-+..+...++.++++.
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            334557899999999987643233335555432       34457889999999999 7777777888889999999998


Q ss_pred             CC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          130 NG-TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       130 ~~-~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      ++ +........ ...+...+...+...-++++++||+-.   -+|+|    ||+..+ +..+..||+....+....   
T Consensus       318 ~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  318 TGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             CCccccccCChh-hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence            76 221111110 011333333445566677899999754   58988    777765 678999999887665432   


Q ss_pred             eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCC
Q 041907          209 HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE  255 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  255 (380)
                       ..+...+|..++|||+...+.+..+.|+|++|+--.++--|..|-.
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence             2455679999999999999999999999999987777777776643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.32  E-value=1.4e-05  Score=68.16  Aligned_cols=135  Identities=23%  Similarity=0.353  Sum_probs=92.2

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEccccC--------------cchHHHHHHHHHHHHHhcCC------CCceece
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKNK--------------HDKCLLLEFKNEILTWSKIE------HLNLVKL  111 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~niv~~  111 (380)
                      -...||.|+.-.||.  ++++...+||+.....              .......+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            356799999988875  4456668899987765              00111344556666555554      7899999


Q ss_pred             EEEEEeCCEEEEEEEeCC------CCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 041907          112 FGFLEHGDERIIVVEYVG------NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~------~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~  185 (380)
                      +|+.+++-...+|+|.+.      .-+|.+++....   ++. .....+.   .-..+|-..+   |+.+|++|.||++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999999864      246888885543   444 3333333   4455666666   99999999999996


Q ss_pred             CCC----ceEEcc-cccc
Q 041907          186 EKL----RAKVTD-FGFA  198 (380)
Q Consensus       186 ~~~----~~kl~D-fg~~  198 (380)
                      ...    .+.|+| ||..
T Consensus       153 ~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             ecCCCceEEEEEeCCCCc
Confidence            432    467776 5643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=3.4e-06  Score=71.59  Aligned_cols=102  Identities=26%  Similarity=0.244  Sum_probs=81.4

Q ss_pred             HHHHHHHhcCCC-CceeceEEEEEeCCEEEEEEEeCCCCCHHHH---hccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 041907           94 KNEILTWSKIEH-LNLVKLFGFLEHGDERIIVVEYVGNGTLREH---LDGRGGNGLELAERLDIAIDVAHALTYLHTYSD  169 (380)
Q Consensus        94 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~---i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~  169 (380)
                      .+|..+++.+.+ +++++++|+|    ..+++.||...+++...   +...  ...+|..+.+|+.++++.+.+|+....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            468888888876 6999999999    33678999987666432   1111  127899999999999999999998544


Q ss_pred             CCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ..+.-.|++++|+-++++|++|++|.......
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            44888999999999999999999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=1.3e-05  Score=67.92  Aligned_cols=127  Identities=27%  Similarity=0.385  Sum_probs=90.8

Q ss_pred             cCCCCCCeeeccCc-eEEEEEEeCCCCEEEEEEccc---cCc-------c--h-------HHHHHHHHHHHHHhcCC---
Q 041907           48 ENFSPANKIGEGGS-GTVYKGKLKDGSIVAVKRARK---NKH-------D--K-------CLLLEFKNEILTWSKIE---  104 (380)
Q Consensus        48 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~-------~--~-------~~~~~~~~e~~~l~~l~---  104 (380)
                      ..++..+.||.|.- |.||++... |+.||+|+++.   ...       .  .       .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78899999999999 999999987 78999999321   100       0  0       12234778888777664   


Q ss_pred             CCce--eceEEEEEeC------------------CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 041907          105 HLNL--VKLFGFLEHG------------------DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL  164 (380)
Q Consensus       105 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~L  164 (380)
                      +.++  |+.+||..-.                  ....||.||.+...           .+...    -+.++.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHH
Confidence            4566  8899987322                  12367788776643           12222    356777788899


Q ss_pred             hhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       165 H~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      |..|   |+-+|+++.|..     .=+|+|||.+
T Consensus       181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCC---eeeccCcccccc-----CCEEEecccC
Confidence            9999   999999999997     4589999853

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=2.1e-05  Score=82.20  Aligned_cols=80  Identities=13%  Similarity=0.258  Sum_probs=57.1

Q ss_pred             CCeeeccCceEEEEEEeCCC---CEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCce--eceEEEEEeC---CEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKDG---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNL--VKLFGFLEHG---DERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l  123 (380)
                      .+.++.|.++.+|+....++   ..+++|+........ ....+.+|+.+|+.+. |.++  .+++.++.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            56788999999999887643   467888765432211 1235779999999885 6654  7788877654   46789


Q ss_pred             EEEeCCCCCH
Q 041907          124 VVEYVGNGTL  133 (380)
Q Consensus       124 v~e~~~~~~L  133 (380)
                      ||||++|..+
T Consensus       122 VME~v~G~~~  131 (822)
T PLN02876        122 IMEYLEGRIF  131 (822)
T ss_pred             EEEecCCccc
Confidence            9999988643

>PRK10593 hypothetical protein; Provisional

Probab=98.20  E-value=3.5e-05  Score=70.59  Aligned_cols=80  Identities=14%  Similarity=0.171  Sum_probs=57.1

Q ss_pred             CCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC---CceeceEEEEEe---CCEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH---LNLVKLFGFLEH---GDERI  122 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~  122 (380)
                      ...-.+.||.|..+.||.....+++ +++|..+.....    ..+..|+..|+.+.-   ..+.++++++..   .+..+
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~----~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARSFSTP----GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCCC-EEEEEecccccc----hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            3344567999999999999876554 777775431111    246788888887743   467888887754   36689


Q ss_pred             EEEEeCCCCCH
Q 041907          123 IVVEYVGNGTL  133 (380)
Q Consensus       123 lv~e~~~~~~L  133 (380)
                      ||||+++|+++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.13  E-value=1.3e-05  Score=70.86  Aligned_cols=73  Identities=14%  Similarity=0.165  Sum_probs=45.9

Q ss_pred             CeeeccCce-EEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC---ceeceEEEEEeC---CEEEEEEE
Q 041907           54 NKIGEGGSG-TVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL---NLVKLFGFLEHG---DERIIVVE  126 (380)
Q Consensus        54 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e  126 (380)
                      +.|+.||.. .||+.    +..+++|..+...    ....+..|+..+..+...   .+..+++.....   ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            567877776 48876    2347788765422    133577888888877531   344445443322   23578999


Q ss_pred             eCCCCCHH
Q 041907          127 YVGNGTLR  134 (380)
Q Consensus       127 ~~~~~~L~  134 (380)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.09  E-value=4.1e-05  Score=67.64  Aligned_cols=73  Identities=16%  Similarity=0.252  Sum_probs=47.6

Q ss_pred             CeeeccCceEEEEEEeCC--CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.|..|-...+|+....+  +..|++|+.......   .....+|+.++..+...++ +++++...  +  .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            457778888999998764  678999987643221   1223478888887754334 44444332  2  479999998


Q ss_pred             CCH
Q 041907          131 GTL  133 (380)
Q Consensus       131 ~~L  133 (380)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            766

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.05  E-value=3e-05  Score=80.14  Aligned_cols=204  Identities=18%  Similarity=0.172  Sum_probs=142.0

Q ss_pred             HHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE----EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 041907           90 LLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI----IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH  165 (380)
Q Consensus        90 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~----lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH  165 (380)
                      +....-|+..+.+..|+|++.++.|........    +..+++...++...++..+.  .+....+.+..++..|+.++|
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHH
Confidence            334557788888999999999999876654443    34578888888888887665  777788888999999999999


Q ss_pred             hCCCCCeeeccCCCC---ceeeCCCCceEEc--cccccccccCCCcceeeeecccCCccccChhhhhhcCCCC--ccchh
Q 041907          166 TYSDPPIIHRDVKAS---NILITEKLRAKVT--DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE--KSDVY  238 (380)
Q Consensus       166 ~~~~~~i~H~dlkp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Diw  238 (380)
                      ...   ..|.-+..+   +..++..+.+.++  ||+....+......    ....-+..|-++|.......+.  ..|+|
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS----FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc----hhhcCccccccccccccccchhhhhhHHH
Confidence            875   666655555   5555666677776  89887765543211    1122455677888777666554  47999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChH
Q 041907          239 SFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMK  318 (380)
Q Consensus       239 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  318 (380)
                      .+|..+..+..|..+-........                      -+.     ......+.++..+|+..++++|+++.
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~~~----------------------~l~-----~~~~~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVPVS----------------------LLD-----VLSTSELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccchhh----------------------hhc-----cccchhhhhhhhhhcchhhhhccchh
Confidence            999999999988766432211000                      000     00111466788899999999999999


Q ss_pred             HHHHHHHHHHh
Q 041907          319 KCAEILWKIRK  329 (380)
Q Consensus       319 eil~~l~~~~~  329 (380)
                      +++.+...-.+
T Consensus       430 ~ll~~~f~~~~  440 (1351)
T KOG1035|consen  430 ELLTHPFLRFP  440 (1351)
T ss_pred             hhhhchhcccc
Confidence            99999875433

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.01  E-value=0.0013  Score=62.40  Aligned_cols=78  Identities=19%  Similarity=0.172  Sum_probs=52.9

Q ss_pred             CCeeeccCceEEEEEEeCCC-CEEEEEEcccc-----CcchHHHHHHHHHHHHHhcCC---CCceeceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKDG-SIVAVKRARKN-----KHDKCLLLEFKNEILTWSKIE---HLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  123 (380)
                      .+.||.|.++.||++...+| +.|+||.-...     ...+.....+..|...|..+.   -.++++++.+.  ....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            35789999999999999876 48999985421     111122345567777777652   24566777663  355789


Q ss_pred             EEEeCCCCC
Q 041907          124 VVEYVGNGT  132 (380)
Q Consensus       124 v~e~~~~~~  132 (380)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998644

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.92  E-value=1.2e-05  Score=72.26  Aligned_cols=142  Identities=19%  Similarity=0.176  Sum_probs=102.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCc--------------------chHHHHHHHHHHHHHhcCCC--C
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKH--------------------DKCLLLEFKNEILTWSKIEH--L  106 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------------~~~~~~~~~~e~~~l~~l~h--~  106 (380)
                      -+.++++||-|.-+.+|.+-+.+|++.++|.=+....                    -...+....+|+..|+.|..  -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4678999999999999999999999999996432211                    11122335678888887743  3


Q ss_pred             ceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC
Q 041907          107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE  186 (380)
Q Consensus       107 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~  186 (380)
                      -|.+.+++.    .-++|||++.|-.|...-+-     .+.   ..+...+...|.-|..+|   +||+|..--||++++
T Consensus       173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-----~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHV-----EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCccccc----ceeeHHHhhcccceeeeeec-----CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            456666654    45789999988777655322     122   234555666677888888   999999999999999


Q ss_pred             CCceEEccccccccccCCC
Q 041907          187 KLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ++.++++||--+....+..
T Consensus       238 d~~i~vIDFPQmvS~sh~n  256 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVSTSHPN  256 (465)
T ss_pred             CCCEEEeechHhhccCCCc
Confidence            9999999998665544433

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.90  E-value=7.2e-05  Score=67.07  Aligned_cols=138  Identities=17%  Similarity=0.192  Sum_probs=77.5

Q ss_pred             eeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEEEeCCCCCH
Q 041907           55 KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      .+..|-.+.+|+... +|+.+++|........  ......+|..+++.+...++ .+++...  .  -++||||++|..+
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKA--LGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCccccc--ccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            355677788998874 4677889976543211  10124578888887754333 3444433  2  3689999998665


Q ss_pred             HHH-----------------hccCC--CCCCCHHHH-HHHHHHH---------HHHHHHHhhC-----CCCCeeeccCCC
Q 041907          134 REH-----------------LDGRG--GNGLELAER-LDIAIDV---------AHALTYLHTY-----SDPPIIHRDVKA  179 (380)
Q Consensus       134 ~~~-----------------i~~~~--~~~~~~~~~-~~i~~~i---------~~~l~~LH~~-----~~~~i~H~dlkp  179 (380)
                      ...                 |+...  ..+++.... ..+..++         ...+..+-..     ....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            421                 11111  111222211 1111111         1112222111     023489999999


Q ss_pred             CceeeCCCCceEEcccccccc
Q 041907          180 SNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       180 ~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .||++++++ +.|+||..+..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999876 78999998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.86  E-value=0.00057  Score=63.35  Aligned_cols=156  Identities=17%  Similarity=0.156  Sum_probs=81.0

Q ss_pred             ccHHHHHHHhcCCCC-----CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC--Cceec
Q 041907           38 FSFEEIYKATENFSP-----ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH--LNLVK  110 (380)
Q Consensus        38 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~  110 (380)
                      .+.+++...-..|.+     .+.|+.|....+|+....+| .+++|+.. . ....   .+..|+..+..|..  -.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~-~~~~---~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R-LTAE---DLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c-CChH---HhHHHHHHHHHHHHCCCCCCc
Confidence            344555544455654     34566777788999887655 58889875 2 1111   22233344433321  11333


Q ss_pred             eEE------EEEeCCEEEEEEEeCCCCCHH-----------HHh---ccCC-C--------CCCCH-HHHHH--------
Q 041907          111 LFG------FLEHGDERIIVVEYVGNGTLR-----------EHL---DGRG-G--------NGLEL-AERLD--------  152 (380)
Q Consensus       111 ~~~------~~~~~~~~~lv~e~~~~~~L~-----------~~i---~~~~-~--------~~~~~-~~~~~--------  152 (380)
                      ++.      +....+..+++++|++|..+.           ..+   +... .        ..+.+ .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            332      223356678999999886431           111   1100 0        00111 11110        


Q ss_pred             ----HHHH-HHHHHHHHhhC----CCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          153 ----IAID-VAHALTYLHTY----SDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       153 ----i~~~-i~~~l~~LH~~----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                          .+.. +...+..+...    -..++||+|+.|.||+++.+...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                1111 11122222211    12359999999999999966556799999775

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.82  E-value=0.00019  Score=65.80  Aligned_cols=144  Identities=16%  Similarity=0.207  Sum_probs=97.8

Q ss_pred             CCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCc----------------------c--hHHHHHHHHHHHHHhcCCC
Q 041907           50 FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKH----------------------D--KCLLLEFKNEILTWSKIEH  105 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~--~~~~~~~~~e~~~l~~l~h  105 (380)
                      -.+-.+|..|.-+.||.|...+|..+|||+.+.+..                      +  .....=...|++.|.+++.
T Consensus       146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            357788999999999999999999999998763210                      0  1111113477888888765


Q ss_pred             CceeceEEEEEeCCEEEEEEEeCCCC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 041907          106 LNLVKLFGFLEHGDERIIVVEYVGNG-TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI  184 (380)
Q Consensus       106 ~niv~~~~~~~~~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~  184 (380)
                      ..|.-.--+..  ..-.|||+|+... -..-.|..   ..++...+..+-.+++..+.-|.+  .+.+||.||+--|+|+
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY  298 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence            55432111111  1236899999531 11222332   237777888888899998888876  4459999999999998


Q ss_pred             CCCCceEEccccccccc
Q 041907          185 TEKLRAKVTDFGFARMS  201 (380)
Q Consensus       185 ~~~~~~kl~Dfg~~~~~  201 (380)
                      - +|.+.|+|.+-+-..
T Consensus       299 h-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             E-CCEEEEEEccccccC
Confidence            7 468999999876543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.80  E-value=0.00028  Score=64.70  Aligned_cols=141  Identities=19%  Similarity=0.169  Sum_probs=81.0

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC--ceeceEE------EEEeCCEEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL--NLVKLFG------FLEHGDERIIV  124 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~------~~~~~~~~~lv  124 (380)
                      .+.|..|....+|+....+ ..+++|+....  .   ...+..|+.++..+.+.  .+.+++.      +....+..+++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            4556777778999987654 46888987641  1   12345666666666332  2444443      22334567899


Q ss_pred             EEeCCCCCHHH----Hh----------ccC----CC-----CCCCHHHHH----------HHHHHHHHHHHHHhh----C
Q 041907          125 VEYVGNGTLRE----HL----------DGR----GG-----NGLELAERL----------DIAIDVAHALTYLHT----Y  167 (380)
Q Consensus       125 ~e~~~~~~L~~----~i----------~~~----~~-----~~~~~~~~~----------~i~~~i~~~l~~LH~----~  167 (380)
                      ++|++|..+..    .+          +..    ..     ....|....          .....+..++.++..    .
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99998866532    01          100    00     001111110          011122333444443    1


Q ss_pred             CCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          168 SDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       168 ~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      -...++|+|+.|.||++++++.+.|.||+.+.
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            12349999999999999988777899999765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.72  E-value=0.00023  Score=65.39  Aligned_cols=74  Identities=26%  Similarity=0.404  Sum_probs=47.2

Q ss_pred             CeeeccCceEEEEEEeCC-------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEE
Q 041907           54 NKIGEGGSGTVYKGKLKD-------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVV  125 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  125 (380)
                      +.|..|-...+|+....+       ++.|++|+.......   ..+..+|..++..+...++ .++++++. +   .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence            445666667899988654       578999997654321   2234577777777743333 44555543 2   3689


Q ss_pred             EeCCCCCHH
Q 041907          126 EYVGNGTLR  134 (380)
Q Consensus       126 e~~~~~~L~  134 (380)
                      +|++|..+.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.69  E-value=0.00072  Score=62.33  Aligned_cols=154  Identities=17%  Similarity=0.135  Sum_probs=83.4

Q ss_pred             HHHHHHhcCCCC-----CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC--ceeceEE
Q 041907           41 EEIYKATENFSP-----ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL--NLVKLFG  113 (380)
Q Consensus        41 ~~~~~~~~~~~~-----~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~  113 (380)
                      +.+...-++|.+     .+.++.|....+|+....+| .+++|+.......    ..+..|..++..|...  .+.+++.
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~----~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKA----EELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCCH----HHHHHHHHHHHHHHHCCCCCCcccc
Confidence            444444445544     34566777789999876645 5788987553221    1233455555555321  2344433


Q ss_pred             E------EEeCCEEEEEEEeCCCCCHHH-----------H---hccCC-CC--------C-CCHHHHH------------
Q 041907          114 F------LEHGDERIIVVEYVGNGTLRE-----------H---LDGRG-GN--------G-LELAERL------------  151 (380)
Q Consensus       114 ~------~~~~~~~~lv~e~~~~~~L~~-----------~---i~~~~-~~--------~-~~~~~~~------------  151 (380)
                      .      ....+..+++++|++|..+..           .   ++... +.        . ..|....            
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            1      123456789999998854321           0   11100 00        0 0010000            


Q ss_pred             HHHHHHHHHHHHHhh----CCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          152 DIAIDVAHALTYLHT----YSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       152 ~i~~~i~~~l~~LH~----~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      .....+...+.++..    .-...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            011123334544532    113459999999999999988777899999765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.63  E-value=0.00061  Score=62.32  Aligned_cols=140  Identities=19%  Similarity=0.263  Sum_probs=84.0

Q ss_pred             CCCeeeccCc-eEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC--CceeceEEEEEeCC--EEEEEEE
Q 041907           52 PANKIGEGGS-GTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH--LNLVKLFGFLEHGD--ERIIVVE  126 (380)
Q Consensus        52 ~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~e  126 (380)
                      +.+.+ +||+ ..+|..... ++.++++ ...............+|+.+++.+.-  .-+...+++|..+.  ..+.||+
T Consensus        29 ~v~~~-~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          29 IVEEI-SGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeec-cCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            33444 3444 345555554 7888888 33212222234445688888887643  34555667776655  6799999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHH-HHHHHHHHHHhh---------------------------------------
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIA-IDVAHALTYLHT---------------------------------------  166 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~-~~i~~~l~~LH~---------------------------------------  166 (380)
                      |++|..+.+......   ..    ...+ ..++..|.-||+                                       
T Consensus       106 ~veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         106 WVEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             EecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            998853333222111   00    0111 234444444443                                       


Q ss_pred             -----------CC-----CCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          167 -----------YS-----DPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       167 -----------~~-----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                                 +-     ...++|+|+.+.|+++++++.+=+.||+++.+-
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                       21     246999999999999999988999999998753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.47  E-value=0.0016  Score=59.04  Aligned_cols=31  Identities=29%  Similarity=0.522  Sum_probs=25.7

Q ss_pred             CCeeeccCCCCceeeCCCCc-eEEcccccccc
Q 041907          170 PPIIHRDVKASNILITEKLR-AKVTDFGFARM  200 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~  200 (380)
                      ..++|+|+.|.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.30  E-value=0.0033  Score=59.55  Aligned_cols=83  Identities=16%  Similarity=0.115  Sum_probs=53.2

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEcccc-----CcchHHHHHHHHHHHHHhcCC---CCceeceEEEEEeCCEEEE
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKN-----KHDKCLLLEFKNEILTWSKIE---HLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  123 (380)
                      ..+.||.|....||+.... +..|+||.-...     ...+........|+..|+.+.   -.++++++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3567899999999998875 456889986521     111112233344566665543   247788888876  44678


Q ss_pred             EEEeCCC--CCHHHHh
Q 041907          124 VVEYVGN--GTLREHL  137 (380)
Q Consensus       124 v~e~~~~--~~L~~~i  137 (380)
                      +||++++  ..+.+.+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            8999976  3455544

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.16  E-value=6.2e-05  Score=79.81  Aligned_cols=159  Identities=12%  Similarity=-0.008  Sum_probs=112.2

Q ss_pred             HHHHHHHHhcCCCCceeceEEEEEe--CCEEEEEEEeCCCCCHHHHhccCCCC--CCCHHHHHHHHHHHHHHHHHHhhCC
Q 041907           93 FKNEILTWSKIEHLNLVKLFGFLEH--GDERIIVVEYVGNGTLREHLDGRGGN--GLELAERLDIAIDVAHALTYLHTYS  168 (380)
Q Consensus        93 ~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~  168 (380)
                      ...|...++...|+++...+.-...  ....+..++|+.+|.+++.|-+....  .+...-+...-.+.+....-+|...
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555566688888776654432  33458889999999999998654322  1222222222233245555555432


Q ss_pred             --CCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHH
Q 041907          169 --DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE  246 (380)
Q Consensus       169 --~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  246 (380)
                        ....+|+++|+.|.++..+..+++.++|+.+...+.   ....+...+++.|+.|++...-.++.++|+|..|+.+|+
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~---~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV---LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCch---HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence              345799999999999999999999999999843332   122344567889999999999999999999999999999


Q ss_pred             HHhCCCCC
Q 041907          247 MMTGRYPI  254 (380)
Q Consensus       247 lltg~~p~  254 (380)
                      .-.|..+|
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            98887776

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=97.15  E-value=0.022  Score=49.26  Aligned_cols=75  Identities=17%  Similarity=0.253  Sum_probs=50.3

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.+.-|.--..|...+- ...|.||+-...     ....|..|+.-|..+   +.-+|.+++.+.....+.|+||||++-
T Consensus        22 ~~v~gG~inea~~v~dg-~~~~FvK~n~~~-----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          22 EEVSGGDINEAWRLRDG-TDPFFVKCNQRE-----QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             cccCCccccceeEeecC-CcceEEEecchh-----hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            34444444444544442 566888875432     234567777766665   445688888888889999999999987


Q ss_pred             CCHH
Q 041907          131 GTLR  134 (380)
Q Consensus       131 ~~L~  134 (380)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6665

>PLN02236 choline kinase

Probab=97.15  E-value=0.0036  Score=58.67  Aligned_cols=138  Identities=18%  Similarity=0.248  Sum_probs=78.6

Q ss_pred             eeeccCceEEEEEEeCC-----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEEEeC
Q 041907           55 KIGEGGSGTVYKGKLKD-----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  128 (380)
                      .|..|-...+|++...+     ++.|++|+......  . ..+-.+|..+++.+..-++ .++++.+.. +   .|.+|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~--~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE--L-FFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC--e-eechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            44456777899987542     36799998865432  1 1223578888887755444 345555532 2   578998


Q ss_pred             CCCCHHHH-----------------hccCC--CC--CCCHHHHHHHHHHH-----------------HHHHHH----Hhh
Q 041907          129 GNGTLREH-----------------LDGRG--GN--GLELAERLDIAIDV-----------------AHALTY----LHT  166 (380)
Q Consensus       129 ~~~~L~~~-----------------i~~~~--~~--~~~~~~~~~i~~~i-----------------~~~l~~----LH~  166 (380)
                      ++.+|...                 +++..  ..  ...+.++.++..++                 ...+..    +..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87666421                 11111  00  11122222222111                 111112    221


Q ss_pred             -CCCCCeeeccCCCCceeeCC-CCceEEccccccc
Q 041907          167 -YSDPPIIHRDVKASNILITE-KLRAKVTDFGFAR  199 (380)
Q Consensus       167 -~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~  199 (380)
                       .....++|+|+++.||++++ ++.+.|+||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             11335899999999999986 4679999999775

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.10  E-value=0.0068  Score=56.43  Aligned_cols=81  Identities=19%  Similarity=0.226  Sum_probs=49.1

Q ss_pred             eeeccCceEEEEEEeCCC-CEEEEEEccc-----cCcchHHHHHHHHHHHHHhcCC--CCc-eeceEEEEEeCCEEEEEE
Q 041907           55 KIGEGGSGTVYKGKLKDG-SIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIE--HLN-LVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-----~~~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv~  125 (380)
                      .||.|....||++...+| +.|+||--..     ....+....+..-|...|....  .|. ++++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999998754 5799986431     1112233344556667776552  354 4444433  344567999


Q ss_pred             EeCCC-CCHHHHh
Q 041907          126 EYVGN-GTLREHL  137 (380)
Q Consensus       126 e~~~~-~~L~~~i  137 (380)
                      |+++. ..|...+
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            99864 3343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.07  E-value=0.0082  Score=55.40  Aligned_cols=31  Identities=19%  Similarity=0.275  Sum_probs=27.7

Q ss_pred             CCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      ..+||+|+.+.|||++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            3599999999999999998999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.98  E-value=0.0098  Score=54.04  Aligned_cols=76  Identities=17%  Similarity=0.313  Sum_probs=46.3

Q ss_pred             CCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEEeCCEEEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ..-.+.|+-|....+|+.. .+++.+.||.-.....     ..|..|+.-|+.|   .--.+++++++....+..+||||
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            3445678888889999887 4578899998763222     2356777777766   34567889998887777899999


Q ss_pred             eCCCC
Q 041907          127 YVGNG  131 (380)
Q Consensus       127 ~~~~~  131 (380)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            98765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.94  E-value=0.0035  Score=59.06  Aligned_cols=83  Identities=23%  Similarity=0.183  Sum_probs=52.1

Q ss_pred             CCeeeccCceEEEEEEeCC-CCEEEEEEcc----ccCcchHHHHHHHHHHHHHhcCC--CCce-eceEEEEEeCCEEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKD-GSIVAVKRAR----KNKHDKCLLLEFKNEILTWSKIE--HLNL-VKLFGFLEHGDERIIV  124 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~----~~~~~~~~~~~~~~e~~~l~~l~--h~ni-v~~~~~~~~~~~~~lv  124 (380)
                      .+.||.|.-..||++.+.+ ++.|+||--.    .....+....+..-|...|+...  .|.. +++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999853 5679988642    22223344555667777777653  3544 445533  34456789


Q ss_pred             EEeCCC-CCHHHHh
Q 041907          125 VEYVGN-GTLREHL  137 (380)
Q Consensus       125 ~e~~~~-~~L~~~i  137 (380)
                      ||+++. ..|++.+
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            999854 2344443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.71  E-value=0.014  Score=54.45  Aligned_cols=140  Identities=14%  Similarity=0.238  Sum_probs=77.9

Q ss_pred             CeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEEEeC
Q 041907           54 NKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  128 (380)
                      +.|..|-...+|+....+    +..|++|+......   ....-.+|..+++.+..-++ .++++++. ++   +|.+|+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            345456667899887542    23799998765432   12233578888888765555 45565552 22   588998


Q ss_pred             CCCCHHHH-----------------hccCCC---CCC-CHHHHHHHHHHH----------------------HHHHHH--
Q 041907          129 GNGTLREH-----------------LDGRGG---NGL-ELAERLDIAIDV----------------------AHALTY--  163 (380)
Q Consensus       129 ~~~~L~~~-----------------i~~~~~---~~~-~~~~~~~i~~~i----------------------~~~l~~--  163 (380)
                      ++.+|...                 ++....   ... -+..+.++..++                      ..-+..  
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            77655220                 111110   001 122222222111                      111111  


Q ss_pred             -Hh-hCC-CCCeeeccCCCCceeeCC-CCceEEcccccccc
Q 041907          164 -LH-TYS-DPPIIHRDVKASNILITE-KLRAKVTDFGFARM  200 (380)
Q Consensus       164 -LH-~~~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~  200 (380)
                       +. ..+ +..++|+|+.+.|||+++ ++.++++||..+..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             11 111 234899999999999975 57899999998753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.70  E-value=0.045  Score=50.42  Aligned_cols=29  Identities=28%  Similarity=0.444  Sum_probs=25.2

Q ss_pred             CCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            34999999999999997 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.67  E-value=0.0026  Score=61.03  Aligned_cols=72  Identities=15%  Similarity=0.228  Sum_probs=47.3

Q ss_pred             EEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-CEEEEEEEeCCCCCHHHHhccCC
Q 041907           64 VYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-DERIIVVEYVGNGTLREHLDGRG  141 (380)
Q Consensus        64 V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~  141 (380)
                      ++.|..+.|... ..-+.....    ...+.....+++.+.|+|....+++.... ....+|||++ +-+|++.+....
T Consensus         5 ~~~a~~~~~~~c-~nglplt~~----s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTPN----SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCCc----HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            455655555533 333332221    23455677888999999999999887653 3467889999 459999887644

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.62  E-value=0.19  Score=46.65  Aligned_cols=92  Identities=18%  Similarity=0.136  Sum_probs=51.8

Q ss_pred             ccHHHHHHHhcCCCCC---C-eeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC--ceece
Q 041907           38 FSFEEIYKATENFSPA---N-KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL--NLVKL  111 (380)
Q Consensus        38 ~~~~~~~~~~~~~~~~---~-~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~  111 (380)
                      ++.+.+..+-+.+.+.   + ..-.+....||+....+|..+++|+.+.....   ..++..|...+..|...  .++..
T Consensus        11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p   87 (325)
T PRK11768         11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAP   87 (325)
T ss_pred             CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCC
Confidence            3445555555544332   1 12234557899999887888999988654322   23445566666555211  12221


Q ss_pred             E---E--EEEeCCEEEEEEEeCCCCC
Q 041907          112 F---G--FLEHGDERIIVVEYVGNGT  132 (380)
Q Consensus       112 ~---~--~~~~~~~~~lv~e~~~~~~  132 (380)
                      .   |  +...++..+.++++++|..
T Consensus        88 ~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         88 LAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            1   1  2333567788999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.55  E-value=0.0092  Score=51.70  Aligned_cols=31  Identities=32%  Similarity=0.493  Sum_probs=21.8

Q ss_pred             CCeeeccCCCCceee-CCCCceEEcccccccc
Q 041907          170 PPIIHRDVKASNILI-TEKLRAKVTDFGFARM  200 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~-~~~~~~kl~Dfg~~~~  200 (380)
                      ..++|+|+.+.||++ +.++.++|+||..+..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            348999999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=96.44  E-value=0.052  Score=58.18  Aligned_cols=149  Identities=16%  Similarity=0.203  Sum_probs=80.3

Q ss_pred             HhcCCCCC---CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-------CCCceeceEE--
Q 041907           46 ATENFSPA---NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-------EHLNLVKLFG--  113 (380)
Q Consensus        46 ~~~~~~~~---~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~--  113 (380)
                      ..+.|.+.   +.|+ |..-.+|+....+|..+++|+.+.....    ..+..|...|..|       .-|.+++..+  
T Consensus        20 ~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~----~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~   94 (1013)
T PRK06148         20 LAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR----VESDFQTAALDHLAAVAPDLPVPRLIPSLSGA   94 (1013)
T ss_pred             HHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch----hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCC
Confidence            33455543   4453 4557889998877888999999865322    1222333444333       2334443221  


Q ss_pred             ---EEEe-CC--EEEEEEEeCCCCCHHHHhc---------------------cCC----CCCCCHH--------------
Q 041907          114 ---FLEH-GD--ERIIVVEYVGNGTLREHLD---------------------GRG----GNGLELA--------------  148 (380)
Q Consensus       114 ---~~~~-~~--~~~lv~e~~~~~~L~~~i~---------------------~~~----~~~~~~~--------------  148 (380)
                         .... .+  ..+-+++|++|..|.+...                     ...    ...+.|.              
T Consensus        95 ~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i  174 (1013)
T PRK06148         95 SLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFI  174 (1013)
T ss_pred             eEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhc
Confidence               1111 22  4677899999987765110                     010    0111121              


Q ss_pred             ---HHHHHHHHHHHHHH-----HHhhCCCCCeeeccCCCCceeeCCCC--ceE-Ecccccccc
Q 041907          149 ---ERLDIAIDVAHALT-----YLHTYSDPPIIHRDVKASNILITEKL--RAK-VTDFGFARM  200 (380)
Q Consensus       149 ---~~~~i~~~i~~~l~-----~LH~~~~~~i~H~dlkp~Nil~~~~~--~~k-l~Dfg~~~~  200 (380)
                         ..+.++..++..+.     .|... ...+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       175 ~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        175 DDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence               11122223333222     12211 24499999999999999775  555 999997753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.29  E-value=0.1  Score=48.30  Aligned_cols=139  Identities=22%  Similarity=0.269  Sum_probs=77.4

Q ss_pred             eeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC---CCc---eeceEE----EEEeCCEEEEE
Q 041907           55 KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE---HLN---LVKLFG----FLEHGDERIIV  124 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~~~~----~~~~~~~~~lv  124 (380)
                      .|.+ .-..||+....+|+. ++|+.+.. ...   .++..|...|..+.   .+=   +..+-|    ........+-+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            3444 556799999887775 88998876 332   34455666666552   111   222222    12222377889


Q ss_pred             EEeCCCCCHHH-H----h--------------ccCC--CC----CCCHH----HH---------HHHHHHHHHHHHHHhh
Q 041907          125 VEYVGNGTLRE-H----L--------------DGRG--GN----GLELA----ER---------LDIAIDVAHALTYLHT  166 (380)
Q Consensus       125 ~e~~~~~~L~~-~----i--------------~~~~--~~----~~~~~----~~---------~~i~~~i~~~l~~LH~  166 (380)
                      ++|++|..+.. .    +              +...  ..    ...|.    ..         ......+...+..+..
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999877762 1    0              0111  00    01221    00         0112223333333332


Q ss_pred             C----CCC---CeeeccCCCCceeeCCCCc-eEEccccccc
Q 041907          167 Y----SDP---PIIHRDVKASNILITEKLR-AKVTDFGFAR  199 (380)
Q Consensus       167 ~----~~~---~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~  199 (380)
                      .    -..   .+||+|+.|.||+++.+.. +-+.||+-+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            1    112   2899999999999998875 8899999765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.09  E-value=0.029  Score=51.90  Aligned_cols=75  Identities=20%  Similarity=0.217  Sum_probs=55.8

Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      ..+.|++|++- |++| ..+..     -.+.++..++.+.+..+.-+..  .-++-|||+...|||++ +|.+-|+||-+
T Consensus       298 ~~y~yl~~kdh-gt~i-s~ik~-----~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDH-GTPI-SIIKA-----DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecC-Ccee-eeeec-----ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeee
Confidence            34456777764 3333 22221     4677888888888888877776  45699999999999999 89999999999


Q ss_pred             ccccc
Q 041907          198 ARMSE  202 (380)
Q Consensus       198 ~~~~~  202 (380)
                      ++.-.
T Consensus       368 sRl~~  372 (488)
T COG5072         368 SRLSY  372 (488)
T ss_pred             eeccc
Confidence            98543

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.88  E-value=0.056  Score=48.07  Aligned_cols=81  Identities=16%  Similarity=0.123  Sum_probs=55.3

Q ss_pred             CCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC-C
Q 041907           51 SPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV-G  129 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~  129 (380)
                      +....+..|..+.|+.+...+|...++|+........   .+. .....|+..+-...|++++.-..  .-.+++|.+ +
T Consensus         5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~---~E~-~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~   78 (253)
T PF04655_consen    5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE---HEA-RGEAALRWWNGRGAVRLLAADPE--RGALLLERLDP   78 (253)
T ss_pred             ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch---hhh-hHHhHhheeCCCCceeeeccccc--cchhhhhhccC
Confidence            3445677889999999999999999999987543321   111 11244666666778899886533  446788988 5


Q ss_pred             CCCHHHHh
Q 041907          130 NGTLREHL  137 (380)
Q Consensus       130 ~~~L~~~i  137 (380)
                      +.+|.++.
T Consensus        79 g~~L~~~~   86 (253)
T PF04655_consen   79 GRSLASLP   86 (253)
T ss_pred             CCchhhcc
Confidence            55776554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.81  E-value=0.036  Score=52.02  Aligned_cols=59  Identities=19%  Similarity=0.175  Sum_probs=43.1

Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeC
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~  185 (380)
                      ..++=+|..|.++..++...+   .+++.+.+++.-.+.|+-.+-- .+   ++|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence            356667888989988887765   4445666677777777654433 33   99999999999985

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.73  E-value=0.068  Score=46.08  Aligned_cols=121  Identities=13%  Similarity=0.136  Sum_probs=74.0

Q ss_pred             HHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 041907           92 EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP  171 (380)
Q Consensus        92 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  171 (380)
                      -+.++.++++++.  .|+++..-  ....+.++.|+|-....           ..    ..++..-+.+|.-.|+. ...
T Consensus       104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~agi~~L~~fH~~-~~~  163 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFITAGIKDLMDFHSE-NQH  163 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHHHhHHHHHHhhcc-CCC
Confidence            4567888888765  46666622  34456789998843100           00    11122224667788854 355


Q ss_pred             eeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhC
Q 041907          172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG  250 (380)
Q Consensus       172 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg  250 (380)
                      .+|||..|+||+.|..|.+||.|=+..-  +.             +..|.-   ......++++.+=+|-.-+++++..
T Consensus       164 ~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-------------~V~~vN---~~Y~~lT~~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  164 CLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-------------QVNMVN---IEYESLTQEAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             eecCCCChhheeecCCCCEEecChhhhh--hh-------------eeeEEe---eeccccChHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999987432  11             111111   0112346667777776666666653

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	380
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		9e-44
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-42
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-42
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-33
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-27
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-22
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-20
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-20
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-20
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-20
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-20
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-20
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-19
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-17
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-14
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-13
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-11
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-10
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		9e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  174 bits (440), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 104/291 (35%), Positives = 166/291 (57%), Gaps = 8/291 (2%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
           FS  E+  A++NFS  N +G GG G VYKG+L DG++VAVKR ++ +     L +F+ E+
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL-QFQTEV 86
Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG--LELAERLDIAI 155
              S   H NL++L GF     ER++V  Y+ NG++   L  R  +   L+  +R  IA+
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
             A  L YLH + DP IIHRDVKA+NIL+ E+  A V DFG A++   D    H+   V+
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHVXXAVR 204
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--VTIRWAMQCL 273
           GT G++ P+YL T + +EK+DV+ +GV+L+E++TG+   +  +   +   + + W    L
Sbjct: 205 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 264
Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           K      ++D  L+     +  VE+++ +A +C   +   RP M +   +L
Sbjct: 265 KEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  169 bits (428), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 163/297 (54%), Gaps = 20/297 (6%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           ++ +AT NF     IG G  G VYKG L+DG+ VA+KR            E + E L++ 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--ERLDIAIDVAH 159
           +  H +LV L GF +  +E I++ +Y+ NG L+ HL G     + ++  +RL+I I  A 
Sbjct: 93  R--HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L YLHT +   IIHRDVK+ NIL+ E    K+TDFG ++   E    +H+   VKGT G
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQ-THLXXVVKGTLG 206
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI-RWAMQCLKAGDA 278
           Y+DP+Y    +LTEKSDVYSFGV+L E++  R  I    P +E V +  WA++    G  
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQL 265
Query: 279 ILVMDPRLRRTPASNMAVEKILGLADV---CLAPTRQSRPTMKKCAEILWKIRKDFR 332
             ++DP L    A  +  E +    D    CLA + + RP+M    ++LWK+    R
Sbjct: 266 EQIVDPNL----ADKIRPESLRKFGDTAVKCLALSSEDRPSM---GDVLWKLEYALR 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 112/297 (37%), Positives = 163/297 (54%), Gaps = 20/297 (6%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           ++ +AT NF     IG G  G VYKG L+DG+ VA+KR            E + E L++ 
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--ERLDIAIDVAH 159
           +  H +LV L GF +  +E I++ +Y+ NG L+ HL G     + ++  +RL+I I  A 
Sbjct: 93  R--HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L YLHT +   IIHRDVK+ NIL+ E    K+TDFG ++   E    +H+   VKGT G
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ-THLXXVVKGTLG 206
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI-RWAMQCLKAGDA 278
           Y+DP+Y    +LTEKSDVYSFGV+L E++  R  I    P +E V +  WA++    G  
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEWAVESHNNGQL 265
Query: 279 ILVMDPRLRRTPASNMAVEKILGLADV---CLAPTRQSRPTMKKCAEILWKIRKDFR 332
             ++DP L    A  +  E +    D    CLA + + RP+M    ++LWK+    R
Sbjct: 266 EQIVDPNL----ADKIRPESLRKFGDTAVKCLALSSEDRPSM---GDVLWKLEYALR 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 103/291 (35%), Positives = 163/291 (56%), Gaps = 8/291 (2%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
           FS  E+  A++NF   N +G GG G VYKG+L DG +VAVKR  K +  +   L+F+ E+
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL-KEERTQGGELQFQTEV 78
Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG--LELAERLDIAI 155
              S   H NL++L GF     ER++V  Y+ NG++   L  R  +   L+  +R  IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
             A  L YLH + DP IIHRDVKA+NIL+ E+  A V DFG A++   D    H+   V+
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM--DYKDXHVXXAVR 196
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--VTIRWAMQCL 273
           G  G++ P+YL T + +EK+DV+ +GV+L+E++TG+   +  +   +   + + W    L
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           K      ++D  L+     +  VE+++ +A +C   +   RP M +   +L
Sbjct: 257 KEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 164/301 (54%), Gaps = 20/301 (6%)
Query: 37  NFSFEEIYKATENFSP------ANKIGEGGSGTVYKGKLKDGSIVAVKR--ARKNKHDKC 88
           +FSF E+   T NF         NK+GEGG G VYKG + + + VAVK+  A  +   + 
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LEL 147
           L  +F  EI   +K +H NLV+L GF   GD+  +V  Y+ NG+L + L    G   L  
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
             R  IA   A+ + +LH       IHRD+K++NIL+ E   AK++DFG AR SE+  A 
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK-FAQ 188
Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI-ESKKPIKERVTI 266
           + + +++ GT  Y+ P+ LR  ++T KSD+YSFGV+L+E++TG   + E ++P  + +  
Sbjct: 189 TVMXSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK 326
                  +       +D ++    A + +VE +  +A  CL   +  RP +KK  ++L +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 327 I 327
           +
Sbjct: 304 M 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 163/301 (54%), Gaps = 20/301 (6%)
Query: 37  NFSFEEIYKATENFSP------ANKIGEGGSGTVYKGKLKDGSIVAVKR--ARKNKHDKC 88
           +FSF E+   T NF         NK+GEGG G VYKG + + + VAVK+  A  +   + 
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LEL 147
           L  +F  EI   +K +H NLV+L GF   GD+  +V  Y+ NG+L + L    G   L  
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
             R  IA   A+ + +LH       IHRD+K++NIL+ E   AK++DFG AR SE+  A 
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK-FAQ 188
Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI-ESKKPIKERVTI 266
           + +  ++ GT  Y+ P+ LR  ++T KSD+YSFGV+L+E++TG   + E ++P  + +  
Sbjct: 189 TVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK 326
                  +       +D ++    A + +VE +  +A  CL   +  RP +KK  ++L +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 327 I 327
           +
Sbjct: 304 M 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 103/301 (34%), Positives = 162/301 (53%), Gaps = 20/301 (6%)
Query: 37  NFSFEEIYKATENFSP------ANKIGEGGSGTVYKGKLKDGSIVAVKR--ARKNKHDKC 88
           +FSF E+   T NF         NK+GEGG G VYKG + + + VAVK+  A  +   + 
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE 66
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LEL 147
           L  +F  EI   +K +H NLV+L GF   GD+  +V  Y+ NG+L + L    G   L  
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
             R  IA   A+ + +LH       IHRD+K++NIL+ E   AK++DFG AR SE+  A 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK-FAQ 182
Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI-ESKKPIKERVTI 266
             +  ++ GT  Y+ P+ LR  ++T KSD+YSFGV+L+E++TG   + E ++P  + +  
Sbjct: 183 XVMXXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 239
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK 326
                  +       +D ++    A + +VE +  +A  CL   +  RP +KK  ++L +
Sbjct: 240 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297
Query: 327 I 327
           +
Sbjct: 298 M 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 155/298 (52%), Gaps = 20/298 (6%)
Query: 37  NFSFEEIYKATENFSP------ANKIGEGGSGTVYKGKLKDGSIVAVKR--ARKNKHDKC 88
           +FSF E+   T NF         NK GEGG G VYKG + + + VAVK+  A  +   + 
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEE 63
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LEL 147
           L  +F  EI   +K +H NLV+L GF   GD+  +V  Y  NG+L + L    G   L  
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
             R  IA   A+ + +LH       IHRD+K++NIL+ E   AK++DFG AR SE+  A 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEK-FAQ 179
Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI-ESKKPIKERVTI 266
               +++ GT  Y  P+ LR  ++T KSD+YSFGV+L+E++TG   + E ++P  + +  
Sbjct: 180 XVXXSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 236
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                  +       +D   +   A + +VE    +A  CL   +  RP +KK  ++L
Sbjct: 237 IKEEIEDEEKTIEDYIDK--KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 75/208 (36%), Positives = 109/208 (52%), Gaps = 6/208 (2%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           KIG G  GTV++ +   GS VAVK   +       + EF  E+    ++ H N+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +       IV EY+  G+L   L   G    L+   RL +A DVA  + YLH   +PPI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+K+ N+L+ +K   KV DFG +R+    ++    S    GT  ++ P+ LR     E
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLK---ASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 234 KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           KSDVYSFGV+L E+ T + P  +  P +
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQ 246

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 75/209 (35%), Positives = 112/209 (53%), Gaps = 8/209 (3%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           KIG G  GTV++ +   GS VAVK   +       + EF  E+    ++ H N+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +       IV EY+  G+L   L   G    L+   RL +A DVA  + YLH   +PPI+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ-VKGTAGYLDPDYLRTYQLT 232
           HR++K+ N+L+ +K   KV DFG +R+     A + +S++   GT  ++ P+ LR     
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           EKSDVYSFGV+L E+ T + P  +  P +
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQ 246

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 71  GY-STAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 15  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 73  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 76  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 71  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 18  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 76  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 99  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 40  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 98  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R     
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 17  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 75  GY-STKPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR---TY 229
           IHRD+K++NI + E    K+ DFG A +    S  SH   Q+ G+  ++ P+ +R   + 
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 87  GY-STAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR---TY 229
           IHRD+K++NI + E    K+ DFG A      S  SH   Q+ G+  ++ P+ +R   + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 71  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A      S  SH   Q+ G+  ++ P+ +R     
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 33  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 91  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A      S  SH   Q+ G+  ++ P+ +R     
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 126/275 (45%), Gaps = 31/275 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E  +   ++G G  G V  GK K    VAVK  ++    +    EF  E  T  K+ H  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPK 64
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LVK +G         IV EY+ NG L  +L   G  GLE ++ L++  DV   + +L ++
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH 123
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
                IHRD+ A N L+   L  KV+DFG  R   +D  VS + T+  VK +A    P+ 
Sbjct: 124 Q---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEV 176
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
              ++ + KSDV++FG+L+ E+ + G+ P +                 L     +++   
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYD-----------------LYTNSEVVLKVS 219
Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
           +  R    ++A + I  +   C     + RPT ++
Sbjct: 220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQ 254

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/204 (34%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 41  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 99  GY-STKPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A      S  SH   Q+ G+  ++ P+ +R     
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  S   I
Sbjct: 87  GY-STKPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR---TY 229
           IHRD+K++NI + E    K+ DFG A      S  SH   Q+ G+  ++ P+ +R   + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVY+FG++L E+MTG+ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           + +IG G  GTVYKGK      VAVK  +           F+NE+    K  H+N++   
Sbjct: 41  STRIGSGSFGTVYKGKWHGD--VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G++   D   IV ++    +L +HL  +     ++ + +DIA   A  + YLH  +   I
Sbjct: 99  GYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---I 153
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-- 230
           IHRD+K++NI + E L  K+ DFG A +    S    +  Q  G+  ++ P+ +R     
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVE-QPTGSVLWMAPEVIRMQDNN 212
Query: 231 -LTEKSDVYSFGVLLVEMMTGRYP 253
             + +SDVYS+G++L E+MTG  P
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV+EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV+EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 114/223 (51%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 330
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 442
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/224 (33%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     KI H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKIRHEKLVQLYAV 81
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 82  V--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 192
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 71
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 72  V--SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 126
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA----PEAALYGRF 182
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 183 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 226

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 247
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 248 V--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 358
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 74
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 75  V--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 129
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 185
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 186 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 229

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 247
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 248 V--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 358
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +           F  E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 70
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 71  V--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 125
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 181
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 182 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 225

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 72
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 73  V--SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 127
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 183
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 184 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 227

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 114/223 (51%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +           F  E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV+EY+  G L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 112/223 (50%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +           F  E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV EY+  G L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 247
Query: 115 LEHGDERIIVV-EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I +V EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +
Sbjct: 248 V--SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 358
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 78
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D++  +A  + Y+   +    +
Sbjct: 79  V--SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YV 133
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTA----PEAALYGRF 189
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 233

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 116/224 (51%), Gaps = 18/224 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 78
Query: 115 LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           +   +E I IV EY+  G+L + L G  G  L L + +D++  +A  + Y+   +    +
Sbjct: 79  V--SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YV 133
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 189
Query: 232 TEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
           T KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 233

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 82  VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 137
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD+ A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + T
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 193
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 194 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G+G  G V+ G     + VA+K  +         L+   E     K+ H  LV+L+  
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 248
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   +    +H
Sbjct: 249 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 304
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD++A+NIL+ E L  KV DFG  R+ E++   +    +  +K TA    P+     + T
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTA----PEAALYGRFT 360
Query: 233 EKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
            KSDV+SFG+LL E+ T GR  YP    + + ++V   + M C
Sbjct: 361 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 403

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 130/280 (46%), Gaps = 30/280 (10%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     ++G G  G V+ G   + + VAVK  +         LE  N + T   ++H  
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKT---LQHDK 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+  G+L + L    G  + L + +D +  +A  + Y+   
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 129
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+N+L++E L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 130 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEA 182
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
           +     T KSDV+SFG+LL E++T G+ P   +            M  L  G  +    P
Sbjct: 183 INFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNAD-------VMTALSQGYRM----P 231
Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           R+   P      +++  +  +C     + RPT      +L
Sbjct: 232 RVENCP------DELYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G +G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E  E +A       +K TA    P+ 
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTA----PEA 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G GG   V+  + L+D   VAVK  R +   D    L F+ E    + + H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E     G    IV+EYV   TLR+ +   G    + A  +++  D   AL + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIADACQALNFSHQNG- 136
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRDVK +NILI+     KV DFG AR   +       +  V GTA YL P+  R  
Sbjct: 137 --IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +  +SDVYS G +L E++TG  P     P+ 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC--LLLEFKNEILTWSKIEHLNLVKLFG 113
           IG GG G VY+     G  VAVK AR +  +     +   + E   ++ ++H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
                    +V+E+   G L   L G+    +     ++ A+ +A  + YLH  +  PII
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 174 HRDVKASNILITEKLR--------AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           HRD+K+SNILI +K+          K+TDFG AR     + +S       G   ++ P+ 
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-----AAGAYAWMAPEV 185
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           +R    ++ SDV+S+GVLL E++TG  P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 30/280 (10%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     K+G G  G V+ G   + + VAVK  +         LE  N + T   ++H  
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKT---LQHDK 68
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ E++  G+L + L    G  + L + +D +  +A  + Y+   
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 128
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+N+L++E L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 129 N---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEA 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
           +     T KS+V+SFG+LL E++T G+ P   +       T    M  L  G  +    P
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVTYGKIPYPGR-------TNADVMSALSQGYRM----P 230
Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           R+   P      +++  +  +C     + RPT      +L
Sbjct: 231 RMENCP------DELYDIMKMCWKEKAEERPTFDYLQSVL 264

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 116/230 (50%), Gaps = 16/230 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     ++G G  G V+ G     + VA+K  +         LE   E     K++H  
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLE---EAQIMKKLKHDK 65
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   IV EY+  G+L + L    G  L+L   +D+A  VA  + Y+   
Sbjct: 66  LVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 124
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++++NIL+   L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTA----PEA 177
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQC 272
               + T KSDV+SFG+LL E++T GR  YP  + + + E+V   + M C
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 227

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 75
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 76  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 135 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 187
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 78
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 79  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 137
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 138 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 190
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 77
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 78  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 136
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 137 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 189
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 71
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 72  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 130
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E  E +A       +K TA    P+ 
Sbjct: 131 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 183
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 70
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 71  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 129
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 130 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTA----PEA 182
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 75  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 133
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 134 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEA 186
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 75
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 76  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 134
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED--SAVSHISTQVKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++  +A       +K TA    P+ 
Sbjct: 135 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEA 187
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 11/212 (5%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G GG   V+  + L+D   VAVK  R +   D    L F+ E    + + H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E     G    IV+EYV   TLR+ +   G    + A  +++  D   AL + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIADACQALNFSHQNG- 136
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA YL P+  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +  +SDVYS G +L E++TG  P     P+ 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 79
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 80  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 138
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED--SAVSHISTQVKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++  +A       +K TA    P+ 
Sbjct: 139 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEA 191
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 116/214 (54%), Gaps = 23/214 (10%)
Query: 55  KIGEGGSGTVYKGKL-KDGSIVAVKRARKNKHDKCLLL-----EFKNEILTWSKIEHLNL 108
           +IG+GG G V+KG+L KD S+VA+K       +    +     EF+ E+   S + H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           VKL+G + H   R+ V+E+V  G L   L  +  + ++ + +L + +D+A  + Y+    
Sbjct: 86  VKLYGLM-HNPPRM-VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 169 DPPIIHRDVKASNILITE-----KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           +PPI+HRD+++ NI +        + AKV DFG ++ S       H  + + G   ++ P
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS------VHSVSGLLGNFQWMAP 195
Query: 224 DYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIE 255
           + +   +   TEK+D YSF ++L  ++TG  P +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEA 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 14/215 (6%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    ++  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 215
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---VI 269
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----RKXLVGTPYWMAPELISRLPYG 325
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
            + D++S G++++EM+ G  P  ++ P+K    IR
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 360

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 14/215 (6%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    ++  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 95
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---VI 149
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----RKXLVGTPYWMAPELISRLPYG 205
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
            + D++S G++++EM+ G  P  ++ P+K    IR
Sbjct: 206 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 240

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 64
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 65  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 123
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 124 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEA 176
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 14/215 (6%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    ++  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 93
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---VI 147
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----RKXLVGTPYWMAPELISRLPYG 203
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
            + D++S G++++EM+ G  P  ++ P+K    IR
Sbjct: 204 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 238

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 14/215 (6%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    ++  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 84
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---VI 138
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----RKXLVGTPYWMAPELISRLPYG 194
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
            + D++S G++++EM+ G  P  ++ P+K    IR
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 116/214 (54%), Gaps = 23/214 (10%)
Query: 55  KIGEGGSGTVYKGKL-KDGSIVAVKRARKNKHDKCLLL-----EFKNEILTWSKIEHLNL 108
           +IG+GG G V+KG+L KD S+VA+K       +    +     EF+ E+   S + H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           VKL+G + H   R+ V+E+V  G L   L  +  + ++ + +L + +D+A  + Y+    
Sbjct: 86  VKLYGLM-HNPPRM-VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 169 DPPIIHRDVKASNILITE-----KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           +PPI+HRD+++ NI +        + AKV DFG ++ S       H  + + G   ++ P
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS------VHSVSGLLGNFQWMAP 195
Query: 224 DYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIE 255
           + +   +   TEK+D YSF ++L  ++TG  P +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 14/215 (6%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    ++  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 138
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---VI 192
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----RKXLVGTPYWMAPELISRLPYG 248
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
            + D++S G++++EM+ G  P  ++ P+K    IR
Sbjct: 249 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 283

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 11/210 (5%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G GG   V+  + L+D   VAVK  R +   D    L F+ E    + + H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E     G    IV+EYV   TLR+ +   G    + A  +++  D   AL + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIADACQALNFSHQNG- 136
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA YL P+  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
            +  +SDVYS G +L E++TG  P     P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 115/215 (53%), Gaps = 14/215 (6%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V    ++  G +VAVK+    K  +  LL   NE++     +H N+V+++ 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL--FNEVVIMRDYQHENVVEMYN 88
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+ LH      +I
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQG---VI 142
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----RKXLVGTPYWMAPELISRLPYG 198
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
            + D++S G++++EM+ G  P  ++ P+K    IR
Sbjct: 199 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 233

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 115/214 (53%), Gaps = 23/214 (10%)
Query: 55  KIGEGGSGTVYKGKL-KDGSIVAVKRARKNKHDKCLLL-----EFKNEILTWSKIEHLNL 108
           +IG+GG G V+KG+L KD S+VA+K       +    +     EF+ E+   S + H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           VKL+G + H   R+ V+E+V  G L   L  +  + ++ + +L + +D+A  + Y+    
Sbjct: 86  VKLYGLM-HNPPRM-VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN-Q 141
Query: 169 DPPIIHRDVKASNILITE-----KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           +PPI+HRD+++ NI +        + AKV DF  ++ S       H  + + G   ++ P
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS------VHSVSGLLGNFQWMAP 195
Query: 224 DYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIE 255
           + +   +   TEK+D YSF ++L  ++TG  P +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++        L   N +    +++H  
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLM---KQLQHQR 65
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 66  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 124
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED--SAVSHISTQVKGTAGYLDPDY 225
           +    IHR+++A+NIL+++ L  K+ DFG AR+ E++  +A       +K TA    P+ 
Sbjct: 125 N---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEA 177
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL E++T GR P
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 138/274 (50%), Gaps = 21/274 (7%)
Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V     K  G  VAVK+    K  +  LL   NE++      H N+V ++ 
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL--FNEVVIMRDYHHDNVVDMYS 109
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+E++  G L + +     N  ++A    + + V  AL+YLH      +I
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVCLSVLRALSYLHNQG---VI 163
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ +IL+T   R K++DFGF A++S+E          + GT  ++ P+ +      
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK----RKXLVGTPYWMAPEVISRLPYG 219
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM----QCLKAGDAIL--VMDPRL 286
            + D++S G++++EM+ G  P  ++ P++    IR ++    + L    ++L   +D  L
Sbjct: 220 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLML 279
Query: 287 RRTPASNMAVEKILGLADVCLA-PTRQSRPTMKK 319
            R P+     +++LG   + LA P     P M++
Sbjct: 280 VREPSQRATAQELLGHPFLKLAGPPSCIVPLMRQ 313

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E+     +IG G  G V+ G+L+ D ++VAVK  R+      L  +F  E     +  H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHP 172
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V+L G         IV+E V  G     L   G   L +   L +  D A  + YL +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLES 231
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS-----TQVKGTAGYL 221
                 IHRD+ A N L+TEK   K++DFG +R  EE   V   S       VK TA   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVKWTA--- 283
Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVTIRWAMQCLKAGDA 278
            P+ L   + + +SDV+SFG+LL E  +     YP  S +  +E V         K G  
Sbjct: 284 -PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--------KGG-- 332
Query: 279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR 332
                    R P   +  + +  L + C A     RP+     + L  IRK  R
Sbjct: 333 ---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 100/212 (47%), Gaps = 11/212 (5%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G GG   V+  + L+    VAVK  R +   D    L F+ E    + + H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E     G    IV+EYV   TLR+ +   G    + A  +++  D   AL + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIADACQALNFSHQNG- 136
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA YL P+  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +  +SDVYS G +L E++TG  P     P+ 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 88/294 (29%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E+     +IG G  G V+ G+L+ D ++VAVK  R+      L  +F  E     +  H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHP 172
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V+L G         IV+E V  G     L   G   L +   L +  D A  + YL +
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLES 231
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS-----TQVKGTAGYL 221
                 IHRD+ A N L+TEK   K++DFG +R  EE   V   S       VK TA   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTA--- 283
Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVTIRWAMQCLKAGDA 278
            P+ L   + + +SDV+SFG+LL E  +     YP  S +  +E V         K G  
Sbjct: 284 -PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--------KGG-- 332
Query: 279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR 332
                    R P   +  + +  L + C A     RP+     + L  IRK  R
Sbjct: 333 ---------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 113/211 (53%), Gaps = 17/211 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V  G  + G+ VAVK  + +   +  L E    ++T  ++ H NLV+L G +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE--ASVMT--QLRHSNLVQLLGVI 255
Query: 116 -EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E      IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL   +    +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N+L++E   AKV+DFG  +  E  S        VK TA    P+ LR  + + K
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTA----PEALREKKFSTK 366
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERV 264
           SDV+SFG+LL E+ + GR P   + P+K+ V
Sbjct: 367 SDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 396

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 113/211 (53%), Gaps = 17/211 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V  G  + G+ VAVK  + +   +  L E    ++T  ++ H NLV+L G +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE--ASVMT--QLRHSNLVQLLGVI 83
Query: 116 -EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E      IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL   +    +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N+L++E   AKV+DFG  +  E  S        VK TA    P+ LR  + + K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTA----PEALREKKFSTK 194
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERV 264
           SDV+SFG+LL E+ + GR P   + P+K+ V
Sbjct: 195 SDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 224

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 113/211 (53%), Gaps = 17/211 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V  G  + G+ VAVK  + +   +  L E    ++T  ++ H NLV+L G +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE--ASVMT--QLRHSNLVQLLGVI 68
Query: 116 -EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E      IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL   +    +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N+L++E   AKV+DFG  +  E  S        VK TA    P+ LR  + + K
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTA----PEALREKKFSTK 179
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERV 264
           SDV+SFG+LL E+ + GR P   + P+K+ V
Sbjct: 180 SDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 100/212 (47%), Gaps = 11/212 (5%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G GG   V+  + L+    VAVK  R +   D    L F+ E    + + H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E     G    IV+EYV   TLR+ +   G    + A  +++  D   AL + H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEVIADACQALNFSHQNG- 136
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA YL P+  R  
Sbjct: 137 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +  +SDVYS G +L E++TG  P     P+ 
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKN-----KHDKCLLLEFKNEILTWSK 102
           E +   +K+G GG  TVY   L + +I+ +K A K      +  +  L  F+ E+   S+
Sbjct: 11  ERYKIVDKLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           + H N+V +    E  D   +V+EY+   TL E+++  G   ++ A  ++    +   + 
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTA--INFTNQILDGIK 125
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           + H   D  I+HRD+K  NILI      K+ DFG A+   E S     +  V GT  Y  
Sbjct: 126 HAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFS 180
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           P+  +     E +D+YS G++L EM+ G  P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 112/211 (53%), Gaps = 17/211 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V  G  + G+ VAVK  + +   +  L E    ++T  ++ H NLV+L G +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE--ASVMT--QLRHSNLVQLLGVI 74
Query: 116 -EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E      IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL   +    +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N+L++E   AKV+DFG  +  E  S        VK TA    P+ LR    + K
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTA----PEALREAAFSTK 185
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERV 264
           SDV+SFG+LL E+ + GR P   + P+K+ V
Sbjct: 186 SDVWSFGILLWEIYSFGRVPY-PRIPLKDVV 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 56  IGEGGSGTVYKGKLKDGS-----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           IG G  G VYKG LK  S      VA+K  +    +K   ++F  E     +  H N+++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNIIR 110
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L G +      +I+ EY+ NG L + L  + G    + + + +   +A  + YL   +  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMN-- 167
Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
             +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ ++  K    +  P+ +   +
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            T  SDV+SFG+++ E+MT
Sbjct: 227 FTSASDVWSFGIVMWEVMT 245

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +G GG   V+  + L+    VAVK  R +   D    L F+ E    + + H  +V ++ 
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E     G    IV+EYV   TLR+ +   G   +     +++  D   AL + H    
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG- 153
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA YL P+  R  
Sbjct: 154 --IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 211
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +  +SDVYS G +L E++TG  P     P+ 
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 243

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 68
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPP 171
           G         +V E++ +G L ++L  R   GL  AE L  + +DV   + YL   S   
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS--- 123
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +IHRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFSRY 181
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESK 257
           + KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIPYENR 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 14/209 (6%)
Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G SGTVY    +  G  VA+++    +  K  L+   NEIL   + ++ N+V    
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLD 84
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+     +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQ---VI 138
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ NIL+      K+TDFGF A+++ E S  S    ++ GT  ++ P+ +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS----EMVGTPYWMAPEVVTRKAYG 194
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            K D++S G++ +EM+ G  P  ++ P++
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I++E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 133
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNK 189
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 190 FSIKSDVWAFGVLLWEIAT 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I++E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 81  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 193
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 194 FSIKSDVWAFGVLLWEIAT 212

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I++E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 130
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNK 186
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 187 FSIKSDVWAFGVLLWEIAT 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 71
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPP 171
           G         +V E++ +G L ++L  R   GL  AE L  + +DV   + YL    +  
Sbjct: 72  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 126
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +IHRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFSRY 184
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESK 257
           + KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIPYENR 211

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 66
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPP 171
           G         +V E++ +G L ++L  R   GL  AE L  + +DV   + YL    +  
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 121
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +IHRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFSRY 179
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESK 257
           + KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENR 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 69
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPP 171
           G         +V E++ +G L ++L  R   GL  AE L  + +DV   + YL    +  
Sbjct: 70  GVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 124
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +IHRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFSRY 182
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESK 257
           + KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENR 209

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G SGTVY    +  G  VA+++    +  K  L+   NEIL   + ++ N+V    
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLD 84
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+     +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQ---VI 138
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ NIL+      K+TDFGF A+++ E S  S +     GT  ++ P+ +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKAYG 194
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            K D++S G++ +EM+ G  P  ++ P++
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLY 68
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPP 171
           G         +V E++ +G L ++L  R   GL  AE L  + +DV   + YL    +  
Sbjct: 69  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 123
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +IHRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFSRY 181
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESK 257
           + KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIPYENR 208

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I++E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I++E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G SGTVY    +  G  VA+++    +  K  L+   NEIL   + ++ N+V    
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLD 84
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+     +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQ---VI 138
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ NIL+      K+TDFGF A+++ E S  S +     GT  ++ P+ +      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYG 194
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            K D++S G++ +EM+ G  P  ++ P++
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G SGTVY    +  G  VA+++    +  K  L+   NEIL   + ++ N+V    
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLD 85
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+     +I
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQ---VI 139
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HRD+K+ NIL+      K+TDFGF A+++ E S  S +     GT  ++ P+ +      
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEVVTRKAYG 195
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            K D++S G++ +EM+ G  P  ++ P++
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNK 193
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 194 FSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 193
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 194 FSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 136
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 192
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 193 FSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 130
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA----PESLAYNK 186
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 187 FSIKSDVWAFGVLLWEIAT 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 137
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 193
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 194 FSIKSDVWAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 137
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 193
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 194 FSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 190
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 191 FSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 190
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 191 FSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 145
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 201
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 202 FSIKSDVWAFGVLLWEIAT 220

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 130
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTA----PESLAYNK 186
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 187 FSIKSDVWAFGVLLWEIAT 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG AR+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 124/261 (47%), Gaps = 18/261 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEH 105
           E+F   N +G+G    VY+ + +  G  VA+K   K    K  +++  +NE+    +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            ++++L+ + E  +   +V+E   NG +  +L  R     E   R      +   + YLH
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH 129
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFA---RMSEEDSAVSHISTQVKGTAGYLD 222
           ++    I+HRD+  SN+L+T  +  K+ DFG A   +M  E          + GT  Y+ 
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT------LCGTPNYIS 180
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES---KKPIKERVTIRWAMQCLKAGDAI 279
           P+         +SDV+S G +   ++ GR P ++   K  + + V   + M    + +A 
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 280 LVMDPRLRRTPASNMAVEKIL 300
            ++   LRR PA  +++  +L
Sbjct: 241 DLIHQLLRRNPADRLSLSSVL 261

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +IG G  G V+ G   +   VA+K  ++    +    +F  E     K+ H  LV+L+
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE---DDFIEEAEVMMKLSHPKLVQLY 88
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL-DIAIDVAHALTYLHTYSDPP 171
           G         +V E++ +G L ++L  R   GL  AE L  + +DV   + YL    +  
Sbjct: 89  GVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLE---EAC 143
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +IHRD+ A N L+ E    KV+DFG  R   +D   S  ST  K    +  P+     + 
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--STGTKFPVKWASPEVFSFSRY 201
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESK 257
           + KSDV+SFGVL+ E+ + G+ P E++
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIPYENR 228

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G SGTVY    +  G  VA+++    +  K  L+   NEIL   + ++ N+V    
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNYLD 85
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH+     +I
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLHSNQ---VI 139
Query: 174 HRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           HR++K+ NIL+      K+TDFGF A+++ E S  S +     GT  ++ P+ +      
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYG 195
Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            K D++S G++ +EM+ G  P  ++ P++
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 102
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 161
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 162 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 262
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 263 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 308

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 75
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 134
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 235
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 236 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         IV EY+  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKN---F 151
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L    
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNT 207
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 208 FSIKSDVWAFGVLLWEIAT 226

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 126/287 (43%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG  R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 92
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV EY+ NG+L   L         + + + +   +A  + YL
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 151
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 152 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 252
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 253 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 298

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 18/260 (6%)
Query: 56  IGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V  G+LK        VA+K  +    +K    +F  E     + +H N+V L
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEK-QRRDFLCEASIMGQFDHPNVVHL 109
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G +  G   +IV+E++ NG L   L    G    + + + +   +A  + YL   +D  
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-FTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
            +HRD+ A NIL+   L  KV+DFG +R+ E+D    + +T  K    +  P+ ++  + 
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPI------ESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
           T  SDV+S+G+++ E+M+ G  P       +  K I+E   +   M C  AG   L++D 
Sbjct: 226 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDC-PAGLHQLMLDC 284
Query: 285 RLRRTPASNMAVEKILGLAD 304
             ++  A     E+I+G+ D
Sbjct: 285 -WQKERAERPKFEQIVGILD 303

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 12/214 (5%)
Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG +G V   + K  G  VAVK     K  +  LL   NE++     +H N+V+++ 
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL--FNEVVIMRDYQHFNVVEMYK 109
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
               G+E  +++E++  G L + +     N  ++A    +   V  AL YLH      +I
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA---TVCEAVLQALAYLHAQG---VI 163
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+K+ +IL+T   R K++DFGF     +D         + GT  ++ P+ +       
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---XLVGTPYWMAPEVISRSLYAT 220
Query: 234 KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
           + D++S G++++EM+ G  P  S  P++    +R
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHR++ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 395
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 396 FSIKSDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 378
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHR++ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 434
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 435 FSIKSDVWAFGVLLWEIAT 453

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T++ GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTELCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     K+G G  G V+       + VAVK  +         L   N + T   ++H  
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT---LQHDK 71
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LVKL   +   +   I+ E++  G+L + L    G+   L + +D +  +A  + ++   
Sbjct: 72  LVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED--SAVSHISTQVKGTAGYLDPDY 225
           +    IHRD++A+NIL++  L  K+ DFG AR+ E++  +A       +K TA    P+ 
Sbjct: 131 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEA 183
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL+E++T GR P
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 124
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----CHAPSSRRTTLSGTLDYLPP 176
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L  +  +  +         ++A+AL+Y
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 149
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 150 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRTTLCGTLDYLPP 201
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L  +  +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 133
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +    +  +K TA    P+ L   +
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA----PESLAYNK 189
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 190 FSIKSDVWAFGVLLWEIAT 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L  +  +  +         ++A+AL+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPP 176
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 128
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 129 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPP 180
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 126
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 127 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 178
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTDLCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 56  IGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G SG V  G+L+      +    +A K  + +    +F +E     + +H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +  G   +IV EY+ NG+L   L    G    + + + +   V   + YL   SD   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SDLGY 172
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A N+L+   L  KV+DFG +R+ E+D   ++ +T  K    +  P+ +     +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 233 EKSDVYSFGVLLVEMM 248
             SDV+SFGV++ E++
Sbjct: 233 SASDVWSFGVVMWEVL 248

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L  +  +  +         ++A+AL+Y
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 140
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 141 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 192
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 225

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---F 134
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +    +  +K TA    P+ L   +
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA----PESLAYNK 190
Query: 231 LTEKSDVYSFGVLLVEMMT 249
            + KSDV++FGVLL E+ T
Sbjct: 191 FSIKSDVWAFGVLLWEIAT 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 128
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 129 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 180
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 128
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 129 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 180
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTXLCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     K+G G  G V+       + VAVK  +         L   N + T   ++H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT---LQHDK 244
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LVKL   +   +   I+ E++  G+L + L    G+   L + +D +  +A  + ++   
Sbjct: 245 LVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
           +    IHRD++A+NIL++  L  K+ DFG AR+ E++   +    +  +K TA    P+ 
Sbjct: 304 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEA 356
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T KSDV+SFG+LL+E++T GR P
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 152
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 122
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 123 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 174
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 127
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 128 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 179
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 126
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 127 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 178
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   G + + L     +  +         ++A+AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKFDEQRTATYITELANALSY 128
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 129 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 180
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 119
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 177
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 178 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 230
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GDA
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDA 285

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 94
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 155 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDX 205
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 260
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 261 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 306
Query: 325 WKI 327
            +I
Sbjct: 307 DRI 309

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV E + NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 56  IGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G SG V  G+L+      +    +A K  + +    +F +E     + +H N+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +  G   +IV EY+ NG+L   L    G    + + + +   V   + YL   SD   
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SDLGY 172
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A N+L+   L  KV+DFG +R+ E+D   +  +T  K    +  P+ +     +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 233 EKSDVYSFGVLLVEMM 248
             SDV+SFGV++ E++
Sbjct: 233 SASDVWSFGVVMWEVL 248

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 172
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 173 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 232
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 233 FTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 38  FSFEEIYKATENFSPA---------NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNK 84
           F+FE+  +A   F+             IG G  G V  G+LK        VA+K  +   
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 85  HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL---DGRG 141
            DK    +F +E     + +H N++ L G +      +I+ EY+ NG+L   L   DGR 
Sbjct: 70  TDK-QRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR- 127
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
                + + + +   +   + YL   SD   +HRD+ A NIL+   L  KV+DFG +R+ 
Sbjct: 128 ---FTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVL 181
Query: 202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           E+D   ++ +   K    +  P+ +   + T  SDV+S+G+++ E+M+
Sbjct: 182 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 84
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 142
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 143 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 195
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GDA
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDA 250

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 150
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 210
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 145
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 205
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 206 FTTKSDVWSFGVLLWELMTRGAP 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 148
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 209 FTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 153
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 120
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P
Sbjct: 121 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPP 172
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G G  G V K K +    VA+K+       K  ++E +      S++ H N+VKL+G  
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQIESESERKAFIVELRQL----SRVNHPNIVKLYGAC 70
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLEL---AERLDIAIDVAHALTYLHTYSDPPI 172
              +   +V+EY   G+L   L   G   L     A  +   +  +  + YLH+     +
Sbjct: 71  L--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 173 IHRDVKASNILITEK-LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           IHRD+K  N+L+       K+ DFG A        +    T  KG+A ++ P+       
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGSNY 180
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA 291
           +EK DV+S+G++L E++T R P +       R  I WA+                 R P 
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH-------------NGTRPPL 225
Query: 292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                + I  L   C +     RP+M++  +I+  + + F
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 152
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAP 235

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 34/280 (12%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G G  G V K K +    VA+K+       K  ++E +      S++ H N+VKL+G  
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQIESESERKAFIVELRQL----SRVNHPNIVKLYGAC 71
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLEL---AERLDIAIDVAHALTYLHTYSDPPI 172
              +   +V+EY   G+L   L   G   L     A  +   +  +  + YLH+     +
Sbjct: 72  L--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 173 IHRDVKASNILITEKLRA-KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           IHRD+K  N+L+       K+ DFG A        +    T  KG+A ++ P+       
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVFEGSNY 181
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPA 291
           +EK DV+S+G++L E++T R P +       R  I WA+                 R P 
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH-------------NGTRPPL 226
Query: 292 SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                + I  L   C +     RP+M++  +I+  + + F
Sbjct: 227 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 266

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 151
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 211
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 57
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 115
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 168
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GDA
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDA 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 104
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV E + NG+L   L         + + + +   +A  + YL
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 163
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 164 ---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 264
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 265 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 310

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + YL   +   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKYL---ASKK 171
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 172 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 231
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 232 FTTKSDVWSFGVLLWELMTRGAP 254

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 27/287 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           N S    +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFD 75
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L G +      +IV E + NG+L   L         + + + +   +A  + YL
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL 134
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
              SD   +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+
Sbjct: 135 ---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
            +   + T  SDV+S+G++L E+M+ G  P              W M      D I  +D
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMSYGERPY-------------WEMS---NQDVIKAVD 235
Query: 284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              R  P  +        + D C    R +RP  ++   IL K+ ++
Sbjct: 236 EGYRLPPPMDCPAALYQLMLD-CWQKDRNNRPKFEQIVSILDKLIRN 281

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 57
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 115
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 168
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GDA
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDA 223

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 57
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 115
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 168
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GDA
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDA 223

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 29/239 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 57
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 115
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 168
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI    P  +   +     C   GDA
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELELMFGCQVEGDA 223

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L  +  +  +         ++A+AL+Y
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 149
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 150 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRDDLCGTLDYLPP 201
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 234

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 67
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 123
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S + +  K    +  P+ L   + + K
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSK 181
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 224
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFK 249

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 71
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 127
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S + +  K    +  P+ L   + + K
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSK 185
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 228
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 229 LASEKVYTIMYSCWHEKADERPTFK 253

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S + +  K    +  P+ L   + + K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS--KFPVRWSPPEVLMYSKFSSK 201
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 244
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFK 269

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K+   I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 124 CHSKK---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 72
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S + +  K    +  P+ L   + + K
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSK 186
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 229
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 230 LASEKVYTIMYSCWHEKADERPTFK 254

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 78
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 134
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S + +  K    +  P+ L   + + K
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSK 192
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 235
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 236 LASEKVYTIMYSCWHEKADERPTFK 260

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 143
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S + +  K    +  P+ L   + + K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLMYSKFSSK 201
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 244
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFK 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 125
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ +FG++       A S   T + GT  YL P
Sbjct: 126 CHSKR---VIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTLDYLPP 177
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 125
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 126 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLDYLPP 177
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 210

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 126
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 127 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLDYLPP 178
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRAALCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 126
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ +FG++       A S   T + GT  YL P
Sbjct: 127 CHSKR---VIHRDIKPENLLLGSAGELKIANFGWS-----VHAPSSRRTTLCGTLDYLPP 178
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   G + + L     +  +         ++A+AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL--SKFDEQRTATYITELANALSY 128
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 129 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLXGTLDYLPP 180
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 213

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 94
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 155 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 205
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 260
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 261 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 306
Query: 325 WKI 327
            +I
Sbjct: 307 DRI 309

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 123
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 124 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLDYLPP 175
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 208

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 87
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 148 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 198
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 199 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 253
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 254 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 299
Query: 325 WKI 327
            +I
Sbjct: 300 DRI 302

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 126
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 127 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRXXLCGTLDYLPP 178
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L  +  +  +         ++A+AL+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 124
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSRRDTLCGTLDYLPP 176
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 83
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 144 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 194
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 195 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 249
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 250 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 295
Query: 325 WKI 327
            +I
Sbjct: 296 DRI 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 94
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 155 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 205
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 260
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 261 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 306
Query: 325 WKI 327
            +I
Sbjct: 307 DRI 309

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 12/213 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKI 103
           A E+F     +G+G  G VY  + K    I+A+K   K + +K  +  + + E+   S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSY 126
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H+     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P
Sbjct: 127 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV-----HAPSSRRDDLCGTLDYLPP 178
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + +      EK D++S GVL  E + G+ P E+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 211

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 86
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 147 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 197
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 198 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 252
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 253 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 298
Query: 325 WKI 327
            +I
Sbjct: 299 DRI 301

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 126/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 79
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE                + + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 140 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 190
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 245
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 246 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 291
Query: 325 WKI 327
            +I
Sbjct: 292 DRI 294

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 89/301 (29%), Positives = 125/301 (41%), Gaps = 56/301 (18%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 135
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE +              + + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 196 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 246
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI 266
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T G  P          V +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPV 299
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK 326
               + LK G          R    SN   E  + + D C       RPT K+  E L +
Sbjct: 300 EELFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDLDR 349
Query: 327 I 327
           I
Sbjct: 350 I 350

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V  G+LK        VA+K  +    DK    +F +E     + +H N++ L
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 74
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHL---DGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            G +      +I+ EY+ NG+L   L   DGR      + + + +   +   + YL   S
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR----FTVIQLVGMLRGIGSGMKYL---S 127
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
           D   +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ +   K    +  P+ +  
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 229 YQLTEKSDVYSFGVLLVEMMT 249
            + T  SDV+S+G+++ E+M+
Sbjct: 188 RKFTSASDVWSYGIVMWEVMS 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 126/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K    + VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DLISEMEMMKMIGKHK 94
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   GLE                + + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            A  VA  + YL +      IHRD+ A N+L+TE    K+ DFG AR       + HI  
Sbjct: 155 CAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDY 205
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVLL E+ T     YP     P++E  
Sbjct: 206 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP---GVPVEE-- 260
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    SN   E  + + D C       RPT K+  E L
Sbjct: 261 ----LFKLLKEGH---------RMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 306
Query: 325 WKI 327
            +I
Sbjct: 307 DRI 309

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 158
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAP 241

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V  G+LK        VA+K  +    DK    +F +E     + +H N++ L
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDK-QRRDFLSEASIMGQFDHPNIIHL 80
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHL---DGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            G +      +I+ EY+ NG+L   L   DGR      + + + +   +   + YL   S
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGR----FTVIQLVGMLRGIGSGMKYL---S 133
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
           D   +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ +   K    +  P+ +  
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 229 YQLTEKSDVYSFGVLLVEMMT 249
            + T  SDV+S+G+++ E+M+
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 109/226 (48%), Gaps = 8/226 (3%)
Query: 33  ATTINFSFEEIY-KATENFSPANKIGEGGSG-TVYKGKLKDGSIVAVKRARKNKHDKCLL 90
           ++ ++   E +Y ++ E +    KIGEG  G  +     +DG    +K    ++      
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 91  LEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
            E + E+   + ++H N+V+     E      IV++Y   G L + ++ + G   +  + 
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           LD  + +  AL ++H   D  I+HRD+K+ NI +T+    ++ DFG AR+    ++   +
Sbjct: 128 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVEL 181
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           +    GT  YL P+         KSD+++ G +L E+ T ++  E+
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 153
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 212
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 153
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 151
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 57
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 115
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 116 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 168
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 56  IGEGGSGTVYKGKLKDG----SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V +G+LK      S VA+K   K  + +    EF +E     + EH N+++L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIK-TLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G + +    +I+ E++ NG L   L    G    + + + +   +A  + YL   S   
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLAEMS--- 136
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG--YLDPDYLRTY 229
            +HRD+ A NIL+   L  KV+DFG +R  EE+S+    ++ + G     +  P+ +   
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 230 QLTEKSDVYSFGVLLVEMMT 249
           + T  SD +S+G+++ E+M+
Sbjct: 197 KFTSASDAWSYGIVMWEVMS 216

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 76
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 77  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 134
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 135 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 187
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           Y+ P+ L+    + +SD++S G+ LVEM  GRYPI S
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G  G VY G L D     +  A K+ +   D   + +F  E +      H N++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 113 GF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL---ASKK 154
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            +HRD+ A N ++ EK   KV DFG AR M +++    H  T  K    ++  + L+T +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
            T KSDV+SFGVLL E+MT   P
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 118/265 (44%), Gaps = 27/265 (10%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  LV+L+G 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 72
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   I+ EY+ NG L  +L     +  +  + L++  DV  A+ YL +      +H
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLH 128
Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+ A N L+ ++   KV+DFG +R   +D   S  S   K    +  P+ L   + + K
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 235 SDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASN 293
           SD+++FGVL+ E+ + G+ P        ER T     + +  G        RL R    +
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPY-------ERFTNSETAEHIAQG-------LRLYR---PH 229
Query: 294 MAVEKILGLADVCLAPTRQSRPTMK 318
           +A EK+  +   C       RPT K
Sbjct: 230 LASEKVYTIMYSCWHEKADERPTFK 254

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 117/246 (47%), Gaps = 35/246 (14%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRAR-----KNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++G GG G V +   +D G  VA+K+ R     KN+   CL      EI    K+ H N+
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL------EIQIMKKLNHPNV 75
Query: 109 VKL------FGFLEHGDERIIVVEYVGNGTLREHLDG-RGGNGLELAERLDIAIDVAHAL 161
           V           L   D  ++ +EY   G LR++L+      GL+      +  D++ AL
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 162 TYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            YLH      IIHRD+K  NI++    ++L  K+ D G+A+  ++      + T+  GT 
Sbjct: 136 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ----GELCTEFVGTL 188
Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP-IESKKPIKERVTIRWAMQCLKAGD 277
            YL P+ L   + T   D +SFG L  E +TG  P + + +P++    +R      K+ +
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR-----EKSNE 243
Query: 278 AILVMD 283
            I+V D
Sbjct: 244 HIVVYD 249

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKIEH 105
           E+F     +G+G  G VY  + +    I+A+K   K + +K  +  + + E+   S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SRFDEQRTATYITELANALSYCH 129
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +     +IHRD+K  N+L+      K+ DFG++       A S   T + GT  YL P+ 
Sbjct: 130 SKR---VIHRDIKPENLLLGSNGELKIADFGWS-----VHAPSSRRTTLCGTLDYLPPEM 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           +      EK D++S GVL  E + G  P E+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 117/246 (47%), Gaps = 35/246 (14%)
Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRAR-----KNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++G GG G V +   +D G  VA+K+ R     KN+   CL      EI    K+ H N+
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL------EIQIMKKLNHPNV 74
Query: 109 VKL------FGFLEHGDERIIVVEYVGNGTLREHLDG-RGGNGLELAERLDIAIDVAHAL 161
           V           L   D  ++ +EY   G LR++L+      GL+      +  D++ AL
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 162 TYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            YLH      IIHRD+K  NI++    ++L  K+ D G+A+  ++      + T+  GT 
Sbjct: 135 RYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ----GELCTEFVGTL 187
Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP-IESKKPIKERVTIRWAMQCLKAGD 277
            YL P+ L   + T   D +SFG L  E +TG  P + + +P++    +R      K+ +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR-----EKSNE 242
Query: 278 AILVMD 283
            I+V D
Sbjct: 243 HIVVYD 248

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     K+G G  G V+       + VAVK  +         L   N + T   ++H  
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKT---LQHDK 238
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LVKL   +   +   I+ E++  G+L + L    G+   L + +D +  +A  + ++   
Sbjct: 239 LVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 297
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
           +    IHRD++A+NIL++  L  K+ DFG AR+  +          +K TA    P+ + 
Sbjct: 298 N---YIHRDLRAANILVSASLVCKIADFGLARVGAK--------FPIKWTA----PEAIN 342
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYP 253
               T KSDV+SFG+LL+E++T GR P
Sbjct: 343 FGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 56  IGEGGSGTVYKGKLKDG----SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V +G+LK      S VA+K   K  + +    EF +E     + EH N+++L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIK-TLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G + +    +I+ E++ NG L   L    G    + + + +   +A  + YL   S   
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-FTVIQLVGMLRGIASGMRYLAEMS--- 138
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG--YLDPDYLRTY 229
            +HRD+ A NIL+   L  KV+DFG +R  EE+S+    ++ + G     +  P+ +   
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 230 QLTEKSDVYSFGVLLVEMMT 249
           + T  SD +S+G+++ E+M+
Sbjct: 199 KFTSASDAWSYGIVMWEVMS 218

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V+K   K   +V    ARK  H     LE K    N+I+   ++
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVM---ARKLIH-----LEIKPAIRNQIIRELQV 60
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L   G    ++  ++ IA  V  
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIK 118
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            LTYL       I+HRDVK SNIL+  +   K+ DFG +        +  ++ +  GT  
Sbjct: 119 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDEMANEFVGTRS 171
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           Y+ P+ L+    + +SD++S G+ LVEM  GRYP
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDX 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDX 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 12/218 (5%)
Query: 45  KATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           +  E F    K+GEG  G+VYK   K+ G IVA+K+          L E   EI    + 
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQC 81
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +  ++VK +G      +  IV+EY G G++ + +  R     E  E   I       L Y
Sbjct: 82  DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIATILQSTLKGLEY 140
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           LH       IHRD+KA NIL+  +  AK+ DFG A    +  A  +    V GT  ++ P
Sbjct: 141 LHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRN---XVIGTPFWMAP 194
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           + ++       +D++S G+  +EM  G+ P     P++
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 20/283 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +++G+G  G+V   +   L D  G++VAVK+ + +  D+    +F+ EI     +    +
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFI 86
Query: 109 VKLFGFLEHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
           VK  G + +G  R    +V+EY+ +G LR+ L  R    L+ +  L  +  +   + YL 
Sbjct: 87  VKYRG-VSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG 144
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +      +HRD+ A NIL+  +   K+ DFG A++   D     +    +    +  P+ 
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           L     + +SDV+SFGV+L E+ T  Y  +S  P  E + +    + + A   +L +   
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259
Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA---EILW 325
            +R PA      ++  L  +C AP+ Q RP+        ++LW
Sbjct: 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +++G+G  G+V   +   L D  G++VAVK+ + +  D+    +F+ EI     +    +
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFI 70
Query: 109 VKLFGFLEHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
           VK  G + +G  R    +V+EY+ +G LR+ L  R    L+ +  L  +  +   + YL 
Sbjct: 71  VKYRG-VSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG 128
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +      +HRD+ A NIL+  +   K+ DFG A++   D     +    +    +  P+ 
Sbjct: 129 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           L     + +SDV+SFGV+L E+ T  Y  +S  P  E + +   M C +   A+  +   
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAEFLRM---MGCERDVPALCRLLEL 240
Query: 286 L---RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA---EILW 325
           L   +R PA      ++  L  +C AP+ Q RP+        ++LW
Sbjct: 241 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 286

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 136/283 (48%), Gaps = 20/283 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +++G+G  G+V   +   L D  G++VAVK+ + +  D+    +F+ EI     +    +
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFI 73
Query: 109 VKLFGFLEHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
           VK  G + +G  R    +V+EY+ +G LR+ L  R    L+ +  L  +  +   + YL 
Sbjct: 74  VKYRG-VSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG 131
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +      +HRD+ A NIL+  +   K+ DFG A++   D     +    +    +  P+ 
Sbjct: 132 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           L     + +SDV+SFGV+L E+ T  Y  +S  P  E + +  + + + A   +L +   
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGSERDVPALSRLLELLEE 246
Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA---EILW 325
            +R PA      ++  L  +C AP+ Q RP+        ++LW
Sbjct: 247 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 289

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 26/286 (9%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +++G+G  G+V   +   L D  G++VAVK+ + +  D+    +F+ EI     +    +
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFI 74
Query: 109 VKLFGFLEHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
           VK  G + +G  R    +V+EY+ +G LR+ L  R    L+ +  L  +  +   + YL 
Sbjct: 75  VKYRG-VSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLG 132
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +      +HRD+ A NIL+  +   K+ DFG A++   D     +    +    +  P+ 
Sbjct: 133 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           L     + +SDV+SFGV+L E+ T  Y  +S  P  E + +   M C +   A+  +   
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSPSAEFLRM---MGCERDVPALCRLLEL 244
Query: 286 L---RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA---EILW 325
           L   +R PA      ++  L  +C AP+ Q RP+        ++LW
Sbjct: 245 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 290

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN-----KHDKCLLLEFKN 95
           +I    E+F     +G+G  G V+  + K      A+K  +K+        +C ++E + 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
             L W   EH  L  +F   +  +    V+EY+  G L  H+  +  +  +L+     A 
Sbjct: 72  LSLAW---EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 126
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           ++   L +LH+     I++RD+K  NIL+ +    K+ DFG   M +E+      + +  
Sbjct: 127 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG---MCKENMLGDAKTNEFC 180
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           GT  Y+ P+ L   +     D +SFGVLL EM+ G+ P   +
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)
Query: 45  KATENFSPANKIGEGGSGTVYKGKLKDG-SIVAVKRARKNKHDKC-----------LLLE 92
           K  E++    K+G G  G V   K K+G S  A+K  +K++ DK               E
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
             NEI     ++H N++KLF   E      +V E+   G L E +  R  +  +  +  +
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAAN 150
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSH 209
           I   +   + YLH ++   I+HRD+K  NIL+  K   L  K+ DFG +    +D  +  
Sbjct: 151 IMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR- 206
Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
                 GTA Y+ P+ L+  +  EK DV+S GV++  ++ G YP
Sbjct: 207 ---DRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG-YP 245

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKC-LLLEFKNEILTWSKIEH 105
           E+F     +G+G  G VY  + +    I+A+K   K + +K  +  + + E+   S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+++L+G+        +++EY   GT+   L     +  +         ++A+AL+Y H
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SRFDEQRTATYITELANALSYCH 129
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +     +IHRD+K  N+L+      K+ DFG++       A S     + GT  YL P+ 
Sbjct: 130 SKR---VIHRDIKPENLLLGSNGELKIADFGWS-----VHAPSSRRDTLCGTLDYLPPEM 181
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           +      EK D++S GVL  E + G  P E+
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 88
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 149 CTYQLARGMEYLASQK---CIHRDLTARNVLVTENNVMKIADFGLAR------DINNIDY 199
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 254
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 255 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 300
Query: 325 WKI 327
            +I
Sbjct: 301 DRI 303

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 42/285 (14%)
Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN 107
           F     +G G  G VYKG+ +K G + A+K       ++    E K EI    K  H  N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRN 82
Query: 108 LVKLFG-FLEHG-----DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
           +   +G F++       D+  +V+E+ G G++ + +    GN L+      I  ++   L
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
           ++LH +    +IHRD+K  N+L+TE    K+ DFG +  ++ D  V   +T + GT  ++
Sbjct: 143 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-GTPYWM 196
Query: 222 DPDYL-------RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK 274
            P+ +        TY    KSD++S G+  +EM  G  P+    P++       A+  + 
Sbjct: 197 APEVIACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIP 247
Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
              A     PRL+    S    +K     + CL      RP  ++
Sbjct: 248 RNPA-----PRLK----SKKWSKKFQSFIESCLVKNHSQRPATEQ 283

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 147
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 208 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 258
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 313
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 314 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 359
Query: 325 WKI 327
            +I
Sbjct: 360 DRI 362

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 90
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 151 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 201
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 256
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 257 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 302
Query: 325 WKI 327
            +I
Sbjct: 303 DRI 305

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 38  FSFEEIYKATENFSPA---------NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNK 84
           F+FE+  +A   F+             IG G  G V  G LK        VA+K  +   
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 85  HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG 144
            +K    +F +E     + +H N++ L G +      +I+ E++ NG+L   L    G  
Sbjct: 74  TEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 131
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
             + + + +   +A  + YL   +D   +HRD+ A NIL+   L  KV+DFG +R  E+D
Sbjct: 132 FTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 205 SAVSHISTQVKGTAG--YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           ++    ++ + G     +  P+ ++  + T  SDV+S+G+++ E+M+
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 49  NFSPANKIGEGGSGTVYKGKL------KDGSIVAVK-------RARKNKHDKCLLLEFKN 95
           N     ++GEG  G V+  +       +D  +VAVK        ARK+ H +  LL    
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL---- 69
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE------ 149
                + ++H ++VK +G    GD  I+V EY+ +G L + L   G + + +AE      
Sbjct: 70  -----TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE 124
Query: 150 -----RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
                 L IA  +A  + YL   +    +HRD+   N L+ E L  K+ DFG +R     
Sbjct: 125 LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYS 180
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +    +         ++ P+ +   + T +SDV+S GV+L E+ T G+ P
Sbjct: 181 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    ++ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMRIADFGLAR------DINNIDY 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 93
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 154 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 204
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 259
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 260 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 305
Query: 325 WKI 327
            +I
Sbjct: 306 DRI 308

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 133/295 (45%), Gaps = 34/295 (11%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 76
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHA 160
           VK  G       R   +++EY+  G+LR++L          AER+D          +   
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH-------AERIDHIKLLQYTSQICKG 129
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           + YL T      IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +
Sbjct: 130 MEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 186
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL 280
             P+ L   + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+
Sbjct: 187 YAPESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIV 241
Query: 281 VMDPRLR----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                L     R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 242 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V  G+LK        VA+K  +    +K    +F  E     + +H N++ L
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNIIHL 88
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G +      +IV EY+ NG+L   L    G    + + + +   ++  + YL   SD  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
            +HRD+ A NILI   L  KV+DFG +R+ E+D   ++ +   K    +  P+ +   + 
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 232 TEKSDVYSFGVLLVEMMT 249
           T  SDV+S+G+++ E+++
Sbjct: 205 TSASDVWSYGIVMWEVVS 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  ++ L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 110/249 (44%), Gaps = 46/249 (18%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTL--------REHLDGRGGNGLELAERLDIAI 155
           +H N+V L G   HG   +++ EY   G L           LD   G  LEL + L  + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            VA  + +L + +    IHRDV A N+L+T    AK+ DFG AR    DS     +  VK
Sbjct: 168 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NYIVK 219
Query: 216 GTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYP--IESKKPIKERVTI 266
           G A     ++ P+ +     T +SDV+S+G+LL E+ +     YP  + + K  K     
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK----- 274
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK-CAEILW 325
                        LV D      PA   A + I  +   C A     RPT ++ C+ +  
Sbjct: 275 -------------LVKDGYQMAQPA--FAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 319
Query: 326 KIRKDFREK 334
           + ++D RE+
Sbjct: 320 QAQEDRRER 328

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E +    KIGEG  G V+K + +D G IVA+K+  +++ D  +      EI    +++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           NLV L           +V EY  +  L E LD R   G+       I      A+ + H 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHE-LD-RYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           ++    IHRDVK  NILIT+    K+ DFGFAR+    +  S        T  Y  P+ L
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVATRWYRSPELL 174
Query: 227 R-TYQLTEKSDVYSFGVLLVEMMTG 250
               Q     DV++ G +  E+++G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 126/300 (42%), Gaps = 54/300 (18%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++VEY   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR   + + + +   
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDYYKN 215
Query: 213 QVKG--TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVTIR 267
              G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E     
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE----- 267
Query: 268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
              + LK G          R    +N   E  + + D C       RPT K+  E L +I
Sbjct: 268 -LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 97/221 (43%), Gaps = 44/221 (19%)
Query: 56  IGEGGSGTVYKGKLKDGSI---VAVKR----ARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           IGEG  G V K ++K   +    A+KR    A K+ H      +F  E+    K+  H N
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 77
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDI 153
           ++ L G  EH     + +EY  +G L + L                   + L   + L  
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           A DVA  + YL   S    IHRD+ A NIL+ E   AK+ DFG +R  E           
Sbjct: 138 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VY 185
Query: 214 VKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT 249
           VK T G L   ++    L     T  SDV+S+GVLL E+++
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 17/222 (7%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN-----KHDKCLLLEFKN 95
           +I    E+F     +G+G  G V+  + K      A+K  +K+        +C ++E + 
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
             L W   EH  L  +F   +  +    V+EY+  G L  H+  +  +  +L+     A 
Sbjct: 71  LSLAW---EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           ++   L +LH+     I++RD+K  NIL+ +    K+ DFG   M +E+      +    
Sbjct: 126 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG---MCKENMLGDAKTNXFC 179
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           GT  Y+ P+ L   +     D +SFGVLL EM+ G+ P   +
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L++ H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 97/221 (43%), Gaps = 44/221 (19%)
Query: 56  IGEGGSGTVYKGKLKDGSI---VAVKR----ARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           IGEG  G V K ++K   +    A+KR    A K+ H      +F  E+    K+  H N
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 87
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDI 153
           ++ L G  EH     + +EY  +G L + L                   + L   + L  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           A DVA  + YL   S    IHRD+ A NIL+ E   AK+ DFG +R  E           
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---------VY 195
Query: 214 VKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT 249
           VK T G L   ++    L     T  SDV+S+GVLL E+++
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 35/231 (15%)
Query: 48  ENFSPANKIGEGGSGTVYKG-----KLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           +N      +GEG  G V K      K + G + VAVK  ++N      L +  +E     
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLK 81
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLR----------------------EHLDG 139
           ++ H +++KL+G        +++VEY   G+LR                        LD 
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 140 RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
                L + + +  A  ++  + YL   S   ++HRD+ A NIL+ E  + K++DFG +R
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 200 -MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            + EEDS V    +Q +    ++  + L  +  T +SDV+SFGVLL E++T
Sbjct: 199 DVYEEDSXVKR--SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 31/222 (13%)
Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLL--EFKNEILTWSKIEHL 106
           ++GEG  G V+  +       KD  +VAVK  +    D  L    +F+ E    + ++H 
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAELLTNLQHE 77
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG--------------LELAERLD 152
           ++VK +G    GD  I+V EY+ +G L + L   G +               L L++ L 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           IA  +A  + YL   +    +HRD+   N L+   L  K+ DFG +R     +    +  
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGG 193
Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
                  ++ P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           ++  F    K+G G   TVYKG  K  G  VA+K  + +  +       + EI    +++
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELK 61
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG-GN---GLELAERLDIAIDVAHA 160
           H N+V+L+  +   ++  +V E++ N  L++++D R  GN   GLEL         +   
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L + H   +  I+HRD+K  N+LI ++ + K+ DFG AR       V+  S++V  T  Y
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVV-TLWY 174
Query: 221 LDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
             PD L   RTY  +   D++S G +L EM+TG+
Sbjct: 175 RAPDVLMGSRTY--STSIDIWSCGCILAEMITGK 206

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 182
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 80
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 140 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 251
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 252 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 300

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPE 174
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 182
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 78
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 138 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 249
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 250 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 298

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++V Y   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 22/288 (7%)
Query: 55  KIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+V
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIV 77
Query: 110 KLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           K  G       R   +++E++  G+LRE+L  +    ++  + L     +   + YL T 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
                IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L 
Sbjct: 137 R---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L 
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIELL 248
Query: 288 ----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
               R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 249 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 79
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 139 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 250
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 251 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 299

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/314 (27%), Positives = 136/314 (43%), Gaps = 39/314 (12%)
Query: 33  ATTINFSFEEIY-KATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLL 90
           ++ ++   E +Y ++ E +     +GEG  G V K + KD G IVA+K+  ++  DK + 
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK 68
Query: 91  LEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
                EI    ++ H NLV L    +      +V E+V + T+ + L+    NGL+    
Sbjct: 69  KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE-LFPNGLDYQVV 126
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
                 + + + + H+++   IIHRD+K  NIL+++    K+ DFGFAR     +A   +
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL---AAPGEV 180
Query: 211 STQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA 269
                 T  Y  P+ L    +  +  DV++ G L+ EM  G         I +   I   
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI--- 237
Query: 270 MQCLK----------------AG---DAILVMDPRLRRTPASNMAVEKILGLADVCLAPT 310
           M CL                 AG     I   +P  RR P  +   E ++ LA  CL   
Sbjct: 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS---EVVIDLAKKCLHID 294
Query: 311 RQSRPTMKKCAEIL 324
              RP    CAE+L
Sbjct: 295 PDKRPF---CAELL 305

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 179
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 73
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 133 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 244
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E+V +  L+  +D     G+ L         +   L + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 22/286 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 104
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 164 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 275
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
                R P  +   ++I  +   C       RP+ +  A  + +IR
Sbjct: 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 73
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 133 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 244
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 22/286 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 71
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 131 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 242
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
                R P  +   ++I  +   C       RP+ +  A  + +IR
Sbjct: 243 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 76
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 136 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 247
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 72
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 132 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 243
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 244 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 292

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R  + L+LA  +  A  ++ AL YL +      
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STXXKASKGKLPIKWMAPESIN 185
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 22/288 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 73
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 133 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 244
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
                R P  +   ++I  +   C       RP+ +  A  + +IR +
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 22/288 (7%)
Query: 55  KIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+V
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIV 92
Query: 110 KLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           K  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
                IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L 
Sbjct: 152 R---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L 
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIELL 263
Query: 288 ----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
               R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 264 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E+V +  L++ +D     G+ L         +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 176
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 133/289 (46%), Gaps = 22/289 (7%)
Query: 54  NKIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 77
Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L
Sbjct: 137 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIEL 248
Query: 287 R----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
                R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 249 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 297

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 13/218 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKN-EILTWSKI 103
           + ++F     +G G  G V+  + + +G   A+K  +K    +   +E  N E L  S +
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H  +++++G  +   +  ++++Y+  G L   L  R             A +V  AL Y
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALEY 121
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           LH+     II+RD+K  NIL+ +    K+TDFGFA+       V  ++  + GT  Y+ P
Sbjct: 122 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY------VPDVTYXLCGTPDYIAP 172
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           + + T    +  D +SFG+L+ EM+ G  P      +K
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 22/288 (7%)
Query: 55  KIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+V
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIV 92
Query: 110 KLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           K  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
                IHRD+   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L 
Sbjct: 152 R---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L 
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIELL 263
Query: 288 ----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
               R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 264 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +F     IG GG G V+K K + DG    +KR + N        + + E+   +K++H+N
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHVN 65
Query: 108 LVKLFGFLEHGDER----------------IIVVEYVGNGTLREHLDGRGGNGLELAERL 151
           +V   G  +  D                   I +E+   GTL + ++ R G  L+    L
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
           ++   +   + Y+H+     +I+RD+K SNI + +  + K+ DFG     + D       
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK----R 178
Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            + KGT  Y+ P+ + +    ++ D+Y+ G++L E++
Sbjct: 179 XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 83  GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 137
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 190
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 13/217 (5%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN---KHDKCLLLEFKNEILTWS 101
             +NF     +G+G  G V   ++K+ G + AVK  +K+   + D       +  IL+ +
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
           +  H  L +LF   +  D    V+E+V  G L  H+  +     + A     A ++  AL
Sbjct: 81  R-NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISAL 137
Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
            +LH   D  II+RD+K  N+L+  +   K+ DFG   M +E       +    GT  Y+
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFG---MCKEGICNGVTTATFCGTPDYI 191
Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            P+ L+        D ++ GVLL EM+ G  P E++ 
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 127/303 (41%), Gaps = 60/303 (19%)
Query: 56  IGEGGSGTVY--------KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
           +GEG  G V         K K K+   VAVK  + +  +K L  +  +E+     I +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIGKHK 101
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA--------------ERLD 152
           N++ L G         ++V Y   G LRE+L  R   G+E +              + + 
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
               +A  + YL +      IHRD+ A N+L+TE    K+ DFG AR       +++I  
Sbjct: 162 CTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDY 212
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             K T G     ++ P+ L     T +SDV+SFGVL+ E+ T     YP     P++E  
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP---GIPVEE-- 267
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + LK G          R    +N   E  + + D C       RPT K+  E L
Sbjct: 268 ----LFKLLKEGH---------RMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVEDL 313
Query: 325 WKI 327
            +I
Sbjct: 314 DRI 316

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E +    KIGEG  G VYK +   G   A+K+ R  K D+ +      EI    +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKL+  + H  +R+++V    +  L++ LD   G GLE        + + + + Y H  
Sbjct: 62  IVKLYDVI-HTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH-- 117
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            D  ++HRD+K  N+LI  +   K+ DFG AR       V   + +V  T  Y  PD L 
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTG 250
            + + +   D++S G +  EM+ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E +    KIGEG  G VYK +   G   A+K+ R  K D+ +      EI    +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKL+  + H  +R+++V    +  L++ LD   G GLE        + + + + Y H  
Sbjct: 62  IVKLYDVI-HTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH-- 117
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            D  ++HRD+K  N+LI  +   K+ DFG AR       V   + +V  T  Y  PD L 
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVV-TLWYRAPDVLM 173
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTG 250
            + + +   D++S G +  EM+ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 160
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 213
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 245

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 46  ATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           AT  + P  +IG G  GTVYK +    G  VA+K  R    ++ L +    E+    ++E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 105 ---HLNLVKLFGFL--EHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
              H N+V+L         D  I   +V E+V +  LR +LD     GL      D+   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
               L +LH      I+HRD+K  NIL+T     K+ DFG AR+     A++ +      
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV---- 173
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
           T  Y  P+ L         D++S G +  EM 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 80  GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 134
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 187
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 188 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 219

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 43/230 (18%)
Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +F     IG GG G V+K K + DG    ++R + N        + + E+   +K++H+N
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE------KAEREVKALAKLDHVN 66
Query: 108 LVKLFGF--------------LEHGDER---------------IIVVEYVGNGTLREHLD 138
           +V   G               LE  D                  I +E+   GTL + ++
Sbjct: 67  IVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 139 GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA 198
            R G  L+    L++   +   + Y+H+     +IHRD+K SNI + +  + K+ DFG  
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
              + D       T+ KGT  Y+ P+ + +    ++ D+Y+ G++L E++
Sbjct: 184 TSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 81  GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 135
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 188
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 220

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 120 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 173
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 101/238 (42%), Gaps = 45/238 (18%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTL--------REHLDGRGGNGLELAERLDIAI 155
           +H N+V L G   HG   +++ EY   G L           LD   G  LEL + L  + 
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            VA  + +L + +    IHRDV A N+L+T    AK+ DFG AR    DS     +  VK
Sbjct: 160 QVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NYIVK 211
Query: 216 GTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYP--IESKKPIKERVTI 266
           G A     ++ P+ +     T +SDV+S+G+LL E+ +     YP  + + K  K     
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK----- 266
Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                        LV D      PA   A + I  +   C A     RPT ++    L
Sbjct: 267 -------------LVKDGYQMAQPA--FAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 185
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 175
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 129
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 182
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 176
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 176
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 175
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 84/168 (50%), Gaps = 17/168 (10%)
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERL 151
           F  E+     +EH N++K  G L + D+R+  + EY+  GTLR  +          ++R+
Sbjct: 54  FLKEVKVMRCLEHPNVLKFIGVL-YKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRV 111
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHI 210
             A D+A  + YLH+ +   IIHRD+ + N L+ E     V DFG AR M +E +    +
Sbjct: 112 SFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 211 ST----------QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            +           V G   ++ P+ +      EK DV+SFG++L E++
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL YL +      
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 185
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 35/231 (15%)
Query: 48  ENFSPANKIGEGGSGTVYKG-----KLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           +N      +GEG  G V K      K + G + VAVK  ++N      L +  +E     
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLK 81
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLR----------------------EHLDG 139
           ++ H +++KL+G        +++VEY   G+LR                        LD 
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 140 RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
                L + + +  A  ++  + YL   ++  ++HRD+ A NIL+ E  + K++DFG +R
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 200 -MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            + EEDS V    +Q +    ++  + L  +  T +SDV+SFGVLL E++T
Sbjct: 199 DVYEEDSXVKR--SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 173
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 173
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 122 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 175
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 176
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 124 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 177
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 122 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 175
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 121 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 174
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E +    KIGEG  G VYK +   G   A+K+ R  K D+ +      EI    +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKL+  + H  +R+++V    +  L++ LD   G GLE        + + + + Y H  
Sbjct: 62  IVKLYDVI-HTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH-- 117
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            D  ++HRD+K  N+LI  +   K+ DFG AR       V   + ++  T  Y  PD L 
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIV-TLWYRAPDVLM 173
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTG 250
            + + +   D++S G +  EM+ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 173
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 120 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 173
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+ L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 97/221 (43%), Gaps = 44/221 (19%)
Query: 56  IGEGGSGTVYKGKLKDGSI---VAVKR----ARKNKHDKCLLLEFKNEILTWSKI-EHLN 107
           IGEG  G V K ++K   +    A+KR    A K+ H      +F  E+    K+  H N
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 84
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDI 153
           ++ L G  EH     + +EY  +G L + L                   + L   + L  
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           A DVA  + YL   S    IHR++ A NIL+ E   AK+ DFG +R  E           
Sbjct: 145 AADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQE---------VY 192
Query: 214 VKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT 249
           VK T G L   ++    L     T  SDV+S+GVLL E+++
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R  + L+LA  +  A  ++ AL YL +      
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR---F 132
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 185
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 123 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 176
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 121 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 174
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+ L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPEIL 174
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+ L
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPEIL 176
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 35/231 (15%)
Query: 48  ENFSPANKIGEGGSGTVYKG-----KLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           +N      +GEG  G V K      K + G + VAVK  ++N      L +  +E     
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLK 81
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLR----------------------EHLDG 139
           ++ H +++KL+G        +++VEY   G+LR                        LD 
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 140 RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
                L + + +  A  ++  + YL   ++  ++HRD+ A NIL+ E  + K++DFG +R
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 200 -MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            + EEDS V    +Q +    ++  + L  +  T +SDV+SFGVLL E++T
Sbjct: 199 DVYEEDSYVKR--SQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 46  ATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           AT  + P  +IG G  GTVYK +    G  VA+K  R    ++ L +    E+    ++E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 105 ---HLNLVKLFGFL--EHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
              H N+V+L         D  I   +V E+V +  LR +LD     GL      D+   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
               L +LH      I+HRD+K  NIL+T     K+ DFG AR+     A+  +      
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV---- 173
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
           T  Y  P+ L         D++S G +  EM 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGS-IVAVKRARKNKHDKCLLLEFKNEILTW 100
           + +A + +    +IGEG  G V+K + LK+G   VA+KR R    ++ + L    E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 101 SKIE---HLNLVKLFGFL-----EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
             +E   H N+V+LF        +   +  +V E+V +  L  +LD     G+      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           +   +   L +LH++    ++HRD+K  NIL+T   + K+ DFG AR+     A+    T
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----T 177
Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            V  T  Y  P+ L         D++S G +  EM 
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 48  ENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E F+   +IG+G  G V+KG   +   +VA+K     + +  +    + EI   S+ +  
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSS 81
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            + K +G    G +  I++EY+G G+  + L     +  ++A  L    ++   L YLH+
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHS 138
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYL 221
                 IHRD+KA+N+L++E+   K+ DFG A    +        TQ+K     GT  ++
Sbjct: 139 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--------TQIKRNTFVGTPFWM 187
Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+ ++      K+D++S G+  +E+  G  P     P++
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 227

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGS-IVAVKRARKNKHDKCLLLEFKNEILTW 100
           + +A + +    +IGEG  G V+K + LK+G   VA+KR R    ++ + L    E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 101 SKIE---HLNLVKLFGFL-----EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
             +E   H N+V+LF        +   +  +V E+V +  L  +LD     G+      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           +   +   L +LH++    ++HRD+K  NIL+T   + K+ DFG AR+     A+    T
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----T 177
Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            V  T  Y  P+ L         D++S G +  EM 
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L+  +D     G+ L         +   L + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 123 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 176
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 9/208 (4%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           + ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H++    ++HRD+K  N+LI  +   K+ DFG AR       V     +V  T  Y  P+
Sbjct: 121 HSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVV-TLWYRAPE 174
Query: 225 YLRTYQLTEKS-DVYSFGVLLVEMMTGR 251
            L   +    + D++S G +  EM+T R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R  + L+LA  +  A  ++ AL YL +      
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR---F 512
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 565
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 89
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 90  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTA-EIVSALE 146
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  ++ V GTA Y+ 
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVS 202
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L     ++ SD+++ G ++ +++ G  P  +
Sbjct: 203 PELLTEKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGS-IVAVKRARKNKHDKCLLLEFKNEILTW 100
           + +A + +    +IGEG  G V+K + LK+G   VA+KR R    ++ + L    E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 101 SKIE---HLNLVKLFGFL-----EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
             +E   H N+V+LF        +   +  +V E+V +  L  +LD     G+      D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           +   +   L +LH++    ++HRD+K  NIL+T   + K+ DFG AR+     A+    T
Sbjct: 125 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL----T 177
Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            V  T  Y  P+ L         D++S G +  EM 
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 10/242 (4%)
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERII--VVEYVGNGTLREHLDGRGGNGLELAER 150
           +K EI     + H +++K  G  E   E+ +  V+EYV  G+LR++L     + + LA+ 
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQL 119
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           L  A  +   + YLH+      IHR++ A N+L+      K+ DFG A+   E      +
Sbjct: 120 LLFAQQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 176
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM 270
                    +  P+ L+ Y+    SDV+SFGV L E++T  +   S+ P  + + +    
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIGIA 234
Query: 271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
           Q       +  +  R  R P  +    ++  L   C       RPT +    IL  + + 
Sbjct: 235 QGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 294
Query: 331 FR 332
           +R
Sbjct: 295 YR 296

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 33  ATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKC--- 88
            T  N +   I K TE       +G G  GTVYKG  + +G  V +  A K  ++     
Sbjct: 24  GTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK 82
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNG 144
             +EF +E L  + ++H +LV+L G       ++ V + + +G L     EH D  G   
Sbjct: 83  ANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQL 141
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L     L+  + +A  + YL       ++HRD+ A N+L+      K+TDFG AR+ E D
Sbjct: 142 L-----LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 193
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               + +   K    ++  + +   + T +SDV+S+GV + E+MT
Sbjct: 194 EK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+ + R +   + +      EI    ++ H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 175
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+ + R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++ +  L++ +D     G+ L         +   L + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+LI  +   K+ DFG AR            T    T  Y  P+ L
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEIL 174
Query: 227 RTYQLTEKS-DVYSFGVLLVEMMTGR 251
              +    + D++S G +  EM+T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 46  ATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           AT  + P  +IG G  GTVYK +    G  VA+K  R    ++ L +    E+    ++E
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 105 ---HLNLVKLFGFL--EHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
              H N+V+L         D  I   +V E+V +  LR +LD     GL      D+   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
               L +LH      I+HRD+K  NIL+T     K+ DFG AR+     A+  +      
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV---- 173
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
           T  Y  P+ L         D++S G +  EM 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTW 100
           K  E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM-- 64
Query: 101 SKIEHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
           S+++H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  
Sbjct: 65  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVS 121
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           AL YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA 
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 177
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           Y+ P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 133/288 (46%), Gaps = 22/288 (7%)
Query: 55  KIGEGGSGTVYKGK---LKD--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           ++G+G  G+V   +   L+D  G +VAVK+ + +  +   L +F+ EI     ++H N+V
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIV 75
Query: 110 KLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           K  G       R   +++EY+  G+LR++L  +    ++  + L     +   + YL T 
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 134
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
                IHR++   NIL+  + R K+ DFG  ++  +D     +    +    +  P+ L 
Sbjct: 135 R---YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             + +  SDV+SFGV+L E+ T  Y  +SK P  E + +   +   K G  I+     L 
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRM---IGNDKQGQMIVFHLIELL 246
Query: 288 ----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
               R P  +   ++I  +   C       RP+ +  A  + +IR + 
Sbjct: 247 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 294

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTW 100
           K  E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM-- 63
Query: 101 SKIEHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
           S+++H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  
Sbjct: 64  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVS 120
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           AL YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA 
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 176
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           Y+ P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 56  IGEGGSGTVYKG---KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IGEG  G V++G     ++ ++    +  KN     +  +F  E LT  + +H ++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +   +   I++E    G LR  L  R  + L+LA  +  A  ++ AL YL +      
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKR---F 512
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG-----YLDPDYLR 227
           +HRD+ A N+L++     K+ DFG +R  E+       ST  K + G     ++ P+ + 
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMED-------STYYKASKGKLPIKWMAPESIN 565
Query: 228 TYQLTEKSDVYSFGVLLVE-MMTGRYPIESKK 258
             + T  SDV+ FGV + E +M G  P +  K
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/257 (24%), Positives = 119/257 (46%), Gaps = 19/257 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           K+G G  G V+  + +   +  V +       +  + + + EI     ++H N++K+F  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSDPPI 172
            E      IV+E    G L E +      G  L+E    ++   + +AL Y H+     +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---V 145
Query: 173 IHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
           +H+D+K  NIL  +       K+ DFG A + + D      ST   GTA Y+ P+  +  
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH----STNAAGTALYMAPEVFKR- 200
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERVTIR---WAMQCLK-AGDAILVMD 283
            +T K D++S GV++  ++TG  P    S + ++++ T +   +A++C      A+ ++ 
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLK 260
Query: 284 PRLRRTPASNMAVEKIL 300
             L + P    +  ++L
Sbjct: 261 QMLTKDPERRPSAAQVL 277

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTW 100
           K  E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM-- 61
Query: 101 SKIEHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
           S+++H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  
Sbjct: 62  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVS 118
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           AL YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA 
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 174
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           Y+ P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTW 100
           K  E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM-- 62
Query: 101 SKIEHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
           S+++H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  
Sbjct: 63  SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVS 119
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           AL YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA 
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 175
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           Y+ P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 19/225 (8%)
Query: 33  ATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKC--- 88
            T  N +   I K TE       +G G  GTVYKG  + +G  V +  A K  ++     
Sbjct: 1   GTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK 59
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNG 144
             +EF +E L  + ++H +LV+L G       ++ V + + +G L     EH D  G   
Sbjct: 60  ANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQL 118
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L     L+  + +A  + YL       ++HRD+ A N+L+      K+TDFG AR+ E D
Sbjct: 119 L-----LNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 170
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               + +   K    ++  + +   + T +SDV+S+GV + E+MT
Sbjct: 171 EK-EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 10/242 (4%)
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERII--VVEYVGNGTLREHLDGRGGNGLELAER 150
           +K EI     + H +++K  G  E   E+ +  V+EYV  G+LR++L     + + LA+ 
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQL 119
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           L  A  +   + YLH       IHR++ A N+L+      K+ DFG A+   E      +
Sbjct: 120 LLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 176
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM 270
                    +  P+ L+ Y+    SDV+SFGV L E++T  +   S+ P  + + +    
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIGIA 234
Query: 271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
           Q       +  +  R  R P  +    ++  L   C       RPT +    IL  + + 
Sbjct: 235 QGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 294
Query: 331 FR 332
           +R
Sbjct: 295 YR 296

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGG-SGTVYKGKLKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG  S TV   +L      A+K   K    K +K   +  + +++  S++
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 87
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 88  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 144
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 200
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 56  IGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           IG G  G V  G LK        VA+K  +    +K    +F +E     + +H N++ L
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNVIHL 73
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G +      +I+ E++ NG+L   L    G    + + + +   +A  + YL   +D  
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG--YLDPDYLRTY 229
            +HR + A NIL+   L  KV+DFG +R  E+D++    ++ + G     +  P+ ++  
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 230 QLTEKSDVYSFGVLLVEMMT 249
           + T  SDV+S+G+++ E+M+
Sbjct: 190 KFTSASDVWSYGIVMWEVMS 209

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 90
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 91  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 147
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  ++ V GTA Y+ 
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVS 203
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 44  YKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR-------KNKHDKCLLLEFKN 95
           Y    NF    KIG G    VY+   L DG  VA+K+ +       K + D C+      
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CI-----K 81
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDI 153
           EI    ++ H N++K +      +E  IV+E    G L   +         + ER     
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            + +  AL ++H+     ++HRD+K +N+ IT     K+ D G  R     +  +H    
Sbjct: 142 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH---S 195
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL 273
           + GT  Y+ P+ +       KSD++S G LL EM   + P    K           M   
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLY 244
Query: 274 KAGDAILVMD-PRLRRTPASNMAVEKILGLADVCLAPTRQSRP 315
                I   D P L     S+   E++  L ++C+ P  + RP
Sbjct: 245 SLCKKIEQCDYPPL----PSDHYSEELRQLVNMCINPDPEKRP 283

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 55  KIGEGGSGTVYKGKLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG  GTV+K K ++   IVA+KR R +  D+ +      EI    +++H N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            L H D+++ +V    +  L+++ D   G+ L+          +   L + H+ +   ++
Sbjct: 69  VL-HSDKKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+K  N+LI      K+ DFG AR       V   S +V  T  Y  PD L   +L  
Sbjct: 124 HRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 234 KS-DVYSFGVLLVEMMTGRYPI 254
            S D++S G +  E+     P+
Sbjct: 181 TSIDMWSAGCIFAELANAARPL 202

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 94
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 95  DHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 151
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 152 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 207
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 87
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 88  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 144
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQYVS 200
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 86
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 87  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 143
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  ++ V GTA Y+ 
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVS 199
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 22/214 (10%)
Query: 55  KIGEGGSGTVYKGKL-KDGSIVAVKRARK--NKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  G V+K +  K G ++AVK+ R+  NK +   +L   + +L      ++  V+ 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI--VQC 89
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSD 169
           FG      +  I +E +G  T  E L  R      + ER+   + + +  AL YL     
Sbjct: 90  FGTFITNTDVFIAMELMG--TCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG 145
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRDVK SNIL+ E+ + K+ DFG +    +D A      +  G A Y+ P+ +   
Sbjct: 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA----KDRSAGCAAYMAPERIDPP 199
Query: 230 QLTE-----KSDVYSFGVLLVEMMTGRYPIESKK 258
             T+     ++DV+S G+ LVE+ TG++P ++ K
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 48  ENFSPANKIGEGGSGTVYKGK----LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           E ++    +G+G  G V K K     ++ ++  + +A     D   +L    E+    K+
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKL 78
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N++KLF  LE      IV E    G L + +  R       A R  I   V   +TY
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 164 LHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           +H ++   I+HRD+K  NIL+  K +    K+ DFG +   ++++ +        GTA Y
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK----DRIGTAYY 189
Query: 221 LDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + P+ LR TY   EK DV+S GV+L  +++G  P   K
Sbjct: 190 IAPEVLRGTYD--EKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 89
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 90  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 146
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 202
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 87
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 88  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 144
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 200
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 90
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 91  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 147
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 148 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 203
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 204 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 89
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 90  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 146
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 202
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 48  ENFSPANKIGEGGSGTVYKGK----LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           E ++    +G+G  G V K K     ++ ++  + +A     D   +L    E+    K+
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKL 78
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N++KLF  LE      IV E    G L + +  R       A R  I   V   +TY
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 164 LHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           +H ++   I+HRD+K  NIL+  K +    K+ DFG +   ++++ +        GTA Y
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK----DRIGTAYY 189
Query: 221 LDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + P+ LR TY   EK DV+S GV+L  +++G  P   K
Sbjct: 190 IAPEVLRGTYD--EKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 89
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 90  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 146
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 202
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG +G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 92
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 93  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 149
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 150 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 205
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 206 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++GEG  G V+  +       +D  +VAVK  ++         + + E+LT   ++H ++
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT--MLQHQHI 82
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-------------LELAERLDIAI 155
           V+ FG    G   ++V EY+ +G L   L   G +              L L + L +A 
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            VA  + YL        +HRD+   N L+ + L  K+ DFG +R     +    +  +  
Sbjct: 143 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTM 198
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
               ++ P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 89
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 90  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 146
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 202
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 87
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 88  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 144
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 200
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++GEG  G V+  +       +D  +VAVK  ++         + + E+LT   ++H ++
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT--MLQHQHI 76
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-------------LELAERLDIAI 155
           V+ FG    G   ++V EY+ +G L   L   G +              L L + L +A 
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            VA  + YL        +HRD+   N L+ + L  K+ DFG +R     +    +  +  
Sbjct: 137 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTM 192
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
               ++ P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK----NEILTWSKI 103
           ++F   +++G G  G V K + +   ++    ARK  H     LE K    N+I+   ++
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIM---ARKLIH-----LEIKPAIRNQIIRELQV 67
Query: 104 EH----LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            H      +V  +G      E  I +E++  G+L + L        E+  ++ IA  V  
Sbjct: 68  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLR 125
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L YL       I+HRDVK SNIL+  +   K+ DFG +        +  ++    GT  
Sbjct: 126 GLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRS 178
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           Y+ P+ L+    + +SD++S G+ LVE+  GRYPI
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 89
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 90  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 146
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 147 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 202
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 71
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 72  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 128
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 129 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 184
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 185 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 34  TTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK----LKDGSIVAVKRARK-----NK 84
           T++N   E+I    E F     +G+GG G V++ +       G I A+K  +K     N 
Sbjct: 5   TSVNRGPEKI--RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62
Query: 85  HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG 144
            D       K E     +++H  +V L    + G +  +++EY+  G L   L+ R G  
Sbjct: 63  KDTA---HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIF 118
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           +E      +A +++ AL +LH      II+RD+K  NI++  +   K+TDFG  + S  D
Sbjct: 119 MEDTACFYLA-EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI---ESKKPIK 261
             V+H      GT  Y+ P+ L         D +S G L+ +M+TG  P      KK I 
Sbjct: 175 GTVTHTFC---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231
Query: 262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMA 295
           + +  +  +      +A  ++   L+R  AS + 
Sbjct: 232 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLG 265

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E +    K+GEG  G VYK K   G IVA+KR R +  D+ +      EI    ++ H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +V L   + H +  + +V       L++ LD     GL+ ++       +   + + H +
Sbjct: 81  IVSLIDVI-HSERCLTLVFEFMEKDLKKVLD-ENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+K  N+LI      K+ DFG AR       V   + +V  T  Y  PD L 
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTGR 251
            + + +   D++S G +  EM+TG+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 48  ENFSPANKIGEGGSGTVYKGK----LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           E ++    +G+G  G V K K     ++ ++  + +A     D   +L    E+    K+
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKL 78
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N++KLF  LE      IV E    G L + +  R       A R  I   V   +TY
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 164 LHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           +H ++   I+HRD+K  NIL+  K +    K+ DFG +   ++++ +        GTA Y
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK----DRIGTAYY 189
Query: 221 LDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + P+ LR TY   EK DV+S GV+L  +++G  P   K
Sbjct: 190 IAPEVLRGTYD--EKCDVWSAGVILYILLSGTPPFYGK 225

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E +    K+GEG  G VYK K   G IVA+KR R +  D+ +      EI    ++ H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +V L   + H +  + +V       L++ LD     GL+ ++       +   + + H +
Sbjct: 81  IVSLIDVI-HSERCLTLVFEFMEKDLKKVLD-ENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+K  N+LI      K+ DFG AR       V   + +V  T  Y  PD L 
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVV-TLWYRAPDVLM 192
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTGR 251
            + + +   D++S G +  EM+TG+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++GEG  G V+  +       +D  +VAVK  ++         + + E+LT   ++H ++
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT--MLQHQHI 105
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-------------LELAERLDIAI 155
           V+ FG    G   ++V EY+ +G L   L   G +              L L + L +A 
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            VA  + YL        +HRD+   N L+ + L  K+ DFG +R     +    +  +  
Sbjct: 166 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTM 221
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
               ++ P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN---KHDKCLLLEFKNEILTWSKI 103
           E+F     +GEG   TV   + L      A+K   K    K +K   +  + +++  S++
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM--SRL 86
Query: 104 EHLNLVKLFGFLEHGDERIIV-VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           +H   VKL+ F    DE++   + Y  NG L +++  + G+  E   R   A ++  AL 
Sbjct: 87  DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTA-EIVSALE 143
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S  +  +  V GTA Y+ 
Sbjct: 144 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVS 199
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           P+ L      + SD+++ G ++ +++ G  P  +
Sbjct: 200 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 34  TTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK----LKDGSIVAVKRARK-----NK 84
           T++N   E+I    E F     +G+GG G V++ +       G I A+K  +K     N 
Sbjct: 5   TSVNRGPEKI--RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA 62
Query: 85  HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG 144
            D       K E     +++H  +V L    + G +  +++EY+  G L   L+ R G  
Sbjct: 63  KDTA---HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE-REGIF 118
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           +E      +A +++ AL +LH      II+RD+K  NI++  +   K+TDFG  + S  D
Sbjct: 119 MEDTACFYLA-EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI---ESKKPIK 261
             V+H      GT  Y+ P+ L         D +S G L+ +M+TG  P      KK I 
Sbjct: 175 GTVTHXFC---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231
Query: 262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMA 295
           + +  +  +      +A  ++   L+R  AS + 
Sbjct: 232 KILKCKLNLPPYLTQEARDLLKKLLKRNAASRLG 265

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMXGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 17/266 (6%)
Query: 72  GSIVAVKRARKN---KHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII--VVE 126
           G +VAVK  + +   +H       +K EI     + H +++K  G  E      +  V+E
Sbjct: 60  GEMVAVKALKADAGPQHRS----GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115
Query: 127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE 186
           YV  G+LR++L     + + LA+ L  A  +   + YLH       IHRD+ A N+L+  
Sbjct: 116 YVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDN 169
Query: 187 KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
               K+ DFG A+   E      +         +  P+ L+ Y+    SDV+SFGV L E
Sbjct: 170 DRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 247 MMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVC 306
           ++T  +   S+ P  + + +    Q       +  +  R  R P  +    ++  L   C
Sbjct: 230 LLT--HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNC 287
Query: 307 LAPTRQSRPTMKKCAEILWKIRKDFR 332
                  RPT +    IL  + + ++
Sbjct: 288 WETEASFRPTFENLIPILKTVHEKYQ 313

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 109/242 (45%), Gaps = 36/242 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILT 99
           +N +    +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L 
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALI 101
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIA 154
            SK+ H N+V+  G       R I++E +  G L+  L          + L + + L +A
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIS 211
            D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S
Sbjct: 162 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAS 212
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKER 263
              KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E 
Sbjct: 213 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 272
Query: 264 VT 265
           VT
Sbjct: 273 VT 274

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFK- 94
           N     I+K TE       +G G  GTV+KG  + +G  + +    K   DK     F+ 
Sbjct: 21  NKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 79
Query: 95  --NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-DGRGGNGLELAERL 151
             + +L    ++H ++V+L G    G    +V +Y+  G+L +H+   RG  G +L   L
Sbjct: 80  VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL--L 136
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
           +  + +A  + YL  +    ++HR++ A N+L+    + +V DFG A +   D     + 
Sbjct: 137 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-QLLY 192
Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           ++ K    ++  + +   + T +SDV+S+GV + E+MT
Sbjct: 193 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI   + + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINAMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 106/241 (43%), Gaps = 34/241 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNKHDKCLL---LEFKNEILTW 100
           +N +    +G G  G VY+G++     D S + V  A K   + C     L+F  E L  
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLMEALII 88
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAI 155
           SK+ H N+V+  G       R I++E +  G L+  L          + L + + L +A 
Sbjct: 89  SKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
           D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S 
Sbjct: 149 DIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASY 199
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E V
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 259
Query: 265 T 265
           T
Sbjct: 260 T 260

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMXGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 6/162 (3%)
Query: 90  LLEFKNEILTWSKIEHLNLVKLFGFL-EHGDERI-IVVEYVGNGTLREHLDGRGGNGLEL 147
           + + K EI     + H N+VK  G   E G   I +++E++ +G+L+E+L  +  N + L
Sbjct: 67  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINL 125
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
            ++L  A+ +   + YL +      +HRD+ A N+L+  + + K+ DFG  +  E D   
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEX 182
Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +         +  P+ L   +    SDV+SFGV L E++T
Sbjct: 183 XTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMXGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLL 91
           F  +E   + E  +   ++G+G  G VY+G  +D       + VAVK   ++   +   +
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERI 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGN 143
           EF NE          ++V+L G +  G   ++V+E + +G L+ +L        +  G  
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
              L E + +A ++A  + YL+       +HRD+ A N ++      K+ DFG  R    
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR---- 175
Query: 204 DSAVSHISTQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +       KG  G     ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 176 --DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHL 106
           +F P   +G GG G V++ K K D    A+KR R    +  L  E    E+   +K+EH 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHP 63
Query: 107 NLVKLF-GFLE-HGDERI----------IVVEYVGNGTLREHLDGRGGNGLELAER---L 151
            +V+ F  +LE +  E++          I ++      L++ ++GR    +E  ER   L
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCL 121
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            I + +A A+ +LH+     ++HRD+K SNI  T     KV DFG     ++D     + 
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 212 TQVK---------GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           T +          GT  Y+ P+ +     + K D++S G++L E++   YP  ++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQ 230

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMXGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 62
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 120
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 176
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELP 205

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 33/171 (19%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTL---------------------REHLDGRGG 142
           +H N+V L G   HG   +++ EY   G L                      E LD   G
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 143 NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE 202
             LEL + L  +  VA  + +L + +    IHRDV A N+L+T    AK+ DFG AR   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 203 EDSAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            DS     +  VKG A     ++ P+ +     T +SDV+S+G+LL E+ +
Sbjct: 210 NDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 56  IGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +GEG  G V   +        G  VAVK + K +     + + K EI     + H N+VK
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVK-SLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 111 LFGFL-EHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
             G   E G   I +++E++ +G+L+E+L  +  N + L ++L  A+ +   + YL +  
Sbjct: 76  YKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
               +HRD+ A N+L+  + + K+ DFG  +  E D     +         +  P+ L  
Sbjct: 135 ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 229 YQLTEKSDVYSFGVLLVEMMT 249
            +    SDV+SFGV L E++T
Sbjct: 192 SKFYIASDVWSFGVTLHELLT 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVKLF 112
           IG+G  G VY G+  D +   ++ A K+      + +   F  E L    + H N++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 113 GFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           G +   +    +++ Y+ +G L + +     N   + + +   + VA  + YL   ++  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP-TVKDLISFGLQVARGMEYL---AEQK 144
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVS---HISTQVKGTAGYLDPDYL 226
            +HRD+ A N ++ E    KV DFG AR  +  E  +V    H    VK TA     + L
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL----ESL 200
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           +TY+ T KSDV+SFGVLL E++T   P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLL---LEFKNEILTWSKIEHLNLVKLF 112
           +GEG  G VY+G   +     +  A K     C L    +F +E +    ++H ++VKL 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +E  +   I++E    G L  +L+ R  N L++   +  ++ +  A+ YL + +    
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN---C 146
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+   NIL+      K+ DFG +R  E++       T++     ++ P+ +   + T
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFT 204
Query: 233 EKSDVYSFGVLLVEMMT-GRYPI 254
             SDV+ F V + E+++ G+ P 
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPF 227

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMXGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLL---LEFKNEILTWSKIEHLNLVKLF 112
           +GEG  G VY+G   +     +  A K     C L    +F +E +    ++H ++VKL 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +E  +   I++E    G L  +L+ R  N L++   +  ++ +  A+ YL + +    
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN---C 130
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+   NIL+      K+ DFG +R  E++       T++     ++ P+ +   + T
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFT 188
Query: 233 EKSDVYSFGVLLVEMMT-GRYPI 254
             SDV+ F V + E+++ G+ P 
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPF 211

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 36/242 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILT 99
           +N +    +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L 
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALI 103
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIA 154
            SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIS 211
            D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S
Sbjct: 164 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAS 214
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKER 263
              KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E 
Sbjct: 215 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 274
Query: 264 VT 265
           VT
Sbjct: 275 VT 276

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 36/242 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILT 99
           +N +    +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L 
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALI 78
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIA 154
            SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIS 211
            D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S
Sbjct: 139 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAS 189
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKER 263
              KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E 
Sbjct: 190 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 249
Query: 264 VT 265
           VT
Sbjct: 250 VT 251

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 108/242 (44%), Gaps = 36/242 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILT 99
           +N +    +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALI 86
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIA 154
            SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIS 211
            D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S
Sbjct: 147 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAS 197
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKER 263
              KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E 
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 264 VT 265
           VT
Sbjct: 258 VT 259

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 105/234 (44%), Gaps = 36/234 (15%)
Query: 56  IGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILTWSKIEHLN 107
           +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L  SK  H N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 94
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAIDVAHALT 162
           +V+  G       R I++E +  G L+  L          + L + + L +A D+A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 163 YLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           YL        IHRD+ A N L+T       AK+ DFG AR       +   S   KG   
Sbjct: 155 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCA 205
Query: 220 -----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVT 265
                ++ P+       T K+D +SFGVLL E+ +     YP +S + + E VT
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLL---LEFKNEILTWSKIEHLNLVKLF 112
           +GEG  G VY+G   +     +  A K     C L    +F +E +    ++H ++VKL 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G +E  +   I++E    G L  +L+ R  N L++   +  ++ +  A+ YL + +    
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESIN---C 134
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+   NIL+      K+ DFG +R  E++       T++     ++ P+ +   + T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFT 192
Query: 233 EKSDVYSFGVLLVEMMT-GRYPI 254
             SDV+ F V + E+++ G+ P 
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPF 215

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 105/241 (43%), Gaps = 34/241 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNKHDKCLL---LEFKNEILTW 100
           +N +    +G G  G VY+G++     D S + V  A K   + C     L+F  E L  
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLMEALII 88
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAI 155
           SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A 
Sbjct: 89  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
           D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S 
Sbjct: 149 DIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASY 199
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E V
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 259
Query: 265 T 265
           T
Sbjct: 260 T 260

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLL 91
           F  +E   + E  +   ++G+G  G VY+G  +D       + VAVK   ++   +   +
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERI 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGN 143
           EF NE          ++V+L G +  G   ++V+E + +G L+ +L        +  G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
              L E + +A ++A  + YL+       +HRD+ A N ++      K+ DFG  R    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 204 DSAVSHISTQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +       KG  G     ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 179 --DIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 105/241 (43%), Gaps = 34/241 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNKHDKCLL---LEFKNEILTW 100
           +N +    +G G  G VY+G++     D S + V  A K   + C     L+F  E L  
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLMEALII 114
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAI 155
           SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A 
Sbjct: 115 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 174
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
           D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S 
Sbjct: 175 DIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASY 225
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E V
Sbjct: 226 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 285
Query: 265 T 265
           T
Sbjct: 286 T 286

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/257 (26%), Positives = 112/257 (43%), Gaps = 29/257 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E F+  ++IG+G  G VYKG       V   +    +  +  + + + EI   S+ +   
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           + + FG      +  I++EY+G G+    LD      LE      I  ++   L YLH+ 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYLD 222
                IHRD+KA+N+L++E+   K+ DFG A    +        TQ+K     GT  ++ 
Sbjct: 136 RK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--------TQIKRNXFVGTPFWMA 184
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG------ 276
           P+ ++      K+D++S G+  +E+  G  P     P++    I         G      
Sbjct: 185 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPF 244
Query: 277 ----DAILVMDPRLRRT 289
               +A L  DPR R T
Sbjct: 245 KEFVEACLNKDPRFRPT 261

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 105/234 (44%), Gaps = 36/234 (15%)
Query: 56  IGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILTWSKIEHLN 107
           +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L  SK  H N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 109
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAIDVAHALT 162
           +V+  G       R I++E +  G L+  L          + L + + L +A D+A    
Sbjct: 110 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 163 YLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           YL        IHRD+ A N L+T       AK+ DFG AR       +   S   KG   
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCA 220
Query: 220 -----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVT 265
                ++ P+       T K+D +SFGVLL E+ +     YP +S + + E VT
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 105/241 (43%), Gaps = 34/241 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNKHDKCLL---LEFKNEILTW 100
           +N +    +G G  G VY+G++     D S + V  A K   + C     L+F  E L  
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLMEALII 94
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAI 155
           SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A 
Sbjct: 95  SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 154
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
           D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +   S 
Sbjct: 155 DIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASY 205
Query: 213 QVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERV 264
             KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E V
Sbjct: 206 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 265
Query: 265 T 265
           T
Sbjct: 266 T 266

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFK---NEIL 98
           I+K TE       +G G  GTV+KG  + +G  + +    K   DK     F+   + +L
Sbjct: 9   IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-DGRGGNGLELAERLDIAIDV 157
               ++H ++V+L G    G    +V +Y+  G+L +H+   RG  G +L   L+  + +
Sbjct: 68  AIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL--LNWGVQI 124
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           A  + YL  +    ++HR++ A N+L+    + +V DFG A +   D     + ++ K  
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK-QLLYSEAKTP 180
Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             ++  + +   + T +SDV+S+GV + E+MT
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 55  KIGEGGSGTVYKGKLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIGEG  GTV+K K ++   IVA+KR R +  D+ +      EI    +++H N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            L H D+++ +V    +  L+++ D   G+ L+          +   L + H+ +   ++
Sbjct: 69  VL-HSDKKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+K  N+LI      K+ +FG AR       V   S +V  T  Y  PD L   +L  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 234 KS-DVYSFGVLLVEMMTGRYPI 254
            S D++S G +  E+     P+
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL 202

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/255 (28%), Positives = 111/255 (43%), Gaps = 52/255 (20%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLE------------LAER- 150
           +H N+V L G   HG   +++ EY   G L   L  +   GLE            L+ R 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 151 -LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            L  +  VA  + +L + +    IHRDV A N+L+T    AK+ DFG AR    DS    
Sbjct: 168 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---- 220
Query: 210 ISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYP--IESKKPI 260
            +  VKG A     ++ P+ +     T +SDV+S+G+LL E+ +     YP  + + K  
Sbjct: 221 -NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 279
Query: 261 KERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK- 319
           K                  LV D      PA   A + I  +   C A     RPT ++ 
Sbjct: 280 K------------------LVKDGYQMAQPA--FAPKNIYSIMQACWALEPTHRPTFQQI 319
Query: 320 CAEILWKIRKDFREK 334
           C+ +  + ++D RE+
Sbjct: 320 CSFLQEQAQEDRRER 334

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDK-CLLLEFKNEILTWSKIEH 105
           ++F     +G+G  G VY  + K    I+A+K   K++ +K  +  + + EI   S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 106 LNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
            N+++++ +  H  +RI +++E+   G L + L   G    +         ++A AL Y 
Sbjct: 74  PNILRMYNYF-HDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYC 130
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H      +IHRD+K  N+L+  K   K+ DFG++       A S     + GT  YL P+
Sbjct: 131 HERK---VIHRDIKPENLLMGYKGELKIADFGWSV-----HAPSLRRRXMCGTLDYLPPE 182
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
            +      EK D++  GVL  E + G  P +S
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDK-CLLLEFKNEILTWSKIEH 105
           ++F     +G+G  G VY  + K    I+A+K   K++ +K  +  + + EI   S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 106 LNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
            N+++++ +  H  +RI +++E+   G L + L   G    +         ++A AL Y 
Sbjct: 75  PNILRMYNYF-HDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYC 131
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H      +IHRD+K  N+L+  K   K+ DFG++       A S     + GT  YL P+
Sbjct: 132 HERK---VIHRDIKPENLLMGYKGELKIADFGWSV-----HAPSLRRRXMCGTLDYLPPE 183
Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
            +      EK D++  GVL  E + G  P +S
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 64
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 65  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 122
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 123 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 178
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 9/209 (4%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E++     +GEG  G V     +     VAVK     +   C     K EI     + H
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNH 63
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+VK +G    G+ + + +EY   G L + ++   G     A+R      +   + YLH
Sbjct: 64  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH 121
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ 
Sbjct: 122 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPEL 177
Query: 226 LRTYQL-TEKSDVYSFGVLLVEMMTGRYP 253
           L+  +   E  DV+S G++L  M+ G  P
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 105/234 (44%), Gaps = 36/234 (15%)
Query: 56  IGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILTWSKIEHLN 107
           +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L  SK  H N
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDE---LDFLMEALIISKFNHQN 109
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAIDVAHALT 162
           +V+  G       R I++E +  G L+  L          + L + + L +A D+A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 163 YLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           YL        IHRD+ A N L+T       AK+ DFG AR       +   S   KG   
Sbjct: 170 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCA 220
Query: 220 -----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVT 265
                ++ P+       T K+D +SFGVLL E+ +     YP +S + + E VT
Sbjct: 221 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 274

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 55  KIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++G+G  G VY+G  +D       + VAVK   ++   +   +EF NE          ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHV 82
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGNGLELAERLDIAIDVAHA 160
           V+L G +  G   ++V+E + +G L+ +L        +  G     L E + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG- 219
           + YL+       +HRD+ A N ++      K+ DFG  R       +       KG  G 
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR------DIXETDXXRKGGKGL 193
Query: 220 ----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 20/215 (9%)
Query: 46  ATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR---KNKHDKCLLLEFKNEILTWS 101
           AT  + P  +IG G  GTVYK +    G  VA+K  R          L +    E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 102 KIE---HLNLVKLFGFL--EHGDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           ++E   H N+V+L         D  I   +V E+V +  LR +LD     GL      D+
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
                  L +LH      I+HRD+K  NIL+T     K+ DFG AR+     A+    T 
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL----TP 178
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
           V  T  Y  P+ L         D++S G +  EM 
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E F+   KIG+G  G V+KG       V   +    +  +  + + + EI   S+ +   
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           + K +G      +  I++EY+G G+  + L+    +  ++A    I  ++   L YLH+ 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TILREILKGLDYLHSE 138
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYLD 222
                IHRD+KA+N+L++E    K+ DFG A    +        TQ+K     GT  ++ 
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------TQIKRNXFVGTPFWMA 187
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           P+ ++      K+D++S G+  +E+  G  P     P+K
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 81
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL----DGRGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 142 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 192
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E F+   KIG+G  G V+KG       V   +    +  +  + + + EI   S+ +   
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           + K +G      +  I++EY+G G+  + L+    +  ++A    I  ++   L YLH+ 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TILREILKGLDYLHSE 123
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYLD 222
                IHRD+KA+N+L++E    K+ DFG A    +        TQ+K     GT  ++ 
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------TQIKRNXFVGTPFWMA 172
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           P+ ++      K+D++S G+  +E+  G  P     P+K
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 211

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 19/219 (8%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E F+   KIG+G  G V+KG       V   +    +  +  + + + EI   S+ +   
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           + K +G      +  I++EY+G G+  + L+    +  ++A    I  ++   L YLH+ 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TILREILKGLDYLHSE 123
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----GTAGYLD 222
                IHRD+KA+N+L++E    K+ DFG A    +        TQ+K     GT  ++ 
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------TQIKRNTFVGTPFWMA 172
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           P+ ++      K+D++S G+  +E+  G  P     P+K
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 211

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 71
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL----DGRGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 132 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 182
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 183 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 20/232 (8%)
Query: 35  TINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK 94
           T N  F+ +    E F+   KIG+G  G V+KG       V   +    +  +  + + +
Sbjct: 15  TENLYFQSM-DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 73
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
            EI   S+ +   + K +G      +  I++EY+G G+  + L+    +  ++A    I 
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TIL 130
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L YLH+      IHRD+KA+N+L++E    K+ DFG A    +        TQ+
Sbjct: 131 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------TQI 179
Query: 215 K-----GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           K     GT  ++ P+ ++      K+D++S G+  +E+  G  P     P+K
Sbjct: 180 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 66
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 127 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIXETD 177
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 20/188 (10%)
Query: 78  KRARKNKHDKCLLLE--------FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG 129
           KR +K    KC+  E         +NEI    KI+H N+V L    E G    ++++ V 
Sbjct: 40  KRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL---ITE 186
            G L + +  +G      A RL     V  A+ YLH   D  I+HRD+K  N+L   + E
Sbjct: 100 GGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDE 154
Query: 187 KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
             +  ++DFG ++M +  S +S       GT GY+ P+ L     ++  D +S GV+   
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 247 MMTGRYPI 254
           ++ G  P 
Sbjct: 211 LLCGYPPF 218

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 31/273 (11%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII--VVEYVG 129
           G +VAVK A K      L   ++ EI     + H ++VK  G  E   E+ +  V+EYV 
Sbjct: 38  GEMVAVK-ALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR 189
            G+LR++L     + + LA+ L  A  +   + YLH       IHR + A N+L+     
Sbjct: 97  LGSLRDYLPR---HCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRL 150
Query: 190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            K+ DFG A+   E      +         +  P+ L+  +    SDV+SFGV L E++T
Sbjct: 151 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210
Query: 250 GRYPIESKKP----------IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKI 299
             Y   ++ P           + ++T+    + L+ G+ +    PR  R P       +I
Sbjct: 211 --YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERL----PRPDRCPC------EI 258
Query: 300 LGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR 332
             L   C       RPT +    IL   ++ ++
Sbjct: 259 YHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 291

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 31/273 (11%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII--VVEYVG 129
           G +VAVK A K      L   ++ EI     + H ++VK  G  E   E+ +  V+EYV 
Sbjct: 37  GEMVAVK-ALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR 189
            G+LR++L     + + LA+ L  A  +   + YLH       IHR + A N+L+     
Sbjct: 96  LGSLRDYLPR---HCVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRL 149
Query: 190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            K+ DFG A+   E      +         +  P+ L+  +    SDV+SFGV L E++T
Sbjct: 150 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209
Query: 250 GRYPIESKKP----------IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKI 299
             Y   ++ P           + ++T+    + L+ G+ +    PR  R P       +I
Sbjct: 210 --YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERL----PRPDRCPC------EI 257
Query: 300 LGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR 332
             L   C       RPT +    IL   ++ ++
Sbjct: 258 YHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 290

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 20/188 (10%)
Query: 78  KRARKNKHDKCLLLE--------FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG 129
           KR +K    KC+  E         +NEI    KI+H N+V L    E G    ++++ V 
Sbjct: 40  KRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL---ITE 186
            G L + +  +G      A RL     V  A+ YLH   D  I+HRD+K  N+L   + E
Sbjct: 100 GGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDE 154
Query: 187 KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
             +  ++DFG ++M +  S +S       GT GY+ P+ L     ++  D +S GV+   
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 247 MMTGRYPI 254
           ++ G  P 
Sbjct: 211 LLCGYPPF 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLL 91
           F  +E   + E  +   ++G+G  G VY+G  +D       + VAVK   ++   +   +
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERI 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGN 143
           EF NE          ++V+L G +  G   ++V+E + +G L+ +L        +  G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
              L E + +A ++A  + YL+       +HRD+ A N ++      K+ DFG  R    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 204 DSAVSHISTQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +   +   KG  G     ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 179 --DIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 75
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 136 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIXETD 186
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G+G  G VYK + K+ S++A  +    K ++  L ++  EI   +  +H N+VKL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHTYS 168
             + +   I++E+   G +   +       LEL   L       +      AL YLH   
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVM-------LELERPLTESQIQVVCKQTLDALNYLH--- 152
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-- 226
           D  IIHRD+KA NIL T     K+ DFG   +S +++          GT  ++ P+ +  
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 227 -----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                R Y    K+DV+S G+ L+EM     P     P++
Sbjct: 210 ETSKDRPYDY--KADVWSLGITLIEMAEIEPPHHELNPMR 247

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 20/188 (10%)
Query: 78  KRARKNKHDKCLLLE--------FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG 129
           KR +K    KC+  E         +NEI    KI+H N+V L    E G    ++++ V 
Sbjct: 40  KRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 99
Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL---ITE 186
            G L + +  +G      A RL     V  A+ YLH   D  I+HRD+K  N+L   + E
Sbjct: 100 GGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDE 154
Query: 187 KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
             +  ++DFG ++M +  S +S       GT GY+ P+ L     ++  D +S GV+   
Sbjct: 155 DSKIMISDFGLSKMEDPGSVLSTAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 247 MMTGRYPI 254
           ++ G  P 
Sbjct: 211 LLCGYPPF 218

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 56  IGEGGSGTVYKGK------LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           IGEG  G V++ +       +  ++VAVK  ++      +  +F+ E    ++ ++ N+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDNPNIV 113
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHL----------------------DGRGGNGLEL 147
           KL G    G    ++ EY+  G L E L                         G   L  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR---MSEED 204
           AE+L IA  VA  + YL   S+   +HRD+   N L+ E +  K+ DFG +R    ++  
Sbjct: 174 AEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            A  + +  ++    ++ P+ +   + T +SDV+++GV+L E+ +
Sbjct: 231 KADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G+G  G VYK + K+ S++A  +    K ++  L ++  EI   +  +H N+VKL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHTYS 168
             + +   I++E+   G +   +       LEL   L       +      AL YLH   
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVM-------LELERPLTESQIQVVCKQTLDALNYLH--- 152
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-- 226
           D  IIHRD+KA NIL T     K+ DFG   +S +++          GT  ++ P+ +  
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRXIQRRDSFIGTPYWMAPEVVMC 209
Query: 227 -----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                R Y    K+DV+S G+ L+EM     P     P++
Sbjct: 210 ETSKDRPYDY--KADVWSLGITLIEMAEIEPPHHELNPMR 247

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLL 91
           F  +E   + E  +   ++G+G  G VY+G  +D       + VAVK   ++   +   +
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERI 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGN 143
           EF NE          ++V+L G +  G   ++V+E + +G L+ +L        +  G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
              L E + +A ++A  + YL+       +HRD+ A N ++      K+ DFG  R    
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR---- 178
Query: 204 DSAVSHISTQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +       KG  G     ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 179 --DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
            +NEI    KI+H N+V L    E G    ++++ V  G L + +  +G      A RL 
Sbjct: 63  MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL- 121
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNIL---ITEKLRAKVTDFGFARMSEEDSAVSH 209
               V  A+ YLH   D  I+HRD+K  N+L   + E  +  ++DFG ++M +  S +S 
Sbjct: 122 -IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 177
Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
                 GT GY+ P+ L     ++  D +S GV+   ++ G  P 
Sbjct: 178 AC----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G+G  G VYK + K+ S++A  +    K ++  L ++  EI   +  +H N+VKL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHTYS 168
             + +   I++E+   G +   +       LEL   L       +      AL YLH   
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVM-------LELERPLTESQIQVVCKQTLDALNYLH--- 152
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-- 226
           D  IIHRD+KA NIL T     K+ DFG   +S +++          GT  ++ P+ +  
Sbjct: 153 DNKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRXIQRRDXFIGTPYWMAPEVVMC 209
Query: 227 -----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                R Y    K+DV+S G+ L+EM     P     P++
Sbjct: 210 ETSKDRPYDY--KADVWSLGITLIEMAEIEPPHHELNPMR 247

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 108/242 (44%), Gaps = 36/242 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILT 99
           +N +    +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L 
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALI 87
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIA 154
            SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIS 211
            D+A    YL        IHRD+ A N L+T       AK+ DFG A+       +   S
Sbjct: 148 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ------DIYRAS 198
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKER 263
              KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E 
Sbjct: 199 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 258
Query: 264 VT 265
           VT
Sbjct: 259 VT 260

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 12/219 (5%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E +   +K+GEG   TVYKGK K   ++VA+K  R  +H++        E+     ++H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIREVSLLKDLKHA 60
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V L   +       +V EY+ +  L+++LD   GN + +         +   L Y H 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                ++HRD+K  N+LI E+   K+ DFG AR     S  +        T  Y  PD L
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAK---SIPTKTYDNEVVTLWYRPPDIL 172
Query: 227 R-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
             +   + + D++  G +  EM TGR P+     ++E++
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQL 210

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 104/234 (44%), Gaps = 36/234 (15%)
Query: 56  IGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILTWSKIEHLN 107
           +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L  SK  H N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALIISKFNHQN 135
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAIDVAHALT 162
           +V+  G       R I++E +  G L+  L          + L + + L +A D+A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 163 YLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           YL        IHRD+ A N L+T       AK+ DFG AR       +       KG   
Sbjct: 196 YLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGGCA 246
Query: 220 -----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKERVT 265
                ++ P+       T K+D +SFGVLL E+ +     YP +S + + E VT
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 107/242 (44%), Gaps = 36/242 (14%)
Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSI--VAVKRARK--NKHDKCLLLEFKNEILT 99
           +N +    +G G  G VY+G++     D S   VAVK   +  ++ D+   L+F  E L 
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE---LDFLMEALI 104
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIA 154
            SK  H N+V+  G       R I++E +  G L+  L          + L + + L +A
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIS 211
            D+A    YL        IHRD+ A N L+T       AK+ DFG AR       +    
Sbjct: 165 RDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAG 215
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYPIESKKPIKER 263
              KG        ++ P+       T K+D +SFGVLL E+ +     YP +S + + E 
Sbjct: 216 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 275
Query: 264 VT 265
           VT
Sbjct: 276 VT 277

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 56  IGEGGSGTVYKGKLKDGSI-----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           IG+G  G V   + K   +     V  K+A   K ++  ++  +N +L    ++H  LV 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL--KNVKHPFLVG 103
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L    +  D+   V++Y+  G L  HL  R    LE   R   A ++A AL YLH+ +  
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHSLN-- 159
Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            I++RD+K  NIL+  +    +TDFG  + + E ++    ++   GT  YL P+ L    
Sbjct: 160 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQP 215
Query: 231 LTEKSDVYSFGVLLVEMMTGRYPIESK 257
                D +  G +L EM+ G  P  S+
Sbjct: 216 YDRTVDWWCLGAVLYEMLYGLPPFYSR 242

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 42  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 100
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 101 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 154
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI E+   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 155 KPENLLIDEQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 208
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 209 WALGVLIYEMAAGYPPFFADQPIQ 232

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           E  +   ++G+G  G VY+G  +D       + VAVK   ++   +   +EF NE     
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMK 74
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGNGLELAERLDI 153
                ++V+L G +  G   ++V+E + +G L+ +L        +  G     L E + +
Sbjct: 75  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 134
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           A ++A  + YL+       +HRD+ A N ++      K+ DFG  R       +      
Sbjct: 135 AAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETDYY 185
Query: 214 VKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            KG  G     ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 76  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 134
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 135 SNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 189
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 190 PENLLIDQQGYIQVTDFGFAK------RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 76  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 134
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 135 SN-LYMVMEYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 188
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 242
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 243 WALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 81
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 142 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 192
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFAEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 29/231 (12%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLL 91
           F  +E   A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERI 64
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL-- 145
           EF NE     +    ++V+L G +  G   ++++E +  G L+ +L         N +  
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 146 --ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
              L++ + +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R    
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---- 177
Query: 204 DSAVSHISTQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +       KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 178 --DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 50  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 108
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 109 SN-LYMVMEYVAGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 162
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 216
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 217 WALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 74
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 135 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 185
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 74
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 135 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 185
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 68
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 129 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 179
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDK-CLLLEFKNEILTWSKIEH 105
           ++F     +G+G  G VY  + K    IVA+K   K++ +K  +  + + EI   + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+++L+ +        +++EY   G L + L  +     +      I  ++A AL Y H
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATIMEELADALMYCH 140
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 +IHRD+K  N+L+  K   K+ DFG++       A S     + GT  YL P+ 
Sbjct: 141 GKK---VIHRDIKPENLLLGLKGELKIADFGWS-----VHAPSLRRKTMCGTLDYLPPEM 192
Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           +      EK D++  GVL  E++ G  P ES
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELLVGNPPFES 223

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 75
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 136 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 186
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 56  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAVK   K + +   L +   E+     + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQK 132
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF   S E +  + + T   G+  Y  P+  +
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGF---SNEFTFGNKLDTFC-GSPPYAAPELFQ 185
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 246 KFLILNPSKRGT 257

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/251 (29%), Positives = 106/251 (42%), Gaps = 46/251 (18%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N+V L G   HG   +++ EY   G L   L  R    LE      IA   A     
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR-RKSRVLETDPAFAIANSTASTRDL 166
Query: 164 LHTYSDPP----------IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           LH  S              IHRDV A N+L+T    AK+ DFG AR    DS  ++I   
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS--NYI--- 221
Query: 214 VKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYP--IESKKPIKERV 264
           VKG A     ++ P+ +     T +SDV+S+G+LL E+ +     YP  + + K  K   
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK--- 278
Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK-CAEI 323
                          LV D      PA   A + I  +   C A     RPT ++ C+ +
Sbjct: 279 ---------------LVKDGYQMAQPA--FAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
Query: 324 LWKIRKDFREK 334
             + ++D RE+
Sbjct: 322 QEQAQEDRRER 332

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE       +G G  GTVYKG  + DG      VA+K  R+N   K    
Sbjct: 7   NQALLRILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK- 64
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL-DGRGGNGLELAER 150
           E  +E    + +    + +L G       ++ V + +  G L +H+ + RG  G +  + 
Sbjct: 65  EILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQ--DL 121
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           L+  + +A  ++YL    D  ++HRD+ A N+L+      K+TDFG AR+ + D    H 
Sbjct: 122 LNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH- 177
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           +   K    ++  + +   + T +SDV+S+GV + E+MT
Sbjct: 178 ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAVK   K + +   L +   E+     + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQK 132
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF   S E +  + + T   G+  Y  P+  +
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGF---SNEFTFGNKLDTFC-GSPPYAAPELFQ 185
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 246 KFLILNPSKRGT 257

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 56  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAVK   K + +   L +   E+     + H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGW--MKEKEARAKFRQIVSAVQYCH-- 123
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF   S E +  + + T   G+  Y  P+  +
Sbjct: 124 -QKFIVHRDLKAENLLLDADMNIKIADFGF---SNEFTFGNKLDTFC-GSPPYAAPELFQ 178
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERVT-----IRWAMQ--CLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV      I + M   C     
Sbjct: 179 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 238
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 239 KFLILNPSKRGT 250

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 110/253 (43%), Gaps = 50/253 (19%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGR------------GGNGLELAERL 151
           +H N+V L G   HG   +++ EY   G L   L  +              + L   + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
             +  VA  + +L + +    IHRDV A N+L+T    AK+ DFG AR    DS  ++I 
Sbjct: 168 HFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS--NYI- 221
Query: 212 TQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT---GRYP--IESKKPIKE 262
             VKG A     ++ P+ +     T +SDV+S+G+LL E+ +     YP  + + K  K 
Sbjct: 222 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK- 278
Query: 263 RVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK-CA 321
                            LV D      PA   A + I  +   C A     RPT ++ C+
Sbjct: 279 -----------------LVKDGYQMAQPA--FAPKNIYSIMQACWALEPTHRPTFQQICS 319
Query: 322 EILWKIRKDFREK 334
            +  + ++D RE+
Sbjct: 320 FLQEQAQEDRRER 332

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 103
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG  R       +    
Sbjct: 164 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETD 214
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 141
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 131
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 48  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 106
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 107 SNLYMVMEYVPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 161
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 162 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 215
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 216 ALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 55  KIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +IG G   TVYKG   + ++ VA    +  K  K     FK E      ++H N+V+ + 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 114 FLE---HGDERIIVV-EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E    G + I++V E   +GTL+ +L       +++         +   L +LHT + 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW--CRQILKGLQFLHTRT- 149
Query: 170 PPIIHRDVKASNILITEKL-RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD-YLR 227
           PPIIHRD+K  NI IT      K+ D G A +       +  +  V GT  +  P+ Y  
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-----ASFAKAVIGTPEFXAPEXYEE 204
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYP---IESKKPIKERVT 265
            Y   E  DVY+FG   +E  T  YP    ++   I  RVT
Sbjct: 205 KYD--ESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVT 243

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           +E +    K+G G  G V   + K    + +I  +++   +      LLE   E+     
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE---EVAVLKL 92
Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL- 161
           ++H N++KL+ F E      +V+E    G L + +  R    ++  E +D A+ +   L 
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR----MKFNE-VDAAVIIKQVLS 147
Query: 162 --TYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKG 216
             TYLH ++   I+HRD+K  N+L+  K +    K+ DFG + + E    +     +  G
Sbjct: 148 GVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK----ERLG 200
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           TA Y+ P+ LR  +  EK DV+S GV+L  ++ G YP
Sbjct: 201 TAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG-YP 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 55  KIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++G+G  G VY+G  +D       + VAVK   ++   +   +EF NE          ++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHV 82
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGNGLELAERLDIAIDVAHA 160
           V+L G +  G   ++V+E + +G L+ +L        +  G     L E + +A ++A  
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG- 219
           + YL+       +HR++ A N ++      K+ DFG  R       +       KG  G 
Sbjct: 143 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKGL 193
Query: 220 ----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 194 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 135
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 136 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 56  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 169
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 170 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 76  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 134
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 135 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 189
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 190 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 243
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 244 ALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 56  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 115 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 169
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 170 PENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 55  KIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++G+G  G VY+G  +D       + VAVK   ++   +   +EF NE          ++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNEASVMKGFTCHHV 83
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGNGLELAERLDIAIDVAHA 160
           V+L G +  G   ++V+E + +G L+ +L        +  G     L E + +A ++A  
Sbjct: 84  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG- 219
           + YL+       +HR++ A N ++      K+ DFG  R       +       KG  G 
Sbjct: 144 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKGL 194
Query: 220 ----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               ++ P+ L+    T  SD++SFGV+L E+ +
Sbjct: 195 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 56  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 56  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 141
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 131
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ +M  G  P  + +PI+
Sbjct: 222 WALGVLIYQMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHKETGNHFAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 56  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 35/279 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR---KNKHDKCLLLEFKNEILTWSKI 103
           ++  P  ++G G  G V K + +  G I+AVKR R    ++  K LL++    + T   +
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT---V 107
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHAL 161
           +    V  +G L    +  I +E + + +L +        G  + E +   IA+ +  AL
Sbjct: 108 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 166
Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
            +LH  S   +IHRDVK SN+LI    + K+ DFG +     DS    I     G   Y+
Sbjct: 167 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTIDA---GCKPYM 220
Query: 222 DPDY----LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
            P+     L     + KSD++S G+ ++E+   R+P +S           W     +   
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WGTPFQQLKQ 269
Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT 316
            +    P+L   PA   + E  +     CL    + RPT
Sbjct: 270 VVEEPSPQL---PADKFSAE-FVDFTSQCLKKNSKERPT 304

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 109/235 (46%), Gaps = 21/235 (8%)
Query: 35  TINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK 94
           T N  F+ +      +S   +IG GGS  V++   +   I A+K     + D   L  ++
Sbjct: 15  TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYR 74
Query: 95  NEILTWSKIEHLN--LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
           NEI   +K++  +  +++L+ + E  D+ I +V   GN  L   L  +    ++  ER  
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKS 131
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
              ++  A+  +H +    I+H D+K +N LI + +  K+ DFG A   + D+      +
Sbjct: 132 YWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDS 187
Query: 213 QVKGTAGYLDPDYLRTYQLTEKS-----------DVYSFGVLLVEMMTGRYPIES 256
           QV GT  Y+ P+ ++    + ++           DV+S G +L  M  G+ P + 
Sbjct: 188 QV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P  + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHKETGNHFAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHKETGNHFAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 48  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 106
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 107 SN-LYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 160
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 214
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 215 WALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 13/220 (5%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAVK   K + +   L +   E+     + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQK 133
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF   S E +  + + T   G+  Y  P+  +
Sbjct: 134 Y---IVHRDLKAENLLLDGDMNIKIADFGF---SNEFTVGNKLDT-FCGSPPYAAPELFQ 186
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV 264
             +    + DV+S GV+L  +++G  P + +  K ++ERV
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 135
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 136 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAV+   K + +   L +   E+     + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQK 132
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF   S E +  + + T   G+  Y  P+  +
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGF---SNEFTFGNKLDTFC-GSPPYAAPELFQ 185
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 246 KFLILNPSKRGT 257

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKH 85
           G     N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+   
Sbjct: 1   GSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRG 141
            K    E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G
Sbjct: 60  PKANK-EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIG 117
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++ 
Sbjct: 118 SQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169
Query: 202 EEDSAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +    H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 216

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 46  ATENFSPANKIGEGGSGTVY----KGKLKDG--SIVAVKRARKNKHDKCLLLEFKNEILT 99
           A E  + + ++G+G  G VY    KG +KD   + VA+K   +    +   +EF NE   
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASV 68
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGL----ELAERL 151
             +    ++V+L G +  G   ++++E +  G L+ +L         N +     L++ +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
            +A ++A  + YL+       +HRD+ A N  + E    K+ DFG  R       +    
Sbjct: 129 QMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR------DIYETD 179
Query: 212 TQVKGTAG-----YLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG  G     ++ P+ L+    T  SDV+SFGV+L E+ T
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 41  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 99
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 100 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 154
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 155 PENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWW 208
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 209 ALGVLIYEMAAGYPPFFADQPIQ 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL-----LLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S   V  A K      L     + +F  E+     ++H NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L+G +     ++ V E    G+L + L    G+ L L      A+ VA  + YL +   
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESKR- 131
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
              IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  P+ L+T 
Sbjct: 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 230 QLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  SD + FGV L EM T G+ P
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 15/146 (10%)
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS--EEDSAVSHISTQ 213
           ++A AL +LH+     II+RD+K  NIL+ E+   K+TDFG ++ S   E  A S     
Sbjct: 135 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--- 188
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI----RWA 269
             GT  Y+ P+ +     T+ +D +SFGVL+ EM+TG  P + K   KE +T+    +  
Sbjct: 189 --GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLG 245
Query: 270 MQCLKAGDAILVMDPRLRRTPASNMA 295
           M    + +A  ++    +R PA+ + 
Sbjct: 246 MPQFLSPEAQSLLRMLFKRNPANRLG 271

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N++I ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLIIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VA+K   K + +   L +   E+     + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +++EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 73  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK 130
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF   S E +    + T   G+  Y  P+  +
Sbjct: 131 R---IVHRDLKAENLLLDADMNIKIADFGF---SNEFTVGGKLDT-FCGSPPYAAPELFQ 183
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 243
Query: 278 AILVMDPRLRRT 289
             LV++P  R T
Sbjct: 244 RFLVLNPIKRGT 255

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 94  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 143
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 144 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 94  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 143
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 144 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 235

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 15/146 (10%)
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS--EEDSAVSHISTQ 213
           ++A AL +LH+     II+RD+K  NIL+ E+   K+TDFG ++ S   E  A S     
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--- 187
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI----RWA 269
             GT  Y+ P+ +     T+ +D +SFGVL+ EM+TG  P + K   KE +T+    +  
Sbjct: 188 --GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLG 244
Query: 270 MQCLKAGDAILVMDPRLRRTPASNMA 295
           M    + +A  ++    +R PA+ + 
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANRLG 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 56  IGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G +  V   Y    K+   VA+KR    K    +  E   EI   S+  H N+V  +
Sbjct: 18  IGSGATAVVQAAYCAPKKEK--VAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYY 74
Query: 113 GFLEHGDERIIVVEYVGNGTLRE---HLDGRGGNGLELAERLDIAI---DVAHALTYLHT 166
                 DE  +V++ +  G++ +   H+  +G +   + +   IA    +V   L YLH 
Sbjct: 75  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 134
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQVKGTAGYLDPD 224
                 IHRDVKA NIL+ E    ++ DFG +    +  D   + +     GT  ++ P+
Sbjct: 135 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 191
Query: 225 YL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +   R Y    K+D++SFG+  +E+ TG  P     P+K
Sbjct: 192 VMEQVRGYDF--KADIWSFGITAIELATGAAPYHKYPPMK 229

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYAPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   KVTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR---KNKHDKCLLLEFKNEILTWSKI 103
           ++  P  ++G G  G V K + +  G I+AVKR R    ++  K LL++    + T   +
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT---V 63
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHAL 161
           +    V  +G L    +  I +E + + +L +        G  + E +   IA+ +  AL
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
            +LH  S   +IHRDVK SN+LI    + K+ DFG +    +D A   I     G   Y+
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDA---GCKPYM 176
Query: 222 DPDY----LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
            P+     L     + KSD++S G+ ++E+   R+P +S           W     +   
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WGTPFQQLKQ 225
Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT 316
            +    P+L   PA   + E  +     CL    + RPT
Sbjct: 226 VVEEPSPQL---PADKFSAE-FVDFTSQCLKKNSKERPT 260

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 92  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 141
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 142 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 201
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 233

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++GE   G VYKG L      +    VA+K   K+K +  L  EF++E +  ++++H N+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN--------------GLELAERLDIA 154
           V L G +       ++  Y  +G L E L  R  +               LE  + + + 
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             +A  + YL ++    ++H+D+   N+L+ +KL  K++D G  R          +   +
Sbjct: 152 AQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPI--ESKKPIKERVTIRWAMQ 271
                ++ P+ +   + +  SD++S+GV+L E+ + G  P    S + + E +  R  + 
Sbjct: 209 LPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 267
Query: 272 C 272
           C
Sbjct: 268 C 268

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 78/146 (53%), Gaps = 15/146 (10%)
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS--EEDSAVSHISTQ 213
           ++A AL +LH+     II+RD+K  NIL+ E+   K+TDFG ++ S   E  A S     
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC--- 187
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI----RWA 269
             GT  Y+ P+ +     T+ +D +SFGVL+ EM+TG  P + K   KE +T+    +  
Sbjct: 188 --GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLG 244
Query: 270 MQCLKAGDAILVMDPRLRRTPASNMA 295
           M    + +A  ++    +R PA+ + 
Sbjct: 245 MPQFLSPEAQSLLRMLFKRNPANRLG 270

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 108/235 (45%), Gaps = 21/235 (8%)
Query: 35  TINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFK 94
           T N  F+ +      +S   +IG GGS  V++   +   I A+K     + D   L  ++
Sbjct: 15  TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYR 74
Query: 95  NEILTWSKIEHLN--LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
           NEI   +K++  +  +++L+ + E  D+ I +V   GN  L   L  +    ++  ER  
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKS 131
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
              ++  A+  +H +    I+H D+K +N LI + +  K+ DFG A   + D       +
Sbjct: 132 YWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDS 187
Query: 213 QVKGTAGYLDPDYLRTYQLTEKS-----------DVYSFGVLLVEMMTGRYPIES 256
           QV GT  Y+ P+ ++    + ++           DV+S G +L  M  G+ P + 
Sbjct: 188 QV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G  E  +  ++V+E    G L ++L  +    ++    +++   V+  + YL   +   
Sbjct: 436 IGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN--- 489
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
            +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ +  Y+ 
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESKK 258
           + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 550 SSKSDVWSFGVLMWEAFSYGQKPYRGMK 577

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 133
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 56  IGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           IG G +  V   Y    K+   VA+KR    K    +  E   EI   S+  H N+V  +
Sbjct: 23  IGSGATAVVQAAYCAPKKEK--VAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYY 79
Query: 113 GFLEHGDERIIVVEYVGNGTLRE---HLDGRGGNGLELAERLDIAI---DVAHALTYLHT 166
                 DE  +V++ +  G++ +   H+  +G +   + +   IA    +V   L YLH 
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQVKGTAGYLDPD 224
                 IHRDVKA NIL+ E    ++ DFG +    +  D   + +     GT  ++ P+
Sbjct: 140 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 225 YL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            +   R Y    K+D++SFG+  +E+ TG  P     P+K
Sbjct: 197 VMEQVRGYDF--KADIWSFGITAIELATGAAPYHKYPPMK 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 55  KIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           ++GE   G VYKG L      +    VA+K   K+K +  L  EF++E +  ++++H N+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN--------------GLELAERLDIA 154
           V L G +       ++  Y  +G L E L  R  +               LE  + + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             +A  + YL ++    ++H+D+   N+L+ +KL  K++D G  R          +   +
Sbjct: 135 AQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPI--ESKKPIKERVTIRWAMQ 271
                ++ P+ +   + +  SD++S+GV+L E+ + G  P    S + + E +  R  + 
Sbjct: 192 LPIR-WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 250
Query: 272 C 272
           C
Sbjct: 251 C 251

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDG-------SIVAVKRARKNKHDKC 88
           N +   I K TE F     +G G  GTVYKG  + +G       +I+ ++ A   K +K 
Sbjct: 39  NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK- 96
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNG 144
              E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   
Sbjct: 97  ---EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY 152
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +
Sbjct: 153 L-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204
Query: 205 SAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 205 EKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 248

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   KV DFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/252 (24%), Positives = 111/252 (44%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAV+   K + +   L +   E+     + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQK 132
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF+     +    +   +  G+  Y  P+  +
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDEFCGSPPYAAPELFQ 185
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 246 KFLILNPSKRGT 257

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 27/231 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKH 85
           G     N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+   
Sbjct: 1   GSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRG 141
            K    E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G
Sbjct: 60  PKANK-EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG 117
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++ 
Sbjct: 118 SQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 169
Query: 202 EEDSAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +    H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 115/264 (43%), Gaps = 37/264 (14%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ++ F   +++G G +  VY+ K K        +  K   DK ++   + EI    ++ H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV---RTEIGVLLRLSHP 108
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYL 164
           N++KL    E   E  +V+E V  G L + +  +G      +ER   D    +  A+ YL
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYL 164
Query: 165 HTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
           H   +  I+HRD+K  N+L          K+ DFG +++ E       +   V GT GY 
Sbjct: 165 H---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYC 217
Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC--------- 272
            P+ LR      + D++S G++   ++ G  P   ++   ++   R  + C         
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER--GDQFMFRRILNCEYYFISPWW 275
Query: 273 ----LKAGDAI---LVMDPRLRRT 289
               L A D +   +V+DP+ R T
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLT 299

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 78  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 127
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 128 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 187
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 78  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 127
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 128 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 219

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 72  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 121
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 122 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 181
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G  E  +  ++V+E    G L ++L  +    ++    +++   V+  + YL   +   
Sbjct: 437 IGICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESN--- 490
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
            +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ +  Y+ 
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 232 TEKSDVYSFGVLLVEMMT-GRYPIESKK 258
           + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 551 SSKSDVWSFGVLMWEAFSYGQKPYRGMK 578

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  ++K        +  KN+ +D  L  E   E     ++++  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG----RGGNGLELAERLDIAIDVAHALTYLHTY 167
            G  E  +  ++V+E    G L ++L      +  N +EL  +      V+  + YL   
Sbjct: 74  IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ------VSMGMKYL--- 123
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ + 
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKK 258
            Y+ + KSDV+SFGVL+ E  + G+ P    K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-- 107
           +S   +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L+ + E  D+ I +V   GN  L   L  +    ++  ER     ++  A+  +H +
Sbjct: 118 IIRLYDY-EITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+H D+K +N LI + +  K+ DFG A   + D+      +QV GT  Y+ P+ ++
Sbjct: 175 G---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 229
Query: 228 TYQLTEKS-----------DVYSFGVLLVEMMTGRYPIE 255
               + ++           DV+S G +L  M  G+ P +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 27/231 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKH 85
           G     N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+   
Sbjct: 24  GSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 82
Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRG 141
            K    E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G
Sbjct: 83  PKANK-EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG 140
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++ 
Sbjct: 141 SQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 192
Query: 202 EEDSAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +    H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 193 GAEEKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 239

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 9   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 66
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-- 123
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 124 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 178 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 218

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-----HDKCLLLEFKNEILTW 100
           ++ +    K+G G  G V   K K  G+  A+K  +K+      +   LL    +E+   
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVL 75
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
            +++H N++KL+ F E      +V+E    G L + +  R     +    +D A+ +   
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR-----QKFSEVDAAVIMKQV 130
Query: 161 L---TYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQV 214
           L   TYLH ++   I+HRD+K  N+L+  K R    K+ DFG +   E    V     + 
Sbjct: 131 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE----VGGKMKER 183
Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV 264
            GTA Y+ P+ LR  +  EK DV+S GV+L  ++ G  P   ++ + I +RV
Sbjct: 184 LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 6   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 63
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-- 120
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 121 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 175 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 215

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   KVTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 5   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-- 119
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 120 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 8   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-- 122
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 123 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 177 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIE-- 104
           ++F     IG G    V   +LK    I A+K  +K        L   +E + W + E  
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE-------LVNDDEDIDWVQTEKH 72
Query: 105 -------HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                  H  LV L    +       V+EYV  G L  H+  +     E A     + ++
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEI 130
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           + AL YLH      II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT
Sbjct: 131 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSXFCGT 184
Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
             Y+ P+ LR        D ++ GVL+ EMM GR P +
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 56  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 114
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 115 SNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 169
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N++I ++   KVTDFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 170 PENLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 223
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 224 ALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 109/252 (43%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAVK   K + +   L +   E+     + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V+EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQIVSAVQYCHQK 132
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF+     +    +      G   Y  P+  +
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFS----NEFTFGNKLDAFCGAPPYAAPELFQ 185
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 246 KFLILNPSKRGT 257

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-- 107
           +S   +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +  
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 73
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L+ + E  D+ I +V   GN  L   L  +    ++  ER     ++  A+  +H +
Sbjct: 74  IIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+H D+K +N LI + +  K+ DFG A   + D+      +QV GT  Y+ P+ ++
Sbjct: 131 G---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 185
Query: 228 TYQLTEKS-----------DVYSFGVLLVEMMTGRYPIES 256
               + ++           DV+S G +L  M  G+ P + 
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 225

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIE-- 104
           ++F     IG G    V   +LK    I A+K  +K        L   +E + W + E  
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE-------LVNDDEDIDWVQTEKH 57
Query: 105 -------HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                  H  LV L    +       V+EYV  G L  H+  +     E A     + ++
Sbjct: 58  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEI 115
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           + AL YLH      II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT
Sbjct: 116 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSXFCGT 169
Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
             Y+ P+ LR        D ++ GVL+ EMM GR P +
Sbjct: 170 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 6   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 63
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 64  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYL-- 120
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 121 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 175 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            E +    ++G+G  G VYK K K+   +A  +  + K ++  L ++  EI   +  +H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHP 76
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            +VKL G   H  +  I++E+   G + + +      GL   +   +   +  AL +LH+
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFA-----RMSEEDSAVSHISTQVKGTAGYL 221
                IIHRD+KA N+L+T +   ++ DFG +      + + DS +        GT  ++
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--------GTPYWM 184
Query: 222 DPDYLRTYQLTE-----KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+ +    + +     K+D++S G+ L+EM     P     P++
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            E +    ++G+G  G VYK K K+   +A  +  + K ++  L ++  EI   +  +H 
Sbjct: 10  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHP 68
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            +VKL G   H  +  I++E+   G + + +      GL   +   +   +  AL +LH+
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFA-----RMSEEDSAVSHISTQVKGTAGYL 221
                IIHRD+KA N+L+T +   ++ DFG +      + + DS +        GT  ++
Sbjct: 128 KR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--------GTPYWM 176
Query: 222 DPDYLRTYQLTE-----KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+ +    + +     K+D++S G+ L+EM     P     P++
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 221

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWSKIE-- 104
           ++F     IG G    V   +LK    I A+K  +K        L   +E + W + E  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKE-------LVNDDEDIDWVQTEKH 61
Query: 105 -------HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
                  H  LV L    +       V+EYV  G L  H+  +     E A     + ++
Sbjct: 62  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEI 119
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           + AL YLH      II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT
Sbjct: 120 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSXFCGT 173
Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
             Y+ P+ LR        D ++ GVL+ EMM GR P +
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 23/217 (10%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--- 104
           ++F     IG G    V   +LK    +   R  K +      L   +E + W + E   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKE------LVNDDEDIDWVQTEKHV 105
Query: 105 ------HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
                 H  LV L    +       V+EYV  G L  H+  +     E A     + +++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEIS 163
Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            AL YLH      II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT 
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTP 217
Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
            Y+ P+ LR        D ++ GVL+ EMM GR P +
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-- 107
           +S   +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L+ + E  D+ I +V   GN  L   L  +    ++  ER     ++  A+  +H +
Sbjct: 118 IIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+H D+K +N LI + +  K+ DFG A   + D+      +QV GT  Y+ P+ ++
Sbjct: 175 G---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 229
Query: 228 TYQLTEKS-----------DVYSFGVLLVEMMTGRYPIE 255
               + ++           DV+S G +L  M  G+ P +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 15  NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 72
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 73  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 129
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 130 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 184 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 8   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 122
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 123 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 177 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 5   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 119
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 120 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 12  NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 69
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 126
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 127 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 181 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 31/232 (13%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-----HDKCLLLEFKNEILTW 100
           ++ +    K+G G  G V   K K  G+  A+K  +K+      +   LL    +E+   
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL----DEVAVL 58
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
            +++H N++KL+ F E      +V+E    G L + +  R     +    +D A+ +   
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR-----QKFSEVDAAVIMKQV 113
Query: 161 L---TYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQV 214
           L   TYLH ++   I+HRD+K  N+L+  K R    K+ DFG +   E    V     + 
Sbjct: 114 LSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE----VGGKMKER 166
Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV 264
            GTA Y+ P+ LR  +  EK DV+S GV+L  ++ G  P   ++ + I +RV
Sbjct: 167 LGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRV 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 8   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 122
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 123 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 177 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 217

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKH 85
           G     N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+   
Sbjct: 1   GSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRG 141
            K    E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G
Sbjct: 60  PKANK-EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIG 117
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++ 
Sbjct: 118 SQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169
Query: 202 EEDSAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +    H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 11  NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 68
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 69  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 125
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 126 ---LNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 180 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 5   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 119
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 120 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 214

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-- 107
           +S   +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +  
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L+ + E  D+ I +V   GN  L   L  +    ++  ER     ++  A+  +H +
Sbjct: 70  IIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+H D+K +N LI + +  K+ DFG A   + D+      +QV GT  Y+ P+ ++
Sbjct: 127 G---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 181
Query: 228 TYQLTEKS-----------DVYSFGVLLVEMMTGRYPIES 256
               + ++           DV+S G +L  M  G+ P + 
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKH 85
           G     N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+   
Sbjct: 1   GSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRG 141
            K    E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G
Sbjct: 60  PKANK-EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIG 117
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++ 
Sbjct: 118 SQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169
Query: 202 EEDSAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +    H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-- 107
           +S   +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L+ + E  D+ I +V   GN  L   L  +    ++  ER     ++  A+  +H +
Sbjct: 71  IIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+H D+K +N LI + +  K+ DFG A   + D+      +QV GT  Y+ P+ ++
Sbjct: 128 G---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIK 182
Query: 228 TYQLTEKS-----------DVYSFGVLLVEMMTGRYPIE 255
               + ++           DV+S G +L  M  G+ P +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 8   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 65
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 66  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 122
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 123 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 177 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 217

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EY+  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   KV DFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EY+  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N+LI ++   KV DFGFA+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLLIDQQGYIKVADFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 111/252 (44%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VA+K   K + +   L +   E+     + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +++EY   G + ++L   G   ++  E       +  A+ Y H  
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK 133
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+   +  K+ DFGF+     +  V        G   Y  P+  +
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFS----NEFTVGGKLDAFCGAPPYAAPELFQ 186
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERVT-----IRWAMQ--CLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV      I + M   C     
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 278 AILVMDPRLRRT 289
             LV++P  R T
Sbjct: 247 RFLVLNPIKRGT 258

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 5   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYL-- 119
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 120 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 214

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            L KL F F ++
Sbjct: 56  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYAPGGEMFSHLR-RIGRFXEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   KVTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   +VTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLLEFKNEI 97
           I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    E  +E 
Sbjct: 8   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEA 65
Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLELAERLDI 153
              + +++ ++ +L G       ++I  + +  G L    REH D  G   L     L+ 
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-----LNW 119
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS-- 211
            + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +    H    
Sbjct: 120 CVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 176
Query: 212 -TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 177 KVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 211

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 27/231 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKH 85
           G     N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+   
Sbjct: 1   GSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 59
Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRG 141
            K    E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G
Sbjct: 60  PKANK-EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG 117
Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              L     L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++ 
Sbjct: 118 SQYL-----LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL 169
Query: 202 EEDSAVSHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             +    H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 170 GAEEKEYHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 56  GRVMLVKHKETGNHYAMKILD-KQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVLEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   KV DFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLLIDQQGYIKVADFGFAKR------VKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYVAGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N+LI ++   +VTDFGFA+       V   +  + GT   L P+ + +    +  D 
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK------RVKGRTWXLCGTPEALAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLLEFKNEI 97
           I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    E  +E 
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEA 62
Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLELAERLDI 153
              + +++ ++ +L G       ++I  + +  G L    REH D  G   L     L+ 
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-----LNW 116
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS-- 211
            + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +    H    
Sbjct: 117 CVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 212 -TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 KVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 208

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 9   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 66
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 67  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-- 123
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 124 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 178 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 218

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G G    V+  K +  G + A+K  +K+   +   LE  NEI    KI+H N+V L   
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEIAVLKKIKHENIVTLEDI 74
Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            E      +V++ V  G L + +  RG    + A    +   V  A+ YLH   +  I+H
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAVKYLH---ENGIVH 129
Query: 175 RDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           RD+K  N+L     E  +  +TDFG ++M +       I +   GT GY+ P+ L     
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPY 184
Query: 232 TEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV 264
           ++  D +S GV+   ++ G  P   E++  + E++
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 38/233 (16%)
Query: 101 SKIEHLNLVKLFGFLEHGDER-----IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           +++ H ++V++F F+EH D        IV+EYVG  +L+       G  L +AE +   +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS----KGQKLPVAEAIAYLL 189
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST--Q 213
           ++  AL+YLH+     +++ D+K  NI++TE+ + K+ D G         AVS I++   
Sbjct: 190 EILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLG---------AVSRINSFGY 236
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM------TGRY--PIESKKPIKERVT 265
           + GT G+  P+ +RT   T  +D+Y+ G  L  +        GRY   +    P+ +   
Sbjct: 237 LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYD 295
Query: 266 IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMK 318
             +     +A D     DPR R T A  M+ +    L +V    T   RP + 
Sbjct: 296 -SYGRLLRRAIDP----DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 43/293 (14%)
Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKR-ARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           FS   +IG G  G VY  + +++  +VA+K+ +   K       +   E+    K+ H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 108 LVKLFGFLEHGDERIIVVEY-VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++  G         +V+EY +G+ +    +  +    +E+A     A+     L YLH+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHS 172
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           ++   +IHRDVKA NIL++E    K+ DFG A       ++   +    GT  ++ P+ +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVI 222
Query: 227 RTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
                 Q   K DV+S G+  +E+       E K P+       + M  + A   I    
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA------ERKPPL-------FNMNAMSALYHI---- 265
Query: 284 PRLRRTPA--SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
                +PA  S    E      D CL    Q RPT    +E+L K R   RE+
Sbjct: 266 -AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRER 313

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            L KL F F ++
Sbjct: 56  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   KVTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 43/293 (14%)
Query: 50  FSPANKIGEGGSGTVYKGK-LKDGSIVAVKR-ARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           FS   +IG G  G VY  + +++  +VA+K+ +   K       +   E+    K+ H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 108 LVKLFGFLEHGDERIIVVEY-VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++  G         +V+EY +G+ +    +  +    +E+A     A+     L YLH+
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHS 133
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           ++   +IHRDVKA NIL++E    K+ DFG A       ++   +    GT  ++ P+ +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANXFVGTPYWMAPEVI 183
Query: 227 RTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD 283
                 Q   K DV+S G+  +E+       E K P+       + M  + A   I    
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELA------ERKPPL-------FNMNAMSALYHI---- 226
Query: 284 PRLRRTPA--SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
                +PA  S    E      D CL    Q RPT    +E+L K R   RE+
Sbjct: 227 -AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRER 274

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            L KL F F ++
Sbjct: 56  GRVMLVKHMETGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDN 114
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 115 SN-LYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 168
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   KVTDFGFA+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 222
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 223 WALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE-----FKNEILTWSKI 103
           N+     +GEG  G V   KL   +    K A K  + K L         + EI     +
Sbjct: 5   NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H +++KL+  ++  DE I+V+EY GN  L +++  R     + A R      +  A+ Y
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRF--FQQIISAVEY 118
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H +    I+HRD+K  N+L+ E L  K+ DFG + +  + + +        G+  Y  P
Sbjct: 119 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAP 171
Query: 224 DYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + +  + Y   E  DV+S GV+L  M+  R P + +
Sbjct: 172 EVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFDDE 206

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 5   NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 119
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 120 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +G G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 12  NQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 69
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 126
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 127 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 181 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 221

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE-----FKNEILTWSKI 103
           N+     +GEG  G V   KL   +    K A K  + K L         + EI     +
Sbjct: 9   NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 65
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H +++KL+  ++  DE I+V+EY GN  L +++  R     + A R      +  A+ Y
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRF--FQQIISAVEY 122
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H +    I+HRD+K  N+L+ E L  K+ DFG + +  + + +        G+  Y  P
Sbjct: 123 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAP 175
Query: 224 DYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + +  + Y   E  DV+S GV+L  M+  R P + +
Sbjct: 176 EVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFDDE 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE-----FKNEILTWSKI 103
           N+     +GEG  G V   KL   +    K A K  + K L         + EI     +
Sbjct: 14  NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 70
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H +++KL+  ++  DE I+V+EY GN  L +++  R     + A R      +  A+ Y
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRF--FQQIISAVEY 127
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H +    I+HRD+K  N+L+ E L  K+ DFG + +  + + +        G+  Y  P
Sbjct: 128 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAP 180
Query: 224 DYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + +  + Y   E  DV+S GV+L  M+  R P + +
Sbjct: 181 EVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFDDE 215

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 108
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 168 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 219
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 114
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 225
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-- 107
           +S   +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L+ + E  D+ I +V   GN  L   L  +    ++  ER     ++  A+  +H +
Sbjct: 118 IIRLYDY-EITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+H D+K +N LI + +  K+ DFG A   + D+      +QV G   Y+ P+ ++
Sbjct: 175 G---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIK 229
Query: 228 TYQLTEKS-----------DVYSFGVLLVEMMTGRYPIE 255
               + ++           DV+S G +L  M  G+ P +
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 116
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 117 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 176 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 227
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 93
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 153 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 204
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 118
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 178 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 229
Query: 224 DYL-RTYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++     R+         +   EI     + H ++V
Sbjct: 52  FAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---------KMSMEISIHRSLAHQHVV 102
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +     YLH    
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRNR- 159
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + E L  K+ DFG A   E D     +   + GT  Y+ P+ L   
Sbjct: 160 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 214
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + DV+S G ++  ++ G+ P E+
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFET 241

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+VKL           +V+E +  G L E +  +        E   I   +  A++++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHM 122
Query: 165 HTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
           H   D  ++HRD+K  N+L T++   L  K+ DFGFAR+   D+           T  Y 
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC---FTLHYA 176
Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
            P+ L      E  D++S GV+L  M++G+ P +S
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++     R+         +   EI     + H ++V
Sbjct: 54  FAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---------KMSMEISIHRSLAHQHVV 104
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +     YLH    
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRNR- 161
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + E L  K+ DFG A   E D     +   + GT  Y+ P+ L   
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 216
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + DV+S G ++  ++ G+ P E+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFET 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +  G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 12  NQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 69
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I+ + +  G L    REH D  G   L  
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL-- 126
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 127 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 181 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 221

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 21/216 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE-----FKNEILTWSKI 103
           N+     +GEG  G V   KL   +    K A K  + K L         + EI     +
Sbjct: 15  NYQIVKTLGEGSFGKV---KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 71
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            H +++KL+  ++  DE I+V+EY GN  L +++  R     + A R      +  A+ Y
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRF--FQQIISAVEY 128
Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
            H +    I+HRD+K  N+L+ E L  K+ DFG + +  + + +        G+  Y  P
Sbjct: 129 CHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAP 181
Query: 224 DYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + +  + Y   E  DV+S GV+L  M+  R P + +
Sbjct: 182 EVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFDDE 216

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           NE     K+    +V L    E  D   +V+  +  G L+ H+   G  G   A  +  A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L  LH      I++RD+K  NIL+ +    +++D G A    E      I  +V
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV 346
Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK-------------KPIK 261
            GT GY+ P+ ++  + T   D ++ G LL EM+ G+ P + +             K + 
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 262 ERVTIRWAMQCLKAGDAILVMDPRLR 287
           E  + R++ Q       +L  DP  R
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++     R+         +   EI     + H ++V
Sbjct: 28  FAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---------KMSMEISIHRSLAHQHVV 78
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +     YLH    
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRNR- 135
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + E L  K+ DFG A   E D     +   + GT  Y+ P+ L   
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 190
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + DV+S G ++  ++ G+ P E+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFET 217

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           NE     K+    +V L    E  D   +V+  +  G L+ H+   G  G   A  +  A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L  LH      I++RD+K  NIL+ +    +++D G A    E      I  +V
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRV 346
Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK-------------KPIK 261
            GT GY+ P+ ++  + T   D ++ G LL EM+ G+ P + +             K + 
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 262 ERVTIRWAMQCLKAGDAILVMDPRLR 287
           E  + R++ Q       +L  DP  R
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 124/301 (41%), Gaps = 47/301 (15%)
Query: 34  TTINFSFEEIYKATENFS-------PANKIGEGGSGTVYKGK-LKDGSIVAVKRAR---K 82
           TT N  F+    A ENF        P  ++G G  G V K + +  G I AVKR R    
Sbjct: 16  TTENLYFQ---GAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVN 72
Query: 83  NKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRG 141
           ++  K LL +     ++   ++    V  +G L   GD  + +   + + +L +      
Sbjct: 73  SQEQKRLLXDLD---ISXRTVDCPFTVTFYGALFREGD--VWICXELXDTSLDKFYKQVI 127
Query: 142 GNGLELAERL--DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
             G  + E +   IA+ +  AL +LH  S   +IHRDVK SN+LI    + K  DFG + 
Sbjct: 128 DKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISG 185
Query: 200 MSEEDSAVSHISTQVKGTAGYLDPDY----LRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
              +D A   I     G   Y  P+     L     + KSD++S G+  +E+   R+P +
Sbjct: 186 YLVDDVA-KDIDA---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241
Query: 256 SKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP 315
           S           W     +    +    P+L   PA   + E  +     CL    + RP
Sbjct: 242 S-----------WGTPFQQLKQVVEEPSPQL---PADKFSAE-FVDFTSQCLKKNSKERP 286
Query: 316 T 316
           T
Sbjct: 287 T 287

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +  G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 5   NQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 62
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 119
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 120 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 174 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 214

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 25/203 (12%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKLFGFLEHG 118
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL    +  
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK 178
               +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+K
Sbjct: 114 SNLYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
             N++I ++   KVTDFG A+       V   +  + GT  YL P+ + +    +  D +
Sbjct: 169 PENLMIDQQGYIKVTDFGLAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWW 222
Query: 239 SFGVLLVEMMTGRYPIESKKPIK 261
           + GVL+ EM  G  P  + +PI+
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 85
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 145 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 196
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 159
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 160 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 219 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 270
Query: 224 DYL-RTYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 37  NFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGS----IVAVKRARKNKHDKCLLL 91
           N +   I K TE F     +  G  GTVYKG  + +G      VA+K  R+    K    
Sbjct: 12  NQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK- 69
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL----REHLDGRGGNGLEL 147
           E  +E    + +++ ++ +L G       ++I  + +  G L    REH D  G   L  
Sbjct: 70  EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL-- 126
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
              L+  + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +   
Sbjct: 127 ---LNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180
Query: 208 SHIS---TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            H       +K  A  L+    R Y  T +SDV+S+GV + E+MT
Sbjct: 181 YHAEGGKVPIKWMA--LESILHRIY--THQSDVWSYGVTVWELMT 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 56  IGEGGSGTVYKGK-----LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G G  G V+K +     LK  + +   R  K+K       E KNEI   ++++H NL++
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE------EVKNEISVMNQLDHANLIQ 150
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+   E  ++ ++V+EYV  G L + +     N  EL   L +   +   + ++H     
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQMY-- 207
Query: 171 PIIHRDVKASNILITEK--LRAKVTDFGFARM--SEEDSAVSHISTQVKGTAGYLDPDYL 226
            I+H D+K  NIL   +   + K+ DFG AR     E   V+       GT  +L P+ +
Sbjct: 208 -ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF------GTPEFLAPEVV 260
Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPI---ESKKPIKERVTIRWAMQ 271
               ++  +D++S GV+   +++G  P       + +   +  RW ++
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 20/252 (7%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           N+     IG+G    V   + +  G  VAVK   K + +   L +   E+     + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKLF  +E      +V EY   G + ++L   G    E   R      +  A+ Y H  
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHG-RXKEKEARAKFR-QIVSAVQYCHQK 132
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               I+HRD+KA N+L+      K+ DFGF+      + +        G   Y  P+  +
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC----GAPPYAAPELFQ 185
Query: 228 TYQLT-EKSDVYSFGVLLVEMMTGRYPIESK--KPIKERV-------TIRWAMQCLKAGD 277
             +    + DV+S GV+L  +++G  P + +  K ++ERV           +  C     
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLK 245
Query: 278 AILVMDPRLRRT 289
             L+++P  R T
Sbjct: 246 KFLILNPSKRGT 257

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDERII-----VVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++ +     V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  + K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 39/248 (15%)
Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           +   +F     +G+G  G V K +   D    A+K+ R  +     +L   +E++  + +
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 104 EHL-------------NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
            H              N VK    ++      I +EY  NGTL + +     N  +  E 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEY 118
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
             +   +  AL+Y+H+     IIHRD+K  NI I E    K+ DFG A+       +  +
Sbjct: 119 WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 211 STQ-----------VKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            +Q             GTA Y+  + L  T    EK D+YS G++  EM+   YP  +  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTG- 231
Query: 259 PIKERVTI 266
              ERV I
Sbjct: 232 --MERVNI 237

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  + K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS+I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 108 LVKLFGFLEHGDE-RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           ++ ++  + HG    +I++E +  G L   +  RG       E  +I  D+  A+ +LH+
Sbjct: 68  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 127
Query: 167 YSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           ++   I HRDVK  N+L T K +    K+TDFGFA+ + +++  +   T       Y+ P
Sbjct: 128 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVAP 179
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + L   +  +  D++S GV++  ++ G  P  S
Sbjct: 180 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 212

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 114
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 174 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 225
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 92
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 203
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRY 81
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 141 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 192
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 12/153 (7%)
Query: 108 LVKLFGFLEHGDE-RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           ++ ++  + HG    +I++E +  G L   +  RG       E  +I  D+  A+ +LH+
Sbjct: 87  ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 167 YSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           ++   I HRDVK  N+L T K +    K+TDFGFA+ + +++  +   T       Y+ P
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-----YVAP 198
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES 256
           + L   +  +  D++S GV++  ++ G  P  S
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 88
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 148 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 199
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 99
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 159 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 210
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRY 92
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 152 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 203
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++     R+         +   EI     + H ++V
Sbjct: 30  FAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---------KMSMEISIHRSLAHQHVV 80
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +     YLH    
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRNR- 137
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + E L  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKK 192
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + DV+S G ++  ++ G+ P E+
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++     R+         +   EI     + H ++V
Sbjct: 30  FAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---------KMSMEISIHRSLAHQHVV 80
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +     YLH    
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRNR- 137
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + E L  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKK 192
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + DV+S G ++  ++ G+ P E+
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFET 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRY 84
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 144 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 195
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++     R+         +   EI     + H ++V
Sbjct: 34  FAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---------KMSMEISIHRSLAHQHVV 84
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +     YLH    
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRNR- 141
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + E L  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 142 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKK 196
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + DV+S G ++  ++ G+ P E+
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPFET 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 15/146 (10%)
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVSHISTQ 213
           ++A  L +LH+     II+RD+K  NIL+ E+   K+TDFG ++  +  E  A S     
Sbjct: 138 ELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC--- 191
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI----RWA 269
             GT  Y+ P+ +     +  +D +S+GVL+ EM+TG  P + K   KE +T+    +  
Sbjct: 192 --GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDR-KETMTLILKAKLG 248
Query: 270 MQCLKAGDAILVMDPRLRRTPASNMA 295
           M    + +A  ++    +R PA+ + 
Sbjct: 249 MPQFLSTEAQSLLRALFKRNPANRLG 274

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           + E  +G  Y  K+    ++  K       D+      +N +L  S+   L  +K + F 
Sbjct: 167 VKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALK-YSFQ 218
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
            H D    V+EY   G L  HL  R     E   R     ++  AL YLH  S+  +++R
Sbjct: 219 TH-DRLCFVMEYANGGELFFHL-SRERVFSEDRARF-YGAEIVSALDYLH--SEKNVVYR 273
Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+K  N+++ +    K+TDFG  +   +D A         GT  YL P+ L         
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGRAV 330
Query: 236 DVYSFGVLLVEMMTGRYPI 254
           D +  GV++ EMM GR P 
Sbjct: 331 DWWGLGVVMYEMMCGRLPF 349

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LN------------LVKL-FGFLEH 117
           G ++ VK      H    +L+ K +++   +IEH LN            LVKL F F ++
Sbjct: 55  GRVMLVKHMETGNHYAMKILD-KQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDN 113
Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV 177
            +   +V+EY   G +  HL  R G   E   R   A  +     YLH+     +I+RD+
Sbjct: 114 SN-LYMVMEYAPGGEMFSHLR-RIGRFSEPHARF-YAAQIVLTFEYLHSLD---LIYRDL 167
Query: 178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDV 237
           K  N++I ++   +VTDFG A+       V   +  + GT  YL P+ + +    +  D 
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAK------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW 221
Query: 238 YSFGVLLVEMMTGRYPIESKKPIK 261
           ++ GVL+ EM  G  P  + +PI+
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           + E  +G  Y  K+    ++  K       D+      +N +L  S+   L  +K + F 
Sbjct: 170 VKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALK-YSFQ 221
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
            H D    V+EY   G L  HL  R     E   R     ++  AL YLH  S+  +++R
Sbjct: 222 TH-DRLCFVMEYANGGELFFHL-SRERVFSEDRARF-YGAEIVSALDYLH--SEKNVVYR 276
Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+K  N+++ +    K+TDFG  +   +D A         GT  YL P+ L         
Sbjct: 277 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYGRAV 333
Query: 236 DVYSFGVLLVEMMTGRYPI 254
           D +  GV++ EMM GR P 
Sbjct: 334 DWWGLGVVMYEMMCGRLPF 352

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 29/234 (12%)
Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGKLK--DGSIV--AVKRARKNKHDKCLLLEFKN 95
            E++    + F+    +G+G  G+V + +LK  DGS V  AVK  + +      + EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDER------IIVVEYVGNGTLREHL----DGRGGNGL 145
           E     + +H ++ KL G       +      ++++ ++ +G L   L     G     L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 146 ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS 205
            L   +   +D+A  + YL + +    IHRD+ A N ++ E +   V DFG +R      
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSR------ 185
Query: 206 AVSHISTQVKGTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMT-GRYP 253
            +       +G A  L   +L    L     T  SDV++FGV + E+MT G+ P
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLL-EF 93
           +NF   EI +A         IG+G  G V   +  D   + A+K   K K   C+   E 
Sbjct: 12  VNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQK---CVERNEV 59
Query: 94  KN---EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
           +N   E+     +EH  LV L+   +  ++  +VV+ +  G LR HL  +  +  E   +
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVK 118
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           L I  ++  AL YL       IIHRD+K  NIL+ E     +TDF  A M   ++ +   
Sbjct: 119 LFIC-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--- 171
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKS---DVYSFGVLLVEMMTGRYP 253
            T + GT  Y+ P+   + +    S   D +S GV   E++ GR P
Sbjct: 172 -TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKR--ARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +G+G  G VY G+ L +   +A+K    R +++ + L      EI     ++H N+V+  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL----HEEIALHKHLKHKNIVQYL 85
Query: 113 G-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI-DVAHALTYLHTYSDP 170
           G F E+G  +I + E V  G+L   L  + G   +  + +      +   L YLH   D 
Sbjct: 86  GSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 141
Query: 171 PIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--- 226
            I+HRD+K  N+LI T     K++DFG    S+  + ++  +    GT  Y+ P+ +   
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFG---TSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 227 -RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            R Y   + +D++S G  ++EM TG+ P 
Sbjct: 199 PRGY--GKAADIWSLGCTIIEMATGKPPF 225

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 145
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHIS-TQVKGTAGYLDPDYLRTYQLTEKSDV 237
           +L T K      K+TDFGFA+        SH S T+   T  Y+ P+ L   +  +  D+
Sbjct: 146 LLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDM 200
Query: 238 YSFGVLLVEMMTGRYPIES 256
           +S GV++  ++ G  P  S
Sbjct: 201 WSLGVIMYILLCGYPPFYS 219

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E++     IG G  G   K + K DG I+  K        +       +E+    +++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 107 NLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALT 162
           N+V+ +   ++  +  + IV+EY   G L   +         L E   L +   +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 163 YLHTYSDP--PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             H  SD    ++HRD+K +N+ +  K   K+ DFG AR+   D++ +       GT  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYY 182
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEM 247
           + P+ +      EKSD++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E++     IG G  G   K + K DG I+  K        +       +E+    +++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 107 NLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALT 162
           N+V+ +   ++  +  + IV+EY   G L   +         L E   L +   +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 163 YLHTYSDP--PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             H  SD    ++HRD+K +N+ +  K   K+ DFG AR+   D++    +    GT  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS---FAKAFVGTPYY 182
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEM 247
           + P+ +      EKSD++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 53  ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLL-EFKNEILTWSKIEHLNLVK 110
            + +G G  G V  GK +  G  VAVK   + K     ++ + + EI       H +++K
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+  +    +  +V+EYV  G L +++   G   L+  E   +   +   + Y H +   
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RT 228
            ++HRD+K  N+L+   + AK+ DFG + M  +   +        G+  Y  P+ +  R 
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC----GSPNYAAPEVISGRL 191
Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           Y   E  D++S GV+L  ++ G  P +
Sbjct: 192 YAGPE-VDIWSSGVILYALLCGTLPFD 217

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKR--ARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +G+G  G VY G+ L +   +A+K    R +++ + L      EI     ++H N+V+  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL----HEEIALHKHLKHKNIVQYL 71
Query: 113 G-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI-DVAHALTYLHTYSDP 170
           G F E+G  +I + E V  G+L   L  + G   +  + +      +   L YLH   D 
Sbjct: 72  GSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DN 127
Query: 171 PIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--- 226
            I+HRD+K  N+LI T     K++DFG    S+  + ++  +    GT  Y+ P+ +   
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFG---TSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 227 -RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            R Y   + +D++S G  ++EM TG+ P 
Sbjct: 185 PRGY--GKAADIWSLGCTIIEMATGKPPF 211

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           + E  +G  Y  K+    ++  K       D+      +N +L  S+   L  +K + F 
Sbjct: 29  VKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALK-YSFQ 80
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
            H D    V+EY   G L  HL  R     E   R     ++  AL YLH  S+  +++R
Sbjct: 81  TH-DRLCFVMEYANGGELFFHL-SRERVFSEDRARF-YGAEIVSALDYLH--SEKNVVYR 135
Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+K  N+++ +    K+TDFG  +   +D A         GT  YL P+ L         
Sbjct: 136 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC---GTPEYLAPEVLEDNDYGRAV 192
Query: 236 DVYSFGVLLVEMMTGRYPI 254
           D +  GV++ EMM GR P 
Sbjct: 193 DWWGLGVVMYEMMCGRLPF 211

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           L +L    +  D    V+EYV  G L  H+   G    +    +  A ++A  L +L + 
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK 461
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               II+RD+K  N+++  +   K+ DFG   M +E+      +    GT  Y+ P+ + 
Sbjct: 462 G---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKXFCGTPDYIAPEII- 514
Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIESK 257
            YQ   KS D ++FGVLL EM+ G+ P E +
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           + E  +G  Y  K+    ++  K       D+      +N +L  S+   L  +K + F 
Sbjct: 28  VKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALK-YSFQ 79
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
            H D    V+EY   G L  HL  R     E   R     ++  AL YLH  S+  +++R
Sbjct: 80  TH-DRLCFVMEYANGGELFFHL-SRERVFSEDRARF-YGAEIVSALDYLH--SEKNVVYR 134
Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+K  N+++ +    K+TDFG  +   +D A         GT  YL P+ L         
Sbjct: 135 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC---GTPEYLAPEVLEDNDYGRAV 191
Query: 236 DVYSFGVLLVEMMTGRYPI 254
           D +  GV++ EMM GR P 
Sbjct: 192 DWWGLGVVMYEMMCGRLPF 210

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 153
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 154 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 209
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 210 SLGVIMYILLCGYPPFYS 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKL-F 112
           IG G  G VY+ KL D G +VA+K+  + K        FKN E+    K++H N+V+L +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRLRY 80
Query: 113 GFLEHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            F   G+++      +V++YV     R   H   R    L +         +  +L Y+H
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 166 TYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDP 223
           ++    I HRD+K  N+L+  +    K+ DFG A+ +   +  VS I ++      Y  P
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-----YRAP 191
Query: 224 DYLR-TYQLTEKSDVYSFGVLLVEMMTGR 251
           + +      T   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 161
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 162 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 217
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 218 SLGVIMYILLCGYPPFYS 235

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           + E  +G  Y  K+    ++  K       D+      +N +L  S+   L  +K + F 
Sbjct: 27  VKEKATGRYYAMKILKKEVIVAK-------DEVAHTLTENRVLQNSRHPFLTALK-YSFQ 78
Query: 116 EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR 175
            H D    V+EY   G L  HL  R     E   R     ++  AL YLH  S+  +++R
Sbjct: 79  TH-DRLCFVMEYANGGELFFHL-SRERVFSEDRARF-YGAEIVSALDYLH--SEKNVVYR 133
Query: 176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
           D+K  N+++ +    K+TDFG  +   +D A         GT  YL P+ L         
Sbjct: 134 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC---GTPEYLAPEVLEDNDYGRAV 190
Query: 236 DVYSFGVLLVEMMTGRYPI 254
           D +  GV++ EMM GR P 
Sbjct: 191 DWWGLGVVMYEMMCGRLPF 209

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 151
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 152 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 207
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 208 SLGVIMYILLCGYPPFYS 225

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 247
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 248 SLGVIMYILLCGYPPFYS 265

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 152
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 153 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 208
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 209 SLGVIMYILLCGYPPFYS 226

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 147
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 203
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 204 SLGVIMYILLCGYPPFYS 221

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 101/207 (48%), Gaps = 8/207 (3%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           ++G G  G+V +G  +++   I    +  K   +K    E   E     ++++  +V+L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G  +  +  ++V+E  G G L + L G+    + ++   ++   V+  + YL    +   
Sbjct: 77  GVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE---EKNF 131
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A N+L+  +  AK++DFG ++    D +     +  K    +  P+ +   + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 233 EKSDVYSFGVLLVEMMT-GRYPIESKK 258
            +SDV+S+GV + E ++ G+ P +  K
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  K            
Sbjct: 25  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY 81
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 137
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + +D    
Sbjct: 138 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMTG 193
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           +++T+      Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 194 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 146
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 147 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 202
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 203 SLGVIMYILLCGYPPFYS 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 112/269 (41%), Gaps = 41/269 (15%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARKNKHDKCLLLEFKNEILTWS 101
           I   ++ +     IG G  G     + K  + +VAVK   + +    +    K EI+   
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEK---IAANVKREIINHR 70
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA----ERLDIAIDV 157
            + H N+V+    +       IV+EY   G L E +   G    + A    ++L   +  
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 130
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSHISTQ-V 214
            HA+          + HRD+K  N L+  +   R K+ DFG+++     S+V H   +  
Sbjct: 131 CHAMQ---------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKST 176
Query: 215 KGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIES-------KKPIKERVTI 266
            GT  Y+ P+ L   +   K +DV+S GV L  M+ G YP E        +K I   + +
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV 236
Query: 267 RWAM--------QCLKAGDAILVMDPRLR 287
           ++A+        +C      I V DP  R
Sbjct: 237 QYAIPDYVHISPECRHLISRIFVADPAKR 265

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 197
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 198 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 253
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 254 SLGVIMYILLCGYPPFYS 271

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHL 106
           ++   + +G G  G V  G+ +  G  VAVK   + K     ++ + K EI       H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           +++KL+  +    +  +V+EYV  G L +++   G   +E  E   +   +  A+ Y H 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHR 129
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+L+   + AK+ DFG + M  +   +        G+  Y  P+ +
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC----GSPNYAAPEVI 182
Query: 227 --RTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
             R Y   E  D++S GV+L  ++ G  P + +
Sbjct: 183 SGRLYAGPE-VDIWSCGVILYALLCGTLPFDDE 214

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 9   LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 65
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 174
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 9   LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 65
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++ A  
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-- 176
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
                   T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 177 ----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 145
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 146 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 201
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 202 SLGVIMYILLCGYPPFYS 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 147
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D++
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 203
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 204 SLGVIMYILLCGYPPFYS 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 49  NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC-LLLEFKNEILTWSKIEHL 106
           ++   + +G G  G V  G+ +  G  VAVK   + K     ++ + K EI       H 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           +++KL+  +    +  +V+EYV  G L +++   G   +E  E   +   +  A+ Y H 
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHR 129
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
           +    ++HRD+K  N+L+   + AK+ DFG + M   D      S    G+  Y  P+ +
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC---GSPNYAAPEVI 182
Query: 227 --RTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
             R Y   E  D++S GV+L  ++ G  P + +
Sbjct: 183 SGRLYAGPE-VDIWSCGVILYALLCGTLPFDDE 214

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 49/273 (17%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKR-ARKNKHDKCLLLEFKNEILTW 100
           I   ++ +     IG G  G     + K  + +VAVK   R  K D+ +    K EI+  
Sbjct: 14  IMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENV----KREIINH 69
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA----ERLDIAID 156
             + H N+V+    +       IV+EY   G L E +   G    + A    ++L   + 
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMS----EEDSAVSHI 210
            AHA+          + HRD+K  N L+  +   R K+ DFG+++ S    +  SAV   
Sbjct: 130 YAHAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV--- 177
Query: 211 STQVKGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIES-------KKPIKE 262
                GT  Y+ P+ L   +   K +DV+S GV L  M+ G YP E        +K I  
Sbjct: 178 -----GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 232
Query: 263 RVTIRWAM--------QCLKAGDAILVMDPRLR 287
            + +++A+        +C      I V DP  R
Sbjct: 233 ILNVQYAIPDYVHISPECRHLISRIFVADPAKR 265

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           + EI+    + H N+V+    +       I++EY   G L E +    G   E   R   
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFF 122
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSHIS 211
              +   ++Y H+     I HRD+K  N L+  +   R K+ DFG+++     S+V H  
Sbjct: 123 Q-QLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQ 173
Query: 212 TQ-VKGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIES-------KKPIKE 262
            +   GT  Y+ P+ L   +   K +DV+S GV L  M+ G YP E        +K I+ 
Sbjct: 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR 233
Query: 263 RVTIRWAM--------QCLKAGDAILVMDPRLR 287
            +++++++        +C      I V DP  R
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPATR 266

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++ A  
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-- 180
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
                   T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 181 ----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++ A  
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA-- 180
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
                   T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 181 ----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 111/239 (46%), Gaps = 28/239 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNK-HDKC 88
           G   ++   FE++YK T        +GEG    V     L++G   AVK   K   H + 
Sbjct: 1   GSTDSLPGKFEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS 55
Query: 89  LLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLEL 147
            +     E+ T  + + + N+++L  F E      +V E +  G++  H+  +       
Sbjct: 56  RVF---REVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNERE 112
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI--TEKLR-AKVTDFGFARMSEED 204
           A R  +  DVA AL +LHT     I HRD+K  NIL    EK+   K+ DF      + +
Sbjct: 113 ASR--VVRDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLN 167
Query: 205 SAVSHIS----TQVKGTAGYLDPDYLRTY--QLT---EKSDVYSFGVLLVEMMTGRYPI 254
           ++ + I+    T   G+A Y+ P+ +  +  Q T   ++ D++S GV+L  M++G  P 
Sbjct: 168 NSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 19  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 75
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 132 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 184
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G+G +  V++G+ K  G + A+K        + + ++ + E     K+ H N+VKLF  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFAI 75
Query: 115 LEHGDER--IIVVEYVGNGTLREHLD-GRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            E    R  ++++E+   G+L   L+      GL  +E L +  DV   + +L    +  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 172 IIHRDVKASNIL--ITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
           I+HR++K  NI+  I E  ++  K+TDFG AR  E+D         + GT  YL PD   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VSLYGTEEYLHPDMYE 188
Query: 228 TYQLTEKS--------DVYSFGVLLVEMMTGRYPI 254
              L +          D++S GV      TG  P 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 32  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 88
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 144
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 145 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 197
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 198 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 10/207 (4%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E++     IG G  G   K + K DG I+  K        +       +E+    +++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 107 NLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALT 162
           N+V+ +   ++  +  + IV+EY   G L   +         L E   L +   +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 163 YLHTYSDP--PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             H  SD    ++HRD+K +N+ +  K   K+ DFG AR+   D      + +  GT  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---EDFAKEFVGTPYY 182
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEM 247
           + P+ +      EKSD++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G+G  G V   K K  G   AVK    R  K K DK  LL    E+    +++H N++K
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL---REVQLLKQLDHPNIMK 96
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+ F E      +V E    G L + +  R       A R  I   V   +TY+H     
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHK---N 151
Query: 171 PIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            I+HRD+K  N+L+  K +    ++ DFG +   E   A   +  ++ GTA Y+ P+ L 
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKI-GTAYYIAPEVLH 207
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            TY   EK DV+S GV+L  +++G  P 
Sbjct: 208 GTYD--EKCDVWSTGVILYILLSGCPPF 233

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 43/270 (15%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKR-ARKNKHDKCLLLEFKNEILTW 100
           I   ++ +     IG G  G     + K  + +VAVK   R  K D+      K EI+  
Sbjct: 13  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE----NVKREIINH 68
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA----ERLDIAID 156
             + H N+V+    +       IV+EY   G L E +   G    + A    ++L   + 
Sbjct: 69  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 128
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSHISTQ- 213
             HA+          + HRD+K  N L+  +   R K+ DFG+++     S+V H   + 
Sbjct: 129 YCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKS 174
Query: 214 VKGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIES-------KKPIKERVT 265
             GT  Y+ P+ L   +   K +DV+S GV L  M+ G YP E        +K I   + 
Sbjct: 175 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 234
Query: 266 IRWAM--------QCLKAGDAILVMDPRLR 287
           +++A+        +C      I V DP  R
Sbjct: 235 VQYAIPDYVHISPECRHLISRIFVADPAKR 264

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G+G  G V   K K  G   AVK    R  K K DK  LL    E+    +++H N++K
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL---REVQLLKQLDHPNIMK 90
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+ F E      +V E    G L + +  R       A R  I   V   +TY+H     
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHK---N 145
Query: 171 PIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            I+HRD+K  N+L+  K +    ++ DFG +   E   A   +  ++ GTA Y+ P+ L 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKI-GTAYYIAPEVLH 201
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            TY   EK DV+S GV+L  +++G  P 
Sbjct: 202 GTYD--EKCDVWSTGVILYILLSGCPPF 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 33  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 89
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 146 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 198
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 199 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   IG G  G+V      K G  VAVK+  +            
Sbjct: 18  LNKTIWEVPERYQNLSP---IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 74
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 131 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---- 183
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 11  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 67
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 68  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 123
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 124 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 176
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 177 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G+G +  V++G+ K  G + A+K        + + ++ + E     K+ H N+VKLF  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFAI 75
Query: 115 LEHGDER--IIVVEYVGNGTLREHLD-GRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            E    R  ++++E+   G+L   L+      GL  +E L +  DV   + +L    +  
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 172 IIHRDVKASNIL--ITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
           I+HR++K  NI+  I E  ++  K+TDFG AR  E+D         + GT  YL PD   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF----VXLYGTEEYLHPDMYE 188
Query: 228 TYQLTEKS--------DVYSFGVLLVEMMTGRYPI 254
              L +          D++S GV      TG  P 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 9   LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 122 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 174
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 10/151 (6%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           L +L    +  D    V+EYV  G L  H+   G    +    +  A ++A  L +L + 
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK 140
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               II+RD+K  N+++  +   K+ DFG  + +  D   +       GT  Y+ P+ + 
Sbjct: 141 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFC---GTPDYIAPEII- 193
Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIESK 257
            YQ   KS D ++FGVLL EM+ G+ P E +
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 101/207 (48%), Gaps = 8/207 (3%)
Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           ++G G  G+V +G  +++   I    +  K   +K    E   E     ++++  +V+L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G  +  +  ++V+E  G G L + L G+    + ++   ++   V+  + YL   +    
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKN---F 457
Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HR++ A N+L+  +  AK++DFG ++    D +     +  K    +  P+ +   + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 233 EKSDVYSFGVLLVEMMT-GRYPIESKK 258
            +SDV+S+GV + E ++ G+ P +  K
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 18  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 74
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 131 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 183
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 18  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 74
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 131 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 183
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 12  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 68
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 69  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 124
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 125 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 177
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 178 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 10  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 66
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 123 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 175
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 176 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 15  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 71
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 128 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 180
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 10  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 66
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 123 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 175
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 176 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 32  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 88
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 144
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 145 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 197
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 198 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 20  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 133 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 185
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 24  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 80
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 136
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + +D    
Sbjct: 137 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMTG 192
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           +++T+      Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 193 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 15  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 71
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 128 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 180
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 19  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 75
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 132 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 184
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 25  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 81
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 137
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 138 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 190
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 191 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 25  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 81
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 137
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 138 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 190
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 191 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 36  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 92
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 148
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + +D    
Sbjct: 149 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMTG 204
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           +++T+      Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 205 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 15  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 71
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 128 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 180
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G+G  G V   K K  G   AVK    R  K K DK  LL    E+    +++H N++K
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL---REVQLLKQLDHPNIMK 113
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+ F E      +V E    G L + +  R       A R  I   V   +TY+H     
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHK---N 168
Query: 171 PIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            I+HRD+K  N+L+  K +    ++ DFG +   E   A   +  ++ GTA Y+ P+ L 
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKI-GTAYYIAPEVLH 224
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            TY   EK DV+S GV+L  +++G  P 
Sbjct: 225 GTYD--EKCDVWSTGVILYILLSGCPPF 250

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 33  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 89
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 146 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 198
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 199 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 75  VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLR 134
           V  KR  K K DK  LL    E+    +++H N++KL+ F E      +V E    G L 
Sbjct: 82  VISKRQVKQKTDKESLL---REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 138
Query: 135 EHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AK 191
           + +  R       A R  I   V   +TY+H      I+HRD+K  N+L+  K +    +
Sbjct: 139 DEIISRKRFSEVDAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIR 193
Query: 192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTG 250
           + DFG +   E   A   +  ++ GTA Y+ P+ L  TY   EK DV+S GV+L  +++G
Sbjct: 194 IIDFGLSTHFE---ASKKMKDKI-GTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSG 247
Query: 251 RYPI 254
             P 
Sbjct: 248 CPPF 251

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+  L      +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 19  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 75
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 132 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 184
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           I++  E +   + +G G  G+V     +K G  +AVK+  +             E+    
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAI 155
            ++H N++ L             +E   +  L  HL G   N +   ++L       +  
Sbjct: 106 HMKHENVIGLLDVFTPATS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 161
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++       T   
Sbjct: 162 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYV 212
Query: 216 GTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ +  +       D++S G ++ E++TGR
Sbjct: 213 ATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 18  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 74
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 131 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---- 183
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 184 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 102/238 (42%), Gaps = 55/238 (23%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNE--ILTWSKIEHLNLVKLFG 113
           IG G  G VYKG L +  +     +  N+ +      F NE  I     +EH N+ +   
Sbjct: 21  IGRGRYGAVYKGSLDERPVAVKVFSFANRQN------FINEKNIYRVPLMEHDNIARFIV 74
Query: 114 FLEHGDERI---------IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
               GDER+         +V+EY  NG+L ++L     + +       +A  V   L YL
Sbjct: 75  ----GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCR---LAHSVTRGLAYL 127
Query: 165 HT------YSDPPIIHRDVKASNILITEKLRAKVTDFGFA---------RMSEED-SAVS 208
           HT      +  P I HRD+ + N+L+       ++DFG +         R  EED +A+S
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 209 HISTQVKGTAGYLDPDYLR-------TYQLTEKSDVYSFGVLLVEMM---TGRYPIES 256
            +     GT  Y+ P+ L             ++ D+Y+ G++  E+    T  +P ES
Sbjct: 188 EV-----GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 124/295 (42%), Gaps = 35/295 (11%)
Query: 49  NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +F P + +G G  GT+    + D   VAVKR       +C     +   L     EH N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP----ECFSFADREVQLLRESDEHPNV 80
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           ++ F   +    + I +E     TL+E+++ +    L L E + +       L +LH+ +
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL-EPITLLQQTTSGLAHLHSLN 138
Query: 169 DPPIIHRDVKASNILITE-----KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
              I+HRD+K  NILI+      K++A ++DFG  +            + V GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 224 DYLR---TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI 279
           + L        T   D++S G +   +++ G +P    K ++ +  I      L    ++
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--GKSLQRQANI------LLGACSL 247
Query: 280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAE--ILWKIRKDFR 332
             + P       +   +EK++ +         Q RP+ K   +    W + K  +
Sbjct: 248 DCLHPEKHEDVIARELIEKMIAMDP-------QKRPSAKHVLKHPFFWSLEKQLQ 295

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E +     L + +  RG    ELA        V  A+ + H  
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 133
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 185
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 243

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 24  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 80
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 136
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + +D    
Sbjct: 137 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHT-DDEMTG 192
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           +++T+      Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 193 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N +P   +G G  G+V      K G  VAVK+  +            
Sbjct: 23  LNKTIWEVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 79
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 135
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 136 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 188
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 189 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 39/244 (15%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL- 106
           +F     +G+G  G V K +   D    A+K+ R  +     +L   +E++  + + H  
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASLNHQY 63
Query: 107 ------------NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
                       N VK    ++      I +EY  N TL + +     N  +  E   + 
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ-QRDEYWRLF 122
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ- 213
             +  AL+Y+H+     IIHRD+K  NI I E    K+ DFG A+       +  + +Q 
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 214 ----------VKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE 262
                       GTA Y+  + L  T    EK D+YS G++  EM+   YP  +     E
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTG---ME 233
Query: 263 RVTI 266
           RV I
Sbjct: 234 RVNI 237

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           +NEI    KI+H N+V L    E  +   +V++ V  G L + +  +G    + A  L  
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL-- 125
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARMSEEDSAVSHI 210
              V  A+ YLH      I+HRD+K  N+L     E+ +  ++DFG ++M  +   +S  
Sbjct: 126 IRQVLDAVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA 182
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
                GT GY+ P+ L     ++  D +S GV+   ++ G  P 
Sbjct: 183 C----GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 36  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 92
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 148
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + +D    
Sbjct: 149 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMXG 204
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           +++T+      Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 205 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 20  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + ++    
Sbjct: 133 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE---- 185
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 20  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + ++    
Sbjct: 133 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE---- 185
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 20  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 76
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + ++    
Sbjct: 133 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE---- 185
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 149
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 201
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 259

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 27/282 (9%)
Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKN---KHDKCLLLEFKNEILTWS 101
             E+     +IG G  G+V K   K  G I+AVKR R     K  K LL++  + ++  S
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL-DVVMRSS 78
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
              ++  V+ +G L    +  I +E +     + +          + E +   I +A   
Sbjct: 79  DCPYI--VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
              H   +  IIHRD+K SNIL+      K+ DFG +    +  A     T+  G   Y+
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA----KTRDAGCRPYM 192
Query: 222 DPDYLRTYQLTE----KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
            P+ +      +    +SDV+S G+ L E+ TGR+P      + +++T     Q +K GD
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT-----QVVK-GD 246
Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
                 P+L  +     +    +   ++CL      RP  K+
Sbjct: 247 P-----PQLSNSEEREFS-PSFINFVNLCLTKDESKRPKYKE 282

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKXQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 21/217 (9%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           I++  E +   + +G G  G+V      K G  VAVK+  +             E+    
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAI 155
            ++H N++ L             +E   +  L  HL G   N +    +L       +  
Sbjct: 73  HMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIY 128
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++       T   
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------MTGYV 179
Query: 216 GTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           L +L    +  D    V+EYV  G L  H+   G    +  + +  A +++  L +LH  
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISIGLFFLHKR 139
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               II+RD+K  N+++  +   K+ DFG  +    D   +    +  GT  Y+ P+ + 
Sbjct: 140 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTR---EFCGTPDYIAPEII- 192
Query: 228 TYQLTEKS-DVYSFGVLLVEMMTGRYPIESK 257
            YQ   KS D +++GVLL EM+ G+ P + +
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 223

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 161
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 213
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 271

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 33  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 89
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + +D    
Sbjct: 146 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-DDEMXG 201
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
            ++T+      Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 202 XVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 148
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 200
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 258

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 148
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 149 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 200
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 258

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 15  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 71
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 128 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---- 180
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 181 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 162
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 214
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCL 272

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 162
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 214
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCL 272

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 161
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 213
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCL 271

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 149
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 201
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 259

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 162
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 214
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCL 272

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 149
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 150 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 201
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 259

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 161
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 213
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCL 271

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 162
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 163 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 214
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCL 272

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 161
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 162 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 213
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWCL 271

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 176
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 228
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 286

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 19  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 75
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG AR ++++    
Sbjct: 132 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE---- 184
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 185 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 181
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 182 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 233
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 291

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 176
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 228
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 286

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 17/218 (7%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTW 100
           +++     ++  + IGEG  G V         + VA+K+    +H        + EI   
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKIL 95
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IA 154
            +  H N++ +   +     R   +E + +  L  HL G     L   + L         
Sbjct: 96  LRFRHENIIGINDII-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+ 
Sbjct: 151 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 215 KGTAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
             T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 168
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 169 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 220
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 278

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 26/285 (9%)
Query: 45  KATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           K ++N+    ++G+G    V +   K  G   A K     K       + + E     K+
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N+V+L   ++      +V + V  G L E +  R       A+       +  ++ Y
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAY 120
Query: 164 LHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
            H+     I+HR++K  N+L+  K +    K+ DFG A +   DS   H      GT GY
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---GFAGTPGY 173
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR----------WAM 270
           L P+ L+    ++  D+++ GV+L  ++ G  P   +   +    I+          W  
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233
Query: 271 QCLKAG---DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQ 312
              +A    D++L ++P+ R T    + V  I     V  A  RQ
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ 278

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ D+G AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 134
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 186
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 244

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 134
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 186
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 244

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 26/285 (9%)
Query: 45  KATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           K ++N+    ++G+G    V +   K  G   A K     K       + + E     K+
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N+V+L   ++      +V + V  G L E +  R       A+       +  ++ Y
Sbjct: 62  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAY 119
Query: 164 LHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
            H+     I+HR++K  N+L+  K +    K+ DFG A +   DS   H      GT GY
Sbjct: 120 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---GFAGTPGY 172
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR----------WAM 270
           L P+ L+    ++  D+++ GV+L  ++ G  P   +   +    I+          W  
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 232
Query: 271 QCLKAG---DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQ 312
              +A    D++L ++P+ R T    + V  I     V  A  RQ
Sbjct: 233 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ 277

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 133
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 185
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 243

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 134
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 186
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 244

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 31/212 (14%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVK-RARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G+G  G V++G L  G  VAVK  + +++       E  N +L    + H N++   GF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL----LRHDNIL---GF 67
Query: 115 L-------EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH-- 165
           +           +  ++  Y  +G+L + L  +    LE    L +A+  A  L +LH  
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQT---LEPHLALRLAVSAACGLAHLHVE 124
Query: 166 ---TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-GTAGYL 221
              T   P I HRD K+ N+L+   L+  + D G A M  + S    I    + GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 222 DPDYL----RT--YQLTEKSDVYSFGVLLVEM 247
            P+ L    RT  ++  + +D+++FG++L E+
Sbjct: 185 APEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 129
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 181
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 26/292 (8%)
Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNE 96
           F      K ++N+    ++G+G    V +   K  G   A K     K       + + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78
Query: 97  ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
                K++H N+V+L   ++      +V + V  G L E +  R       A+       
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQ 136
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHISTQ 213
           +  ++ Y H+     I+HR++K  N+L+  K +    K+ DFG A +   DS   H    
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---G 189
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR------ 267
             GT GYL P+ L+    ++  D+++ GV+L  ++ G  P   +   +    I+      
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 268 ----WAMQCLKAG---DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQ 312
               W     +A    D++L ++P+ R T    + V  I     V  A  RQ
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ 301

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 24/224 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLL-LEFKNEILTW 100
           +Y  + +F   + +GEG  G V     K  G IVA+K+      DK L  L    EI   
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKIL 63
Query: 101 SKIEHLNLVKLFGF-----LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
              +H N++ +F        E+ +E  I+ E +         D       ++     I  
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-------DLHRVISTQMLSDDHIQY 116
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA-VSHISTQV 214
            +   L  +       +IHRD+K SN+LI      KV DFG AR+ +E +A  S  + Q 
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 215 KGTAGYLDPDYLRTYQLTEKS-------DVYSFGVLLVEMMTGR 251
            G   Y+   + R  ++   S       DV+S G +L E+   R
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 132
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 184
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 242

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNC 129
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 181
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCL 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF--FWQVLEAVRHCHNX 129
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 181
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 239

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 10/138 (7%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN---IAHRDVKPEN 191
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA+   E ++ + ++T    T  Y+ P+ L   +  +  D +
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDXW 247
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV+   ++ G  P  S
Sbjct: 248 SLGVIXYILLCGYPPFYS 265

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLL----EFKNEILTWSKIE--HLNL 108
           +G GG G+VY G ++ D   VA+K   K++      L        E++   K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 109 VKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H  
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHNC 156
Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 157 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWI 208
Query: 227 RTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCL 266

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 77  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 130
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC---GTPEYLAPEVLEDNDY 187
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQ 213

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG------------NGLELAERL 151
           HLN+V L G   + G   +++VE+   G L  +L  +              + L L   +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
             +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D       
Sbjct: 152 XYSFQVAKGMEFLASRK---XIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR-- 206
Query: 212 TQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 207 ---KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 72  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 125
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC---GTPEYLAPEVLEDNDY 182
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 72  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 125
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC---GTPEYLAPEVLEDNDY 182
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 72  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 125
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 182
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 45  KATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           K ++N+    ++G+G    V +   K  G   A K     K       + + E     K+
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N+V+L   ++      +V + V  G L E +  R       A+       +  ++ Y
Sbjct: 63  QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAY 120
Query: 164 LHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
            H+     I+HR++K  N+L+  K +    K+ DFG A +   DS   H      GT GY
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWH---GFAGTPGY 173
Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           L P+ L+    ++  D+++ GV+L  ++ G  P 
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 72  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 125
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC---GTPEYLAPEVLEDNDY 182
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 72  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 125
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 182
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 65/146 (44%), Gaps = 9/146 (6%)
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + F  H D    V+EY   G L  HL  R     E   R     ++  AL YLH+     
Sbjct: 75  YAFQTH-DRLCFVMEYANGGELFFHL-SRERVFTEERARF-YGAEIVSALEYLHSRD--- 128
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ L     
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDY 185
Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
               D +  GV++ EMM GR P  ++
Sbjct: 186 GRAVDWWGLGVVMYEMMCGRLPFYNQ 211

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG-------------NGLELAER 150
           HLN+V L G   + G   +++VE+   G L  +L  +               + L L   
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D      
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR- 206
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
               +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G+G  G V   K K  G   AVK    R  K K DK  LL    E+    +++H N+ K
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL---REVQLLKQLDHPNIXK 90
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+ F E      +V E    G L + +  R       A R  I   V   +TY H     
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYXHK---N 145
Query: 171 PIIHRDVKASNILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            I+HRD+K  N+L+  K +    ++ DFG +   E     S       GTA Y+ P+ L 
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE----ASKKXKDKIGTAYYIAPEVLH 201
Query: 228 -TYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            TY   EK DV+S GV+L  +++G  P 
Sbjct: 202 GTYD--EKCDVWSTGVILYILLSGCPPF 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +  +++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKSQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DFG  R ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 119/263 (45%), Gaps = 41/263 (15%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKH--------DKCLLLEFKNEILTWSKIEHL 106
           +G G  G V    + K    VA+K   K K         D  L +E + EIL   K+ H 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL--KKLNHP 75
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++K+  F +  ++  IV+E +  G L + +   G   L+ A        +  A+ YLH 
Sbjct: 76  CIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 167 YSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
             +  IIHRD+K  N+L++   E    K+TDFG +++  E S +  +     GT  YL P
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----GTPTYLAP 185
Query: 224 DYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIKERVTI--------RWA 269
           + L    T       D +S GV+L   ++G  P     ++  +K+++T          WA
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 270 MQCLKAGDAI---LVMDPRLRRT 289
               KA D +   LV+DP+ R T
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFT 268

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 119/263 (45%), Gaps = 41/263 (15%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKH--------DKCLLLEFKNEILTWSKIEHL 106
           +G G  G V    + K    VA+K   K K         D  L +E + EIL   K+ H 
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL--KKLNHP 74
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++K+  F +  ++  IV+E +  G L + +   G   L+ A        +  A+ YLH 
Sbjct: 75  CIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH- 130
Query: 167 YSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
             +  IIHRD+K  N+L++   E    K+TDFG +++  E S +  +     GT  YL P
Sbjct: 131 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----GTPTYLAP 184
Query: 224 DYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIKERVTI--------RWA 269
           + L    T       D +S GV+L   ++G  P     ++  +K+++T          WA
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 270 MQCLKAGDAI---LVMDPRLRRT 289
               KA D +   LV+DP+ R T
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFT 267

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++VE+   G L  +L  +                + L L  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 150 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG----------NGLELAERLDI 153
           HLN+V L G   + G   +++VE+   G L  +L  +            + L L   +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D         
Sbjct: 150 SFQVAKGMEFLASRK---XIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGD 205
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 119/263 (45%), Gaps = 41/263 (15%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKH--------DKCLLLEFKNEILTWSKIEHL 106
           +G G  G V    + K    VA+K   K K         D  L +E + EIL   K+ H 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL--KKLNHP 75
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++K+  F +  ++  IV+E +  G L + +   G   L+ A        +  A+ YLH 
Sbjct: 76  CIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 167 YSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
             +  IIHRD+K  N+L++   E    K+TDFG +++  E S +  +     GT  YL P
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----GTPTYLAP 185
Query: 224 DYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIKERVTI--------RWA 269
           + L    T       D +S GV+L   ++G  P     ++  +K+++T          WA
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 270 MQCLKAGDAI---LVMDPRLRRT 289
               KA D +   LV+DP+ R T
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFT 268

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 119/263 (45%), Gaps = 41/263 (15%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKH--------DKCLLLEFKNEILTWSKIEHL 106
           +G G  G V    + K    VA+K   K K         D  L +E + EIL   K+ H 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL--KKLNHP 75
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++K+  F +  ++  IV+E +  G L + +   G   L+ A        +  A+ YLH 
Sbjct: 76  CIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 167 YSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
             +  IIHRD+K  N+L++   E    K+TDFG +++  E S +  +     GT  YL P
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----GTPTYLAP 185
Query: 224 DYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIKERVTI--------RWA 269
           + L    T       D +S GV+L   ++G  P     ++  +K+++T          WA
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 270 MQCLKAGDAI---LVMDPRLRRT 289
               KA D +   LV+DP+ R T
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFT 268

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 91  LEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
           L  + EI    K+ H  ++K+  F +  ++  IV+E +  G L + +   G   L+ A  
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATC 241
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAV 207
                 +  A+ YLH   +  IIHRD+K  N+L++   E    K+TDFG +++  E S +
Sbjct: 242 KLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 208 SHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIK 261
             +     GT  YL P+ L    T       D +S GV+L   ++G  P     ++  +K
Sbjct: 299 RTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354
Query: 262 ERVTI--------RWAMQCLKAGDAI---LVMDPRLRRT 289
           +++T          WA    KA D +   LV+DP+ R T
Sbjct: 355 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 393

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++VE+   G L  +L  +                + L L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 141 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 210 ISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 198 -----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 41/263 (15%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKH--------DKCLLLEFKNEILTWSKIEHL 106
           +G G  G V    + K    VA+K   K K         D  L +E + EIL   K+ H 
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL--KKLNHP 81
Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            ++K+  F +  ++  IV+E +  G L + +   G   L+ A        +  A+ YLH 
Sbjct: 82  CIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHE 138
Query: 167 YSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
                IIHRD+K  N+L++   E    K+TDFG +++  E S +  +     GT  YL P
Sbjct: 139 NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----GTPTYLAP 191
Query: 224 DYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIKERVTI--------RWA 269
           + L    T       D +S GV+L   ++G  P     ++  +K+++T          WA
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 270 MQCLKAGDAI---LVMDPRLRRT 289
               KA D +   LV+DP+ R T
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFT 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 91  LEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
           L  + EI    K+ H  ++K+  F +  ++  IV+E +  G L + +   G   L+ A  
Sbjct: 199 LNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKV--VGNKRLKEATC 255
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAV 207
                 +  A+ YLH   +  IIHRD+K  N+L++   E    K+TDFG +++  E S +
Sbjct: 256 KLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 312
Query: 208 SHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIE---SKKPIK 261
             +     GT  YL P+ L    T       D +S GV+L   ++G  P     ++  +K
Sbjct: 313 RTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 368
Query: 262 ERVTI--------RWAMQCLKAGDAI---LVMDPRLRRT 289
           +++T          WA    KA D +   LV+DP+ R T
Sbjct: 369 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 407

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 43/270 (15%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKR-ARKNKHDKCLLLEFKNEILTW 100
           I   ++ +     IG G  G     + K  + +VAVK   R  K D+      K EI+  
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE----NVKREIINH 69
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA----ERLDIAID 156
             + H N+V+    +       IV+EY   G L E +   G    + A    ++L   + 
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSHISTQ- 213
             HA+          + HRD+K  N L+  +   R K+  FG+++     S+V H   + 
Sbjct: 130 YCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKS 175
Query: 214 VKGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIES-------KKPIKERVT 265
             GT  Y+ P+ L   +   K +DV+S GV L  M+ G YP E        +K I   + 
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 266 IRWAM--------QCLKAGDAILVMDPRLR 287
           +++A+        +C      I V DP  R
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKR 265

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 43/270 (15%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKR-ARKNKHDKCLLLEFKNEILTW 100
           I   ++ +     IG G  G     + K  + +VAVK   R  K D+      K EI+  
Sbjct: 14  IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDE----NVKREIINH 69
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA----ERLDIAID 156
             + H N+V+    +       IV+EY   G L E +   G    + A    ++L   + 
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSHISTQ- 213
             HA+          + HRD+K  N L+  +   R K+  FG+++     S+V H   + 
Sbjct: 130 YCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKD 175
Query: 214 VKGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIES-------KKPIKERVT 265
             GT  Y+ P+ L   +   K +DV+S GV L  M+ G YP E        +K I   + 
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILN 235
Query: 266 IRWAM--------QCLKAGDAILVMDPRLR 287
           +++A+        +C      I V DP  R
Sbjct: 236 VQYAIPDYVHISPECRHLISRIFVADPAKR 265

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNL 108
           A   G+    T Y     D ++ VAVK  + + H    + L+ E K  +L++    H+N+
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK--VLSYLG-NHMNI 112
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL----------------ELAERLD 152
           V L G    G   +++ EY   G L   L  +  + +                +L + L 
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            +  VA  + +L + +    IHRD+ A NIL+T     K+ DFG AR  + DS     + 
Sbjct: 173 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDS-----NY 224
Query: 213 QVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT------GRYPIESK--KPI 260
            VKG A     ++ P+ +     T +SDV+S+G+ L E+ +         P++SK  K I
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284
Query: 261 KE 262
           KE
Sbjct: 285 KE 286

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG----------NGLELAERLDI 153
           HLN+V L G   + G   +++VE+   G L  +L  +            + L L   +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D         
Sbjct: 150 SFQVAKGMEFLASRK---XIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR-KGD 205
Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 206 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 48/245 (19%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTW 100
           E ++A     P   +G+GG GTV+ G +L D   VA+K   +N+            +L W
Sbjct: 27  EAFEAEYRLGPL--LGKGGFGTVFAGHRLTDRLQVAIKVIPRNR------------VLGW 72
Query: 101 SKIE--------------------HLNLVKLFGFLEHGDERIIVVEY-VGNGTLREHLDG 139
           S +                     H  +++L  + E  +  ++V+E  +    L +++  
Sbjct: 73  SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 140 RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFA 198
           +G  G E   R      VA A+ + H+     ++HRD+K  NILI   +  AK+ DFG  
Sbjct: 133 KGPLG-EGPSRCFFGQVVA-AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187
Query: 199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESK 257
            +  ++       T   GT  Y  P+++  +Q     + V+S G+LL +M+ G  P E  
Sbjct: 188 ALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242
Query: 258 KPIKE 262
           + I E
Sbjct: 243 QEILE 247

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ DF  AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 24/224 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLL-LEFKNEILTW 100
           +Y  + +F   + +GEG  G V     K  G IVA+K+      DK L  L    EI   
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKIL 63
Query: 101 SKIEHLNLVKLFGF-----LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
              +H N++ +F        E+ +E  I+ E +         D       ++     I  
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-------DLHRVISTQMLSDDHIQY 116
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA-VSHISTQV 214
            +   L  +       +IHRD+K SN+LI      KV DFG AR+ +E +A  S  + Q 
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 215 KGTAGYLDPDYLRTYQLTEKS-------DVYSFGVLLVEMMTGR 251
            G   ++   + R  ++   S       DV+S G +L E+   R
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNL 108
           A   G+    T Y     D ++ VAVK  + + H    + L+ E K  +L++    H+N+
Sbjct: 49  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK--VLSYLG-NHMNI 105
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL----------------ELAERLD 152
           V L G    G   +++ EY   G L   L  +  + +                +L + L 
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            +  VA  + +L + +    IHRD+ A NIL+T     K+ DFG AR  + DS     + 
Sbjct: 166 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 217
Query: 213 QVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT------GRYPIESK--KPI 260
            VKG A     ++ P+ +     T +SDV+S+G+ L E+ +         P++SK  K I
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 277
Query: 261 KE 262
           KE
Sbjct: 278 KE 279

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNL 108
           A   G+    T Y     D ++ VAVK  + + H    + L+ E K  +L++    H+N+
Sbjct: 51  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK--VLSYLG-NHMNI 107
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL----------------ELAERLD 152
           V L G    G   +++ EY   G L   L  +  + +                +L + L 
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            +  VA  + +L + +    IHRD+ A NIL+T     K+ DFG AR  + DS     + 
Sbjct: 168 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 219
Query: 213 QVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT------GRYPIESK--KPI 260
            VKG A     ++ P+ +     T +SDV+S+G+ L E+ +         P++SK  K I
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 279
Query: 261 KE 262
           KE
Sbjct: 280 KE 281

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNL 108
           A   G+    T Y     D ++ VAVK  + + H    + L+ E K  +L++    H+N+
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK--VLSYLG-NHMNI 89
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL----------------ELAERLD 152
           V L G    G   +++ EY   G L   L  +  + +                +L + L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            +  VA  + +L + +    IHRD+ A NIL+T     K+ DFG AR  + DS     + 
Sbjct: 150 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 201
Query: 213 QVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT------GRYPIESK--KPI 260
            VKG A     ++ P+ +     T +SDV+S+G+ L E+ +         P++SK  K I
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 261 KE 262
           KE
Sbjct: 262 KE 263

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++VE+   G L  +L  +                + L L  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 150 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+  FG AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 56  IGEGGSGTVYKGKLK--DGSI--VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           +GEG  G+V +G LK  DG+   VAVK  + +   +  + EF +E        H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 112 FGF-LEHGDERI----IVVEYVGNGTLREHLD----GRGGNGLELAERLDIAIDVAHALT 162
            G  +E   + I    +++ ++  G L  +L       G   + L   L   +D+A  + 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YL   S+   +HRD+ A N ++ + +   V DFG ++               K    ++ 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ-GRIAKMPVKWIA 217
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT 249
            + L     T KSDV++FGV + E+ T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 24/224 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLL-LEFKNEILTW 100
           +Y  + +F   + +GEG  G V     K  G IVA+K+      DK L  L    EI   
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFALRTLREIKIL 63
Query: 101 SKIEHLNLVKLFGF-----LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
              +H N++ +F        E+ +E  I+ E +         D       ++     I  
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-------DLHRVISTQMLSDDHIQY 116
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS---- 211
            +   L  +       +IHRD+K SN+LI      KV DFG AR+ +E +A +       
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 212 ---TQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGR 251
              T+   T  Y  P+ + T  + +   DV+S G +L E+   R
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++VE+   G L  +L  +                + L L  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 150 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 207 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 19/160 (11%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++VE+   G L  +L  +                + L L  
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 152 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 209 -KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 43/242 (17%)
Query: 53  ANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNL 108
           A   G+    T Y     D ++ VAVK  + + H    + L+ E K  +L++    H+N+
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK--VLSYLG-NHMNI 112
Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL----------------ELAERLD 152
           V L G    G   +++ EY   G L   L  +  + +                +L + L 
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
            +  VA  + +L + +    IHRD+ A NIL+T     K+ DFG AR  + DS     + 
Sbjct: 173 FSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----NY 224
Query: 213 QVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT------GRYPIESK--KPI 260
            VKG A     ++ P+ +     T +SDV+S+G+ L E+ +         P++SK  K I
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284
Query: 261 KE 262
           KE
Sbjct: 285 KE 286

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++VE+   G L  +L  +                + L L  
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 187 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 210 ISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 244 -----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G+G  G V++G  + G  VAVK    ++ +K    E   E+     + H N++   GF+
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRE--TELYNTVMLRHENIL---GFI 68
Query: 116 ------EHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
                  H   ++ ++  Y   G+L ++L       L+    L I + +A  L +LH   
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-GTAGYLD 222
             T   P I HRD+K+ NIL+ +  +  + D G A M  + +    +    + GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 223 PDYL-RTYQLT-----EKSDVYSFGVLLVEM---MTGRYPIESKKP 259
           P+ L  T Q+      ++ D+++FG++L E+   M     +E  KP
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ D G AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G+G  G V++G  + G  VAVK    ++ +K    E   E+     + H N++   GF+
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRE--TELYNTVMLRHENIL---GFI 68
Query: 116 ------EHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
                  H   ++ ++  Y   G+L ++L       L+    L I + +A  L +LH   
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-GTAGYLD 222
             T   P I HRD+K+ NIL+ +  +  + D G A M  + +    +    + GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 223 PDYL-RTYQLT-----EKSDVYSFGVLLVEM---MTGRYPIESKKP 259
           P+ L  T Q+      ++ D+++FG++L E+   M     +E  KP
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFK-NEIL 98
           EE++  T       ++G G  G V++ K K  G   AVK+ R        L  F+  E++
Sbjct: 55  EEVHWMTHQ----PRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELV 102
Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
             + +    +V L+G +  G    I +E +  G+L + +   G   L     L       
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQAL 160
Query: 159 HALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQ--VK 215
             L YLHT     I+H DVKA N+L+ ++  RA + DFG A   + D     + T   + 
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           GT  ++ P+ +       K D++S   +++ M+ G +P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFK-NEIL 98
           EE++  T       ++G G  G V++ K K  G   AVK+ R        L  F+  E++
Sbjct: 71  EEVHWMTHQ----PRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELV 118
Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
             + +    +V L+G +  G    I +E +  G+L + +   G   L     L       
Sbjct: 119 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQAL 176
Query: 159 HALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHIST--QVK 215
             L YLHT     I+H DVKA N+L+ ++  RA + DFG A   + D     + T   + 
Sbjct: 177 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           GT  ++ P+ +       K D++S   +++ M+ G +P
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ D G AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           +G+G  G V++G  + G  VAVK    ++ +K    E   E+     + H N++   GF+
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK-IFSSRDEKSWFRE--TELYNTVMLRHENIL---GFI 97
Query: 116 ------EHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
                  H   ++ ++  Y   G+L ++L       L+    L I + +A  L +LH   
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-GTAGYLD 222
             T   P I HRD+K+ NIL+ +  +  + D G A M  + +    +    + GT  Y+ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 223 PDYL-RTYQLT-----EKSDVYSFGVLLVEM---MTGRYPIESKKP 259
           P+ L  T Q+      ++ D+++FG++L E+   M     +E  KP
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 260

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 24/224 (10%)
Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFK 94
           +N +  E+ +  +N SP   +G G  G+V      K G  VAVK+  +            
Sbjct: 13  LNKTIWEVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 69
Query: 95  NEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD-- 152
            E+     ++H N++ L             +E   +  L  HL G   N +   ++L   
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 153 ----IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +   L Y+H+     IIHRD+K SN+ + E    K+ D G AR ++++    
Sbjct: 126 HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE---- 178
Query: 209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T    T  Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 179 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++ +K  +K K           EI     +++ ++V
Sbjct: 55  FAKCYEITDMDTKEVFAGKVVPKSML-LKPHQKEK--------MSTEIAIHKSLDNPHVV 105
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +   + YLH    
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLHNNR- 162
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + + +  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCKK 217
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + D++S G +L  ++ G+ P E+
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++ +K  +K K           EI     +++ ++V
Sbjct: 55  FAKCYEITDMDTKEVFAGKVVPKSML-LKPHQKEK--------MSTEIAIHKSLDNPHVV 105
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +   + YLH    
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLHNNR- 162
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + + +  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVLCKK 217
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + D++S G +L  ++ G+ P E+
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++ +K  +K K           EI     +++ ++V
Sbjct: 55  FAKCYEITDMDTKEVFAGKVVPKSML-LKPHQKEK--------MSTEIAIHKSLDNPHVV 105
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +   + YLH    
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLHNNR- 162
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + + +  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPNYIAPEVLCKK 217
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + D++S G +L  ++ G+ P E+
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 22/218 (10%)
Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFK-NEIL 98
           EE++  T       ++G G  G V++ K K  G   AVK+ R        L  F+  E++
Sbjct: 69  EEVHWMTHQ----PRLGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELV 116
Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
             + +    +V L+G +  G    I +E +  G+L + +   G   L     L       
Sbjct: 117 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQAL 174
Query: 159 HALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQ--VK 215
             L YLHT     I+H DVKA N+L+ ++  RA + DFG A   + D     + T   + 
Sbjct: 175 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           GT  ++ P+ +       K D++S   +++ M+ G +P
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 27/164 (16%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++ E+   G L  +L  +                + L L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 141 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 210 ISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 198 -----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILT 99
           EE++ AT       ++G G  G V++ + K  G   AVK+ R       L +    E++ 
Sbjct: 90  EEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMA 138
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            + +    +V L+G +  G    I +E +  G+L + +  +G   L     L        
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALE 196
Query: 160 ALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKG 216
            L YLH+     I+H DVKA N+L+ ++   A + DFG A   + D     + T   + G
Sbjct: 197 GLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG 253
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           T  ++ P+ +       K DV+S   +++ M+ G +P
Sbjct: 254 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           F+   +I +  +  V+ GK+   S++ +K  +K K           EI     +++ ++V
Sbjct: 39  FAKCYEITDMDTKEVFAGKVVPKSML-LKPHQKEK--------MSTEIAIHKSLDNPHVV 89
Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
              GF E  D   +V+E     +L E L  R     E   R  +   +   + YLH    
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI-QGVQYLHNNR- 146
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +IHRD+K  N+ + + +  K+ DFG A   E D         + GT  Y+ P+ L   
Sbjct: 147 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCKK 201
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIES 256
             + + D++S G +L  ++ G+ P E+
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDK-C--------LLL 91
           +++     ++  + IGEG  G V         + VA+K+    +H   C        +LL
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 92  EFK-------NEILTWSKIEHLNLVKLFGFLEHGD-ERIIVVEYVGNGTLREHLDGRGGN 143
            F+       N+I+    IE +  V +   L   D  +++  +++ N  +   L      
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFL------ 134
Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
                        +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ 
Sbjct: 135 -----------YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 204 DSAVSHISTQVKGTAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           D   +   T+   T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 81/152 (53%), Gaps = 6/152 (3%)
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
           SK+ H +LV  +G    GDE I+V E+V  G+L  +L  +  N + +  +L++A  +A A
Sbjct: 67  SKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAWA 125
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV-KGTAG 219
           + +L   +   +IH +V A NIL+  +   K  +  F ++S+   +++ +   + +    
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 220 YLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTG 250
           ++ P+ +   + L   +D +SFG  L E+ +G
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILT 99
           EE++ AT       ++G G  G V++ + K  G   AVK+ R       L +    E++ 
Sbjct: 71  EEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMA 119
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            + +    +V L+G +  G    I +E +  G+L + +  +G   L     L        
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGC--LPEDRALYYLGQALE 177
Query: 160 ALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKG 216
            L YLH+     I+H DVKA N+L+ ++   A + DFG A   + D     + T   + G
Sbjct: 178 GLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPG 234
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           T  ++ P+ +       K DV+S   +++ M+ G +P
Sbjct: 235 TETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 26/228 (11%)
Query: 35  TINFSFEEIYKATEN-----FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCL 89
           T N  F+ +Y+  E      FS   +  +  +G  Y  K     I+  K+     H K  
Sbjct: 15  TENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAK-----IINTKKLSARDHQK-- 67
Query: 90  LLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAE 149
               + E      ++H N+V+L   +       ++ + V  G L E +  R     E   
Sbjct: 68  ---LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYS 119
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSA 206
             D +  +   L  +       ++HRD+K  N+L+  KL+    K+ DFG A   E +  
Sbjct: 120 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 179
Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
                    GT GYL P+ LR     +  D+++ GV+L  ++ G  P 
Sbjct: 180 AWF---GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 27/164 (16%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++ E+   G L  +L  +                + L L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 141 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 210 ISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 198 -----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 56  IGEGGSGTV-----YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +GEG  G V     YK + K  ++  + R    K D  + +E   EI     + H +++K
Sbjct: 17  LGEGSFGKVKLATHYKTQQK-VALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIK 73
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+  +    + ++V+EY G G L +++  +     +   R      +  A+ Y H +   
Sbjct: 74  LYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCHRHK-- 128
Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RT 228
            I+HRD+K  N+L+ + L  K+ DFG + +  + + +        G+  Y  P+ +  + 
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKL 183
Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           Y   E  DV+S G++L  M+ GR P + +
Sbjct: 184 YAGPE-VDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 20/184 (10%)
Query: 82  KNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREH----- 136
           K+K+D     +FKNE+   + I++   +   G + + DE  I+ EY+ N ++ +      
Sbjct: 84  KSKYD-----DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 137 -LDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF 195
            LD      + +     I   V ++ +Y+H  ++  I HRDVK SNIL+ +  R K++DF
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE--KSDVYSFGVLLVEMMTGRYP 253
           G     E +  V       +GT  ++ P++          K D++S G+ L  M     P
Sbjct: 197 G-----ESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
Query: 254 IESK 257
              K
Sbjct: 252 FSLK 255

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 141 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 139 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 130 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 131 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 81/152 (53%), Gaps = 6/152 (3%)
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
           SK+ H +LV  +G    GDE I+V E+V  G+L  +L  +  N + +  +L++A  +A A
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAA 125
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV-KGTAG 219
           + +L   +   +IH +V A NIL+  +   K  +  F ++S+   +++ +   + +    
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 220 YLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTG 250
           ++ P+ +   + L   +D +SFG  L E+ +G
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDK-C--------LLL 91
           +++     ++  + IGEG  G V         + VA+K+    +H   C        +LL
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 92  EFK-------NEILTWSKIEHLNLVKLFGFLEHGD-ERIIVVEYVGNGTLREHLDGRGGN 143
            F+       N+I+    IE +  V +   L   D  +++  +++ N  +   L      
Sbjct: 79  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL------ 132
Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE 203
                        +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ 
Sbjct: 133 -----------YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 178
Query: 204 DSAVSHISTQVKGTAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           D   +   T+   T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 179 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTW---SKIEHLNLVK- 110
           +IG+G  G V+ GK + G  VAVK            + F  E  +W   ++I    L++ 
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVK------------VFFTTEEASWFRETEIYQTVLMRH 90
Query: 111 --LFGFLE-------HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
             + GF+           +  ++ +Y  NG+L ++L       L+    L +A      L
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGL 147
Query: 162 TYLHT-----YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK- 215
            +LHT        P I HRD+K+ NIL+ +     + D G A     D+    I    + 
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 216 GTAGYLDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           GT  Y+ P+ L        +Q    +D+YSFG++L E+
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 27/164 (16%)
Query: 105 HLNLVKLFGFL-EHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAE 149
           HLN+V L G   + G   +++ E+   G L  +L  +                + L L  
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D     
Sbjct: 141 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 210 ISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 198 -----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H +++ L    E      +V + +  G L ++L  +    L   E   I   +  A+++L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H  +   I+HRD+K  NIL+ + ++ +++DFGF+   E    +  +     GT GYL P+
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----GTPGYLAPE 269
Query: 225 YLRTYQ------LTEKSDVYSFGVLLVEMMTGRYPIESKKPI 260
            L+           ++ D+++ GV+L  ++ G  P   ++ I
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 45  KATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           + T  F    KIG G  G+V+K  K  DG I A+KR++K             E+   + +
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 104 -EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHA 160
            +H ++V+ F      D  +I  EY   G+L + +  + R  +  + AE  D+ + V   
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA-------------V 207
           L Y+H+ S   ++H D+K SNI I+   R  + +       E+D A             V
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 179
Query: 208 SHIST-QV-KGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLV 245
           + IS+ QV +G + +L  + L+  Y    K+D+++  + +V
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 220

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 45  KATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           + T  F    KIG G  G+V+K  K  DG I A+KR++K             E+   + +
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 65
Query: 104 -EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHA 160
            +H ++V+ F      D  +I  EY   G+L + +  + R  +  + AE  D+ + V   
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI---------- 210
           L Y+H+ S   ++H D+K SNI I+   R  + +       E+D A + +          
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 179
Query: 211 ----STQV-KGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLV 245
               S QV +G + +L  + L+  Y    K+D+++  + +V
Sbjct: 180 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 220

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+LI      K+ DFG AR+++ +   +   T+   
Sbjct: 153 ILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 133 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 45  KATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           + T  F    KIG G  G+V+K  K  DG I A+KR++K             E+   + +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 104 -EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHA 160
            +H ++V+ F      D  +I  EY   G+L + +  + R  +  + AE  D+ + V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI---------- 210
           L Y+H+ S   ++H D+K SNI I+   R  + +       E+D A + +          
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 211 ----STQV-KGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLV 245
               S QV +G + +L  + L+  Y    K+D+++  + +V
Sbjct: 182 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 135 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRAR---KNKHDKCLLLEFKNEILTWSKI 103
           ++F   +++G G  G V+K + K DG + AVKR+    +   D+   L    E+ +  K+
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL---AEVGSHEKV 113
Query: 104 -EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
            +H   V+L    E G    +  E  G  +L++H +  G + L  A+      D   AL 
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGAS-LPEAQVWGYLRDTLLALA 171
Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           +LH+     ++H DVK +NI +  + R K+ DFG   + E  +A +      +G   Y+ 
Sbjct: 172 HLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGA--GEVQEGDPRYMA 224
Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEM 247
           P+ L+    T  +DV+S G+ ++E+
Sbjct: 225 PELLQGSYGT-AADVFSLGLTILEV 248

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 59  GGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG 118
           G  G V+K +L +  +       ++K       + + EI +   ++H NL++     + G
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQS----WQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 119 D----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-------- 166
                E  ++  +   G+L ++L G   N +   E   +A  ++  L+YLH         
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
              P I HRD K+ N+L+   L A + DFG A   E          QV GT  Y+ P+ L
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-GTRRYMAPEVL 197
Query: 227 R---TYQLTE--KSDVYSFGVLLVEMMT 249
                +Q     + D+Y+ G++L E+++
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 45  KATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           + T  F    KIG G  G+V+K  K  DG I A+KR++K             E+   + +
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 63
Query: 104 -EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--DGRGGNGLELAERLDIAIDVAHA 160
            +H ++V+ F      D  +I  EY   G+L + +  + R  +  + AE  D+ + V   
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA-------------V 207
           L Y+H+ S   ++H D+K SNI I+   R  + +       E+D A             V
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFIS---RTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 177
Query: 208 SHIST-QV-KGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLV 245
           + IS+ QV +G + +L  + L+  Y    K+D+++  + +V
Sbjct: 178 TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 12/107 (11%)
Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           L I I +A A+ +LH+     ++HRD+K SNI  T     KV DFG     ++D     +
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 211 STQVK---------GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T +          GT  Y+ P+ +     + K D++S G++L E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 93/233 (39%), Gaps = 39/233 (16%)
Query: 48  ENFSPANKIGEGGSGTVYK----GKLKDG-SIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           EN      +G G  G V      G  K G SI    +  K K D        +E+   ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 103 I-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG------------------- 142
           +  H N+V L G         ++ EY   G L  +L  +                     
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 143 --NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM 200
             N L   + L  A  VA  + +L   S    +HRD+ A N+L+T     K+ DFG AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 201 SEEDSAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
              DS     +  V+G A     ++ P+ L     T KSDV+S+G+LL E+ +
Sbjct: 222 IMSDS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +    +   
Sbjct: 137 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 25/222 (11%)
Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFG 113
           + EGG   VY+ + +  G   A+KR   N+ +K   +    E+    K+  H N+V+   
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI--IQEVCFMKKLSGHPNIVQFCS 93
Query: 114 FLEHGDER-------IIVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDVAHALTYLH 165
               G E         +++  +  G L E L      G L     L I      A+ ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM---------SEEDSAVSHISTQVKG 216
               PPIIHRD+K  N+L++ +   K+ DFG A           S +  A+         
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 217 TAGYLDPDYLRTYQ---LTEKSDVYSFGVLLVEMMTGRYPIE 255
           T  Y  P+ +  Y    + EK D+++ G +L  +   ++P E
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +    +   
Sbjct: 138 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 217 TAGYLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+  L +   T+  D++S G +L EM++ R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 38/238 (15%)
Query: 55  KIGEGGSGTVYKG-KLKDGSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKIE-HLNLV 109
           K+G+G  G V+K    + G +VAVK+   A +N  D         EI+  +++  H N+V
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR---EIMILTELSGHENIV 72
Query: 110 KLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
            L   L   ++R   +V +Y+       H   R  N LE   +  +   +   + YLH+ 
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMETDL---HAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH------------------ 209
               ++HRD+K SNIL+  +   KV DFG +R       V++                  
Sbjct: 129 G---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 210 ISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGR--YPIESKKPIKERV 264
           I T    T  Y  P+ L  + + T+  D++S G +L E++ G+  +P  S     ER+
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 42/244 (17%)
Query: 45  KATENFSPANKI-GEGGSGTV-YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           ++ +N   + KI G G SGTV ++G  + G  VAVKR   +  D   L+E K  +LT S 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD-IALMEIK--LLTESD 66
Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG--GNGLELAER---LDIAIDV 157
            +H N+++ +   E  D  + +   + N  L++ ++ +      L+L +    + +   +
Sbjct: 67  -DHPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILIT-------------EKLRAKVTDFGFARMSEED 204
           A  + +LH+     IIHRD+K  NIL++             E LR  ++DFG  +  + D
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLD 179
Query: 205 SAVSHISTQVK---GTAGYLDPDYLRTY-------QLTEKSDVYSFGVLLVEMMT-GRYP 253
           S  S   T +    GT+G+  P+ L          +LT   D++S G +   +++ G++P
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 254 IESK 257
              K
Sbjct: 240 FGDK 243

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 11/167 (6%)
Query: 94  KNEILTWSKIEHLNLVKLFGFL--EHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL 151
           K EI    ++ H N+++L   L  E   +  +V+EY   G ++E LD        + +  
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAH 112
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS 211
                +   L YLH+     I+H+D+K  N+L+T     K++  G A      +A     
Sbjct: 113 GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 212 TQVKGTAGYLDPDY---LRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           T  +G+  +  P+    L T+    K D++S GV L  + TG YP E
Sbjct: 170 TS-QGSPAFQPPEIANGLDTFS-GFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/304 (23%), Positives = 131/304 (43%), Gaps = 56/304 (18%)
Query: 40  FEEIYKATENFSPANKIGEGGSGTVY--KGKLKDG--SIVAVKRARKNKHDKCLLLEFKN 95
           +E + + +  F   +KIGEG   +VY    +L+ G    +A+K      H   +  E   
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAEL-- 70
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           + LT +  +  N++ +       D  +I + Y+ + +  + L     N L   E  +  +
Sbjct: 71  QCLTVAGGQD-NVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-----NSLSFQEVREYML 124
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA-KVTDFGFA---------------- 198
           ++  AL  +H +    I+HRDVK SN L   +L+   + DFG A                
Sbjct: 125 NLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 199 -----RMSEEDSAVSHISTQV----KGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMM 248
                R S+   ++     Q      GT G+  P+ L +    T   D++S GV+ + ++
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 249 TGRYPI----ESKKPIKERVTIRWAMQCLKA----GDAILVMDPRLRRTPASNM--AVEK 298
           +GRYP     +    + + +TIR + + ++A    G +IL      +  PA ++    E+
Sbjct: 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCS----KEVPAQDLRKLCER 297
Query: 299 ILGL 302
           + G+
Sbjct: 298 LRGM 301

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 100/244 (40%), Gaps = 39/244 (15%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +F     +G+G  G V K +   D    A+K+ R  +     +L   +E+   + + H  
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVXLLASLNHQY 63
Query: 108 LVKLFG-FLEHGD------------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           +V+ +  +LE  +               I  EY  N TL + +     N  +  E   + 
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ-QRDEYWRLF 122
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ- 213
             +  AL+Y+H+     IIHR++K  NI I E    K+ DFG A+       +  + +Q 
Sbjct: 123 RQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 214 ----------VKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE 262
                       GTA Y+  + L  T    EK D YS G++  E +   YP  +     E
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTG---XE 233
Query: 263 RVTI 266
           RV I
Sbjct: 234 RVNI 237

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           FEE+ K    FS   +  +  +G  Y  K     I+  K+     H K      + E   
Sbjct: 9   FEELGKGA--FSVVRRCMKIPTGQEYAAK-----IINTKKLSARDHQK-----LEREARI 56
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
              ++H N+V+L   +       +V + V  G L E +  R     E     D +  +  
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQ 111
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHISTQVKG 216
            L  ++      I+HRD+K  N+L+  K +    K+ DFG A   + D           G
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF---GFAG 168
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           T GYL P+ LR     +  D+++ GV+L  ++ G  P 
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKH--DKCLLLEFKNEILTWSKIEHLNLVKLF 112
           ++G G  G V++   K    V V +     +  DK  +   KNEI   +++ H  L+ L 
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHPKLINLH 114
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
              E   E ++++E++  G L + +        E AE ++        L ++H +S   I
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE-AEVINYMRQACEGLKHMHEHS---I 170
Query: 173 IHRDVKASNILITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
           +H D+K  NI+   K  +  K+ DFG A     D  V  ++T    TA +  P+ +    
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-VTT---ATAEFAAPEIVDREP 226
Query: 231 LTEKSDVYSFGVLLVEMMTGRYPI 254
           +   +D+++ GVL   +++G  P 
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSPF 250

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD--IAIDVAHALTYLH 165
           +V+LF   +      +V+EY+  G L   +     +  ++ E+       +V  AL  +H
Sbjct: 137 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +     +IHRDVK  N+L+ +    K+ DFG   M  +++ + H  T V GT  Y+ P+ 
Sbjct: 192 SMG---LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCDTAV-GTPDYISPEV 246
Query: 226 LRTY----QLTEKSDVYSFGVLLVEMMTGRYPI 254
           L++         + D +S GV L EM+ G  P 
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/219 (22%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 45  KATENFSPANKIGEGGSGTVYK------GKLKDGSIVAVKRARKNKHDKCLLLEFKNEIL 98
           + TE +    ++G+G    V +      G+     I+  K+     H K      + E  
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-----LEREAR 62
Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
               ++H N+V+L   +       ++ + V  G L E +  R     E     D +  + 
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQ 117
Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHISTQVK 215
             L  +       ++HR++K  N+L+  KL+    K+ DFG A   E +           
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFA 174
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           GT GYL P+ LR     +  D+++ GV+L  ++ G  P 
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 47  TENFSPANKIGEGGSGTVYKG-KLKDG-----SIVAVKRARKNKHDKCLLLEFKNEILTW 100
           T+ +     IG+G    V +  KL  G      I+  K+     H K      + E    
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-----LEREARIC 57
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
             ++H N+V+L   +       +V + V  G L E +  R     E     D +  +   
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQI 112
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHISTQVKGT 217
           L  +       ++HRD+K  N+L+  K +    K+ DFG A   + D           GT
Sbjct: 113 LEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF---GFAGT 169
Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            GYL P+ LR     +  D+++ GV+L  ++ G  P 
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPF 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEI 97
           I+    +FS    IG GG G VY  +  D G + A+K    +  K K  + L L   NE 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NER 240
Query: 98  LTWSKIE--HLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           +  S +       +    +  H  +++  +++ +  G L  HL   G      A+    A
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYA 298
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L ++H      +++RD+K +NIL+ E    +++D G A   +      H S   
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-- 351
Query: 215 KGTAGYLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPIESKK 258
            GT GY+ P+ L+     + S D +S G +L +++ G  P    K
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEI 97
           I+    +FS    IG GG G VY  +  D G + A+K    +  K K  + L L   NE 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NER 240
Query: 98  LTWSKIE--HLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           +  S +       +    +  H  +++  +++ +  G L  HL   G      A+    A
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYA 298
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L ++H      +++RD+K +NIL+ E    +++D G A   +      H S   
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-- 351
Query: 215 KGTAGYLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPIESKK 258
            GT GY+ P+ L+     + S D +S G +L +++ G  P    K
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 24/233 (10%)
Query: 33  ATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE 92
           ++ ++   E +Y  +           G  G V+K +L +  +       ++K       +
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS----WQ 64
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGD----ERIIVVEYVGNGTLREHLDGRGGNGLELA 148
            + E+ +   ++H N+++  G  + G     +  ++  +   G+L + L     N +   
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 149 ERLDIAIDVAHALTYLHT-------YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
           E   IA  +A  L YLH           P I HRD+K+ N+L+   L A + DFG A   
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 202 EEDSAVSHISTQVKGTAGYLDPDYLR---TYQLTE--KSDVYSFGVLLVEMMT 249
           E   +      QV GT  Y+ P+ L     +Q     + D+Y+ G++L E+ +
Sbjct: 182 EAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEI 97
           I+    +FS    IG GG G VY  +  D G + A+K    +  K K  + L L   NE 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NER 240
Query: 98  LTWSKIE--HLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           +  S +       +    +  H  +++  +++ +  G L  HL   G      A+    A
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYA 298
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L ++H      +++RD+K +NIL+ E    +++D G A   +      H S   
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-- 351
Query: 215 KGTAGYLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPIESKK 258
            GT GY+ P+ L+     + S D +S G +L +++ G  P    K
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 43  IYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEI 97
           I+    +FS    IG GG G VY  +  D G + A+K    +  K K  + L L   NE 
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL---NER 239
Query: 98  LTWSKIE--HLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
           +  S +       +    +  H  +++  +++ +  G L  HL   G      A+    A
Sbjct: 240 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYA 297
Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
            ++   L ++H      +++RD+K +NIL+ E    +++D G A   +      H S   
Sbjct: 298 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-- 350
Query: 215 KGTAGYLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPIESKK 258
            GT GY+ P+ L+     + S D +S G +L +++ G  P    K
Sbjct: 351 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 394

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 23/218 (10%)
Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           FEE+ K    FS   +  +  +G  Y  K     I+  K+     H K      + E   
Sbjct: 9   FEELGKGA--FSVVRRCMKIPTGQEYAAK-----IINTKKLSARDHQK-----LEREARI 56
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
              ++H N+V+L   +       +V + V  G L E +  R     E     D +  +  
Sbjct: 57  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQ 111
Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHISTQVKG 216
            L  ++      I+HRD+K  N+L+  K +    K+ DFG A   + D           G
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF---GFAG 168
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           T GYL P+ LR     +  D+++ GV+L  ++ G  P 
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGF 114
           IG G  G V++ KL +   VA+K+  ++K        FKN  L   +I +H N+V L  F
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAF 100
Query: 115 L-EHGDER-----IIVVEYVGNGTLR--EHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
              +GD++      +V+EYV     R   H          L  +L +   +  +L Y+H+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM-YQLLRSLAYIHS 159
Query: 167 YSDPPIIHRDVKASNILITEKLRA-KVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPD 224
                I HRD+K  N+L+       K+ DFG A+ +   +  VS I ++      Y  P+
Sbjct: 160 IG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPE 211
Query: 225 YLR-TYQLTEKSDVYSFGVLLVEMMTGR--YPIES 256
            +      T   D++S G ++ E+M G+  +P ES
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTW 100
           T+++    ++G+G    V +   K         I+  K+     H K      + E    
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK-----LEREARIC 84
Query: 101 SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
             ++H N+V+L   +       +V + V  G L E +  R     E     D +  +   
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIHQI 139
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFA-RMSEEDSAVSHISTQVKG 216
           L  ++      I+HRD+K  N+L+  K +    K+ DFG A  +  E  A    +    G
Sbjct: 140 LESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA----G 195
Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           T GYL P+ LR     +  D+++ GV+L  ++ G  P 
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 37/233 (15%)
Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-IVAVKRARK----NKHDKCLLLEFKNEILT--- 99
           E+F     IG G  G V   KLK+   + A+K   K     + +     E ++ ++    
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 100 -WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG--TLREHLDGRGGNGLE---LAERLDI 153
            W    H      + F +  +  +++  YVG    TL    + R    +    LAE + I
Sbjct: 134 KWITTLH------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMV-I 186
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
           AID  H L Y         +HRD+K  NIL+      ++ DFG      ED  V   S+ 
Sbjct: 187 AIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSV 235
Query: 214 VKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
             GT  Y+ P+ L+  +        + D +S GV + EM+ G  P  ++  ++
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 95  NEILTWSKIEHLNLVKLFGFLE--HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
            EI    K++H N+VKL   L+  + D   +V E V  G + E    +  +  E   R  
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS--EDQARFY 142
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
              D+   + YLH      IIHRD+K SN+L+ E    K+ DFG   +S E      + +
Sbjct: 143 FQ-DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG---VSNEFKGSDALLS 195
Query: 213 QVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
              GT  ++ P+ L   R     +  DV++ GV L   + G+ P 
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/313 (21%), Positives = 125/313 (39%), Gaps = 36/313 (11%)
Query: 32  QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLL 91
           +A+  +   +E     E       IG+G  G VY G+      + +    ++  D+  L 
Sbjct: 17  KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQ--LK 74
Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL 151
            FK E++ + +  H N+V   G         I+       TL   +       L++ +  
Sbjct: 75  AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTR 133
Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS---EEDSAVS 208
            IA ++   + YLH      I+H+D+K+ N+   +  +  +TDFG   +S   +      
Sbjct: 134 QIAQEIVKGMGYLHAKG---ILHKDLKSKNVF-YDNGKVVITDFGLFSISGVLQAGRRED 189
Query: 209 HISTQVKGTAGYLDPDYLRTYQ---------LTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
            +  Q  G   +L P+ +R             ++ SDV++ G +  E+    +P ++ +P
Sbjct: 190 KLRIQ-NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QP 247
Query: 260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
            +    I W M     G     M P L +        + +L     C A  ++ RPT  K
Sbjct: 248 AE---AIIWQM-----GTG---MKPNLSQIGMGKEISDILL----FCWAFEQEERPTFTK 292
Query: 320 CAEILWKIRKDFR 332
             ++L K+ K  R
Sbjct: 293 LMDMLEKLPKRNR 305

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAG 219
           L Y+H+     +IHRD+K SN+L+ E    K+ DFG AR +    +   +  T+   T  
Sbjct: 172 LKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 228
Query: 220 YLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           Y  P+  L  ++ T+  D++S G +  EM+  R
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V++GK + G  VAVK    ++ ++    E   EI     + H N++   GF+
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFRE--AEIYQTVMLRHENIL---GFI 63
Query: 116 EHGD-------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
              +       +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH   
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK---GTAGY 220
             T   P I HRD+K+ NIL+ +     + D G A     DSA   I        GT  Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 178
Query: 221 LDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           + P+ L      + ++  +++D+Y+ G++  E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V++GK + G  VAVK    ++ ++    E   EI     + H N++   GF+
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFRE--AEIYQTVMLRHENIL---GFI 66
Query: 116 EHGD-------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
              +       +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH   
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK---GTAGY 220
             T   P I HRD+K+ NIL+ +     + D G A     DSA   I        GT  Y
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 181
Query: 221 LDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           + P+ L      + ++  +++D+Y+ G++  E+
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 51  SPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           SP + +G G  G+V      + G  VA+K+  +    +        E+L    ++H N++
Sbjct: 46  SPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 104
Query: 110 KLFG-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            L   F      R     Y+    ++  L    G      +   +   +   L Y+H+  
Sbjct: 105 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG---TAGYLDPDY 225
              ++HRD+K  N+ + E    K+ DFG AR         H   ++ G   T  Y  P+ 
Sbjct: 165 ---VVHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTRWYRAPEV 212
Query: 226 LRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           + ++    +  D++S G ++ EM+TG+
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V++GK + G  VAVK    ++ ++    E   EI     + H N++   GF+
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFRE--AEIYQTVMLRHENIL---GFI 64
Query: 116 EHGD-------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
              +       +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH   
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK---GTAGY 220
             T   P I HRD+K+ NIL+ +     + D G A     DSA   I        GT  Y
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 179
Query: 221 LDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           + P+ L      + ++  +++D+Y+ G++  E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V++GK + G  VAVK    ++ ++    E   EI     + H N++   GF+
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFRE--AEIYQTVMLRHENIL---GFI 69
Query: 116 EHGD-------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
              +       +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH   
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK---GTAGY 220
             T   P I HRD+K+ NIL+ +     + D G A     DSA   I        GT  Y
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 184
Query: 221 LDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           + P+ L      + ++  +++D+Y+ G++  E+
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            F+   K  + G+G  Y  K +K   + + +R    +       E + E+    +I H N
Sbjct: 24  QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE-------EIEREVNILREIRHPN 76
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++ L    E+  + ++++E V  G L + L  +    L   E       +   + YLH+ 
Sbjct: 77  IITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK 134
Query: 168 SDPPIIHRDVKASNILITEK----LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
               I H D+K  NI++ +K     R K+ DFG A   E  +   +I     GT  ++ P
Sbjct: 135 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAP 187
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           + +    L  ++D++S GV+   +++G  P 
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            F+   K  + G+G  Y  K +K   + + +R    +       E + E+    +I H N
Sbjct: 38  QFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSRE-------EIEREVNILREIRHPN 90
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++ L    E+  + ++++E V  G L + L  +    L   E       +   + YLH+ 
Sbjct: 91  IITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK 148
Query: 168 SDPPIIHRDVKASNILITEK----LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
               I H D+K  NI++ +K     R K+ DFG A   E  +   +I     GT  ++ P
Sbjct: 149 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAP 201
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           + +    L  ++D++S GV+   +++G  P 
Sbjct: 202 EIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 49  NFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            F+   K  + G+G  Y  K +K   + + +R    +       E + E+    +I H N
Sbjct: 17  QFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE-------EIEREVNILREIRHPN 69
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++ L    E+  + ++++E V  G L + L  +    L   E       +   + YLH+ 
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK 127
Query: 168 SDPPIIHRDVKASNILITEK----LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
               I H D+K  NI++ +K     R K+ DFG A   E  +   +I     GT  ++ P
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTPEFVAP 180
Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           + +    L  ++D++S GV+   +++G  P 
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 51  SPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
           SP + +G G  G+V      + G  VA+K+  +    +        E+L    ++H N++
Sbjct: 28  SPTH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 110 KLFG-FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            L   F      R     Y+    ++  L    G      +   +   +   L Y+H+  
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG---TAGYLDPDY 225
              ++HRD+K  N+ + E    K+ DFG AR         H   ++ G   T  Y  P+ 
Sbjct: 147 ---VVHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTRWYRAPEV 194
Query: 226 LRTY-QLTEKSDVYSFGVLLVEMMTGR 251
           + ++    +  D++S G ++ EM+TG+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 45  KATENFSPANKI-GEGGSGTV-YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           ++ +N   + KI G G SGTV ++G  + G  VAVKR   +  D   L+E K  +LT S 
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD-IALMEIK--LLTESD 84
Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG--GNGLELAER---LDIAIDV 157
            +H N+++ +   E  D  + +   + N  L++ ++ +      L+L +    + +   +
Sbjct: 85  -DHPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILIT-------------EKLRAKVTDFGFARMSEED 204
           A  + +LH+     IIHRD+K  NIL++             E LR  ++DFG  +  + D
Sbjct: 143 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLD 197
Query: 205 SAVSHISTQVK---GTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMT-GRYPIESK 257
           S        +    GT+G+  P+ L      +LT   D++S G +   +++ G++P   K
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V++GK + G  VAVK    ++ ++    E   EI     + H N++   GF+
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFRE--AEIYQTVMLRHENIL---GFI 102
Query: 116 EHGD-------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
              +       +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH   
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK---GTAGY 220
             T   P I HRD+K+ NIL+ +     + D G A     DSA   I        GT  Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 217
Query: 221 LDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           + P+ L      + ++  +++D+Y+ G++  E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAG 219
           L Y+H+     +IHRD+K SN+L+ E    K+ DFG AR +    +   +  T+   T  
Sbjct: 171 LKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRW 227
Query: 220 YLDPD-YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           Y  P+  L  ++ T+  D++S G +  EM+  R
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 115/240 (47%), Gaps = 38/240 (15%)
Query: 45  KATENFSPANKI-GEGGSGTV-YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           ++ +N   + KI G G SGTV ++G  + G  VAVKR   +  D   L+E K  +LT S 
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD-IALMEIK--LLTESD 84
Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG--GNGLELAER---LDIAIDV 157
            +H N+++ +   E  D  + +   + N  L++ ++ +      L+L +    + +   +
Sbjct: 85  -DHPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILIT-------------EKLRAKVTDFGFARMSEED 204
           A  + +LH+     IIHRD+K  NIL++             E LR  ++DFG  +  + D
Sbjct: 143 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLD 197
Query: 205 SAVSHISTQVK---GTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMT-GRYPIESK 257
           S        +    GT+G+  P+ L      +LT   D++S G +   +++ G++P   K
Sbjct: 198 SGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 257

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 56  IGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL 115
           IG+G  G V++GK + G  VAVK    ++ ++    E   EI     + H N++   GF+
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFRE--AEIYQTVMLRHENIL---GFI 89
Query: 116 EHGD-------ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--- 165
              +       +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH   
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 166 --TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK---GTAGY 220
             T   P I HRD+K+ NIL+ +     + D G A     DSA   I        GT  Y
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRY 204
Query: 221 LDPDYL------RTYQLTEKSDVYSFGVLLVEM 247
           + P+ L      + ++  +++D+Y+ G++  E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 56  IGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G G  G V      + G+ VA+K+  +    +        E+     + H N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 115 ------LEHGDERIIVVEYVGN--GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
                 L+   +  +V+ ++G   G L +H +  G + ++      +   +   L Y+H 
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQF-----LVYQMLKGLRYIHA 146
Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                IIHRD+K  N+ + E    K+ DFG AR ++ +     +      T  Y  P+ +
Sbjct: 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV------TRWYRAPEVI 197
Query: 227 RTY-QLTEKSDVYSFGVLLVEMMTGR 251
             + + T+  D++S G ++ EM+TG+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 56  IGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G GG+G V+     D    VA+K+      D   +     EI    +++H N+VK+F  
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 115 LEHGDERIIVVEYVGNGT-------LREHLDGRGGNGLELAERLD-----IAIDVAHALT 162
           L  G     + + VG+ T       ++E+++    N LE    L+         +   L 
Sbjct: 77  L--GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLK 134
Query: 163 YLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKG--TAG 219
           Y+H+ +   ++HRD+K +N+ I TE L  K+ DFG AR+   D   SH     +G  T  
Sbjct: 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM--DPHYSHKGHLSEGLVTKW 189
Query: 220 YLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGR 251
           Y  P  L +    T+  D+++ G +  EM+TG+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 28/239 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNK-HDKC 88
           G   + +  FE++Y+  E+      +GEG    V     L      AVK   K   H + 
Sbjct: 1   GSTDSFSGRFEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG-NGLEL 147
            +  F+   + +    H N+++L  F E  D   +V E +  G++  H+  R   N LE 
Sbjct: 56  RV--FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEED 204
           +    +  DVA AL +LH      I HRD+K  NIL     +    K+ DFG     + +
Sbjct: 114 SV---VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 205 SAVSHISTQ----VKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPI 254
              S IST       G+A Y+ P+ +  +        ++ D++S GV+L  +++G  P 
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           + EI T S + H  LV L    E  +E +++ E++  G L E +     N +   E ++ 
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEY 260
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL--RAKVTDFGFARMSEEDSAVSHIS 211
              V   L ++H  +    +H D+K  NI+ T K     K+ DFG     +   +V  ++
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VT 316
Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           T   GTA +  P+      +   +D++S GVL   +++G  P 
Sbjct: 317 T---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           + EI T S + H  LV L    E  +E +++ E++  G L E +     N +   E ++ 
Sbjct: 96  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEY 154
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL--RAKVTDFGFARMSEEDSAVSHIS 211
              V   L ++H  +    +H D+K  NI+ T K     K+ DFG     +   +V  ++
Sbjct: 155 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VT 210
Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           T   GTA +  P+      +   +D++S GVL   +++G  P 
Sbjct: 211 T---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N++ L    + G    +V E +  G L + +  +        E   +   +   + Y
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEY 131
Query: 164 LHTYSDPPIIHRDVKASNILITEKL----RAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           LH      ++HRD+K SNIL  ++       ++ DFGFA+    ++ +         TA 
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY---TAN 185
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           ++ P+ L         D++S GVLL  M+TG  P 
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKVVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S GV++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 26/179 (14%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           +++L  + E  D  ++++E       L + +  RG    ELA        V  A+ + H 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--SFFWQVLEAVRHCHN 175
Query: 167 YSDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P++
Sbjct: 176 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEW 227
Query: 226 LRTYQLTEKSD-VYSFGVLLVEMMTGRYPIESKKPI-------KERVT------IRWAM 270
           +R ++   +S  V+S G+LL +M+ G  P E  + I       ++RV+      IRW +
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL 286

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKVVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR----TAGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S GV++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 42/229 (18%)
Query: 48  ENFSPANKIGEGGSGTVY---------KGKLKDGSIVA----VKRARKNKHDKCLLLEFK 94
           ENF     +G G  G V+          GKL    ++     V++A+  +H +      +
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT-----E 108
Query: 95  NEILTWSKIEHLN----LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER 150
            ++L     EH+     LV L    +   +  ++++Y+  G L  HL  R     E    
Sbjct: 109 RQVL-----EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-----ERFTE 158
Query: 151 LDIAI---DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
            ++ I   ++  AL +LH      II+RD+K  NIL+       +TDFG ++    D   
Sbjct: 159 HEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-- 213
Query: 208 SHISTQVKGTAGYLDPDYLR--TYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           +  +    GT  Y+ PD +R       +  D +S GVL+ E++TG  P 
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 76  AVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLRE 135
           AVK   K+K D    +E    +L +   +H N++ L    + G    +V E +  G L +
Sbjct: 56  AVKVIDKSKRDPSEEIEI---LLRYG--QHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 136 HLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT------EKLR 189
            +  +        E   +   +   + YLH+     ++HRD+K SNIL        E LR
Sbjct: 111 KILRQ--KFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
             + DFGFA+    ++ +         TA ++ P+ L+     E  D++S G+LL  M+ 
Sbjct: 166 --ICDFGFAKQLRAENGLLMTPCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 250 GRYPI 254
           G  P 
Sbjct: 221 GYTPF 225

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 88/219 (40%), Gaps = 25/219 (11%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           +++  +       +G G  G+V   Y  +L+    VAVK+  +             E+  
Sbjct: 15  VWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRL 72
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------I 153
              ++H N++ L             +E      L   L G   N +   + L       +
Sbjct: 73  LKHLKHENVIGLLDVFTPATS----IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 128
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
              +   L Y+H+     IIHRD+K SN+ + E    ++ DFG AR ++E+       T 
Sbjct: 129 VYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEE------MTG 179
Query: 214 VKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T  Y  P+ +  +    +  D++S G ++ E++ G+
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 82/183 (44%), Gaps = 17/183 (9%)
Query: 76  AVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLRE 135
           AVK   K+K D    +E    +L +   +H N++ L    + G    +V E +  G L +
Sbjct: 56  AVKVIDKSKRDPSEEIEI---LLRYG--QHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 136 HLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR----AK 191
            +  +        E   +   +   + YLH+     ++HRD+K SNIL  ++       +
Sbjct: 111 KILRQ--KFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
           + DFGFA+    ++ +         TA ++ P+ L+     E  D++S G+LL  M+ G 
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCY---TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGY 222
Query: 252 YPI 254
            P 
Sbjct: 223 TPF 225

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 115/244 (47%), Gaps = 42/244 (17%)
Query: 45  KATENFSPANKI-GEGGSGTV-YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           ++ +N   + KI G G SGTV ++G  + G  VAVKR   +  D   L+E K  +LT S 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD-IALMEIK--LLTESD 66
Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG--GNGLELAER---LDIAIDV 157
            +H N+++ +   E  D  + +   + N  L++ ++ +      L+L +    + +   +
Sbjct: 67  -DHPNVIRYYCS-ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 158 AHALTYLHTYSDPPIIHRDVKASNILIT-------------EKLRAKVTDFGFARMSEED 204
           A  + +LH+     IIHRD+K  NIL++             E LR  ++DFG  +  + D
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK--KLD 179
Query: 205 SAVSHISTQVK---GTAGYLDPDYLRTY-------QLTEKSDVYSFGVLLVEMMT-GRYP 253
           S        +    GT+G+  P+ L          +LT   D++S G +   +++ G++P
Sbjct: 180 SGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 254 IESK 257
              K
Sbjct: 240 FGDK 243

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVKL 111
           +G GG G V+  ++K  G + A K+  K +  K    +    + +IL  +K+    +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL--AKVHSRFIVSL 250
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYSD 169
               E   +  +V+  +  G +R H+        G +    +     +   L +LH  + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+ +    +++D G A    E  A    +    GT G++ P+ L   
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESK------KPIKERV 264
           +     D ++ GV L EM+  R P  ++      K +K+RV
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 23  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 78  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 187
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVKL 111
           +G GG G V+  ++K  G + A K+  K +  K    +    + +IL  +K+    +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL--AKVHSRFIVSL 250
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYSD 169
               E   +  +V+  +  G +R H+        G +    +     +   L +LH  + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+ +    +++D G A    E  A    +    GT G++ P+ L   
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESK------KPIKERV 264
           +     D ++ GV L EM+  R P  ++      K +K+RV
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVKL 111
           +G GG G V+  ++K  G + A K+  K +  K    +    + +IL  +K+    +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL--AKVHSRFIVSL 250
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYSD 169
               E   +  +V+  +  G +R H+        G +    +     +   L +LH  + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+ +    +++D G A    E  A    +    GT G++ P+ L   
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESK------KPIKERV 264
           +     D ++ GV L EM+  R P  ++      K +K+RV
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 56  IGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVKL 111
           +G GG G V+  ++K  G + A K+  K +  K    +    + +IL  +K+    +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL--AKVHSRFIVSL 250
Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYSD 169
               E   +  +V+  +  G +R H+        G +    +     +   L +LH  + 
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+ +    +++D G A    E  A    +    GT G++ P+ L   
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESK------KPIKERV 264
           +     D ++ GV L EM+  R P  ++      K +K+RV
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L L   +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                     +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 247 PDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L L   +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                     +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 245 PDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L L   +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                     +    ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 254 PDYVR-KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L L   +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 205 SAVSHISTQVKGTA----GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                     KG A     ++ P+ +     T +SDV+SFGVLL E+ +
Sbjct: 252 PDYVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKVVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPEV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           +++  +       +G G  G+V   Y  +L+    VAVK+  +             E+  
Sbjct: 23  VWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRL 80
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------I 153
              ++H N++ L             +E      L   L G   N +  ++ L       +
Sbjct: 81  LKHLKHENVIGLLDVFTPATS----IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL 136
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
              +   L Y+H+     IIHRD+K SN+ + E    ++ DFG AR ++E+       T 
Sbjct: 137 VYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE------MTG 187
Query: 214 VKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
              T  Y  P+ +  +    +  D++S G ++ E++ G+
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKVVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L Y+H+     IIHRD+K SN+ + E    ++ DFG AR ++E+       T    T  Y
Sbjct: 144 LKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEE------MTGYVATRWY 194
Query: 221 LDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGR 251
             P+ +  +    +  D++S G ++ E++ G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 28/239 (11%)
Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNK-HDKC 88
           G   + +  FE++Y+  E+      +GEG    V     L      AVK   K   H + 
Sbjct: 1   GSTDSFSGRFEDVYQLQEDV-----LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55
Query: 89  LLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG-NGLEL 147
            +  F+   + +    H N+++L  F E  D   +V E +  G++  H+  R   N LE 
Sbjct: 56  RV--FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSEED 204
           +    +  DVA AL +LH      I HRD+K  NIL     +    K+ DF      + +
Sbjct: 114 SV---VVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 205 SAVSHISTQ----VKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPI 254
              S IST       G+A Y+ P+ +  +        ++ D++S GV+L  +++G  P 
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 6/116 (5%)
Query: 135 EHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD 194
           E  DG     + + + +  +  VA  + +L   S    IHRD+ A NIL++E    K+ D
Sbjct: 186 EDSDGFYKEPITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICD 242
Query: 195 FGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           FG AR + +    V    T++     ++ P+ +     + KSDV+S+GVLL E+ +
Sbjct: 243 FGLARDIYKNPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 22/215 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 24  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 78
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 79  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 135
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S +     
Sbjct: 136 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMVPFV 188
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG 250
            T  Y  P+ +      E  D++S G ++ EM+ G
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 31/138 (22%)
Query: 122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           +IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRDVK  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 147
Query: 182 ILITEKLR---AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +L T K      K+TDFGFA                K T G          +  +  D++
Sbjct: 148 LLYTSKRPNAILKLTDFGFA----------------KETTG---------EKYDKSCDMW 182
Query: 239 SFGVLLVEMMTGRYPIES 256
           S GV++  ++ G  P  S
Sbjct: 183 SLGVIMYILLCGYPPFYS 200

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVK 110
           N IG G  G V K  ++ G+   ++RA K K  K  + +   FK EI     ++H N+++
Sbjct: 15  NTIGRGSWGEV-KIAVQKGT--RIRRAAK-KIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+   E   +  +V+E    G L E +  +       A R  I  DV  A+ Y H  +  
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCHKLN-- 126
Query: 171 PIIHRDVKASNILI---TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            + HRD+K  N L    +     K+ DFG A   +       + T+V GT  Y+ P  L 
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKV-GTPYYVSPQVLE 181
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
                E  D +S GV++  ++ G  P  +    +  + IR
Sbjct: 182 GLYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIR 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 16/114 (14%)
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           +AID  H L Y         +HRD+K  N+L+      ++ DFG      +D  V   S+
Sbjct: 202 LAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ--SS 250
Query: 213 QVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
              GT  Y+ P+ L+  +        + D +S GV + EM+ G  P  ++  ++
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 304

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLE---FKNEILTWSKIEHLNLVK 110
           N IG G  G V K  ++ G+   ++RA K K  K  + +   FK EI     ++H N+++
Sbjct: 32  NTIGRGSWGEV-KIAVQKGT--RIRRAAK-KIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L+   E   +  +V+E    G L E +  +       A R  I  DV  A+ Y H  +  
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCHKLN-- 143
Query: 171 PIIHRDVKASNILI---TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            + HRD+K  N L    +     K+ DFG A   +       + T+V GT  Y+ P  L 
Sbjct: 144 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKV-GTPYYVSPQVLE 198
Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
                E  D +S GV++  ++ G  P  +    +  + IR
Sbjct: 199 GLYGPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIR 237

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 14/218 (6%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD---------KCLLLE 92
           E++     ++    I  G  G V  G   +G  VA+KR      D           L   
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
              EI   +   H N++ L     H +E  +   Y+    +R  L     +   +     
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           I   + H L  LH   +  ++HRD+   NIL+ +     + DF  AR    D+  +H  T
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 213 QVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMT 249
                  Y  P+ +  ++  T+  D++S G ++ EM  
Sbjct: 196 H----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 16/114 (14%)
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           +AID  H L Y         +HRD+K  N+L+      ++ DFG      +D  V   S+
Sbjct: 186 LAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQ--SS 234
Query: 213 QVKGTAGYLDPDYLRTYQ-----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
              GT  Y+ P+ L+  +        + D +S GV + EM+ G  P  ++  ++
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 14/218 (6%)
Query: 42  EIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD---------KCLLLE 92
           E++     ++    I  G  G V  G   +G  VA+KR      D           L   
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD 152
              EI   +   H N++ L     H +E  +   Y+    +R  L     +   +     
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIST 212
           I   + H L  LH   +  ++HRD+   NIL+ +     + DF  AR    D+  +H  T
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 213 QVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMT 249
                  Y  P+ +  ++  T+  D++S G ++ EM  
Sbjct: 196 H----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 12/155 (7%)
Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H N++ L    + G    +V E    G L + +  +        E   +   +   + Y
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQ--KFFSEREASAVLFTITKTVEY 131
Query: 164 LHTYSDPPIIHRDVKASNILITEKL----RAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           LH      ++HRD+K SNIL  ++       ++ DFGFA+    ++ +         TA 
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY---TAN 185
Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           ++ P+ L         D++S GVLL   +TG  P 
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKXVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 15/160 (9%)
Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N+++L    E      +V + +  G L ++L  +    L   E   I   +   +  L
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICAL 127
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H  +   I+HRD+K  NIL+ + +  K+TDFGF+   +    +     +V GT  YL P+
Sbjct: 128 HKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----EVCGTPSYLAPE 180
Query: 225 YLRTYQ------LTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            +            ++ D++S GV++  ++ G  P   +K
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G  G V+K +  K G  VA+K+       +   +    EI     ++H N+V L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 114 FLEHGD---ERIIVVEYVGNGTLREHLDGRGGNGL---ELAERLDIAIDVAHALTYLHTY 167
                     R     Y+        L G   N L    L+E   +   + + L Y+H  
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDY 225
               I+HRD+KA+N+LIT     K+ DFG AR     ++S  +    +V  T  Y  P+ 
Sbjct: 145 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPEL 200
Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           L   R Y      D++  G ++ EM T R PI
Sbjct: 201 LLGERDY--GPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 24/226 (10%)
Query: 48  ENFSPANKIGEGGSGTV----YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           EN+ P   +G G S  V    +K   K+ ++  +            + E +   L    I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 104 -----EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
                 H N+++L    E      +V + +  G L ++L  +    L   E   I   + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALL 134
Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
             +  LH  +   I+HRD+K  NIL+ + +  K+TDFGF+   +    +     +V GT 
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----EVCGTP 187
Query: 219 GYLDPDYLRTYQ------LTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            YL P+ +            ++ D++S GV++  ++ G  P   +K
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 60  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 115 MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 171
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 224
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 54  NKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            K+GEG  G VYK         VA+KR R    ++ +      E+    +++H N+++L 
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
             + H     ++ EY  N  L++++D      + + +       + + + + H+      
Sbjct: 100 SVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIK--SFLYQLINGVNFCHSRR---C 153
Query: 173 IHRDVKASNILI-----TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
           +HRD+K  N+L+     +E    K+ DFG AR       +   + ++  T  Y  P+ L 
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEII-TLWYRPPEILL 210
Query: 228 -TYQLTEKSDVYSFGVLLVEMM--TGRYPIESK 257
            +   +   D++S   +  EM+  T  +P +S+
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 21/228 (9%)
Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLL---EFKN 95
           FE++Y+  E       IG+G    V +   ++ G   AVK     K      L   + K 
Sbjct: 22  FEDVYELCE------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 75
Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DI 153
           E      ++H ++V+L           +V E++    L   +  R   G   +E +    
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHI 210
              +  AL Y H   D  IIHRDVK  N+L+  K  +   K+ DFG A    E   V+  
Sbjct: 136 MRQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
                GT  ++ P+ ++     +  DV+  GV+L  +++G  P    K
Sbjct: 193 RV---GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 60  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 115 MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 171
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 224
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 70  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYV 179
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 16  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 71  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYV 180
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 16  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 71  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 180
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 23  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 78  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 187
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 21  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 75
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 76  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 132
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 133 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 185
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 20/218 (9%)
Query: 47  TENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNK-HDKCLLLEFKN-----EILT 99
           ++ +S  + +G G  G V+    K+    V VK  +K K  + C + + K      EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGT-LREHLDGRGGNGLELAERLDIAIDVA 158
            S++EH N++K+    E+     +V+E  G+G  L   +D        LA    I   + 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY--IFRQLV 140
Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            A+ YL       IIHRD+K  NI+I E    K+ DFG A   E       +     GT 
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER----GKLFYTFCGTI 193
Query: 219 GYLDPDYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
            Y  P+ L    Y+  E  +++S GV L  ++    P 
Sbjct: 194 EYCAPEVLMGNPYRGPE-LEMWSLGVTLYTLVFEENPF 230

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 27  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 81
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 82  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 138
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 139 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYV 191
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ +      E  D++S G ++ EM+  +
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 15  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 70  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 126
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 127 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART----AGTSFMMTPYV 179
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 23  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 78  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 134
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 135 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMTPYV 187
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKXVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 16  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 71  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 127
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 128 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYV 180
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ +      E  D++S G ++ EM+  +
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART----AGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L     VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++ L         +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKXVNHKNIISLLNVFT---PQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S + T   
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
            T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/226 (22%), Positives = 93/226 (41%), Gaps = 24/226 (10%)
Query: 48  ENFSPANKIGEGGSGTV----YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           EN+ P   +G G S  V    +K   K+ ++  +            + E +   L    I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 104 -----EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
                 H N+++L    E      +V + +  G L ++L  +    L   E   I   + 
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALL 134
Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
             +  LH  +   I+HRD+K  NIL+ + +  K+TDFGF+   +    +  +     GT 
Sbjct: 135 EVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC----GTP 187
Query: 219 GYLDPDYLRTYQ------LTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            YL P+ +            ++ D++S GV++  ++ G  P   +K
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G  G V+K +  K G  VA+K+       +   +    EI     ++H N+V L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 114 FLEHGD---ERIIVVEYVGNGTLREHLDGRGGNGL---ELAERLDIAIDVAHALTYLHTY 167
                     R     Y+        L G   N L    L+E   +   + + L Y+H  
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDY 225
               I+HRD+KA+N+LIT     K+ DFG AR     ++S  +    +V  T  Y  P+ 
Sbjct: 145 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPEL 200
Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           L   R Y      D++  G ++ EM T R PI
Sbjct: 201 LLGERDY--GPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/206 (22%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 55  KIGEGGSGTVYKGKLKDGSIVA-VKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           K+ E  SG ++KG+ +   IV  V + R     K    +F  E        H N++ + G
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSR--DFNEECPRLRIFSHPNVLPVLG 74
Query: 114 FLEH--GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
             +        ++  ++  G+L   L       ++ ++ +  A+D+A  + +LHT  +P 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL 231
           I    + + +++I E + A        R+S  D   S  S        ++ P+ L+    
Sbjct: 134 IPRHALNSRSVMIDEDMTA--------RISMADVKFSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 232 T---EKSDVYSFGVLLVEMMTGRYPI 254
                 +D++SF VLL E++T   P 
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPF 211

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G  G V+K +  K G  VA+K+       +   +    EI     ++H N+V L  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 114 FLEHGD---ERIIVVEYVGNGTLREHLDGRGGNGL---ELAERLDIAIDVAHALTYLHTY 167
                     R     Y+        L G   N L    L+E   +   + + L Y+H  
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 143
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDY 225
               I+HRD+KA+N+LIT     K+ DFG AR     ++S  +    +V  T  Y  P+ 
Sbjct: 144 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPEL 199
Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           L   R Y      D++  G ++ EM T R PI
Sbjct: 200 LLGERDY--GPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG+G  G V+K +  K G  VA+K+       +   +    EI     ++H N+V L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 114 FLEHGD---ERIIVVEYVGNGTLREHLDGRGGNGL---ELAERLDIAIDVAHALTYLHTY 167
                     R     Y+        L G   N L    L+E   +   + + L Y+H  
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 144
Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDY 225
               I+HRD+KA+N+LIT     K+ DFG AR     ++S  +    +V  T  Y  P+ 
Sbjct: 145 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPEL 200
Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           L   R Y      D++  G ++ EM T R PI
Sbjct: 201 LLGERDY--GPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD--IAIDVAHALTYLH 165
           +V+LF   +      +V+EY+  G L   +     +  ++ E+       +V  AL  +H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWARFYTAEVVLALDAIH 185
Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDPD 224
           +      IHRDVK  N+L+ +    K+ DFG   +M++E   +    T V GT  Y+ P+
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAV-GTPDYISPE 239
Query: 225 YLRTY----QLTEKSDVYSFGVLLVEMMTGRYPI 254
            L++         + D +S GV L EM+ G  P 
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 20/155 (12%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNG---TLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           +V+LF   +      +V+EY+  G    L  + D            + +A+D  H++ + 
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF- 194
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDP 223
                   IHRDVK  N+L+ +    K+ DFG   +M++E   +    T V GT  Y+ P
Sbjct: 195 --------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAV-GTPDYISP 243
Query: 224 DYLRTY----QLTEKSDVYSFGVLLVEMMTGRYPI 254
           + L++         + D +S GV L EM+ G  P 
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 2/85 (2%)
Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRDVK  NIL++    A + DFG A  +  D  ++ +   V GT  Y  P+       T 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTV-GTLYYXAPERFSESHATY 214
Query: 234 KSDVYSFGVLLVEMMTGRYPIESKK 258
           ++D+Y+   +L E +TG  P +  +
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 20/155 (12%)
Query: 108 LVKLFGFLEHGDERIIVVEYVGNG---TLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           +V+LF   +      +V+EY+  G    L  + D            + +A+D  H++ + 
Sbjct: 136 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF- 194
Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDP 223
                   IHRDVK  N+L+ +    K+ DFG   +M++E   +    T V GT  Y+ P
Sbjct: 195 --------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAV-GTPDYISP 243
Query: 224 DYLRTY----QLTEKSDVYSFGVLLVEMMTGRYPI 254
           + L++         + D +S GV L EM+ G  P 
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 43  IYKATENFSPANKIGEGGSGTV---YKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + K  +N  P   IG G  G V   Y   L+    VA+K+  +   ++        E++ 
Sbjct: 22  VLKRYQNLKP---IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---ERLDIAI- 155
              + H N++   G L     +  + E+     + E +D      +++    ER+   + 
Sbjct: 77  MKCVNHKNII---GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   + +LH+     IIHRD+K SNI++      K+ DFG AR     +  S +     
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART----AGTSFMMEPEV 186
Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ +      E  D++S G ++ EM+  +
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	380
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-125
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-111
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-100
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-45
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-43
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-40
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-31
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	7e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-05
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-20
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-20
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-12
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-11
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-06
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  361 bits (929), Expect = e-125
 Identities = 116/318 (36%), Positives = 167/318 (52%), Gaps = 16/318 (5%)

Query: 12  TKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD 71
           +K S+ ++    + SS       +      ++ +AT NF     IG G  G VYKG L+D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 72  GSIVAVKRARKNKH--DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG 129
           G+ VA+KR         +    EF+ EI T S   H +LV L GF +  +E I++ +Y+ 
Sbjct: 63  GAKVALKRRTPESSQGIE----EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 130 NGTLREHLDGRGGNGLEL--AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK 187
           NG L+ HL G     + +   +RL+I I  A  L YLHT     IIHRDVK+ NIL+ E 
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDEN 175

Query: 188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEM 247
              K+TDFG ++   E    +H+ST VKGT GY+DP+Y    +LTEKSDVYSFGV+L E+
Sbjct: 176 FVPKITDFGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 248 MTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCL 307
           +  R  I    P +      WA++    G    ++DP L        ++ K    A  CL
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE-SLRKFGDTAVKCL 293

Query: 308 APTRQSRPTMKKCAEILW 325
           A + + RP+M    ++LW
Sbjct: 294 ALSSEDRPSM---GDVLW 308

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  326 bits (838), Expect = e-111
 Identities = 103/284 (36%), Positives = 164/284 (57%), Gaps = 8/284 (2%)

Query: 38  FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
           FS  E+  A++NFS  N +G GG G VYKG+L DG++VAVKR ++ +  +   L+F+ E+
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEV 78

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLEL--AERLDIAI 155
              S   H NL++L GF     ER++V  Y+ NG++   L  R  +   L   +R  IA+
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
             A  L YLH + DP IIHRDVKA+NIL+ E+  A V DFG A++ +     +H++T V+
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DTHVTTAVR 196

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT--IRWAMQCL 273
           GT G++ P+YL T + +EK+DV+ +GV+L+E++TG+   +  +   +     + W    L
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM 317
           K      ++D  L+        VE+++ +A +C   +   RP M
Sbjct: 257 KEKKLEALVDVDLQGNYKDE-EVEQLIQVALLCTQSSPMERPKM 299

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  299 bits (767), Expect = e-100
 Identities = 100/297 (33%), Positives = 163/297 (54%), Gaps = 20/297 (6%)

Query: 38  FSFEEIYKATENFSP------ANKIGEGGSGTVYKGKLKDGSIVAVKR--ARKNKHDKCL 89
           FSF E+   T NF         NK+GEGG G VYKG + + + VAVK+  A  +   + L
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73

Query: 90  LLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LELA 148
             +F  EI   +K +H NLV+L GF   GD+  +V  Y+ NG+L + L    G   L   
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 149 ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
            R  IA   A+ + +LH   +   IHRD+K++NIL+ E   AK++DFG AR SE+ +  +
Sbjct: 134 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-QT 189

Query: 209 HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW 268
            +++++ GT  Y+ P+ LR  ++T KSD+YSFGV+L+E++TG   ++  +    ++ +  
Sbjct: 190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDI 246

Query: 269 AMQCLKAGDAIL-VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
             +       I   +D ++    ++  +VE +  +A  CL   +  RP +KK  ++L
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADST--SVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  219 bits (561), Expect = 2e-69
 Identities = 64/319 (20%), Positives = 124/319 (38%), Gaps = 29/319 (9%)

Query: 32  QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLL 91
            ++ ++   E +Y  +           G  G V+K +L     VAVK             
Sbjct: 8   HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS---W 63

Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGD----ERIIVVEYVGNGTLREHLDGRGGNGLEL 147
           + + E+ +   ++H N+++  G  + G     +  ++  +   G+L + L     N +  
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSW 120

Query: 148 AERLDIAIDVAHALTYLHT-------YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM 200
            E   IA  +A  L YLH           P I HRD+K+ N+L+   L A + DFG A  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 201 SEEDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPI- 254
            E   +      QV GT  Y+ P+ L            + D+Y+ G++L E+ +      
Sbjct: 181 FEAGKSAGDTHGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 255 ----ESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPT 310
               E   P +E +    +++ ++         P LR     +  +  +    + C    
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 311 RQSRPTMKKCAEILWKIRK 329
            ++R +     E + ++++
Sbjct: 300 AEARLSAGCVGERITQMQR 318

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  202 bits (517), Expect = 6e-63
 Identities = 88/336 (26%), Positives = 134/336 (39%), Gaps = 42/336 (12%)

Query: 6   HSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVY 65
           H            +   +       G    I +    I +         KIG G  GTV+
Sbjct: 4   HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE---------KIGAGSFGTVH 54

Query: 66  KGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV 125
           + +   GS VAVK   +       + EF  E+    ++ H N+V   G +       IV 
Sbjct: 55  RAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113

Query: 126 EYVGNGTLREHL-DGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI 184
           EY+  G+L   L        L+   RL +A DVA  + YLH   +PPI+HR++K+ N+L+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLV 172

Query: 185 TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
            +K   KV DFG +R+          S    GT  ++ P+ LR     EKSDVYSFGV+L
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFL---SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVIL 229

Query: 245 VEMMTGRYPIESKKPIKERVTIRWA-MQCLKAGDAILVMDPRL---RRTPASNMAVEKIL 300
            E+ T + P              W  +   +   A+     RL   R          ++ 
Sbjct: 230 WELATLQQP--------------WGNLNPAQVVAAVGFKCKRLEIPRNLN------PQVA 269

Query: 301 GLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAP 336
            + + C       RP+    A I+  +R   +   P
Sbjct: 270 AIIEGCWTNEPWKRPSF---ATIMDLLRPLIKSAVP 302

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (494), Expect = 7e-60
 Identities = 53/282 (18%), Positives = 111/282 (39%), Gaps = 33/282 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            K+ E  SG ++KG+ + G+ + VK  +          +F  E        H N++ + G
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 114 F-LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
                      ++  ++  G+L   L       ++ ++ +  A+D+A  + +LHT  +P 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR---T 228
           I    + + +++I E + A+++              S  S        ++ P+ L+    
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKF--------SFQSPGRMYAPAWVAPEALQKKPE 185

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA-MQCLKAGDAILVMDPRLR 287
                 +D++SF VLL E++T   P              +A +  ++ G  + +   R  
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVP--------------FADLSNMEIGMKVALEGLRPT 231

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
             P  +  V K++    +C+      RP       IL K++ 
Sbjct: 232 IPPGISPHVSKLM---KICMNEDPAKRPKFDMIVPILEKMQD 270

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  194 bits (494), Expect = 2e-59
 Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 33/317 (10%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEIL 98
           S   I    +       +G G  G V K K +    VA+K+       K     F  E+ 
Sbjct: 1   SLHMI--DYKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK----AFIVELR 53

Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDV 157
             S++ H N+VKL+G     +   +V+EY   G+L   L G         A  +   +  
Sbjct: 54  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLR-AKVTDFGFARMSEEDSAVSHISTQVKG 216
           +  + YLH+     +IHRD+K  N+L+       K+ DFG A        +    T  KG
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD------IQTHMTNNKG 165

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG 276
           +A ++ P+       +EK DV+S+G++L E++T R P              +      A 
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--------------FDEIGGPAF 211

Query: 277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF-REKA 335
             +  +    R     N+  + I  L   C +     RP+M++  +I+  + + F     
Sbjct: 212 RIMWAVHNGTRPPLIKNLP-KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270

Query: 336 PSSFSSSSSPASASESH 352
           P  +    S     +  
Sbjct: 271 PLQYPCQHSLPPGEDGR 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  194 bits (494), Expect = 2e-59
 Identities = 71/355 (20%), Positives = 131/355 (36%), Gaps = 51/355 (14%)

Query: 8   TESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKG 67
            E N   S  S+RS+   +S  S      +  FE++            IG+G  G VY G
Sbjct: 2   PEMNL--SLLSARSFPRKASQTSIFLQEWDIPFEQLEIG-------ELIGKGRFGQVYHG 52

Query: 68  KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY 127
           +      VA++     + ++  L  FK E++ + +  H N+V   G         I+   
Sbjct: 53  RWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110

Query: 128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK 187
               TL   +       L++ +   IA ++   + YLH      I+H+D+K+ N+     
Sbjct: 111 CKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDNG 166

Query: 188 LRAKVTDFGFARMSE--EDSAVSHISTQVKGTAGYLDPDYLRTYQL---------TEKSD 236
            +  +TDFG   +S   +            G   +L P+ +R             ++ SD
Sbjct: 167 -KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225

Query: 237 VYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAV 296
           V++ G +  E+    +P ++                  A   I  M   ++   +     
Sbjct: 226 VFALGTIWYELHAREWPFKT----------------QPAEAIIWQMGTGMKPNLSQIGMG 269

Query: 297 EKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPASASES 351
           ++I  +   C A  ++ RPT     +++  +     EK P      S P    +S
Sbjct: 270 KEISDILLFCWAFEQEERPTFT---KLMDML-----EKLPKRNRRLSHPGHFWKS 316

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  189 bits (481), Expect = 8e-58
 Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 28/284 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N++   G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 114 FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           +      ++ IV ++    +L  HL        E+ + +DIA   A  + YLH      I
Sbjct: 88  YST--APQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL- 231
           IHRD+K++NI + E    K+ DFG A   +   + SH   Q+ G+  ++ P+ +R     
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 232 --TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT 289
             + +SDVY+FG++L E+MTG+ P  +     +   I   +           + P L + 
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS-------LSPDLSKV 250

Query: 290 PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE 333
            ++    +++  L   CL   R  RP+      IL +I +  RE
Sbjct: 251 RSN--CPKRMKRLMAECLKKKRDERPSF---PRILAEIEELARE 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  187 bits (478), Expect = 1e-57
 Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 40/287 (13%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD--KCLLLEFKNEILTWSKIEHLNLVKL 111
             IG GG G VY+     G  VAVK AR +  +     +   + E   ++ ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G         +V+E+   G L   L G+    +     ++ A+ +A  + YLH  +  P
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 172 IIHRDVKASNILITEKLR--------AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           IIHRD+K+SNILI +K+          K+TDFG AR     + +S       G   ++ P
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-----AGAYAWMAP 183

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA-MQCLKAGDAILVM 282
           + +R    ++ SDV+S+GVLL E++TG  P              +  +  L     + + 
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVP--------------FRGIDGLAVAYGVAMN 229

Query: 283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
              L           K++   + C  P   SRP+      IL ++  
Sbjct: 230 KLALPIPSTCPEPFAKLM---EDCWNPDPHSRPSFT---NILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (477), Expect = 4e-57
 Identities = 70/288 (24%), Positives = 133/288 (46%), Gaps = 39/288 (13%)

Query: 54  NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-----KCLLLEFKNEILTWSKIEHLN 107
            +IG+GG G V+KG+L  D S+VA+K       +          EF+ E+   S + H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKL+G +   +   +V+E+V  G L   L  +    ++ + +L + +D+A  + Y+   
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN- 140

Query: 168 SDPPIIHRDVKASNILITEK-----LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
            +PPI+HRD+++ NI +        + AKV DFG ++ S          + + G   ++ 
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV------SGLLGNFQWMA 194

Query: 223 PDYLRTYQL--TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA-MQCLKAGDAI 279
           P+ +   +   TEK+D YSF ++L  ++TG  P              +      K     
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGP--------------FDEYSYGKIKFIN 240

Query: 280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
           ++ +  LR T   +    ++  + ++C +   + RP      + L ++
Sbjct: 241 MIREEGLRPTIPEDCP-PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  179 bits (456), Expect = 7e-54
 Identities = 63/313 (20%), Positives = 109/313 (34%), Gaps = 33/313 (10%)

Query: 54  NKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             +G+G  G   K   ++ G ++ +K     + D+     F  E+     +EH N++K  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G L        + EY+  GTLR  +          ++R+  A D+A  + YLH+ +   I
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMN---I 129

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK-----------GTAGYL 221
           IHRD+ + N L+ E     V DFG AR+  ++         +K           G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV 281
            P+ +      EK DV+SFG++L E++          P                     +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM---------------DFGL 234

Query: 282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSS 341
                               +   C     + RP+  K    L  +R       P     
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294

Query: 342 SSSPASASESHYP 354
                   E++  
Sbjct: 295 EQLDRGFWETYRR 307

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  175 bits (446), Expect = 5e-52
 Identities = 70/343 (20%), Positives = 126/343 (36%), Gaps = 47/343 (13%)

Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKN 95
           +  +  E     +N      IG G  G VYKG L D   VAVK              F N
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-----NFIN 54

Query: 96  E--ILTWSKIEHLNLVKLFGFLEHGD-----ERIIVVEYVGNGTLREHLDGRGGNGLELA 148
           E  I     +EH N+ +     E        E ++V+EY  NG+L ++L     +  +  
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWV 111

Query: 149 ERLDIAIDVAHALTYLHT------YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-- 200
               +A  V   L YLHT      +  P I HRD+ + N+L+       ++DFG +    
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 201 ---SEEDSAVSHISTQVKGTAGYLDPDYLR-------TYQLTEKSDVYSFGVLLVEMMTG 250
                      + +    GT  Y+ P+ L             ++ D+Y+ G++  E+   
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 251 RYPI-------ESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR---RTPASNMAVEKIL 300
              +       E +   +  V      + ++    +     R +       +++AV  + 
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ--VLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 301 GLADVCLAPTRQSRPTMKKCAEILWKIRKDF-REKAPSSFSSS 342
              + C     ++R T +   E + ++   + R K+ S  +  
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  163 bits (414), Expect = 2e-47
 Identities = 76/347 (21%), Positives = 128/347 (36%), Gaps = 33/347 (9%)

Query: 10  SNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKL 69
           S T      S   +   S  SG  + +    +      +      +IG+G  G V+ GK 
Sbjct: 1   SMTYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTI--AKQIQMVKQIGKGRYGEVWMGKW 58

Query: 70  KDGSIVAVKRARKNKHDKCLLLEFKNE--ILTWSKIEHLNLVKLFGFLEHGDERI----I 123
           + G  VAVK     +        +  E  I     + H N++        G        +
Sbjct: 59  R-GEKVAVKVFFTTEEA-----SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112

Query: 124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-----YSDPPIIHRDVK 178
           + +Y  NG+L ++L       L+    L +A      L +LHT        P I HRD+K
Sbjct: 113 ITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLK 169

Query: 179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHI-STQVKGTAGYLDP------DYLRTYQL 231
           + NIL+ +     + D G A     D+    I      GT  Y+ P           +Q 
Sbjct: 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229

Query: 232 TEKSDVYSFGVLLVEMMTGRYPI----ESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
              +D+YSFG++L E+           E + P  + V    + + ++    I  + P   
Sbjct: 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP 289

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
              +S+  + ++  L   C A    SR T  +  + L K+ +    K
Sbjct: 290 NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  162 bits (411), Expect = 3e-47
 Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 31/296 (10%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNE--ILTWSKIEHLNLVKL 111
             +G+G  G V++G  + G  VAVK              +  E  +     + H N++  
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK-----SWFRETELYNTVMLRHENILGF 67

Query: 112 FGFLEHGDERI----IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT- 166
                          ++  Y   G+L ++L       L+    L I + +A  L +LH  
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 167 ----YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQVKGTAGYL 221
                  P I HRD+K+ NIL+ +  +  + D G A M S+  + +   +    GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 222 DPDYLR------TYQLTEKSDVYSFGVLLVEMMTGRYPI----ESKKPIKERVTIRWAMQ 271
            P+ L        +   ++ D+++FG++L E+           + K P  + V    + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
            ++    +    P +     S+  +  +  L   C      +R T  +  + L KI
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  155 bits (393), Expect = 1e-44
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 9/208 (4%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           K+G GG  TVY  +       VA+K      +  +  L  F+ E+   S++ H N+V + 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
              E  D   +V+EY+   TL E+++  G   L +   ++    +   + + H      I
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMR---I 132

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+K  NILI      K+ DFG A+   E S     +  V GT  Y  P+  +     
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFSPEQAKGEATD 190

Query: 233 EKSDVYSFGVLLVEMMTGRYPIESKKPI 260
           E +D+YS G++L EM+ G  P   +  +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  156 bits (395), Expect = 2e-44
 Identities = 57/299 (19%), Positives = 119/299 (39%), Gaps = 31/299 (10%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNE--ILTWSKIEHLNLVKL 111
             IG+G  G V++GK + G  VAVK     +        +  E  I     + H N++  
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-----SWFREAEIYQTVMLRHENILGF 101

Query: 112 FGFLEHGDERI----IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH-- 165
                  +       +V +Y  +G+L ++L+      + +   + +A+  A  L +LH  
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHME 158

Query: 166 ---TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI-STQVKGTAGYL 221
              T   P I HRD+K+ NIL+ +     + D G A   +  +    I      GT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 222 DP------DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPI----ESKKPIKERVTIRWAMQ 271
            P        ++ ++  +++D+Y+ G++  E+           + + P  + V    +++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
            ++       + P +     S  A+  +  +   C      +R T  +  + L ++ + 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  153 bits (388), Expect = 3e-43
 Identities = 81/292 (27%), Positives = 122/292 (41%), Gaps = 35/292 (11%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E+     +IG G  G V+ G+L+  +  VAVK  R+      L  +F  E     +  H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-LKAKFLQEARILKQYSHP 172

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V+L G         IV+E V  G     L   G   L +   L +  D A  + YL  
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE- 230

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ---VKGTAGYLDP 223
                 IHRD+ A N L+TEK   K++DFG +R   +    +    +   VK TA    P
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----P 284

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMT-GR--YPIESKKPIKERVTIRWAMQCLKAGDAIL 280
           + L   + + +SDV+SFG+LL E  + G   YP          ++ +   + ++ G    
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYP---------NLSNQQTREFVEKGG--- 332

Query: 281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR 332
               RL        AV +++     C A     RP+     + L  IRK  R
Sbjct: 333 ----RLPCPELCPDAVFRLMEQ---CWAYEPGQRPSFSTIYQELQSIRKRHR 377

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (382), Expect = 5e-43
 Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 11/212 (5%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            +G GG   V+  + L+D   VAVK  R +   D    L F+ E    + + H  +V ++
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 113 --GFLEHGDERI--IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
             G  E     +  IV+EYV   TLR+ +   G   +     +++  D   AL + H   
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG 136

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
              IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA YL P+  R 
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI 260
             +  +SDVYS G +L E++TG  P     P+
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  145 bits (368), Expect = 4e-41
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 16/202 (7%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
             IG+G  G V  G  + G+ VAVK  + +   +     F  E    +++ H NLV+L G
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLG 81

Query: 114 FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
            +      + IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A N+L++E   AKV+DFG  + +        +   VK TA    P+ LR  + +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTA----PEALREKKFS 192

Query: 233 EKSDVYSFGVLLVEMMT-GRYP 253
            KSDV+SFG+LL E+ + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  145 bits (367), Expect = 5e-41
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           +IG G   TVYKG   +    VA    +  K  K     FK E      ++H N+V+ + 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 114 FLEHGDER----IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E   +     ++V E + +GTL+ +L  +    +++         +   L +LHT   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHT-RT 149

Query: 170 PPIIHRDVKASNILITEKL-RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
           PPIIHRD+K  NI IT      K+ D G A +     A +     V GT  ++ P+    
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-----VIGTPEFMAPEMYEE 204

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYP 253
            +  E  DVY+FG+ ++EM T  YP
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSEYP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  149 bits (378), Expect = 8e-41
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 14/204 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK     K D   + EF  E     +I+H NLV+L 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL   +    
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHR++ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 395

Query: 231 LTEKSDVYSFGVLLVEMMT-GRYP 253
            + KSDV++FGVLL E+ T G  P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  143 bits (363), Expect = 1e-40
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  LV+L+G
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYG 70

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
                    +V E++ +G L ++L  + G        L + +DV   + YL    +  +I
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD+ A N L+ E    KV+DFG  R   +D   S   T+  VK  +    P+     + 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFSRY 182

Query: 232 TEKSDVYSFGVLLVEMMT-GRYP 253
           + KSDV+SFGVL+ E+ + G+ P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (362), Expect = 2e-40
 Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 14/209 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           ++ +   ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 80

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+G         I+ EY+ NG L  +L        +  + L++  DV  A+ YL   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL--- 136

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDY 225
                +HRD+ A N L+ ++   KV+DFG +R   +D   S + ++  V+ +     P+ 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEV 192

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           L   + + KSD+++FGVL+ E+ + G+ P
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (365), Expect = 2e-40
 Identities = 65/333 (19%), Positives = 117/333 (35%), Gaps = 52/333 (15%)

Query: 18  SSRSYVSSSSPKS-----GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKD 71
           SS  +   SS +      G    I+          +++    K+GEGG   V   + L D
Sbjct: 3   SSHHHHHHSSGRENLYFQGHMVIID---------NKHYLFIQKLGEGGFSYVDLVEGLHD 53

Query: 72  GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF----LEHGDERIIVVEY 127
           G   A+KR   ++       E + E        H N+++L  +         E  +++ +
Sbjct: 54  GHFYALKRILCHEQQD--REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111

Query: 128 VGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT 185
              GTL   ++     G  L E   L + + +   L  +H        HRD+K +NIL+ 
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLG 168

Query: 186 EKLRAKVTDFGFAR-------MSEEDSAVSHISTQVKGTAGYLDP---DYLRTYQLTEKS 235
           ++ +  + D G           S +   +   + Q   T  Y  P          + E++
Sbjct: 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR-CTISYRAPELFSVQSHCVIDERT 227

Query: 236 DVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMA 295
           DV+S G +L  MM G  P +      + V        ++   +I          P S   
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSV-----ALAVQNQLSI----------PQSPRH 272

Query: 296 VEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
              +  L +  +      RP +      L  ++
Sbjct: 273 SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (362), Expect = 3e-40
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 14/204 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
           +K+G G  G VY+G  K  S+ VAVK  +++  +     EF  E     +I+H NLV+L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLL 75

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G         I+ E++  G L ++L       +     L +A  ++ A+ YL        
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQ 230
           IHRD+ A N L+ E    KV DFG +R+   D+  +H   +  +K TA    P+ L   +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNK 188

Query: 231 LTEKSDVYSFGVLLVEMMT-GRYP 253
            + KSDV++FGVLL E+ T G  P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  142 bits (361), Expect = 3e-40
 Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 14/203 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            ++G G  G V+ G     + VAVK  ++          F  E     +++H  LV+L+ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYA 75

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++    +   I
Sbjct: 76  VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+++ L  K+ DFG AR+ E++   +    +  +K TA    P+ +     
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTF 187

Query: 232 TEKSDVYSFGVLLVEMMT-GRYP 253
           T KSDV+SFG+LL E++T GR P
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIP 210

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  142 bits (360), Expect = 3e-40
 Identities = 68/202 (33%), Positives = 101/202 (50%), Gaps = 14/202 (6%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           ++G G  G V  GK K    VAVK  ++    +    EF  E  T  K+ H  LVK +G 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
                   IV EY+ NG L  +L   G   LE ++ L++  DV   + +L        IH
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLT 232
           RD+ A N L+   L  KV+DFG  R   +D  VS + T+  VK +A    P+    ++ +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYFKYS 183

Query: 233 EKSDVYSFGVLLVEMMT-GRYP 253
            KSDV++FG+L+ E+ + G+ P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  143 bits (362), Expect = 4e-40
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 9/201 (4%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            +G GG G VY+ +      IVA+K   +    D       + E  T  +++  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
            F E   +  + +  +    L   L  +G   L     + I   +  AL   H       
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAG---A 155

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
            HRDVK  NIL++    A + DFG A  +  D  ++ +   V GT  Y+ P+       T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAPERFSESHAT 213

Query: 233 EKSDVYSFGVLLVEMMTGRYP 253
            ++D+Y+   +L E +TG  P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (371), Expect = 5e-40
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 16/202 (7%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
             IG+G  G V  G  + G+ VAVK  + +   +     F  E    +++ H NLV+L G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLG 253

Query: 114 FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
            +      + IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
           +HRD+ A N+L++E   AKV+DFG  + +        +   VK TA    P+ LR  + +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--VKWTA----PEALREKKFS 364

Query: 233 EKSDVYSFGVLLVEMMT-GRYP 253
            KSDV+SFG+LL E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  146 bits (370), Expect = 5e-40
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            K+G+G  G V+ G     + VA+K     K        F  E     K+ H  LV+L+ 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+        +
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 358

Query: 232 TEKSDVYSFGVLLVEMMT-GRYP 253
           T KSDV+SFG+LL E+ T GR P
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVP 381

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  145 bits (367), Expect = 5e-40
 Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 21/260 (8%)

Query: 7   STESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYK 66
           S    T +++   +   S            + + E I      +S   +IG GGS  V++
Sbjct: 15  SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74

Query: 67  GKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL--VKLFGFLEHGDERIIV 124
              +   I A+K     + D   L  ++NEI   +K++  +   ++L+ +        +V
Sbjct: 75  VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134

Query: 125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI 184
           +E  GN  L   L  +    ++  ER     ++  A+  +H +    I+H D+K +N LI
Sbjct: 135 MEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188

Query: 185 TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP-----------DYLRTYQLTE 233
            +    K+ DFG A   + D+      +QV G   Y+ P           +     +++ 
Sbjct: 189 VDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISP 246

Query: 234 KSDVYSFGVLLVEMMTGRYP 253
           KSDV+S G +L  M  G+ P
Sbjct: 247 KSDVWSLGCILYYMTYGKTP 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (370), Expect = 6e-40
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 14/203 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            K+G G  G V+       + VAVK  +           F  E      ++H  LVKL  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV---EAFLAEANVMKTLQHDKLVKLHA 250

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +   +   I+ E++  G+L + L    G+   L + +D +  +A  + ++        I
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL++  L  K+ DFG AR+ E++   +    +  +K TA    P+ +     
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSF 362

Query: 232 TEKSDVYSFGVLLVEMMT-GRYP 253
           T KSDV+SFG+LL+E++T GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  141 bits (358), Expect = 1e-39
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 10/217 (4%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E++     IG G  G   K +   DG I+  K        +       +E+    +++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 107 NLVKLFG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALT 162
           N+V+ +   ++  +  + IV+EY   G L   +         L E   L +   +  AL 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 163 YLHTYSDPP--IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             H  SD    ++HRD+K +N+ +  K   K+ DFG AR+   D++ +   T V GT  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYY 182

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
           + P+ +      EKSD++S G LL E+     P  + 
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  148 bits (375), Expect = 1e-39
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 35/277 (12%)

Query: 55  KIGEGGSGTVYKGK--LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            I  GG G +Y       +G  V +K    +  D         E    +++ H ++V++F
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 113 GFLEHGDERI-----IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
            F+EH D        IV+EYVG  +L+     +    L +AE +   +++  AL+YLH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH-- 199

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               +++ D+K  NI++TE+ + K+ D G          +        GT G+  P+ +R
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-------GTPGFQAPEIVR 250

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERVTIRWAMQCLKAGDAILVM--- 282
           T   T  +D+Y+ G  L  +              + E   +             L+    
Sbjct: 251 T-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR----LLRRAI 305

Query: 283 --DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM 317
             DPR R T A  M+ +    L +V    T   RP +
Sbjct: 306 DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGL 342

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  141 bits (358), Expect = 2e-39
 Identities = 61/240 (25%), Positives = 95/240 (39%), Gaps = 10/240 (4%)

Query: 18  SSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVA 76
             +S      P            +  Y    NF    KIG G    VY+   L DG  VA
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61

Query: 77  VKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLRE 135
           +K+ +     D     +   EI    ++ H N++K +      +E  IV+E    G L  
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121

Query: 136 HLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT 193
            +         + ER      + +  AL ++H      ++HRD+K +N+ IT     K+ 
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLG 178

Query: 194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           D G  R     S  +   + V GT  Y+ P+ +       KSD++S G LL EM   + P
Sbjct: 179 DLGLGRFFS--SKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  142 bits (361), Expect = 2e-39
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 8/228 (3%)

Query: 28  PKSGQATTINFSFEEIYKAT-ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKH 85
                ++ ++   E +Y  + E +    KIGEG  G     K  +DG    +K    ++ 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62

Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGL 145
                 E + E+   + ++H N+V+     E      IV++Y   G L + ++ + G   
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122

Query: 146 ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS 205
           +  + LD  + +  AL ++H   D  I+HRD+K+ NI +T+    ++ DFG AR+     
Sbjct: 123 QEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179

Query: 206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
            ++     + GT  YL P+         KSD+++ G +L E+ T ++ 
Sbjct: 180 ELAR--ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  141 bits (357), Expect = 3e-39
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 21/243 (8%)

Query: 24  SSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKN 83
                      T N  F+ +      +S   +IG GGS  V++   +   I A+K     
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63

Query: 84  KHDKCLLLEFKNEILTWSKIEHLNL--VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG 141
           + D   L  ++NEI   +K++  +   ++L+ +        +V+E  GN  L   L  + 
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122

Query: 142 GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS 201
              ++  ER     ++  A+  +H +    I+H D+K +N LI +    K+ DFG A   
Sbjct: 123 --SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQM 176

Query: 202 EEDSAVSHISTQVKGTAGYLDP-----------DYLRTYQLTEKSDVYSFGVLLVEMMTG 250
           + D+      +QV GT  Y+ P           +     +++ KSDV+S G +L  M  G
Sbjct: 177 QPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235

Query: 251 RYP 253
           + P
Sbjct: 236 KTP 238

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (366), Expect = 5e-39
 Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            K+G+G  G V+ G     + VA+K     K        F  E     K+ H  LV+L+ 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+        +
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQL 231
           HRD++A+NIL+ E L  KV DFG AR+ E++   +    +  +K TA    P+     + 
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRF 441

Query: 232 TEKSDVYSFGVLLVEMMT-GRYP 253
           T KSDV+SFG+LL E+ T GR P
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVP 464

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  138 bits (351), Expect = 2e-38
 Identities = 59/255 (23%), Positives = 105/255 (41%), Gaps = 19/255 (7%)

Query: 2   DSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGS 61
           ++    +    +  R S R   S +    G   +   SF +     ++F   +++G G  
Sbjct: 16  ENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSY 70

Query: 62  GTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGD 119
           G V+K + K DG + AVKR+               E+ +  K+ +H   V+L    E G 
Sbjct: 71  GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130

Query: 120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKA 179
              +  E  G  +L++H +   G  L  A+      D   AL +LH+     ++H DVK 
Sbjct: 131 ILYLQTELCG-PSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKP 185

Query: 180 SNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVY 238
           +NI +  + R K+ DFG    +    +          G   Y+ P+ L+       +DV+
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMAPELLQG-SYGTAADVF 239

Query: 239 SFGVLLVEMMTGRYP 253
           S G+ ++E+      
Sbjct: 240 SLGLTILEVACNMEL 254

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  139 bits (351), Expect = 3e-38
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 21/213 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL--VKL 111
            +IG GGS  V++   +   I A+K     + D   L  ++NEI   +K++  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
           + +        +V+E  GN  L   L  +    ++  ER     ++  A+  +H +    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--- 128

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP-------- 223
           I+H D+K +N LI +    K+ DFG A   + D+      +QV GT  Y+ P        
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 186

Query: 224 ---DYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
              +     +++ KSDV+S G +L  M  G+ P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (341), Expect = 7e-37
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 18/209 (8%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             IG G SG V  G+L+        VA+K  +    ++    +F +E     + +H N++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-QRRDFLSEASIMGQFDHPNII 113

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L G +  G   +IV EY+ NG+L   L    G    + + + +   V   + YL   SD
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLDPDY 225
              +HRD+ A N+L+   L  KV+DFG +R+ E+D   ++ +T     ++ TA    P+ 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEA 225

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     +  SDV+SFGV++ E++  G  P
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  133 bits (338), Expect = 1e-36
 Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 20/208 (9%)

Query: 55  KIGEGGSGTVYKGKLKDGSI---VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  GTV KG  +   +   VAVK  +   +D  L  E   E     ++++  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 112 FGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
            G  E   E   +V+E    G L ++L  +    ++    +++   V+  + YL    + 
Sbjct: 84  IGICE--AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQ--VKGTAGYLDPDYL 226
             +HRD+ A N+L+  +  AK++DFG ++   ++E+   +    +  VK  A    P+ +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECI 192

Query: 227 RTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             Y+ + KSDV+SFGVL+ E  + G+ P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  134 bits (340), Expect = 1e-36
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 19/209 (9%)

Query: 55  KIGEGGSGTVYKGKLKDGSI-----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
            IG G  G VYKG LK  S      VA+K  +    +K   ++F  E     +  H N++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNII 109

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L G +      +I+ EY+ NG L + L  + G    + + + +   +A  + YL   ++
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLDPDY 225
              +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ ++     ++ TA    P+ 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEA 221

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +   + T  SDV+SFG+++ E+MT G  P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  134 bits (339), Expect = 1e-36
 Identities = 79/303 (26%), Positives = 121/303 (39%), Gaps = 40/303 (13%)

Query: 54  NKIGEGGSGTVYKGKLKD-----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
             +GEG  G V            G +VAVK A K          +K EI     + H ++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVK-ALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           +K  G  E        +V+EYV  G+LR++L     + + LA+ L  A  +   + YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA 152

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLD 222
                 IHRD+ A N+L+      K+ DFG A+   E      +       V   A    
Sbjct: 153 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA---- 205

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKER-------VTIRWAMQCLK 274
           P+ L+ Y+    SDV+SFGV L E++T             E        +T+    + L+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
            G+       RL R       V  ++     C       RPT +    IL  + + ++ +
Sbjct: 266 RGE-------RLPRPDKCPAEVYHLMKN---CWETEASFRPTFENLIPILKTVHEKYQGQ 315

Query: 335 APS 337
           APS
Sbjct: 316 APS 318

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  135 bits (341), Expect = 2e-36
 Identities = 72/271 (26%), Positives = 114/271 (42%), Gaps = 32/271 (11%)

Query: 3   STDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSP---------A 53
            +     ++      S   Y   ++      + +N    E+ +A ++             
Sbjct: 38  CSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN---PELVQAVQHVVIGPSSLIVHFN 94

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             IG G  G VY G L D        AVK +     D   + +F  E +      H N++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 110 KLFGF-LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            L G  L      ++V+ Y+ +G LR  +     N   + + +   + VA  + +L   +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFL---A 209

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ----VKGTAGYLDP 223
               +HRD+ A N ++ EK   KV DFG AR M +++    H  T     VK  A     
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----L 265

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           + L+T + T KSDV+SFGVLL E+MT G  P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (336), Expect = 2e-36
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             IG+G  G VY G+  D +      A+K +     +   +  F  E L    + H N++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 110 KLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            L G +   +    +++ Y+ +G L + +     N   + + +   + VA  + YL   +
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYL---A 141

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ-----VKGTAGYLDP 223
           +   +HRD+ A N ++ E    KV DFG AR   +    S    +     VK TA     
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----L 197

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           + L+TY+ T KSDV+SFGVLL E++T G  P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  133 bits (337), Expect = 2e-36
 Identities = 74/317 (23%), Positives = 134/317 (42%), Gaps = 39/317 (12%)

Query: 54  NKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
           +++G+G  G+V   +        G++VAVK+ + +  D+    +F+ EI     +    +
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFI 86

Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       +   +V+EY+ +G LR+ L       L+ +  L  +  +   + YL +
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGS 145

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQ--VKGTAGYLD 222
                 +HRD+ A NIL+  +   K+ DFG A++   ++D  V     Q  +   A    
Sbjct: 146 RR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA---- 198

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP-------IESKKPIKERVTIRWAMQCLK 274
           P+ L     + +SDV+SFGV+L E+ T            +      ++   +   ++ L+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
            G        RL   PA    V +++ L   C AP+ Q RP+       L  +    R  
Sbjct: 259 EGQ-------RLPAPPACPAEVHELMKL---CWAPSPQDRPSFSALGPQLDMLWSGSRGC 308

Query: 335 APSSFSSSSSPASASES 351
              +F++       S S
Sbjct: 309 ETHAFTAHPEGKHHSLS 325

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (338), Expect = 3e-36
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 19/209 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGS-----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
             +G G  GTVYKG            VA+K  R+    K    E  +E    + +++ ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHV 79

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            +L G         ++ + +  G L +++     N +     L+  + +A  + YL    
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL---E 134

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ---VKGTAGYLDPDY 225
           D  ++HRD+ A N+L+      K+TDFG A++   +    H       +K  A     + 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----LES 190

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T +SDV+S+GV + E+MT G  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (340), Expect = 3e-36
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 18/209 (8%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             +G G  G V  G+LK  S     VA+K  +    +K    +F  E     + +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK-QRRDFLGEASIMGQFDHPNII 109

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L G +      +IV EY+ NG+L   L         + + + +   +A  + YL   SD
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL---SD 165

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLDPDY 225
              +HRD+ A NILI   L  KV+DFG  R+ E+D   ++ +      ++ T+    P+ 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEA 221

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +   + T  SDV+S+G++L E+M+ G  P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  132 bits (334), Expect = 3e-36
 Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 30/234 (12%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            +F     IG GG G V+K K   DG    +KR + N          + E+   +K++H+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAKLDHV 64

Query: 107 NLVKLFGFLEHGDERI----------------IVVEYVGNGTLREHLDGRGGNGLELAER 150
           N+V   G  +  D                   I +E+   GTL + ++ R G  L+    
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
           L++   +   + Y+H      +I+RD+K SNI + +  + K+ DFG     + D      
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---- 177

Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
            T+ KGT  Y+ P+ + +    ++ D+Y+ G++L E++               +
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 231

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  132 bits (335), Expect = 3e-36
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 54  NKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
             +GEG  G V   +        G  VAVK  +        + + K EI     + H N+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENI 85

Query: 109 VKLFGF-LEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G   E G   I +++E++ +G+L+E+L       + L ++L  A+ +   + YL +
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGS 144

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLD 222
                 +HRD+ A N+L+  + + K+ DFG  +  E D     +       V   A    
Sbjct: 145 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA---- 197

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           P+ L   +    SDV+SFGV L E++T
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 7e-36
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             +G+G  G+V + +LK        VAVK  + +      + EF  E     + +H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 110 KLFGF------LEHGDERIIVVEYVGNGTLREHL----DGRGGNGLELAERLDIAIDVAH 159
           KL G              ++++ ++ +G L   L     G     L L   +   +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ--VKG 216
            + YL   S    IHRD+ A N ++ E +   V DFG +R +   D      +++  VK 
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            A     + L     T  SDV++FGV + E+MT G+ P
Sbjct: 206 LA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  131 bits (332), Expect = 7e-36
 Identities = 67/211 (31%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             IG G  G VY G L D        AVK +     D   + +F  E +      H N++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 110 KLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            L G     +    +V+ Y+ +G LR  +     N   + + +   + VA  + YL   +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYL---A 145

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ----VKGTAGYLDP 223
               +HRD+ A N ++ EK   KV DFG AR M +++    H  T     VK  A     
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA----L 201

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           + L+T + T KSDV+SFGVLL E+MT G  P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  134 bits (339), Expect = 8e-36
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 24/238 (10%)

Query: 25  SSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNK 84
           S     G   T      +I     +F P + +G G  GT+    + D   VAVKR     
Sbjct: 6   SLEQDDGDEETSVVIVGKI-----SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC 60

Query: 85  HDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN 143
                      E+    +  EH N+++ F   +    + I +E     TL+E+++ +   
Sbjct: 61  FSF-----ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA 114

Query: 144 GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-----LRAKVTDFGFA 198
            L L E + +       L +LH+ +   I+HRD+K  NILI+       ++A ++DFG  
Sbjct: 115 HLGL-EPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170

Query: 199 RMSEEDSAVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYP 253
           +            + V GT G++ P+ L        T   D++S G +   +++    
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (330), Expect = 2e-35
 Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 40/299 (13%)

Query: 54  NKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +        G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 73

Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L       ++  + L     +   + YL T
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 132

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLD 222
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +       +   A    
Sbjct: 133 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA---- 185

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER---------VTIRWAMQCL 273
           P+ L   + +  SDV+SFGV+L E+ T     +S      R         + +   ++ L
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR 332
           K          RL R       +  I+     C       RP+ +  A  + +IR +  
Sbjct: 246 KNNG-------RLPRPDGCPDEIYMIMTE---CWNNNVNQRPSFRDLALRVDQIRDNMA 294

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (328), Expect = 3e-35
 Identities = 48/207 (23%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 55  KIGEGGSGTVYKGKLK--DGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  G+V +G  +     I VA+K  ++         E   E     ++++  +V+L
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRL 75

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G  +  +  ++V+E  G G L + L G+    + ++   ++   V+  + YL    +  
Sbjct: 76  IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLDPDYLR 227
            +HRD+ A N+L+  +  AK++DFG ++    D +     +     +K  A    P+ + 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             + + +SDV+S+GV + E ++ G+ P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKP 213

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (329), Expect = 3e-35
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLV 109
             +GEG  G+V +G LK        VAVK  + +   +  + EF +E        H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 110 KLFG-----FLEHGDERIIVVEYVGNGTLREHL----DGRGGNGLELAERLDIAIDVAHA 160
           +L G       +   + ++++ ++  G L  +L       G   + L   L   +D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ--VKGT 217
           + YL   S+   +HRD+ A N ++ + +   V DFG ++ +   D        +  VK  
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           A     + L     T KSDV++FGV + E+ T G  P
Sbjct: 217 A----IESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  129 bits (326), Expect = 4e-35
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 55  KIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
            IGEG  G V++G           VA+K  +    D  +  +F  E LT  + +H ++VK
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQFDHPHIVK 80

Query: 111 LFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           L G +   +  + I++E    G LR  L  R  + L+LA  +  A  ++ AL YL     
Sbjct: 81  LIGVIT--ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL---ES 134

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLR 227
              +HRD+ A N+L++     K+ DFG +R  E+ +       +  +K  A    P+ + 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA----PESIN 190

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             + T  SDV+ FGV + E++  G  P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  130 bits (328), Expect = 5e-35
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 54  NKIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
            ++G+G  G+V   +        G +VAVK+ + +  +   L +F+ EI     ++H N+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNI 104

Query: 109 VKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           VK  G       R   +++EY+  G+LR++L       ++  + L     +   + YL T
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGT 163

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLD 222
                 IHRD+   NIL+  + R K+ DFG  ++  +D     +       +   A    
Sbjct: 164 KR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA---- 216

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMT 249
           P+ L   + +  SDV+SFGV+L E+ T
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  129 bits (326), Expect = 6e-35
 Identities = 57/230 (24%), Positives = 93/230 (40%), Gaps = 33/230 (14%)

Query: 47  TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
             +F     +G+G  G V K +   D    A+K+ R  +     L    +E++  + + H
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNH 61

Query: 106 LNLVKLFGFLEHGDERI-------------IVVEYVGNGTLREHLDGRGGNGLELAERLD 152
             +V+ +         +             I +EY  NGTL + +     N  +  E   
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWR 120

Query: 153 IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS- 211
           +   +  AL+Y+H+     IIHRD+K  NI I E    K+ DFG A+       +  +  
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 212 ----------TQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTG 250
                     T   GTA Y+  + L  T    EK D+YS G++  EM+  
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  128 bits (325), Expect = 2e-34
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGS-----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
             +G G  GTV+KG            V +K        +       + +L    ++H ++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-SFQAVTDHMLAIGSLDHAHI 77

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           V+L G    G    +V +Y+  G+L +H+    G  L     L+  + +A  + YL    
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYL---E 132

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS---AVSHISTQVKGTAGYLDPDY 225
           +  ++HR++ A N+L+    + +V DFG A +   D      S   T +K  A     + 
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA----LES 188

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +   + T +SDV+S+GV + E+MT G  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  127 bits (321), Expect = 2e-34
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 55  KIGEGGSGTVYKGKLKDGSI----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
            +GEG  G VY+G   +       VAVK  +K+        +F +E +    ++H ++VK
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFMSEAVIMKNLDHPHIVK 77

Query: 111 LFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           L G +E  +E   I++E    G L  +L+    + L++   +  ++ +  A+ YL     
Sbjct: 78  LIGIIE--EEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYL---ES 131

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLR 227
              +HRD+   NIL+      K+ DFG +R  E++       T+  +K  +    P+ + 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS----PESIN 187

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             + T  SDV+ F V + E+++ G+ P
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQP 214

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (323), Expect = 3e-34
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            ++G+G  G VY+G  K          VA+K   +    +   +EF NE     +    +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNEASVMKEFNCHH 89

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL--------DGRGGNGLELAERLDIAIDVAH 159
           +V+L G +  G   ++++E +  G L+ +L        +        L++ + +A ++A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ--VKG 216
            + YL   +    +HRD+ A N ++ E    K+ DFG  R + E D           V+ 
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            +    P+ L+    T  SDV+SFGV+L E+ T    P
Sbjct: 207 MS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  128 bits (323), Expect = 3e-34
 Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 25/223 (11%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLF 112
            + EGG   VY+ + +  G   A+KR     +++        E+    K+  H N+V+  
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 113 GF-------LEHGDERIIVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDVAHALTYL 164
                     + G    +++  +  G L E L      G L     L I      A+ ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK--------- 215
           H    PPIIHRD+K  N+L++ +   K+ DFG A         S  + +           
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 216 GTAGYLDP---DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
            T  Y  P   D    + + EK D+++ G +L  +   ++P E
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  126 bits (319), Expect = 5e-34
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 21/210 (10%)

Query: 55  KIGEGGSGTVYKGKLKDGSI----VAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLV 109
           K+G+G  G V +G+    S     VAVK  + +       + +F  E+     ++H NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 110 KLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           +L+G +      + +V E    G+L + L    G+   L      A+ VA  + YL    
Sbjct: 85  RLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYL---E 138

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARM--SEEDSAVSHISTQ--VKGTAGYLDPD 224
               IHRD+ A N+L+  +   K+ DFG  R     +D  V     +      A    P+
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PE 194

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            L+T   +  SD + FGV L EM T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (321), Expect = 6e-34
 Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 31/221 (14%)

Query: 54  NKIGEGGSGTVYKGKLKDGS---IVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLV 109
           + IGEG  G V K ++K        A+KR ++         +F  E+    K+  H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-DHRDFAGELEVLCKLGHHPNII 89

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDIAI 155
            L G  EH     + +EY  +G L + L                   + L   + L  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ-- 213
           DVA  + YL   S    IHRD+ A NIL+ E   AK+ DFG +R   ++  V     +  
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLP 204

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           V+  A     + L     T  SDV+S+GVLL E+++ G  P
Sbjct: 205 VRWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (320), Expect = 7e-34
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 40/232 (17%)

Query: 54  NKIGEGGSGTVYKGKLKDG------SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
             +GEG  G V K            + VAVK  ++N      L +  +E     ++ H +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLSEFNVLKQVNHPH 87

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL----------------------DGRGGNGL 145
           ++KL+G        +++VEY   G+LR  L                      D      L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 146 ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEED 204
            + + +  A  ++  + YL   ++  ++HRD+ A NIL+ E  + K++DFG +R + EED
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 205 SAVSHISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           S V     +  VK  A     + L  +  T +SDV+SFGVLL E++T G  P
Sbjct: 205 SYVKRSQGRIPVKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (320), Expect = 7e-34
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 19/209 (9%)

Query: 54  NKIGEGGSGTVYKGKLKDGS-----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL 108
             +G G  GTVYKG            VA+K  R+    K    E  +E    + +++ ++
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEILDEAYVMASVDNPHV 79

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
            +L G         ++ + +  G L +++     N +     L+  + +A  + YL    
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL---E 134

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ---VKGTAGYLDPDY 225
           D  ++HRD+ A N+L+      K+TDFG A++   +    H       +K  A     + 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA----LES 190

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           +     T +SDV+S+GV + E+MT G  P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (320), Expect = 7e-34
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 34/226 (15%)

Query: 54  NKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
             +G G  G V +              VAVK  ++            +E+     I  HL
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHL 91

Query: 107 NLVKLFGF-LEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERL 151
           N+V L G   + G   +++VE+   G L  +L              +    + L L   +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHI 210
             +  VA  + +L   +    IHRD+ A NIL++EK   K+ DFG AR + ++   V   
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 211 STQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             +  +K  A    P+ +     T +SDV+SFGVLL E+ + G  P
Sbjct: 209 DARLPLKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (318), Expect = 8e-34
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 27/225 (12%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            +F P   +G GG G V++ K K D    A+KR R    +     +   E+   +K+EH 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHP 63

Query: 107 NLVKLFGFLEHGDERI------------IVVEYVGNGTLREHLDGRGGNG-LELAERLDI 153
            +V+ F      +               I ++      L++ ++GR      E +  L I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS-- 211
            + +A A+ +LH      ++HRD+K SNI  T     KV DFG     ++D     +   
Sbjct: 124 FLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 212 -------TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT 249
                  T   GT  Y+ P+ +     + K D++S G++L E++ 
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (320), Expect = 9e-34
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 35/227 (15%)

Query: 54  NKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-E 104
             +GEG  G V   +              VAVK  + +  +K  L +  +E+     I +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGK 99

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAER 150
           H N++ L G         ++VEY   G LRE+L              +      +   + 
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSH 209
           +     +A  + YL   +    IHRD+ A N+L+TE    K+ DFG AR ++  D     
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 210 ISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            + +  VK  A    P+ L     T +SDV+SFGVL+ E+ T G  P
Sbjct: 217 TNGRLPVKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  125 bits (315), Expect = 2e-33
 Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 39/228 (17%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSI--------VAVKRARKNKHDKCLLLEFKNEILT 99
           E+      +G+G    ++KG  ++           V +K   K   +      F      
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFFEAASM 65

Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            SK+ H +LV  +G    GDE I+V E+V  G+L  +L       + +  +L++A  +A 
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAA 124

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLR--------AKVTDFGFARMSEEDSAVSHIS 211
           A+ +L    +  +IH +V A NIL+  +           K++D G +             
Sbjct: 125 AMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----I 176

Query: 212 TQ--VKGTAGYLDP---DYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            Q  +        P   +  +       +D +SFG  L E+ + G  P
Sbjct: 177 LQERIPWVP----PECIENPKNL--NLATDKWSFGTTLWEICSGGDKP 218

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  130 bits (328), Expect = 2e-33
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 17/213 (7%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           E       IGEG  G V++G           VA+K  +    D  +  +F  E LT  + 
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS-VREKFLQEALTMRQF 448

Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H ++VKL G +   +   I++E    G LR  L  R  + L+LA  +  A  ++ AL Y
Sbjct: 449 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAY 506

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYL 221
           L        +HRD+ A N+L++     K+ DFG +R  E+ +       +  +K  A   
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA--- 560

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            P+ +   + T  SDV+ FGV + E++  G  P
Sbjct: 561 -PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (316), Expect = 2e-33
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 26/216 (12%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            +G+G +  V++G+ K  G + A+K        +  +     E     K+ H N+VKLF 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 114 FLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSD 169
             E    R  ++++E+   G+L   L+    N   L E   L +  DV   + +L     
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 170 PPIIHRDVKASNILIT----EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
             I+HR++K  NI+       +   K+TDFG AR  E+D         + GT  YL PD 
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDM 186

Query: 226 LRTYQL--------TEKSDVYSFGVLLVEMMTGRYP 253
                L            D++S GV      TG  P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  127 bits (320), Expect = 3e-33
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 26/216 (12%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
            +G+G +  V++G+ K  G + A+K        +  +     E     K+ H N+VKLF 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 114 FLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSD 169
             E    R  ++++E+   G+L   L+    N   L E   L +  DV   + +L     
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG- 132

Query: 170 PPIIHRDVKASNILIT----EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
             I+HR++K  NI+       +   K+TDFG AR  E+D       +   GT  YL PD 
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLY-GTEEYLHPDM 186

Query: 226 LRTYQL--------TEKSDVYSFGVLLVEMMTGRYP 253
                L            D++S GV      TG  P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (316), Expect = 3e-33
 Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 35/227 (15%)

Query: 54  NKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
             +G G  G V +              VAVK  + + H         +E+   S +  H+
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-EREALMSELKVLSYLGNHM 87

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHL----------------DGRGGNGLELAER 150
           N+V L G    G   +++ EY   G L   L                       L+L + 
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSH 209
           L  +  VA  + +L   +    IHRD+ A NIL+T     K+ DFG AR +  + + V  
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 210 ISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            + +  VK  A    P+ +     T +SDV+S+G+ L E+ + G  P
Sbjct: 205 GNARLPVKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (317), Expect = 4e-33
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 40/281 (14%)

Query: 3   STDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFE---EIYKATENFSPANKIGEG 59
            +  S  SNT   R ++R   ++ +P     +      +   E  +  +  +    +GEG
Sbjct: 35  ESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPR--DKLTLGKPLGEG 92

Query: 60  GSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVK 110
             G V   +              VAVK  + +  +K  L +  +E+     I +H N++ 
Sbjct: 93  CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNIIN 151

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDIAID 156
           L G         ++VEY   G LRE+L              +      +   + +     
Sbjct: 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ-- 213
           +A  + YL   +    IHRD+ A N+L+TE    K+ DFG AR ++  D      + +  
Sbjct: 212 LARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           VK  A    P+ L     T +SDV+SFGVL+ E+ T G  P
Sbjct: 269 VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (314), Expect = 6e-33
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 31/223 (13%)

Query: 54  NKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
             +G G  G V +              VAVK  +   H         +E+   S + +H 
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHE 110

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHL------------DGRGGNGLELAERLDIA 154
           N+V L G   HG   +++ EY   G L   L                 +     + L  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ 213
             VA  + +L   +    IHRDV A N+L+T    AK+ DFG AR +  + + +   + +
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 214 --VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             VK  A    P+ +     T +SDV+S+G+LL E+ + G  P
Sbjct: 228 LPVKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (324), Expect = 6e-33
 Identities = 47/207 (22%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 55  KIGEGGSGTVYKGKLK--DGSI-VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           ++G G  G+V +G  +     I VA+K  ++         E   E     ++++  +V+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-DTEEMMREAQIMHQLDNPYIVRL 401

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPP 171
            G  +  +  ++V+E  G G L + L G+    + ++   ++   V+  + YL    +  
Sbjct: 402 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ----VKGTAGYLDPDYLR 227
            +HR++ A N+L+  +  AK++DFG ++    D +     +     +K  A    P+ + 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             + + +SDV+S+GV + E ++ G+ P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (312), Expect = 1e-32
 Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 40/232 (17%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL 106
             +G G  G V        S       VAVK  ++            +E+   +++  H 
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-EREALMSELKMMTQLGSHE 109

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHL---------------------DGRGGNGL 145
           N+V L G         ++ EY   G L  +L                     +    N L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 146 ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEED 204
              + L  A  VA  + +L        +HRD+ A N+L+T     K+ DFG AR +  + 
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 205 SAVSHISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
           + V   + +  VK  A    P+ L     T KSDV+S+G+LL E+ + G  P
Sbjct: 227 NYVVRGNARLPVKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (308), Expect = 2e-32
 Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 34/231 (14%)

Query: 47  TENFSPANKIGEGGSGTVYKG-KLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-E 104
           T  F    KIG G  G+V+K  K  DG I A+KR++K             E+   + + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALT 162
           H ++V+ F      D  +I  EY   G+L + +           E    D+ + V   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 163 YLHTYSDPPIIHRDVKASNILITE-------------------KLRAKVTDFGFARMSEE 203
           Y+H      ++H D+K SNI I+                    K+  K+ D G       
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--- 183

Query: 204 DSAVSHISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYP 253
              +S    +  G + +L  + L+  Y    K+D+++  + +V        
Sbjct: 184 ---ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (313), Expect = 2e-32
 Identities = 66/227 (29%), Positives = 96/227 (42%), Gaps = 35/227 (15%)

Query: 54  NKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-E 104
             +GEG  G V   +            + VAVK  + +  +K  L +  +E+     I +
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEMMKMIGK 133

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAER 150
           H N++ L G         ++VEY   G LRE+L                     L   + 
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSH 209
           +  A  VA  + YL   +    IHRD+ A N+L+TE    K+ DFG AR +   D     
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 210 ISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            + +  VK  A    P+ L     T +SDV+SFGVLL E+ T G  P
Sbjct: 251 TNGRLPVKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 3e-32
 Identities = 54/254 (21%), Positives = 101/254 (39%), Gaps = 22/254 (8%)

Query: 7   STESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYK 66
           +   ++ S++       +  +        +     E  +     +   ++G G  G V++
Sbjct: 17  AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR 76

Query: 67  GK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV 125
            K  + G   AVK+ R              E++  + +    +V L+G +  G    I +
Sbjct: 77  MKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAVREGPWVNIFM 129

Query: 126 EYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHTYSDPPIIHRDVKASNI 182
           E +  G+L + +   G     L E              L YLHT     I+H DVKA N+
Sbjct: 130 ELLEGGSLGQLIKQMG----CLPEDR-ALYYLGQALEGLEYLHTRR---ILHGDVKADNV 181

Query: 183 LITEK-LRAKVTDFGFARMSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYS 239
           L++    RA + DFG A   + D     + T   + GT  ++ P+ +       K D++S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241

Query: 240 FGVLLVEMMTGRYP 253
              +++ M+ G +P
Sbjct: 242 SCCMMLHMLNGCHP 255

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  121 bits (307), Expect = 3e-32
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 32/224 (14%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            ++GE   G VYKG L   +       VA+K  +       L  EF++E +  ++++H N
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-LREEFRHEAMLRARLQHPN 73

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDI 153
           +V L G +       ++  Y  +G L E L              D    + LE  + + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHIST 212
              +A  + YL   S   ++H+D+   N+L+ +KL  K++D G  R +   D      ++
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 213 Q--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
              ++  A    P+ +   + +  SD++S+GV+L E+ + G  P
Sbjct: 191 LLPIRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  127 bits (319), Expect = 3e-32
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 33/292 (11%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           ++G GG G V +   +D G  VA+K+ R+    K     +  EI    K+ H N+V    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSARE 79

Query: 114 FLE------HGDERIIVVEYVGNGTLREHLDGRG-GNGLELAERLDIAIDVAHALTYLHT 166
             +        D  ++ +EY   G LR++L+      GL+      +  D++ AL YLH 
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 167 YSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
                IIHRD+K  NI++    ++L  K+ D G+A+  ++      + T+  GT  YL P
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQYLAP 192

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES-------KKPIKERVTIRWAMQCLKAG 276
           + L   + T   D +SFG L  E +TG  P             ++E+      +     G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 277 DAIL---VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW 325
                  +  P       +      +  +    L   ++ R T  +   +  
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCM----LMWHQRQRGTDPQNPNVGC 300

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  120 bits (304), Expect = 1e-31
 Identities = 65/220 (29%), Positives = 93/220 (42%), Gaps = 30/220 (13%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
             +G G  G VY+G++           VAVK   +   ++   L+F  E L  SK  H N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISKFNHQN 94

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAIDVAHALT 162
           +V+  G       R I++E +  G L+  L          + L + + L +A D+A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 163 YLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           YL    +   IHRD+ A N L+T       AK+ DFG AR           S   KG   
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------SYYRKGGCA 205

Query: 220 YL-----DPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
            L      P+       T K+D +SFGVLL E+ + G  P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  120 bits (302), Expect = 2e-31
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            ++GEG  G V+  +  + S      +VAVK  +          +F+ E    + ++H +
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEH 78

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL--------------DGRGGNGLELAERLDI 153
           +VK +G    GD  I+V EY+ +G L + L                +    L L++ L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHIST 212
           A  +A  + YL   +    +HRD+   N L+   L  K+ DFG +R +   D       T
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 213 Q--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
              ++       P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 196 MLPIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (307), Expect = 3e-31
 Identities = 58/282 (20%), Positives = 102/282 (36%), Gaps = 51/282 (18%)

Query: 50  FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNL 108
                 +G G SGTV       G  VAVKR   +  D         EI   ++  +H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDHPNV 71

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLEL-----AERLDIAIDVAHALTY 163
           ++ +          I +E      L++ ++ +  +   L        + +   +A  + +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 164 LHTYSDPPIIHRDVKASNILITEK-------------LRAKVTDFGFAR-MSEEDSAVSH 209
           LH+     IIHRD+K  NIL++               LR  ++DFG  + +    S+   
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 210 ISTQVKGTAGYLDPDYLR-------TYQLTEKSDVYSFGVLLVEMMTGRYP--------- 253
                 GT+G+  P+ L          +LT   D++S G +   +++             
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 254 --IESKKP-IKERVTIRWAMQCLKAGDAI---LVMDPRLRRT 289
             I      + E   +       +A D I   +  DP  R T
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  120 bits (302), Expect = 3e-31
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)

Query: 54  NKIGEGGSGTVYKGKLKDG------SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
             IGEG  G V++ +          ++VAVK  ++      +  +F+ E    ++ ++ N
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQADFQREAALMAEFDNPN 111

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL----------------------DGRGGNGL 145
           +VKL G    G    ++ EY+  G L E L                         G   L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 146 ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEED 204
             AE+L IA  VA  + YL   S+   +HRD+   N L+ E +  K+ DFG +R +   D
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 205 SAVSHISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
              +  +    ++       P+ +   + T +SDV+++GV+L E+ + G  P
Sbjct: 229 YYKADGNDAIPIRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (304), Expect = 5e-31
 Identities = 39/312 (12%), Positives = 80/312 (25%), Gaps = 64/312 (20%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVK--------------RARKNKHDKCLLLEFKNE---- 96
           +G+       +    + G    V               + ++      LL   KN+    
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 97  -----ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG-------NGTLREHLDGRGGNG 144
                I  +  ++     K+        +  ++  +           T  E L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 145 --LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE 202
             L    RL + + V   L  LH Y    ++H  ++  +I++ ++    +T F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 203 EDSAVSHISTQVKGTAGYLDPDYL----------RTYQLTEKSDVYSFGVLLVEMMTGRY 252
                   S       G+  P+                +T   D ++ G+ +  +     
Sbjct: 263 A-------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 253 PIESKKPIKERVTIRWAMQCLK-----AGDAI---LVMDPRLRRTPASNMAVEKILGLAD 304
           P      +       W  +  K         +   L      R  P   M   +   L  
Sbjct: 316 PNTDDAALG---GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372

Query: 305 VCLAPTRQSRPT 316
              A     +  
Sbjct: 373 ELSAALPLYQTD 384

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  119 bits (301), Expect = 7e-31
 Identities = 63/218 (28%), Positives = 92/218 (42%), Gaps = 26/218 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
             +G G  G VY+G++           VAVK   +   ++   L+F  E L  SK  H N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-DELDFLMEALIISKFNHQN 135

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-----DGRGGNGLELAERLDIAIDVAHALT 162
           +V+  G       R I++E +  G L+  L          + L + + L +A D+A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 163 YLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFAR-MSEEDSAVSHISTQ--VKG 216
           YL    +   IHRD+ A N L+T       AK+ DFG AR +               VK 
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
                 P+       T K+D +SFGVLL E+ + G  P
Sbjct: 253 MP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (300), Expect = 7e-31
 Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 15/249 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ++F   +++G G  G V+K   K  G ++A K          +  +   E+    +    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSP 91

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYL 164
            +V  +G      E  I +E++  G+L + L   G     + E++   ++I V   LTYL
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYL 147

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
                  I+HRDVK SNIL+  +   K+ DFG +    +  A S +     GT  Y+ P+
Sbjct: 148 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE 200

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
            L+    + +SD++S G+ LVEM  GRYPI      +  +     ++   A        P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 285 RLRRTPASN 293
                    
Sbjct: 261 GRPLNKFGM 269

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  118 bits (299), Expect = 8e-31
 Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 32/223 (14%)

Query: 54  NKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
            ++GEG  G V+  +  +        +VAVK  ++    +    +F+ E    + ++H +
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQH 104

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHL-------------DGRGGNGLELAERLDIA 154
           +V+ FG    G   ++V EY+ +G L   L             +      L L + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQ 213
             VA  + YL   +    +HRD+   N L+ + L  K+ DFG +R +   D       T 
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 214 --VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYP 253
             ++       P+ +   + T +SDV+SFGV+L E+ T G+ P
Sbjct: 222 LPIRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  117 bits (296), Expect = 1e-30
 Identities = 64/245 (26%), Positives = 114/245 (46%), Gaps = 21/245 (8%)

Query: 26  SSPKSGQATTINFSFEEIYKAT-ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKN 83
           SS  SG+ T       + Y+A   +     ++G G  G V+K + +  G ++AVK+ R++
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61

Query: 84  KHD---KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGR 140
            +    K +L++   +++     +   +V+ FG      +  I +E +G    +  L  R
Sbjct: 62  GNKEENKRILMDL--DVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKR 116

Query: 141 GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM 200
               +       + + +  AL YL       +IHRDVK SNIL+ E+ + K+ DFG +  
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174

Query: 201 SEEDSAVSHISTQVKGTAGY-----LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
             +D A      +  G A Y     +DP          ++DV+S G+ LVE+ TG++P +
Sbjct: 175 LVDDKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230

Query: 256 SKKPI 260
           + K  
Sbjct: 231 NCKTD 235

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (297), Expect = 2e-30
 Identities = 60/242 (24%), Positives = 101/242 (41%), Gaps = 20/242 (8%)

Query: 32  QATTINFSFEEIYKAT-ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCL 89
            +  +  S E+ +  T E+     +IG G  G+V K   K  G I+AVKR R    D+  
Sbjct: 5   SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKE 63

Query: 90  LLEFKNEILTW-SKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA 148
             +   ++       +   +V+ +G L    +  I +E +     + +          + 
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123

Query: 149 ERL--DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
           E +   I +    AL +L    +  IIHRD+K SNIL+      K+ DFG +    +  A
Sbjct: 124 EEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181

Query: 207 VSHISTQVKGTAGYLDP------DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI 260
                T+  G   Y+ P         + Y    +SDV+S G+ L E+ TGR+P      +
Sbjct: 182 ----KTRDAGCRPYMAPERIDPSASRQGY--DVRSDVWSLGITLYELATGRFPYPKWNSV 235

Query: 261 KE 262
            +
Sbjct: 236 FD 237

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (295), Expect = 2e-30
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +G+G  G VY G+ L +   +A+K   +   D         EI     ++H N+V+  G 
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHTYSDPP 171
                   I +E V  G+L   L  + G  L+  E+  I      +   L YLH   D  
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQT-IGFYTKQILEGLKYLH---DNQ 142

Query: 172 IIHRDVKASNILITEKL-RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
           I+HRD+K  N+LI       K++DFG    S+  + ++  +    GT  Y+ P+ +    
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFG---TSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 231 L--TEKSDVYSFGVLLVEMMTGRYP 253
               + +D++S G  ++EM TG+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 3e-30
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 26/223 (11%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEH 105
           E+F     +G+G  G VY  + K    I+A+K   K + +K  +    + E+   S + H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 106 LNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVA 158
            N+++L+G+  H   R+ +++EY   GT+   L            + D         ++A
Sbjct: 69  PNILRLYGYF-HDATRVYLILEYAPLGTVYRELQKLS--------KFDEQRTATYITELA 119

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
           +AL+Y H+     +IHRD+K  N+L+      K+ DFG++  +         +    GT 
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLC-GTL 171

Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            YL P+ +      EK D++S GVL  E + G+ P E+    +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 4e-30
 Identities = 36/374 (9%), Positives = 88/374 (23%), Gaps = 58/374 (15%)

Query: 1   ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGG 60
            +   +  E   K       +  ++  P++ + T  +   +              +  G 
Sbjct: 19  EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG----ERKLKLVEPLRVGD 74

Query: 61  SGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKL---FGFL 115
              V+  +  +     A+K       +    LE         +++   +  +       L
Sbjct: 75  RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLL 134

Query: 116 EHGD-----------------------ERIIVVEYVG--NGTLREHLD--GRGGNGLELA 148
              D                         ++++         L   LD          + 
Sbjct: 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGIL 194

Query: 149 ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
               +   +      L +     ++H      N+ I    R  + D            V 
Sbjct: 195 ALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW------KVG 245

Query: 209 HISTQVKGTAGYLDPDYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI 266
                      Y   ++L   T   T   + +  G+ +  +     P     P  +    
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305

Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW- 325
           R +++              L      +     I       L   R+ R    +  E    
Sbjct: 306 RPSLRVPGTDSLAFGSCTPL-----PDFVKTLIGRF----LNFDRRRRLLPLEAMETPEF 356

Query: 326 -KIRKDFREKAPSS 338
            +++ +      + 
Sbjct: 357 LQLQNEISSSLSTG 370

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (292), Expect = 2e-29
 Identities = 50/235 (21%), Positives = 83/235 (35%), Gaps = 28/235 (11%)

Query: 41  EEIYKATENFSPANKIGEGGS--GTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEI 97
              Y+          IG+G     TV   +    G  V V+R         ++   + E+
Sbjct: 24  GGCYELLT------VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI-- 155
                  H N+V         +E  +V  ++  G+ ++ +     +G+   E   IA   
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN--ELA-IAYIL 134

Query: 156 -DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDS---AVSHI 210
             V  AL Y+H       +HR VKAS+ILI+   +  ++       M         V   
Sbjct: 135 QGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 211 STQVKGTAGYLDP----DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                    +L P      L+ Y    KSD+YS G+   E+  G  P +     +
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGY--DAKSDIYSVGITACELANGHVPFKDMPATQ 244

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (286), Expect = 7e-29
 Identities = 54/276 (19%), Positives = 103/276 (37%), Gaps = 42/276 (15%)

Query: 10  SNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKL 69
            + K    +  + +  +     +   IN           ++     + +G    +   + 
Sbjct: 4   GSMKDILSNYSNLIYLNKYVKEKDKYIN-----------DYRIIRTLNQGKFNKIILCE- 51

Query: 70  KDGSIVAVKRARKNKHDKCLLLE---------------FKNEILTWSKIEHLNLVKLFGF 114
           KD    A+K+  K+  +K                    FKNE+   + I++   +   G 
Sbjct: 52  KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHTYS 168
           + + DE  I+ EY+ N ++ +  +            +       I   V ++ +Y+H   
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
           +  I HRDVK SNIL+ +  R K++DFG +    +      I     GT  ++ P++   
Sbjct: 172 N--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----KKIKGSR-GTYEFMPPEFFSN 224

Query: 229 YQLT--EKSDVYSFGVLLVEMMTGRYPIESKKPIKE 262
                  K D++S G+ L  M     P   K  + E
Sbjct: 225 ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (283), Expect = 8e-29
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 20/227 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           +++     IG G +  V           VA+KR    +  +  + E   EI   S+  H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLD---IAI---DVAHA 160
           N+V  +      DE  +V++ +  G++ + +      G   +  LD   IA    +V   
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHIS--TQVKGT 217
           L YLH       IHRDVKA NIL+ E    ++ DFG  A ++       +    T V GT
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GT 189

Query: 218 AGYLDP---DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
             ++ P   + +R Y    K+D++SFG+  +E+ TG  P     P+K
Sbjct: 190 PCWMAPEVMEQVRGY--DFKADIWSFGITAIELATGAAPYHKYPPMK 234

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (285), Expect = 1e-28
 Identities = 39/337 (11%), Positives = 91/337 (27%), Gaps = 68/337 (20%)

Query: 7   STESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYK 66
           +  + ++  + ++ S VS+S   +GQ   +     E             +G+       +
Sbjct: 35  NVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE---RPRTLVRGTVLGQEDPYAYLE 91

Query: 67  GK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKI--------------------- 103
               + G    V      +      ++  K E+L    +                     
Sbjct: 92  ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151

Query: 104 ----EHLNLVKLFGFLEHGDER-IIVVEYVGNGTLREHLD-----GRGGNGLELAERLDI 153
               +   ++++              +       L+   +           L    RL +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            + V   L  LH Y    ++H  ++  +I++ ++    +T F                  
Sbjct: 212 TLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-------VV 261

Query: 214 VKGTAGYLDPDYL-----------RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE 262
              + G+  P+             R   +T   D ++ G+++  +     PI     +  
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG- 320

Query: 263 RVTIRWAMQCLK-----AGDAI---LVMDPRLRRTPA 291
                W  +  K         +   L      R  P 
Sbjct: 321 --GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 355

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (282), Expect = 1e-28
 Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 35/282 (12%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEI-LTWSKIEH 105
           ++  P  ++G G  G V K +    G I+AVKR R    +         ++ ++   ++ 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDC 65

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTY 163
              V  +G L    +  I +E +   +L +        G  + E +   IA+ +  AL +
Sbjct: 66  PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           LH  S   +IHRDVK SN+LI    + K+ DFG +    +D A         G   Y+ P
Sbjct: 125 LH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDA-GCKPYMAP 178

Query: 224 ------DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
                    + Y  + KSD++S G+ ++E+   R+P +S     +       ++ +    
Sbjct: 179 ERINPELNQKGY--SVKSDIWSLGITMIELAILRFPYDSWGTPFQ------QLKQVVEEP 230

Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
           +     P+L     S   V+        CL    + RPT  +
Sbjct: 231 S-----PQLPADKFSAEFVDFT----SQCLKKNSKERPTYPE 263

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (282), Expect = 1e-28
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 12/216 (5%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            + ++   KIG+G SGTVY    +  G  VA+++    +  K       NEIL   + ++
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKN 76

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+V        GDE  +V+EY+  G+L + +     +  ++A    +  +   AL +LH
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA---VCRECLQALEFLH 133

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
           +     +IHRD+K+ NIL+      K+TDFGF   ++     S  ST V GT  ++ P+ 
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMV-GTPYWMAPEV 187

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           +       K D++S G++ +EM+ G  P  ++ P++
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  111 bits (281), Expect = 1e-28
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFG 113
           +G+G  G VY  + K    I+A+K   K++ +K  +    + EI   S + H N+++++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 114 FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLD------IAIDVAHALTYLHT 166
           +  H  +RI +++E+   G L + L   G        R D         ++A AL Y H 
Sbjct: 82  YF-HDRKRIYLMLEFAPRGELYKELQKHG--------RFDEQRSATFMEELADALHYCHE 132

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                +IHRD+K  N+L+  K   K+ DFG++  +          T   GT  YL P+ +
Sbjct: 133 RK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RTMC-GTLDYLPPEMI 184

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
                 EK D++  GVL  E + G  P +S    +
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (281), Expect = 2e-28
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 20/220 (9%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
                   KIGEG +G V   +    G  VAVK     K  +       NE++     +H
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQH 101

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALT 162
            N+V+++     G+E  +++E++  G L + +         L E   IA     V  AL 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEE-QIATVCEAVLQALA 155

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYL 221
           YLH      +IHRD+K+ +IL+T   R K++DFGF A++S++   V    + V GT  ++
Sbjct: 156 YLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VPKRKSLV-GTPYWM 208

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
            P+ +       + D++S G++++EM+ G  P  S  P++
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (282), Expect = 3e-28
 Identities = 32/234 (13%), Positives = 73/234 (31%), Gaps = 28/234 (11%)

Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARK-NKHDKCLLLEF 93
            E    ++     + +GEG    VY+    D           +K  +  N  +  +  + 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG---GNGLELAER 150
              +           +K +      +  ++V E    GTL   ++         +     
Sbjct: 118 MERLK---PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA-----------KVTDFGFAR 199
           +  A+ + + +  +H      IIH D+K  N ++                  + D G + 
Sbjct: 175 ISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
             +     +  + +   T+G+   + L       + D +     +  M+ G Y 
Sbjct: 232 DMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 6e-28
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 18/219 (8%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E F    K+GEG  G+VYK    + G IVA+K+       +    E   EI    + + 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ----EIIKEISIMQQCDS 83

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALT 162
            ++VK +G      +  IV+EY G G++ + +  R      L E   IA         L 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDE-IATILQSTLKGLE 139

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH       IHRD+KA NIL+  +  AK+ DFG A   +    ++  +T + GT  ++ 
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVI-GTPFWMA 193

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           P+ ++       +D++S G+  +EM  G+ P     P++
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (275), Expect = 7e-28
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 13/206 (6%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFG 113
           +G+G    VY+ + +  G  VA+K   K    K  +++  +NE+    +++H ++++L+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           + E  +   +V+E   NG +  +L  R     E   R  +   +   + YLH++    I+
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSHG---IL 134

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQL 231
           HRD+  SN+L+T  +  K+ DFG A   +      +      GT  Y+ P+      +  
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSAH-- 189

Query: 232 TEKSDVYSFGVLLVEMMTGRYPIESK 257
             +SDV+S G +   ++ GR P ++ 
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTD 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (276), Expect = 9e-28
 Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 21/216 (9%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            E +    ++G+G  G VYK K  + G++ A K       ++  L ++  EI   +  +H
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDH 75

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALT 162
             +VKL G   H  +  I++E+   G +   +         L E   I +    +  AL 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQ-IQVVCRQMLEALN 131

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           +LH+     IIHRD+KA N+L+T +   ++ DFG +  ++    +    + + GT  ++ 
Sbjct: 132 FLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFI-GTPYWMA 185

Query: 223 P-----DYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           P     + ++      K+D++S G+ L+EM     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (276), Expect = 9e-28
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 25/226 (11%)

Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRAR-KNKHDKCLLLEFKNEIL 98
           EE++   E      KIG+G  G V+KG   +   +VA+K    +   D+  + + + EI 
Sbjct: 21  EELFTKLE------KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEIT 72

Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI--- 155
             S+ +   + K +G      +  I++EY+G G+  + L+        L E   IA    
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQ-IATILR 126

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           ++   L YLH+      IHRD+KA+N+L++E    K+ DFG A   +        +T V 
Sbjct: 127 EILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV- 180

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           GT  ++ P+ ++      K+D++S G+  +E+  G  P     P+K
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  112 bits (281), Expect = 2e-27
 Identities = 69/297 (23%), Positives = 117/297 (39%), Gaps = 36/297 (12%)

Query: 15  SRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGS 73
                 +       ++     I      +   +E +    K+G G  G V   + K    
Sbjct: 7   HSSGRENLYFQGDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCRDKVTHV 63

Query: 74  IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTL 133
             A+K  RK         +   E+     ++H N++KL+ F E      +V+E    G L
Sbjct: 64  ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123

Query: 134 REHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKL 188
            + +  R     +  E     I   V   +TYLH ++   I+HRD+K  N+L+    +  
Sbjct: 124 FDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176

Query: 189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEM 247
             K+ DFG + + E    +     +  GTA Y+ P+ L + Y   EK DV+S GV+L  +
Sbjct: 177 LIKIVDFGLSAVFENQKKM----KERLGTAYYIAPEVLRKKY--DEKCDVWSIGVILFIL 230

Query: 248 MTGRYPI--ESKKPIKERV--------TIRWAMQCLKAGDAI---LVMDPRLRRTPA 291
           + G  P   ++ + I  +V        +  W      A D I   L  D + R +  
Sbjct: 231 LAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ 287

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (272), Expect = 4e-27
 Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 38/305 (12%)

Query: 1   ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGG 60
                HS+    + S  +  + + ++    G+      S  ++            +G GG
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGP---------LLGSGG 55

Query: 61  SGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEF----KNEILTWSKIEHL--NLVKLFG 113
            G+VY G  + D   VA+K   K++      L        E++   K+      +++L  
Sbjct: 56  FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115

Query: 114 FLEHGDERIIVVEYV-GNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSDP 170
           + E  D  ++++E       L + +  RG     L E L       V  A+ + H     
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG-- 169

Query: 171 PIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--R 227
            ++HRD+K  NILI   +   K+ DFG   + ++    +  +    GT  Y  P+++   
Sbjct: 170 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFD-GTRVYSPPEWIRYH 223

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE-RVTIRWAM--QCLKAGDAILVMDP 284
            Y     + V+S G+LL +M+ G  P E  + I   +V  R  +  +C       L + P
Sbjct: 224 RYHGRS-AAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRP 282

Query: 285 RLRRT 289
             R T
Sbjct: 283 SDRPT 287

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  106 bits (267), Expect = 9e-27
 Identities = 23/201 (11%), Positives = 53/201 (26%), Gaps = 39/201 (19%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
             G       ++         VA+            +L E  +  L  S+I+   + ++ 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
             +      ++V E++  G+L+E  D            +     +A A    H      +
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAH---RAGV 150

Query: 173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT 232
                  S + ++      +                            +           
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-----------------------TMPDA-------N 180

Query: 233 EKSDVYSFGVLLVEMMTGRYP 253
            + D+   G  L  ++  R+P
Sbjct: 181 PQDDIRGIGASLYALLVNRWP 201

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (269), Expect = 1e-26
 Identities = 54/250 (21%), Positives = 93/250 (37%), Gaps = 14/250 (5%)

Query: 12  TKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LK 70
               +       +  +P +              ++   +     +G+GG    ++     
Sbjct: 5   ADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDAD 64

Query: 71  DGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVG 129
              + A K   K+   K    E    EI     + H ++V   GF E  D   +V+E   
Sbjct: 65  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124

Query: 130 NGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR 189
             +L E    R    L   E       +     YLH      +IHRD+K  N+ + E L 
Sbjct: 125 RRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 179

Query: 190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQLTEKSDVYSFGVLLVEM 247
            K+ DFG A   E D     +     GT  Y+ P+ L  + +  + + DV+S G ++  +
Sbjct: 180 VKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH--SFEVDVWSIGCIMYTL 234

Query: 248 MTGRYPIESK 257
           + G+ P E+ 
Sbjct: 235 LVGKPPFETS 244

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  105 bits (265), Expect = 3e-26
 Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 10/204 (4%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFG 113
           +G+GG    ++        + A K   K+   K    E    EI     + H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           F E  D   +V+E     +L E    R    L   E       +     YLH      +I
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRNR---VI 137

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           HRD+K  N+ + E L  K+ DFG A   E D     +     GT  Y+ P+ L     + 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSF 194

Query: 234 KSDVYSFGVLLVEMMTGRYPIESK 257
           + DV+S G ++  ++ G+ P E+ 
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETS 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  108 bits (272), Expect = 3e-26
 Identities = 76/312 (24%), Positives = 124/312 (39%), Gaps = 47/312 (15%)

Query: 11  NTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK 70
           +      S R  +            +     +I    E++    K+G G  G V   K K
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEK 58

Query: 71  -DGSIVAVKRARKNK-----------HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG 118
              S  A+K  +K++           + +    E  NEI     ++H N++KLF   E  
Sbjct: 59  NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118

Query: 119 DERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRD 176
               +V E+   G L E +  R     +  E    +I   +   + YLH ++   I+HRD
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKHN---IVHRD 171

Query: 177 VKASNILITEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL-RTYQLT 232
           +K  NIL+  K   L  K+ DFG +    +D  +        GTA Y+ P+ L + Y   
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL----RDRLGTAYYIAPEVLKKKY--N 225

Query: 233 EKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV--------TIRWAMQCLKAGDAI--- 279
           EK DV+S GV++  ++ G  P   ++ + I ++V           W     +A + I   
Sbjct: 226 EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285

Query: 280 LVMDPRLRRTPA 291
           L  D   R T  
Sbjct: 286 LTYDYNKRCTAE 297

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  108 bits (271), Expect = 4e-26
 Identities = 69/259 (26%), Positives = 107/259 (41%), Gaps = 34/259 (13%)

Query: 54  NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKL 111
             +G+G  G V   K K  G   AVK   K +   K        E+    +++H N++KL
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 112 FGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSD 169
           + F E      +V E    G L + +  R       +E     I   V   +TY+H    
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKNK- 146

Query: 170 PPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
             I+HRD+K  N+L+  K      ++ DFG +   E    +        GTA Y+ P+ L
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM----KDKIGTAYYIAPEVL 200

Query: 227 -RTYQLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV--------TIRWAMQCLKA 275
             TY   EK DV+S GV+L  +++G  P    ++  I ++V          +W      A
Sbjct: 201 HGTY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 276 GDAI---LVMDPRLRRTPA 291
            D I   L   P +R +  
Sbjct: 259 KDLIRKMLTYVPSMRISAR 277

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  106 bits (266), Expect = 5e-26
 Identities = 64/271 (23%), Positives = 118/271 (43%), Gaps = 33/271 (12%)

Query: 6   HSTESNTKSSRKSSRSYVSSSSPKSGQATTIN-FSFEEIYKA---TENFSPANKIGEGGS 61
           H  + +  ++            P  G+A ++      E++      + FS   +IG G  
Sbjct: 8   HHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSF 67

Query: 62  GTVYKGK-LKDGSIVAVKR---ARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH 117
           G VY  + +++  +VA+K+   + K  ++K    +   E+    K+ H N ++  G    
Sbjct: 68  GAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPNTIQYRGCYLR 125

Query: 118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHTYSDPPIIH 174
                +V+EY   G+  + L+        L E   IA         L YLH+++   +IH
Sbjct: 126 EHTAWLVMEYCL-GSASDLLEVHKKP---LQEVE-IAAVTHGALQGLAYLHSHN---MIH 177

Query: 175 RDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           RDVKA NIL++E    K+ DFG  + M+  +S V        GT  ++ P+ +      +
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV--------GTPYWMAPEVILAMDEGQ 229

Query: 234 ---KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
              K DV+S G+  +E+   + P+ +   + 
Sbjct: 230 YDGKVDVWSLGITCIELAERKPPLFNMNAMS 260

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  107 bits (268), Expect = 9e-26
 Identities = 77/273 (28%), Positives = 115/273 (42%), Gaps = 39/273 (14%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEI 97
           +F E Y           +G+G  G V K K +      AVK   K             E+
Sbjct: 19  TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAI 155
               K++H N++KLF  LE      IV E    G L + +  R       +E     I  
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIK 128

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSHIST 212
            V   +TY+H ++   I+HRD+K  NIL+  K      K+ DFG +   ++++ +     
Sbjct: 129 QVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----K 181

Query: 213 QVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMTGRYPI--ESKKPIKERV----- 264
              GTA Y+ P+ L  TY   EK DV+S GV+L  +++G  P   +++  I +RV     
Sbjct: 182 DRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239

Query: 265 ---TIRWAMQCLKAGDAI---LVMDPRLRRTPA 291
                +W      A D I   L   P LR T  
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  101 bits (254), Expect = 1e-24
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 20/246 (8%)

Query: 24  SSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARK 82
           +   P +G         +   K  E+F     +GEG   TV   +        A+K   K
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK 65

Query: 83  -----NKHDKCLLLEFKNEILTWSKIEHLNLVKLFG-FLEHGDERI-IVVEYVGNGTLRE 135
                      +  E   +++  S+++H   VKL+  F    DE++   + Y  NG L +
Sbjct: 66  RHIIKENKVPYVTRE--RDVM--SRLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLK 119

Query: 136 HLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF 195
           ++  + G+  E   R   A ++  AL YLH      IIHRD+K  NIL+ E +  ++TDF
Sbjct: 120 YIR-KIGSFDETCTRFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174

Query: 196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
           G A++   +S  +  ++ V GTA Y+ P+ L      + SD+++ G ++ +++ G  P  
Sbjct: 175 GTAKVLSPESKQARANSFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 256 SKKPIK 261
           +     
Sbjct: 234 AGNEYL 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  101 bits (253), Expect = 2e-24
 Identities = 64/296 (21%), Positives = 113/296 (38%), Gaps = 40/296 (13%)

Query: 12  TKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LK 70
           TK  +       + + P  G+      +   +            +G+GG GTV+ G  L 
Sbjct: 4   TKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGP---------LLGKGGFGTVFAGHRLT 54

Query: 71  DGSIVAVKRARKNKHDKCLLLE----FKNEI----LTWSKIEHLNLVKLFGFLEHGDERI 122
           D   VA+K   +N+      L        E+       +   H  +++L  + E  +  +
Sbjct: 55  DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114

Query: 123 IVVEYVGNGT-LREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSDPPIIHRDVKA 179
           +V+E       L +++  +G     L E         V  A+ + H+     ++HRD+K 
Sbjct: 115 LVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKD 167

Query: 180 SNILI-TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQLTEKSD 236
            NILI   +  AK+ DFG   +  +       +    GT  Y  P+++    Y     + 
Sbjct: 168 ENILIDLRRGCAKLIDFGSGALLHD----EPYTDFD-GTRVYSPPEWISRHQYH-ALPAT 221

Query: 237 VYSFGVLLVEMMTGRYPIESKKPIKE-RVTIRWAM--QCLKAGDAILVMDPRLRRT 289
           V+S G+LL +M+ G  P E  + I E  +     +   C       L   P  R +
Sbjct: 222 VWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPS 277

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 66/257 (25%), Positives = 101/257 (39%), Gaps = 39/257 (15%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +GEG  G V           VAVK     +         K EI     + H N+VK +G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGH 73

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH--------ALTYLHT 166
              G+ + + +EY   G L + ++   G    + E        A          + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIG----MPE------PDAQRFFHQLMAGVVYLHG 123

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                I HRD+K  N+L+ E+   K++DFG A +   ++    ++    GT  Y+ P+ L
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179

Query: 227 --RTYQLTEKSDVYSFGVLLVEMMTGRYPIE---------SKKPIKERVTIRWAM---QC 272
             R +   E  DV+S G++L  M+ G  P +         S    K+     W       
Sbjct: 180 KRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 273 LKAGDAILVMDPRLRRT 289
           L     ILV +P  R T
Sbjct: 239 LALLHKILVENPSARIT 255

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (250), Expect = 6e-24
 Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 28/231 (12%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-E 104
              F     +G G  G VYKG+ +K G + A+K       ++    E K EI    K   
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSH 79

Query: 105 HLNLVKLFG-FLEHGDERI-----IVVEYVGNGTLREHLDGRGGNGLELAERLDIAI--- 155
           H N+   +G F++     +     +V+E+ G G++ + +    GN L+      IA    
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW---IAYICR 136

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
           ++   L++LH +    +IHRD+K  N+L+TE    K+ DFG +  ++ D  V   +T + 
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI- 190

Query: 216 GTAGYLDPDYLRTYQLTE-----KSDVYSFGVLLVEMMTGRYPIESKKPIK 261
           GT  ++ P+ +   +  +     KSD++S G+  +EM  G  P+    P++
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 75/328 (22%), Positives = 119/328 (36%), Gaps = 52/328 (15%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           +GEG  G V           VAVK     +         K EI     + H N+VK +G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGH 73

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH--------ALTYLHT 166
              G+ + + +EY   G L + ++   G    + E        A          + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIG----MPE------PDAQRFFHQLMAGVVYLHG 123

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                I HRD+K  N+L+ E+   K++DFG A +   ++    ++    GT  Y+ P+ L
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179

Query: 227 --RTYQLTEKSDVYSFGVLLVEMMTGRYPIE---------SKKPIKERVTIRWAM---QC 272
             R +   E  DV+S G++L  M+ G  P +         S    K+     W       
Sbjct: 180 KRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238

Query: 273 LKAGDAILVMDPRLRRTPASNMAVEKIL-------GLADVCLAPTRQSRPTMKKCAEILW 325
           L     ILV +P  R T      +  I         L      P   S    +  +    
Sbjct: 239 LALLHKILVENPSARIT------IPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSK 292

Query: 326 KIRKDFREKAPSSFSSSSSPASASESHY 353
            I+ +      +S S +     + E H+
Sbjct: 293 HIQSNLDFSPVNSASRTPGSGWSKEHHH 320

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 13/201 (6%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           IG+G    V   + +  G  VA+K   K + +   L +   E+     + H N+VKLF  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
           +E      +++EY   G + ++L   G   ++  E       +  A+ Y H      I+H
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---IVH 137

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQLT 232
           RD+KA N+L+   +  K+ DFGF+           +     G   Y  P+    + Y   
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFC-GAPPYAAPELFQGKKYDGP 193

Query: 233 EKSDVYSFGVLLVEMMTGRYP 253
           E  DV+S GV+L  +++G  P
Sbjct: 194 E-VDVWSLGVILYTLVSGSLP 213

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.8 bits (244), Expect = 5e-23
 Identities = 52/228 (22%), Positives = 86/228 (37%), Gaps = 15/228 (6%)

Query: 26  SSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNK 84
           S   SG    I    ++     + +     IG+G    V +   ++ G   AVK     K
Sbjct: 2   SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61

Query: 85  HDKCLLLE---FKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG 141
                 L     K E      ++H ++V+L           +V E++    L   +  R 
Sbjct: 62  FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121

Query: 142 GNGLELAERL--DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFG 196
             G   +E +       +  AL Y H  +   IIHRDVK   +L+  K  +   K+  FG
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178

Query: 197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
            A    E   V   +    GT  ++ P+ ++     +  DV+  GV+L
Sbjct: 179 VAIQLGESGLV---AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 30/218 (13%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEF 93
             E+ Y   E      ++G G    V K + K  G   A K    R  +         E 
Sbjct: 9   KVEDFYDIGE------ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           + E+    ++ H N++ L    E+  + ++++E V  G L + L  +      L+E  + 
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SLSEE-EA 117

Query: 154 AI---DVAHALTYLHTYSDPPIIHRDVKASNILITEK----LRAKVTDFGFARMSEEDSA 206
                 +   + YLHT     I H D+K  NI++ +K       K+ DFG A   E+   
Sbjct: 118 TSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
                  + GT  ++ P+ +    L  ++D++S GV+ 
Sbjct: 175 F----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 27/222 (12%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
           +F E Y           +G+G  G V K K +      AVK   K             E+
Sbjct: 19  TFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAI 155
               K++H N++KLF  LE      IV E    G L + +  R       +E     I  
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIK 128

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
            V   +TY+H ++   I+HRD+K  NIL+    +    K+ DFG +   ++++ +     
Sbjct: 129 QVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----K 181

Query: 213 QVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMTGRYP 253
              GTA Y+ P+ L  TY   EK DV+S GV+L  +++G  P
Sbjct: 182 DRIGTAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSG-TP 220

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 28/217 (12%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEF 93
             E+ Y   E      ++G G    V K + K  G   A K    R  +         E 
Sbjct: 9   KVEDFYDIGE------ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--L 151
           + E+    ++ H N++ L    E+  + ++++E V  G L + L  +      L+E    
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE----SLSEEEAT 118

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK----LRAKVTDFGFARMSEEDSAV 207
                +   + YLHT     I H D+K  NI++ +K       K+ DFG A   E+    
Sbjct: 119 SFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
                 + GT  ++ P+ +    L  ++D++S GV+ 
Sbjct: 176 ----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 62/260 (23%), Positives = 104/260 (40%), Gaps = 40/260 (15%)

Query: 10  SNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKL 69
           + + S  K    +  +   +S        +  + Y  ++       +G G  G V     
Sbjct: 107 ALSLSRNKVFVFFDLTVDDQSVYPK----ALRDEYIMSK------TLGSGACGEVKLAFE 156

Query: 70  KD-GSIVAVKRARKNK------HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI 122
           +     VA++   K K       +    L  + EI    K+ H  ++K+  F +   E  
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--AEDY 214

Query: 123 -IVVEYVGNGTLREHLDGRGGNGLELAERL--DIAIDVAHALTYLHTYSDPPIIHRDVKA 179
            IV+E +  G L + + G       L E         +  A+ YLH      IIHRD+K 
Sbjct: 215 YIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKP 267

Query: 180 SNILITEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL---TE 233
            N+L++ +      K+TDFG +++  E S    + T   GT  YL P+ L +        
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC-GTPTYLAPEVLVSVGTAGYNR 323

Query: 234 KSDVYSFGVLLVEMMTGRYP 253
             D +S GV+L   ++G YP
Sbjct: 324 AVDCWSLGVILFICLSG-YP 342

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 28/217 (12%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEF 93
             E+ Y+  E      ++G G    V K + K  G   A K    R   +        E 
Sbjct: 2   MVEDHYEMGE------ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 55

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--L 151
           + E+    +I H N++ L    E+  + ++++E V  G L + L  +      L E    
Sbjct: 56  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE----SLTEDEAT 111

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA----KVTDFGFARMSEEDSAV 207
                +   + YLH+     I H D+K  NI++ +K       K+ DFG A   E  +  
Sbjct: 112 QFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
                 + GT  ++ P+ +    L  ++D++S GV+ 
Sbjct: 169 ----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 4e-22
 Identities = 56/258 (21%), Positives = 104/258 (40%), Gaps = 31/258 (12%)

Query: 2   DSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFS------PANK 55
           +       +   + R   +S  +S+      A    F    +       +          
Sbjct: 37  NEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEI 96

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           +G G  G V+K +    G  +A K    R  K+K +       KNEI   ++++H NL++
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE------VKNEISVMNQLDHANLIQ 150

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYS 168
           L+   E  ++ ++V+EYV  G L + +     N   L E   +     +   + ++H   
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYN---LTELDTILFMKQICEGIRHMHQMY 207

Query: 169 DPPIIHRDVKASNILITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
              I+H D+K  NIL   +     K+ DFG AR  +    +        GT  +L P+ +
Sbjct: 208 ---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL----KVNFGTPEFLAPEVV 260

Query: 227 RTYQLTEKSDVYSFGVLL 244
               ++  +D++S GV+ 
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.1 bits (232), Expect = 8e-22
 Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 21/221 (9%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
           + ++++          K+G G  G V+  + +  G    +K   K++    +  + + EI
Sbjct: 19  TIDDLFIFKR------KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEI 71

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAI 155
                ++H N++K+F   E      IV+E    G L E +      G  L+E    ++  
Sbjct: 72  EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
            + +AL Y H+     ++H+D+K  NIL          K+ DFG A + + D    H + 
Sbjct: 132 QMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTN 185

Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
              GTA Y+ P+  +   +T K D++S GV++  ++TG  P
Sbjct: 186 AA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 26/211 (12%)

Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEIL 98
             E Y   E       +G G  G V++            K  +    D+ L+   K EI 
Sbjct: 3   LYEKYMIAE------DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV---KKEIS 53

Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI--- 155
             +   H N++ L    E  +E +++ E++    + E ++       EL ER +I     
Sbjct: 54  ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF---ELNER-EIVSYVH 109

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA--KVTDFGFARMSEEDSAVSHISTQ 213
            V  AL +LH+++   I H D++  NI+   +  +  K+ +FG AR  +           
Sbjct: 110 QVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RL 162

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
           +     Y  P+  +   ++  +D++S G L+
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK----------CLLLEFKNEI 97
           E +    KIGEG  G VYK +   G   A+K+ R  K D+           +L E K   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK--- 58

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
                  H N+VKL+  + H  +R+ +V E++ +  L++ LD   G GLE        + 
Sbjct: 59  -------HSNIVKLYD-VIHTKKRLVLVFEHL-DQDLKKLLDVCEG-GLESVTAKSFLLQ 108

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQVK 215
           + + + Y H      ++HRD+K  N+LI  +   K+ DFG AR         +H   ++ 
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV 162

Query: 216 GTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  PD L   + Y  +   D++S G +  EM+ G 
Sbjct: 163 -TLWYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGT 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 28/217 (12%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEF 93
           + ++ Y   E      ++G G    V K + K  G   A K    R  K+        + 
Sbjct: 8   NVDDYYDTGE------ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--L 151
           + E+    +I+H N++ L    E+  + I+++E V  G L + L  +      L E    
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE----SLTEEEAT 117

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA----KVTDFGFARMSEEDSAV 207
           +    + + + YLH+     I H D+K  NI++ ++       K+ DFG A   +  +  
Sbjct: 118 EFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174

Query: 208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
                 + GT  ++ P+ +    L  ++D++S GV+ 
Sbjct: 175 ----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 47/231 (20%), Positives = 88/231 (38%), Gaps = 16/231 (6%)

Query: 20  RSYVSSSSPKSGQATTINFSFEEIYKATENFS-PANKIGEGGSGTVYKGKLKD-GSIVAV 77
             +  SS    G       S E        +   + ++G G    V +   K  G   A 
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMENF---NNFYILTSKELGRGKFAVVRQCISKSTGQEYAA 59

Query: 78  KRARKNKHDKCLLLEFKNEILTWSKIEHL-NLVKLFGFLEHGDERIIVVEYVGNGTLREH 136
           K  +K +  +    E  +EI      +    ++ L    E+  E I+++EY   G +   
Sbjct: 60  KFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119

Query: 137 LDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVT 193
                   +   + + +   +   + YLH  +   I+H D+K  NIL+         K+ 
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176

Query: 194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
           DFG +R       +     ++ GT  YL P+ L    +T  +D+++ G++ 
Sbjct: 177 DFGMSRKIGHACEL----REIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.2 bits (230), Expect = 2e-21
 Identities = 63/219 (28%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDK----------CLLLEFKNE 96
           E +    KIGEG  G V+K + +D G IVA+K+  +++ D            +L + K  
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-- 60

Query: 97  ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
                   H NLV L           +V EY  + T+   LD R   G+       I   
Sbjct: 61  --------HPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELD-RYQRGVPEHLVKSITWQ 110

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQVK 215
              A+ + H ++    IHRDVK  NILIT+    K+ DFGFAR+ +           +V 
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EV- 163

Query: 216 GTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  P+ L     Y      DV++ G +  E+++G 
Sbjct: 164 ATRWYRSPELLVGDTQY--GPPVDVWAIGCVFAELLSGV 200

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 58/312 (18%), Positives = 100/312 (32%), Gaps = 69/312 (22%)

Query: 40  FEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK---RARKNKHDKCLLLEFKN 95
            ++ Y           IG+G  G V         +I A+K   + +  + +   +   K 
Sbjct: 24  LQKKYHLKG------AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL---- 151
           E+    K+ H N+ +L+   E      +V+E    G L + L+    +            
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137

Query: 152 ----------------------------------DIAIDVAHALTYLHTYSDPPIIHRDV 177
                                             +I   +  AL YLH      I HRD+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDI 194

Query: 178 KASNILITEKLRA--KVTDFGFARMSE-EDSAVSHISTQVKGTAGYLDPDYLRTYQL--T 232
           K  N L +       K+ DFG ++     ++   +  T   GT  ++ P+ L T      
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254

Query: 233 EKSDVYSFGVLLVEMMTGRYP--IESKKPIKERVTI--------RWAMQCLKAGDAI--- 279
            K D +S GVLL  ++ G  P    +      +V           + +    A D +   
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNL 314

Query: 280 LVMDPRLRRTPA 291
           L  +   R    
Sbjct: 315 LNRNVDERFDAM 326

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 65/249 (26%), Positives = 100/249 (40%), Gaps = 27/249 (10%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNK------HDKCLLLEFKNEILTWSKIEHLNL 108
           +G G  G V+     +    V VK  +K K       +   L +   EI   S++EH N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 109 VKLFGFLEHGDERIIVVEYVGNGT-LREHLDGRGGNGLELAERLDIAI--DVAHALTYLH 165
           +K+    E+     +V+E  G+G  L   +D        L E L   I   +  A+ YL 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLR 147

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 IIHRD+K  NI+I E    K+ DFG A   E         T   GT  Y  P+ 
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFC-GTIEYCAPEV 200

Query: 226 L--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE-RVTIRWAM--QCLKAGDAIL 280
           L    Y+  E  +++S GV L  ++    P    +   E  +   + +  + +     +L
Sbjct: 201 LMGNPYRGPE-LEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLL 259

Query: 281 VMDPRLRRT 289
              P  R T
Sbjct: 260 QPVPERRTT 268

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 91.8 bits (229), Expect = 4e-21
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 37/219 (16%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK----------CLLLEFKNEI 97
           E +    K+GEG  G VYK K   G IVA+KR R +  D+           LL E     
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
                  H N+V L   + H +  + +V E++    L++ LD     GL+ ++       
Sbjct: 78  -------HPNIVSLID-VIHSERCLTLVFEFM-EKDLKKVLDENKT-GLQDSQIKIYLYQ 127

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQVK 215
           +   + + H +    I+HRD+K  N+LI      K+ DFG AR       + +H   +V 
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV 181

Query: 216 GTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
            T  Y  PD L   + Y  +   D++S G +  EM+TG+
Sbjct: 182 -TLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITGK 217

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 25/249 (10%)

Query: 6   HSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFS----PANKIGEGGS 61
           HS+  +  +     +S  S ++  +    ++   +       +  S      +++G G +
Sbjct: 7   HSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGAT 66

Query: 62  GTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE 120
             VY+ K K      A+K  +K    K      + EI    ++ H N++KL    E   E
Sbjct: 67  SIVYRCKQKGTQKPYALKVLKKTVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTE 122

Query: 121 RIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRDVK 178
             +V+E V  G L + +  +G      +ER   D    +  A+ YLH      I+HRD+K
Sbjct: 123 ISLVLELVTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175

Query: 179 ASNILITEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKS 235
             N+L          K+ DFG +++ E       + T   GT GY  P+ LR      + 
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVC-GTPGYCAPEILRGCAYGPEV 231

Query: 236 DVYSFGVLL 244
           D++S G++ 
Sbjct: 232 DMWSVGIIT 240

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.0 bits (227), Expect = 5e-21
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 38/223 (17%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDK----------CLLLEFKNE 96
           + +    KIGEG  GTV+K K  +   IVA+KR R +  D+          CLL E K  
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-- 59

Query: 97  ILTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
                   H N+V+L   + H D+++ +V E+  +  L+++ D   G  L+         
Sbjct: 60  --------HKNIVRLHD-VLHSDKKLTLVFEFC-DQDLKKYFDSCNG-DLDPEIVKSFLF 108

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQV 214
            +   L + H+ +   ++HRD+K  N+LI      K+ +FG AR         S    +V
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EV 162

Query: 215 KGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
             T  Y  PD L   + Y  +   D++S G +  E+     P+
Sbjct: 163 V-TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPL 202

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 23/212 (10%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
            F + Y   E      ++G+G    V +   K  G   A K     K       + + E 
Sbjct: 3   KFSDNYDVKE------ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 56

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAI 155
               K++H N+V+L   ++      +V + V  G L E +  R       +E        
Sbjct: 57  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQ 112

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHIST 212
            +  ++ Y H+     I+HR++K  N+L+  K +    K+ DFG A    +  A      
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHG 166

Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
              GT GYL P+ L+    ++  D+++ GV+L
Sbjct: 167 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 55/222 (24%), Positives = 87/222 (39%), Gaps = 26/222 (11%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
            F + Y   +       +GEG      K   K      AVK   K           + EI
Sbjct: 5   PFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEI 56

Query: 98  LTWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIA 154
                   H N+VKL           +V+E +  G L E +  +       +E     I 
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIM 112

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGFARMSEEDSAVSHIS 211
             +  A++++H      ++HRD+K  N+L T++      K+ DFGFAR+   D+    + 
Sbjct: 113 RKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LK 167

Query: 212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           T    T  Y  P+ L      E  D++S GV+L  M++G   
Sbjct: 168 TPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-QV 207

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 28/215 (13%)

Query: 47  TENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE-------FKNEIL 98
            EN+ P   +G G S  V +   K      AVK             E          E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 99  TWSKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAI 155
              K+  H N+++L    E      +V + +  G L ++L  +      L+E+    I  
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMR 131

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   +  LH  +   I+HRD+K  NIL+ + +  K+TDFGF+   +       +     
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVC- 184

Query: 216 GTAGYLDPDYLRTYQL------TEKSDVYSFGVLL 244
           GT  YL P+ +            ++ D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 48/216 (22%), Positives = 88/216 (40%), Gaps = 33/216 (15%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVK----RARKNKHDKCLLLEF 93
           S  + Y   E      ++G G  G V++   K  G +   K        +K+        
Sbjct: 48  SVYDYYDILE------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT------V 95

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
           KNEI   +++ H  L+ L    E   E ++++E++  G L + +         ++E  ++
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEA-EV 151

Query: 154 AI---DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA--KVTDFGFARMSEEDSAVS 208
                     L ++H +S   I+H D+K  NI+   K  +  K+ DFG A     D  V 
Sbjct: 152 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV- 207

Query: 209 HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
                   TA +  P+ +    +   +D+++ GVL 
Sbjct: 208 ---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 51/260 (19%), Positives = 100/260 (38%), Gaps = 27/260 (10%)

Query: 1   ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGG 60
             S   +  +  K    +      +   +S         +    +  + + P + IG G 
Sbjct: 47  DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGV 106

Query: 61  SGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-------HLNLVKLF 112
           S  V +   +  G   AVK               +    T  +         H +++ L 
Sbjct: 107 SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIAIDVAHALTYLHTYSDP 170
              E      +V + +  G L ++L  +      L+E+    I   +  A+++LH  +  
Sbjct: 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHANN-- 220

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            I+HRD+K  NIL+ + ++ +++DFGF+   E       +     GT GYL P+ L+   
Sbjct: 221 -IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELC-GTPGYLAPEILKCSM 275

Query: 231 L------TEKSDVYSFGVLL 244
                   ++ D+++ GV+L
Sbjct: 276 DETHPGYGKEVDLWACGVIL 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.1 bits (227), Expect = 8e-21
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 42/222 (18%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDK----------CLLLEFKNE 96
           E +     +GEG  G V K + KD G IVA+K+  ++  DK           LL + +  
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-- 82

Query: 97  ILTWSKIEHLNLVKLFGFLE--HGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
                   H NLV L   LE     +R  +V E+V + T+ + L+    NGL+       
Sbjct: 83  --------HENLVNL---LEVCKKKKRWYLVFEFV-DHTILDDLE-LFPNGLDYQVVQKY 129

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHIST 212
              + + + + H+++   IIHRD+K  NIL+++    K+ DFGFAR  +           
Sbjct: 130 LFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD--- 183

Query: 213 QVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
           +V  T  Y  P+ L     Y   +  DV++ G L+ EM  G 
Sbjct: 184 EVA-TRWYRAPELLVGDVKY--GKAVDVWAIGCLVTEMFMGE 222

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 51/259 (19%), Positives = 99/259 (38%), Gaps = 23/259 (8%)

Query: 5   DHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSP----ANKIGEGG 60
               + + +      +  VSS+           +  + +    ++         ++G G 
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169

Query: 61  SGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD 119
            G V++   +  G+  A K               + EI T S + H  LV L    E  +
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI---DVAHALTYLHTYSDPPIIHRD 176
           E +++ E++  G L E +        +++E  +       V   L ++H  +    +H D
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHN---KMSED-EAVEYMRQVCKGLCHMHENN---YVHLD 280

Query: 177 VKASNILITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           +K  NI+ T K     K+ DFG     +   +V   +    GTA +  P+      +   
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYY 336

Query: 235 SDVYSFGVLLVEMMTGRYP 253
           +D++S GVL   +++G  P
Sbjct: 337 TDMWSVGVLSYILLSGLSP 355

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.7 bits (226), Expect = 9e-21
 Identities = 64/228 (28%), Positives = 92/228 (40%), Gaps = 38/228 (16%)

Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDK-------------CLL 90
            AT  + P  +IG G  GTVYK +    G  VA+K  R                    LL
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 91  LEFKNEILTWSKIEHLNLVKLF----GFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGL 145
              +         EH N+V+L           + ++ +V E+V +  LR +LD     GL
Sbjct: 66  RRLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 117

Query: 146 ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS 205
                 D+       L +LH      I+HRD+K  NIL+T     K+ DFG AR+     
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 206 AVSHISTQVKGTAGYLDPDYL--RTYQLTEKSDVYSFGVLLVEMMTGR 251
           A++     V  T  Y  P+ L   TY      D++S G +  EM   +
Sbjct: 175 ALTP---VVV-TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRK 216

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 90.3 bits (225), Expect = 9e-21
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 26/212 (12%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
           +  + +   E       +G G    V+  K +  G + A+K  +K+   +   LE  NEI
Sbjct: 6   NIRKTFIFME------VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE--NEI 57

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL--DIAI 155
               KI+H N+V L    E      +V++ V  G L + +  RG       E+    +  
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQ 113

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHIST 212
            V  A+ YLH      I+HRD+K  N+L     E  +  +TDFG ++M +       +ST
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MST 166

Query: 213 QVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
              GT GY+ P+ L     ++  D +S GV+ 
Sbjct: 167 AC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 36/217 (16%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFK--NEILTWSKIEHLNLVKLF 112
           +GEG  G V +    +     AVK  +K K  +    E     EI    ++ H N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 113 GFLEHGDER--IIVVEYVGNGTLREHLD----GRGGNGLELAERLDIAIDVAH------- 159
             L + +++   +V+EY   G ++E LD     R                 AH       
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKR------FPV------CQAHGYFCQLI 119

Query: 160 -ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
             L YLH+     I+H+D+K  N+L+T     K++  G A      +A     T   G+ 
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSP 175

Query: 219 GYLDPDYLRTYQLTE--KSDVYSFGVLLVEMMTGRYP 253
            +  P+           K D++S GV L  + TG YP
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 56/252 (22%), Positives = 105/252 (41%), Gaps = 37/252 (14%)

Query: 11  NTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK 70
           +                PK         +  + Y+ ++       +G G +G V +   +
Sbjct: 4   HHHHHSSGLEVLFQGPEPKKY-------AVTDDYQLSKQ-----VLGLGVNGKVLECFHR 51

Query: 71  D-GSIVAVKRARKNKHDKCLLLEFKNEI-LTWSKIEHLNLVKLFGFLE---HGDERI-IV 124
             G   A+K    +        + + E+   W      ++V +    E   HG   + I+
Sbjct: 52  RTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104

Query: 125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI 184
           +E +  G L   +  RG       E  +I  D+  A+ +LH+++   I HRDVK  N+L 
Sbjct: 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLY 161

Query: 185 TEK---LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFG 241
           T K      K+TDFGFA+ + +++    + T    T  Y+ P+ L   +  +  D++S G
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNA----LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLG 216

Query: 242 VLLVEMMTGRYP 253
           V++  ++ G +P
Sbjct: 217 VIMYILLCG-FP 227

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 33/240 (13%)

Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNK-HDKC 88
           G   + +  FE++Y+  E+      +GEG    V            AVK   K   H + 
Sbjct: 1   GSTDSFSGRFEDVYQLQED-----VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR- 54

Query: 89  LLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLEL 147
                  E+    + + H N+++L  F E  D   +V E +  G++  H+  R       
Sbjct: 55  --SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HF 108

Query: 148 AER--LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSE 202
            E     +  DVA AL +LH   +  I HRD+K  NIL          K+ DF      +
Sbjct: 109 NELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165

Query: 203 EDSAVSHISTQVK----GTAGYLDPDYLRTYQLTEKS-----DVYSFGVLLVEMMTGRYP 253
            +   S IST       G+A Y+ P+ +  +           D++S GV+L  +++G YP
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-YP 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 13/138 (9%)

Query: 123 IVVEYVGNGTLREHLDGRGGNG-LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           I ++      L++ ++ R      E    L I I +A A+ +LH      ++HRD+K SN
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSN 194

Query: 182 ILITEKLRAKVTDFGFARMSEEDSAVSHIS---------TQVKGTAGYLDPDYLRTYQLT 232
           I  T     KV DFG     ++D     +          T   GT  Y+ P+ +     +
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254

Query: 233 EKSDVYSFGVLLVEMMTG 250
            K D++S G++L E++  
Sbjct: 255 HKVDIFSLGLILFELLYS 272

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 2/73 (2%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            +F P   +G GG G V++ K K D    A+KR R    +     +   E+   +K+EH 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHP 64

Query: 107 NLVKLFGFLEHGD 119
            +V+ F       
Sbjct: 65  GIVRYFNAWLETP 77

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 17/227 (7%)

Query: 24  SSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARK 82
           +S +          F      K ++N+    ++G+G    V +   K  G   A K    
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64

Query: 83  NKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG 142
            K       + + E     K++H N+V+L   ++      +V + V  G L E +  R  
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE- 123

Query: 143 NGLELAER--LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFGF 197
                +E         +  ++ Y H+     I+HR++K  N+L+  K +    K+ DFG 
Sbjct: 124 ---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
           A    +  A         GT GYL P+ L+    ++  D+++ GV+L
Sbjct: 178 AIEVNDSEA---WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 4e-20
 Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 35/239 (14%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
            F + Y+  E       IG G      +   K      AVK   K+K D         EI
Sbjct: 19  QFTDGYEVKE------DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP------TEEI 66

Query: 98  -LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--LDIA 154
            +     +H N++ L    + G    +V E +  G L + +  +       +ER    + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVL 122

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEK----LRAKVTDFGFARMSEEDSAVSHI 210
             +   + YLH      ++HRD+K SNIL  ++       ++ DFGFA+    ++ +  +
Sbjct: 123 FTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--L 177

Query: 211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG-----RYPIESKKPIKERV 264
            T    TA ++ P+ L         D++S GVLL  M+TG       P ++ + I  R+
Sbjct: 178 MTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.4 bits (220), Expect = 6e-20
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 36/226 (15%)

Query: 45  KATENFSPANKIGEGGSGTVYKGK--LKDGSIVAVKRARKNKHDK----------CLLLE 92
           +A + +    +IGEG  G V+K +     G  VA+KR R    ++           +L  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 93  FKNEILTWSKIEHLNLVKLF----GFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLEL 147
            +         EH N+V+LF          + ++ +V E+V +  L  +LD     G+  
Sbjct: 68  LETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT 119

Query: 148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV 207
               D+   +   L +LH++    ++HRD+K  NIL+T   + K+ DFG AR+     A+
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176

Query: 208 SHISTQVKGTAGYLDPDYL--RTYQLTEKSDVYSFGVLLVEMMTGR 251
           +     V  T  Y  P+ L   +Y      D++S G +  EM   +
Sbjct: 177 TS---VVV-TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRK 216

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 87.3 bits (217), Expect = 8e-20
 Identities = 54/217 (24%), Positives = 81/217 (37%), Gaps = 36/217 (16%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLE----F 93
              + Y           IG G  G V     K      A K+  K        +E    F
Sbjct: 6   DINQYYTLEN------TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF------VEDVDRF 53

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAER--L 151
           K EI     ++H N+++L+   E   +  +V+E    G L E +  +        E    
Sbjct: 54  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR----VFRESDAA 109

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVS 208
            I  DV  A+ Y H  +   + HRD+K  N L          K+ DFG A   +      
Sbjct: 110 RIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-- 164

Query: 209 HISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLL 244
            + T+V GT  Y+ P  L   Y    + D +S GV++
Sbjct: 165 -MRTKV-GTPYYVSPQVLEGLY--GPECDEWSAGVMM 197

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 87.7 bits (218), Expect = 8e-20
 Identities = 53/228 (23%), Positives = 88/228 (38%), Gaps = 39/228 (17%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVK---RARKNKHDKCLLLEF------------------ 93
           IG+G  G V       D +  A+K   + +  +                           
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 94  ---KNEILTWSKIEHLNLVKLFGFLEHGDERII--VVEYVGNGTLREHLDGRGGNGLELA 148
                EI    K++H N+VKL   L+  +E  +  V E V  G +   ++      L   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSED 137

Query: 149 ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS 208
           +      D+   + YLH      IIHRD+K SN+L+ E    K+ DFG +   +   A+ 
Sbjct: 138 QARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194

Query: 209 HISTQVKGTAGYLDPDYLRTYQLT---EKSDVYSFGVLLVEMMTGRYP 253
             +    GT  ++ P+ L   +     +  DV++ GV L   + G+ P
Sbjct: 195 SNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 38/224 (16%)

Query: 46  ATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDK---------CLLLEFKN 95
           ++  F    K+G G   TVYKG     G  VA+K  + +  +           L+ E K 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK- 61

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGN---GTLREHLDGRGGNGLELAERL 151
                    H N+V+L+  + H + ++ +V E++ N     +     G    GLEL    
Sbjct: 62  ---------HENIVRLYD-VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 152 DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHI 210
                +   L + H      I+HRD+K  N+LI ++ + K+ DFG AR      +  S  
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS- 167

Query: 211 STQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
             +V  T  Y  PD L   RTY  +   D++S G +L EM+TG+
Sbjct: 168 --EVV-TLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITGK 206

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 42/228 (18%)

Query: 33  ATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLL 91
           AT     F E Y+  E      ++G+G    V +      G   A       K       
Sbjct: 2   ATITCTRFTEEYQLFE------ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ 55

Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERL 151
           + + E      ++H N+V+L   +       ++ + V            GG   EL E +
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV-----------TGG---ELFEDI 101

Query: 152 ------------DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRA---KVTDFG 196
                            +  A+ + H      ++HR++K  N+L+  KL+    K+ DFG
Sbjct: 102 VAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158

Query: 197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
            A   E +           GT GYL P+ LR     +  D+++ GV+L
Sbjct: 159 LAIEVEGEQQA--WFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFG 113
           +G G  G V  G+    G  VAVK   + K     ++   K EI       H +++KL+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +    +  +V+EYV  G L +++   G      A RL   I    A+ Y H +    ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI--LSAVDYCHRHM---VV 133

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQL 231
           HRD+K  N+L+   + AK+ DFG + M  +      + T   G+  Y  P+ +  R Y  
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC-GSPNYAAPEVISGRLYA- 188

Query: 232 TEKSDVYSFGVLLVEMMTGRYP 253
             + D++S GV+L  ++ G  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           IG+G  G V   +  D   + A+K   K         + +  E   +I+    +EH  LV
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE--LQIM--QGLEHPFLV 78

Query: 110 KL-FGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
            L + F    +E + +VV+ +  G LR HL  +  +  E   +L I  ++  AL YL   
Sbjct: 79  NLWYSF--QDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFIC-ELVMALDYLQNQ 134

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGYLDPDYL 226
               IIHRD+K  NIL+ E     +TDF  A  +  E    +     + GT  Y+ P+  
Sbjct: 135 R---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-----MAGTKPYMAPEMF 186

Query: 227 RTYQLTEKS---DVYSFGVLLVEMMTGRYP 253
            + +    S   D +S GV   E++ GR P
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 35/218 (16%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN--------EIL 98
           E +   +K+GEG   TVYKGK K   ++VA+K  R         LE +         E+ 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIREVS 52

Query: 99  TWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
               ++H N+V L   + H ++ + +V EY+ +  L+++LD   GN + +         +
Sbjct: 53  LLKDLKHANIVTLHD-IIHTEKSLTLVFEYL-DKDLKQYLD-DCGNIINMHNVKLFLFQL 109

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM-SEEDSAVSHISTQVKG 216
              L Y H      ++HRD+K  N+LI E+   K+ DFG AR  S       +   +V  
Sbjct: 110 LRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV- 162

Query: 217 TAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  PD L     Y  + + D++  G +  EM TGR
Sbjct: 163 TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATGR 198

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 36/231 (15%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNK------HDKCLLL 91
           +  + Y  ++       +G G  G V     +     VA+K   K K       +    L
Sbjct: 7   ALRDEYIMSK------TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 92  EFKNEILTWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAER 150
             + EI    K+ H  ++K+  F +   E   IV+E +  G L + + G       L E 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----RLKEA 114

Query: 151 L--DIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMSEEDS 205
                   +  A+ YLH      IIHRD+K  N+L++ +      K+TDFG +++  E S
Sbjct: 115 TCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171

Query: 206 AVSHISTQVKGTAGYLDPDYLRTYQL---TEKSDVYSFGVLLVEMMTGRYP 253
               + T   GT  YL P+ L +          D +S GV+L   ++G YP
Sbjct: 172 L---MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-YP 217

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 56/264 (21%), Positives = 104/264 (39%), Gaps = 48/264 (18%)

Query: 10  SNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKL 69
           S T S+   +   ++     +     +    +   +    ++    IG G  G V++ KL
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61

Query: 70  KDGSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKLFGFLEHGDERI------ 122
            +   VA+K+  ++K        FKN E+     ++H N+V L  F     ++       
Sbjct: 62  VESDEVAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114

Query: 123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH----------ALTYLHTYSDPPI 172
           +V+EYV   T+             +         +            +L Y+H+     I
Sbjct: 115 LVLEYVPE-TVYRASRHYAKLKQTM--------PMLLIKLYMYQLLRSLAYIHSIG---I 162

Query: 173 IHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSA-VSHISTQVKGTAGYLDPDYL---R 227
            HRD+K  N+L+       K+ DFG A++       VS+I ++      Y  P+ +    
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGAT 217

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGR 251
            Y  T   D++S G ++ E+M G+
Sbjct: 218 NY--TTNIDIWSTGCVMAELMQGQ 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 87.5 bits (217), Expect = 6e-19
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+GG G V   +++  G + A K+  K      K +   L E   +IL   K+    +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE--KQIL--EKVNSRFVV 247

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E  D   +V+  +  G L+ H+   G  G   A  +  A ++   L  LH    
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER- 306

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
             I++RD+K  NIL+ +    +++D G A  + E  +       +V GT GY+ P+ ++ 
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----KGRV-GTVGYMAPEVVKN 359

Query: 229 YQLTEKSDVYSFGVLLVEMMTGRYPIESKK 258
            + T   D ++ G LL EM+ G+ P + +K
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 85.7 bits (213), Expect = 8e-19
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 31/218 (14%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN--------EIL 98
           + +   + +GEG   TVYK +      IVA+K+ +          E K+        EI 
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64

Query: 99  TWSKIEHLNLVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
              ++ H N++ L          I +V +++    L   +       L  +      +  
Sbjct: 65  LLQELSHPNIIGLLD-AFGHKSNISLVFDFM-ETDLEVIIKDNSL-VLTPSHIKAYMLMT 121

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKG 216
              L YLH +    I+HRD+K +N+L+ E    K+ DFG A+     + A +H   QV  
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV- 174

Query: 217 TAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGR 251
           T  Y  P+ L   R Y      D+++ G +L E++   
Sbjct: 175 TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLLRV 210

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 15/202 (7%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFG 113
           +GEG  G V      K    VA+K   +    K  +    + EI     + H +++KL+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +    + ++V+EY G G L +++  +    +   E       +  A+ Y H +    I+
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHK---IV 130

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQL 231
           HRD+K  N+L+ + L  K+ DFG + +  +    + + T   G+  Y  P+ +  + Y  
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSC-GSPNYAAPEVINGKLYA- 185

Query: 232 TEKSDVYSFGVLLVEMMTGRYP 253
             + DV+S G++L  M+ GR P
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLP 207

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 20/220 (9%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTW-SKIEHLNL 108
           IG GG G VY  +  D G + A+K   K      + +   L E    +L+  S  +   +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE--RIMLSLVSTGDCPFI 254

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           V +       D+   +++ +  G L  HL   G        R   A ++   L ++H   
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RFYAA-EIILGLEHMHNRF 312

Query: 169 DPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT 228
              +++RD+K +NIL+ E    +++D G A    +          V GT GY+ P+ L+ 
Sbjct: 313 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASV-GTHGYMAPEVLQK 364

Query: 229 YQLTEKS-DVYSFGVLLVEMMTGRYPIESKKPIKERVTIR 267
               + S D +S G +L +++ G  P    K   +    R
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 52/257 (20%), Positives = 100/257 (38%), Gaps = 46/257 (17%)

Query: 18  SSRSYVSSSSPKSGQATTINFSFEEIYKAT--ENFSPANKIGEGGSGTVYKGK-LKDGSI 74
           +   +    + ++      + S      AT  + +    K+GEG  G VYK         
Sbjct: 2   AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNET 61

Query: 75  VAVKRARKNKHDK----------CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI-I 123
           VA+KR R    ++           LL E +          H N+++L   + H + R+ +
Sbjct: 62  VAIKRIRLEHEEEGVPGTAIREVSLLKELQ----------HRNIIELKS-VIHHNHRLHL 110

Query: 124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL 183
           + EY     L++++D      + +         + + + + H+      +HRD+K  N+L
Sbjct: 111 IFEYA-ENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLL 164

Query: 184 ITEKLRA-----KVTDFGFARM-SEEDSAVSHISTQVKGTAGYLDPDYL---RTYQLTEK 234
           ++    +     K+ DFG AR         +H   ++  T  Y  P+ L   R Y  +  
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TLWYRPPEILLGSRHY--STS 218

Query: 235 SDVYSFGVLLVEMMTGR 251
            D++S   +  EM+   
Sbjct: 219 VDIWSIACIWAEMLMKT 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 51/216 (23%), Positives = 93/216 (43%), Gaps = 18/216 (8%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G GG G V+  ++K  G + A K+  K      K  +  ++E   +IL  +K+    +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE--KKIL--AKVHSRFIV 248

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI--AIDVAHALTYLHTY 167
            L    E   +  +V+  +  G +R H+     +     E   I     +   L +LH  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
           +   II+RD+K  N+L+ +    +++D G A   +     +       GT G++ P+ L 
Sbjct: 309 N---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYA-GTPGFMAPELLL 362

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER 263
             +     D ++ GV L EM+  R P  ++    E 
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 62/260 (23%), Positives = 106/260 (40%), Gaps = 30/260 (11%)

Query: 3   STDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSG 62
               +                     KSG     N +  + YK T        +G G +G
Sbjct: 23  PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKN-AIIDDYKVTSQ-----VLGLGING 76

Query: 63  TVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI-LTWSKIEHLNLVKLFGFLE---H 117
            V +   K      A+K  +          + + E+ L W   +  ++V++    E    
Sbjct: 77  KVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 118 GDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRD 176
           G + + IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +   I HRD
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRD 186

Query: 177 VKASNILITEKLRA---KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           VK  N+L T K      K+TDFGFA+ +   ++   ++T    T  Y+ P+ L   +  +
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPC-YTPYYVAPEVLGPEKYDK 242

Query: 234 KSDVYSFGVLLVEMMTGRYP 253
             D++S GV++  ++ G YP
Sbjct: 243 SCDMWSLGVIMYILLCG-YP 261

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 38/223 (17%)

Query: 55  KIGEGGSGTVYKGKLKD---GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKL 111
           K+G G  G VYK K KD       A+K+                EI    +++H N++ L
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----REIALLRELKHPNVISL 83

Query: 112 FG-FLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH---------- 159
              FL H D ++ ++ +Y  +  L   +     +    A +  + +              
Sbjct: 84  QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK---ANKKPVQLPRGMVKSLLYQILD 139

Query: 160 ALTYLHTYSDPPIIHRDVKASNILIT----EKLRAKVTDFGFARM-SEEDSAVSHISTQV 214
            + YLH      ++HRD+K +NIL+     E+ R K+ D GFAR+ +     ++ +   V
Sbjct: 140 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 215 KGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
             T  Y  P+ L   R Y  T+  D+++ G +  E++T   PI
Sbjct: 197 V-TFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSE-PI 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEHLNLVKLFG 113
           +G G  G V  GK    G  VAVK   + K     ++   + EI       H +++KL+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
            +    +  +V+EYV  G L +++   G    + + RL   I     + Y H +    ++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI--LSGVDYCHRHM---VV 138

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQL 231
           HRD+K  N+L+   + AK+ DFG + M  +      + T   G+  Y  P+ +  R Y  
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSC-GSPNYAAPEVISGRLYAG 194

Query: 232 TEKSDVYSFGVLLVEMMTGRYP 253
            E  D++S GV+L  ++ G  P
Sbjct: 195 PE-VDIWSSGVILYALLCGTLP 215

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 34/211 (16%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
           IG G  G     +      +VAVK   +       +   + EI+    + H N+V+    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFKEV 84

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH--------ALTYLHT 166
           +       I++EY   G L E +   G      +E      D A          ++Y H+
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGR----FSE------DEARFFFQQLLSGVSYCHS 134

Query: 167 YSDPPIIHRDVKASNILITEK--LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
                I HRD+K  N L+      R K+ DFG+++ S   S      + V GT  Y+ P+
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV-GTPAYIAPE 187

Query: 225 YL--RTYQLTEKSDVYSFGVLLVEMMTGRYP 253
            L  + Y   + +DV+S GV L  M+ G YP
Sbjct: 188 VLLRQEYD-GKIADVWSCGVTLYVMLVGAYP 217

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 65/260 (25%), Positives = 98/260 (37%), Gaps = 18/260 (6%)

Query: 1   ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKAT-ENFSPANKIGEG 59
             +     +   K +         S S  SG         +  ++ T   F     +G+G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKG 159

Query: 60  GSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
             G V   K K  G   A+K  +K            L E  N +L      H  L  L  
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE--NRVLQ--NSRHPFLTALKY 215

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
             +  D    V+EY   G L  HL        + A R   A ++  AL YLH+  +  ++
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGA-EIVSALDYLHSEKN--VV 271

Query: 174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
           +RD+K  N+++ +    K+TDFG   + +E            GT  YL P+ L       
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFG---LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 328

Query: 234 KSDVYSFGVLLVEMMTGRYP 253
             D +  GV++ EMM GR P
Sbjct: 329 AVDWWGLGVVMYEMMCGRLP 348

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 74/272 (27%), Positives = 115/272 (42%), Gaps = 52/272 (19%)

Query: 3   STDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSG 62
               S   + K SR    S V++     GQ    +   E  Y  T+       IG G  G
Sbjct: 17  VQQPSAFGSMKVSRDKDGSKVTTVVATPGQGP--DRPQEVSYTDTK------VIGNGSFG 68

Query: 63  TVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKLFGFLEHGDE 120
            VY+ KL D G +VA+K+  ++K        FKN E+    K++H N+V+L  F     E
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGE 121

Query: 121 RI------IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV-------AHALTYLHTY 167
           +       +V++YV   T+             L       I V         +L Y+H++
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPV-----IYVKLYMYQLFRSLAYIHSF 175

Query: 168 SDPPIIHRDVKASNILI-TEKLRAKVTDFGFARMSEEDSA-VSHISTQVKGTAGYLDPDY 225
               I HRD+K  N+L+  +    K+ DFG A+        VS+I ++      Y  P+ 
Sbjct: 176 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPEL 227

Query: 226 L---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           +     Y  T   DV+S G +L E++ G+ PI
Sbjct: 228 IFGATDY--TSSIDVWSAGCVLAELLLGQ-PI 256

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 44/239 (18%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
           + E   K  + F      G+G  GTV  GK K  G  VA+K+  ++   +   L+    +
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IM 70

Query: 98  LTWSKIEHLNLVKLFGFLEHGDER-------IIVVEYVGNGTLREHLDGRGGNGLELAER 150
              + + H N+V+L  +     ER        +V+EYV + TL           +     
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP--- 126

Query: 151 LDIAIDVAH----------ALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKVTDFGFAR 199
                              ++  LH  S   + HRD+K  N+L+       K+ DFG A+
Sbjct: 127 -----PPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

Query: 200 MSEEDSA-VSHISTQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
                   V++I ++      Y  P+ +   + Y  T   D++S G +  EMM G  PI
Sbjct: 181 KLSPSEPNVAYICSRY-----YRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGE-PI 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 70/259 (27%), Positives = 110/259 (42%), Gaps = 23/259 (8%)

Query: 11  NTKSSRK-SSRSYVSSSSPKSGQATTINFSFEEIYKAT-ENFSPANKIGEGGSGTVYKGK 68
           N  +++K S +  V     K+ +     +       A  + F     +G G  G V   K
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 69  LKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI 122
            K+ G+  A+K   K      K  +  L E    IL    +    LVKL    +      
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNE--KRIL--QAVNFPFLVKLEFSFKDNSNLY 117

Query: 123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI 182
           +V+EYV  G +  HL  R G   E   R   A  +     YLH+     +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLR-RIGRFSEPHARFYAA-QIVLTFEYLHSLD---LIYRDLKPENL 172

Query: 183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGV 242
           LI ++   +VTDFGFA+       V   +  + GT   L P+ + +    +  D ++ GV
Sbjct: 173 LIDQQGYIQVTDFGFAKR------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226

Query: 243 LLVEMMTGRYPIESKKPIK 261
           L+ EM  G  P  + +PI+
Sbjct: 227 LIYEMAAGYPPFFADQPIQ 245

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 45/237 (18%), Positives = 88/237 (37%), Gaps = 53/237 (22%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDK-----CLLLE 92
           S    +   +++    K+G G    V++   + +   V VK  +  K  K      +L  
Sbjct: 27  SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILEN 86

Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAER 150
            +            N++ L   ++    R   +V E+V N   ++               
Sbjct: 87  LRG---------GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------------ 125

Query: 151 LDIAIDVAH----------ALTYLHTYSDPPIIHRDVKASNILITEKLRA-KVTDFGFAR 199
               +              AL Y H+     I+HRDVK  N++I  + R  ++ D+G A 
Sbjct: 126 ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179

Query: 200 MSEEDSAVSH-ISTQVKGTAGYLDPDYLRTYQLTEKS-DVYSFGVLLVEMMTGRYPI 254
                   +  ++++      +  P+ L  YQ+ + S D++S G +L  M+  + P 
Sbjct: 180 FYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 59/240 (24%), Positives = 91/240 (37%), Gaps = 61/240 (25%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN--------EIL 98
             +    KIG+G  G V+K +  K G  VA+K+          +   K         EI 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKEGFPITALREIK 68

Query: 99  TWSKIEHLNLVKLFGFLEHGDERI---------IVVEYVGNGTLREH-LDGRGGNGLELA 148
               ++H N+V L   +                +V ++       EH L G       L 
Sbjct: 69  ILQLLKHENVVNLIE-ICRTKASPYNRCKGSIYLVFDFC------EHDLAG-------LL 114

Query: 149 ERLDIAIDVAH----------ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA 198
             + +   ++            L Y+H      I+HRD+KA+N+LIT     K+ DFG A
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171

Query: 199 R-MSEEDSAVSHISTQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPI 254
           R  S   ++  +  T    T  Y  P+ L   R Y      D++  G ++ EM T   PI
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRS-PI 228

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 52/227 (22%), Positives = 83/227 (36%), Gaps = 23/227 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWS 101
           ++F     IG G    V   K+K  G + A+K   K          C   E   ++L   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE--RDVLV-- 116

Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
             +   + +L    +  +   +V+EY   G L   L   G        R  +A ++  A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAI 175

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYL 221
             +H       +HRD+K  NIL+      ++ DFG       D  V   S    GT  YL
Sbjct: 176 DSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR--SLVAVGTPDYL 230

Query: 222 DPDYLRTYQLTEKSDVY-------SFGVLLVEMMTGRYPIESKKPIK 261
            P+ L+       +  Y       + GV   EM  G+ P  +    +
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 11/124 (8%)

Query: 134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT 193
            E  +    + L L   +  +  VA  + +L   +    IHRD+ A NIL++EK   K+ 
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 235

Query: 194 DFGFAR-MSEEDSAVSHISTQ--VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT- 249
           DFG AR + ++   V     +  +K  A    P+ +     T +SDV+SFGVLL E+ + 
Sbjct: 236 DFGLARDIYKDPDYVRKGDARLPLKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSL 291

Query: 250 GRYP 253
           G  P
Sbjct: 292 GASP 295

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 23/226 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN-----KHDKCLLLEFKNEILTWS 101
           E+F     IG G  G V   KLK+   + A+K   K          C   E   ++L   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE--RDVL--V 129

Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
             +   +  L    +  +   +V++Y   G L   L        E   R  +A ++  A+
Sbjct: 130 NGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAI 188

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGY 220
             +H       +HRD+K  NIL+      ++ DFG   ++ E+ +  S     V GT  Y
Sbjct: 189 DSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS--VAV-GTPDY 242

Query: 221 LDPDYLRTYQLTEKS-----DVYSFGVLLVEMMTGRYPIESKKPIK 261
           + P+ L+  +  +       D +S GV + EM+ G  P  ++  ++
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/259 (22%), Positives = 107/259 (41%), Gaps = 18/259 (6%)

Query: 2   DSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKAT-ENFSPANKIGEGG 60
           + ++ + E   K  R        +   K+    +   +     +    +F+    +G+G 
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353

Query: 61  SGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
            G V   + K    + AVK  +K     +   +C ++E    +L     +   L +L   
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE--KRVLA-LPGKPPFLTQLHSC 410

Query: 115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIH 174
            +  D    V+EYV  G L  H+   G      A     A ++A  L +L +     II+
Sbjct: 411 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAA-EIAIGLFFLQSKG---IIY 465

Query: 175 RDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK 234
           RD+K  N+++  +   K+ DFG   M +E+      +    GT  Y+ P+ +      + 
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 522

Query: 235 SDVYSFGVLLVEMMTGRYP 253
            D ++FGVLL EM+ G+ P
Sbjct: 523 VDWWAFGVLLYEMLAGQAP 541

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 66/253 (26%), Positives = 106/253 (41%), Gaps = 22/253 (8%)

Query: 14  SSRKSSRSYVSSSSPKSGQATTINFSFEEIYKAT-ENFSPANKIGEGGSGTVYKGKLKD- 71
           S  +      ++ +P    +  IN        A   +F     IG+G  G V   + K  
Sbjct: 3   SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62

Query: 72  GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE 126
               AVK  +K      K +K ++ E +N +L    ++H  LV L    +  D+   V++
Sbjct: 63  EVFYAVKVLQKKAILKKKEEKHIMSE-RN-VLL-KNVKHPFLVGLHFSFQTADKLYFVLD 119

Query: 127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE 186
           Y+  G L  HL          A R   A ++A AL YLH+ +   I++RD+K  NIL+  
Sbjct: 120 YINGGELFYHLQRERCFLEPRA-RFYAA-EIASALGYLHSLN---IVYRDLKPENILLDS 174

Query: 187 KLRAKVTDFGFAR--MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLL 244
           +    +TDFG  +  +    +  +       GT  YL P+ L         D +  G +L
Sbjct: 175 QGHIVLTDFGLCKENIEHNSTTSTFC-----GTPEYLAPEVLHKQPYDRTVDWWCLGAVL 229

Query: 245 VEMMTGRYPIESK 257
            EM+ G  P  S+
Sbjct: 230 YEMLYGLPPFYSR 242

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 18/204 (8%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   + K  G   A+K  RK            + E  + +L      H  L 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE--SRVLQ--NTRHPFLT 68

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    +  D    V+EY   G L  HL        E A R   A ++  AL YLH+   
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGA-EIVSALEYLHSRD- 125

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             +++RD+K  N+++ +    K+TDFG   + +E  +         GT  YL P+ L   
Sbjct: 126 --VVYRDIKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
                 D +  GV++ EMM GR P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 21/212 (9%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G G  G V+  + +  G   A+K  +K      K  +    E    +L  S + H  ++
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE--RLML--SIVTHPFII 69

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +++G  +   +  ++++Y+  G L   L  +         +   A +V  AL YLH+   
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAA-EVCLALEYLHSKD- 126

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  NIL+ +    K+TDFGFA+       V  ++  + GT  Y+ P+ + T 
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKY------VPDVTYTLCGTPDYIAPEVVSTK 178

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK 261
              +  D +SFG+L+ EM+ G  P      +K
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 24/225 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN-----KHDKCLLLEFKNEILTWS 101
           E++     IG G  G V   + K    + A+K   K              E   +I+  +
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE--RDIM--A 124

Query: 102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
                 +V+LF   +      +V+EY+  G L   +     +  E   R   A +V  AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTA-EVVLAL 181

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA-RMSEEDSAVSHISTQVKGTAGY 220
             +H+      IHRDVK  N+L+ +    K+ DFG   +M++E        T V GT  Y
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD--TAV-GTPDY 235

Query: 221 LDPDYLRTYQLTEK----SDVYSFGVLLVEMMTGRYPIESKKPIK 261
           + P+ L++           D +S GV L EM+ G  P  +   + 
Sbjct: 236 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   ++K+ G + AVK  +K     +   +C + E    IL+ +   H  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRILSLA-RNHPFLT 87

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +LF   +  D    V+E+V  G L  H+          A R   A ++  AL +LH    
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-RFYAA-EIISALMFLHDKG- 144

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+  +   K+ DFG   M +E       +    GT  Y+ P+ L+  
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFG---MCKEGICNGVTTATFCGTPDYIAPEILQEM 199

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
                 D ++ GVLL EM+ G  P
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAP 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V   + K    + AVK  +K     +   +C ++E    +L     +   L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE--KRVLA-LPGKPPFLT 84

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
           +L    +  D    V+EYV  G L  H+   G      A     A ++A  L +L +   
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAA-EIAIGLFFLQSKG- 141

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+++  +   K+ DFG   M +E+      +    GT  Y+ P+ +   
Sbjct: 142 --IIYRDLKLDNVMLDSEGHIKIADFG---MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 196

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
              +  D ++FGVLL EM+ G+ P
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAP 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.7 bits (174), Expect = 8e-14
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           +G+G  G V+  + K      A+K  +K     +   +C ++E K  +L+ +  EH  L 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE-KR-VLSLA-WEHPFLT 81

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            +F   +  +    V+EY+  G L  H+       L  A     A ++   L +LH+   
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-TFYAA-EIILGLQFLHSKG- 138

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFAR--MSEEDSAVSHISTQVKGTAGYLDPDYLR 227
             I++RD+K  NIL+ +    K+ DFG  +  M  +    +       GT  Y+ P+ L 
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-----GTPDYIAPEILL 191

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYP 253
             +     D +SFGVLL EM+ G+ P
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 56  IGEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLV 109
           IG G    V   +LK    I A+K  +K     ++    +  E    +   +   H  LV
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE--KHVFEQA-SNHPFLV 73

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    +       V+EYV  G L  H+  +     E A R   A +++ AL YLH    
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSA-EISLALNYLHERG- 130

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT  Y+ P+ LR  
Sbjct: 131 --IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185

Query: 230 QLTEKSDVYSFGVLLVEMMTGRYP 253
                 D ++ GVL+ EMM GR P
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 23/263 (8%)

Query: 2   DSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPAN----K-I 56
               H    +      +   Y   +     +      +  E  KA+ +    +    + I
Sbjct: 2   SYYHHHHHHDYDIP-TTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60

Query: 57  GEGGSGTVYKGKLKD-GSIVAVKRARK-----NKHDKCLLLEFKNEILTWSKIEHLNLVK 110
           G G    V   +LK    I A++  +K     ++    +  E    +   +   H  LV 
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE--KHVFEQA-SNHPFLVG 117

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           L    +       V+EYV  G L  H+  +     E A R   A +++ AL YLH     
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSA-EISLALNYLHERG-- 173

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
            II+RD+K  N+L+  +   K+TD+G   M +E       ++   GT  Y+ P+ LR   
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229

Query: 231 LTEKSDVYSFGVLLVEMMTGRYP 253
                D ++ GVL+ EMM GR P
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSP 252

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)

Query: 48  ENFSPANKIGEGGSGTVY---KGKLKD-GSIVAVKRARK------NKHDKCLLLEFKNEI 97
           E F     +G+GG G V+   K    + G I A+K  +K       K       E    I
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE--RNI 74

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
           L   +++H  +V L    + G +  +++EY+  G L   L+  G    + A    +A ++
Sbjct: 75  LE--EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLA-EI 130

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           + AL +LH      II+RD+K  NI++  +   K+TDFG   + +E      ++    GT
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG---LCKESIHDGTVTHTFCGT 184

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
             Y+ P+ L         D +S G L+ +M+TG  P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 53/290 (18%), Positives = 99/290 (34%), Gaps = 45/290 (15%)

Query: 4   TDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGT 63
             HS+  +   +       +++S       T +       +K                G 
Sbjct: 5   HHHSSGVD-LGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKS------FQTRDNQGI 57

Query: 64  VYKGK---------LKDGSIVAVKRARKNKHDKCLLLEF-----KNEILTWSK---IEHL 106
           +Y+                  ++K   K+         F       ++  W K      L
Sbjct: 58  LYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117

Query: 107 NLVKLFGFLEHGDE-RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            +    GF  H D+ R +V+  +G  +L+  LD    + L     L +A  +  AL +LH
Sbjct: 118 AIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRLLDALEFLH 176

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVT--DFGFARM---------SEEDSAVSHISTQV 214
                  +H +V A NI +  + +++VT   +GFA             E S   H     
Sbjct: 177 ENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE---- 229

Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
            G   ++  D  +    + +SD+ S G  +++ + G  P  +  P  E +
Sbjct: 230 -GDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 47/235 (20%), Positives = 85/235 (36%), Gaps = 30/235 (12%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC----LLLEFK--------NEILTWSK 102
            IG+GG G +Y   +     V        K +      L  E K         +I  W +
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 103 IEHLNLV---KLFGFLEHGDE----RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
              L  +   K +G   H       R ++++  G+  L + +             L +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DL-QKIYEANAKRFSRKTVLQLSL 159

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT--DFGFARMSEEDSAVSHISTQ 213
            +   L Y+H +     +H D+KASN+L+  K   +V   D+G A     +      +  
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 214 VK----GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
            K    GT  +   D       + + D+   G  +++ +TG  P E      + V
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 56  IGEGGSGTVY---KGKLKD-GSIVAVKRARKN---KHDKCLLLEFKNE--ILTWSKIEHL 106
           +G+G  G V+   K    D   + A+K  +K      D+   +  K E  IL   ++ H 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDIL--VEVNHP 86

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            +VKL    +   +  ++++++  G L   L        E   +  +A ++A AL +LH+
Sbjct: 87  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLA-ELALALDHLHS 144

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                II+RD+K  NIL+ E+   K+TDFG   +S+E       +    GT  Y+ P+ +
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFG---LSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYP 253
                T+ +D +SFGVL+ EM+TG  P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 47/251 (18%), Positives = 84/251 (33%), Gaps = 51/251 (20%)

Query: 29  KSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC 88
             G+A   +    E++     ++    I  G  G V  G   +G  VA+KR      D  
Sbjct: 4   AKGEAAMRDL-IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGR 62

Query: 89  LLLEFKN---------EILTWSKIEHLNLVKLFGFLEHGDERI-----IVVEYVG---NG 131
            +    +         EI   +   H N++ L     H +E       +V E +      
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122

Query: 132 TLREHLDGRGGNGLELAERLDIAIDVAH----------ALTYLHTYSDPPIIHRDVKASN 181
            +           + ++          H           L  LH      ++HRD+   N
Sbjct: 123 VIH-------DQRIVISP--------QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164

Query: 182 ILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSF 240
           IL+ +     + DF  AR    D+      T       Y  P+ +  ++  T+  D++S 
Sbjct: 165 ILLADNNDITICDFNLAREDTADAN----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSA 220

Query: 241 GVLLVEMMTGR 251
           G ++ EM   +
Sbjct: 221 GCVMAEMFNRK 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 29/266 (10%)

Query: 6   HSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPAN----K-IGEGG 60
           H  E    S   +  S       +             +    E     N    K +G G 
Sbjct: 7   HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGA 66

Query: 61  SGTVY---KGKLKD-GSIVAVKRARK------NKHDKCLLLEFKNEILTWSKIEHLN-LV 109
            G V+   K    D G + A+K  +K       K  +    E   ++L    I     LV
Sbjct: 67  YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE--RQVLE--HIRQSPFLV 122

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    +   +  ++++Y+  G L  HL  R         ++ +  ++  AL +LH    
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVG-EIVLALEHLHKLG- 179

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT- 228
             II+RD+K  NIL+       +TDFG ++  E  +  +  +    GT  Y+ PD +R  
Sbjct: 180 --IIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVRGG 235

Query: 229 -YQLTEKSDVYSFGVLLVEMMTGRYP 253
                +  D +S GVL+ E++TG  P
Sbjct: 236 DSGHDKAVDWWSLGVLMYELLTGASP 261

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 41/258 (15%), Positives = 88/258 (34%), Gaps = 77/258 (29%)

Query: 47  TENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIE 104
           ++ +S    +G G  G V +    + G   A+K+  ++         +KN E+     ++
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLD 58

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV------- 157
           H+N++KL  +     +         +   +      G N    +  ++ + +        
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 158 ----------------------AH----------ALTYLHTYSDPPIIHRDVKASNILI- 184
                                             A+ ++H+     I HRD+K  N+L+ 
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVN 175

Query: 185 TEKLRAKVTDFGFARMSEEDSA-VSHISTQVKGTAGYLDPDYLRTY----------QLTE 233
           ++    K+ DFG A+        V++I +              R Y          + T 
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICS--------------RFYRAPELMLGATEYTP 221

Query: 234 KSDVYSFGVLLVEMMTGR 251
             D++S G +  E++ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 19/153 (12%)

Query: 55  KIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI-LTWSKIEHLNLVKLF 112
            +G G +G V +   K      A+K  +          + + E+ L W   +  ++V++ 
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIV 77

Query: 113 GFLEHGDERI----IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
              E+         IV+E +  G L   +  RG       E  +I   +  A+ YLH+ +
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137

Query: 169 DPPIIHRDVKASNILITEK---LRAKVTDFGFA 198
              I HRDVK  N+L T K      K+TDFGFA
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 40/223 (17%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHD-KCLLLEFK-------NEILTWSKIEH 105
           K+G G   TV+  K + + + VA+K  R +K   +    E K        +      +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 106 LNLVKLFGFLEH-GDERI---IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHAL 161
            +++KL     H G   +   +V E +G   L   +      G+ L     I+  +   L
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGL 144

Query: 162 TYLHTYSDPPIIHRDVKASNILITEKLRA------KVTDFGFARMSEEDSAVSHISTQVK 215
            Y+H      IIH D+K  N+L+            K+ D G A   +E     H +    
Sbjct: 145 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTN--- 194

Query: 216 GTAGYLDPDYLRT------YQLTEKSDVYSFGVLLVEMMTGRY 252
                +     R+            +D++S   L+ E++TG +
Sbjct: 195 ----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 20/207 (9%)

Query: 54  NKIGEGGSGTVYKGK-LKDGSIVAVK--RARKNKHDKCL----LLEFKNEILTWSKIEHL 106
           + IG+G  G V K     +   VA+K  + +K   ++      LLE  N+          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK---HDTEMKY 116

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            +V L       +   +V E +    L + L      G+ L      A  +  AL +L T
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 167 YSDPPIIHRDVKASNILITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
             +  IIH D+K  NIL+    R+  K+ DFG +    +      I   ++ +  Y  P+
Sbjct: 176 -PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQ-SRFYRSPE 228

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGR 251
            L         D++S G +LVEM TG 
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 52/283 (18%), Positives = 96/283 (33%), Gaps = 37/283 (13%)

Query: 5   DHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTV 64
            H    ++     +   Y  S     G    ++      +   +      KIG GG G +
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMPFPEG--KVLDDMEGNQWVLGK------KIGSGGFGLI 53

Query: 65  YKGK-LKDGSIVAVKRAR-KNKHDKCLLLEFK--------NEILTWSKIEHLNLV---KL 111
           Y           A    + + + +  L  E K        + I  W + + L+ +     
Sbjct: 54  YLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113

Query: 112 FGFLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +G           R +V+E +G   L++     G         L + I +   L Y+H  
Sbjct: 114 YGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTV--LQLGIRMLDVLEYIHEN 170

Query: 168 SDPPIIHRDVKASNILITEKLRAKVT--DFGFARMSEEDSAVSHISTQVK----GTAGYL 221
                +H D+KA+N+L+  K   +V   D+G +     +          +    GT  + 
Sbjct: 171 E---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227

Query: 222 DPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
             D  +   L+ +SDV   G  ++  + G+ P E        V
Sbjct: 228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 44/210 (20%), Positives = 86/210 (40%), Gaps = 20/210 (9%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKLF 112
           +IGEG  G +++G  L +   VA+K   +      L  E++  ++L         +  ++
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT----GIPNVY 72

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
            F + G   ++V++ +G  +L E L    G    +      A  +   +  +H  S   +
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 127

Query: 173 IHRDVKASNILITEKLRAK-----VTDFGFARMSEEDSAVSHI----STQVKGTAGYLDP 223
           ++RD+K  N LI            V DFG  +   +     HI       + GTA Y+  
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
           +     + + + D+ + G + +  + G  P
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.9 bits (157), Expect = 7e-12
 Identities = 37/214 (17%), Positives = 61/214 (28%), Gaps = 54/214 (25%)

Query: 31  GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRAR------KNK 84
            Q   + FS       TE      KIGEG  G V++      + VA+K          N 
Sbjct: 6   SQKGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNG 61

Query: 85  HDKCLLLEFKNEILTWSKIEHL---------NLVKLFGF--------------------- 114
             +    E   EI+   ++  L           + L                        
Sbjct: 62  SHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 115 ---------LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
                        D+  IV+E+   G   E +  +  +   LA    I   +  +L    
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAE 178

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
                   HRD+   N+L+ +    K+      +
Sbjct: 179 AS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 56/250 (22%), Positives = 96/250 (38%), Gaps = 39/250 (15%)

Query: 21  SYVSSSSPKSGQATTINFSFEEIYKAT----ENFSPANKIGEGGSGTVYKGK-LKDGSIV 75
           SY++     S       F   E+  +T    + +     IG G  G V           V
Sbjct: 31  SYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV 90

Query: 76  AVK---RARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLF------GFLEHGDERIIVV 125
           A+K   R  +N+   K    E    ++    + H N++ L         LE   +  +V+
Sbjct: 91  AIKKLSRPFQNQTHAKRAYRELV--LMK--CVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146

Query: 126 EYVG---NGTLREHLDGRGGNGLELAERLD-IAIDVAHALTYLHTYSDPPIIHRDVKASN 181
           E +       ++  LD          ER+  +   +   + +LH+     IIHRD+K SN
Sbjct: 147 ELMDANLCQVIQMELD---------HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 194

Query: 182 ILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFG 241
           I++      K+ DFG AR +        + T    T  Y  P+ +      E  D++S G
Sbjct: 195 IVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250

Query: 242 VLLVEMMTGR 251
            ++ EM+  +
Sbjct: 251 CIMGEMVRHK 260

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.3 bits (157), Expect = 9e-12
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 18/208 (8%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKLF 112
           KIG G  G +Y G  +  G  VA+K          L +E K  +++       +  ++  
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM--QGGVGIPTIRWC 73

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G    GD  ++V+E +G  +L E L         L   L +A  +   + Y+H+ +    
Sbjct: 74  G--AEGDYNVMVMELLGP-SL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 126

Query: 173 IHRDVKASNILITEKLRAK---VTDFGFARMSEEDSAVSHISTQVK----GTAGYLDPDY 225
           IHRDVK  N L+    +     + DFG A+   +     HI  +      GTA Y   + 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 186

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
               + + + D+ S G +L+    G  P
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 36/243 (14%)

Query: 24  SSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVK---R 79
            S S +     ++    +  +   + +     IG G  G V           VA+K   R
Sbjct: 2   GSRSKRDNNFYSVEI-GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 80  ARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLF------GFLEHGDERIIVVEYVG--- 129
             +N+   K    E    ++    + H N++ L         LE   +  IV+E +    
Sbjct: 61  PFQNQTHAKRAYRELV--LM--KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 116

Query: 130 NGTLREHLDGRGGNGLELAERLD-IAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL 188
              ++  LD          ER+  +   +   + +LH+     IIHRD+K SNI++    
Sbjct: 117 CQVIQMELD---------HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 164

Query: 189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMM 248
             K+ DFG AR +        + T    T  Y  P+ +      E  D++S G ++ EM+
Sbjct: 165 TLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

Query: 249 TGR 251
            G 
Sbjct: 221 KGG 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 47/254 (18%), Positives = 87/254 (34%), Gaps = 41/254 (16%)

Query: 1   ADSTDHSTESNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGG 60
           A   +  T+     S++  +      S K   +     S  +I    + +   + IG G 
Sbjct: 9   AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGS 65

Query: 61  SGTVYKGK-LKDGSIVAVKRARKNKHDK----------CLLLEFKNEILTWSKIEHLNLV 109
            G V +     +  +VA+K+  +   D            +L              H ++V
Sbjct: 66  YGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN----------HDHVV 115

Query: 110 KLF-----GFLEHGDERIIVVEYVGNGT-LREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           K+        +E  DE  +V+E     +  ++    R    L       +  ++   + Y
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLF--RTPVYLTELHIKTLLYNLLVGVKY 171

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR----MSEEDSAVSHISTQVKGTAG 219
           +H+     I+HRD+K +N L+ +    KV DFG AR        +S +     +      
Sbjct: 172 VHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 220 YLDPDYLRTYQLTE 233
                     QLT 
Sbjct: 229 TFPHTKNLKRQLTG 242

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 22/205 (10%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVK--RARKNKHDKCL----LLEFKNEILTWSKIEHLNL 108
           IG+G  G V K    K    VA+K  R  K  H +      +LE   +     K   +N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK---QDKDNTMNV 161

Query: 109 VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
           + +       +   +  E +    L E +      G  L      A  +   L  LH   
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217

Query: 169 DPPIIHRDVKASNILITEKLRA--KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
              IIH D+K  NIL+ ++ R+  KV DFG +    +      + T ++ +  Y  P+ +
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQ-SRFYRAPEVI 271

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGR 251
              +     D++S G +L E++TG 
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTGY 296

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 29/93 (31%), Positives = 52/93 (55%), Gaps = 4/93 (4%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y+H+ +   ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 220 YLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
           Y  P+ +   +  T+  D++S G +L EM++ R
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 18/208 (8%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKN-EILTWSKIEHLNLVKLF 112
           KIG G  G +Y G  ++    VA+K          LL E K   IL       +  V+ F
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRIL--QGGTGIPNVRWF 71

Query: 113 GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
           G    GD  ++V++ +G  +L E L       L L   L +A  + + + ++H+ S    
Sbjct: 72  G--VEGDYNVLVMDLLGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 173 IHRDVKASNILITEKLRAK---VTDFGFARMSEEDSAVSHI----STQVKGTAGYLDPDY 225
           +HRD+K  N L+    RA    + DFG A+   + S   HI    +  + GTA Y   + 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT 184

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYP 253
               + + + D+ S G +L+  + G  P
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 41/240 (17%)

Query: 35  TIN-FSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKR-ARKNKHD-KCLL 90
           ++N   F+        +     +G GG+G V+          VA+K+    +    K  L
Sbjct: 1   SMNIHGFD----LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL 56

Query: 91  LEFKNEILTWSKIEHLNLVKLF--------------GFLEHGDERIIVVEYVG---NGTL 133
            E K  I+   +++H N+VK+F              G L   +   IV EY+       L
Sbjct: 57  REIK--IIR--RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL 112

Query: 134 REHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI-TEKLRAKV 192
                      L           +   L Y+H+ +   ++HRD+K +N+ I TE L  K+
Sbjct: 113 E-------QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162

Query: 193 TDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
            DFG AR+ +   +     ++   T  Y  P  L +    T+  D+++ G +  EM+TG+
Sbjct: 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 24/212 (11%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG G  G +  GK L     VA+K          L LE++      S      + +++ 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD---GIPQVYY 72

Query: 114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII 173
           F   G    +V+E +G  +L E L         L   L IAI +   + Y+H+ +   +I
Sbjct: 73  FGPCGKYNAMVLELLGP-SL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LI 127

Query: 174 HRDVKASNILI--TEKLRAK---VTDFGFARMSEEDSAVSHI----STQVKGTAGYLDPD 224
           +RDVK  N LI        +   + DF  A+   +     HI       + GTA Y+   
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS-- 185

Query: 225 YLRTYQLTEKS---DVYSFGVLLVEMMTGRYP 253
            + T+   E+S   D+ + G + +  + G  P
Sbjct: 186 -INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 6e-10
 Identities = 44/227 (19%), Positives = 90/227 (39%), Gaps = 50/227 (22%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVK---RARKNKHD-KCLLLEFKNEILTWS 101
            + +     +G G  G+V      + G  VA+K   R  +++   K    E    +L   
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL--LLK-- 78

Query: 102 KIEHLNLVKLF------GFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
            ++H N++ L         L +  +  +V+ ++                 +L + + +  
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---------------DLQKIMGLKF 123

Query: 156 DVAH----------ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS 205
                          L Y+H+     ++HRD+K  N+ + E    K+ DFG AR ++ + 
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE- 179

Query: 206 AVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
                 T    T  Y  P+ + ++    +  D++S G ++ EM+TG+
Sbjct: 180 -----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y+H      IIHRD+K  N+ + E    K+ DFG AR ++ +       T    T  
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRW 190

Query: 220 YLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
           Y  P+ +  +   T+  D++S G ++ EM+TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 11/100 (11%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG--- 216
           A+  LH  +   +IHRD+K SN+LI      KV DFG AR+ +E +A +   T  +    
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 217 ----TAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
               T  Y  P+ + T    +   DV+S G +L E+   R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 52/289 (17%), Positives = 98/289 (33%), Gaps = 78/289 (26%)

Query: 23  VSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVK--- 78
           +      S     + F   +     +N+   + IG G  G VY          VA+K   
Sbjct: 1   MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60

Query: 79  RARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFL----EHGDERIIVVEYVGNGTL 133
           R  ++  D K +L E    IL  ++++   +++L+  +        + + +V        
Sbjct: 61  RMFEDLIDCKRILREIT--IL--NRLKSDYIIRLYDLIIPDDLLKFDELYIVL------- 109

Query: 134 REHLDGRGGNGLELAE-------RLDIAIDVAH----------ALTYLHTYSDPPIIHRD 176
                       E+A+       +  I +   H             ++H      IIHRD
Sbjct: 110 ------------EIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRD 154

Query: 177 VKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE--- 233
           +K +N L+ +    KV DFG AR    +   ++I   ++        +     QLT    
Sbjct: 155 LKPANCLLNQDCSVKVCDFGLARTINSEKD-TNIVNDLEENEEPGPHNKNLKKQLTSHVV 213

Query: 234 -----------------KS-DVYSFGVLLVEMMTGRYPIES----KKPI 260
                            KS D++S G +  E++       +    + P+
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y+H+     IIHRD+K SN+ + E    K+ DFG AR + ++       T    T  
Sbjct: 144 GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYVATRW 194

Query: 220 YLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGR 251
           Y  P+ +  +    +  D++S G ++ E++TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 56/240 (23%), Positives = 95/240 (39%), Gaps = 54/240 (22%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVK---RARKNKHDK-------CLLLEFKN 95
              +    K+G+G  G V+K    + G +VAVK    A +N  D         +L E   
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 96  EILTWSKIEHLNLVKLFGFL--EHGDERIIVVEYVG---NGTLREHLDGRGGNGLELAER 150
                    H N+V L   L  ++  +  +V +Y+    +  +R        N LE   +
Sbjct: 68  ---------HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR-------ANILEPVHK 111

Query: 151 LDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI 210
             +   +   + YLH+     ++HRD+K SNIL+  +   KV DFG +R       V++ 
Sbjct: 112 QYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 211 STQVKGTAGYLDP-------DYLRT--Y----------QLTEKSDVYSFGVLLVEMMTGR 251
                               DY+ T  Y          + T+  D++S G +L E++ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 36/223 (16%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVK--RARKNKHDKCL----LLEFKNEILTWSKIEHLN 107
           K+G+G  G V   + + +    AVK  R  K           +L+          I + N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN----DDINNNN 97

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VK  G   + D   ++ E +G  +L E +     NG  + +     I++  AL YL   
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-- 154

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI-STQVK----GTAGYLD 222
               + H D+K  NIL+ +    K           +   +    ST +K    G A +  
Sbjct: 155 -KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213

Query: 223 PDYLRTYQLT---------------EKSDVYSFGVLLVEMMTG 250
            DY  +   T                 SD++SFG +L E+ TG
Sbjct: 214 -DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 44/223 (19%), Positives = 74/223 (33%), Gaps = 40/223 (17%)

Query: 55  KIGEGGSGTVYKG--KLKDGSIVAVK--RARKNKHDKCL----LLEFKNEILTWSKIEHL 106
            +GEG  G V +     +  S VA+K  R      +       +L+   E     K    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKE---KDKENKF 82

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
             V +  +        I  E +G     E L         L     +A  + HAL +LH 
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH- 140

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK----GTAGYLD 222
             +  + H D+K  NIL        + +   +   +        +T ++    G+A +  
Sbjct: 141 --ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK-----NTSIRVADFGSATFDH 193

Query: 223 PDYLRTYQLT---------------EKSDVYSFGVLLVEMMTG 250
            ++  T   T               +  DV+S G +L E   G
Sbjct: 194 -EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 57/266 (21%), Positives = 88/266 (33%), Gaps = 72/266 (27%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHD-KCLLLEFKNEILTW---SKIEHLN-- 107
           K+G G   TV+    ++    VA+K  +  +H  +  L E +  +L     S     N  
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR--LLKSVRNSDPNDPNRE 101

Query: 108 -LVKLFGFLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
            +V+L    +     G    +V E +G+  L + +      GL L     I   V   L 
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 163 YLHTYSDPPIIHRDVKASNILIT------------------------------------- 185
           YLHT     IIH D+K  NIL++                                     
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 186 ------------EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTE 233
                       EKL+ K+ D G A    +      I T+      Y   + L       
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-EDIQTRQ-----YRSLEVLIGSGYNT 272

Query: 234 KSDVYSFGVLLVEMMTGRYPIESKKP 259
            +D++S   +  E+ TG Y  E    
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSG 298

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 47/223 (21%), Positives = 79/223 (35%), Gaps = 40/223 (17%)

Query: 55  KIGEGGSGTVYKGK--LKDGSIVAVK--RARKNKHDKCL----LLEFKNEILTWSKIEHL 106
            +GEG  G V +       G  VAVK  +      +       +LE  N           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT---TDPNSTF 77

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
             V++  + EH     IV E +G  +  + +   G     L     +A  +  ++ +LH 
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH- 135

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK----GTAGYLD 222
                + H D+K  NIL  +    +  +    R        + I+  +K    G+A Y D
Sbjct: 136 --SNKLTHTDLKPENILFVQSDYTEAYNPKIKR-----DERTLINPDIKVVDFGSATYDD 188

Query: 223 PDYLRTYQLT---------------EKSDVYSFGVLLVEMMTG 250
            ++  T   T               +  DV+S G +L+E   G
Sbjct: 189 -EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 49/222 (22%), Positives = 89/222 (40%), Gaps = 30/222 (13%)

Query: 45  KATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
           K  +   P + IG+G    + +    D  ++  +R +K   D+ L    +    T  +  
Sbjct: 333 KGKKRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKS-RTAREAR 391

Query: 105 HLNLVKLFG------FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
           +L LVK FG      F    D + I++ Y+     ++ ++          + LDIA  + 
Sbjct: 392 YLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE----------DNLDIAYKIG 441

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE--EDSAVS-HISTQVK 215
             +  LH      +IH D+  SN +  + L   + DFG  ++S   ED AV   +  +  
Sbjct: 442 EIVGKLH---KNDVIHNDLTTSNFIFDKDL--YIIDFGLGKISNLDEDKAVDLIVFKKAV 496

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-----GRY 252
            +  +   D +    L     VY    +++E+M       RY
Sbjct: 497 LSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	380
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.46
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.21
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.19
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.64
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.18
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.13
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.11
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.86
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.77
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.72
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.6
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.49
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.32
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.2
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.06
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.35
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.7
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.76
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.41
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	93.98
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.91

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-61  Score=447.27  Aligned_cols=257  Identities=24%  Similarity=0.354  Sum_probs=215.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||+||+|++. +|+.||||++............+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            78999999999999999999986 59999999998776666667789999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ||+||+|.++|...+...+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            999999999998776666899999999999999999999999   9999999999999999999999999998764321 


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                        ......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+....       +..+..        
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~-------i~~~~~--------  242 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK-------IISGSF--------  242 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHTCC--------
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-------HHcCCC--------
Confidence              123456799999999999999999999999999999999999999987654332111       111111        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        .+.+..++.++.+||.+||+.||.+|||++|+++|.|-.
T Consensus       243 --~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  281 (350)
T 4b9d_A          243 --PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA  281 (350)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence              122334567899999999999999999999999998854

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-60  Score=439.36  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=215.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|++.++||+|+||+||+|.++ +|+.||||++.......  ...+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            56999999999999999999987 59999999997554332  3457799999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ||+||+|.+++....   +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++.+.....
T Consensus       152 y~~gg~L~~~l~~~~---l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          152 FLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CCTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999999997643   999999999999999999999999   99999999999999999999999999987654321


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|..||......+....+   ..    +.     .   
T Consensus       226 ---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~----~~-----~---  287 (346)
T 4fih_A          226 ---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD----NL-----P---  287 (346)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH----SS-----C---
T ss_pred             ---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---Hc----CC-----C---
Confidence               234678999999999999999999999999999999999999999876543322111   11    10     0   


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ........++.++.+||.+||+.||++|||++|+++|.|-.
T Consensus       288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence            11122334567899999999999999999999999999854

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.1e-60  Score=431.27  Aligned_cols=255  Identities=22%  Similarity=0.289  Sum_probs=213.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++..... .......+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999987 599999999975432 2223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |||+||+|.++|...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.+....
T Consensus       112 Ey~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999987654  999999999999999999999999   9999999999999999999999999999775432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      . .......+||+.|||||++.+..|+.++|||||||+||+|++|..||...+.......       +..+..       
T Consensus       187 ~-~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-------i~~~~~-------  251 (311)
T 4aw0_A          187 K-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK-------IIKLEY-------  251 (311)
T ss_dssp             T-CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCC-------
T ss_pred             C-cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcCCC-------
Confidence            2 2224567899999999999999999999999999999999999999987554322111       111110       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ..+...+.++.+||.+||+.||.+|||++|++.+.|-
T Consensus       252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i  288 (311)
T 4aw0_A          252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL  288 (311)
T ss_dssp             ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHH
T ss_pred             ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHH
Confidence                1122345678999999999999999999987555543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-59  Score=428.01  Aligned_cols=267  Identities=28%  Similarity=0.469  Sum_probs=214.0

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ...+++.+.++||+|+||+||+|.++  ..||||+++...........|.+|+.+|++++|||||++++++.+ +.++||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            34578899999999999999999975  359999998766666667789999999999999999999998865 568999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||||++|+|.++|..... .+++..++.|+.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       110 mEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            999999999999976543 4999999999999999999999988   999999999999999999999999999876532


Q ss_pred             CcceeeeecccCCccccChhhhhh---cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRT---YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .. ........||+.|||||++.+   +.|+.++|||||||+||||+||+.||..........      .....+.    
T Consensus       186 ~~-~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~------~~~~~~~----  254 (307)
T 3omv_A          186 SG-SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII------FMVGRGY----  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH------HHHHTTC----
T ss_pred             Cc-ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcCC----
Confidence            21 122345679999999999974   358999999999999999999999998765432211      1111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ..+.+  ......++..+.+||.+||+.+|++|||+.||+++|+.++..+
T Consensus       255 ~~p~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          255 ASPDL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CCCCS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             CCCCc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            11111  1223456678999999999999999999999999999887654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.2e-60  Score=435.95  Aligned_cols=260  Identities=25%  Similarity=0.428  Sum_probs=209.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++|.+.++||+|+||+||+|.++      +++.||||+++...  .....+|.+|+.+|++++|||||+++++|.+.+.
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            356778899999999999999864      37889999997543  3446779999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          121 RIIVVEYVGNGTLREHLDGRG-------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      .+||||||++|+|.++|....             ..++++.+++.++.||+.||.|||+++   |+||||||+|||++++
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCC
Confidence            999999999999999997643             234899999999999999999999988   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.+||+|||+++....... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||......+..   
T Consensus       195 ~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~---  270 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI---  270 (329)
T ss_dssp             TEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH---
T ss_pred             CcEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH---
Confidence            9999999999987644321 223345679999999999999999999999999999999999 89999876543221   


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          ..+..+.          ..+.+..+++++.+|+.+||+.||++|||++||+++|+.+.+
T Consensus       271 ----~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 ----DCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             ----HHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                1111111          112233466789999999999999999999999999998765

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-59  Score=428.99  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=215.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++|.+.+.||+|+||+||+|.+.      +|..||||+++...  ....++|.+|+.+|++++|||||+++|+|.+.+.
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            367888999999999999999864      36789999997543  3446779999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          121 RIIVVEYVGNGTLREHLDGRG-----------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      .+||||||++|+|.++|...+           ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence            999999999999999997642           345999999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  268 (380)
                      +||+|||+++...... .........||+.|||||++.+..|+.++|||||||+||||+| |+.||......+..     
T Consensus       167 ~Ki~DFGla~~~~~~~-~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~-----  240 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTD-YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-----  240 (299)
T ss_dssp             EEECCCSCHHHHTGGG-CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----
T ss_pred             EEECCcccceecCCCC-ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            9999999998665422 1222334569999999999999999999999999999999999 89999876543221     


Q ss_pred             HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                        ..+..+..          .+.+..++.++.+|+.+||+.||++|||+++|++.|+.+.+
T Consensus       241 --~~i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          241 --ECITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             --HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence              11111211          12234466789999999999999999999999999887755

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.1e-59  Score=428.94  Aligned_cols=259  Identities=22%  Similarity=0.245  Sum_probs=213.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+.|.+.++||+|+||.||+|+++ +|+.||||+++.....       .+|+.+|++++|||||++++++.+.+.+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            356788889999999999999987 5999999999765432       37999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  204 (380)
                      |||+||+|.++|...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.+| .+||+|||+++.....
T Consensus       130 Ey~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             eccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            99999999999987653  999999999999999999999998   99999999999999887 6999999999877543


Q ss_pred             Cccee--eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          205 SAVSH--ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       205 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+..       +.     
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~-----  272 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-------EP-----  272 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-------SC-----
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-------CC-----
Confidence            32211  22346799999999999999999999999999999999999999987655443222211       00     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                         ......+..++..+.+||.+||+.||.+|||+.|++++++.......
T Consensus       273 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          273 ---PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             ---CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ---CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence               00011223456789999999999999999999999999998876554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-59  Score=422.32  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=207.5

Q ss_pred             CCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe----CCEEEEEE
Q 041907           51 SPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GDERIIVV  125 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  125 (380)
                      ++.++||+|+||+||+|.+. +|+.||+|++............+.+|+.+|++++|||||++++++..    ...+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            67788999999999999987 58999999998766666666779999999999999999999999865    35689999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+||+|.+++.+.+.  +++..++.++.||+.||.|||+++ ++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus       109 Ey~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             ECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             eCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            99999999999987543  899999999999999999999865 56999999999999984 789999999999864432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                           .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.........      ...+..+..      
T Consensus       186 -----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~------~~~i~~~~~------  247 (290)
T 3fpq_A          186 -----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVK------  247 (290)
T ss_dssp             -----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCC------
T ss_pred             -----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH------HHHHHcCCC------
Confidence                 2345689999999999875 6999999999999999999999999765443221      111111111      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ....+...+.++.+||.+||+.||.+|||++|+++|.|-
T Consensus       248 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~  286 (290)
T 3fpq_A          248 ---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             ---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence               011112234578999999999999999999999999884

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-59  Score=441.00  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=215.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|++.+.||+|+||.||+|.++ +|+.||||++.......  ...+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            56999999999999999999987 59999999997654332  3457899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ||+||+|.+++....   +++..+..++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++.+.....
T Consensus       229 y~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          229 FLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CCTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            999999999997643   999999999999999999999999   99999999999999999999999999987654321


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.   .    +.     .+. 
T Consensus       303 ---~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---~----~~-----~~~-  366 (423)
T 4fie_A          303 ---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---D----NL-----PPR-  366 (423)
T ss_dssp             ---CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---H----SC-----CCC-
T ss_pred             ---cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---c----CC-----CCC-
Confidence               2346789999999999999999999999999999999999999998765433222111   1    10     011 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        ......++.++.+||.+||+.||.+|||++|+++|.|-.
T Consensus       367 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~  405 (423)
T 4fie_A          367 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  405 (423)
T ss_dssp             --CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             --CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence              112223457899999999999999999999999999854

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.8e-59  Score=426.01  Aligned_cols=257  Identities=23%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++++.++||+|+||+||+|.+.      +++.||||+++..... ....+|.+|+.++++++|||||+++|+|.+.+..
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            45677889999999999999863      4678999999765432 3456799999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          122 IIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      +||||||++|+|.++|....              ...+++..++.++.||+.||.|||+++   |+||||||+|||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence            99999999999999996542              134899999999999999999999998   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.+||+|||+++....... ........||+.|||||++.++.|+.++|||||||+||||+| |..||.+....+.    
T Consensus       182 ~~~Ki~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~----  256 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADY-YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV----  256 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGC-BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH----
T ss_pred             CCEEECCcccceeccCCCc-eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH----
Confidence            9999999999987643221 223345679999999999999999999999999999999998 8999987654321    


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ...+..+.          ..+.+..++..+.+|+.+||+.||.+|||+.||+++|+.
T Consensus       257 ---~~~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          257 ---VEMIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             ---HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---HHHHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               11121211          122344567889999999999999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-58  Score=415.71  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...... ......+.+|+.+|++++|||||++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999986 5999999999765432 233456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+ +|+|.+++...+.  +++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus        93 Ey~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 6799999987654  999999999999999999999999   9999999999999999999999999998755422


Q ss_pred             cceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                          .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||........   +    ..+..+.       
T Consensus       167 ----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~---~----~~i~~~~-------  228 (275)
T 3hyh_A          167 ----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL---F----KNISNGV-------  228 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHTC-------
T ss_pred             ----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHcCC-------
Confidence                2345679999999999999887 4799999999999999999999986543221   1    1111111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ...+...+.++.+||.+||+.||++|||++|+++|.|-
T Consensus       229 ----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          229 ----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence                11122345778999999999999999999999999995

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.7e-59  Score=424.14  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=206.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ++|++.+.||+|+||+||+|++.    +++.||||++............+.+|+.+|++++|||||++++++.+.+.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999863    47899999997654332223457789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||||+||+|.++|.+.+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++....
T Consensus       104 vmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            9999999999999987654  999999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+       ..+.      
T Consensus       179 ~~---~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~~------  242 (304)
T 3ubd_A          179 HE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI-------LKAK------  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC------
T ss_pred             CC---ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-------HcCC------
Confidence            22   1234578999999999999999999999999999999999999999876543322111       1111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                           ...+..++.++.+||.+||+.||.+|||     ++|+++|.|-
T Consensus       243 -----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          243 -----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             -----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence                 1122335678999999999999999998     5799999884

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-56  Score=416.35  Aligned_cols=272  Identities=26%  Similarity=0.350  Sum_probs=222.2

Q ss_pred             ccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC-Cceec
Q 041907           38 FSFEEIYKATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LNLVK  110 (380)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~  110 (380)
                      +....++...++|++.+.||+|+||+||+|.+..      ++.||||.+...... .....+.+|+.+|.+++| ||||+
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-HHHHHHHHHHHHHHHcCCCCcEEE
Confidence            4456676777899999999999999999998652      357999999765443 345678999999999965 89999


Q ss_pred             eEEEEEe-CCEEEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 041907          111 LFGFLEH-GDERIIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHR  175 (380)
Q Consensus       111 ~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~  175 (380)
                      ++|+|.. ...++||||||++|+|.++|+...              ...+++..++.++.||+.||.|||+++   ||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            9999976 456899999999999999997532              234899999999999999999999998   9999


Q ss_pred             cCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCC
Q 041907          176 DVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPI  254 (380)
Q Consensus       176 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~  254 (380)
                      ||||+|||+++++.+||+|||+++....... ........||+.|||||++.+..|+.++|||||||+||||+| |..||
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~-~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCC-ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            9999999999999999999999987654332 223345679999999999999999999999999999999998 99999


Q ss_pred             CCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          255 ESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      .+.......      ...+..+..          .+.+..++.++.+||.+||+.||.+|||+.+|+++|..+.+.
T Consensus       289 ~~~~~~~~~------~~~i~~g~~----------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          289 PGVKIDEEF------CRRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             TTCCCSHHH------HHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHH------HHHHHcCCC----------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            876543221      111111111          122334567899999999999999999999999999987653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.5e-57  Score=412.54  Aligned_cols=271  Identities=20%  Similarity=0.298  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----EEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----ERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l  123 (380)
                      ++|.+.+.||+|+||+||+|.+. |+.||||++......   ...+..|+..+.+++|||||++++++.+.+    .++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            46788899999999999999985 899999998654321   223346777778899999999999997653    6799


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS-----DPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ||||+++|+|.++|....   +++..+.+++.|++.||.|||++.     .++|+||||||+|||++.++.+||+|||++
T Consensus        79 V~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999998654   899999999999999999999761     124999999999999999999999999999


Q ss_pred             ccccCCCccee-eeecccCCccccChhhhhhc------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcch--------h
Q 041907          199 RMSEEDSAVSH-ISTQVKGTAGYLDPDYLRTY------QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE--------R  263 (380)
Q Consensus       199 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~--------~  263 (380)
                      +.......... ......||+.|||||++.+.      .++.++|||||||+||||+||..||........        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            87654332221 22346799999999999764      467899999999999999999887753322110        0


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .............    .+++.+........++..+.+|+.+||+.||.+|||+.||++.|..+.+
T Consensus       236 ~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            0011111111111    1122222222334567889999999999999999999999999998865

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-55  Score=402.51  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=194.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-------
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-------  119 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  119 (380)
                      ++|++.+.||+|+||+||+|.++ +|+.||||+++.... ......+.+|+.+|++++|||||++++++.+.+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            35889999999999999999987 699999999976543 334567889999999999999999999986544       


Q ss_pred             -----EEEEEEEeCCCCCHHHHhccCCCC-CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          120 -----ERIIVVEYVGNGTLREHLDGRGGN-GLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       120 -----~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                           .+|+|||||++|+|.+++...... ..++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 379999999999999999876532 2556778899999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCcce---------eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 041907          194 DFGFARMSEEDSAVS---------HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV  264 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  264 (380)
                      |||+++.........         ......+||+.|||||++.+..|+.++|||||||++|||++   ||.....  .  
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~--  233 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--R--  233 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--H--
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--H--
Confidence            999998765432211         11234679999999999999999999999999999999996   7753211  1  


Q ss_pred             HHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                       .. ........          ...+........+.+||.+||+.||.+|||+.|+++|.|.
T Consensus       234 -~~-~~~~~~~~----------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          234 -VR-TLTDVRNL----------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             -HH-HHHHHHTT----------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             -HH-HHHHHhcC----------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence             11 01111111          1111223344567889999999999999999999998773

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-55  Score=417.63  Aligned_cols=275  Identities=20%  Similarity=0.263  Sum_probs=213.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe------CC
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH------GD  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~  119 (380)
                      .++|++.+.||+|+||+||+|.++ +|+.||||+++...........+.+|+.+|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999987 69999999998766555556678899999999999999999998754      36


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      .+|||||||+ |+|.++|...+  .+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            7899999996 58999998754  4999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCc-ceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          200 MSEEDSA-VSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       200 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .+..... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+...........
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7643211 12233567899999999998875 468999999999999999999999988765544333321111000000


Q ss_pred             cc--------cccccCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          278 AI--------LVMDPRLRRTPAS-----NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       278 ~~--------~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..        ..+.......+..     ...+.++.+||.+||+.||.+|||++|+++|.|-.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            00        0000000001111     12346788999999999999999999999999854

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.7e-53  Score=395.82  Aligned_cols=272  Identities=22%  Similarity=0.318  Sum_probs=204.6

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      +....++|++.+.||+|+||+||+|.++    .++.||||.+.....    ...+.+|+.+|+.+ +||||+++++++.+
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            3345688999999999999999999864    367899999866533    23567899999988 69999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEcccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFG  196 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg  196 (380)
                      .+.+|+||||+++|+|.+++..     +++.+++.++.||+.||.|||++|   |+||||||+|||++.+ +.+||+|||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            9999999999999999999942     889999999999999999999999   9999999999999876 799999999


Q ss_pred             ccccccCCCcc-------------------------eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhC
Q 041907          197 FARMSEEDSAV-------------------------SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTG  250 (380)
Q Consensus       197 ~~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg  250 (380)
                      +|+........                         .......+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            99865432110                         0112345799999999999876 489999999999999999999


Q ss_pred             CCCCCCCCCc-chhhHHHHHHH-------hhccCC------------cc------cccc-----------cCCCCCCCCH
Q 041907          251 RYPIESKKPI-KERVTIRWAMQ-------CLKAGD------------AI------LVMD-----------PRLRRTPASN  293 (380)
Q Consensus       251 ~~p~~~~~~~-~~~~~~~~~~~-------~~~~~~------------~~------~~~~-----------~~~~~~~~~~  293 (380)
                      +.||...... +....+.....       ....+.            ..      ...+           ..........
T Consensus       244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  323 (361)
T 4f9c_A          244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN  323 (361)
T ss_dssp             CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence            9999654432 11111110000       000000            00      0000           0000001112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          294 MAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       294 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ..++++.+||.+||+.||.+|||++|+++|+|-
T Consensus       324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             cCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence            345678899999999999999999999999983

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.5e-52  Score=411.98  Aligned_cols=255  Identities=22%  Similarity=0.302  Sum_probs=209.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc----chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH----DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.+...    ..........++.+++.++|||||++++++.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999987 599999999975421    1112222345577788889999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |||||++||+|.++|...+.  +++..++.++.||+.||.|||++|   ||||||||+|||++.+|.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999987654  999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhh-hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLR-TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...     ....+||+.|||||++. +..|+.++|||||||+||||++|..||......+..........    .     
T Consensus       344 ~~~-----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~-----  409 (689)
T 3v5w_A          344 KKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M-----  409 (689)
T ss_dssp             SCC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----C-----
T ss_pred             CCC-----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----C-----
Confidence            432     24568999999999996 45799999999999999999999999976544332211111111    0     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~  327 (380)
                         .   ...+..++.++.+||.+||+.||.+|++     ++||++|.|--
T Consensus       410 ---~---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          410 ---A---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             ---C---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             ---C---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence               0   1122345678999999999999999998     79999999853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.4e-52  Score=411.60  Aligned_cols=256  Identities=22%  Similarity=0.311  Sum_probs=214.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++......  ....+.+|+.+|+.++|||||++++++.+...+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~--~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh--hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            368999999999999999999987 5999999999765432  3456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC--CceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK--LRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~~  203 (380)
                      |||+||+|.++|....+ .+++..+..++.||+.||.|||++|   |+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       234 E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          234 EFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             ECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             eecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            99999999999976543 3999999999999999999999999   9999999999999854  8999999999998765


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..    .....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+....+....+       .....     
T Consensus       310 ~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-------~~~~~-----  373 (573)
T 3uto_A          310 KQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-------KSCDW-----  373 (573)
T ss_dssp             TS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HTTCC-----
T ss_pred             CC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------HhCCC-----
Confidence            32    234567999999999999999999999999999999999999999876543322111       11110     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                       .. .......++.++.+||.+||+.||.+|||++|+++|.|.
T Consensus       374 -~~-~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~  414 (573)
T 3uto_A          374 -NM-DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL  414 (573)
T ss_dssp             -CC-CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             -CC-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence             00 011122345778999999999999999999999999884

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-50  Score=375.27  Aligned_cols=286  Identities=39%  Similarity=0.586  Sum_probs=238.4

Q ss_pred             cccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE
Q 041907           37 NFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE  116 (380)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  116 (380)
                      .+++.++....++|.+.+.||+|+||.||+|.+++|+.||||++......  ....+.+|+.++++++||||+++++++.
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ--GIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS--HHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34445566688999999999999999999999888999999998765433  3567889999999999999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGG--NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                      ..+..++||||+++++|.+++.....  ..+++..++.++.|++.||.|||++|   ++||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999976542  34899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ||++........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........|......
T Consensus       183 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          183 FGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CTTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             cccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            999986543221 1122345689999999999999999999999999999999999999987766555555555544444


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .+.....+++... .......+..+.+++.+||+.||++|||+.+++++|+.+.+
T Consensus       262 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          262 NGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            4444444444433 33567788999999999999999999999999999998765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.3e-50  Score=370.21  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=217.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4578999999999999999999985 699999999987665555667788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...+.  +++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999977644  899999999999999999999999   999999999999999999999999999866543


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .    .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||...........       ...+.      
T Consensus       168 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------i~~~~------  230 (328)
T 3fe3_A          168 G----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER-------VLRGK------  230 (328)
T ss_dssp             C----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCC------
T ss_pred             C----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCC------
Confidence            2    23456799999999999988876 789999999999999999999987654322111       11111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+...+..+.+|+.+||+.||.+|||++|+++|.|..
T Consensus       231 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          231 -----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred             -----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence                 011222456788999999999999999999999999854

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.4e-49  Score=360.93  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=214.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.......  ...+.+|+.++++++||||+++++++...+..++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            468999999999999999999975 69999999987654332  345789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++....   +++..++.++.|++.||.|||+.|   ++||||||+|||++.++.+||+|||++.......
T Consensus        97 e~~~~~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           97 EYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             ECCTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ECCCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999998753   899999999999999999999998   9999999999999999999999999988765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||....+......+.   .   .+         
T Consensus       171 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~---~~---------  232 (297)
T 3fxz_A          171 S---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---T---NG---------  232 (297)
T ss_dssp             C---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---H---HC---------
T ss_pred             c---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---CC---------
Confidence            2   2334679999999999999999999999999999999999999998665433221111   0   00         


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ......+...+..+.+|+.+||+.||.+|||++|++++.|..
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence            001112334557789999999999999999999999998854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-49  Score=369.15  Aligned_cols=289  Identities=35%  Similarity=0.589  Sum_probs=233.8

Q ss_pred             CCCccccccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceec
Q 041907           31 GQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK  110 (380)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~  110 (380)
                      .......+++.++....++|++.+.||+|+||.||+|.+.+|+.||||++....... ....+.+|+.++++++||||++
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~   91 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLR   91 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccc
Confidence            334456789999999999999999999999999999998889999999997654321 1225789999999999999999


Q ss_pred             eEEEEEeCCEEEEEEEeCCCCCHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCCCeeeccCCCCceeeC
Q 041907          111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGG--NGLELAERLDIAIDVAHALTYLHTY---SDPPIIHRDVKASNILIT  185 (380)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~---~~~~i~H~dlkp~Nil~~  185 (380)
                      +++++......++||||+++++|.+++.....  ..+++..++.++.|++.||.|||+.   |   ++||||||+|||++
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLD  168 (326)
T ss_dssp             CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEEC
T ss_pred             eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEEC
Confidence            99999999999999999999999999987543  3489999999999999999999998   7   99999999999999


Q ss_pred             CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCC--Ccchh
Q 041907          186 EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK--PIKER  263 (380)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~--~~~~~  263 (380)
                      .++.+||+|||++........  .......||+.|+|||++.+..++.++|||||||++|+|++|..||....  .....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV  246 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred             CCCCEEeccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence            999999999999987654322  22344569999999999999999999999999999999999999996321  11111


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ....+..............+.... .......+..+.+++.+||+.+|.+|||+.+|+++|+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          247 MLLDWVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             BHHHHHTTTTSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hHHHHHHHHhhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            222333333333333333333333 34567788999999999999999999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.7e-49  Score=362.70  Aligned_cols=270  Identities=30%  Similarity=0.468  Sum_probs=212.8

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      .++....++|++.+.||+|+||+||+|.+. |+.||||++............+.+|+.++++++||||+++++++...+.
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            334445678999999999999999999885 8889999998776666666788999999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      .++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.| .+|+||||||+|||++.++.+||+|||+++
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999999986542 23889999999999999999999765 459999999999999999999999999997


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.   .   .    
T Consensus       188 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~---~----  254 (309)
T 3p86_A          188 LKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---F---K----  254 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---H---S----
T ss_pred             cccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---c----
Confidence            544321   11234569999999999999999999999999999999999999998665432211110   0   0    


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                            ......+..++..+.+||.+||+.+|.+|||++++++.|..+.+..
T Consensus       255 ------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          255 ------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             ------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                  0111222345577999999999999999999999999999887654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.5e-49  Score=363.28  Aligned_cols=264  Identities=26%  Similarity=0.414  Sum_probs=215.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||++..... ......+.+|+.++++++||||+++++++......
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            3467899999999999999999985    345699999976533 33456789999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++..... .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++..
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999999976543 4999999999999999999999999   999999999999999999999999999877


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........       ...+.   
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~~~~~---  271 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS-------VEEGY---  271 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-------HHTTC---
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HHcCC---
Confidence            654333333344557889999999999999999999999999999999 9999976544322111       11110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                             ..+....++..+.+|+.+||+.+|.+||++.+|++.|..+....
T Consensus       272 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 -------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                   11223345678999999999999999999999999999887644

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=358.31  Aligned_cols=265  Identities=23%  Similarity=0.386  Sum_probs=216.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||+||+|.+. +|+.||+|++...  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            478899999999999999999987 5999999988553  3344667899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+.|   ++|+||||+|||++.++.+||+|||++.......
T Consensus        87 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             ECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999999998754 34899999999999999999999999   9999999999999999999999999998764432


Q ss_pred             ccee-----------eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh--HHHHHHHh
Q 041907          206 AVSH-----------ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV--TIRWAMQC  272 (380)
Q Consensus       206 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~  272 (380)
                      ....           ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+.....  ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            2110           0114579999999999999999999999999999999999999987644332111  01100000


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhcc
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK  334 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~~  334 (380)
                                  .     .+..++..+.+++.+||+.||.+|||++++++.|..++..+...
T Consensus       243 ------------~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~  287 (310)
T 3s95_A          243 ------------Y-----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH  287 (310)
T ss_dssp             ------------T-----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred             ------------c-----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence                        0     11123356889999999999999999999999999998877543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.3e-49  Score=371.28  Aligned_cols=263  Identities=27%  Similarity=0.384  Sum_probs=215.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      .++|.+.+.||+|+||.||+|.+.        ++..||||+++.... ......+.+|+.+++++ +||||+++++++..
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-HHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            468899999999999999999863        356799999976543 34456789999999999 89999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcee
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL  183 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  183 (380)
                      .+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||++|   |+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            9999999999999999999976532              34789999999999999999999999   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcch
Q 041907          184 ITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKE  262 (380)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~  262 (380)
                      ++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTT-CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ECCCCCEEEccccCCcccCcccce-ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999865542211 11233457889999999999999999999999999999999 9999986543322


Q ss_pred             hhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          263 RVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ..       ....+.          ....+..++..+.++|.+||+.+|.+||++.|+++.|..+....
T Consensus       315 ~~-------~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          315 FK-------LLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HH-------HHHTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HH-------HHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11       111111          01122345578999999999999999999999999999886643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.4e-48  Score=357.56  Aligned_cols=271  Identities=24%  Similarity=0.389  Sum_probs=220.6

Q ss_pred             CccccccHHHHHHHhcC----------CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHh
Q 041907           33 ATTINFSFEEIYKATEN----------FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWS  101 (380)
Q Consensus        33 ~~~~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~  101 (380)
                      -.+..++++++..+.+.          |...+.||+|+||.||+|.+. +|+.||||++.......  ...+.+|+.+++
T Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~   97 (321)
T 2c30_A           20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMR   97 (321)
T ss_dssp             -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHT
T ss_pred             ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHH
Confidence            33445788888887764          677789999999999999987 69999999997654332  456789999999


Q ss_pred             cCCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 041907          102 KIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN  181 (380)
Q Consensus       102 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  181 (380)
                      +++||||+++++++...+..++||||+++++|.+++...   .+++..++.++.|++.||.|||+.|   ++||||||+|
T Consensus        98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N  171 (321)
T 2c30_A           98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS  171 (321)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred             hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence            999999999999999999999999999999999998754   3899999999999999999999998   9999999999


Q ss_pred             eeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 041907          182 ILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK  261 (380)
Q Consensus       182 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~  261 (380)
                      ||++.++.+||+|||++........   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~  248 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ  248 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             EEECCCCcEEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999999999887654321   1234579999999999999999999999999999999999999997654432


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ....   ...    ..     .+   ........+..+.+++.+||+.||.+|||++++++++|-...
T Consensus       249 ~~~~---~~~----~~-----~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          249 AMKR---LRD----SP-----PP---KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             HHHH---HHH----SS-----CC---CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             HHHH---Hhc----CC-----CC---CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            2111   111    00     00   011122345678999999999999999999999999986543

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-48  Score=360.31  Aligned_cols=273  Identities=24%  Similarity=0.299  Sum_probs=211.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||+||+|.+.+|+.||+|++............+.+|+.++++++||||+++++++......++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            45889999999999999999999988999999999766544444567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++ +|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++......
T Consensus        99 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             ECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             cCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            99975 8888887654 34899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc--
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM--  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  282 (380)
                      .   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+................  
T Consensus       174 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          174 R---SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             C------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             c---cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            1   1234568999999999976 568999999999999999999999998766554433322211111111000000  


Q ss_pred             ----ccCCC---CCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          283 ----DPRLR---RTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       283 ----~~~~~---~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          .....   ..+   .....+.++.+||.+||+.||.+|||++|+++|.|-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                00000   000   011234678899999999999999999999999884

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-48  Score=366.12  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=215.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.+.+.||+|+||.||+|.++ +|+.||+|++............+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4578999999999999999999987 589999999987665555566788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~  201 (380)
                      |||+++|+|.+++....  .+++..++.++.||+.||.|||++|   |+||||||+|||++.++   .+||+|||++...
T Consensus       107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            99999999999997654  3899999999999999999999999   99999999999998654   5999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....    .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .+..+...  
T Consensus       182 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~~~~--  248 (362)
T 2bdw_A          182 NDSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA-------QIKAGAYD--  248 (362)
T ss_dssp             TTCCS----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTCCC--
T ss_pred             cCCcc----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHhCCCC--
Confidence            54321    234679999999999999999999999999999999999999997654322111       11111100  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+....++..+.+||.+||+.||.+||++.+++++.|..
T Consensus       249 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  289 (362)
T 2bdw_A          249 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  289 (362)
T ss_dssp             -----CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred             -----CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence                 01112233457789999999999999999999999998853

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-48  Score=366.28  Aligned_cols=259  Identities=22%  Similarity=0.322  Sum_probs=213.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++.......    .....+.+|+.+|++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4578999999999999999999987 59999999997654321    124568899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL----RAKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg  196 (380)
                      .++||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999997654  4899999999999999999999999   99999999999998877    79999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++.......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........       +..+
T Consensus       165 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~-------i~~~  233 (361)
T 2yab_A          165 LAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------ITAV  233 (361)
T ss_dssp             SCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTT
T ss_pred             CceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhc
Confidence            998765432    12346799999999999999999999999999999999999999987543322111       1111


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...  ++     .......+..+.+||.+||+.||.+|||++|+++|+|-.
T Consensus       234 ~~~--~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          234 SYD--FD-----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             CCC--CC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             CCC--CC-----chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            000  00     000112346789999999999999999999999998853

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.7e-48  Score=372.35  Aligned_cols=260  Identities=21%  Similarity=0.286  Sum_probs=215.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999986 589999999987766555566789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  201 (380)
                      |||+++|+|.+.+.....  +++..+..++.||+.||.|||+.|   |+||||||+|||++   .++.+||+|||++...
T Consensus        89 ~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999987654  899999999999999999999999   99999999999998   4578999999999866


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .+..+...  
T Consensus       164 ~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~~~--  231 (444)
T 3soa_A          164 EGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ-------QIKAGAYD--  231 (444)
T ss_dssp             CTTCC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHTCCC--
T ss_pred             cCCCc---eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHhCCCC--
Confidence            54321   1234679999999999999999999999999999999999999997654322211       11111100  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+.....+..+.+||.+||+.||.+|||+.|+++|+|-.
T Consensus       232 -----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          232 -----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             -----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                 01112234457799999999999999999999999998854

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.8e-48  Score=359.23  Aligned_cols=255  Identities=23%  Similarity=0.285  Sum_probs=212.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|+++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999987 599999999975421 112345678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++|+|..++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            999999999999986543  899999999999999999999999   999999999999999999999999999854322


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .   ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........       .+..+.       
T Consensus       159 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~i~~~~-------  221 (337)
T 1o6l_A          159 G---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILMEE-------  221 (337)
T ss_dssp             T---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC-------
T ss_pred             C---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH-------HHHcCC-------
Confidence            1   12345679999999999999999999999999999999999999997654322111       111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                          ...+...+.++.+||.+||+.||.+||     +++++++|.|-.
T Consensus       222 ----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence                011223457789999999999999999     899999998853

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-48  Score=353.58  Aligned_cols=271  Identities=25%  Similarity=0.330  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      ++|++.+.||+|+||.||+|.+.+|+.||+|++............+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999999998899999999976554433345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++ +|.+++.... ..+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (288)
T ss_dssp             CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence            976 9999987653 34899999999999999999999998   9999999999999999999999999998654321  


Q ss_pred             eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc-----cc
Q 041907          208 SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI-----LV  281 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  281 (380)
                       .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.............     ..
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence             112345689999999999764 58999999999999999999999998765433222221111000000000     00


Q ss_pred             cccCCCC------CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          282 MDPRLRR------TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       282 ~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      +++....      .......+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence            1111100      00112345678899999999999999999999999874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-48  Score=361.01  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=210.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            478999999999999999999987 69999999986543322 2345789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.....  +++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++..+....
T Consensus        85 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             ECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            99999999999976543  899999999999999999999999   9999999999999999999999999998654322


Q ss_pred             cceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      . ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||............ +    ....        
T Consensus       160 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~----~~~~--------  225 (323)
T 3tki_A          160 R-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-W----KEKK--------  225 (323)
T ss_dssp             E-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-H----HTTC--------
T ss_pred             c-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-H----hccc--------
Confidence            1 222345679999999999988776 67899999999999999999999865543221110 0    0000        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                        .........+..+.+|+.+||+.||.+|||++|++++.|-.
T Consensus       226 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  266 (323)
T 3tki_A          226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  266 (323)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             --ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence              00111233456788999999999999999999999999854

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-48  Score=360.03  Aligned_cols=272  Identities=21%  Similarity=0.281  Sum_probs=212.9

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----  119 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  119 (380)
                      ....++|++.+.||+|+||+||+|.+. |+.||||++.....   .......|+.++.+++||||+++++++....    
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch---HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            345689999999999999999999987 88999999975432   2344567999999999999999999998743    


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeeeccCCCCceeeCCCCc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY----------SDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      ..++||||+++|+|.+++....   +++..++.++.|++.||.|||+.          +   |+||||||+|||++.++.
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCC
T ss_pred             eEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCe
Confidence            4799999999999999997643   89999999999999999999988          7   999999999999999999


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV  264 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  264 (380)
                      +||+|||+++........ .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||..........
T Consensus       170 ~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             EEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             EEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999876543221 12234579999999999987     345678899999999999999999997654322111


Q ss_pred             HH---------HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          265 TI---------RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       265 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      ..         ..........    ...+...........+..+.+||.+||+.||.+|||+++|++.|+.+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHK----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcc----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            10         0011111111    01111111112335667799999999999999999999999999988764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-47  Score=350.12  Aligned_cols=269  Identities=21%  Similarity=0.294  Sum_probs=210.3

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999987 58999999998766555556778899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++ +|.+.+.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            9976 6666665543 34999999999999999999999999   9999999999999999999999999998664322 


Q ss_pred             ceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc---CCccccc
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA---GDAILVM  282 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  282 (380)
                        .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||........  .+.........   .......
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhc
Confidence              1223456899999999998766 79999999999999999998888644333222  11111111111   0000000


Q ss_pred             c-----------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          283 D-----------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       283 ~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .           ............+..+.+|+.+||+.||.+|||++|+++|.|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence            0           0000011122355778899999999999999999999999884

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-47  Score=364.79  Aligned_cols=279  Identities=19%  Similarity=0.251  Sum_probs=216.8

Q ss_pred             HhcCCCCCCeeecc--CceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEG--GSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|++.+.||+|  +||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45789999999999  99999999987 6999999999877665666677889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++.......+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999998875556999999999999999999999999   9999999999999999999999999886543


Q ss_pred             CCCcc----eeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-HHhh--
Q 041907          203 EDSAV----SHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA-MQCL--  273 (380)
Q Consensus       203 ~~~~~----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~--  273 (380)
                      .....    ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||............... ....  
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            22111    111223478999999999987  67899999999999999999999999875544322111000 0000  


Q ss_pred             ----ccCC-------------ccccc--------ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          274 ----KAGD-------------AILVM--------DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       274 ----~~~~-------------~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          ....             .....        .......+.....+..+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence                0000             00000        000001112334557799999999999999999999999998853

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.3e-48  Score=347.22  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=215.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|++.......   ..+.+|+.++++++||||+++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            347899999999999999999999888899999998765443   46889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++..... .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.+||+|||++.......
T Consensus        85 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             ECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            99999999999976543 4899999999999999999999999   9999999999999999999999999998654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                        ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........       ...+.       
T Consensus       161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~-------~~~~~-------  224 (269)
T 4hcu_A          161 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------ISTGF-------  224 (269)
T ss_dssp             --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTTC-------
T ss_pred             --cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------HhcCc-------
Confidence              111233457889999999999999999999999999999999 9999986544321111       11110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         ....+...+..+.+++.+||+.+|.+||++++++++|..+.+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          225 ---RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               011122235678999999999999999999999999998865

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.9e-48  Score=365.02  Aligned_cols=264  Identities=27%  Similarity=0.418  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|.+.+.||+|+||.||+|.+.    ++..||||.++.... ......+.+|+.++.+++||||+++++++......
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            3468999999999999999999875    477899999976543 34456789999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999998654 34899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..............++..|+|||++.+..++.++|||||||++|||++ |..||.........       .....+.   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-------~~i~~~~---  267 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI-------KAVDEGY---  267 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-------HHHHTTE---
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---
Confidence            543222222223346788999999999999999999999999999998 99999765432211       1111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                            . .+....++..+.+++.+||+.+|.+||++.+|++.|..+....
T Consensus       268 ------~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          268 ------R-LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ------E-CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ------C-CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                  0 1122235577999999999999999999999999999886644

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=363.12  Aligned_cols=256  Identities=24%  Similarity=0.316  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|++.+.||+|+||.||+|.++ +|+.||||+++.... .......+.+|..++..+ +||||+++++++......|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            4589999999999999999999987 589999999976422 122344577899999987 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++|+|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...
T Consensus       101 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999999987644  899999999999999999999999   9999999999999999999999999997533


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|..||......+....+       ..+.     
T Consensus       176 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-------~~~~-----  240 (353)
T 3txo_A          176 CNG---VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI-------LNDE-----  240 (353)
T ss_dssp             C------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC-----
T ss_pred             cCC---ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCC-----
Confidence            221   1234567999999999999999999999999999999999999999876543221111       1111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM------KKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~eil~~l~~~  327 (380)
                            ...+...+..+.+||.+||+.+|.+||++      +++++|.|-.
T Consensus       241 ------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          241 ------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence                  11122345678899999999999999998      8999998853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-48  Score=357.55  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=212.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|.+.....   ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc---cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            478999999999999999999987 588999999875432   2455789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE--KLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~  203 (380)
                      ||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   ++||||||+|||++.  ++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           81 EFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999997654 34899999999999999999999999   999999999999997  78999999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........       ...+...  . 
T Consensus       157 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~~~~~--~-  222 (321)
T 1tki_A          157 GD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN-------IMNAEYT--F-  222 (321)
T ss_dssp             TC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHHTCCC--C-
T ss_pred             CC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-------HHcCCCC--C-
Confidence            32    12345699999999999998899999999999999999999999987543321111       1111000  0 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          ........+.++.+||.+||+.||.+|||+.|+++|.|-.
T Consensus       223 ----~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          223 ----DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             ----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ----ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence                0000112356789999999999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-47  Score=346.23  Aligned_cols=258  Identities=29%  Similarity=0.463  Sum_probs=215.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||.||+|.++++..||+|++.......   .++.+|+.++.+++||||+++++++......++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            457899999999999999999999888889999998765442   46789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.......
T Consensus        83 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999997653 24899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........       ...+.       
T Consensus       159 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~-------  222 (268)
T 3sxs_A          159 Y--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK-------VSQGH-------  222 (268)
T ss_dssp             E--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTC-------
T ss_pred             h--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-------HHcCC-------
Confidence            1  22234557788999999999999999999999999999999 9999976554322111       11110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         ....+...+..+.+++.+||+.+|.+|||+++++++|+.+++
T Consensus       223 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          223 ---RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               011122234678999999999999999999999999988754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.7e-46  Score=343.71  Aligned_cols=287  Identities=34%  Similarity=0.566  Sum_probs=230.5

Q ss_pred             ccccccHHHHHHHhcCCCCC------CeeeccCceEEEEEEeCCCCEEEEEEccccC--cchHHHHHHHHHHHHHhcCCC
Q 041907           34 TTINFSFEEIYKATENFSPA------NKIGEGGSGTVYKGKLKDGSIVAVKRARKNK--HDKCLLLEFKNEILTWSKIEH  105 (380)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h  105 (380)
                      ....|++.++..++++|...      +.||+|+||.||+|.+. ++.||||++....  ........+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678999999999998877      89999999999999974 8899999987542  223345678899999999999


Q ss_pred             CceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 041907          106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRG-GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI  184 (380)
Q Consensus       106 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~  184 (380)
                      |||+++++++...+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|   ++|+||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            999999999999999999999999999999997543 345899999999999999999999998   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 041907          185 TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV  264 (380)
Q Consensus       185 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  264 (380)
                      +.++.+||+|||++........ ........||+.|+|||++.+ .++.++||||||+++|+|++|..||..........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSS-CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             cCCCcEEEeecccccccccccc-cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            9999999999999986654222 122334579999999999876 47899999999999999999999998765443322


Q ss_pred             HHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .+...... ........++...  .......+..+.+++.+||+.+|.+||++++++++|..+..
T Consensus       245 ~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIED-EEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHT-TSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhh-hhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            22211111 0111112222222  23456788899999999999999999999999999998743

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=347.70  Aligned_cols=273  Identities=22%  Similarity=0.292  Sum_probs=216.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC--EEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD--ERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  123 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++++++||||+++++++....  ..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            468999999999999999999987 49999999997543322 2456779999999999999999999998765  7899


Q ss_pred             EEEeCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI----TEKLRAKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~  198 (380)
                      ||||+++++|.+++..... ..+++..++.++.||+.||.|||+.|   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999987543 33899999999999999999999999   9999999999999    78888999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhh--------hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHH
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLR--------TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI-RWA  269 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~-~~~  269 (380)
                      +.......    .....||+.|+|||++.        +..++.++|||||||++|+|++|..||...........+ ...
T Consensus       164 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          164 RELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             EECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             eecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            87654322    23456999999999987        467899999999999999999999999765433322222 222


Q ss_pred             HHhhccCCcccc----------cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 MQCLKAGDAILV----------MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ............          .................+.+++.+||+.||++|||++|+++++.+.
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            221111111000          0011112245678889999999999999999999999999999865

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-47  Score=348.83  Aligned_cols=258  Identities=26%  Similarity=0.410  Sum_probs=212.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||.||++.+.++..||+|++.......   .++.+|+.++.+++||||+++++++......++||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            567899999999999999999999988899999998765443   46789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++..... .+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+||+|||++.......
T Consensus        99 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           99 EYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             eccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999999999977432 3899999999999999999999998   9999999999999999999999999998654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                        ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........       ...+.       
T Consensus       175 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------~~~~~-------  238 (283)
T 3gen_A          175 --YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------IAQGL-------  238 (283)
T ss_dssp             --HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------HHTTC-------
T ss_pred             --cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-------Hhccc-------
Confidence              111223457888999999999999999999999999999998 9999986554322111       11110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         ....+...+..+.+++.+||+.+|.+|||+++++++|+.+..
T Consensus       239 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          239 ---RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence               011122234678999999999999999999999999998865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-47  Score=353.33  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=211.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|..+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367899999999999999999987 5999999999754321 12244577899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++|+|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 ~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             EeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999999987543  899999999999999999999988   999999999999999999999999999865432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                            ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........       +..+        
T Consensus       160 ------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------i~~~--------  218 (318)
T 1fot_A          160 ------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-------ILNA--------  218 (318)
T ss_dssp             ------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHHC--------
T ss_pred             ------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhC--------
Confidence                  2345799999999999999999999999999999999999999976543322111       1111        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                      ..   ..+...+.++.++|.+||+.||.+||     +++++++|.|-.
T Consensus       219 ~~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          219 EL---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             CC---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             CC---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence            00   11123456789999999999999999     999999998853

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-47  Score=351.38  Aligned_cols=270  Identities=24%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe----C-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL----K-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--G  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~----~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~  118 (380)
                      ..++|++.+.||+|+||.||+|.+    . +|+.||||++....  ......+.+|+.++++++||||+++++++..  .
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            357899999999999999999984    2 58899999987543  3345678899999999999999999999854  3


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ...++||||+++++|.+++..... .+++..++.++.|++.||.|||+.|   ++|+||||+|||++.++.+||+|||++
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            558999999999999999977543 3899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHH
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI---------KERVTIRWA  269 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~---------~~~~~~~~~  269 (380)
                      .................++..|+|||++.+..++.++||||||+++|+|++|..||......         .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87654433333334456788899999999999999999999999999999999998643211         000001111


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ......+          ...+.+..++..+.+++.+||+.+|.+|||++++++.|..++..+
T Consensus       242 ~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          242 IELLKNN----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHTT----------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhcc----------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111111          112233345678999999999999999999999999999987755

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.3e-48  Score=365.46  Aligned_cols=263  Identities=29%  Similarity=0.457  Sum_probs=215.8

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||.++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC-HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            35578999999999999999999997 699999999975432 3344568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++...+ ..+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||+++....
T Consensus       190 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999997653 23899999999999999999999999   99999999999999999999999999986443


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .. .........++..|+|||++.+..++.++|||||||++|||++ |..||.........       .....+.     
T Consensus       266 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~-----  332 (377)
T 3cbl_A          266 GV-YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-------EFVEKGG-----  332 (377)
T ss_dssp             SE-EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-------HHHHTTC-----
T ss_pred             Cc-eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC-----
Confidence            21 1111112335778999999999999999999999999999998 99999865433211       1111111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                           ..+.+..++..+.+||.+||+.+|.+|||++++++.|..+.+.
T Consensus       333 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 -----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                 1122334567899999999999999999999999999988764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.7e-48  Score=357.29  Aligned_cols=259  Identities=20%  Similarity=0.332  Sum_probs=212.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++.......    .....+.+|+.++++++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467899999999999999999987 59999999997654321    124568899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL----RAKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg  196 (380)
                      .++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++||||||+|||++.++    .+||+|||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999997654  3899999999999999999999999   99999999999999887    79999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++........    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.   .    .
T Consensus       164 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~----~  232 (326)
T 2y0a_A          164 LAHKIDFGNE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---A----V  232 (326)
T ss_dssp             TCEECCTTSC----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H----T
T ss_pred             CCeECCCCCc----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---h----c
Confidence            9987654321    234569999999999999999999999999999999999999997654332211111   0    0


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..      ... .......+..+.+||.+||+.||.+|||+.++++|.|-.
T Consensus       233 ~~------~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  276 (326)
T 2y0a_A          233 NY------EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  276 (326)
T ss_dssp             CC------CCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred             CC------CcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence            00      000 000112346788999999999999999999999998854

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.8e-47  Score=350.21  Aligned_cols=270  Identities=27%  Similarity=0.407  Sum_probs=216.9

Q ss_pred             CCCCCeeeccCceEEEEEEeC-----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERI  122 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  122 (380)
                      |++.+.||+|+||.||++.+.     +|+.||||++..... ......+.+|+.++++++||||+++++++..  ....+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            499999999999999998653     588899999986533 3345678899999999999999999999988  46889


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++....   +++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999998754   899999999999999999999999   9999999999999999999999999998876


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--------hhhHHHHHHHhhc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK--------ERVTIRWAMQCLK  274 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~  274 (380)
                      .............+|..|+|||++.+..++.++||||||+++|+|++|..||.......        .............
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            54433334455678999999999999999999999999999999999999997532110        0001111111111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhccCC
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAP  336 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~~~~  336 (380)
                      .+          ...+....++..+.+||.+||+.+|.+|||++++++.|..+...+..+.|
T Consensus       266 ~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          266 RG----------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             cc----------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            11          11222334567899999999999999999999999999999988876544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-47  Score=349.82  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=209.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.... ........+.+|+.++.+++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            478999999999999999999986 58999999986543 3344566789999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...+  ++++..++.++.|++.||.|||+.|   ++||||||+|||++.++.+||+|||++......
T Consensus        90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999998764  3899999999999999999999999   999999999999999999999999999865432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .  ........||+.|+|||++.+..++.++||||||+++|+|++|..||.........      ....... .... . 
T Consensus       165 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~-~~~~-~-  233 (294)
T 4eqm_A          165 S--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDS-VPNV-T-  233 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSC-CCCH-H-
T ss_pred             c--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhcc-CCCc-c-
Confidence            2  11223456999999999999999999999999999999999999999865543211      1111110 0000 0 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRP-TMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~eil~~l~~~~~  329 (380)
                          .......+..+.++|.+||+.||.+|| +++++.+.+..+..
T Consensus       234 ----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          234 ----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             ----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             ----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                001123457799999999999999998 78888887775533

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=361.25  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=212.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+|+.++||||+++++++......++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            478999999999999999999987 589999999865431 122345678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+.+|+|.+++.....  +++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++......
T Consensus        94 ~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            999999999999987543  899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcceeeeecccCCccccChhhhhh---cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRT---YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .    ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||...........+.....    .     
T Consensus       169 ~----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~-----  235 (384)
T 4fr4_A          169 T----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T-----  235 (384)
T ss_dssp             C----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C-----
T ss_pred             C----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c-----
Confidence            2    2345679999999999964   4589999999999999999999999986554333222221111    0     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-hHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-MKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~eil~~l~~~  327 (380)
                            ....+..++..+.+||.+||+.+|.+||+ ++++++|.|.-
T Consensus       236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence                  01122334577999999999999999998 89999887753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-47  Score=358.36  Aligned_cols=270  Identities=24%  Similarity=0.371  Sum_probs=218.6

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEE
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG  113 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  113 (380)
                      +..+....++|.+.+.||+|+||.||+|.+.      +++.||||+++.... ......+.+|+.++++++||||+++++
T Consensus        39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~  117 (343)
T 1luf_A           39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLG  117 (343)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3344456789999999999999999999975      247899999976543 334567899999999999999999999


Q ss_pred             EEEeCCEEEEEEEeCCCCCHHHHhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 041907          114 FLEHGDERIIVVEYVGNGTLREHLDGRGG----------------------NGLELAERLDIAIDVAHALTYLHTYSDPP  171 (380)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  171 (380)
                      ++...+..++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||++|   
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---  194 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  194 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence            99999999999999999999999976431                      45899999999999999999999999   


Q ss_pred             eeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-C
Q 041907          172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-G  250 (380)
Q Consensus       172 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g  250 (380)
                      ++||||||+|||++.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCcc-ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence            99999999999999999999999999986543221 122234568999999999999999999999999999999999 9


Q ss_pred             CCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          251 RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       251 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      ..||.........       .....+..          ...+..++..+.+++.+||+.+|.+||++.+++++|..+...
T Consensus       274 ~~p~~~~~~~~~~-------~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          274 LQPYYGMAHEEVI-------YYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CCTTTTSCHHHHH-------HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCcCCCCChHHHH-------HHHhCCCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            9999765432211       11111111          112223456799999999999999999999999999988665


Q ss_pred             h
Q 041907          331 F  331 (380)
Q Consensus       331 ~  331 (380)
                      .
T Consensus       337 ~  337 (343)
T 1luf_A          337 A  337 (343)
T ss_dssp             -
T ss_pred             h
Confidence            4

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.6e-47  Score=357.49  Aligned_cols=285  Identities=22%  Similarity=0.283  Sum_probs=219.4

Q ss_pred             CCCCCCccccccHHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC--
Q 041907           28 PKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--  104 (380)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--  104 (380)
                      .+.+......+++++.....++|.+.+.||+|+||.||+|.+. +|+.||||++...   ......+..|+.+++.+.  
T Consensus        15 ~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~   91 (360)
T 3llt_A           15 YFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQND   91 (360)
T ss_dssp             -----CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCC
T ss_pred             eeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhccc
Confidence            3445555566666666777899999999999999999999986 5899999998743   223445678999998886  


Q ss_pred             ---CCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 041907          105 ---HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN  181 (380)
Q Consensus       105 ---h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  181 (380)
                         ||||+++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++|   |+||||||+|
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  167 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN  167 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence               999999999999999999999999 889999998877666999999999999999999999999   9999999999


Q ss_pred             eeeCC-------------------------CCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccc
Q 041907          182 ILITE-------------------------KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSD  236 (380)
Q Consensus       182 il~~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  236 (380)
                      ||++.                         ++.+||+|||++......      .....||+.|+|||++.+..++.++|
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~D  241 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTRQYRAPEVILNLGWDVSSD  241 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcccccCcHHHcCCCCCCccc
Confidence            99975                         788999999999864432      23456899999999999999999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc--------cCCcccccccC-----CCCCCCCH----------
Q 041907          237 VYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK--------AGDAILVMDPR-----LRRTPASN----------  293 (380)
Q Consensus       237 iwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-----~~~~~~~~----------  293 (380)
                      ||||||++|+|++|+.||......+....+........        ........+..     ........          
T Consensus       242 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  321 (360)
T 3llt_A          242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL  321 (360)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred             hHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence            99999999999999999987654433222211100000        00000000000     00000000          


Q ss_pred             -----HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          294 -----MAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       294 -----~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .....+.+||.+||+.||.+|||++|+++|.|
T Consensus       322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             cccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence                 01156789999999999999999999999887

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=349.96  Aligned_cols=256  Identities=25%  Similarity=0.347  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch------------------------HHHHHHHHHHHHH
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK------------------------CLLLEFKNEILTW  100 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~~~e~~~l  100 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.......                        .....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3478999999999999999999986 58899999997543211                        1134578999999


Q ss_pred             hcCCCCceeceEEEEEe--CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 041907          101 SKIEHLNLVKLFGFLEH--GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK  178 (380)
Q Consensus       101 ~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  178 (380)
                      ++++||||+++++++..  ....++||||+++++|.+++...   .+++..++.++.||+.||.|||+.|   ++|+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            99999999999999987  67899999999999998876543   4899999999999999999999998   9999999


Q ss_pred             CCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcC---CCCccchhhHHHHHHHHHhCCCCCC
Q 041907          179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ---LTEKSDVYSFGVLLVEMMTGRYPIE  255 (380)
Q Consensus       179 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~p~~  255 (380)
                      |+|||++.++.+||+|||++........   ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999999987654321   234567999999999998765   3678999999999999999999997


Q ss_pred             CCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          256 SKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ........       ........         ..+.....+..+.+||.+||+.||.+||++.|+++|.|-
T Consensus       242 ~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~  296 (298)
T 2zv2_A          242 DERIMCLH-------SKIKSQAL---------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV  296 (298)
T ss_dssp             CSSHHHHH-------HHHHHCCC---------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred             CccHHHHH-------HHHhcccC---------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence            65432111       11111100         011112345678999999999999999999999999884

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-46  Score=349.32  Aligned_cols=267  Identities=18%  Similarity=0.227  Sum_probs=215.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......    ..+.+|+.+++++ +||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            3578999999999999999999975 6899999998755332    2467899999999 99999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-----eEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR-----AKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~Dfg~~  198 (380)
                      ||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.     +||+|||++
T Consensus        83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            99999 889999998653 34999999999999999999999998   999999999999998887     999999999


Q ss_pred             ccccCCCccee----eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          199 RMSEEDSAVSH----ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       199 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      +..........    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            87654322111    12456799999999999999999999999999999999999999987654433322222211111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      ....          .......+ .+.+++..||+.+|.+||++++|++.+..+.....
T Consensus       238 ~~~~----------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          238 ATPI----------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HSCH----------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCCH----------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            0000          00001123 79999999999999999999999999998877654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-47  Score=355.21  Aligned_cols=271  Identities=24%  Similarity=0.366  Sum_probs=202.4

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeCC-C---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEE
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLKD-G---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL  115 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  115 (380)
                      ++++....++|++.+.||+|+||.||+|.+.. +   ..||||++............+.+|+.++++++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34444566889999999999999999999764 3   2799999987654445567789999999999999999999999


Q ss_pred             EeCCEE------EEEEEeCCCCCHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 041907          116 EHGDER------IIVVEYVGNGTLREHLDGRG----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       116 ~~~~~~------~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~  185 (380)
                      ......      ++||||+++++|.+++....    ...+++..++.++.||+.||.|||+.|   ++||||||+|||++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence            877665      99999999999999996532    124899999999999999999999999   99999999999999


Q ss_pred             CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 041907          186 EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERV  264 (380)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~  264 (380)
                      .++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDY-YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             TTSCEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CCCCEEEeecccccccccccc-ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999999999999986544321 112234457889999999999999999999999999999999 999998765433211


Q ss_pred             HHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .       ...+.          .......++..+.+|+.+||+.||.+|||+.++++.+..+....
T Consensus       251 ~-------~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          251 Y-------LIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             H-------HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             H-------HhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1       11110          01122234567999999999999999999999999999887754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.9e-47  Score=354.38  Aligned_cols=251  Identities=25%  Similarity=0.319  Sum_probs=212.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            67999999999999999999987 599999999975432 1123456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++..... 
T Consensus       121 e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999987543  899999999999999999999999   999999999999999999999999999865432 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .+..+.        
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-------~i~~~~--------  254 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE-------KIVSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC--------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH-------HHHcCC--------
Confidence                 234569999999999999999999999999999999999999998654432211       111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~~  327 (380)
                         ...+..++..+.+||.+||+.||.+||+     +++|++|.|-.
T Consensus       255 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence               0112234577899999999999999998     99999998854

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.8e-47  Score=359.25  Aligned_cols=276  Identities=25%  Similarity=0.346  Sum_probs=222.3

Q ss_pred             ccccccHHHHHHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCC
Q 041907           34 TTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHL  106 (380)
Q Consensus        34 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~  106 (380)
                      ....+....+....++|++.+.||+|+||.||+|.+.      +++.||||++...... .....+.+|+.++.++ +||
T Consensus         8 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp   86 (359)
T 3vhe_A            8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHL   86 (359)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCT
T ss_pred             hhCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-HHHHHHHHHHHHHHhhcCCc
Confidence            3445566777778899999999999999999999842      4678999999765433 3456788999999999 789


Q ss_pred             ceeceEEEEEeCC-EEEEEEEeCCCCCHHHHhccCCC-------------------------------------------
Q 041907          107 NLVKLFGFLEHGD-ERIIVVEYVGNGTLREHLDGRGG-------------------------------------------  142 (380)
Q Consensus       107 niv~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~-------------------------------------------  142 (380)
                      ||+++++++...+ ..++||||+++|+|.+++.....                                           
T Consensus        87 niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             TBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             ceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            9999999998754 48999999999999999976542                                           


Q ss_pred             ---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          143 ---------------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       143 ---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                                           ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                 12889999999999999999999998   999999999999999999999999999866


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...........      ....+.   
T Consensus       244 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------~~~~~~---  313 (359)
T 3vhe_A          244 YKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR------RLKEGT---  313 (359)
T ss_dssp             TSCTT-CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH------HHHHTC---
T ss_pred             ccccc-chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH------HHHcCC---
Confidence            44322 222345668999999999999999999999999999999998 9999986554322111      111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                             ....+...+..+.+++.+||+.+|.+|||+++++++|..+...
T Consensus       314 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 -------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                   0112223456789999999999999999999999999988654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.8e-47  Score=342.73  Aligned_cols=258  Identities=24%  Similarity=0.384  Sum_probs=215.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            578999999999999999999987 5899999999876655555677889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEcccccccccc
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARMSE  202 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~  202 (380)
                      ||+++++|.+.+.....  +++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            99999999998876543  899999999999999999999998   999999999999987655   9999999997665


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+       ..+..    
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~-------~~~~~----  224 (284)
T 3kk8_A          160 DSEA----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAY----  224 (284)
T ss_dssp             SSCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC----
T ss_pred             cCcc----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH-------Hhccc----
Confidence            4321    23456999999999999999999999999999999999999999765433221111       11100    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .   ...+.....+..+.+|+.+||+.+|.+|||+++++++.|-.
T Consensus       225 ~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (284)
T 3kk8_A          225 D---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  266 (284)
T ss_dssp             C---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred             c---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence            0   01111223456789999999999999999999999999964

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-47  Score=357.34  Aligned_cols=253  Identities=20%  Similarity=0.326  Sum_probs=209.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....... .....+.+|+.+++.++||||+++++++......++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            368999999999999999999985 68999999987542211 1234578999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+ +|+|.+++...+.  +++..++.++.||+.||.|||+.|   ++||||||+|||++.++.+||+|||++......
T Consensus        88 ~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 6799999876543  899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .    .....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.........                ..+.
T Consensus       162 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~  221 (336)
T 3h4j_B          162 N----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVN  221 (336)
T ss_dssp             B----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCC
T ss_pred             c----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH
Confidence            2    1244579999999999988776 68999999999999999999999764432110                0011


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..  ....+...+..+.+||.+||+.||.+|||++|++++.|-.
T Consensus       222 ~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          222 SC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             SS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             cC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            11  1112233557789999999999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=350.48  Aligned_cols=273  Identities=26%  Similarity=0.339  Sum_probs=210.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            368999999999999999999987 4999999999777666556677889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.....  +++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             ECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999999998876543  899999999999999999999999   9999999999999999999999999998755322


Q ss_pred             cceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh--------hccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC--------LKAG  276 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~  276 (380)
                      .   ......||..|+|||++.+ ..++.++||||||+++|+|++|..||......+....+......        ....
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          157 D---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             c---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            1   1234568999999999986 66899999999999999999999999876654433322211100        0000


Q ss_pred             Ccccccc-cCCCC-CC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMD-PRLRR-TP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~-~~~~~-~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....... +.... .+   .....+..+.+|+.+||+.||.+|||++++++|.|-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence            0000000 00000 00   0012456688999999999999999999999998843

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.9e-47  Score=358.23  Aligned_cols=258  Identities=23%  Similarity=0.345  Sum_probs=201.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||++.+. +|+.||||++.......   ..+.+|+.++++++||||+++++++......++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            4578999999999999999999987 69999999997654332   4577999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--eEEcccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR--AKVTDFGFARMSE  202 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~  202 (380)
                      |||+++|+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.  +||+|||+++...
T Consensus        95 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           95 MEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999999976543  899999999999999999999999   999999999999987765  9999999987433


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEK-SDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.............   .......    
T Consensus       170 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~~~~~~~----  238 (361)
T 3uc3_A          170 LHS----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---QRILSVK----  238 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH---HHHHTTC----
T ss_pred             ccC----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH---HHHhcCC----
Confidence            211    1234569999999999998888765 899999999999999999998655433222111   1111100    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          . ..+.....+..+.+||.+||+.+|.+|||+.|+++|.|-.
T Consensus       239 ----~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          239 ----Y-SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             ----C-CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             ----C-CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence                0 0111112346788999999999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.1e-48  Score=355.17  Aligned_cols=264  Identities=27%  Similarity=0.373  Sum_probs=204.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.++.+++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999999985 689999999976543 3344567889999999999999999999987643    


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++++|.+++...+  .+++..++.++.||+.||.|||+++   ++|+||||+|||++.++.+||+|||++.
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3499999999999999998654  3899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ................||+.|+|||++.+..++.++|||||||++|+|++|..||..........      ........ 
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~~-  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI-  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC-
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCCC-
Confidence            76543322222344669999999999999999999999999999999999999998765432211      11111000 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                             ........++..+.++|.+||+.||.+||+..+++.+.|...
T Consensus       238 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 -------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             -------CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -------CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                   000011124567899999999999999999888888777543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-47  Score=361.18  Aligned_cols=263  Identities=23%  Similarity=0.308  Sum_probs=210.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|++.+.||+|+||.||+|+++ +++.||+|+++...... .....+..|..++.++ +||||+++++++......+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3478999999999999999999987 48899999997653322 2234467889998876 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++|+|..++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...
T Consensus       130 lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999999987543  899999999999999999999999   9999999999999999999999999998532


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHhhccCCccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--VTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~  280 (380)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........  .........+...    
T Consensus       205 ~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----  277 (396)
T 4dc2_A          205 RPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----  277 (396)
T ss_dssp             CTT---CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred             cCC---CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence            221   1234567999999999999999999999999999999999999999754321110  0011111111111    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM------KKCAEILWKI  327 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~eil~~l~~~  327 (380)
                          .   ...+..++..+.+||.+||+.||.+||++      ++|++|.|-.
T Consensus       278 ----~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          278 ----Q---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             ----C---CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             ----c---cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence                1   11222355778999999999999999985      7999998753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.3e-48  Score=361.17  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=197.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++.....    ...+.+|+.++++++||||+++++++......++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            4578999999999999999999987 488999999976432    34577899999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~  201 (380)
                      |||+++++|.+++...+.  +++..++.++.||+.||.|||+.|   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       127 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            999999999999976543  899999999999999999999998   999999999999975   889999999999865


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  .+.    .+.....   
T Consensus       202 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~----~i~~~~~---  268 (349)
T 2w4o_A          202 EHQV----LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR----RILNCEY---  268 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH----HHHTTCC---
T ss_pred             Cccc----ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH----HHHhCCC---
Confidence            4321    22346699999999999999999999999999999999999999976543321  111    1111100   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          ....+.....+..+.+||.+||+.||.+|||+.+++++.|-.
T Consensus       269 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          269 ----YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             ----ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence                001112233456789999999999999999999999998843

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.5e-48  Score=367.94  Aligned_cols=264  Identities=22%  Similarity=0.261  Sum_probs=213.4

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ++....++|.+.+.||+|+||.||+|.++ +|+.||+|++...... ......+.+|+.++..++||||+++++++.+..
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999987 5899999998653211 111223678999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..|+||||++||+|.+++....   +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999997643   899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ----LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ......  .......+||+.|+|||++.+..    ++.++|||||||++|||++|..||...........+.......  
T Consensus       217 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--  292 (410)
T 3v8s_A          217 KMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--  292 (410)
T ss_dssp             ECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred             eeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--
Confidence            765432  12234577999999999998766    7899999999999999999999998765433222211100000  


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWKI  327 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~~  327 (380)
                                  ..+.....+.++.+||.+||+.+|.+  ||+++||++|.|-.
T Consensus       293 ------------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          293 ------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             ------------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             ------------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence                        01111124567899999999999988  99999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.3e-47  Score=359.25  Aligned_cols=261  Identities=22%  Similarity=0.272  Sum_probs=210.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc---hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD---KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|++.+.||+|+||.||+|.++ +|+.||||++......   ......+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4567999999999999999999986 5999999998643211   11245688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEcccc
Q 041907          122 IIVVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFG  196 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg  196 (380)
                      ++||||+++++|.+++....  ...+++..++.++.||+.||.|||++|   |+||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999998886532  334899999999999999999999998   999999999999987654   9999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++........   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ...    .....+
T Consensus       179 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~----~~i~~~  247 (351)
T 3c0i_A          179 VAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF----EGIIKG  247 (351)
T ss_dssp             TCEECCTTSC---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH----HHHHHT
T ss_pred             ceeEecCCCe---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH----HHHHcC
Confidence            9987654321   12345799999999999999999999999999999999999999976421    111    111111


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...  ..     .......+..+.+||.+||+.||.+|||+.++++|.|..
T Consensus       248 ~~~--~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          248 KYK--MN-----PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             CCC--CC-----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCC--CC-----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence            100  00     000012346789999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=359.85  Aligned_cols=257  Identities=21%  Similarity=0.301  Sum_probs=212.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++......  ....+.+|+.+|++++||||+++++++.+....++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999987 5899999999765432  2456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE--KLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~  203 (380)
                      ||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.  ++.+||+|||++.....
T Consensus       128 E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          128 EFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             ECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999997654 34899999999999999999999999   999999999999984  46799999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+       ......  . 
T Consensus       204 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i-------~~~~~~--~-  269 (387)
T 1kob_A          204 DEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDWE--F-  269 (387)
T ss_dssp             TSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HHCCCC--C-
T ss_pred             Ccc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCC--C-
Confidence            321    23446999999999999999999999999999999999999999875543221111       111000  0 


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                          ........+..+.+||.+||+.||.+|||+.+++++.|-.
T Consensus       270 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (387)
T 1kob_A          270 ----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  309 (387)
T ss_dssp             ----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             ----CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence                0111223457789999999999999999999999998853

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.9e-48  Score=374.37  Aligned_cols=263  Identities=26%  Similarity=0.432  Sum_probs=217.0

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..+....++|.+.+.||+|+||.||+|.+.++..||||+++.....   ...+.+|+.+|++++||||+++++++. ...
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            3344566889999999999999999999988889999999865432   457889999999999999999999986 567


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .++||||+++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            899999999999999998654445889999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .....  ........+|..|+|||++.+..++.++|||||||++|||++ |..||......+....       +..+.  
T Consensus       334 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~--  402 (454)
T 1qcf_A          334 IEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-------LERGY--  402 (454)
T ss_dssp             BCCHH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-------HHHTC--
T ss_pred             cCCCc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC--
Confidence            64321  111223457889999999999999999999999999999999 9999986543322111       11111  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                              ..+.+..++..+.+||.+||+.||.+|||+++|++.|+.+..
T Consensus       403 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 --------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                    112233456789999999999999999999999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-47  Score=355.44  Aligned_cols=272  Identities=21%  Similarity=0.283  Sum_probs=203.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++......++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4578999999999999999999986 689999999987655544455678999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-----CCCceEEccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-----EKLRAKVTDFGFAR  199 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-----~~~~~kl~Dfg~~~  199 (380)
                      |||+++ +|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++     ..+.+||+|||++.
T Consensus       112 ~e~~~~-~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EECCSE-EHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EecCCC-CHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999975 99999987654  899999999999999999999998   99999999999994     55569999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ......   .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+............
T Consensus       186 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            764321   112345689999999999875 4899999999999999999999999876554333222111111000000


Q ss_pred             cccc------c--cCCCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          279 ILVM------D--PRLRRTP----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       279 ~~~~------~--~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ....      .  +......    .....+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence            0000      0  0000000    001134678899999999999999999999999884

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=355.76  Aligned_cols=259  Identities=22%  Similarity=0.348  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC--CceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH--LNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||++.+.+++.||||++............+.+|+.+|.+++|  +||+++++++......++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            456799999999999999999999889999999998776666666788999999999976  999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||+ .+++|.+++....  .+++..++.++.||+.||.|||+.|   |+||||||+|||++ ++.+||+|||+++....
T Consensus        87 v~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            9995 5789999998754  3899999999999999999999998   99999999999997 57899999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhh-----------cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRT-----------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      ... ........||+.|+|||++.+           ..++.++|||||||++|+|++|..||........     .....
T Consensus       160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~  233 (343)
T 3dbq_A          160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAI  233 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHH
T ss_pred             ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHHH
Confidence            321 112345679999999999976           6788999999999999999999999975432211     11111


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....         .. ...+...+..+.+|+.+||+.||.+|||+.++++|+|..
T Consensus       234 ~~~~---------~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          234 IDPN---------HE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HCTT---------SC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             hcCC---------cc-cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            1111         00 111112235688999999999999999999999999965

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4e-47  Score=351.16  Aligned_cols=273  Identities=24%  Similarity=0.329  Sum_probs=196.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+|+.++++++||||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            468999999999999999999986 5899999999755422 12345779999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          126 EYVGNGTLREHLDGRG----GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ||++ ++|.+++....    ...+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 59999986542    234899999999999999999999998   999999999999999999999999999875


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....   ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+..............
T Consensus       159 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          159 GIPVN---TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             TSCCC---CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             CCCcc---cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            43211   12345689999999999864 689999999999999999999999987654332222211110000000000


Q ss_pred             -----ccccCCCC--C---------CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          281 -----VMDPRLRR--T---------PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       281 -----~~~~~~~~--~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+....  .         ......+..+.+||.+||+.||.+|||++|++++.|-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~  298 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA  298 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence                 00000000  0         00112346789999999999999999999999998843

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-47  Score=352.28  Aligned_cols=262  Identities=24%  Similarity=0.312  Sum_probs=211.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      .++|++.+.||+|+||.||+|.++ +|+.||+|++..... .......+.+|..++.++ +||||+++++++......++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999987 589999999986543 333455678999999887 89999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999999987543  899999999999999999999999   99999999999999999999999999985332


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--hHHHHHHHhhccCCcccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--VTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  281 (380)
                      ..   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........  .........+....    
T Consensus       163 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          163 PG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             TT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             CC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            21   1234567999999999999999999999999999999999999999753221100  00111111111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh------HHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM------KKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~eil~~l~~~  327 (380)
                             ...+...+..+.+||.+||+.||.+||++      +++++|.|-.
T Consensus       236 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          236 -------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence                   11122345678999999999999999995      7999998853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.5e-48  Score=369.05  Aligned_cols=269  Identities=20%  Similarity=0.232  Sum_probs=215.1

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEe
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEH  117 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  117 (380)
                      +.++....++|++.+.||+|+||+||+|.++. |+.||+|++....... .....+.+|..++..++||||+++++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34444556899999999999999999999874 8899999996532111 112237789999999999999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      ....++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999998743 23999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      ++.......  ......+||+.|+|||++.     ...++.++|||||||++|||++|..||......+....+......
T Consensus       222 a~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  299 (437)
T 4aw2_A          222 CLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  299 (437)
T ss_dssp             CEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred             hhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence            976654321  2234467999999999997     456899999999999999999999999876544332222110000


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCC--CCChHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQS--RPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~eil~~l~~~  327 (380)
                      .             .........+.++.+||.+||+.+|.+  ||+++|+++|.|-.
T Consensus       300 ~-------------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          300 F-------------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             C-------------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             c-------------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence            0             001111224567899999999988888  99999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8e-47  Score=350.62  Aligned_cols=262  Identities=23%  Similarity=0.367  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCE----EEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSI----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|++.+.||+|+||+||+|.+. +|+.    ||+|.+..... ......+.+|+.++++++||||+++++++.... 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            3468999999999999999999975 3443    68888764432 233567889999999999999999999998765 


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .++|+||+.+|+|.+++..... .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence            7889999999999999987543 4899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ....... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||...........       ...+.  
T Consensus       167 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~--  236 (327)
T 3poz_A          167 LGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE--  236 (327)
T ss_dssp             HTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTC--
T ss_pred             ccCCccc-ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcCC--
Confidence            6543321 12234457889999999999999999999999999999999 9999987554332111       11110  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                              ..+....++..+.+++.+||+.+|.+||++.+++++|..+....
T Consensus       237 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          237 --------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             --------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                    11122334567899999999999999999999999999886643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.7e-47  Score=340.69  Aligned_cols=257  Identities=19%  Similarity=0.318  Sum_probs=213.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--CEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--DERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. |+.||||++............+.+|+.++++++||||+++++++...  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            468999999999999999999997 88899999987766656667799999999999999999999999877  788999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++|+|.+++.......+++..++.++.||+.||.|||+.+ .+++|+||||+||+++.++.++|+|||++..... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            99999999999998876666999999999999999999999764 4599999999999999999999999887654322 


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCC---ccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTE---KSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                             ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||..........      .....+.    
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~----  228 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALEGL----  228 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHSCC----
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhcCC----
Confidence                   2345899999999998765554   7999999999999999999997654332211      1111110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                            ....+..++..+.+++.+||+.||.+|||++++++.|..+..
T Consensus       229 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 ------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                  011223355779999999999999999999999999987753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-47  Score=357.93  Aligned_cols=257  Identities=22%  Similarity=0.303  Sum_probs=210.3

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  120 (380)
                      ....++|.+.+.||+|+||.||+|.++ +|+.||||+++.... .......+..|..++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999999987 589999999976421 111234567888888876 99999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .|+||||+++|+|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999999987543  899999999999999999999999   99999999999999999999999999975


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....   ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........       +..+.   
T Consensus       168 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------i~~~~---  234 (345)
T 1xjd_A          168 NMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-------IRMDN---  234 (345)
T ss_dssp             CCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCC---
T ss_pred             cccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHhCC---
Confidence            43221   113456799999999999999999999999999999999999999986554322111       11110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMK-KCAEILWK  326 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~l~~  326 (380)
                              ...+...+..+.+||.+||+.||.+||++. ++++|.|-
T Consensus       235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f  273 (345)
T 1xjd_A          235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  273 (345)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence                    011223456789999999999999999998 99988875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-46  Score=343.51  Aligned_cols=268  Identities=16%  Similarity=0.260  Sum_probs=217.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......    ..+.+|+..+.++ +|+|++++++++......++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            3578999999999999999999975 6899999998654332    2467899999998 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-----eEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR-----AKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~Dfg~~  198 (380)
                      ||||+ +++|.+++...+ ..+++..++.++.||+.||.|||++|   ++||||||+|||++.++.     +||+|||++
T Consensus        84 v~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            99999 889999998654 34899999999999999999999988   999999999999987776     999999999


Q ss_pred             ccccCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          199 RMSEEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       199 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ..........    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            8765432211    112456799999999999999999999999999999999999999987655443333322222111


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .....          .....++..+.+++.+||+.+|.+||++++|++.+..+.....
T Consensus       239 ~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          239 STPLR----------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HSCHH----------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CccHH----------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            11000          0011235679999999999999999999999999999887664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=350.07  Aligned_cols=274  Identities=26%  Similarity=0.293  Sum_probs=208.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc---hHHHHHHHHHHHHHhcC---CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD---KCLLLEFKNEILTWSKI---EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++......   ......+.+|+.+++++   .||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4689999999999999999999985 6999999999754311   11122345666666655   599999999999876


Q ss_pred             C-----EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          119 D-----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       119 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                      .     ..++||||+. ++|.+++.......+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence            5     5899999997 59999998877666999999999999999999999999   9999999999999999999999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      |||++.......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.......
T Consensus       163 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC----CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eCccccccCCCc----ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998654322    2245679999999999999999999999999999999999999998766544332222111111


Q ss_pred             ccCCcccccc---cCCC-CCC-----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          274 KAGDAILVMD---PRLR-RTP-----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       274 ~~~~~~~~~~---~~~~-~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..........   .... ..+     .....+..+.+||.+||+.||.+|||+.|+++|.|-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~  301 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  301 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence            1111100000   0000 000     0112346788999999999999999999999998854

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-47  Score=369.27  Aligned_cols=256  Identities=23%  Similarity=0.265  Sum_probs=204.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.++++++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999986 599999999975421 22234557789999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ||||+++|+|.+++....  .+++..++.++.||+.||.|||+ .|   |+||||||+|||++.++.+||+|||+++...
T Consensus       226 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             EECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999999997754  38999999999999999999998 88   9999999999999999999999999997543


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ...   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+       ...      
T Consensus       301 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i-------~~~------  364 (446)
T 4ejn_A          301 KDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LME------  364 (446)
T ss_dssp             C--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC------
T ss_pred             CCC---cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-------HhC------
Confidence            221   1234567999999999999999999999999999999999999999765443221111       111      


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                        .   ...+...+..+.+||.+||+.||.+||     +++++++|.|-.
T Consensus       365 --~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          365 --E---IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             --C---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             --C---CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence              0   111223456789999999999999999     999999998854

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=342.13  Aligned_cols=264  Identities=21%  Similarity=0.382  Sum_probs=216.4

Q ss_pred             hcCCCCCC-eeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPAN-KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||++..... ......+.+|+.++++++||||+++++++ ..+..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            45676766 9999999999999864   577899999986533 34566788999999999999999999999 456789


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.++|+|||++....
T Consensus        86 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999997543 34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+..       ..+..+.    
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~i~~~~----  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK----  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTC----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-------HHHhcCC----
Confidence            44332222334557899999999999999999999999999999998 99999865543211       1111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhc
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE  333 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~  333 (380)
                            ....+..++..+.++|.+||+.+|.+||++.+++++|+.+......
T Consensus       231 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          231 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                  0112234557899999999999999999999999999999886654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.3e-47  Score=348.06  Aligned_cols=263  Identities=27%  Similarity=0.411  Sum_probs=216.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|.+.+.||+|+||.||+|.+.      +++.||||++..... ......+.+|+.++++++||||+++++++...+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            4578999999999999999999862      357899999976543 344567889999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG----------------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV  177 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  177 (380)
                      ..++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||++|   ++|+||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            99999999999999999986543                      23889999999999999999999998   999999


Q ss_pred             CCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041907          178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIES  256 (380)
Q Consensus       178 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~  256 (380)
                      ||+||+++.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDS-YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSC-EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chheEEEcCCCCEEEcccccccccccccc-ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999986654322 112234557889999999999999999999999999999999 9999986


Q ss_pred             CCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          257 KKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      .........       ...+.          .......++..+.+++.+||+.||.+||++.+++++|..+...
T Consensus       256 ~~~~~~~~~-------~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          256 IPPERLFNL-------LKTGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             CCGGGHHHH-------HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHH-------hhcCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            654332111       11110          0112233457799999999999999999999999999987653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1e-47  Score=356.68  Aligned_cols=268  Identities=20%  Similarity=0.311  Sum_probs=215.4

Q ss_pred             HHHHHHHhcCCCCC-CeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           40 FEEIYKATENFSPA-NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        40 ~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ++......++|.+. +.||+|+||.||+|.+. +|+.||+|++............+.+|+.++.++ .||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            34445566778877 88999999999999987 599999999986554444456788999999998 5699999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAKVT  193 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~kl~  193 (380)
                      .....++||||+++++|.+++.......+++..++.++.||+.||.|||+.|   ++||||||+|||++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence            9999999999999999999997765566999999999999999999999999   999999999999997   7899999


Q ss_pred             cccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      |||++.......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.   .. 
T Consensus       177 Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~-  248 (327)
T 3lm5_A          177 DFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---QV-  248 (327)
T ss_dssp             CGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HT-
T ss_pred             eCccccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---hc-
Confidence            999998765322    1234569999999999999999999999999999999999999997755432211111   10 


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ..       .   ........++..+.+||.+||+.||.+|||+++++++.|-..
T Consensus       249 ~~-------~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          249 NV-------D---YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             CC-------C---CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             cc-------c---cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence            00       0   011122234567899999999999999999999999998543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.5e-47  Score=342.12  Aligned_cols=255  Identities=26%  Similarity=0.430  Sum_probs=209.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....... .....+.+|+.++++++||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3478999999999999999999987 47899999986543221 224568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++++|.+++.....  +++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.++|+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999999987543  899999999999999999999988   99999999999999999999999999865432


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .     ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.       ...      
T Consensus       162 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~------  223 (279)
T 3fdn_A          162 S-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------RVE------  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------HTC------
T ss_pred             c-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH-------hCC------
Confidence            2     1234568999999999999999999999999999999999999998654332211111       100      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                           ...+...+..+.+||.+||+.+|.+||+++|+++|.|-..
T Consensus       224 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          224 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence                 1112234567889999999999999999999999999653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=358.11  Aligned_cols=265  Identities=28%  Similarity=0.377  Sum_probs=217.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ..++|.+.+.||+|+||.||+|.+.        .+..||||++..... ......+.+|+.+++++ +||||+++++++.
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-HHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            4578999999999999999999863        235799999976543 33456788999999999 9999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      ..+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.|   |+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            99999999999999999999987542              34899999999999999999999998   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      |++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999866542211 12234557899999999999999999999999999999999 999997654322


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .       ...+..+..          ...+..++..+.+|+.+||+.+|.+||++++|+++|..+.....
T Consensus       302 ~-------~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          302 L-------FKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             H-------HHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             H-------HHHHHcCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            1       111111110          11122345679999999999999999999999999999876554

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4e-47  Score=361.96  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=198.4

Q ss_pred             cCCCCC-CeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHh-cCCCCceeceEEEEEe----CCE
Q 041907           48 ENFSPA-NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWS-KIEHLNLVKLFGFLEH----GDE  120 (380)
Q Consensus        48 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~  120 (380)
                      ++|.+. +.||+|+||+||+|.+. +|+.||||++...       ..+.+|+.++. ..+||||+++++++..    ...
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            456665 68999999999999987 5899999998642       23557777764 4589999999999876    567


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAKVTDFGF  197 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~  197 (380)
                      +|+||||+++|+|.+++.......+++..++.++.||+.||.|||+.|   |+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            899999999999999998876566999999999999999999999998   999999999999997   78899999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ++......    .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...   +..+.
T Consensus       211 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~  283 (400)
T 1nxk_A          211 AKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQ  283 (400)
T ss_dssp             CEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTC
T ss_pred             ccccCCCC----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCc
Confidence            98654321    124567899999999999999999999999999999999999999865543211111100   00110


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .    .   ...+....++.++.+||.+||+.||.+|||++++++|.|...
T Consensus       284 ~----~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          284 Y----E---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             C----C---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             c----c---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            0    0   001112235577999999999999999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.3e-47  Score=354.86  Aligned_cols=255  Identities=21%  Similarity=0.281  Sum_probs=210.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|.+.+.||+|+||.||+|.++. |+.||||++..... .......+..|..++..+ +||||+++++++...+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45789999999999999999999874 88999999976422 112244577899999887 8999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||++||+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            99999999999999987543  899999999999999999999999   9999999999999999999999999998543


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|..||..........       .+..+.     
T Consensus       173 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~-------~i~~~~-----  237 (353)
T 2i0e_A          173 WDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ-------SIMEHN-----  237 (353)
T ss_dssp             CTT---CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC-----
T ss_pred             cCC---cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH-------HHHhCC-----
Confidence            221   12345679999999999999999999999999999999999999998654332111       111110     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                            ...+...+..+.+||.+||+.+|.+||+     +++|++|.|-
T Consensus       238 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f  280 (353)
T 2i0e_A          238 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  280 (353)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence                  1112234577899999999999999995     6999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=359.03  Aligned_cols=265  Identities=27%  Similarity=0.361  Sum_probs=214.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||+++.... ......+.+|+.++.+++||||+++++++....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            3478999999999999999999953      367899999975433 334556889999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceE
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG-----NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAK  191 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~k  191 (380)
                      ..++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            99999999999999999976532     34899999999999999999999999   99999999999999555   599


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  270 (380)
                      |+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.........       
T Consensus       225 L~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~-------  296 (367)
T 3l9p_A          225 IGDFGMARDIYRAGY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-------  296 (367)
T ss_dssp             ECCCHHHHHHHHHSS-CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-------
T ss_pred             ECCCccccccccccc-cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------
Confidence            999999975432111 112234568999999999999999999999999999999998 99999765432211       


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .....+.          .......++..+.+|+.+||+.+|.+||++.+|+++|+.+.....
T Consensus       297 ~~i~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          297 EFVTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHHcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            1111111          011222345678999999999999999999999999999877554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.8e-47  Score=351.53  Aligned_cols=256  Identities=23%  Similarity=0.312  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe----CCCCEEEEEEccccCcc--hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNKHD--KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|++.+.||+|+||.||+|..    .+|+.||+|+++.....  ......+.+|+.++++++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            347899999999999999999997    36899999999765321  122345778999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++++|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999999986543  889999999999999999999998   9999999999999999999999999987


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ......   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........   ...    .   
T Consensus       170 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~----~---  236 (327)
T 3a62_A          170 ESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK---ILK----C---  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHH----T---
T ss_pred             ccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHh----C---
Confidence            543221   123456799999999999999999999999999999999999999986543321111   111    1   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                           .   ...+...+..+.+||.+||+.+|.+||     +++++++|.|-.
T Consensus       237 -----~---~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          237 -----K---LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             -----C---CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             -----C---CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence                 0   011223456789999999999999999     889999998853

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-47  Score=361.83  Aligned_cols=275  Identities=22%  Similarity=0.316  Sum_probs=201.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCC--EE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGD--ER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~  121 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++.++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            5689999999999999999999986 5999999999766555555667889999999997 999999999997644  78


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      |+||||++ ++|..++...   .+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999997 5999999764   3899999999999999999999999   999999999999999999999999999865


Q ss_pred             cCCCc------------------ceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 041907          202 EEDSA------------------VSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE  262 (380)
Q Consensus       202 ~~~~~------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~  262 (380)
                      .....                  .........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            32110                  0112344679999999999987 6789999999999999999999999987665443


Q ss_pred             hhHHHHHHHhhccCCcccccc-------------c---CCCCCC-------------CCHHHHHHHHHHHHHhcCCCCCC
Q 041907          263 RVTIRWAMQCLKAGDAILVMD-------------P---RLRRTP-------------ASNMAVEKILGLADVCLAPTRQS  313 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~-------------~---~~~~~~-------------~~~~~~~~l~~li~~cl~~~p~~  313 (380)
                      ...+.................             .   ......             ....++..+.+|+.+||+.||.+
T Consensus       240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~  319 (388)
T 3oz6_A          240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK  319 (388)
T ss_dssp             HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence            322211100000000000000             0   000000             00023467889999999999999


Q ss_pred             CCChHHHHHHHHHH
Q 041907          314 RPTMKKCAEILWKI  327 (380)
Q Consensus       314 RPt~~eil~~l~~~  327 (380)
                      |||++|+++|+|-.
T Consensus       320 R~t~~e~l~Hp~~~  333 (388)
T 3oz6_A          320 RISANDALKHPFVS  333 (388)
T ss_dssp             SCCHHHHTTSTTTT
T ss_pred             CCCHHHHhCCHHHH
Confidence            99999999998843

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=364.08  Aligned_cols=269  Identities=20%  Similarity=0.230  Sum_probs=214.7

Q ss_pred             cHHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEE
Q 041907           39 SFEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLE  116 (380)
Q Consensus        39 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  116 (380)
                      .+.++....++|++.+.||+|+||.||+|.++ +|+.||||++...... ......+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556789999999999999999999986 6999999999753211 112234778999999999999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      +.+..|+||||+++|+|.+++...+ ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999998654 24899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhh-------cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      +++.......  ......+||+.|+|||++.+       ..++.++|||||||++|||++|+.||...........+...
T Consensus       208 la~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          208 SCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             TCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             hheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            9987654321  12234679999999999973       56899999999999999999999999876543322221110


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC---CChHHHHHHHHHH
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSR---PTMKKCAEILWKI  327 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~eil~~l~~~  327 (380)
                      ...             .........++.++.+||.+||+ +|.+|   |+++|+++|.|-.
T Consensus       286 ~~~-------------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~  332 (412)
T 2vd5_A          286 KEH-------------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF  332 (412)
T ss_dssp             HHH-------------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred             ccC-------------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence            000             00011122345789999999999 99998   6999999999853

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-46  Score=343.49  Aligned_cols=264  Identities=22%  Similarity=0.338  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhc--CCCCceeceEEEEEe----CC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK--IEHLNLVKLFGFLEH----GD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~  119 (380)
                      ..++|++.+.||+|+||+||+|.+. |+.||||++.....     ..+..|.+++..  ++||||+++++++..    ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDE-----KSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGGGH-----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccccc-----hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            4578999999999999999999984 89999999865422     233445555544  899999999998654    24


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeccCCCCceeeCCCCceE
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--------TYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                      ..++||||+++|+|.+++...   .+++..++.++.|++.||.|||        +.+   ++||||||+|||++.++.+|
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             eeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            589999999999999999654   3999999999999999999999        888   99999999999999999999


Q ss_pred             EccccccccccCCCcceee-eecccCCccccChhhhhhc------CCCCccchhhHHHHHHHHHhC----------CCCC
Q 041907          192 VTDFGFARMSEEDSAVSHI-STQVKGTAGYLDPDYLRTY------QLTEKSDVYSFGVLLVEMMTG----------RYPI  254 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg----------~~p~  254 (380)
                      |+|||+++........... .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            9999999866543322111 2345799999999999876      455799999999999999999          8888


Q ss_pred             CCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          255 ESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....+.........  .......    ..+...........+..+.+|+.+||+.||.+|||+.+|++.|..+
T Consensus       234 ~~~~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDMR--KVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHHH--HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhhh--HHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            65443322211111  1111100    0111111112345778899999999999999999999999999865

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.1e-46  Score=345.52  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=212.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEe-----CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC--C
Q 041907           47 TENFSPANKIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG--D  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  119 (380)
                      .++|++.+.||+|+||.||+|.+     .+|+.||+|++...... .....+.+|+.++++++||||+++++++...  .
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            46689999999999999999984     25889999999755322 2345688999999999999999999999876  6


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++.
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            6899999999999999996544 23899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCC--------cchhhHHHHHHH
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP--------IKERVTIRWAMQ  271 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~--------~~~~~~~~~~~~  271 (380)
                      ................||..|+|||++.+..++.++||||||+++|+|++|..|+.....        ............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            776554433444566789999999999999999999999999999999999998753211        111111111111


Q ss_pred             hhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ....+.          ..+.+..++..+.+|+.+||+.||.+|||+.++++.|..+.
T Consensus       255 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111111          11223345678999999999999999999999999998764

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.9e-47  Score=340.36  Aligned_cols=255  Identities=29%  Similarity=0.466  Sum_probs=199.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcc--hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD--KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. |+.||||+++.....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            468999999999999999999986 889999998765332  22345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--------CCceEEcccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE--------KLRAKVTDFG  196 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~--------~~~~kl~Dfg  196 (380)
                      |||+++++|.+++...   .+++..++.++.|++.||.|||+.|..+++|+||||+||+++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999999654   3899999999999999999999987455889999999999986        6789999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++.......     .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........      .... 
T Consensus       162 ~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~-  229 (271)
T 3dtc_A          162 LAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG------VAMN-  229 (271)
T ss_dssp             C------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------HHTS-
T ss_pred             ccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh------hhcC-
Confidence            998654322     2245699999999999999999999999999999999999999986543221111      1000 


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .         ...+....++..+.+++.+||+.+|.+|||+.+++++|..
T Consensus       230 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          230 K---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             C---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             C---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            0         0111223445779999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.1e-47  Score=345.12  Aligned_cols=267  Identities=24%  Similarity=0.399  Sum_probs=214.2

Q ss_pred             HHHHhcCCCCCC-eeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           43 IYKATENFSPAN-KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        43 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      +....++|.+.+ .||+|+||.||+|.+.   .++.||||++............+.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            333557788888 9999999999999653   478899999987655555567799999999999999999999999 56


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      +..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            67899999999999999998754  3899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .................+++.|+|||++.+..++.++||||||+++|+|++ |..||.........       .....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~  237 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE  237 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCC
Confidence            876554333233334457899999999999899999999999999999999 99999865442211       1111111


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                                ....+..++..+.+++.+||+.||.+||++.++++.|..+.....
T Consensus       238 ----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          238 ----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                      011223455789999999999999999999999999998876543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.5e-47  Score=365.99  Aligned_cols=254  Identities=23%  Similarity=0.376  Sum_probs=212.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....... .....+.+|+.+++.++||||+++++++......++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999987 69999999997543211 2345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++|+|.+++...+  .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++......
T Consensus        95 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999997654  3899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .    .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........       .+..+.      
T Consensus       170 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-------~i~~~~------  232 (476)
T 2y94_A          170 E----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK-------KICDGI------  232 (476)
T ss_dssp             C----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH-------HHHTTC------
T ss_pred             c----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH-------HHhcCC------
Confidence            2    2345679999999999998876 679999999999999999999998655432111       111111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+...+..+.+||.+||+.||.+|||++++++|.|-.
T Consensus       233 -----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          233 -----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             -----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence                 011122346789999999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-46  Score=365.64  Aligned_cols=277  Identities=19%  Similarity=0.242  Sum_probs=196.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-----CC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-----GD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~  119 (380)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.+|++++||||+++++++..     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            3478999999999999999999987 59999999997765555566778999999999999999999999843     35


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      .+|+||||+ +++|.+++....  .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             eEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            789999998 569999997654  3999999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcc------------------------eeeeecccCCccccChhhh-hhcCCCCccchhhHHHHHHHHHh-----
Q 041907          200 MSEEDSAV------------------------SHISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMT-----  249 (380)
Q Consensus       200 ~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt-----  249 (380)
                      ........                        ........||+.|+|||++ .+..++.++|||||||+||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            76432111                        0123456789999999986 56679999999999999999999     


Q ss_pred             ------CCCCCCCCCCcc-----------------hhhHHHHHHHhhccCCcc--------------ccccc--CCCCCC
Q 041907          250 ------GRYPIESKKPIK-----------------ERVTIRWAMQCLKAGDAI--------------LVMDP--RLRRTP  290 (380)
Q Consensus       250 ------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~--------------~~~~~--~~~~~~  290 (380)
                            |..+|.+.....                 ....+.............              ..+..  ......
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  666665433110                 001111111111000000              00000  000001


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      .....+..+.+||.+||+.||.+|||++|+++|.|-..
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~  402 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE  402 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence            11223567899999999999999999999999999653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-46  Score=358.10  Aligned_cols=258  Identities=22%  Similarity=0.351  Sum_probs=206.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC--CCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--HLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+.+|+.||||++............+.+|+.+|.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4569999999999999999999888999999999876655566778999999999996  59999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      || +.+++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.....
T Consensus       135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99 56789999998764  4889999999999999999999988   99999999999996 579999999999876532


Q ss_pred             CcceeeeecccCCccccChhhhhh-----------cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRT-----------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL  273 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .. ........||+.|+|||++.+           ..++.++|||||||++|+|++|..||........  .   .....
T Consensus       208 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--~---~~~~~  281 (390)
T 2zmd_A          208 TT-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K---LHAII  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--H---HHHHH
T ss_pred             Cc-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH--H---HHHHh
Confidence            21 112345679999999999975           4688999999999999999999999975432211  1   11111


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...         .. ...+...+..+.+||.+||+.||.+||++.++++++|..
T Consensus       282 ~~~---------~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          282 DPN---------HE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             CTT---------SC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             Ccc---------cc-CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            111         00 011111246788999999999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-46  Score=364.63  Aligned_cols=269  Identities=18%  Similarity=0.243  Sum_probs=206.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------C
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------D  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  119 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999987 589999999987655555667788999999999999999999999654      4


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..|+||||+++ +|.+.+..    .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            67999999976 67777753    2889999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh-------
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC-------  272 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------  272 (380)
                      ......    ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....+....+......       
T Consensus       213 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          213 TAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             ----CC----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             ecCCCc----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            654321    234567999999999999999999999999999999999999999876654332222111000       


Q ss_pred             ---------hccC-C-----cccccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 ---------LKAG-D-----AILVMDPRLRR--TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ---------~~~~-~-----~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                               .... .     ....+......  ..........+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                     0000 0     00000000000  001122367799999999999999999999999998853

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.1e-47  Score=351.86  Aligned_cols=271  Identities=25%  Similarity=0.365  Sum_probs=214.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe-----CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE--eC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE--HG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+     .+++.||||++....  ......+.+|+.++++++||||+++++++.  ..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            347899999999999999999984     258899999997653  334566889999999999999999999886  45


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ...++||||+++++|.+++..... .+++..++.++.||+.||.|||+.|   ++|+||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             ceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccc
Confidence            678999999999999999976432 3899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHH
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--------VTIRWAM  270 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~--------~~~~~~~  270 (380)
                      .................||..|+|||++.+..++.++||||||+++|+|++|..||.........        .......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            87765443333344566899999999999999999999999999999999999998653221000        0001111


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .....+         . ..+....++..+.+|+.+||+.||.+|||+++++++|+.+.....
T Consensus       255 ~~~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          255 ELLEEG---------Q-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHHTT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HHhhcc---------c-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            111111         1 122233456789999999999999999999999999998766443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-46  Score=363.37  Aligned_cols=254  Identities=30%  Similarity=0.451  Sum_probs=212.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-EEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-ERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. |+.||||+++....    ...+.+|+.+|++++||||+++++++.... ..++|
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            4578999999999999999999987 78999999976542    356889999999999999999999987765 78999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++|+|.+++...+...+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            99999999999998776555799999999999999999999998   999999999999999999999999999854321


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                            .....++..|+|||++.+..++.++|||||||++|||++ |..||......+....       +..+.      
T Consensus       343 ------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~------  403 (450)
T 1k9a_A          343 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGY------  403 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------HHTTC------
T ss_pred             ------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC------
Confidence                  122357889999999999999999999999999999998 9999987654332111       11111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                          ..+.+..++..+.+||.+||+.+|.+|||+.++++.|..++..
T Consensus       404 ----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          404 ----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                1122334567899999999999999999999999999988653

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5e-47  Score=349.55  Aligned_cols=251  Identities=23%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.++||+|+||+||+|.+. +|+.||||++...............|+..+.++ +||||+++++++...+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999987 699999999876554444444555666666555 999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+ +++|.+++...+ ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            9999 669999987764 34999999999999999999999998   999999999999999999999999998765432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .    ......||+.|+|||++.+ .++.++|||||||++|||++|..|+......          .....+...     
T Consensus       211 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~-----  270 (311)
T 3p1a_A          211 G----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGYLP-----  270 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTCCC-----
T ss_pred             C----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccCCC-----
Confidence            2    2234569999999999886 7999999999999999999997766532211          111111000     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          .......+..+.++|.+||+.||.+|||++|++++.|-
T Consensus       271 ----~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~  308 (311)
T 3p1a_A          271 ----PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL  308 (311)
T ss_dssp             ----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence                00111234679999999999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.9e-46  Score=340.61  Aligned_cols=261  Identities=27%  Similarity=0.404  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|.+..... ......+.+|+..+++++||||+++++++. .+..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            56789999999999999999999752    45799999876433 344567889999999999999999999984 4568


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|   ++|+||||+|||++.++.+||+|||+++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999999998654 34899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....       +..+.   
T Consensus       167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~-------i~~~~---  234 (281)
T 1mp8_A          167 EDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENGE---  234 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTC---
T ss_pred             Ccccc--cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH-------HHcCC---
Confidence            53221  11233457889999999999999999999999999999997 9999987654332111       11111   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                             ..+....++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       235 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          235 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                   01122345577999999999999999999999999999886643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.8e-47  Score=346.17  Aligned_cols=263  Identities=27%  Similarity=0.377  Sum_probs=220.9

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ....++|++.+.||+|+||.||+|.+.. +..||+|.+.....   ....+.+|+.++++++||||+++++++......+
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            3467889999999999999999999874 88999999976543   3456889999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++.......+++..++.++.+++.||.|||+.|   ++|+||||+||+++.++.++|+|||++....
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999998876667999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...  ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+       ....    
T Consensus       163 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-------~~~~----  229 (288)
T 3kfa_A          163 GDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDY----  229 (288)
T ss_dssp             SSS--SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------HTTC----
T ss_pred             CCc--cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hccC----
Confidence            432  222334557889999999999999999999999999999999 99999765543321111       1100    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                            ....+..++..+.+|+.+||+.+|.+||+++++++.+..+....
T Consensus       230 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          230 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                  01122334577999999999999999999999999999876643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-46  Score=351.83  Aligned_cols=268  Identities=23%  Similarity=0.267  Sum_probs=209.5

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc---chHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH---DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      +....++|++.+.||+|+||.||+|.+. +++.||+|++.....   .......+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4557789999999999999999999986 588999999865421   223456788999999999999999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 041907          119 DERIIVVEYVGNGTLREHLDGRG--------------------------------------GNGLELAERLDIAIDVAHA  160 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------~~~~~~~~~~~i~~~i~~~  160 (380)
                      +..++||||+++|+|.+++....                                      ...+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999996311                                      1113567788899999999


Q ss_pred             HHHHhhCCCCCeeeccCCCCceeeCCCC--ceEEccccccccccCCCc-ceeeeecccCCccccChhhhhh--cCCCCcc
Q 041907          161 LTYLHTYSDPPIIHRDVKASNILITEKL--RAKVTDFGFARMSEEDSA-VSHISTQVKGTAGYLDPDYLRT--YQLTEKS  235 (380)
Q Consensus       161 l~~LH~~~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  235 (380)
                      |.|||+.+   ++|+||||+|||++.++  .+||+|||++........ .........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999998   99999999999998776  899999999986543221 1112345679999999999975  6789999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 041907          236 DVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP  315 (380)
Q Consensus       236 DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  315 (380)
                      |||||||++|+|++|..||......+....+      .....        ....+.....+..+.+||.+||+.+|.+||
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~------~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQV------LNKKL--------CFENPNYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC--------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHH------Hhccc--------ccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence            9999999999999999999866543321111      11100        001112223457789999999999999999


Q ss_pred             ChHHHHHHHHHH
Q 041907          316 TMKKCAEILWKI  327 (380)
Q Consensus       316 t~~eil~~l~~~  327 (380)
                      ++.+++++.|--
T Consensus       324 s~~~~l~hp~~~  335 (345)
T 3hko_A          324 DAMRALQHPWIS  335 (345)
T ss_dssp             CHHHHHHSHHHH
T ss_pred             CHHHHhcChhhc
Confidence            999999999853

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=351.12  Aligned_cols=267  Identities=25%  Similarity=0.327  Sum_probs=213.1

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      ...++|.+.+.||+|+||.||+|.+.      ++..||||++..... ......+.+|+.++.++ +||||+++++++..
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            35688999999999999999999962      356899999975432 22345688999999999 89999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGG---------------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRD  176 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d  176 (380)
                      .+..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.|   |+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence            9999999999999999999986542                     23789999999999999999999998   99999


Q ss_pred             CCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCC
Q 041907          177 VKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIE  255 (380)
Q Consensus       177 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~  255 (380)
                      |||+|||++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCcc-ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            999999999999999999999986654322 222344567899999999999999999999999999999998 999997


Q ss_pred             CCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          256 SKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .........      .....+.          ....+..++..+.+|+.+||+.||.+||++.+++++|+.+.....
T Consensus       277 ~~~~~~~~~------~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          277 GIPVDANFY------KLIQNGF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             TCCCSHHHH------HHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cCCcHHHHH------HHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            655432211      1111110          011122345779999999999999999999999999998866543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-46  Score=351.22  Aligned_cols=257  Identities=23%  Similarity=0.322  Sum_probs=208.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.++ +|+.||||++......      ..+|+.++.++ +||||+++++++.+....++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            4578999999999999999999987 5899999999765432      24677788777 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC----CceEEccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK----LRAKVTDFGFAR  199 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~  199 (380)
                      ||||+++|+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||+.++    +.+||+|||++.
T Consensus        94 v~E~~~gg~L~~~i~~~~~--~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTT--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999999987543  899999999999999999999999   9999999999998543    359999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+    ..+..+...
T Consensus       169 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~  241 (342)
T 2qr7_A          169 QLRAENG---LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS  241 (342)
T ss_dssp             ECBCTTC---CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC
T ss_pred             cCcCCCC---ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc
Confidence            6654321   223567899999999999988999999999999999999999999764322221111    111111110


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                             .........+..+.+||.+||+.||.+||++.++++|.|-.
T Consensus       242 -------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 -------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             -------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             -------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence                   00111233557789999999999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.9e-47  Score=351.07  Aligned_cols=256  Identities=24%  Similarity=0.357  Sum_probs=202.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD------  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  119 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.+..      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            467899999999999999999987 699999999976543 234567889999999999999999999986543      


Q ss_pred             ---------------------------------------------------EEEEEEEeCCCCCHHHHhccCCC-CCCCH
Q 041907          120 ---------------------------------------------------ERIIVVEYVGNGTLREHLDGRGG-NGLEL  147 (380)
Q Consensus       120 ---------------------------------------------------~~~lv~e~~~~~~L~~~i~~~~~-~~~~~  147 (380)
                                                                         ..++||||+++++|.+++..... ....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               38999999999999999987653 23566


Q ss_pred             HHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce---------eeeecccCCc
Q 041907          148 AERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS---------HISTQVKGTA  218 (380)
Q Consensus       148 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~gt~  218 (380)
                      ..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||+++.........         .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            678999999999999999999   9999999999999999999999999998765432111         1123456999


Q ss_pred             cccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHH
Q 041907          219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEK  298 (380)
Q Consensus       219 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (380)
                      .|+|||++.+..++.++|||||||++|+|++|..|+...      ..   ........          ............
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~---~~~~~~~~----------~~~~~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VR---IITDVRNL----------KFPLLFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HH---HHHHHHTT----------CCCHHHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HH---HHHHhhcc----------CCCcccccCChh
Confidence            999999999999999999999999999999987764211      00   01111110          111122344567


Q ss_pred             HHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          299 ILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       299 l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      +.+||.+||+.||.+|||+++++++.|
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~~~  328 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIENAI  328 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhchh
Confidence            889999999999999999999999876

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=359.04  Aligned_cols=251  Identities=22%  Similarity=0.334  Sum_probs=201.8

Q ss_pred             CCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           53 ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .+.||+|+||.||+|.+. +|+.||+|++......  ....+.+|+.++++++||||+++++++...+..++||||++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            567999999999999986 5999999999765432  3457889999999999999999999999999999999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee--CCCCceEEccccccccccCCCccee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSH  209 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  209 (380)
                      +|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9999887543 23899999999999999999999999   9999999999999  5678899999999987654322   


Q ss_pred             eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCC
Q 041907          210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT  289 (380)
Q Consensus       210 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........   ....    ..    +  . ..
T Consensus       245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~---i~~~----~~----~--~-~~  309 (373)
T 2x4f_A          245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN---ILAC----RW----D--L-ED  309 (373)
T ss_dssp             -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHHT----CC----C--S-CS
T ss_pred             -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc----cC----C--C-Ch
Confidence             2334699999999999999999999999999999999999999987654322111   1111    00    0  0 00


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          290 PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       290 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ......+..+.+||.+||+.||.+||+++|++++.|-.
T Consensus       310 ~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~  347 (373)
T 2x4f_A          310 EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS  347 (373)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence            11123456789999999999999999999999999965

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.5e-47  Score=350.53  Aligned_cols=261  Identities=22%  Similarity=0.375  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCE----EEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSI----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.    ||+|.+...... .....+.+|+.++.+++||||+++++++.. +..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            468999999999999999999976 3543    788877543221 122346689999999999999999999864 568


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            89999999999999997653 24888999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..... ........||..|+|||++.+..++.++|||||||++|+|++ |..||...........+       ..+..  
T Consensus       166 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~--  235 (325)
T 3kex_A          166 PPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGER--  235 (325)
T ss_dssp             CCCTT-CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-------HTTCB--
T ss_pred             Ccccc-cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCCC--
Confidence            54322 222345568889999999999999999999999999999999 99999876543321111       11110  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                              ...+..++..+.+++.+||+.+|.+||++.+++++|..+....
T Consensus       236 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          236 --------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             --------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             --------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                    1111123345788999999999999999999999999886644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9e-47  Score=350.83  Aligned_cols=276  Identities=25%  Similarity=0.341  Sum_probs=213.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++...+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            4578999999999999999999987 499999999977766665666788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.....  +++..++.++.||+.||.|||+.|   ++|+||||+|||++.++.+||+|||++......
T Consensus       103 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             EECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999999888888765443  899999999999999999999999   999999999999999999999999999765432


Q ss_pred             CcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------hhcc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ--------CLKA  275 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~  275 (380)
                      .   .......||..|+|||++.+. .++.++|||||||++|+|++|..||......+....+.....        ....
T Consensus       178 ~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          178 G---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             c---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            2   122345689999999999875 789999999999999999999999987654433222211000        0000


Q ss_pred             CC-cccccccCCCCC-C---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          276 GD-AILVMDPRLRRT-P---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       276 ~~-~~~~~~~~~~~~-~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .. ......+..... +   ....++..+.+||.+||+.||.+|||++|++++.|--..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            00 000000000000 0   011245779999999999999999999999999996543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=376.24  Aligned_cols=258  Identities=21%  Similarity=0.377  Sum_probs=206.7

Q ss_pred             eeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           55 KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        55 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .||+|+||.||+|.++   ++..||||+++..... .....+.+|+.+|++++||||+++++++.. +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            7999999999999874   4667999999865332 235678999999999999999999999976 5689999999999


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceeee
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHIS  211 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  211 (380)
                      +|.+++.... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++............
T Consensus       421 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          421 PLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             BHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             cHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            9999997653 34899999999999999999999998   9999999999999999999999999998765433222222


Q ss_pred             ecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCC
Q 041907          212 TQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTP  290 (380)
Q Consensus       212 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..       ..+..+.          ...
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~----------~~~  559 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGK----------RME  559 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTTC----------CCC
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCC----------CCC
Confidence            33446789999999999999999999999999999998 99999876553321       1111111          112


Q ss_pred             CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhccC
Q 041907          291 ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKA  335 (380)
Q Consensus       291 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~~~  335 (380)
                      .+..++..+.+||.+||+.+|.+||++++|++.|..+........
T Consensus       560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~  604 (613)
T 2ozo_A          560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  604 (613)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence            233456789999999999999999999999999998877665433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-46  Score=370.30  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=216.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|+.+|.+++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999987 6999999999654221 1123457899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||++||+|.+++...+...+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++....
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999998776666999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+........         
T Consensus       339 ~~~----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---------  405 (576)
T 2acx_A          339 GQT----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---------  405 (576)
T ss_dssp             TCC----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---------
T ss_pred             Ccc----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---------
Confidence            321    2345799999999999999999999999999999999999999987654322222221111110         


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                           ...+...+..+.+||.+||+.||.+||     +++||++|.|-.
T Consensus       406 -----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          406 -----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             -----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence                 111223457799999999999999999     789999998854

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-46  Score=346.45  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++|.+.+.||+|+||.||+|.+..     +..||||.+..... ......+.+|+.++++++||||+++++++...+..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            4567788999999999999998752     23599999976543 33455788999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++...
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999997653 34899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..............+|..|+|||++.+..++.++|||||||++|+|++ |..||........       ...+..+.   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~---  267 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------MKAINDGF---  267 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTC---
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHCCC---
Confidence            543222222233456889999999999999999999999999999999 9999976543221       11111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                             ..+....++..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus       268 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          268 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                   011223455778999999999999999999999999998876443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-46  Score=342.45  Aligned_cols=264  Identities=30%  Similarity=0.500  Sum_probs=203.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||.||+|.+.  ..||+|+++...........+.+|+.++++++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            5688999999999999999999875  3599999987766666677899999999999999999999965 455689999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++.......
T Consensus        99 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999997654 34899999999999999999999998   9999999999999999999999999997654322


Q ss_pred             cceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      . ........||+.|+|||++.   +..++.++||||||+++|+|++|..||...........      ....+..    
T Consensus       175 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~----  243 (289)
T 3og7_A          175 G-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE------MVGRGSL----  243 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH------HHHHTSC----
T ss_pred             c-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH------Hhccccc----
Confidence            1 11223456999999999997   66788899999999999999999999986554332111      1111111    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .+..  ......++..+.+|+.+||+.+|.+||+++++++.|+.+.+
T Consensus       244 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 SPDL--SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCCT--TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             Ccch--hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            0110  11223455789999999999999999999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-47  Score=351.06  Aligned_cols=255  Identities=25%  Similarity=0.328  Sum_probs=186.3

Q ss_pred             CCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           53 ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      .+.||+|+||.||+|.+. +|+.||||++...     ....+.+|+.++.++. ||||+++++++.+....++||||+++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            488999999999999987 5899999998653     2345678999999997 99999999999999999999999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEccccccccccCCCcc
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~  207 (380)
                      ++|.+++....  .+++..++.++.||+.||.|||++|   |+||||||+|||++.++   .+||+|||+++......  
T Consensus        91 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--  163 (325)
T 3kn6_A           91 GELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--  163 (325)
T ss_dssp             CBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--
Confidence            99999998754  3999999999999999999999998   99999999999998765   89999999998654322  


Q ss_pred             eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCC
Q 041907          208 SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR  287 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (380)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||..................+..+...       .
T Consensus       164 -~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-------~  235 (325)
T 3kn6_A          164 -QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-------F  235 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-------C
T ss_pred             -CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-------C
Confidence             12244568999999999999999999999999999999999999998654322111111122222222110       0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       288 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ........+..+.+||.+||+.||.+|||+++++++.|-.
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence            0011123467899999999999999999999999998843

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.5e-46  Score=354.13  Aligned_cols=254  Identities=24%  Similarity=0.302  Sum_probs=201.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHH-HhcCCCCceeceEEEEEeCCEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILT-WSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      .++|++.+.||+|+||.||+|+++ +++.||||++...... ......+..|..+ ++.++||||+++++++...+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            478999999999999999999987 4899999999765432 2223445666666 567899999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||++||+|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999987543  889999999999999999999999   99999999999999999999999999986432


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..   ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........       +...       
T Consensus       192 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~-------i~~~-------  254 (373)
T 2r5t_A          192 HN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-------ILNK-------  254 (373)
T ss_dssp             CC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHH-------HHHS-------
T ss_pred             CC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHhc-------
Confidence            21   123456799999999999999999999999999999999999999986543322111       1111       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh----HHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM----KKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~eil~~l~~  326 (380)
                       ...   .+...+..+.+||.+||+.||.+||++    .++++|.|-
T Consensus       255 -~~~---~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f  297 (373)
T 2r5t_A          255 -PLQ---LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF  297 (373)
T ss_dssp             -CCC---CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred             -ccC---CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence             011   112245678999999999999999997    577777664

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-46  Score=336.73  Aligned_cols=258  Identities=26%  Similarity=0.409  Sum_probs=214.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|++.......   ..+.+|+.++++++||||+++++++...+..++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            347899999999999999999999888899999998765432   46889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+||+|||++.......
T Consensus        83 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             eCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999998654 34899999999999999999999999   9999999999999999999999999998654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                        ........++..|+|||++.+..++.++||||||+++|+|++ |..||.........       .....+..      
T Consensus       159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~i~~~~~------  223 (267)
T 3t9t_A          159 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-------EDISTGFR------  223 (267)
T ss_dssp             --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTCC------
T ss_pred             --ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH-------HHHhcCCc------
Confidence              111233457889999999999999999999999999999999 89999765432211       11111100      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          ...+...+..+.+++.+||+.+|.+||++.+++++|..+.+
T Consensus       224 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          224 ----LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                11122245678999999999999999999999999998865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.7e-46  Score=335.69  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=210.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+.. +..||+|++.......  ...+.+|+.++++++||||+++++++......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            45679999999999999999999874 7899999997654332  45688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  201 (380)
                      |||+++++|.+++.....  +++..++.++.|++.||.|||++|   ++|+||||+||++   +.++.++|+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             EECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999999999877543  899999999999999999999999   9999999999999   78889999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....    ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...........+       ..+.    
T Consensus       160 ~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~----  223 (277)
T 3f3z_A          160 KPGK----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI-------REGT----  223 (277)
T ss_dssp             CTTS----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC----
T ss_pred             cCcc----chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhCC----
Confidence            5432    12345699999999998764 899999999999999999999999875543221111       1110    


Q ss_pred             cccCCCCCCCCH----HHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASN----MAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                             ...+.    ..+..+.+++.+||+.+|.+||++.+++++.|-.
T Consensus       224 -------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~  266 (277)
T 3f3z_A          224 -------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE  266 (277)
T ss_dssp             -------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             -------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence                   00111    2356789999999999999999999999999854

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-46  Score=368.18  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=217.6

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ...++|.+.+.||+|+||.||+|.+.. +..||||.++.....   ...+.+|+.+|++++||||+++++++......++
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            355778999999999999999999875 889999999865433   4578899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999999998766666999999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ..  ........++..|+|||++.+..++.++|||||||++|||++ |..||..........       .+..+.     
T Consensus       371 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~-----  436 (495)
T 1opk_A          371 DT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKDY-----  436 (495)
T ss_dssp             CC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTC-----
T ss_pred             Cc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCC-----
Confidence            22  222234457789999999999999999999999999999999 999998765432211       111110     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                           ....+..++..+.+||.+||+.+|.+|||+.+|++.|..+.
T Consensus       437 -----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          437 -----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                 11223345678999999999999999999999999998664

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3e-46  Score=349.46  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=207.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.|++.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            55889999999999999999975 689999999976533 3334567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+. |+|.+++.... ..+++..++.++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||++...... 
T Consensus       134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence            9997 58888886543 34899999999999999999999998   999999999999999999999999999765432 


Q ss_pred             cceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                            ....||+.|+|||++.   +..++.++|||||||++|+|++|..||...........      ... +..    
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~------~~~-~~~----  270 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ-NES----  270 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHH-SCC----
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HHh-cCC----
Confidence                  2356999999999985   56789999999999999999999999976543322111      111 100    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       +    .......+..+.+||.+||+.+|.+|||++++++++|..
T Consensus       271 -~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          271 -P----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             -C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             -C----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence             0    111223456788999999999999999999999999965

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-46  Score=343.60  Aligned_cols=265  Identities=25%  Similarity=0.392  Sum_probs=217.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe------CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||++...... .....+.+|+.++.++ +||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-HHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            557899999999999999999985      24678999999765432 3456788999999999 999999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGG----------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      +..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||++|   ++|+||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence            999999999999999999986543                24899999999999999999999998   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      +++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEcCCCCEEEcccccccccccccc-ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            999999999999999987654332 222334567889999999999999999999999999999999 999997655432


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ....      ....+.          ........+..+.+++.+||+.||.+|||+.+++++|..+....
T Consensus       256 ~~~~------~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          256 KFYK------MIKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHH------HHHHTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHH------HhccCC----------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            2111      111110          01112234567899999999999999999999999999886643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-46  Score=339.13  Aligned_cols=264  Identities=27%  Similarity=0.443  Sum_probs=216.0

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +....++|++.+.||+|+||.||+|.+.++..||+|.+......   ...+.+|+.++++++||||+++++++.. +..+
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            34456789999999999999999999988889999999765433   3568899999999999999999999864 4589


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            9999999999999998654335899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...  ........++..|+|||++.+..++.++||||||+++|+|++ |..||.........       .....+..   
T Consensus       161 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~~~~~~~---  228 (279)
T 1qpc_A          161 DNE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI-------QNLERGYR---  228 (279)
T ss_dssp             SSC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCC---
T ss_pred             Ccc--cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH-------HHHhcccC---
Confidence            432  122234457889999999999999999999999999999999 99999765432211       11111100   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                             ......++..+.+++.+||+.+|.+|||++++++.|..+.....
T Consensus       229 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          229 -------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                   11122345779999999999999999999999999998876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-46  Score=364.52  Aligned_cols=262  Identities=29%  Similarity=0.442  Sum_probs=211.3

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +....++|++.+.||+|+||.||+|.+.++..||||+++.....   ...+.+|+.+|++++||||+++++++.. +..+
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            33456789999999999999999999987788999999865433   3568899999999999999999999876 6789


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++|+|.+++.......+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            9999999999999998654445899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...  ........++..|+|||++.+..++.++|||||||++|||++ |..||......+..       .....+.    
T Consensus       332 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~----  398 (452)
T 1fmk_A          332 DNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY----  398 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC----
T ss_pred             CCc--eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC----
Confidence            322  112233457889999999999999999999999999999999 99999765433211       1111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                            ..+.+..++..+.+||.+||+.+|.+|||++++++.|..+...
T Consensus       399 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          399 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                  1122334567899999999999999999999999999876543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-46  Score=368.66  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|++............+.+|+.+++.++||||+++++++......++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3467999999999999999999987 589999999986544333355688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~  201 (380)
                      |||+++|+|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++..   +.+||+|||++...
T Consensus       115 ~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999999876543  899999999999999999999999   9999999999999764   45999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+       ..+...  
T Consensus       190 ~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------~~~~~~--  255 (494)
T 3lij_A          190 ENQK----KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV-------EKGKYT--  255 (494)
T ss_dssp             BTTB----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCC--
T ss_pred             CCCc----cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCC--
Confidence            5432    1234569999999999874 6999999999999999999999999876543221111       111100  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                           ...+.....+..+.+||.+||+.+|.+|||+.++++|+|-..
T Consensus       256 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          256 -----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             -----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             -----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence                 001112234567899999999999999999999999999653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.5e-46  Score=345.22  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=214.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.+.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            4578999999999999999999987 488999999876532 33445668899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++++|.+++....  .+++..++.++.||+.||.|||++|   ++|+||||+|||++.++.+||+|||++.....
T Consensus       119 v~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999999987654  3899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   ......||..|+|||++.+..++.++||||||+++|+|++|..||......+....+       ..+.      
T Consensus       194 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-------~~~~------  257 (335)
T 2owb_A          194 DGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNE------  257 (335)
T ss_dssp             TTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHTC------
T ss_pred             Ccc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH-------hcCC------
Confidence            221   123456999999999999999999999999999999999999999765432211111       1110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                           ...+..++..+.+||.+||+.||.+||++++++++.|-...
T Consensus       258 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          258 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence                 01112234678899999999999999999999999986533

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.6e-47  Score=352.76  Aligned_cols=249  Identities=26%  Similarity=0.353  Sum_probs=208.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch------HHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK------CLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.......      .....+.+|+.++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3568999999999999999999986 58999999997654221      1223466899999999999999999999999


Q ss_pred             CEEEEEEEeCCCC-CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          119 DERIIVVEYVGNG-TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       119 ~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      +..++||||+.+| +|.+++.....  +++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999776 99999987543  899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      +........    .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......               
T Consensus       177 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------  237 (335)
T 3dls_A          177 AAYLERGKL----FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------  237 (335)
T ss_dssp             CEECCTTCC----BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred             ceECCCCCc----eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence            987654322    234569999999999998887 789999999999999999999996522110               


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ....   ..+...+..+.+||.+||+.+|.+|||+++++++.|-.
T Consensus       238 ------~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~  279 (335)
T 3dls_A          238 ------EAAI---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT  279 (335)
T ss_dssp             ------TTCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTT
T ss_pred             ------hhcc---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence                  0000   11112456789999999999999999999999999853

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=346.16  Aligned_cols=261  Identities=23%  Similarity=0.373  Sum_probs=204.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCE----EEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSI----VAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.    |++|.+...... .....+.+|+.++++++||||+++++++.... .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            478999999999999999999976 3543    577777543322 23567889999999999999999999998765 7


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++|++|+.+|+|.+++..... .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             eEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            889999999999999987543 4899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........       ...+.   
T Consensus       168 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-------~~~~~---  236 (327)
T 3lzb_A          168 GAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE---  236 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTC---
T ss_pred             cCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCC---
Confidence            543221 12233457889999999999999999999999999999999 9999987654332111       11110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                             ..+....++..+.+++.+||+.+|.+||+++++++.|..+....
T Consensus       237 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          237 -------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                   11222335567899999999999999999999999999987543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.9e-46  Score=338.95  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=211.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.++++++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999987 5788999998654221 11235688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...+.  +++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.++|+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999999987543  899999999999999999999988   999999999999999999999999998755432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .     .....|++.|+|||++.+..++.++||||||+++|+|++|..||..........       ......       
T Consensus       168 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~-------  228 (284)
T 2vgo_A          168 R-----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR-------RIVNVD-------  228 (284)
T ss_dssp             C-----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTC-------
T ss_pred             c-----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH-------HHhccc-------
Confidence            1     234569999999999999999999999999999999999999997654322111       111110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          ...+...+..+.++|.+||+.+|.+||+++++++|.|-...
T Consensus       229 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          229 ----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence                01112345678999999999999999999999999996543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-45  Score=340.97  Aligned_cols=271  Identities=24%  Similarity=0.336  Sum_probs=207.0

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhc--CCCCceeceEEEEEeC--
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK--IEHLNLVKLFGFLEHG--  118 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~--  118 (380)
                      .....++|++.+.||+|+||.||+|.+. |+.||||++.....     ..+..|..++..  ++||||+++++++...  
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            3345689999999999999999999987 89999999865422     223344455444  5999999999999887  


Q ss_pred             --CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------CCCCeeeccCCCCceeeCCCC
Q 041907          119 --DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY--------SDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       119 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------~~~~i~H~dlkp~Nil~~~~~  188 (380)
                        ...++||||+++|+|.+++....   +++..++.++.|++.||.|||+.        |   ++||||||+|||++.++
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTS
T ss_pred             CCCceEEEEeccCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCC
Confidence              78999999999999999997653   89999999999999999999987        7   99999999999999999


Q ss_pred             ceEEccccccccccCCCccee-eeecccCCccccChhhhhhcCCCCc------cchhhHHHHHHHHHhC----------C
Q 041907          189 RAKVTDFGFARMSEEDSAVSH-ISTQVKGTAGYLDPDYLRTYQLTEK------SDVYSFGVLLVEMMTG----------R  251 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlGvil~elltg----------~  251 (380)
                      .+||+|||++........... ......||+.|+|||++.+..++.+      +|||||||++|||++|          .
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            999999999976544322111 1234579999999999998877765      9999999999999999          6


Q ss_pred             CCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          252 YPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       252 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .||....+.......  ........    ...+..........++..+.+|+.+||+.||.+|||+.+|+++|..+.+..
T Consensus       260 ~p~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          260 LPYHDLVPSDPSYED--MREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CTTTTTSCSSCCHHH--HHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             ccHhhhcCCCCchhh--hHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            666544332221111  11111110    011111111123467888999999999999999999999999999887643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.1e-46  Score=338.25  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=207.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe----CCEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GDERI  122 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  122 (380)
                      +.|.+.+.||+|+||.||+|.+. ++..||+|++............+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45788889999999999999986 58899999998776666667778999999999999999999999875    45689


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRAKVTDFGFARMS  201 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~  201 (380)
                      +||||+++++|.+++.....  +++..++.++.+|+.||.|||+.+ .+++|+||||+|||++ .++.+||+|||++...
T Consensus       106 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999999987543  899999999999999999999764 4599999999999998 7899999999999754


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....     .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........      .....+...  
T Consensus       183 ~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~--  248 (290)
T 1t4h_A          183 RASF-----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------RRVTSGVKP--  248 (290)
T ss_dssp             CTTS-----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH------HHHTTTCCC--
T ss_pred             cccc-----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH------HHHhccCCc--
Confidence            4321     234569999999998875 58999999999999999999999997654432211      111111110  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                             .......+..+.++|.+||+.+|.+|||++++++|.|-
T Consensus       249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence                   11111223568999999999999999999999999873

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-46  Score=348.05  Aligned_cols=258  Identities=21%  Similarity=0.325  Sum_probs=211.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++.......    .....+.+|+.++++++||||+++++++.....
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467999999999999999999987 58999999997653321    124568899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL----RAKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg  196 (380)
                      .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++    .+||+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999997654  3899999999999999999999998   99999999999999887    79999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++........    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........       ....
T Consensus       165 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------i~~~  233 (321)
T 2a2a_A          165 LAHEIEDGVE----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------ITSV  233 (321)
T ss_dssp             TCEECCTTCC----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-------HHTT
T ss_pred             cceecCcccc----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHhc
Confidence            9987654321    2345699999999999999999999999999999999999999976543221111       1110


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ..  ....     ......+..+.+||.+||+.||.+|||+++++++.|-
T Consensus       234 ~~--~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~  276 (321)
T 2a2a_A          234 SY--DFDE-----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI  276 (321)
T ss_dssp             CC--CCCH-----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred             cc--ccCh-----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            00  0000     0001234678899999999999999999999999884

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-46  Score=365.52  Aligned_cols=258  Identities=27%  Similarity=0.364  Sum_probs=211.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999987 699999999865433223345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  201 (380)
                      |||+.+++|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++   .++.+||+|||++...
T Consensus       100 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999999999876543  899999999999999999999999   99999999999995   4567999999999866


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........       +..+...  
T Consensus       175 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~~~~~--  240 (486)
T 3mwu_A          175 QQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-------VETGKYA--  240 (486)
T ss_dssp             CCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHTCCC--
T ss_pred             CCCC----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhCCCC--
Confidence            5432    2234579999999999986 589999999999999999999999987654322111       1111100  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+.....+..+.+||.+||+.+|.+|||+.++++|+|-.
T Consensus       241 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~  281 (486)
T 3mwu_A          241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (486)
T ss_dssp             -----SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred             -----CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence                 01122234557799999999999999999999999999964

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-45  Score=337.71  Aligned_cols=257  Identities=22%  Similarity=0.318  Sum_probs=214.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3468999999999999999999987 488999999876532 33445668899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++++|.+++....  .+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+||+|||++.....
T Consensus        93 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            999999999999987654  3899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....       ...+.      
T Consensus       168 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~------  231 (294)
T 2rku_A          168 DGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-------IKKNE------  231 (294)
T ss_dssp             TTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTTC------
T ss_pred             Ccc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------Hhhcc------
Confidence            221   12345689999999999999999999999999999999999999976543221111       11110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                           ...+...+..+.+++.+||+.||.+||++++++++.|-..
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence                 0111234467889999999999999999999999998653

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.2e-46  Score=350.88  Aligned_cols=277  Identities=18%  Similarity=0.243  Sum_probs=210.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC------CCEEEEEEccccCcchHH---------HHHHHHHHHHHhcCCCCceec
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD------GSIVAVKRARKNKHDKCL---------LLEFKNEILTWSKIEHLNLVK  110 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~  110 (380)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++.........         ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45689999999999999999999864      478999998765321111         112345666778889999999


Q ss_pred             eEEEEEeC----CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-
Q 041907          111 LFGFLEHG----DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-  185 (380)
Q Consensus       111 ~~~~~~~~----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-  185 (380)
                      +++++...    ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|   |+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            99998764    4589999999 999999998753 34999999999999999999999998   99999999999999 


Q ss_pred             -CCCceEEccccccccccCCCccee----eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 041907          186 -EKLRAKVTDFGFARMSEEDSAVSH----ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI  260 (380)
Q Consensus       186 -~~~~~kl~Dfg~~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~  260 (380)
                       .++.+||+|||+++.+........    ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             889999999999987654321111    113455999999999999999999999999999999999999999864332


Q ss_pred             chhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhcc
Q 041907          261 KERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK  334 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~~  334 (380)
                      .......  .... .......++..+..    ..++..+.+++..||+.+|.+||++++|++.|..+.......
T Consensus       268 ~~~~~~~--~~~~-~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~  334 (364)
T 3op5_A          268 PKYVRDS--KIRY-RENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK  334 (364)
T ss_dssp             HHHHHHH--HHHH-HHCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHH--HHHh-hhhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            2211111  1100 00111112222111    123467899999999999999999999999999988866544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.4e-46  Score=341.84  Aligned_cols=269  Identities=23%  Similarity=0.338  Sum_probs=206.6

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      +....++|.+.+.||+|+||.||+|.+.    .+..||+|.+............+.+|+.++++++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3345568889999999999999999864    245899999987765555667789999999999999999999998775


Q ss_pred             C-----EEEEEEEeCCCCCHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          119 D-----ERIIVVEYVGNGTLREHLDGR----GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       119 ~-----~~~lv~e~~~~~~L~~~i~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      .     ..++||||+++++|.+++...    ....+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence            5     349999999999999998432    2345899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~  268 (380)
                      +||+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........   
T Consensus       186 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---  261 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---  261 (313)
T ss_dssp             EEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---
T ss_pred             EEEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH---
Confidence            99999999986543221 112234557889999999999999999999999999999999 8999976554332111   


Q ss_pred             HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                          ...+.          .......++..+.+++.+||+.+|.+||++.+++++|..+...+.
T Consensus       262 ----~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          262 ----LLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ----HHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ----HHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                11110          011223345679999999999999999999999999999877653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6e-46  Score=345.70  Aligned_cols=265  Identities=26%  Similarity=0.380  Sum_probs=215.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||||++..... ......+.+|+.+++++ +||||+++++++.
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-HHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            4578999999999999999999863        467899999976543 33456788999999999 8999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGG--------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      ..+..++||||+++++|.+++.....              ..+++..++.++.||+.||.|||+.|   ++|+||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            99999999999999999999986542              23889999999999999999999998   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      +++.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCCEEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999987654321 112233457889999999999999999999999999999999 999997654322


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      ..       .....+..          ......++..+.+++.+||+.+|.+||++.+++++|..+.....
T Consensus       268 ~~-------~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          268 LF-------KLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HH-------HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HH-------HHHhcCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            11       11111110          11122345678999999999999999999999999999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.5e-46  Score=349.60  Aligned_cols=276  Identities=21%  Similarity=0.233  Sum_probs=211.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--------  117 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  117 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999986 69999999997665444444567799999999999999999999877        


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      .+..++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4568999999975 88888766543 3899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcc-eeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          198 ARMSEEDSAV-SHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       198 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9876532211 122345678999999999976 45799999999999999999999999876654433333222111111


Q ss_pred             CCcccc-----cccC---CCCCC-CCHH-----HHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          276 GDAILV-----MDPR---LRRTP-ASNM-----AVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       276 ~~~~~~-----~~~~---~~~~~-~~~~-----~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ......     .+..   ..... ....     ....+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence            110000     0000   00000 0011     135688999999999999999999999999853

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.6e-46  Score=364.41  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=214.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            4568999999999999999999987 6999999998654322 2235568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEcccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARM  200 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  200 (380)
                      ||||+.+++|.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||+   +.++.+||+|||++..
T Consensus       104 v~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999999977543  899999999999999999999999   9999999999999   4678999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........       +..+... 
T Consensus       179 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-------i~~~~~~-  245 (484)
T 3nyv_A          179 FEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKK-------VEKGKYT-  245 (484)
T ss_dssp             BCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCCC-
T ss_pred             ccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHcCCCC-
Confidence            65432    1234569999999999977 699999999999999999999999987654332111       1111100 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                            ...+.....+..+.+||.+||+.+|.+|||+.++++|.|-..
T Consensus       246 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          246 ------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             ------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence                  011222345678999999999999999999999999999653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.5e-46  Score=340.64  Aligned_cols=268  Identities=23%  Similarity=0.336  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... ........+.+|+.++++++||||+++++++...+..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3468999999999999999999985 69999999997543 334455678899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          124 VVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ||||+++++|.+++...  ....+++..++.++.+|+.||.|||+.|   ++|+||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999999752  2344899999999999999999999998   999999999999999999999999998765


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....   ......|+..|+|||++.+..++.++||||||+++|+|++|..||.........     ...........  
T Consensus       187 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~--  256 (310)
T 2wqm_A          187 SSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDYP--  256 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-----HHHHHHTTCSC--
T ss_pred             cCCCc---cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-----HHHHhhcccCC--
Confidence            43221   123456899999999999999999999999999999999999999754322111     11111111110  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhc
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE  333 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~  333 (380)
                             .......+..+.+++.+||+.||.+||+++++++.+..+.+...+
T Consensus       257 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          257 -------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             -------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             -------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence                   011123456799999999999999999999999999999876643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-45  Score=338.85  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=202.3

Q ss_pred             hcCCCCC-CeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           47 TENFSPA-NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        47 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      .+.|++. +.||+|+||.||+|.+. +|+.||||++......  ....+.+|+.++.++ +||||+++++++...+..++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            4678874 78999999999999976 6999999999765432  245678999999884 79999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEcccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFGFARM  200 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~  200 (380)
                      ||||+++++|.+++....  .+++..++.++.||+.||.|||+++   ++||||||+|||++.++.   +||+|||++..
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999998754  3899999999999999999999998   999999999999998776   99999999876


Q ss_pred             ccCCCcce----eeeecccCCccccChhhhhh-----cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH------
Q 041907          201 SEEDSAVS----HISTQVKGTAGYLDPDYLRT-----YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT------  265 (380)
Q Consensus       201 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~------  265 (380)
                      ........    .......||+.|+|||++.+     ..++.++|||||||++|+|++|..||......+....      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            54321111    11223569999999999975     5688999999999999999999999986543221000      


Q ss_pred             --HHHHHHhhccCCcccccccCCCCCCC--CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          266 --IRWAMQCLKAGDAILVMDPRLRRTPA--SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       266 --~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ..........+..        . .+.  ....+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       244 ~~~~~~~~~i~~~~~--------~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY--------E-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHHHHHHHCCC--------C-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             hHHHHHHHHHhccCc--------c-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence              0001111111110        0 000  01234678999999999999999999999999884

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.1e-46  Score=337.29  Aligned_cols=257  Identities=27%  Similarity=0.479  Sum_probs=206.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHH-----HHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLL-----LEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++..........     ..+.+|+.++++++||||+++++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            4478999999999999999999986 69999999987544322111     56889999999999999999999986655


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-----eEEcc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR-----AKVTD  194 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~-----~kl~D  194 (380)
                        ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++| .+++|+||||+|||++.++.     +||+|
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             --eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence              69999999999999887654 34899999999999999999999764 45999999999999988776     99999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhh--hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYL--RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      ||+++....      ......||+.|+|||++  ....++.++|||||||++|+|++|..||............    ..
T Consensus       173 fg~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~  242 (287)
T 4f0f_A          173 FGLSQQSVH------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----MI  242 (287)
T ss_dssp             CTTCBCCSS------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----HH
T ss_pred             CCccccccc------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----HH
Confidence            999875432      13446699999999998  4556788999999999999999999999765543321111    11


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ...+          ........++..+.+++.+||+.||.+|||++++++.|..
T Consensus       243 ~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          243 REEG----------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHSC----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             hccC----------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1110          0111223455789999999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=349.69  Aligned_cols=271  Identities=24%  Similarity=0.323  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            57999999999999999999987 68999999987543221 11234579999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++ +|.+++...+ ..+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cccc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            9975 9999987654 34899999999999999999999999   9999999999999999999999999997654321 


Q ss_pred             ceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc--
Q 041907          207 VSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD--  283 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  283 (380)
                        .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.................  
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred             --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence              12234568999999999987 5689999999999999999999999987665443332222111111111100000  


Q ss_pred             -------cCCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          284 -------PRLRRT---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       284 -------~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                             +.....   ......+..+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence                   000000   00112346788999999999999999999999999965

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-46  Score=348.28  Aligned_cols=267  Identities=23%  Similarity=0.365  Sum_probs=216.2

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEE
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF  114 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  114 (380)
                      +++....++|++.+.||+|+||.||+|.+.      .++.||||.+...... .....+.+|+.++++++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-HHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            344556789999999999999999999865      3678999999755432 345568899999999999999999999


Q ss_pred             EEeCCEEEEEEEeCCCCCHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC
Q 041907          115 LEHGDERIIVVEYVGNGTLREHLDGRG--------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE  186 (380)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~i~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~  186 (380)
                      +......++||||+++++|.+++....        ...+++..++.++.||+.||.|||++|   ++||||||+||+++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence            999999999999999999999997532        134789999999999999999999998   999999999999999


Q ss_pred             CCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 041907          187 KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVT  265 (380)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~  265 (380)
                      ++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........  
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--  250 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--  250 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH--
T ss_pred             CCeEEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH--
Confidence            99999999999986543221 112233457889999999999999999999999999999999 89999765432211  


Q ss_pred             HHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          266 IRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                           .....+..          ......++..+.+++.+||+.+|.+||++.+++++|..+..
T Consensus       251 -----~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 -----RFVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -----HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -----HHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence                 11111110          11222345678999999999999999999999999987644

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.7e-46  Score=343.31  Aligned_cols=275  Identities=25%  Similarity=0.341  Sum_probs=221.0

Q ss_pred             ccccHHHHHHHhcCCCCCCeeeccCceEEEEEEe------CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCce
Q 041907           36 INFSFEEIYKATENFSPANKIGEGGSGTVYKGKL------KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNL  108 (380)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni  108 (380)
                      ..+....+....++|++.+.||+|+||.||+|.+      .+++.||||++...... .....+.+|+.++.++ +||||
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~hp~i   93 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNV   93 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-HHHHHHHHHHHHHHhcccCCCe
Confidence            3445566666789999999999999999999985      24688999999765433 3456788999999999 78999


Q ss_pred             eceEEEEEeCC-EEEEEEEeCCCCCHHHHhccCCCC--------------CCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 041907          109 VKLFGFLEHGD-ERIIVVEYVGNGTLREHLDGRGGN--------------GLELAERLDIAIDVAHALTYLHTYSDPPII  173 (380)
Q Consensus       109 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~--------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~  173 (380)
                      +++++++...+ ..++||||+++++|.+++......              .+++..++.++.||+.||.|||+.|   ++
T Consensus        94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~  170 (316)
T 2xir_A           94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI  170 (316)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            99999987654 589999999999999999875431              2789999999999999999999998   99


Q ss_pred             eccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCC
Q 041907          174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRY  252 (380)
Q Consensus       174 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~  252 (380)
                      |+||||+||+++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccCccceEEECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999986654322 122334568899999999999999999999999999999998 999


Q ss_pred             CCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          253 PIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       253 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ||..........      .....+..          .......+..+.+++.+||+.+|.+|||+.+++++|..+.+..
T Consensus       250 p~~~~~~~~~~~------~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          250 PYPGVKIDEEFC------RRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             SSTTCCCSHHHH------HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcccchhHHHH------HHhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            997655332211      11111100          1112224567899999999999999999999999999887644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=335.63  Aligned_cols=259  Identities=22%  Similarity=0.297  Sum_probs=206.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc--hHHHHHHHHHHHHHhcCCCCceeceEEEEE--eCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD--KCLLLEFKNEILTWSKIEHLNLVKLFGFLE--HGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  120 (380)
                      ..++|.+.+.||+|+||.||+|.+. +++.||+|++......  ......+.+|+.++++++||||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3478999999999999999999986 5899999999754321  123466889999999999999999999984  4567


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .++||||++++ |.+++.......+++..++.++.||+.||.|||++|   ++|+||||+||+++.++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999875 888887766666999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCC--CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQL--TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ...... ........||..|+|||++.+...  +.++||||||+++|+|++|..||.........       ..+..+. 
T Consensus       159 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~-  229 (305)
T 2wtk_C          159 LHPFAA-DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF-------ENIGKGS-  229 (305)
T ss_dssp             CCTTCS-SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------HHHHHCC-
T ss_pred             cCcccc-ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH-------HHHhcCC-
Confidence            643221 122345569999999999987543  67999999999999999999999865432211       1111111 


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                                ......++..+.+++.+||+.||.+||++++++++.|..
T Consensus       230 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  268 (305)
T 2wtk_C          230 ----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR  268 (305)
T ss_dssp             ----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred             ----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence                      011123456788999999999999999999999999865

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.5e-46  Score=363.57  Aligned_cols=260  Identities=20%  Similarity=0.280  Sum_probs=213.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||+|.++ +|+.||+|++....... .....+.+|+.++++++||||+++++++......|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999987 59999999997543221 22456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||++||+|.+++....  ...+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999997654  345999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ...   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.   ..+...       
T Consensus       342 ~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~---~~i~~~-------  408 (543)
T 3c4z_A          342 GQT---KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRVLEQ-------  408 (543)
T ss_dssp             TCC---CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH---HHHHHC-------
T ss_pred             CCc---ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH---HHHhhc-------
Confidence            321   1234579999999999999999999999999999999999999998754322211111   111111       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILWKI  327 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~~~  327 (380)
                       .   ...+..++..+.+||.+||+.||.+||++     ++|++|.|-.
T Consensus       409 -~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~  453 (543)
T 3c4z_A          409 -A---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR  453 (543)
T ss_dssp             -C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred             -c---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence             0   11223345778999999999999999964     8899988753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=5.8e-46  Score=338.17  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|..||+|++...... .....+.+|+.++++++||||+++++++......++|
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            3467999999999999999999986 5899999999765432 2245688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEccccccc
Q 041907          125 VEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFAR  199 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~  199 (380)
                      |||+++++|.+++...  ....+++..++.++.||+.||.|||+.|   ++|+||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999998653  2344999999999999999999999998   9999999999999   456789999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ......    ......||+.|+|||++. ..++.++||||||+++|+|++|..||............    .....    
T Consensus       176 ~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~----~~~~~----  242 (285)
T 3is5_A          176 LFKSDE----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA----TYKEP----  242 (285)
T ss_dssp             C--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCC----
T ss_pred             ecCCcc----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh----ccCCc----
Confidence            654322    123456999999999986 46889999999999999999999999865432211111    00000    


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                           ...  ......+..+.+|+.+||+.||.+|||+.|++++.|-
T Consensus       243 -----~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f  282 (285)
T 3is5_A          243 -----NYA--VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF  282 (285)
T ss_dssp             -----CCC--C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             -----ccc--cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence                 000  0001134678899999999999999999999998874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=337.79  Aligned_cols=256  Identities=21%  Similarity=0.355  Sum_probs=190.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467999999999999999999985 6999999999654321 11245688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.... ..+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.+||+|||++......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999998653 34899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..   ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........       ..        ...
T Consensus       166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~--------~~~  227 (278)
T 3cok_A          166 HE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KV--------VLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C--------CSS
T ss_pred             CC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HH--------hhc
Confidence            21   1224568999999999999999999999999999999999999997654322100       00        000


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .   ...+...+..+.++|.+||+.||.+||++++++++.|..
T Consensus       228 ~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          228 D---YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             C---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             c---cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence            0   111223456789999999999999999999999998843

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=350.50  Aligned_cols=275  Identities=22%  Similarity=0.280  Sum_probs=216.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC--EEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD--ERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  123 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++++++||||+++++++....  ..++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            468999999999999999999987 49999999997543322 2455779999999999999999999998765  7899


Q ss_pred             EEEeCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCceEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI----TEKLRAKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg~~  198 (380)
                      ||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.|   |+||||||+|||+    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999986542 33899999999999999999999999   9999999999999    77788999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhh--------cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHH
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRT--------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT-IRWA  269 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~-~~~~  269 (380)
                      +.......    .....||+.|+|||++.+        ..++.++|||||||++|+|++|..||........... +...
T Consensus       164 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          164 RELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             EECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             eEccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            87654321    234569999999999876        5678899999999999999999999975443222222 1111


Q ss_pred             HHhhccCCccc----------ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          270 MQCLKAGDAIL----------VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       270 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ...........          +.................+.+++.+||+.||++||+++++++.+..+..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            11111111100          0001111223457888999999999999999999999999999998755

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=352.38  Aligned_cols=268  Identities=19%  Similarity=0.285  Sum_probs=205.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            4578999999999999999999986 6999999999766555555677889999999999999999999997653     


Q ss_pred             -EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          120 -ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       120 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                       ..|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence             459999999 78999999863   3899999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH------
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ------  271 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~------  271 (380)
                      +.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....      
T Consensus       176 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          176 RQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             EECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            865432      234568999999999987 6799999999999999999999999987654433222211000      


Q ss_pred             --hhccCCccc---cccc--CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          272 --CLKAGDAIL---VMDP--RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       272 --~~~~~~~~~---~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        .........   .+..  ...........+..+.+|+.+||+.||.+|||++++++|.|-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f  311 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  311 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence              000000000   0000  000001112345678999999999999999999999999884

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-45  Score=370.83  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=206.3

Q ss_pred             CeeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.||+|+||.||+|.+.   .++.||||+++..........++.+|+.+|.+++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            37999999999999763   46789999998765555556789999999999999999999999975 458899999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|.+++....  .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...........
T Consensus       454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            99999997654  3899999999999999999999998   999999999999999999999999999877654333333


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT  289 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+..       ..+..+.          ..
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~----------~~  591 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE----------RM  591 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC----------CC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC----------CC
Confidence            344557899999999999999999999999999999998 99999876543221       1111111          11


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          290 PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       290 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ..+..++..+.+||.+||+.||++||++++|++.|..+..++
T Consensus       592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            223345678999999999999999999999999999887654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-46  Score=346.41  Aligned_cols=276  Identities=20%  Similarity=0.233  Sum_probs=204.8

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch---HHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK---CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++.......   .....+.+|+.++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345689999999999999999999987 58999999997543221   12235779999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.|   ++||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999976 8999887654 34888899999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ......   .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+............
T Consensus       161 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          161 SFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            764322   123345689999999999764 4889999999999999999999999876544332222111110000000


Q ss_pred             cccc---ccC-CC-CCCC-----CHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          279 ILVM---DPR-LR-RTPA-----SNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       279 ~~~~---~~~-~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....   +.. .. ....     ....+..+.+||.+||+.||.+|||++|++++.|-.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence            0000   000 00 0000     122347799999999999999999999999999854

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=340.13  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|++.+.||+|+||.||+|.+. ++.||||.+....    ....+.+|+.++++++||||+++++++.+  ..++|||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            467899999999999999999986 7889999986432    34568899999999999999999998863  4789999


Q ss_pred             eCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc-eEEccccccccccCC
Q 041907          127 YVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR-AKVTDFGFARMSEED  204 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~-~kl~Dfg~~~~~~~~  204 (380)
                      |+++++|.+++..... ..++...++.++.|++.||.|||+.+..+++||||||+||+++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999986543 23788999999999999999999922223999999999999998886 799999998754321


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                            .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  +.+...   .+.       
T Consensus       160 ------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~---~~~-------  221 (307)
T 2eva_A          160 ------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH---NGT-------  221 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHH---TTC-------
T ss_pred             ------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHh---cCC-------
Confidence                  22345999999999999999999999999999999999999999754432211  111111   110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                         ..+....++..+.+++.+||+.+|.+|||++++++.|..+...+.
T Consensus       222 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          222 ---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             ---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence               011222345678999999999999999999999999999877664

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.3e-46  Score=335.47  Aligned_cols=259  Identities=24%  Similarity=0.384  Sum_probs=211.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            4478999999999999999999987 6899999998755432 2345688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++....  .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             EECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            99999999999997643  3899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .. ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||........... .+    ....       
T Consensus       159 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~----~~~~-------  225 (276)
T 2yex_A          159 NR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DW----KEKK-------  225 (276)
T ss_dssp             TE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH-HH----HTTC-------
T ss_pred             cc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH-Hh----hhcc-------
Confidence            21 112344679999999999988775 6789999999999999999999986554322111 00    0000       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         .........+..+.+|+.+||+.||.+|||+++++++.|-
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (276)
T 2yex_A          226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (276)
T ss_dssp             ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             ---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence               0011122345678899999999999999999999998873

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.8e-45  Score=333.97  Aligned_cols=268  Identities=18%  Similarity=0.254  Sum_probs=208.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEE-EeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL-EHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......    ..+.+|+.++..++|++++..+.++ ......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            5588999999999999999999985 6899999987654332    2467899999999988777666554 77888999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEcccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARM  200 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  200 (380)
                      ||||+ +++|.+++..... .+++..++.++.||+.||.|||++|   ++||||||+|||+   +.++.+||+|||++..
T Consensus        83 v~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            99999 8899999985432 4999999999999999999999999   9999999999999   7889999999999987


Q ss_pred             ccCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          201 SEEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       201 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ........    .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            65432211    12235679999999999999999999999999999999999999998755443322222221111110


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      ..          ......++..+.+++.+||+.+|.+||+++++++.+..+.....
T Consensus       238 ~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          238 PI----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             CH----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hh----------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            00          00001224679999999999999999999999999999877654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-45  Score=345.87  Aligned_cols=269  Identities=19%  Similarity=0.243  Sum_probs=202.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD------  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  119 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999986 5899999999876555555677889999999999999999999997654      


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++ +|.+++..    .+++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            78999999975 88888863    3889999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH----------
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA----------  269 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~----------  269 (380)
                      ......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...          
T Consensus       176 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          176 TAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            654321    223457999999999999999999999999999999999999999876543221111000          


Q ss_pred             ------HHhhccC-Cc-----ccccccCCCC--CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 ------MQCLKAG-DA-----ILVMDPRLRR--TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 ------~~~~~~~-~~-----~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ....... ..     ...+......  .......+..+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                  0000000 00     0000000000  001123467899999999999999999999999999964

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-45  Score=362.41  Aligned_cols=258  Identities=27%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch-----------HHHHHHHHHHHHHhcCCCCceeceEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK-----------CLLLEFKNEILTWSKIEHLNLVKLFG  113 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~~~~  113 (380)
                      ..++|.+.+.||+|+||+||+|.+. +++.||||++.......           .....+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            5688999999999999999999987 58899999997653221           22456889999999999999999999


Q ss_pred             EEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ce
Q 041907          114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RA  190 (380)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~  190 (380)
                      ++......++||||+++|+|.+++.....  +++..++.++.||+.||.|||+.|   |+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            99999999999999999999999976543  899999999999999999999999   99999999999999776   69


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  270 (380)
                      ||+|||++.......    ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+    
T Consensus       189 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----  259 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV----  259 (504)
T ss_dssp             EECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred             EEEECCCCEEcCCCC----ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----
Confidence            999999998765432    1234569999999999875 6899999999999999999999999876543321111    


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ..+....       ..+.....+..+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       260 ---~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          260 ---EKGKYYF-------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             ---HHCCCCC-------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ---HcCCCCC-------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence               1111000       0000112356789999999999999999999999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.7e-45  Score=344.74  Aligned_cols=272  Identities=24%  Similarity=0.364  Sum_probs=212.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            467999999999999999999987 58999999997653 3344567889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      ||+++++|.+++...+.  +++..+..++.+++.||.|||+. |   |+|+||||+|||++.++.+||+|||++......
T Consensus       111 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             ECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999999987643  89999999999999999999985 8   999999999999999999999999998754321


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh------------
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC------------  272 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------------  272 (380)
                           ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......            
T Consensus       186 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          186 -----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             -----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             -----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence                 123456999999999999999999999999999999999999999765432221111000000            


Q ss_pred             -----------hccCCccccc---ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          273 -----------LKAGDAILVM---DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       273 -----------~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                                 ..........   .............+..+.+||.+||+.||.+|||++++++|.|-...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                       0000000000   00000011112245678999999999999999999999999997644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=345.70  Aligned_cols=263  Identities=25%  Similarity=0.424  Sum_probs=206.6

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEe
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEH  117 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  117 (380)
                      +.++....++|++.+.||+|+||.||+|.+. +|+.||||++......   ...+.+|+.+++++ +||||+++++++..
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            3344446789999999999999999999986 6999999999765433   34678999999998 89999999999987


Q ss_pred             ------CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 041907          118 ------GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       118 ------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                            ....++||||+++++|.+++.......+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                  568899999999999999998765556899999999999999999999998   99999999999999999999


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI  266 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~  266 (380)
                      |+|||++.......   .......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+
T Consensus       170 l~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             ECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            99999987654321   1123456999999999997     567899999999999999999999999765543221111


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                             .....     +.    .....++..+.+||.+||+.||.+||++++++++.|-.
T Consensus       247 -------~~~~~-----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          247 -------PRNPA-----PR----LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             -------HHSCC-----CC----CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             -------hcCcc-----cc----CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence                   00000     00    11122346789999999999999999999999998854

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-45  Score=336.42  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=214.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..+.|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            4467999999999999999999986 5899999999765433 2356788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++...   .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++......
T Consensus        99 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A           99 MEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             EECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999999753   3899999999999999999999999   999999999999999999999999999866543


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........       ...+..      
T Consensus       173 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~~------  236 (303)
T 3a7i_A          173 QI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------IPKNNP------  236 (303)
T ss_dssp             BC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------HHHSCC------
T ss_pred             cc---ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------hhcCCC------
Confidence            21   12345689999999999999999999999999999999999999976543322111       111100      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                          ......++..+.+|+.+||+.+|.+|||+.++++++|....
T Consensus       237 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          237 ----PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             ----CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             ----CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                11112234678999999999999999999999999996543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=7.6e-45  Score=332.12  Aligned_cols=268  Identities=18%  Similarity=0.257  Sum_probs=211.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEE-EeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL-EHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.......    .+.+|+.+++.++|++++..+.++ ......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            3578999999999999999999985 69999999987654432    477999999999988766666554 67788899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEcccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARM  200 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~  200 (380)
                      ||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|   ++||||||+|||+   +.++.+||+|||++..
T Consensus        83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            99999 889999997543 34999999999999999999999999   9999999999999   4888999999999987


Q ss_pred             ccCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          201 SEEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       201 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ........    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            65433211    11234679999999999999999999999999999999999999998754433222222211111100


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      ..          ......++..+.+++.+||+.+|.+||+++++++.|..+.....
T Consensus       238 ~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          238 PI----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             CH----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ch----------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            00          00011234678999999999999999999999999998877654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=342.27  Aligned_cols=270  Identities=24%  Similarity=0.393  Sum_probs=214.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe-----CCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL-----KDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  119 (380)
                      ..++|++.+.||+|+||.||+|.+     .+|+.||||++.....  .....+.+|+.++++++||||+++++++...+ 
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--HHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            346789999999999999999984     2588999999976533  34567889999999999999999999886543 


Q ss_pred             -EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          120 -ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       120 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                       ..++||||+++++|.+++..... .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CceEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence             67999999999999999987643 4899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHH
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPI---------KERVTIRWA  269 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~---------~~~~~~~~~  269 (380)
                      .................++..|+|||++.+..++.++||||||+++|+|++|..||......         .........
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87765433223333456788999999999999999999999999999999999998643110         000001111


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ......+.          ..+.+..++..+.++|.+||+.+|.+||++.++++.|..++..+
T Consensus       273 ~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          273 IELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhhcCC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11111110          11223345678999999999999999999999999999988765

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-45  Score=335.33  Aligned_cols=264  Identities=27%  Similarity=0.410  Sum_probs=209.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEE-EeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFL-EHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~  121 (380)
                      ..+|++.+.||+|+||.||+|.+.+    +..||+|.+..... ......+.+|+.++++++||||+++++++ ...+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            3568889999999999999999652    23589999876433 33456788999999999999999999986 445678


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|   ++||||||+||+++.++.+||+|||++...
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999997644 34899999999999999999999999   999999999999999999999999999866


Q ss_pred             cCCCcc-eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          202 EEDSAV-SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       202 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ...... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+       ..+.  
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~-------~~~~--  249 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGR--  249 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH-------HTTC--
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hcCC--
Confidence            543221 112234567889999999999999999999999999999999 56666654443321111       1110  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                              ....+..++..+.+++.+||+.+|.+||+++++++.|..+...+.
T Consensus       250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                    011122345679999999999999999999999999999877653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-45  Score=334.20  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|.+.+.||+|+||.||+|.+..    +..||+|.+..... ......+.+|+.++++++||||+++++++... ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            45789999999999999999998652    34699999976543 23456788999999999999999999998654 56


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+||+|||++...
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            89999999999999997654 34899999999999999999999999   999999999999999999999999999866


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+       ..+.   
T Consensus       164 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~-------~~~~---  231 (281)
T 3cc6_A          164 EDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-------EKGD---  231 (281)
T ss_dssp             -----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-------HHTC---
T ss_pred             ccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH-------hcCC---
Confidence            54221  11233457889999999999999999999999999999998 99999765443321111       1110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                             ..+....++..+.+++.+||+.+|.+||++.+++++|..+...
T Consensus       232 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          232 -------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                   0112223456799999999999999999999999999988653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.7e-46  Score=337.07  Aligned_cols=258  Identities=22%  Similarity=0.341  Sum_probs=208.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.......    .....+.+|+.++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999987 59999999987653321    1245688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL----RAKVTDFGF  197 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg~  197 (380)
                      ++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++    .+||+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999997644  3899999999999999999999998   99999999999999877    899999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      +.......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........       .....
T Consensus       159 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------~~~~~  227 (283)
T 3bhy_A          159 AHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN-------ISAVN  227 (283)
T ss_dssp             CEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTTC
T ss_pred             ceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH-------hHhcc
Confidence            98654322    12345689999999999999999999999999999999999999986543221111       11100


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..  ..     .......+..+.+++.+||+.+|.+||++.+++++.|..
T Consensus       228 ~~--~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  270 (283)
T 3bhy_A          228 YD--FD-----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK  270 (283)
T ss_dssp             CC--CC-----HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred             cC--Cc-----chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence            00  00     000012346788999999999999999999999998854

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.3e-46  Score=338.35  Aligned_cols=261  Identities=23%  Similarity=0.332  Sum_probs=210.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERII  123 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  123 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|.+............+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            478999999999999999999987 59999999998766555566778999999999999999999998754  678999


Q ss_pred             EEEeCCCCCHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          124 VVEYVGNGTLREHLDGRG--GNGLELAERLDIAIDVAHALTYLHTYS--DPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ||||+++++|.+++....  ...+++..++.++.|++.||.|||+.+  ..+++|+||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999997542  334899999999999999999999865  2349999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........       ..+..+.. 
T Consensus       165 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~i~~~~~-  233 (279)
T 2w5a_A          165 ILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-------GKIREGKF-  233 (279)
T ss_dssp             HC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCC-
T ss_pred             eeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH-------HHHhhccc-
Confidence            6543221   123456899999999999999999999999999999999999999865432211       11111111 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                               ......++..+.++|.+||+.+|.+||+++++++++|..
T Consensus       234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                     111223457799999999999999999999999988743

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-45  Score=343.66  Aligned_cols=268  Identities=26%  Similarity=0.376  Sum_probs=216.6

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeCC-C-----CEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLKD-G-----SIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFL  115 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  115 (380)
                      +....++|.+.+.||+|+||.||+|.+.. +     ..||+|.+...... .....+.+|+.++.++ +||||+++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-DEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-HHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            33456889999999999999999999752 3     47999999765432 3456788999999999 899999999999


Q ss_pred             EeCCEEEEEEEeCCCCCHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcee
Q 041907          116 EHGDERIIVVEYVGNGTLREHLDGRG------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNIL  183 (380)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~i~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil  183 (380)
                      ...+..++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+.|   ++|+||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999997532            234799999999999999999999998   999999999999


Q ss_pred             eCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcch
Q 041907          184 ITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKE  262 (380)
Q Consensus       184 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~  262 (380)
                      ++.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSN-YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTT-SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             ECCCCeEEECccccccccccccc-eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            99999999999999986544322 122334567889999999999999999999999999999998 9999976544322


Q ss_pred             hhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          263 RVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      ...      ....+.          ....+...+..+.+++.+||+.+|.+|||+.+++++|..+....
T Consensus       276 ~~~------~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          276 FYK------LVKDGY----------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHH------HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHH------HHhcCC----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            111      111110          01112223567899999999999999999999999999886654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-46  Score=350.13  Aligned_cols=261  Identities=24%  Similarity=0.306  Sum_probs=208.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe----CCCCEEEEEEccccCc--chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNKH--DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+    .+|+.||||+++....  .......+.+|+.++.++ .||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            347899999999999999999997    3689999999875421  111223456889999999 699999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ...++||||+++++|.+++.....  +++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999987543  899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      +.......  .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||...........+......   .
T Consensus       207 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~  281 (355)
T 1vzo_A          207 KEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S  281 (355)
T ss_dssp             EECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---C
T ss_pred             eecccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc---c
Confidence            86543221  11234679999999999986  34789999999999999999999999765443322222111110   0


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~~  327 (380)
                                 ..+.+...+..+.+||.+||+.||.+||     +++++++++|..
T Consensus       282 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          282 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             -----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence                       0112233456788999999999999999     999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-45  Score=338.36  Aligned_cols=256  Identities=26%  Similarity=0.346  Sum_probs=209.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||+|++......  ....+.+|+.++++++||||+++++++......++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            4578999999999999999999987 6999999999765332  234578999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  201 (380)
                      |||+++++|.+++...+.  +++..++.++.|++.||.|||+.|   ++|+||||+||++   +.++.++|+|||++...
T Consensus        85 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           85 MQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999999999976543  899999999999999999999998   9999999999999   77889999999998754


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...     ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........       .+..+...  
T Consensus       160 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~i~~~~~~--  225 (304)
T 2jam_A          160 QNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE-------KIKEGYYE--  225 (304)
T ss_dssp             CCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------HHHHCCCC--
T ss_pred             CCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------HHHcCCCC--
Confidence            322     1233568999999999999999999999999999999999999997654322111       11111100  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+.....+..+.++|.+||+.||.+||++++++++.|-.
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          226 -----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             -----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence                 01112233457799999999999999999999999999853

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.7e-45  Score=345.39  Aligned_cols=261  Identities=22%  Similarity=0.350  Sum_probs=210.7

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc------hHHHHHHHHHHHHHhcC-CCCceeceEEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD------KCLLLEFKNEILTWSKI-EHLNLVKLFGF  114 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~niv~~~~~  114 (380)
                      .....++|.+.+.||+|+||.||+|.+. +|+.||||++......      ......+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445578999999999999999999987 6999999998765321      12245578999999999 79999999999


Q ss_pred             EEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          115 LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                      +......++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++|+||||+|||++.++.++|+|
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999998654  3899999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhc------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY------QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~  268 (380)
                      ||++........    .....||+.|+|||++.+.      .++.++|||||||++|+|++|..||.........   ..
T Consensus       244 fG~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~  316 (365)
T 2y7j_A          244 FGFSCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML---RM  316 (365)
T ss_dssp             CTTCEECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HH
T ss_pred             cCcccccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH---HH
Confidence            999987654321    2346799999999998743      5788999999999999999999999765432211   11


Q ss_pred             HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .    ..+...       ...+.....+..+.+||.+||+.||.+||++++++++.|-
T Consensus       317 i----~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          317 I----MEGQYQ-------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             H----HHTCCC-------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             H----HhCCCC-------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence            1    111000       0000001234568899999999999999999999999873

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-45  Score=335.77  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=197.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++............+.++...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4578999999999999999999986 689999999987655444444556666678889999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      |||+++ +|.+++...  ....+++..++.++.||+.||.|||++ |   ++|+||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 888877542  234599999999999999999999997 8   999999999999999999999999999865


Q ss_pred             cCCCcceeeeecccCCccccChhhh----hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYL----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ....    ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.........  +.   .......
T Consensus       161 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~---~~~~~~~  231 (290)
T 3fme_A          161 VDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LK---QVVEEPS  231 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HH---HHHHSCC
T ss_pred             cccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HH---HHhccCC
Confidence            4322    12334699999999996    5667889999999999999999999999754332111  11   1111110


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                                ........+..+.+++.+||+.+|.+|||+.++++|+|-...
T Consensus       232 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          232 ----------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                      011112345678999999999999999999999999986543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-45  Score=337.96  Aligned_cols=264  Identities=20%  Similarity=0.257  Sum_probs=203.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|+.++.+++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3489999999999999999999987 5889999999765432 3345678899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++++|.+++....  .+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.+||+|||++.....
T Consensus       112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999998754  3899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..  ........||+.|+|||++.+..++.++||||||+++|+|++|..||.......    +.   ........     
T Consensus       187 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---~~~~~~~~-----  252 (309)
T 2h34_A          187 EK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV----MG---AHINQAIP-----  252 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----HH---HHHHSCCC-----
T ss_pred             cc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----HH---HHhccCCC-----
Confidence            22  111234569999999999999999999999999999999999999997643221    11   11111000     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHHhhh
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRP-TMKKCAEILWKIRKDF  331 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~eil~~l~~~~~~~  331 (380)
                         ........++..+.++|.+||+.+|.+|| +++++++.++......
T Consensus       253 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          253 ---RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ---CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ---CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence               00111223446788999999999999999 9999999998765543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=348.00  Aligned_cols=262  Identities=27%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             CCCCCCeeeccCceEEEEEEeC--C--CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CCEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK--D--GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GDERII  123 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  123 (380)
                      .|.+.+.||+|+||.||+|.+.  +  +..||+|.+..... ......+.+|+.++++++||||+++++++.. .+..++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            3567789999999999999864  2  23689999875433 2345678999999999999999999998754 567899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++....
T Consensus       169 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999997654 34889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcc-eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          204 DSAV-SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       204 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+       ..+.    
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-------~~~~----  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGR----  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-------HTTC----
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-------HcCC----
Confidence            2211 111234567889999999999999999999999999999999 77888765544322111       1111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                            ....+..++..+.+++.+||+.+|.+||++.++++.|..+...+.
T Consensus       314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                  011122345679999999999999999999999999999887664

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.7e-45  Score=341.17  Aligned_cols=273  Identities=20%  Similarity=0.310  Sum_probs=213.2

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhc--CCCCceeceEEEEEeC
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSK--IEHLNLVKLFGFLEHG  118 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~  118 (380)
                      .......++|.+.+.||+|+||.||+|.+. |+.||||++....     ...+.+|..++..  ++||||+++++++...
T Consensus        35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            334456789999999999999999999985 8999999986432     2346677777776  7999999999999887


Q ss_pred             C----EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeccCCCCceeeCC
Q 041907          119 D----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH--------TYSDPPIIHRDVKASNILITE  186 (380)
Q Consensus       119 ~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlkp~Nil~~~  186 (380)
                      .    ..++||||+++|+|.+++....   +++..++.++.|++.||.|||        +.+   ++|+||||+|||++.
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK  182 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred             CCccceeEEEEeecCCCcHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence            6    7899999999999999997643   899999999999999999999        778   999999999999999


Q ss_pred             CCceEEccccccccccCCCccee-eeecccCCccccChhhhhhcC------CCCccchhhHHHHHHHHHhC---------
Q 041907          187 KLRAKVTDFGFARMSEEDSAVSH-ISTQVKGTAGYLDPDYLRTYQ------LTEKSDVYSFGVLLVEMMTG---------  250 (380)
Q Consensus       187 ~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlGvil~elltg---------  250 (380)
                      ++.+||+|||++........... ......||+.|+|||++.+..      ++.++|||||||++|+|++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            99999999999987654332211 224457999999999998763      33689999999999999999         


Q ss_pred             -CCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          251 -RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       251 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                       ..||...........  ..........    ..+..........++..+.+|+.+||+.+|.+|||+.+|+++|..+.+
T Consensus       263 ~~~p~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVE--EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCTTTTTSCSSCCHH--HHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCccccCcCcccHH--HHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence             788876543221111  1111111110    111111111234677889999999999999999999999999999876


Q ss_pred             hh
Q 041907          330 DF  331 (380)
Q Consensus       330 ~~  331 (380)
                      +.
T Consensus       337 ~~  338 (342)
T 1b6c_B          337 QE  338 (342)
T ss_dssp             TT
T ss_pred             Hh
Confidence            53

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=8.8e-46  Score=336.60  Aligned_cols=252  Identities=22%  Similarity=0.352  Sum_probs=206.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++............+.+|+..+.++ +||||+++++++...+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999987 699999999987655555566788999999998 99999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC--------------
Q 041907          124 VVEYVGNGTLREHLDGRGG--NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK--------------  187 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~--------------  187 (380)
                      ||||+++++|.+++.....  ..+++..++.++.||+.||.|||++|   ++|+||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999976421  34899999999999999999999999   9999999999999844              


Q ss_pred             -----CceEEccccccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 041907          188 -----LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK  261 (380)
Q Consensus       188 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~  261 (380)
                           ..+||+|||++......       ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+...... 
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-
T ss_pred             ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-
Confidence                 47999999998865532       223489999999999876 5668999999999999999999876533211 


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                               .....+..          ...+..++..+.+++.+||+.||.+|||+.+++++.|-.
T Consensus       238 ---------~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          238 ---------HEIRQGRL----------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             ---------HHHHTTCC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             ---------HHHHcCCC----------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence                     11111110          111223456789999999999999999999999998743

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.2e-45  Score=340.82  Aligned_cols=265  Identities=27%  Similarity=0.364  Sum_probs=210.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||++..... ......+.+|+.++++++||||+++++++....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4578999999999999999999842      477899999975433 334557889999999999999999999999999


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceE
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGG-----NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAK  191 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~k  191 (380)
                      ..++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.|   ++|+||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999987542     34889999999999999999999998   999999999999994   44699


Q ss_pred             EccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 041907          192 VTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  270 (380)
                      |+|||++........ ........||+.|+|||++.+..++.++||||||+++|+|++ |..||........       .
T Consensus       184 l~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------L  255 (327)
T ss_dssp             ECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------H
T ss_pred             ECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-------H
Confidence            999999976543221 112234568999999999999999999999999999999998 9999976543221       1


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .....+..          ......++..+.++|.+||+.+|.+||++.+++++++.+.....
T Consensus       256 ~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          256 EFVTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHhcCCC----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence            11111110          11122345678999999999999999999999999999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-45  Score=354.12  Aligned_cols=276  Identities=20%  Similarity=0.254  Sum_probs=205.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----D  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  119 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+|++++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4689999999999999999999987 588999999987655555567789999999999999999999998766     5


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..|+||||+. ++|.+++....  .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            7899999996 59999997654  3899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcce-------------------eeeecccCCccccChhhh-hhcCCCCccchhhHHHHHHHHHhCCCCCC----
Q 041907          200 MSEEDSAVS-------------------HISTQVKGTAGYLDPDYL-RTYQLTEKSDVYSFGVLLVEMMTGRYPIE----  255 (380)
Q Consensus       200 ~~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltg~~p~~----  255 (380)
                      .........                   .......||+.|+|||++ .+..++.++|||||||++|||++|..||.    
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            765432110                   123456799999999986 56679999999999999999998655443    


Q ss_pred             -------CCCCcc--------------hhhHHHHHHHhhccCCc-----------ccccccCCCCCCC-----CHHHHHH
Q 041907          256 -------SKKPIK--------------ERVTIRWAMQCLKAGDA-----------ILVMDPRLRRTPA-----SNMAVEK  298 (380)
Q Consensus       256 -------~~~~~~--------------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~-----~~~~~~~  298 (380)
                             +.....              ....+......+.....           ...+.......+.     ....+..
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                   222100              01111111111100000           0000000000000     0124577


Q ss_pred             HHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          299 ILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       299 l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      +.+||.+||+.||.+|||++|+++|+|-.
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence            89999999999999999999999999854

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=340.60  Aligned_cols=274  Identities=22%  Similarity=0.326  Sum_probs=203.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-----CCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-----GDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  120 (380)
                      ..++|++.+.||+|+||.||+|.+. |+.||||++.......   .....++..+..++||||+++++.+..     ...
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~---~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGGHHH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccchhh---HHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            3578999999999999999999874 8999999997543221   122344445556899999999986543     236


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeeeccCCCCceeeCCCCceE
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY---------SDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                      .++||||+++|+|.+++....   .++..++.++.||+.||.|||+.         |   |+||||||+|||++.++.+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            789999999999999997654   68899999999999999999988         7   99999999999999999999


Q ss_pred             EccccccccccCCCcc-----eeeeecccCCccccChhhhhh-------cCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 041907          192 VTDFGFARMSEEDSAV-----SHISTQVKGTAGYLDPDYLRT-------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKP  259 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~  259 (380)
                      |+|||++.........     ........||+.|+|||++.+       ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999876532211     111234569999999999987       4567899999999999999999877644332


Q ss_pred             cchh-hH----------HHHHHHhhccCCcccccccCC-CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          260 IKER-VT----------IRWAMQCLKAGDAILVMDPRL-RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       260 ~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .... ..          .............    .+.. ........++..+.+||.+||+.||.+|||++|+++.|..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            1110 00          0000011111100    0111 11122345777899999999999999999999999999999


Q ss_pred             Hhhhhc
Q 041907          328 RKDFRE  333 (380)
Q Consensus       328 ~~~~~~  333 (380)
                      ......
T Consensus       317 l~~~~~  322 (336)
T 3g2f_A          317 MMIWER  322 (336)
T ss_dssp             HHCCCC
T ss_pred             HHHHHh
Confidence            876643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.3e-45  Score=343.99  Aligned_cols=274  Identities=22%  Similarity=0.290  Sum_probs=211.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----D  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++.+++||||+++++++...     .
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC-cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            4578999999999999999999987 588999999975432 33456788999999999999999999998654     4


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+.+ +|.+++....   +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++.
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEcccCc-CHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            68999999975 9999997643   899999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ................||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+............
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            765433222223456799999999987654 4899999999999999999999999877655443332211000000000


Q ss_pred             c--------cccc--cCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          279 I--------LVMD--PRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       279 ~--------~~~~--~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .        ....  +.....+   .....+..+.+||.+||+.||.+|||++++++|.|-.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  318 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE  318 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence            0        0000  0000000   0012346789999999999999999999999999854

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-46  Score=356.17  Aligned_cols=248  Identities=13%  Similarity=0.173  Sum_probs=194.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccC-cchHHHHHHHHHH---HHHhcCCCCceeceE-------EE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEI---LTWSKIEHLNLVKLF-------GF  114 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  114 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.... ........+.+|+   ..+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            356888999999999999999975 59999999997542 2223456788999   555666899999998       77


Q ss_pred             EEeCCE-----------------EEEEEEeCCCCCHHHHhccCCCC-----CCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 041907          115 LEHGDE-----------------RIIVVEYVGNGTLREHLDGRGGN-----GLELAERLDIAIDVAHALTYLHTYSDPPI  172 (380)
Q Consensus       115 ~~~~~~-----------------~~lv~e~~~~~~L~~~i~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  172 (380)
                      +...+.                 .++||||+ +|+|.+++...+..     .+++..++.++.||+.||.|||++|   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            765542                 78999999 67999999864321     1335788889999999999999999   9


Q ss_pred             eeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhc-----------CCCCccchhhHH
Q 041907          173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-----------QLTEKSDVYSFG  241 (380)
Q Consensus       173 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG  241 (380)
                      +||||||+|||++.++.+||+|||+++....      ......| +.|+|||++.+.           .++.++||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            9999999999999999999999999985332      2344567 999999999988           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHH
Q 041907          242 VLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA  321 (380)
Q Consensus       242 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil  321 (380)
                      |++|+|++|..||...........               .. ..      ...++..+.+||.+||+.||.+||++.+++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~---------------~~-~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l  358 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEW---------------IF-RS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  358 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGG---------------GG-SS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred             HHHHHHHHCCCCCcccccccchhh---------------hh-hh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence            999999999999976443221100               00 00      012346789999999999999999999999


Q ss_pred             HHHHHH
Q 041907          322 EILWKI  327 (380)
Q Consensus       322 ~~l~~~  327 (380)
                      ++.|-.
T Consensus       359 ~hp~f~  364 (377)
T 3byv_A          359 ETPEYE  364 (377)
T ss_dssp             TSHHHH
T ss_pred             hChHHH
Confidence            988743

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.3e-45  Score=349.89  Aligned_cols=269  Identities=21%  Similarity=0.255  Sum_probs=209.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC------CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI------EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~  118 (380)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++....   .....+.+|+.++..+      .|+||+++++++...
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            3467999999999999999999987 48999999997542   2344566777777766      577999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--eEEcccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR--AKVTDFG  196 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg  196 (380)
                      ...++||||+. ++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||
T Consensus       172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999996 59999998877666999999999999999999999998   999999999999999887  9999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc-
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA-  275 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  275 (380)
                      ++......      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......... 
T Consensus       248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          248 SSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             TCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            99764432      23456999999999999999999999999999999999999999876554332222111000000 


Q ss_pred             ----C-Cccccccc---------------------------CCCCCCCC--------HHHHHHHHHHHHHhcCCCCCCCC
Q 041907          276 ----G-DAILVMDP---------------------------RLRRTPAS--------NMAVEKILGLADVCLAPTRQSRP  315 (380)
Q Consensus       276 ----~-~~~~~~~~---------------------------~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RP  315 (380)
                          . .....++.                           .....+..        ......+.+||.+||+.||.+||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence                0 00000000                           00000000        01146688999999999999999


Q ss_pred             ChHHHHHHHHHH
Q 041907          316 TMKKCAEILWKI  327 (380)
Q Consensus       316 t~~eil~~l~~~  327 (380)
                      |++|+++|.|-.
T Consensus       402 ta~e~L~Hpw~~  413 (429)
T 3kvw_A          402 TPGQALRHPWLR  413 (429)
T ss_dssp             CHHHHHTSTTTC
T ss_pred             CHHHHhCChhhc
Confidence            999999999954

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.7e-46  Score=367.96  Aligned_cols=261  Identities=29%  Similarity=0.443  Sum_probs=215.3

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +....++|++.+.||+|+||.||+|.+.++..||||+++.....   ...+.+|+.+|++++||||+++++++.. ...+
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            34456789999999999999999999987788999999865433   3568899999999999999999999876 6789


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |||||+++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            9999999999999998654445899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...  ........++..|+|||++.+..++.++|||||||+||||++ |..||......+..       ..+..+.    
T Consensus       415 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-------~~i~~~~----  481 (535)
T 2h8h_A          415 DNE--YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGY----  481 (535)
T ss_dssp             CHH--HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-------HHHHTTC----
T ss_pred             CCc--eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC----
Confidence            321  111223457889999999999999999999999999999999 99999765432211       1111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                            ..+....++..+.+||.+||+.+|.+|||+++|++.|..+..
T Consensus       482 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          482 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                  111223456789999999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.5e-46  Score=337.05  Aligned_cols=252  Identities=25%  Similarity=0.437  Sum_probs=207.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-------  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  117 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++.....      .+.+|+.++++++||||+++++++..       
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            4467999999999999999999987 699999999976532      35689999999999999999998854       


Q ss_pred             ---------CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          118 ---------GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       118 ---------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                               ....++||||+++++|.+++.......+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                     445799999999999999998765556999999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~  268 (380)
                      .+||+|||++........    .....||+.|+|||++.+..++.++||||||+++|+|++|..|+....     .    
T Consensus       160 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~----  226 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K----  226 (284)
T ss_dssp             EEEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H----
T ss_pred             CEEECcchhheecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H----
Confidence            999999999987654321    234569999999999999999999999999999999999998874211     0    


Q ss_pred             HHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          269 AMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      .......+.             .....+..+.++|.+||+.||.+||++.+++++++.+.+..+
T Consensus       227 ~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          227 FFTDLRDGI-------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHHTTC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHHhhccc-------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            111111110             111234568899999999999999999999999998866543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=343.23  Aligned_cols=268  Identities=19%  Similarity=0.221  Sum_probs=211.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC---------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceec-------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD---------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK-------  110 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-------  110 (380)
                      .++|.+.+.||+|+||.||+|.+..         ++.||||++...       ..+.+|+.++++++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            4789999999999999999999863         788999998754       24678999999999999887       


Q ss_pred             --------eEEEEEe-CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 041907          111 --------LFGFLEH-GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASN  181 (380)
Q Consensus       111 --------~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~N  181 (380)
                              +++++.. ....++||||+ +++|.+++.......+++..++.++.||+.||.|||++|   |+||||||+|
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N  189 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN  189 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence                    6777776 78899999999 999999998764455999999999999999999999998   9999999999


Q ss_pred             eeeCCCC--ceEEccccccccccCCCccee----eeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCC
Q 041907          182 ILITEKL--RAKVTDFGFARMSEEDSAVSH----ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE  255 (380)
Q Consensus       182 il~~~~~--~~kl~Dfg~~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  255 (380)
                      ||++.++  .+||+|||+++..........    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  899999999987653321111    1134579999999999999999999999999999999999999998


Q ss_pred             CCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          256 SKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                      ..........  ......... .....+..    ......+..+.+|+.+||+.||.+||++++|++.|..+.....
T Consensus       270 ~~~~~~~~~~--~~~~~~~~~-~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          270 NCLPNTEDIM--KQKQKFVDK-PGPFVGPC----GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGTTCHHHHH--HHHHHHHHS-CCCEECTT----SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCCcCHHHHH--HHHHhccCC-hhhhhhhc----cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            6543222111  111111110 00011110    0111234679999999999999999999999999999887664

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-45  Score=332.46  Aligned_cols=255  Identities=23%  Similarity=0.373  Sum_probs=203.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+..++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3478999999999999999999987 6999999998654321 1234568899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++++|.+++.....  +++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.++|+|||++.....
T Consensus        89 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999999977543  899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ..    ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........       .....+.     
T Consensus       164 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~-----  227 (276)
T 2h6d_A          164 GE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF-------KKIRGGV-----  227 (276)
T ss_dssp             -----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCC-----
T ss_pred             Cc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH-------HHhhcCc-----
Confidence            22    1234568999999999998776 58999999999999999999999764432211       1111110     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ...+...+..+.+++.+||+.||.+|||+++++++.|-.
T Consensus       228 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~  266 (276)
T 2h6d_A          228 ------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK  266 (276)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             ------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence                  011122346788999999999999999999999998853

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=335.82  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=206.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||.+.....    ...+.+|+.++.+++||||+++++++...+..++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            4578999999999999999999987 599999999976543    24578999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.... ..+++..++.++.+|+.||.|||+.|   ++|+||||+||+++.++.+||+|||++......
T Consensus       103 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             eecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999999997433 34899999999999999999999999   999999999999999999999999999765432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..   ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+       ....       
T Consensus       179 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-------  241 (314)
T 3com_A          179 MA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------PTNP-------  241 (314)
T ss_dssp             BS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSC-------
T ss_pred             cc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------hcCC-------
Confidence            11   123456899999999999999999999999999999999999999765433221110       0000       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ..........+..+.+||.+||+.||.+|||+.+++++.|-.
T Consensus       242 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          242 -PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             -CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             -CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence             000112223456789999999999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-45  Score=341.62  Aligned_cols=261  Identities=28%  Similarity=0.395  Sum_probs=209.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCE--EEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSI--VAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|++.+.||+|+||.||+|.+. +|..  +|+|.+..... ......+.+|+.++.++ +||||+++++++...+..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            3478999999999999999999976 4664  49998875332 22345688999999999 899999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC
Q 041907          122 IIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK  187 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~  187 (380)
                      ++||||+++++|.+++....              ...+++..++.++.||+.||.|||++|   ++||||||+|||++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCC
Confidence            99999999999999997653              235899999999999999999999999   9999999999999999


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~  266 (380)
                      +.+||+|||+++.....    .......+++.|+|||++.+..++.++|||||||++|+|++ |..||........    
T Consensus       179 ~~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~----  250 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----  250 (327)
T ss_dssp             GCEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred             CeEEEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH----
Confidence            99999999998743221    11223457889999999999999999999999999999998 9999976543221    


Q ss_pred             HHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                         ......+.          .......++..+.+||.+||+.+|.+||++++++++|..+....
T Consensus       251 ---~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          251 ---YEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             ---HHHGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---HHHhhcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence               11111110          01112234577999999999999999999999999999887654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.9e-44  Score=350.17  Aligned_cols=265  Identities=18%  Similarity=0.263  Sum_probs=212.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC-CceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.......    .+..|+.++..+.| +++..+..++......+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            578999999999999999999985 69999999987654432    36789999999977 5666666777888999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee---CCCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI---TEKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~  201 (380)
                      |||+ +++|.+++.... ..+++..++.++.||+.||.|||++|   |+||||||+||||   +.++.+||+|||+++.+
T Consensus        82 me~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            9999 889999998543 34999999999999999999999999   9999999999999   58899999999999876


Q ss_pred             cCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          202 EEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       202 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .......    .......||+.|+|||++.+..++.++|||||||+||+|++|..||...........+...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            5433221    112356799999999999999999999999999999999999999987665443333332222211110


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      ...          ....++.++.+||..||+.+|.+||++++|++.|..+...
T Consensus       237 ~~~----------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          237 IEA----------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHH----------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHH----------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            000          0012346799999999999999999999999999988553

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.1e-46  Score=338.34  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-C-------CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-G-------SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      .++|.+.+.||+|+||.||+|.+.. +       ..||+|++.....  .....+.+|+.++++++||||+++++++...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            4689999999999999999998763 4       4699999865433  2356788999999999999999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc--------e
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR--------A  190 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~--------~  190 (380)
                      +..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+++   ++||||||+|||++.++.        +
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999998754 23899999999999999999999999   999999999999998887        9


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      ||+|||++......       ....||..|+|||++.+ ..++.++|||||||++|+|++|..|+...........    
T Consensus       161 kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~----  229 (289)
T 4fvq_A          161 KLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ----  229 (289)
T ss_dssp             EECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----
T ss_pred             eeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH----
Confidence            99999998754321       23457899999999987 7789999999999999999996555433322211111    


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                        .....       ..     .+...+..+.+|+.+||+.||.+|||+++++++|..+..
T Consensus       230 --~~~~~-------~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          230 --FYEDR-------HQ-----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             --HHHTT-------CC-----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             --Hhhcc-------CC-----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              00000       00     001113458899999999999999999999999986644

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.2e-45  Score=346.32  Aligned_cols=267  Identities=22%  Similarity=0.253  Sum_probs=208.6

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC--------CCceeceEEEEE-
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--------HLNLVKLFGFLE-  116 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~-  116 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...   ......+.+|+.+++.++        |+||+++++++. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            478999999999999999999986 5889999999753   233456789999999885        788999999987 


Q ss_pred             ---eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCC----
Q 041907          117 ---HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKL----  188 (380)
Q Consensus       117 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~----  188 (380)
                         .....++||||+ +++|.+.+.......+++..++.++.||+.||.|||++ |   |+||||||+|||++.++    
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence               456789999999 56787777666555699999999999999999999997 8   99999999999999775    


Q ss_pred             ---------------------------------------------ceEEccccccccccCCCcceeeeecccCCccccCh
Q 041907          189 ---------------------------------------------RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP  223 (380)
Q Consensus       189 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aP  223 (380)
                                                                   .+||+|||++......      .....||+.|+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aP  262 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCC
Confidence                                                         7999999999865432      2345689999999


Q ss_pred             hhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch---hhHHHHHHHhhcc--------CCcc-cccccC--C---
Q 041907          224 DYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE---RVTIRWAMQCLKA--------GDAI-LVMDPR--L---  286 (380)
Q Consensus       224 E~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~--------~~~~-~~~~~~--~---  286 (380)
                      |++.+..++.++|||||||++|+|++|..||........   ...+.........        +... ..+...  .   
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            999999999999999999999999999999986553321   1111111111100        0000 000000  0   


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          287 -------------RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       287 -------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                                   .........+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  395 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL  395 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence                         0112346677889999999999999999999999999873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-45  Score=334.57  Aligned_cols=254  Identities=29%  Similarity=0.438  Sum_probs=204.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-CEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-DERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. |+.||||++....    ....+.+|+.++++++||||+++++++... +..++|
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            4578999999999999999999986 8899999997643    245688999999999999999999987554 478999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.......+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999999998654434788999999999999999999998   999999999999999999999999998754432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                            .....+++.|+|||++.+..++.++||||||+++|+|++ |..||..........       ....+.      
T Consensus       171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~-------~~~~~~------  231 (278)
T 1byg_A          171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGY------  231 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-------HHTTTC------
T ss_pred             ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhcCC------
Confidence                  123357889999999999999999999999999999998 999997654332111       111110      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                          .......++..+.+++.+||+.+|.+||++.++++.|..++..
T Consensus       232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          232 ----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                0112233457799999999999999999999999999988653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.4e-46  Score=354.70  Aligned_cols=259  Identities=25%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc------hHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD------KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ..++|.+.+.||+|+||.||+|.+. +++.||||++......      ......+.+|+.+|++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            5689999999999999999999987 5899999998754321      1122347899999999999999999999854 


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC---ceEEccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL---RAKVTDF  195 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~---~~kl~Df  195 (380)
                      +..++||||+++++|.+++....  .+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence            56899999999999999987654  3899999999999999999999998   99999999999997554   5999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhh---cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT---YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      |+++......    ......||+.|+|||++.+   ..++.++|||||||++|+|++|..||...........      .
T Consensus       287 G~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~------~  356 (419)
T 3i6u_A          287 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD------Q  356 (419)
T ss_dssp             STTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH------H
T ss_pred             ccceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH------H
Confidence            9998765322    2345679999999999853   6678899999999999999999999976543322111      1


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ...+....       ........+..+.+||.+||+.||.+||+++++++|.|-.
T Consensus       357 i~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          357 ITSGKYNF-------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             HHTTCCCC-------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HhcCCCCC-------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence            11110000       0000112356789999999999999999999999999853

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.5e-46  Score=342.27  Aligned_cols=273  Identities=22%  Similarity=0.352  Sum_probs=209.5

Q ss_pred             CCccccccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC--CCcee
Q 041907           32 QATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--HLNLV  109 (380)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv  109 (380)
                      ..+..++.++.+....++|++.+.||+|+||.||+|.+.+|+.||||++............+.+|+.++.+++  |+||+
T Consensus        12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv   91 (313)
T 3cek_A           12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII   91 (313)
T ss_dssp             --------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred             cCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence            3344455556666677899999999999999999999988999999999876655566677899999999997  59999


Q ss_pred             ceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc
Q 041907          110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR  189 (380)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~  189 (380)
                      ++++++...+..++||| +.+++|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||||+|||+++ +.
T Consensus        92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A           92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             CEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TE
T ss_pred             EEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-Ce
Confidence            99999999999999999 55789999998754  3899999999999999999999998   999999999999975 89


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhh-----------cCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-----------YQLTEKSDVYSFGVLLVEMMTGRYPIESKK  258 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~elltg~~p~~~~~  258 (380)
                      +||+|||++........ ........||+.|+|||++.+           ..++.++||||||+++|+|++|..||....
T Consensus       165 ~kL~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             EEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             EEEeeccccccccCccc-cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            99999999986654321 112234569999999999976           468889999999999999999999997543


Q ss_pred             CcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          259 PIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....  .   .........         . ...+...+..+.+++.+||+.||.+||++++++++.|..
T Consensus       244 ~~~~--~---~~~~~~~~~---------~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~  297 (313)
T 3cek_A          244 NQIS--K---LHAIIDPNH---------E-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  297 (313)
T ss_dssp             SHHH--H---HHHHHCTTS---------C-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHH--H---HHHHHhccc---------c-cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence            3211  1   111111110         0 011112246788999999999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-45  Score=342.26  Aligned_cols=263  Identities=20%  Similarity=0.284  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEe--CCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEH--GDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~  122 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....     ...+.+|+.++++++ ||||+++++++..  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            467999999999999999999985 68999999987533     345789999999997 9999999999988  67889


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMS  201 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  201 (380)
                      +||||+++++|.+++..     ++...++.++.||+.||.|||++|   ++||||||+|||++.++ .+||+|||+++..
T Consensus       110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999999999999864     788999999999999999999999   99999999999999776 8999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHH------HHHhh
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER-VTIRW------AMQCL  273 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~-~~~~~------~~~~~  273 (380)
                      .....    .....||..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..+..      .....
T Consensus       182 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          182 HPGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             CTTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCCc----cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHH
Confidence            54322    234568999999999987 67899999999999999999999999654332111 11100      00000


Q ss_pred             ccCCcc------cccc-------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          274 KAGDAI------LVMD-------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       274 ~~~~~~------~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ......      ....       ............+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            000000      0000       0000011122246789999999999999999999999999884

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=330.39  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=208.2

Q ss_pred             CCCCCCeeeccCceEEEEEEeCC-C---CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE-EE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKD-G---SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER-II  123 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~l  123 (380)
                      .|.+.+.||+|+||.||+|.+.+ +   ..||+|.+..... ......+.+|+.++++++||||+++++++...+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            45566899999999999998642 2   3799999875433 33456788999999999999999999999766555 99


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|   ++|+||||+||+++.++.+||+|||+++....
T Consensus       101 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             EECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999997743 34899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcc-eeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          204 DSAV-SHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP-IESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       204 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .... ........+|..|+|||.+.+..++.++||||||+++|+|++|..| |...........       ...+.    
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~-------~~~~~----  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF-------LAQGR----  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH-------HHTTC----
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH-------hhcCC----
Confidence            2211 1122345688999999999999999999999999999999996555 444333221111       11110    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                            ..+....++..+.+++.+||+.+|.+|||++++++.+..+...+.
T Consensus       246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                  111222345679999999999999999999999999999988664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=344.14  Aligned_cols=270  Identities=18%  Similarity=0.218  Sum_probs=202.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCcchH---------HHHHHHHHHHHHhcCCCCceeceE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKHDKC---------LLLEFKNEILTWSKIEHLNLVKLF  112 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~  112 (380)
                      ..++|.+.+.||+|+||.||+|.+.    .+..||||++........         ....+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3478999999999999999999986    478899999876532211         112356788899999999999999


Q ss_pred             EEEEe----CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          113 GFLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       113 ~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      +++..    ....++||||+ +++|.+++...+  .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            99988    78899999999 999999998765  4999999999999999999999998   99999999999999887


Q ss_pred             --ceEEccccccccccCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 041907          189 --RAKVTDFGFARMSEEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE  262 (380)
Q Consensus       189 --~~kl~Dfg~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~  262 (380)
                        .+||+|||+++.+.......    .......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              99999999998764322111    111345799999999999999999999999999999999999999964322211


Q ss_pred             hhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          263 RVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      ...  ......... ....+....    ....++..+.+++.+||+.+|.+||++++|++.|+.+.
T Consensus       269 ~~~--~~~~~~~~~-~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          269 AVQ--TAKTNLLDE-LPQSVLKWA----PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHH--HHHHHHHHT-TTHHHHHHS----CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHH--HHHHhhccc-ccHHHHhhc----cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111  111111100 000000000    00124467999999999999999999999999997653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=329.87  Aligned_cols=257  Identities=20%  Similarity=0.294  Sum_probs=205.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|.....||+|+||.||+|.+. +++.||||.+.....  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            45556669999999999999986 588999999876543  234568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEccccccccccCC
Q 041907          127 YVGNGTLREHLDGRG-GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGFARMSEED  204 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~  204 (380)
                      |+++++|.+++.... ...+++..++.++.|++.||.|||+.|   ++|+||||+||+++. ++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999999998653 234678899999999999999999998   999999999999987 899999999999865432


Q ss_pred             CcceeeeecccCCccccChhhhhhcC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQ--LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .   .......||+.|+|||++.+..  ++.++||||||+++|+|++|..||........... .  .....       .
T Consensus       177 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~--~~~~~-------~  243 (295)
T 2clq_A          177 N---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-K--VGMFK-------V  243 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-H--HHHHC-------C
T ss_pred             C---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-h--hcccc-------c
Confidence            1   1123456899999999998754  78999999999999999999999975433221110 0  00000       0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ....+...+..+.+++.+||+.||.+||++.+++++.|..
T Consensus       244 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          244 -----HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             -----cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence                 0112223456789999999999999999999999988753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-45  Score=340.81  Aligned_cols=273  Identities=24%  Similarity=0.291  Sum_probs=208.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEE----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLE----  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  116 (380)
                      ..++|++.+.||+|+||.||+|.+.  +|+.||+|++............+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984  588999999975433221122345666666655   8999999999987    


Q ss_pred             -eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccc
Q 041907          117 -HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDF  195 (380)
Q Consensus       117 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Df  195 (380)
                       .....++||||++ ++|.+++.......+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence             5567899999997 59999998876666999999999999999999999999   999999999999999999999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      |++.......    ......||..|+|||++.+..++.++|||||||++|+|++|..||...........+.........
T Consensus       165 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             cccccccCCC----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            9998654321    123456899999999999999999999999999999999999999876543322221111000000


Q ss_pred             CCccc-------cccc-C-CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          276 GDAIL-------VMDP-R-LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       276 ~~~~~-------~~~~-~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .....       .+.. . ..........+..+.+|+.+||+.||.+||++.++++|.|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  300 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  300 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence            00000       0000 0 00001112345678899999999999999999999999884

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.7e-45  Score=341.55  Aligned_cols=259  Identities=23%  Similarity=0.333  Sum_probs=181.7

Q ss_pred             HhcCCCCCC-eeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe----CC
Q 041907           46 ATENFSPAN-KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GD  119 (380)
Q Consensus        46 ~~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~  119 (380)
                      ..++|.+.+ .||+|+||.||+|.+. +|+.||||++....   ..   ..+....++.+.||||+++++++..    ..
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            568899855 6999999999999987 69999999986532   11   1223334566799999999999876    45


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEcccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFG  196 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg  196 (380)
                      ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++|   ++||||||+|||++.+   +.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            5899999999999999999876667999999999999999999999998   9999999999999864   459999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++......     ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............   ....+
T Consensus       177 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~  248 (336)
T 3fhr_A          177 FAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRLG  248 (336)
T ss_dssp             TCEEC---------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred             cceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhcc
Confidence            99765432     12345689999999999988899999999999999999999999976543221110000   00000


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                            ... ...+....++..+.+||.+||+.||.+|||++++++++|-..
T Consensus       249 ------~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          249 ------QYG-FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             --------C-CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ------ccc-cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence                  000 011122345677999999999999999999999999999654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-45  Score=336.34  Aligned_cols=263  Identities=25%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--CCC--EEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--DGS--IVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|++.+.||+|+||.||+|.+.  +++  .||||++..... .......+.+|+.++++++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            4578999999999999999999864  233  699999876532 2334567889999999999999999999998765 


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+||+|||++..
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            789999999999999997653 23899999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ...............+|..|+|||++.+..++.++||||||+++|+|++ |..||..........       ......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------~~~~~~--  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------KIDKEG--  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-------HHHTSC--
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH-------HHHccC--
Confidence            6554333333345568889999999999889999999999999999999 999997654322111       111100  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                             ...+....++..+.+++.+||+.+|.+||++.++++.|..+..
T Consensus       242 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                   0112223456789999999999999999999999999987754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4e-46  Score=351.06  Aligned_cols=269  Identities=20%  Similarity=0.275  Sum_probs=193.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  118 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            4589999999999999999999976 589999999976655555566788999999999999999999998654      


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ...++|||++ +++|.+++...   .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            5679999999 67999998763   3999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc--
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA--  275 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  275 (380)
                      +.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.........  
T Consensus       180 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          180 RHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             cccccc------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            864421      234569999999999987 67899999999999999999999999876654332222111000000  


Q ss_pred             ------CCcccccccCCCCCCCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          276 ------GDAILVMDPRLRRTPAS-----NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       276 ------~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ......+..........     ...+..+.+||.+||+.||.+|||++++++|.|-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence                  00000000000000000     12246788999999999999999999999998843

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-45  Score=337.87  Aligned_cols=271  Identities=23%  Similarity=0.357  Sum_probs=193.5

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++.+++||||+++++++...+..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            35689999999999999999999976 5899999998754322 234567899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          124 VVEYVGNGTLREHLDGR------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      ||||+++++|.+++...      ....+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998741      2334899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcc--eeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhc
Q 041907          198 ARMSEEDSAV--SHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK  274 (380)
Q Consensus       198 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      +.........  ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........   .   ..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~---~~  241 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---T---LQ  241 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---H---HT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---H---hc
Confidence            9865432211  112234569999999999976 5789999999999999999999999987654332111   1   10


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       ..... ..............+..+.+++.+||+.||.+||++.+++++.|-.
T Consensus       242 -~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  292 (303)
T 2vwi_A          242 -NDPPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ  292 (303)
T ss_dssp             -SSCCC-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred             -cCCCc-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence             00000 0000000111122346788999999999999999999999998743

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9e-45  Score=341.43  Aligned_cols=279  Identities=19%  Similarity=0.214  Sum_probs=209.4

Q ss_pred             cccHHHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCc---------chHHHHHHHHHHHHHhcCCCCc
Q 041907           37 NFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKH---------DKCLLLEFKNEILTWSKIEHLN  107 (380)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~n  107 (380)
                      ...++++....++|++.+.||+|+||.||+|.+.+|+.||||++.....         .......+.+|+.++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            3456788889999999999999999999999998899999999865432         1223467889999999999999


Q ss_pred             eeceEEEEEe-----CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          108 LVKLFGFLEH-----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       108 iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      |+++++++..     ....++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+.|   ++|+||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            9999999854     336899999997 58888887654 34899999999999999999999998   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~  261 (380)
                      |++.++.+||+|||++.......    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  241 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN  241 (362)
T ss_dssp             EECTTCCEEECCTTC-------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEcCCCCEEEEecCccccccccc----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999997544322    1234568999999999987 678999999999999999999999998765433


Q ss_pred             hhhHHHHHHHhhccCCc-----------ccccccCCCCCC------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHH
Q 041907          262 ERVTIRWAMQCLKAGDA-----------ILVMDPRLRRTP------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL  324 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l  324 (380)
                      ....+..   .......           ...+.......+      .....+..+.+||.+||+.||.+|||+.++++|.
T Consensus       242 ~~~~i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          242 QLNKIVE---VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             HHHHHHH---HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHH---HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence            2222111   0000000           000000000000      0112246788999999999999999999999998


Q ss_pred             HHH
Q 041907          325 WKI  327 (380)
Q Consensus       325 ~~~  327 (380)
                      |--
T Consensus       319 ~f~  321 (362)
T 3pg1_A          319 YFE  321 (362)
T ss_dssp             GGT
T ss_pred             hhh
Confidence            843

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=339.27  Aligned_cols=264  Identities=22%  Similarity=0.283  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe----CCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~  120 (380)
                      ..++|++.+.||+|+||.||++.+. +|+.||||++....  ......+.+|+.++++++||||+++++++..    ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            5578999999999999999999985 69999999986643  2345678899999999999999999999863    347


Q ss_pred             EEEEEEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      .++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            89999999999999999763  2345899999999999999999999998   999999999999999999999999988


Q ss_pred             ccccCCCcce------eeeecccCCccccChhhhhhcC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          199 RMSEEDSAVS------HISTQVKGTAGYLDPDYLRTYQ---LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       199 ~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      ..........      .......||+.|+|||++.+..   ++.++||||||+++|+|++|..||..........  ...
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~  259 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--ALA  259 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH--HHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh--hHH
Confidence            7543211000      0012345799999999987554   6899999999999999999999995321111000  000


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ..   .         . ...+.....+..+.++|.+||+.||.+||++++++++|+.+..
T Consensus       260 ~~---~---------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          260 VQ---N---------Q-LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HH---C---------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             hh---c---------c-CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            00   0         0 0011222345679999999999999999999999999987643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-44  Score=337.22  Aligned_cols=268  Identities=20%  Similarity=0.294  Sum_probs=211.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEe-C-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC------ceeceEEEEEe
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKL-K-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL------NLVKLFGFLEH  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~  117 (380)
                      ..++|++.+.||+|+||.||+|.+ . +|+.||||++....   .....+.+|+.++..++|+      +++++++++..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            357899999999999999999997 3 58899999987532   3345677899988888665      49999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-----------
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-----------  186 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-----------  186 (380)
                      .+..++||||+ +++|.+++......++++..++.++.||+.||.|||++|   ++||||||+|||++.           
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999 789999998877667999999999999999999999998   999999999999987           


Q ss_pred             --------CCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 041907          187 --------KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK  258 (380)
Q Consensus       187 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~  258 (380)
                              ++.+||+|||++......      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                    668999999999864432      234568999999999999999999999999999999999999998765


Q ss_pred             CcchhhHHHHHHHhhcc-----CCcccc---------------------cccCCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 041907          259 PIKERVTIRWAMQCLKA-----GDAILV---------------------MDPRLRRTPASNMAVEKILGLADVCLAPTRQ  312 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~-----~~~~~~---------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  312 (380)
                      ..+....+.........     ......                     ..+...........+..+.+||.+||+.||.
T Consensus       239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence            43322222111100000     000000                     0000001112335678899999999999999


Q ss_pred             CCCChHHHHHHHHH
Q 041907          313 SRPTMKKCAEILWK  326 (380)
Q Consensus       313 ~RPt~~eil~~l~~  326 (380)
                      +|||++|+++|.|-
T Consensus       319 ~Rpt~~ell~hp~f  332 (339)
T 1z57_A          319 KRITLREALKHPFF  332 (339)
T ss_dssp             TSCCHHHHTTSGGG
T ss_pred             cccCHHHHhcCHHH
Confidence            99999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.2e-45  Score=336.77  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=204.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++......  ....+.+|+.++.+++||||+++++++...+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            4578999999999999999999987 5899999998765332  245688999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++.... ..+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||++......
T Consensus        95 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             EECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999999987643 33899999999999999999999998   999999999999999999999999987643211


Q ss_pred             CcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .   .......||..|+|||++.     +..++.++||||||+++|+|++|..||...........      .. .... 
T Consensus       171 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~-  239 (302)
T 2j7t_A          171 L---QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK------IA-KSDP-  239 (302)
T ss_dssp             H---HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HH-HSCC-
T ss_pred             c---cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH------Hh-ccCC-
Confidence            0   1123356899999999984     56788999999999999999999999986554322111      11 0100 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                             ........++..+.+++.+||+.+|.+|||+.++++|.|-
T Consensus       240 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          240 -------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             -------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred             -------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence                   0111223345678999999999999999999999998773

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-44  Score=330.86  Aligned_cols=258  Identities=24%  Similarity=0.305  Sum_probs=210.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-------chHHHHHHHHHHHHHhcCC-CCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-------DKCLLLEFKNEILTWSKIE-HLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  116 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++.....       .......+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4589999999999999999999987 589999999975431       1223455789999999995 999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      .....++||||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            9999999999999999999998754  3899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhh------hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLR------TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM  270 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~  270 (380)
                      ++........    .....||+.|+|||++.      ...++.++||||||+++|+|++|..||...........     
T Consensus       170 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----  240 (298)
T 1phk_A          170 FSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-----  240 (298)
T ss_dssp             TCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-----
T ss_pred             chhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH-----
Confidence            9987654321    23456899999999986      44678899999999999999999999976543221111     


Q ss_pred             HhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ...+..       ....+.....+..+.+++.+||+.||.+||++.+++++.|-
T Consensus       241 --~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (298)
T 1phk_A          241 --IMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  287 (298)
T ss_dssp             --HHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             --HhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence              111110       00111223456779999999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-45  Score=370.06  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=211.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      ..++|.+.+.||+|+||.||+|.++ +|+.||||+++.... .......+..|..++..+ +||||+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999987 588999999975421 112234567899999887 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      |||||+++|+|.+++...+.  +++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            99999999999999987653  899999999999999999999999   9999999999999999999999999998643


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....   ......||+.|+|||++.+..++.++|||||||+||||++|..||......+..       ..+..+.     
T Consensus       494 ~~~~---~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~-----  558 (674)
T 3pfq_A          494 WDGV---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------QSIMEHN-----  558 (674)
T ss_dssp             CTTC---CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHSSC-----
T ss_pred             cCCc---ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH-------HHHHhCC-----
Confidence            2221   234567999999999999999999999999999999999999999875543221       1111111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCCh-----HHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM-----KKCAEILWK  326 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~eil~~l~~  326 (380)
                            ...+...+.++.+||.+||+.||.+||++     ++|++|.|-
T Consensus       559 ------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff  601 (674)
T 3pfq_A          559 ------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  601 (674)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred             ------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence                  11223456789999999999999999998     899998874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-45  Score=346.77  Aligned_cols=259  Identities=10%  Similarity=0.029  Sum_probs=189.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHH---HHHhcCCCCceeceE-------EEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEI---LTWSKIEHLNLVKLF-------GFL  115 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~~  115 (380)
                      .+|.+.+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+   ..|+. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45889999999999999999987 689999999987654 333445577774   45555 799987755       555


Q ss_pred             EeC-----------------CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCCe
Q 041907          116 EHG-----------------DERIIVVEYVGNGTLREHLDGRGGNGLELAER------LDIAIDVAHALTYLHTYSDPPI  172 (380)
Q Consensus       116 ~~~-----------------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~i  172 (380)
                      ...                 ...++||||++ ++|.+++...+.. +....+      +.++.||+.||.|||++|   |
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            443                 34799999998 7999999865322 444455      677899999999999999   9


Q ss_pred             eeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhC
Q 041907          173 IHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTG  250 (380)
Q Consensus       173 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg  250 (380)
                      +||||||+|||++.++.+||+|||+++.....      .....+|+.|+|||++.+  ..++.++|||||||++|+|++|
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            99999999999999999999999999865421      124557799999999987  7899999999999999999999


Q ss_pred             CCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          251 RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       251 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      +.||....+.....        .............. ..+....++..+.+||.+||+.||.+|||+.++++|.|-.
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            99998654321100        00000000000011 1111224567899999999999999999999999998854

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-44  Score=329.39  Aligned_cols=258  Identities=28%  Similarity=0.365  Sum_probs=210.7

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++............+.+|+.++++++||||+++++++......++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4578999999999999999999987 699999999976544333456788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC---CceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK---LRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~  201 (380)
                      |||+++++|.+++....  .+++..++.++.||+.||.|||+.|   ++|+||||+||+++.+   +.+||+|||++...
T Consensus       100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999987654  3899999999999999999999998   9999999999999764   46999999999866


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..........       .+..+...  
T Consensus       175 ~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~--  240 (287)
T 2wei_A          175 QQNTK----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-------RVETGKYA--  240 (287)
T ss_dssp             CCCSS----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCCCC--
T ss_pred             cCCCc----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHcCCCC--
Confidence            54321    223458999999999876 48999999999999999999999998754332111       11111100  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           ...+.....+..+.++|.+||+.+|.+|||+.+++++.|-.
T Consensus       241 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~  281 (287)
T 2wei_A          241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (287)
T ss_dssp             -----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred             -----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence                 00111123456789999999999999999999999998854

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=338.04  Aligned_cols=255  Identities=16%  Similarity=0.185  Sum_probs=205.0

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEE------eCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC---CCceeceEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGK------LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE---HLNLVKLFGFL  115 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~  115 (380)
                      ...++|.+.+.||+|+||.||+|.      ..+++.||||++....     ..++..|+.++.+++   |+||+++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            356789999999999999999994      3358899999997643     234567777777775   99999999999


Q ss_pred             EeCCEEEEEEEeCCCCCHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC------
Q 041907          116 EHGDERIIVVEYVGNGTLREHLDGR---GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE------  186 (380)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~------  186 (380)
                      ...+..++||||+++|+|.+++...   ....+++..++.++.||+.||.|||++|   |+||||||+|||++.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence            9999999999999999999999752   2345999999999999999999999988   999999999999998      


Q ss_pred             -----CCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 041907          187 -----KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK  261 (380)
Q Consensus       187 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~  261 (380)
                           ++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                 89999999999976543221 223455679999999999999999999999999999999999999996432211


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCC-CChHHHHHHHHHHHhh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSR-PTMKKCAEILWKIRKD  330 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~eil~~l~~~~~~  330 (380)
                      .                  .........+    ..+.+.+++..||+.+|.+| |+++++.+.+..+...
T Consensus       293 ~------------------~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 C------------------KPEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             E------------------EECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             e------------------eechhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            0                  0111111121    24567889999999999999 6788888877776554

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=342.73  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=191.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEE-------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLE-------  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------  116 (380)
                      ...+|++.+.||+|+||.||+|.+. +|+.||||++....  ......+.+|+.++.++. ||||+++++++.       
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            5578999999999999999999986 58999999986543  234556889999999996 999999999984       


Q ss_pred             -eCCEEEEEEEeCCCCCHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcc
Q 041907          117 -HGDERIIVVEYVGNGTLREHLDGR-GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTD  194 (380)
Q Consensus       117 -~~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~D  194 (380)
                       .....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.+ .+++|+||||+|||++.++.+||+|
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence             3445899999996 6999988652 2334999999999999999999999764 4599999999999999999999999


Q ss_pred             ccccccccCCCccee---------eeecccCCccccChhhh---hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 041907          195 FGFARMSEEDSAVSH---------ISTQVKGTAGYLDPDYL---RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE  262 (380)
Q Consensus       195 fg~~~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~  262 (380)
                      ||++...........         ......||+.|+|||++   .+..++.++|||||||++|+|++|..||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            999987654322110         11134589999999998   577788999999999999999999999975432210


Q ss_pred             hhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          263 RVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                                .         ..... .+.....+..+.+|+.+||+.+|.+||++.+++++|+.+....
T Consensus       262 ----------~---------~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          262 ----------V---------NGKYS-IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             -----------------------CC-CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----------h---------cCccc-CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                      0         00000 0111122245789999999999999999999999999987654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.2e-45  Score=345.72  Aligned_cols=268  Identities=20%  Similarity=0.273  Sum_probs=202.7

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-----
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-----  117 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  117 (380)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......      ..+|+.+++.++||||+++++++..     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            345689999999999999999999986 6999999998755322      2379999999999999999999844     


Q ss_pred             ---------------------------------CCEEEEEEEeCCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHH
Q 041907          118 ---------------------------------GDERIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALT  162 (380)
Q Consensus       118 ---------------------------------~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~i~~~i~~~l~  162 (380)
                                                       ....++||||+++ +|.+.+..  .....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             3448899999985 88887764  22345999999999999999999


Q ss_pred             HHhhCCCCCeeeccCCCCceeeC-CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcC-CCCccchhhH
Q 041907          163 YLHTYSDPPIIHRDVKASNILIT-EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSF  240 (380)
Q Consensus       163 ~LH~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSl  240 (380)
                      |||+.|   |+||||||+|||++ .++.+||+|||+++.......    .....||+.|+|||++.+.. ++.++|||||
T Consensus       156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            999988   99999999999998 688999999999987644321    23456899999999988754 8999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------hhccCCcccccccCCCCCC----CCHHHHHHHHHHHHHhcC
Q 041907          241 GVLLVEMMTGRYPIESKKPIKERVTIRWAMQ--------CLKAGDAILVMDPRLRRTP----ASNMAVEKILGLADVCLA  308 (380)
Q Consensus       241 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~  308 (380)
                      ||++|+|++|..||......+....+.....        ..... .....-+......    .+...+..+.+||.+||+
T Consensus       229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH-YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT-C--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc-cccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            9999999999999987665443322211100        00000 0000000000000    112245678999999999


Q ss_pred             CCCCCCCChHHHHHHHHH
Q 041907          309 PTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       309 ~~p~~RPt~~eil~~l~~  326 (380)
                      .+|.+|||+.|+++|.|-
T Consensus       308 ~dP~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          308 YEPDLRINPYEAMAHPFF  325 (383)
T ss_dssp             SSGGGSCCHHHHHTSGGG
T ss_pred             CChhhCCCHHHHhcCHHH
Confidence            999999999999999884

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=339.54  Aligned_cols=273  Identities=21%  Similarity=0.283  Sum_probs=200.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE--------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE--------  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--------  116 (380)
                      ..++|++.+.||+|+||.||+|.+.. |+.||+|++....  ......+.+|+.++++++||||+++++++.        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            35789999999999999999999874 8999999987543  334567889999999999999999999873        


Q ss_pred             ------eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCc
Q 041907          117 ------HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLR  189 (380)
Q Consensus       117 ------~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~  189 (380)
                            .....++||||++ |+|.+++...   .+++..++.++.||+.||.|||++|   ++|+||||+||+++ +++.
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence                  4468899999997 5999999753   3899999999999999999999999   99999999999997 5679


Q ss_pred             eEEccccccccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 041907          190 AKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRW  268 (380)
Q Consensus       190 ~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~  268 (380)
                      +||+|||++.................+|..|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999876432222222334568999999998875 6789999999999999999999999987654332221110


Q ss_pred             HHHhhcc-------CCcccccccCCCCC-----CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          269 AMQCLKA-------GDAILVMDPRLRRT-----PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       269 ~~~~~~~-------~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .......       ......+.......     ......+..+.+||.+||+.||.+|||++++++|.|-.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            0000000       00000000000000     00112457799999999999999999999999999954

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-45  Score=345.43  Aligned_cols=268  Identities=19%  Similarity=0.292  Sum_probs=207.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE---
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER---  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  121 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3578999999999999999999987 589999999987666666667789999999999999999999999877655   


Q ss_pred             ---EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          122 ---IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       122 ---~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                         ++||||+. ++|.+++..    .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence               99999997 588888743    3899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      +.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...........
T Consensus       192 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          192 RHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             --------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccC------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            764432      234568999999999987 7889999999999999999999999987654433222211000000000


Q ss_pred             --------ccccccc--CCCCC---CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          278 --------AILVMDP--RLRRT---PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       278 --------~~~~~~~--~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                              .......  .....   ......+..+.+||.+||+.||.+|||++++++|.|--
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                    0000000  00000   00112356789999999999999999999999999853

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3e-45  Score=342.69  Aligned_cols=266  Identities=22%  Similarity=0.328  Sum_probs=211.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchH---------------HHHHHHHHHHHHhcCCCCceece
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKC---------------LLLEFKNEILTWSKIEHLNLVKL  111 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~niv~~  111 (380)
                      .++|.+.+.||+|+||.||+|.+ +|+.||||++........               ....+.+|+.++.+++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 799999999875432110               11568899999999999999999


Q ss_pred             EEEEEeCCEEEEEEEeCCCCCHHHH------hccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceee
Q 041907          112 FGFLEHGDERIIVVEYVGNGTLREH------LDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILI  184 (380)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~------i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~  184 (380)
                      ++++...+..++||||+++++|.++      +.......+++..++.++.||+.||.|||+ .|   ++|+||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence            9999999999999999999999999      665445569999999999999999999998 88   9999999999999


Q ss_pred             CCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhc-CCCC-ccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 041907          185 TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTE-KSDVYSFGVLLVEMMTGRYPIESKKPIKE  262 (380)
Q Consensus       185 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~  262 (380)
                      +.++.+||+|||++......     ......||..|+|||++.+. .++. ++|||||||++|+|++|..||........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             cCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999865432     23456699999999999887 6666 99999999999999999999987654221


Q ss_pred             hhHHHHHHHhhccCCcccccc------cCCC--CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          263 RVTIRWAMQCLKAGDAILVMD------PRLR--RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .      ......+....-.+      ....  ........+..+.+|+.+||+.||.+||++.+++++.|-.
T Consensus       261 ~------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          261 L------FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             H------HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             H------HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            1      11111111100000      0000  0001133557889999999999999999999999998743

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4e-45  Score=338.38  Aligned_cols=258  Identities=26%  Similarity=0.367  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc------hHHHHHHHHHHHHHhcCCCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD------KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  118 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++......      ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4578999999999999999999987 5889999998754321      11233478999999999999999999998766


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDF  195 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Df  195 (380)
                      . .++||||+++++|.+++....  .+++..++.++.||+.||.|||++|   ++|+||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 899999999999999997654  4899999999999999999999998   999999999999987664   999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC  272 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  272 (380)
                      |++.......    ......||+.|+|||++.   ...++.++|||||||++|+|++|..||...........   .   
T Consensus       162 g~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~---  231 (322)
T 2ycf_A          162 GHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---Q---  231 (322)
T ss_dssp             TTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH---H---
T ss_pred             ccceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH---H---
Confidence            9998654321    123456999999999974   56788999999999999999999999976543322111   0   


Q ss_pred             hccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ...+....       ........+..+.+||.+||+.||.+||++.+++++.|.
T Consensus       232 ~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          232 ITSGKYNF-------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             HHHTCCCC-------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHhCcccc-------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence            00110000       000011234678999999999999999999999998774

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=345.18  Aligned_cols=273  Identities=20%  Similarity=0.245  Sum_probs=189.1

Q ss_pred             cCCCC-CCeeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEE
Q 041907           48 ENFSP-ANKIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDER  121 (380)
Q Consensus        48 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  121 (380)
                      +.|.+ .++||+|+||.||+|.++   +++.||||++......    ..+.+|+.+|++++||||+++++++..  ....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            44665 457999999999999976   4788999999765443    246789999999999999999999955  6789


Q ss_pred             EEEEEeCCCCCHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee----CCCCce
Q 041907          122 IIVVEYVGNGTLREHLDGR-------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI----TEKLRA  190 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~----~~~~~~  190 (380)
                      ++||||+.+ +|.+++...       ....+++..++.++.||+.||.|||+.|   |+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            999999965 888887532       1224899999999999999999999999   9999999999999    677899


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcc------hh
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK------ER  263 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~------~~  263 (380)
                      ||+|||+++................||+.|+|||++.+. .++.++|||||||++|+|++|..||.......      ..
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998765432222233456799999999999874 48999999999999999999999997554310      01


Q ss_pred             hHHHHHHHhhccCCcc--cccc-------------cC-CCCCCC-------CHHHHHHHHHHHHHhcCCCCCCCCChHHH
Q 041907          264 VTIRWAMQCLKAGDAI--LVMD-------------PR-LRRTPA-------SNMAVEKILGLADVCLAPTRQSRPTMKKC  320 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~--~~~~-------------~~-~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPt~~ei  320 (380)
                      ..+......+......  ..+.             .. ......       .......+.+||.+||+.||.+|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            1111111111100000  0000             00 000000       00013567899999999999999999999


Q ss_pred             HHHHHHHH
Q 041907          321 AEILWKIR  328 (380)
Q Consensus       321 l~~l~~~~  328 (380)
                      ++|.|-..
T Consensus       332 L~hp~f~~  339 (405)
T 3rgf_A          332 MQDPYFLE  339 (405)
T ss_dssp             HTSGGGTS
T ss_pred             hcChhhcc
Confidence            99999653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-44  Score=338.45  Aligned_cols=269  Identities=21%  Similarity=0.281  Sum_probs=206.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-----------CCceeceEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-----------HLNLVKLFG  113 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~  113 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++....   .....+.+|+.+++++.           |+||+++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3478999999999999999999986 68999999997532   23455778999888876           899999999


Q ss_pred             EEEeCC----EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeC---
Q 041907          114 FLEHGD----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILIT---  185 (380)
Q Consensus       114 ~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~---  185 (380)
                      ++...+    ..++|||++ +++|.+++.......+++..++.++.||+.||.|||++ |   |+||||||+|||++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence            987654    789999999 88999999886666699999999999999999999997 8   99999999999994   


Q ss_pred             ---CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-
Q 041907          186 ---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK-  261 (380)
Q Consensus       186 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~-  261 (380)
                         ..+.+||+|||++......      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... 
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence               4458999999999865432      234568999999999999999999999999999999999999998654221 


Q ss_pred             --hhhHHHHHHHhhcc------------------CCccccccc---------CCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 041907          262 --ERVTIRWAMQCLKA------------------GDAILVMDP---------RLRRTPASNMAVEKILGLADVCLAPTRQ  312 (380)
Q Consensus       262 --~~~~~~~~~~~~~~------------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~  312 (380)
                        ....+.........                  ......+..         ...........+..+.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence              11111111111100                  000000000         0001224467788999999999999999


Q ss_pred             CCCChHHHHHHHHHH
Q 041907          313 SRPTMKKCAEILWKI  327 (380)
Q Consensus       313 ~RPt~~eil~~l~~~  327 (380)
                      +|||++|+++|.|-.
T Consensus       324 ~Rpt~~ell~hp~f~  338 (373)
T 1q8y_A          324 KRADAGGLVNHPWLK  338 (373)
T ss_dssp             TCBCHHHHHTCGGGT
T ss_pred             ccCCHHHHhhChhhh
Confidence            999999999999854

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.8e-43  Score=335.07  Aligned_cols=268  Identities=23%  Similarity=0.233  Sum_probs=207.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CC-----ceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HL-----NLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...   ......+..|+.++..++ |+     +|+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            4578999999999999999999987 5889999999753   233455677888887774 44     599999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh--CCCCCeeeccCCCCceeeC--CCCceEEcc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT--YSDPPIIHRDVKASNILIT--EKLRAKVTD  194 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--~~~~~i~H~dlkp~Nil~~--~~~~~kl~D  194 (380)
                      +..++||||+++ +|.+++.......+++..++.++.|++.||.|||.  .|   |+||||||+|||++  .++.+||+|
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999965 99999988765669999999999999999999994  56   99999999999995  477899999


Q ss_pred             ccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh-
Q 041907          195 FGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL-  273 (380)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-  273 (380)
                      ||+++.....      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+....... 
T Consensus       205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             CTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             ccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999876432      234569999999999999999999999999999999999999998765543322221110000 


Q ss_pred             -----------------ccCCccccc--cc--------------------------CCCCCCCCHHHHHHHHHHHHHhcC
Q 041907          274 -----------------KAGDAILVM--DP--------------------------RLRRTPASNMAVEKILGLADVCLA  308 (380)
Q Consensus       274 -----------------~~~~~~~~~--~~--------------------------~~~~~~~~~~~~~~l~~li~~cl~  308 (380)
                                       ..+......  +.                          ..............+.+||.+||+
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                             000000000  00                          000001122344678999999999


Q ss_pred             CCCCCCCChHHHHHHHHH
Q 041907          309 PTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       309 ~~p~~RPt~~eil~~l~~  326 (380)
                      .||.+|||++|+++|.|-
T Consensus       359 ~dP~~Rpta~e~L~hp~f  376 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFF  376 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGG
T ss_pred             CChhhCCCHHHHhcCccc
Confidence            999999999999999884

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=337.50  Aligned_cols=260  Identities=23%  Similarity=0.361  Sum_probs=190.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++............+.++..+++.++||||+++++++...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            34578999999999999999999987 69999999998765544444445566667888899999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ||||+ ++.+..+.... ...+++..++.++.+|+.||.|||+. |   ++|+||||+||+++.++.+||+|||++....
T Consensus       102 v~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            99999 55666655543 23489999999999999999999985 8   9999999999999999999999999987654


Q ss_pred             CCCcceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ...    ......||+.|+|||++.     +..++.++|||||||++|+|++|..||........  .+.....    +.
T Consensus       177 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~~  246 (318)
T 2dyl_A          177 DDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTKVLQ----EE  246 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHH----SC
T ss_pred             CCc----cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHHHhc----cC
Confidence            322    123456899999999994     56788999999999999999999999976433211  1111111    10


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      .        ...+....++..+.++|.+||+.||.+||++++++++.|-.
T Consensus       247 ~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          247 P--------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             C--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             C--------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            0        01111122456789999999999999999999999998854

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=339.52  Aligned_cols=267  Identities=20%  Similarity=0.305  Sum_probs=206.4

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE-----
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE-----  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  120 (380)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            478999999999999999999986 58999999998765555566778899999999999999999999987654     


Q ss_pred             -EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          121 -RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       121 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                       .++||||+. ++|.+++..    .+++..++.++.||+.||.|||++|   ++|+||||+||+++.++.+||+|||++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999997 588887743    3899999999999999999999999   9999999999999999999999999997


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh-----
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL-----  273 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  273 (380)
                      .....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.......     
T Consensus       175 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C--------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             CCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            64321      234568999999999987 678999999999999999999999998765433222111100000     


Q ss_pred             ---ccCC---ccccc--ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          274 ---KAGD---AILVM--DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       274 ---~~~~---~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ....   ....+  .+...........+..+.+||.+||+.||.+|||++++++|.|-.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  310 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  310 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence               0000   00000  000001112224467899999999999999999999999999853

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.6e-44  Score=338.36  Aligned_cols=274  Identities=24%  Similarity=0.297  Sum_probs=207.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----D  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  119 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++...     .
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            4578999999999999999999987 58999999996543 233455678999999999999999999988654     6


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+. ++|.+++...   .+++..++.++.||+.||.|||++|   ++||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            7899999997 5999999864   3899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccee-------eeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 041907          200 MSEEDSAVSH-------ISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ  271 (380)
Q Consensus       200 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  271 (380)
                      ..........       ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            7653221111       1223568999999998765 6789999999999999999999999987654322221111000


Q ss_pred             hhccCCcccccc--------cCCCCCC------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          272 CLKAGDAILVMD--------PRLRRTP------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       272 ~~~~~~~~~~~~--------~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..........+.        ..+...+      .....+..+.+||.+||+.||.+|||++++++|.|-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            000000000000        0000000      0113456788999999999999999999999999853

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.5e-44  Score=334.57  Aligned_cols=269  Identities=21%  Similarity=0.254  Sum_probs=209.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CC-CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc------eeceEEEEEe
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DG-SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN------LVKLFGFLEH  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~  117 (380)
                      ..++|++.+.||+|+||.||+|.+. ++ +.||+|+++...   .....+.+|+.++++++|++      ++.+++++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3578999999999999999999986 34 689999997532   33456778999998887665      8999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee-------------
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI-------------  184 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~-------------  184 (380)
                      .+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++|   |+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            99999999999 668888887766556999999999999999999999988   9999999999999             


Q ss_pred             ------CCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 041907          185 ------TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKK  258 (380)
Q Consensus       185 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~  258 (380)
                            +.++.+||+|||++......      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                  56789999999999864432      234569999999999999999999999999999999999999998765


Q ss_pred             CcchhhHHHHHHHhhcc-----CCccccc---------------------ccCCCCCCCCHHHHHHHHHHHHHhcCCCCC
Q 041907          259 PIKERVTIRWAMQCLKA-----GDAILVM---------------------DPRLRRTPASNMAVEKILGLADVCLAPTRQ  312 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~-----~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  312 (380)
                      .......+.........     .......                     .+...........+..+.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence            43332222111100000     0000000                     000000112234566899999999999999


Q ss_pred             CCCChHHHHHHHHHH
Q 041907          313 SRPTMKKCAEILWKI  327 (380)
Q Consensus       313 ~RPt~~eil~~l~~~  327 (380)
                      +|||++++++|.|-.
T Consensus       324 ~Rpt~~e~l~hp~f~  338 (355)
T 2eu9_A          324 QRITLAEALLHPFFA  338 (355)
T ss_dssp             TSCCHHHHTTSGGGG
T ss_pred             hCcCHHHHhcChhhc
Confidence            999999999998854

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.8e-44  Score=343.67  Aligned_cols=264  Identities=23%  Similarity=0.322  Sum_probs=200.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------CE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------DE  120 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  120 (380)
                      .+|.+.+.||+|+||.||+|.+. +|+.||||++......      ..+|+.+|++++||||+++++++...      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46899999999999999999987 5999999998654321      23799999999999999999988542      23


Q ss_pred             EEEEEEeCCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-CceEEccccc
Q 041907          121 RIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGF  197 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~  197 (380)
                      .++||||+++ +|.+.+..  .....+++..++.++.||+.||.|||++|   |+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence            6799999976 77776653  22345999999999999999999999988   9999999999999955 5789999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH------
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM------  270 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------  270 (380)
                      ++.......    .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+....      
T Consensus       204 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          204 AKQLVRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  279 (420)
T ss_dssp             CEECCTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             hhhcccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            987543321    2345689999999999765 78999999999999999999999998765443322221110      


Q ss_pred             --HhhccCCcccccccCCCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 --QCLKAGDAILVMDPRLRRTP----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 --~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ..... ......-+.....+    .....+.++.+||.+||+.||.+||++.|+++|.|-
T Consensus       280 ~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          280 QIREMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHHCS-CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhhCh-hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence              00000 00000000000000    111235679999999999999999999999999885

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=341.70  Aligned_cols=268  Identities=23%  Similarity=0.350  Sum_probs=205.9

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      +++....++|++.+.||+|+||.||+|.+..  .||+|++............+.+|+.++++++||||+++++++.....
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            4444467899999999999999999999863  49999997654433333457789999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .++||||+++++|.+++.... ..+++..++.++.||+.||.|||++|   ++|+||||+||+++ ++.+||+|||++..
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             eEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999998754 34899999999999999999999998   99999999999998 67999999999876


Q ss_pred             ccCCCcc--eeeeecccCCccccChhhhhh---------cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          201 SEEDSAV--SHISTQVKGTAGYLDPDYLRT---------YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       201 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      .......  ........||+.|+|||++.+         ..++.++|||||||++|+|++|..||..........     
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----  253 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-----  253 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-----
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----
Confidence            4321111  111233568999999999975         457889999999999999999999997654322111     


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                        ....+..     +..    ....++..+.+++.+||+.+|.+|||+.++++.|..+.+..
T Consensus       254 --~~~~~~~-----~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          254 --QMGTGMK-----PNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             --HHHTTCC-----CCC----CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             --HhccCCC-----CCC----CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence              1111111     111    11123356889999999999999999999999998876654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.3e-44  Score=335.26  Aligned_cols=276  Identities=21%  Similarity=0.230  Sum_probs=196.7

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      .......++|++.+.||+|+||.||+|.+. +|+.||||++......   .....+++..+..++||||+++++++...+
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            445567799999999999999999999986 5899999998654322   123457788888899999999999987643


Q ss_pred             E-------EEEEEEeCCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeeeccCCCCceeeCC-C
Q 041907          120 E-------RIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLH--TYSDPPIIHRDVKASNILITE-K  187 (380)
Q Consensus       120 ~-------~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlkp~Nil~~~-~  187 (380)
                      .       .++||||+++ +|...+..  .....+++..++.++.|++.||.|||  +.|   |+||||||+|||++. +
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTT
T ss_pred             cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCC
Confidence            3       7899999976 66555442  22344889999999999999999999  888   999999999999996 8


Q ss_pred             CceEEccccccccccCCCcceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 041907          188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI  266 (380)
Q Consensus       188 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~  266 (380)
                      +.+||+|||++........    .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...........+
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  244 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI  244 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence            9999999999987654321    23456899999999997654 899999999999999999999999876544332222


Q ss_pred             HHHH--------HhhccCCc-ccccccCCC-----CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          267 RWAM--------QCLKAGDA-ILVMDPRLR-----RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       267 ~~~~--------~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ....        ........ ....+....     ........+..+.+||.+||+.||.+|||+.|+++|.|--
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  319 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD  319 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence            1110        00000000 000000000     0001112457899999999999999999999999999854

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.7e-44  Score=331.30  Aligned_cols=262  Identities=24%  Similarity=0.378  Sum_probs=186.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHH-HHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEIL-TWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++....... ...++..|+. +++.++||||+++++++...+..++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            3478999999999999999999986 68999999997654433 3334455555 7778899999999999999999999


Q ss_pred             EEEeCCCCCHHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          124 VVEYVGNGTLREHLDG---RGGNGLELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ||||+++ +|.+++..   .....+++..++.++.+++.||.|||+. |   ++|+||||+|||++.++.+||+|||++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999976 88887763   2234589999999999999999999998 8   9999999999999999999999999997


Q ss_pred             cccCCCcceeeeecccCCccccChhhh----hhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYL----RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ......    ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.........      ......
T Consensus       175 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~  244 (327)
T 3aln_A          175 QLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVVK  244 (327)
T ss_dssp             C----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCC
T ss_pred             eccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHhc
Confidence            654321    12234699999999998    5667899999999999999999999999764321110      000000


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                      +.     .+.+. ......++..+.+|+.+||+.||.+||++.+++++.|...
T Consensus       245 ~~-----~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          245 GD-----PPQLS-NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             SC-----CCCCC-CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CC-----CCCCC-CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            00     00000 1111234567999999999999999999999999998753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=334.58  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchH----HHHHHHHHHHHHhcC----CCCceeceE
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKC----LLLEFKNEILTWSKI----EHLNLVKLF  112 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~----~~~~~~~e~~~l~~l----~h~niv~~~  112 (380)
                      +.....++|++.+.||+|+||.||+|.+. +|+.||||++........    ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34456789999999999999999999986 589999999976543221    122355788888888    899999999


Q ss_pred             EEEEeCCEEEEEEEe-CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCce
Q 041907          113 GFLEHGDERIIVVEY-VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRA  190 (380)
Q Consensus       113 ~~~~~~~~~~lv~e~-~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~  190 (380)
                      +++...+..++|||+ +.+++|.+++.....  +++..++.++.||+.||.|||+.|   ++|+||||+||+++ .++.+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            999999999999999 789999999987543  899999999999999999999998   99999999999999 88999


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLT-EKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      ||+|||++.......     .....||..|+|||++.+..+. .++||||||+++|+|++|+.||.....         .
T Consensus       180 kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~  245 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------I  245 (312)
T ss_dssp             EECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H
T ss_pred             EEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------H
Confidence            999999998765432     2345699999999999887775 489999999999999999999964211         0


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..    .        .   .......+..+.++|.+||+.+|.+||++++++++.|..
T Consensus       246 ~~----~--------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~  288 (312)
T 2iwi_A          246 LE----A--------E---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ  288 (312)
T ss_dssp             HH----T--------C---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred             hh----h--------c---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence            00    0        0   011123456788999999999999999999999998843

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.4e-44  Score=342.21  Aligned_cols=265  Identities=22%  Similarity=0.284  Sum_probs=200.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC------E
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD------E  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  120 (380)
                      ..+|++.+.||+|+||.||+|.+..+..||+|++......      ..+|+.+++.++||||+++++++...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4579999999999999999999987667999988654322      237999999999999999999986543      3


Q ss_pred             EEEEEEeCCCCCHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEccccc
Q 041907          121 RIIVVEYVGNGTLREHLDG--RGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRAKVTDFGF  197 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~  197 (380)
                      .++||||+++ ++...+..  .....+++..++.++.||+.||.|||++|   |+||||||+|||++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            7899999987 45444432  12334899999999999999999999999   99999999999999 789999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH------
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM------  270 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~------  270 (380)
                      ++.......    .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+....+....      
T Consensus       189 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          189 AKILIAGEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             CEECCTTCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cccccCCCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            987644321    2345689999999999765 58999999999999999999999998766544332221110      


Q ss_pred             --HhhccCCcccccccCCCCCC----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 --QCLKAGDAILVMDPRLRRTP----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 --~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ...... .....-+.....+    .....+.++.+||.+||+.||.+|||+.|+++|.|-
T Consensus       265 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (394)
T 4e7w_A          265 QIKTMNPN-YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF  325 (394)
T ss_dssp             HHHHHCGG-GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHhhChh-hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence              000000 0000000000000    111244689999999999999999999999999884

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-45  Score=337.69  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCC--CCceeceE
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIE--HLNLVKLF  112 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~~  112 (380)
                      ..+.....++|++.+.||+|+||.||+|.+. +|+.||||++.......    .....+.+|+.++++++  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            3455556789999999999999999999986 58999999997653221    01123567899999986  59999999


Q ss_pred             EEEEeCCEEEEEEEeCCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCce
Q 041907          113 GFLEHGDERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRA  190 (380)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~  190 (380)
                      +++...+..++|||++.+ ++|.+++....  .+++..++.++.||+.||.|||+.|   |+||||||+|||++ +++.+
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence            999999999999999976 89999998754  3899999999999999999999998   99999999999999 78899


Q ss_pred             EEccccccccccCCCcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 041907          191 KVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA  269 (380)
Q Consensus       191 kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~  269 (380)
                      ||+|||++.......     .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....         .
T Consensus       190 kL~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~  255 (320)
T 3a99_A          190 KLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------I  255 (320)
T ss_dssp             EECCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H
T ss_pred             EEeeCcccccccccc-----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------h
Confidence            999999998765321     234569999999999988776 5789999999999999999999964311         0


Q ss_pred             HHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..    +.           .......+..+.+||.+||+.||.+||++++++++.|..
T Consensus       256 ~~----~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          256 IR----GQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             HH----CC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hc----cc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence            00    00           001112346788999999999999999999999998853

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=345.97  Aligned_cols=256  Identities=24%  Similarity=0.323  Sum_probs=194.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  124 (380)
                      +..+|.+.+.||+|+||+|+.....+|+.||||++......     .+.+|+.+|+++ +||||+++++++.+....++|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            45679999999999999976655567999999999764433     245899999998 899999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-----CCceEEccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-----KLRAKVTDFGFAR  199 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~  199 (380)
                      |||+. |+|.+++...... +....++.++.||+.||.|||+.|   |+||||||+|||++.     ...+||+|||+++
T Consensus        97 ~E~~~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             EECCC-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            99996 5999999876532 445566789999999999999999   999999999999953     2358899999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhh---hcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLR---TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ................||+.|+|||++.   +..++.++|||||||++|+|++ |..||..........       ....
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~  244 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGA  244 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTC
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------Hhcc
Confidence            7654332223334567999999999997   5677889999999999999999 999996543221110       0000


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                              ...............+.+||.+||+.||.+|||++++++|+|-
T Consensus       245 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f  287 (432)
T 3p23_A          245 --------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF  287 (432)
T ss_dssp             --------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred             --------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence                    0111111223456678899999999999999999999998764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7.9e-44  Score=326.06  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-------
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-------  117 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  117 (380)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...   ......+.+|+.++++++||||+++++++.+       
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            3467899999999999999999986 6999999999653   2345678899999999999999999998865       


Q ss_pred             ------CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceE
Q 041907          118 ------GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAK  191 (380)
Q Consensus       118 ------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~k  191 (380)
                            ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|   ++|+||||+||+++.++.+|
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence                  356799999999999999998654 34788999999999999999999998   99999999999999999999


Q ss_pred             EccccccccccCCCcc-----------eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 041907          192 VTDFGFARMSEEDSAV-----------SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKP  259 (380)
Q Consensus       192 l~Dfg~~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~  259 (380)
                      |+|||++.........           ........||+.|+|||++.+. .++.++|||||||++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            9999999865432110           1112345689999999999864 68999999999999999998   5542111


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ...   .........      ... ........+..+.+++.+||+.||.+|||+++++++.|-
T Consensus       234 ---~~~---~~~~~~~~~------~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          234 ---RVN---ILKKLRSVS------IEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             ---HHH---HHHHHHSTT------CCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             ---HHH---HHHhccccc------ccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence               011   111111110      000 011223345678899999999999999999999999885

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-43  Score=355.66  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=210.2

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD  119 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  119 (380)
                      ....++|.+.+.||+|+||.||+|.+..    +..||+|.+..... ......+.+|+.++++++||||+++++++. .+
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3355788999999999999999999752    45799999876433 334567889999999999999999999985 45


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence            6899999999999999998654 34899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....       +..+. 
T Consensus       540 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-------i~~~~-  609 (656)
T 2j0j_A          540 YMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENGE-  609 (656)
T ss_dssp             SCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHHTC-
T ss_pred             ecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-------HHcCC-
Confidence            7654321  12233457889999999999999999999999999999997 9999986554322111       11111 


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                               ..+.+..++..+.++|.+||+.||.+||++.++++.|..+...
T Consensus       610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                     0112234557899999999999999999999999999988654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.9e-43  Score=338.91  Aligned_cols=257  Identities=21%  Similarity=0.288  Sum_probs=192.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....     ...+.+|+.++.++ +||||+++++++......++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            4456678899999999987766679999999986542     23467899999876 89999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCC-----CHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC-------------C
Q 041907          127 YVGNGTLREHLDGRGGNGL-----ELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK-------------L  188 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~-----~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~-------------~  188 (380)
                      |+. |+|.+++........     .+..++.++.||+.||.|||++|   |+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            996 599999987543211     23345779999999999999998   9999999999999754             4


Q ss_pred             ceEEccccccccccCCCcce-eeeecccCCccccChhhhhh-------cCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 041907          189 RAKVTDFGFARMSEEDSAVS-HISTQVKGTAGYLDPDYLRT-------YQLTEKSDVYSFGVLLVEMMT-GRYPIESKKP  259 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~  259 (380)
                      .+||+|||++.......... .......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            89999999998765432211 11234679999999999976       678999999999999999999 9999975433


Q ss_pred             cchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ...  .   ...    +.    ..............+.++.+||.+||+.||.+|||+.++++|+|-
T Consensus       246 ~~~--~---i~~----~~----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f  299 (434)
T 2rio_A          246 RES--N---IIR----GI----FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF  299 (434)
T ss_dssp             HHH--H---HHH----TC----CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             hHH--H---Hhc----CC----CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence            211  0   001    00    000001122345678899999999999999999999999998774

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.2e-41  Score=305.04  Aligned_cols=236  Identities=12%  Similarity=0.075  Sum_probs=189.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-CCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ..++|++.+.||+|+||.||+|.+.. |+.||||++...... ......+.+|+..+.+++||||+++++++...+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34789999999999999999999874 899999999866443 3455678899999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||++|++|.+++...    ....++.+++.||+.||.|||++|   |+||||||+|||++.++.+||+++|       
T Consensus       109 v~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            99999999999999542    455678899999999999999999   9999999999999999999998554       


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                                      |++       .++.++|||||||++|+|++|+.||...........            ......
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~  219 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTA  219 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTT
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhc
Confidence                            222       368899999999999999999999987654321000            000000


Q ss_pred             cCCC-CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          284 PRLR-RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       284 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .... .......++..+.++|.+||+.||.+| |+.++++.|..+....
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0000 000112345779999999999999999 9999999999886543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-42  Score=345.73  Aligned_cols=270  Identities=24%  Similarity=0.322  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe------CCE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH------GDE  120 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  120 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++..      .+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            78999999999999999999986 58999999987653 33445678899999999999999999998755      667


Q ss_pred             EEEEEEeCCCCCHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCc---eEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGG-NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLR---AKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg  196 (380)
                      .++||||+++|+|.+++..... ..+++..++.++.+++.||.|||+.|   ++||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999987542 35889999999999999999999998   999999999999997765   9999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HH--HHHHHhh
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV-TI--RWAMQCL  273 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~-~~--~~~~~~~  273 (380)
                      ++.......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+  .......
T Consensus       170 ~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          170 YAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             ccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            998765432    2244679999999999999999999999999999999999999997532110000 00  0000000


Q ss_pred             ccCCccc--ccccC-CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          274 KAGDAIL--VMDPR-LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       274 ~~~~~~~--~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .......  ..... ..........+..+.++|.+||+.||.+|||+.+++++.|
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~  300 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC  300 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence            0000000  00011 1112234457788999999999999999999999766555

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-41  Score=309.10  Aligned_cols=235  Identities=23%  Similarity=0.333  Sum_probs=186.3

Q ss_pred             HhcCCCCC-CeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHH-hcCCCCceeceEEEEEe----C
Q 041907           46 ATENFSPA-NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTW-SKIEHLNLVKLFGFLEH----G  118 (380)
Q Consensus        46 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~  118 (380)
                      ..++|.+. +.||+|+||.||+|.+. +|+.||+|++...       ..+.+|+.++ +.++||||+++++++..    .
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            34677776 77999999999999986 6899999998642       2355788877 55699999999999887    6


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEccc
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAKVTDF  195 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Df  195 (380)
                      ...++||||+++++|.+++.......+++..++.++.||+.||.|||+.|   ++|+||||+|||++.   ++.+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence            77899999999999999998876667999999999999999999999999   999999999999998   788999999


Q ss_pred             cccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          196 GFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      |++....                         +..++.++|||||||++|+|++|..||..........           
T Consensus       165 g~a~~~~-------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------  208 (299)
T 3m2w_A          165 GFAKETT-------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------  208 (299)
T ss_dssp             TTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------
T ss_pred             ccccccc-------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------
Confidence            9886432                         1346778999999999999999999997644321100           


Q ss_pred             CCcccccccCCCCCCCC----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          276 GDAILVMDPRLRRTPAS----NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      . ....+...  .....    ..++..+.+|+.+||+.||.+|||+.++++|+|-...
T Consensus       209 ~-~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          209 G-MKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             C-SCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             H-HHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            0 00000000  01111    2345789999999999999999999999999996644

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.9e-41  Score=341.54  Aligned_cols=242  Identities=24%  Similarity=0.336  Sum_probs=194.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC--CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE---
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK--DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE---  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  120 (380)
                      ..++|++.+.||+|+||.||+|.+.  +|+.||||++..... ......+.+|+.++.+++||||+++++++...+.   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            3478999999999999999999986  589999999875433 3345568899999999999999999999987655   


Q ss_pred             --EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          121 --RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       121 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                        .||||||+++++|.+++..    .+++..++.++.||+.||.|||++|   |+||||||+|||++.+ .+||+|||++
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             ceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence              7999999999999988765    4899999999999999999999999   9999999999999985 8999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      +.....       ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......                 
T Consensus       229 ~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          229 SRINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             EETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             hhcccC-------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            865432       3456999999999998754 889999999999999999998886421110                 


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHH-HHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK-CAEILWKIR  328 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-il~~l~~~~  328 (380)
                             .............+.++|.+||+.||.+||+..+ +...+..+.
T Consensus       284 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 -------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   0001111233467889999999999999996555 444455443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-41  Score=324.97  Aligned_cols=245  Identities=13%  Similarity=0.187  Sum_probs=183.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCC-Cce---------e------
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEH-LNL---------V------  109 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~ni---------v------  109 (380)
                      .+|...+.||+|+||.||+|.+. +|+.||||++..... .......+.+|+.+++.+.| .|.         +      
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45778889999999999999976 699999999874332 22234568899999999977 211         1      


Q ss_pred             ------ceEEEEEe-----CCEEEEEEEeCCCCCHHHHhc-----cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 041907          110 ------KLFGFLEH-----GDERIIVVEYVGNGTLREHLD-----GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPII  173 (380)
Q Consensus       110 ------~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~  173 (380)
                            .++.++..     ....+++|+++ +++|.+++.     ......+++..++.++.||+.||.|||++|   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                  11111111     22457777766 679999985     222334778899999999999999999999   99


Q ss_pred             eccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhh----------hhcCCCCccchhhHHHH
Q 041907          174 HRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL----------RTYQLTEKSDVYSFGVL  243 (380)
Q Consensus       174 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlGvi  243 (380)
                      ||||||+|||++.++.+||+|||+++.....      .....| +.|+|||++          .+..++.++|||||||+
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999998764421      344567 999999999          55568889999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHH
Q 041907          244 LVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEI  323 (380)
Q Consensus       244 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~  323 (380)
                      +|+|++|+.||..........               ..+...       ..++..+.+||.+||+.+|.+||++.+++++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~~-------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSE---------------WIFRSC-------KNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSG---------------GGGSSC-------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHCCCCCCCcchhhhHH---------------HHHhhc-------ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999997654322110               011100       1234679999999999999999999999887


Q ss_pred             HH
Q 041907          324 LW  325 (380)
Q Consensus       324 l~  325 (380)
                      .|
T Consensus       365 ~~  366 (413)
T 3dzo_A          365 PE  366 (413)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.4e-41  Score=316.47  Aligned_cols=249  Identities=18%  Similarity=0.172  Sum_probs=190.1

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCc------chHHHHHHHHHHHHHhcCC---------CCceec
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKH------DKCLLLEFKNEILTWSKIE---------HLNLVK  110 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~niv~  110 (380)
                      ..++|++.+.||+|+||+||+|.+ +|+.||||++.....      .......+.+|+.++++++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            357789999999999999999998 589999999986532      1222356778888888775         777777


Q ss_pred             eEEEEE------------------------------eCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 041907          111 LFGFLE------------------------------HGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA  160 (380)
Q Consensus       111 ~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~  160 (380)
                      +.+++.                              .....++||||+++|++.+.+..   ..+++..++.++.||+.|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence            777643                              26789999999999977777754   338999999999999999


Q ss_pred             HHHHh-hCCCCCeeeccCCCCceeeCCCC--------------------ceEEccccccccccCCCcceeeeecccCCcc
Q 041907          161 LTYLH-TYSDPPIIHRDVKASNILITEKL--------------------RAKVTDFGFARMSEEDSAVSHISTQVKGTAG  219 (380)
Q Consensus       161 l~~LH-~~~~~~i~H~dlkp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~  219 (380)
                      |.||| ++|   |+||||||+|||++.++                    .+||+|||+++.....        ...||+.
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt~~  242 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECCCC
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEeec
Confidence            99999 899   99999999999999887                    8999999999865432        2369999


Q ss_pred             ccChhhhhhcCCCCccchhhHHHH-HHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHH
Q 041907          220 YLDPDYLRTYQLTEKSDVYSFGVL-LVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEK  298 (380)
Q Consensus       220 y~aPE~~~~~~~~~~~DiwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (380)
                      |+|||++.+.. +.++||||||++ .++++.|..||.....      ............    ..............+.+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQM----TFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHTC----CCSSCCCSHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhhh----ccCcccchhhhhhcCHH
Confidence            99999999766 889999998777 7778889999842100      000111111000    00011112234567889


Q ss_pred             HHHHHHHhcCCCCCCCCChHHHH-HHHH
Q 041907          299 ILGLADVCLAPTRQSRPTMKKCA-EILW  325 (380)
Q Consensus       299 l~~li~~cl~~~p~~RPt~~eil-~~l~  325 (380)
                      +.+||.+||+.|     |++|++ +|.|
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             HHHHHHHHhccC-----CHHHHHhcCCC
Confidence            999999999976     999999 8876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3e-33  Score=276.78  Aligned_cols=186  Identities=15%  Similarity=0.093  Sum_probs=130.6

Q ss_pred             eeccCceEEEEEEeC-CCCEEEEEEccccCc--------chHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEEEEE
Q 041907           56 IGEGGSGTVYKGKLK-DGSIVAVKRARKNKH--------DKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        56 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .+.|++|.+..++.. -|+.|++|++.....        ......++.+|+.+|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            445555555544432 378899999975421        123345699999999999 7999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++|++|.++|...+.  ++..   +|+.||+.||.|||++|   ||||||||+|||++.+|.+||+|||+++......
T Consensus       322 Eyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999987653  5543   48899999999999999   9999999999999999999999999998765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYP  253 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p  253 (380)
                         ......+||+.|||||++.+ .+..++|+|++|++++++.++..+
T Consensus       394 ---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 ---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ---ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence               12345679999999999987 467789999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.4e-29  Score=249.18  Aligned_cols=188  Identities=18%  Similarity=0.232  Sum_probs=146.5

Q ss_pred             CCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcc------hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           51 SPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD------KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ...+.||+|+||.||+|... ++.+++|........      ......+.+|+.++++++||||+++..++......+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44678999999999999554 788999986543221      11234578999999999999999666666677778999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++++|.+++..          +..++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999976          4578999999999999999   999999999999998  9999999999876543


Q ss_pred             Ccce----eeeecccCCccccChhhhhh--cCCCCccchhhHHHHHHHHHhCCCCC
Q 041907          205 SAVS----HISTQVKGTAGYLDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPI  254 (380)
Q Consensus       205 ~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~  254 (380)
                      ....    .......||+.|||||++..  ..|+...|+|+..+-.++-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2111    01235679999999999987  66788899999999998888877666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.5e-26  Score=207.85  Aligned_cols=154  Identities=12%  Similarity=0.130  Sum_probs=121.3

Q ss_pred             HHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcch----------------HHHHHHHHHHHHHhcCCC
Q 041907           42 EIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDK----------------CLLLEFKNEILTWSKIEH  105 (380)
Q Consensus        42 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h  105 (380)
                      .+......|.+.+.||+|+||.||+|.+.+|+.||||+++......                .....+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            3344455677779999999999999999779999999997543211                13456889999999998 


Q ss_pred             CceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC
Q 041907          106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT  185 (380)
Q Consensus       106 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~  185 (380)
                       | +++.+++.. +..++||||++|++|.+ +..        .....++.|++.||.|||+.|   |+||||||+|||++
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence             4 566665544 34599999999999988 421        123468999999999999999   99999999999999


Q ss_pred             CCCceEEccccccccccCCCcceeeeecccCCccccChhhhhh
Q 041907          186 EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRT  228 (380)
Q Consensus       186 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  228 (380)
                       ++.+||+|||+++.                +..++|||++.+
T Consensus       228 -~~~vkl~DFG~a~~----------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE----------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE----------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE----------------CCCCCHHHHHHH
Confidence             99999999999863                445789998864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=2.6e-21  Score=172.72  Aligned_cols=140  Identities=19%  Similarity=0.252  Sum_probs=108.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEe-CCCCE--EEEEEccccCcc----------------------hHHHHHHHHHHHHHhc
Q 041907           48 ENFSPANKIGEGGSGTVYKGKL-KDGSI--VAVKRARKNKHD----------------------KCLLLEFKNEILTWSK  102 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~----------------------~~~~~~~~~e~~~l~~  102 (380)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                      ......+.+|+..|.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999998 57888  999987543211                      1112357899999999


Q ss_pred             CCCCce--eceEEEEEeCCEEEEEEEeCCC-C----CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeee
Q 041907          103 IEHLNL--VKLFGFLEHGDERIIVVEYVGN-G----TLREHLDGRGGNGLELAERLDIAIDVAHALTYLH-TYSDPPIIH  174 (380)
Q Consensus       103 l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H  174 (380)
                      +.|+++  +.++++    ...+|||||+.+ |    +|.+++..     .++..+..++.|++.+|.||| +.|   |+|
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            988754  444443    245899999942 3    77776543     224456789999999999999 888   999


Q ss_pred             ccCCCCceeeCCCCceEEccccccccc
Q 041907          175 RDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       175 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=8.6e-19  Score=163.03  Aligned_cols=139  Identities=17%  Similarity=0.161  Sum_probs=102.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcc----------------h----HHHHHHHHHHHHHhcCCCC
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD----------------K----CLLLEFKNEILTWSKIEHL  106 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------~----~~~~~~~~e~~~l~~l~h~  106 (380)
                      .--|++.++||.|+||.||+|.+.+|+.||||+++.....                .    ........|...|.++.+.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3458999999999999999999999999999987643110                0    0011123567777777554


Q ss_pred             ce--eceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceee
Q 041907          107 NL--VKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILI  184 (380)
Q Consensus       107 ni--v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~  184 (380)
                      ++  ...+++  ..  .+|||||++|++|.++...        .....++.||+.+|.+||+.|   ||||||||.|||+
T Consensus       174 gv~vp~p~~~--~~--~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl  238 (397)
T 4gyi_A          174 GFPVPEPIAQ--SR--HTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI  238 (397)
T ss_dssp             TCSCCCEEEE--ET--TEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             CCCCCeeeec--cC--ceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence            43  223322  22  2799999999888665421        133567899999999999999   9999999999999


Q ss_pred             CCCC----------ceEEcccccccc
Q 041907          185 TEKL----------RAKVTDFGFARM  200 (380)
Q Consensus       185 ~~~~----------~~kl~Dfg~~~~  200 (380)
                      ++++          .+.|+||+-+..
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             eCCCCcccccccccceEEEEeCCccc
Confidence            9876          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.46  E-value=2.2e-13  Score=121.44  Aligned_cols=145  Identities=16%  Similarity=0.145  Sum_probs=112.9

Q ss_pred             HHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEE
Q 041907           45 KATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        45 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  123 (380)
                      .....|.+...++.|+.+.||++... |+.+++|+........  ...+.+|+.+++.+. +..+.++++++...+..++
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            34467888889999999999999865 7889999987532111  124678899988884 6778899999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS-----------------------------------  168 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  168 (380)
                      ||||++|.+|.+.+..       ......++.+++.+|..||+..                                   
T Consensus        88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            9999999999877421       1123467889999999999811                                   


Q ss_pred             ---------------------CCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          169 ---------------------DPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       169 ---------------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                                           ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 1348999999999999876556799999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=6.6e-12  Score=111.38  Aligned_cols=137  Identities=16%  Similarity=0.158  Sum_probs=99.0

Q ss_pred             CCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc--eeceEEEEEeCCEEEEEEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN--LVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e  126 (380)
                      .+.+....+.|..+.||++...+|+.+++|.......     ..+..|+..++.+.+.+  +.+++++....+..++|||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~-----~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc-----hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            4444333345556899999877788899999765421     24668888888875444  5668888888888999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS--------------------------------------  168 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  168 (380)
                      |++|.+|.  ...     ...   ..++.+++..|..||+..                                      
T Consensus        96 ~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           96 EVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             ecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            99998883  221     121   256778888888888643                                      


Q ss_pred             -----------------CCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          169 -----------------DPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       169 -----------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                                       ...++|+|++|.||++++++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             11299999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.21  E-value=3.4e-11  Score=112.26  Aligned_cols=144  Identities=17%  Similarity=0.264  Sum_probs=106.3

Q ss_pred             CCCCeeeccCceEEEEEEeCCCCEEEEEEcc--ccCcchHHHHHHHHHHHHHhcCC--CCceeceEEEEEeC---CEEEE
Q 041907           51 SPANKIGEGGSGTVYKGKLKDGSIVAVKRAR--KNKHDKCLLLEFKNEILTWSKIE--HLNLVKLFGFLEHG---DERII  123 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~l  123 (380)
                      ...+.|+.|.++.||++... +..+++|+..  ..... .....+.+|+.+++.+.  +..+++++.++.+.   +..++
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            34667899999999999876 4678889876  33211 12335778999998886  45688899888766   45789


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS-----------------------------------  168 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  168 (380)
                      ||||++|..+.+..    ...++......++.+++..|..||+..                                   
T Consensus       119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999997774421    122677888889999999999999731                                   


Q ss_pred             --------------------CCCeeeccCCCCceeeCCCCc--eEEcccccccc
Q 041907          169 --------------------DPPIIHRDVKASNILITEKLR--AKVTDFGFARM  200 (380)
Q Consensus       169 --------------------~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~  200 (380)
                                          ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                145999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.19  E-value=1.3e-11  Score=112.34  Aligned_cols=183  Identities=19%  Similarity=0.201  Sum_probs=121.7

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCc--eeceEEEEEeCC---EEEEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLN--LVKLFGFLEHGD---ERIIVVE  126 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e  126 (380)
                      .+.++.|....||++.    ..+++|+....    .....+.+|+..|+.+. +..  +.+++.......   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4668999999999864    45888986532    23456789999998773 332  445555443332   3478999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS--------------------------------------  168 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  168 (380)
                      +++|.+|......    .++..+...++.+++..+..||+..                                      
T Consensus        97 ~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           97 KIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             ccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9999888754321    2677777788888888888888621                                      


Q ss_pred             -----------------CCCeeeccCCCCceeeCC--CCceEEccccccccccCCCcceeeeecccCCccc---cChhhh
Q 041907          169 -----------------DPPIIHRDVKASNILITE--KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY---LDPDYL  226 (380)
Q Consensus       169 -----------------~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~  226 (380)
                                       ...++|+|++|.||++++  +..+.|+||+.+..-.......       ....+   ..|+..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-------~~~~~~~~~~~~~~  245 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-------SLMEDDEEYGMEFV  245 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-------TTCCTTTSCCHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-------HHHhhccccCHHHH
Confidence                             134899999999999998  5568899999886533211110       11111   223321


Q ss_pred             ----hhcCC----------CCccchhhHHHHHHHHHhCCCCC
Q 041907          227 ----RTYQL----------TEKSDVYSFGVLLVEMMTGRYPI  254 (380)
Q Consensus       227 ----~~~~~----------~~~~DiwSlGvil~elltg~~p~  254 (380)
                          .....          ....+.|++|.++|.+.+|..+|
T Consensus       246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                11111          12258999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=1.3e-07  Score=84.16  Aligned_cols=135  Identities=19%  Similarity=0.248  Sum_probs=98.1

Q ss_pred             eeeccCce-EEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           55 KIGEGGSG-TVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        55 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .+..|.-+ .||+.... ++..+++|+-...     ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            45555554 68988765 4667999986543     2345778888888774 334788899999999999999999998


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------------------
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS-------------------------------------------  168 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------  168 (380)
                      ++.+......      .....+..++...|..||...                                           
T Consensus       106 ~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          106 TAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             EHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            8877664321      223345667777777777521                                           


Q ss_pred             ------------CCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          169 ------------DPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       169 ------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                                  ...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        11389999999999999877777999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.68  E-value=2.5e-07  Score=84.00  Aligned_cols=136  Identities=17%  Similarity=0.164  Sum_probs=94.1

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC---ceeceEEEEE-eCCEEEEEEEeC
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL---NLVKLFGFLE-HGDERIIVVEYV  128 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~  128 (380)
                      .+.++.|....||+.    |..+++|+...    ......+..|+.+|+.+.+.   .+.+++.++. ..+..++||+|+
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            456788888899988    56688898532    22345688999999988642   3666777664 345678999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS----------------------------------------  168 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  168 (380)
                      +|.+|......    .++......++.++...|..||+..                                        
T Consensus        96 ~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           96 QGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            99888763211    1344445555555555555555432                                        


Q ss_pred             -----------------CCCeeeccCCCCceeeCC---CCc-eEEcccccccc
Q 041907          169 -----------------DPPIIHRDVKASNILITE---KLR-AKVTDFGFARM  200 (380)
Q Consensus       169 -----------------~~~i~H~dlkp~Nil~~~---~~~-~kl~Dfg~~~~  200 (380)
                                       ...++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             234799999999999997   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.41  E-value=5.2e-07  Score=83.61  Aligned_cols=82  Identities=7%  Similarity=0.049  Sum_probs=53.4

Q ss_pred             CCee-eccCceEEEEEEeC-------CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCC---CceeceEEEEEeC--
Q 041907           53 ANKI-GEGGSGTVYKGKLK-------DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEH---LNLVKLFGFLEHG--  118 (380)
Q Consensus        53 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--  118 (380)
                      .+.| +.|..+.+|+....       +++.+++|+...... .......+..|+.+++.+..   ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3556 77888899988754       266799998754320 00001235677777777632   3567788877654  


Q ss_pred             -CEEEEEEEeCCCCCHH
Q 041907          119 -DERIIVVEYVGNGTLR  134 (380)
Q Consensus       119 -~~~~lv~e~~~~~~L~  134 (380)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.18  E-value=1.3e-05  Score=73.37  Aligned_cols=30  Identities=27%  Similarity=0.384  Sum_probs=27.0

Q ss_pred             CCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            459999999999999888899999999765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.13  E-value=2.2e-05  Score=71.14  Aligned_cols=138  Identities=14%  Similarity=0.176  Sum_probs=90.7

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC---CCceeceEEEEEeCCEEEEEEEeC
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE---HLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      -.+.|+.|....+|+.... +..+++|+....     ....+..|+..|+.+.   ...+++++.+....+..++||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            3467899999999999864 678899987643     1345778888888773   357888999888888899999999


Q ss_pred             CCCCHHH-----------HhccCCC---C-----------------CCCHHHHH---HHH----------------HHHH
Q 041907          129 GNGTLRE-----------HLDGRGG---N-----------------GLELAERL---DIA----------------IDVA  158 (380)
Q Consensus       129 ~~~~L~~-----------~i~~~~~---~-----------------~~~~~~~~---~i~----------------~~i~  158 (380)
                      ++..+..           .|+....   .                 .-+|....   ++.                ..++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9876421           1222211   0                 01343221   111                1122


Q ss_pred             HHH-HHHhhC-CCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          159 HAL-TYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       159 ~~l-~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                      ..+ ..|... ..+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            222 234321 135599999999999999887 8899984

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.11  E-value=1e-05  Score=76.04  Aligned_cols=77  Identities=13%  Similarity=0.113  Sum_probs=47.8

Q ss_pred             CCeeeccCceEEEEEEeC-CCCEEEEEEccccCc--ch---HHHHHHHHHHHHHhcCCC--C-ceeceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH--DK---CLLLEFKNEILTWSKIEH--L-NLVKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~---~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l  123 (380)
                      .+.||.|..+.||++... +++.|+||.......  ..   .....+..|...++.+..  + .+.+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999765 478899998653211  00   112235677788776632  3 34455544  3445689


Q ss_pred             EEEeCCCC
Q 041907          124 VVEYVGNG  131 (380)
Q Consensus       124 v~e~~~~~  131 (380)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.86  E-value=0.00013  Score=65.32  Aligned_cols=80  Identities=18%  Similarity=0.226  Sum_probs=55.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC---CceeceEEEEEeCCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH---LNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~lv  124 (380)
                      ....-.+.+|.|..+.||+....+|+.|++|+........  ...+..|+..|+.+..   --+++++++.  .  .++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEE
Confidence            4455677899999999999999999999999876543221  2236688888877732   2345555542  2  3689


Q ss_pred             EEeCCCCCH
Q 041907          125 VEYVGNGTL  133 (380)
Q Consensus       125 ~e~~~~~~L  133 (380)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.77  E-value=0.00015  Score=68.71  Aligned_cols=76  Identities=13%  Similarity=0.151  Sum_probs=45.2

Q ss_pred             CCCeeeccCceEEEEEEeCCCCEEEEEEcccc-----Cc-c-hHHHHHHHHHHHHHh-cCCCCceeceEEEEEeCCEEEE
Q 041907           52 PANKIGEGGSGTVYKGKLKDGSIVAVKRARKN-----KH-D-KCLLLEFKNEILTWS-KIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        52 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~~-~-~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      -.+.||.|..+.||++.. +++.++||.....     .. . ......+..|+..+. ......+.+++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            356789999999999965 4678999943211     00 0 001222334433332 22334567777665  456789


Q ss_pred             EEEeC-CC
Q 041907          124 VVEYV-GN  130 (380)
Q Consensus       124 v~e~~-~~  130 (380)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.75  E-value=0.00021  Score=64.88  Aligned_cols=157  Identities=13%  Similarity=0.122  Sum_probs=84.3

Q ss_pred             ccHHHHHHHhcCCCCC-----CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc--eec
Q 041907           38 FSFEEIYKATENFSPA-----NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN--LVK  110 (380)
Q Consensus        38 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~  110 (380)
                      ++.+++...-.+|.+.     +.|+.|....+|+....+| .+++|+.......    ..+..|+.++..+...+  +.+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~   81 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPL   81 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCc
Confidence            4456666666667653     3455677789999987755 5888988653111    12345566555542111  233


Q ss_pred             eEE------EEEeCCEEEEEEEeCCCCCHHH--------------HhccC----CCC---CCC---HHHHHH--------
Q 041907          111 LFG------FLEHGDERIIVVEYVGNGTLRE--------------HLDGR----GGN---GLE---LAERLD--------  152 (380)
Q Consensus       111 ~~~------~~~~~~~~~lv~e~~~~~~L~~--------------~i~~~----~~~---~~~---~~~~~~--------  152 (380)
                      ++.      +....+..+++|+|++|..+..              .++..    ...   ...   |...+.        
T Consensus        82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (322)
T 2ppq_A           82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE  161 (322)
T ss_dssp             BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred             ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence            331      1233567789999998865311              01111    100   011   111000        


Q ss_pred             ----HHHHHHHHHHHHhhC----CCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          153 ----IAIDVAHALTYLHTY----SDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       153 ----i~~~i~~~l~~LH~~----~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                          +...+...+..+...    ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                001133344555421    12349999999999999987656899999765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.72  E-value=0.00014  Score=66.49  Aligned_cols=140  Identities=14%  Similarity=0.174  Sum_probs=71.4

Q ss_pred             CeeeccCceE-EEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC--CceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGT-VYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH--LNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      +.|+.|+... +|+....+|..+++|.......     ..+..|+.++..+..  -.+.+++.+....+  +++||++.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~   96 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD   96 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence            4565555554 5676654467788886554321     122345555555432  23566776643333  689999987


Q ss_pred             CCHHHHhccCC-----------------------C-CCCCHHHHH-------H-H------------HHHHHHHHHHHh-
Q 041907          131 GTLREHLDGRG-----------------------G-NGLELAERL-------D-I------------AIDVAHALTYLH-  165 (380)
Q Consensus       131 ~~L~~~i~~~~-----------------------~-~~~~~~~~~-------~-i------------~~~i~~~l~~LH-  165 (380)
                      ..+.+.+....                       . ..++.....       . +            ...+...+..+. 
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            77654442110                       0 011111100       0 0            001111222221 


Q ss_pred             --hCCCCCeeeccCCCCceeeCCC----CceEEcccccccc
Q 041907          166 --TYSDPPIIHRDVKASNILITEK----LRAKVTDFGFARM  200 (380)
Q Consensus       166 --~~~~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~  200 (380)
                        ......++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence              1113459999999999999874    6799999998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.60  E-value=0.0015  Score=59.27  Aligned_cols=141  Identities=19%  Similarity=0.124  Sum_probs=78.5

Q ss_pred             CeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCC--ceeceEEE-----EEeCCEEEEEEE
Q 041907           54 NKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL--NLVKLFGF-----LEHGDERIIVVE  126 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e  126 (380)
                      ..|+ |....||+....+|+.+++|.........   ..+..|...+..+...  .+++++..     ....+..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3466 77889999887777789999987442222   2345566666655321  23333332     233567789999


Q ss_pred             eCCCCCHH-----HH---------hcc----CCC---CCCCHHHH----------------------HHHHHHHHHHHHH
Q 041907          127 YVGNGTLR-----EH---------LDG----RGG---NGLELAER----------------------LDIAIDVAHALTY  163 (380)
Q Consensus       127 ~~~~~~L~-----~~---------i~~----~~~---~~~~~~~~----------------------~~i~~~i~~~l~~  163 (380)
                      |++|..+.     .+         ++.    ...   ..+++...                      ..++..++..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875432     00         111    110   01221110                      0111122222222


Q ss_pred             Hhh-CCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          164 LHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       164 LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      +.. .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            211 1134489999999999999 4 899999997653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.59  E-value=0.00024  Score=59.93  Aligned_cols=101  Identities=13%  Similarity=0.061  Sum_probs=65.4

Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      -+|.+.|...+ .++++.++|.++.|.+.+|.-+-....  -..+=+.|..|++..+|.|.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----------
Confidence            37899998775 569999999999999999877632111  11223457889999999888764 2110           


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR  251 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  251 (380)
                          .....+.|||... ...+.+.=|||||++||..+-=.
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                1233456888763 23456788999999999988633

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.49  E-value=0.00015  Score=65.26  Aligned_cols=71  Identities=13%  Similarity=0.216  Sum_probs=43.6

Q ss_pred             CCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEEEeC-CC
Q 041907           53 ANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVVEYV-GN  130 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~  130 (380)
                      .+.|+.|....+|+.     +.+++|+.......   .....+|+..++.+...++ .+++++.  ...-++++||+ +|
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence            678999999999998     44888987653211   1112467776666643223 4555543  33347899999 66


Q ss_pred             CCH
Q 041907          131 GTL  133 (380)
Q Consensus       131 ~~L  133 (380)
                      .+|
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.47  E-value=0.00021  Score=67.84  Aligned_cols=73  Identities=18%  Similarity=0.266  Sum_probs=47.6

Q ss_pred             CCeeeccCceEEEEEEeCC--------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l  123 (380)
                      .+.|+.|....||++...+        ++.|++|+......    ...+..|..+++.+...++ .++++.+.  +  .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            4567788889999998753        57899998843211    1234468888877743333 56666553  2  38


Q ss_pred             EEEeCCCCCH
Q 041907          124 VVEYVGNGTL  133 (380)
Q Consensus       124 v~e~~~~~~L  133 (380)
                      |+||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            8999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.45  E-value=0.00026  Score=65.81  Aligned_cols=141  Identities=13%  Similarity=0.190  Sum_probs=80.3

Q ss_pred             CCeeeccCceEEEEEEeC--------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc-eeceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-LVKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l  123 (380)
                      .+.|..|-...+|++...        +++.|++|+......   ....+.+|..+++.+.--+ ..++++++.+    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            356777777889999874        257899998643211   1334558888887774322 3566665532    38


Q ss_pred             EEEeCCCCCHHHH-----------------hccCC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 041907          124 VVEYVGNGTLREH-----------------LDGRG---GNGLE--LAERLDIAIDVAH-------------------ALT  162 (380)
Q Consensus       124 v~e~~~~~~L~~~-----------------i~~~~---~~~~~--~~~~~~i~~~i~~-------------------~l~  162 (380)
                      ||||++|.+|...                 |+...   +....  +.++.++..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999988655311                 11111   11122  2344444443321                   122


Q ss_pred             ----HHhhCC-CCCeeeccCCCCceeeCCC----CceEEcccccccc
Q 041907          163 ----YLHTYS-DPPIIHRDVKASNILITEK----LRAKVTDFGFARM  200 (380)
Q Consensus       163 ----~LH~~~-~~~i~H~dlkp~Nil~~~~----~~~kl~Dfg~~~~  200 (380)
                          .|...+ ...++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                232221 3459999999999999876    6899999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.32  E-value=0.00072  Score=61.96  Aligned_cols=31  Identities=19%  Similarity=0.338  Sum_probs=27.4

Q ss_pred             CCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.20  E-value=0.001  Score=63.52  Aligned_cols=73  Identities=14%  Similarity=0.141  Sum_probs=45.9

Q ss_pred             CeeeccCceEEEEEEeCC-CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEEEEeCCCC
Q 041907           54 NKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      +.|+.|-...+|++...+ +..|++|+.......   ......|..++..+...++ .++++++  .+  .+||||++|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~  186 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGY  186 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSE
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCc
Confidence            456777778999998864 478999987543211   1112478888887765444 5667666  22  3599999875


Q ss_pred             CH
Q 041907          132 TL  133 (380)
Q Consensus       132 ~L  133 (380)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.06  E-value=0.00072  Score=62.64  Aligned_cols=74  Identities=15%  Similarity=0.202  Sum_probs=43.4

Q ss_pred             CCeeeccCceEEEEEEeCC---------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc-eeceEEEEEeCCEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKD---------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-LVKLFGFLEHGDERI  122 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~  122 (380)
                      .+.|+.|....+|++...+         ++.+++|+.......   ......|..+++.+...+ +.++++..  .+  +
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE---LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG---TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc---eecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence            3467778888999998753         268999987543211   112346777777664333 44666544  22  6


Q ss_pred             EEEEeCCCCCH
Q 041907          123 IVVEYVGNGTL  133 (380)
Q Consensus       123 lv~e~~~~~~L  133 (380)
                      +||+|++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.70  E-value=0.031  Score=52.60  Aligned_cols=74  Identities=11%  Similarity=0.165  Sum_probs=46.5

Q ss_pred             CCeeeccCceEEEEEEeCC--------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCc-eeceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN-LVKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l  123 (380)
                      .+.|..|-...+|+....+        ++.|++|+.......   ..+..+|..+++.+...+ ..++++.+  .+  ++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF--PE--GR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence            3456667778999998763        578999987543211   112346777777764322 35555533  22  68


Q ss_pred             EEEeCCCCCH
Q 041907          124 VVEYVGNGTL  133 (380)
Q Consensus       124 v~e~~~~~~L  133 (380)
                      ||+|++|.+|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            8999998664

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.76  E-value=0.12  Score=43.49  Aligned_cols=117  Identities=9%  Similarity=0.089  Sum_probs=81.6

Q ss_pred             CCCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       103 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      ..||+++.. .+-...+.+.+.++.-+.+.=+..|..     ++...+++++.+|+....+++.     -+|.-|.|+|+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~-----~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS-----FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG-----SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh-----cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            368888877 577777777776666543333333433     7889999999999998866554     57899999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCC
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE  255 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  255 (380)
                      +++.++.+++.--|+-..+.+..               +.+|          .=.-.+=|++..+++++..|+
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P~~---------------~~ee----------~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDPLP---------------VSEA----------EFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSCCC---------------CCHH----------HHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCCCCCC---------------CCHH----------HHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999888654322110               1112          122345678889999988885

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.41  E-value=0.17  Score=47.05  Aligned_cols=30  Identities=30%  Similarity=0.559  Sum_probs=25.0

Q ss_pred             CeeeccCCCCceee------CCCCceEEcccccccc
Q 041907          171 PIIHRDVKASNILI------TEKLRAKVTDFGFARM  200 (380)
Q Consensus       171 ~i~H~dlkp~Nil~------~~~~~~kl~Dfg~~~~  200 (380)
                      .++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4556799999998763

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=93.98  E-value=0.23  Score=41.85  Aligned_cols=115  Identities=14%  Similarity=0.130  Sum_probs=81.5

Q ss_pred             CCCceeceEEEEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeeeccCCCCce
Q 041907          104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT-YLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       104 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      .||++  -..+-..++.+.+.++.-+++.=+..+..     ++...+++++.+|+.... +++.     -+|.-|.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            67877  45556778888888887655544555543     788999999999988776 5554     68889999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCC
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE  255 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  255 (380)
                      +++.++.+++.-.|+-..+.+..               +.+|-+          .-.+=|++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~lpP~e---------------~~ee~f----------l~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESLPPDE---------------WDDERL----------LREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTTBSSCS---------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcccCCCCC---------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            99999999999888754322110               122222          2245578888888887774

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.91  E-value=0.034  Score=53.01  Aligned_cols=64  Identities=11%  Similarity=0.024  Sum_probs=19.2

Q ss_pred             CCCCeeeccCceEEEEEEeCC-CCEEEE------EEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe
Q 041907           51 SPANKIGEGGSGTVYKGKLKD-GSIVAV------KRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH  117 (380)
Q Consensus        51 ~~~~~lg~G~~g~V~~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  117 (380)
                      .+.+.||   ||.||++.+.. ..+||+      |..+...........+.+|..++..++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4566776   99999999864 467888      7766544444445567888899999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	380
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-59
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 6e-72
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 23/285 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
              +   +IG G  GTVYKGK      VAVK           L  FKNE+    K  H+N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           ++   G+     +  IV ++    +L  HL        E+ + +DIA   A  + YLH  
Sbjct: 66  ILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH-- 121

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
               IIHRD+K++NI + E L  K+ DFG A +    S  SH   Q+ G+  ++ P+ +R
Sbjct: 122 -AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIR 179

Query: 228 TYQ---LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
                  + +SDVY+FG++L E+MTG+ P  +     + + +               + P
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----------YLSP 229

Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
            L +  ++    + +  L   CL   R  RP   +    +  + +
Sbjct: 230 DLSKVRSN--CPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-63
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 25/277 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E      ++G G  G V+ G     + VAVK  ++          F  E     +++H  
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   I+ EY+ NG+L + L    G  L + + LD+A  +A  + ++   
Sbjct: 70  LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE-- 126

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +   IHRD++A+NIL+++ L  K+ DFG AR+ E++          K    +  P+ + 
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAIN 183

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
               T KSDV+SFG+LL E++T            E       +Q L+ G           
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERG----------Y 227

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           R    +   E++  L  +C     + RPT      +L
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 6e-63
 Identities = 57/296 (19%), Positives = 117/296 (39%), Gaps = 27/296 (9%)

Query: 55  KIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF 114
            IG+G  G V++GK + G  VAVK     +         + EI     + H N++     
Sbjct: 10  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGFIAA 65

Query: 115 LEHGD----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH----- 165
               +    +  +V +Y  +G+L ++L+      + +   + +A+  A  L +LH     
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGF-ARMSEEDSAVSHISTQVKGTAGYLDPD 224
           T   P I HRD+K+ NIL+ +     + D G   R       +        GT  Y+ P+
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 225 YLRT------YQLTEKSDVYSFGVLLVEMMTGRYPIESKK----PIKERVTIRWAMQCLK 274
            L        ++  +++D+Y+ G++  E+          +    P  + V    +++ ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
                  + P +     S  A+  +  +   C      +R T  +  + L ++ + 
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 8e-62
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 25/277 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E+     K+G+G  G V+ G     + VA+K  +           F  E     K+ H  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+  +   +   IV EY+  G+L + L G  G  L L + +D+A  +A  + Y+   
Sbjct: 74  LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
                +HRD++A+NIL+ E L  KV DFG AR+ E++          K    +  P+   
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAAL 187

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             + T KSDV+SFG+LL E+ T           +E                +L    R  
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGY 231

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
           R P      E +  L   C     + RPT +     L
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 11/213 (5%)

Query: 46  ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
             ++F   +++G G  G V+K   K  G ++A K          +  +   E+    +  
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 62

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
              +V  +G      E  I +E++  G+L + L   G   +       ++I V   LTYL
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYL 120

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
                  I+HRDVK SNIL+  +   K+ DFG +    +  A S +     GT  Y+ P+
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE 173

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
            L+    + +SD++S G+ LVEM  GRYPI   
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-61
 Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 31/283 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +       IG+G  G V  G  + G+ VAVK  + +   +     F  E    +++ H N
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSN 61

Query: 108 LVKLFGFLEHGDERI-IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           LV+L G +      + IV EY+  G+L ++L  RG + L     L  ++DV  A+ YL  
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 120

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                 +HRD+ A N+L++E   AKV+DFG  +        S      K    +  P+ L
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE------ASSTQDTGKLPVKWTAPEAL 172

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
           R  + + KSDV+SFG+LL E+ +       + P+K+       +  ++ G          
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKG---------- 216

Query: 287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
            +  A +     +  +   C       RP+  +  E L  I+ 
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (494), Expect = 3e-60
 Identities = 74/309 (23%), Positives = 129/309 (41%), Gaps = 38/309 (12%)

Query: 38  FSFEEIYKATENFSPA---------NKIGEGGSGTVYKGKLK----DGSIVAVKRARKNK 84
           F+FE+  +A   F+             IG G  G V  G LK        VA+K  +   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 85  HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG 144
            +K    +F +E     + +H N++ L G +      +I+ E++ NG+L   L    G  
Sbjct: 67  TEK-QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
             + + + +   +A  + YL    D   +HRD+ A NIL+   L  KV+DFG +R  E+D
Sbjct: 126 TVI-QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 205 SAVSHISTQV--KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK 261
           ++    ++ +  K    +  P+ ++  + T  SDV+S+G+++ E+M+ G  P        
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239

Query: 262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA 321
                      + A    +  D RL   P        +  L   C    R  RP   +  
Sbjct: 240 --------QDVINA----IEQDYRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 322 EILWKIRKD 330
             L K+ ++
Sbjct: 285 NTLDKMIRN 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 1e-59
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 25/293 (8%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEI 97
           ++++      + +  +K+G G  G VY+G  K     VAVK  +++  +     EF  E 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEA 64

Query: 98  LTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDV 157
               +I+H NLV+L G         I+ E++  G L ++L       +     L +A  +
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 158 AHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           + A+ YL        IHRD+ A N L+ E    KV DFG +R+   D+         K  
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFP 179

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
             +  P+ L   + + KSDV++FGVLL E+ T          + +               
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224

Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD 330
              +++   R         EK+  L   C       RP+  +  +    + ++
Sbjct: 225 VYELLEKDYRMERPEGCP-EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-59
 Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 25/282 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
              +   +IG G  G V+ G   +   VA+K  R+    +    +F  E     K+ H  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPK 61

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+G         +V E++ +G L ++L  + G        L + +DV   + YL   
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA-ETLLGMCLDVCEGMAYLE-- 118

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            +  +IHRD+ A N L+ E    KV+DFG  R   +D      ST  K    +  P+   
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFS 175

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             + + KSDV+SFGVL+ E+ +        +   E                ++       
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGF 219

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
           R     +A   +  + + C     + RP   +    L +I +
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 4e-59
 Identities = 66/320 (20%), Positives = 118/320 (36%), Gaps = 49/320 (15%)

Query: 36  INFSFEEIYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCL 89
           +N     +     N      IGEG  G V++ +          ++VAVK  ++      +
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-M 59

Query: 90  LLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG----- 144
             +F+ E    ++ ++ N+VKL G    G    ++ EY+  G L E L     +      
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 145 -----------------LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK 187
                            L  AE+L IA  VA  + YL        +HRD+   N L+ E 
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176

Query: 188 LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEM 247
           +  K+ DFG +R                    ++ P+ +   + T +SDV+++GV+L E+
Sbjct: 177 MVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235

Query: 248 MTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCL 307
            +           +E +                V D  +   P +     ++  L  +C 
Sbjct: 236 FSYGLQPYYGMAHEEVIY--------------YVRDGNILACPEN--CPLELYNLMRLCW 279

Query: 308 APTRQSRPTMKKCAEILWKI 327
           +     RP+      IL ++
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 5e-59
 Identities = 58/304 (19%), Positives = 127/304 (41%), Gaps = 28/304 (9%)

Query: 41  EEIYKATENFSPAN-KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNE 96
           ++++   +N   A+ ++G G  G+V +G  +       VA+K  ++   +K    E   E
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMRE 59

Query: 97  ILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
                ++++  +V+L G  +  +  ++V+E  G G L + L G+    + ++   ++   
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQ 117

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           V+  + YL    +   +HRD+ A N+L+  +  AK++DFG ++    D +     +  K 
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKA 275
              +  P+ +   + + +SDV+S+GV + E ++ G+ P +  K  +        M  ++ 
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227

Query: 276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKA 335
           G          +R         ++  L   C     + RP      + +         K 
Sbjct: 228 G----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

Query: 336 PSSF 339
               
Sbjct: 278 EGHH 281

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 5e-59
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 27/281 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           ++ +   ++G G  G V  GK +    VA+K  ++    +    EF  E      + H  
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEK 60

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           LV+L+G         I+ EY+ NG L  +L        +  + L++  DV  A+ YL   
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE-- 117

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
                +HRD+ A N L+ ++   KV+DFG +R   +D      S   K    +  P+ L 
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 174

Query: 228 TYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
             + + KSD+++FGVL+ E+ + G+ P E               + +  G          
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQG---------- 217

Query: 287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
            R    ++A EK+  +   C       RPT K     +  +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 75/316 (23%), Positives = 123/316 (38%), Gaps = 29/316 (9%)

Query: 22  YVSSSSPKSGQATTINFSFEEIYKATENFSPANKIGEGGSGTVYKGKLKDGS----IVAV 77
           ++  S+        +            +F+    IG G  G VY G L D        AV
Sbjct: 3   HIDLSALNPELVQAVQHVVIGPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 78  KRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGF-LEHGDERIIVVEYVGNGTLREH 136
           K   +       + +F  E +      H N++ L G  L      ++V+ Y+ +G LR  
Sbjct: 61  KSLNRITDIG-EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119

Query: 137 LDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG 196
           +     N   + + +   + VA  +      +    +HRD+ A N ++ EK   KV DFG
Sbjct: 120 IRNETHN-PTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175

Query: 197 FAR-MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIE 255
            AR M +++    H  T  K    ++  + L+T + T KSDV+SFGVLL E+MT   P  
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-- 233

Query: 256 SKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP 315
              P  +  T    +  L+            RR        + +  +   C  P  + RP
Sbjct: 234 ---PYPDVNTFDITVYLLQG-----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRP 279

Query: 316 TMKKCAEILWKIRKDF 331
           +  +    +  I   F
Sbjct: 280 SFSELVSRISAIFSTF 295

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 3e-57
 Identities = 63/275 (22%), Positives = 115/275 (41%), Gaps = 27/275 (9%)

Query: 54  NKIGEGGSGTVYKGKLKD---GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVK 110
            ++G G  GTV KG  +       VAVK  +   +D  L  E   E     ++++  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 111 LFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDP 170
           + G  E  +  ++V+E    G L ++L       ++    +++   V+  + YL    + 
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ES 126

Query: 171 PIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ 230
             +HRD+ A N+L+  +  AK++DFG ++    D       T  K    +  P+ +  Y+
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 231 LTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT 289
            + KSDV+SFGVL+ E  + G+ P    K              L+ G+          R 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGE----------RM 229

Query: 290 PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                   ++  L ++C     ++RP        L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-57
 Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 27/280 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E++     IG G  G   K + K DG I+  K        +       +E+    +++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 107 NLVKLFGFLEHGDERI--IVVEYVGNGTLREHLD--GRGGNGLELAERLDIAIDVAHALT 162
           N+V+ +  +         IV+EY   G L   +    +    L+    L +   +  AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 163 YLHTYSD--PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
             H  SD    ++HRD+K +N+ +  K   K+ DFG AR+   D   +  +    GT  Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD---TSFAKAFVGTPYY 180

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL 280
           + P+ +      EKSD++S G LL E+     P  +              +         
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------KELAGK----- 225

Query: 281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
           + + + RR P      +++  +    L      RP++++ 
Sbjct: 226 IREGKFRRIPYR--YSDELNEIITRMLNLKDYHRPSVEEI 263

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-56
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 31/302 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS-----IVAVKRARKNKHDKCLLLEFKNEILTWSK 102
              +    IG G  G VYKG LK  S      VA+K  +    +K   ++F  E     +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQ 65

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
             H N+++L G +      +I+ EY+ NG L + L  + G    + + + +   +A  + 
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMK 124

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YL    +   +HRD+ A NIL+   L  KV+DFG +R+ E+D   ++ ++  K    +  
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM 282
           P+ +   + T  SDV+SFG+++ E+MT       +    E       M+ +  G      
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDG------ 229

Query: 283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSS 342
                R P        I  L   C    R  RP       IL K+      +AP S  + 
Sbjct: 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI-----RAPDSLKTL 280

Query: 343 SS 344
           + 
Sbjct: 281 AD 282

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 4e-56
 Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 30/273 (10%)

Query: 54  NKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLF 112
            +IG G   TVYKG   +    VA    +  K  K     FK E      ++H N+V+ +
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 113 GFLEHGDER----IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS 168
              E   +     ++V E + +GTL+ +L       +++         +   L +LHT +
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT 132

Query: 169 DPPIIHRDVKASNILIT-EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            PPIIHRD+K  NI IT      K+ D G A +       +  +  V GT  ++ P+   
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-----ASFAKAVIGTPEFMAPEMYE 186

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLR 287
             +  E  DVY+FG+ ++EM T  YP    +   +    R     +K      V  P ++
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEVK 243

Query: 288 RTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
                         + + C+   +  R ++K  
Sbjct: 244 E-------------IIEGCIRQNKDERYSIKDL 263

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-55
 Identities = 63/275 (22%), Positives = 111/275 (40%), Gaps = 30/275 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLE-FKNEILTWSKIEH 105
           E+F     +G+G  G VY  + K    I+A+K   K + +K  +    + E+   S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+++L+G+        +++EY   GT+   L        +         ++A+AL+Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH 123

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 +IHRD+K  N+L+      K+ DFG++  +      +     + GT  YL P+ 
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           +      EK D++S GVL  E + G+ P E+                            R
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------------QETYKRISR 218

Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
           +  T    +  E    L    L      RP +++ 
Sbjct: 219 VEFTFPDFVT-EGARDLISRLLKHNPSQRPMLREV 252

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-55
 Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 25/286 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSK 102
           ++     K+G+G  G V +G+          VAVK  + +       + +F  E+     
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           ++H NL++L+G +     ++ V E    G+L + L    G+   L      A+ VA  + 
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMG 125

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YL        IHRD+ A N+L+  +   K+ DFG  R   ++     +    K    +  
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM 282
           P+ L+T   +  SD + FGV L EM T         P       +   +  K G      
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEG------ 231

Query: 283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR 328
                R P      + I  +   C A   + RPT     + L + +
Sbjct: 232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-55
 Identities = 67/320 (20%), Positives = 121/320 (37%), Gaps = 29/320 (9%)

Query: 39  SFEEIYKATENFSPANKIGEGGSGTVYKGKLKD-----GSIVAVKRARKNKHDKCLLLEF 93
           +   I K TE F     +G G  GTVYKG            VA+K  R+    K    E 
Sbjct: 1   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-ANKEI 58

Query: 94  KNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
            +E    + +++ ++ +L G       ++I         L    + +   G +    L+ 
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNW 116

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
            + +A  + YL    D  ++HRD+ A N+L+      K+TDFG A++   +    + +  
Sbjct: 117 CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-EYHAEG 172

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL 273
            K    ++  + +     T +SDV+S+GV + E+MT         P  E          L
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSIL 226

Query: 274 KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE 333
           + G           R P   +    +  +   C      SRP  ++      K+ +D + 
Sbjct: 227 EKG----------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276

Query: 334 KAPSSFSSSSSPASASESHY 353
                        S ++S++
Sbjct: 277 YLVIQGDERMHLPSPTDSNF 296

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-54
 Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 25/290 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           E++     +GEG  G V     +     VAVK     +   C     K EI     + H 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHE 63

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VK +G    G+ + + +EY   G L + ++   G  +   +       +   + YLH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH- 120

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                I HRD+K  N+L+ E+   K++DFG A +   ++    +  ++ GT  Y+ P+ L
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELL 177

Query: 227 RTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           +  +   E  DV+S G++L  M+ G  P +      +  +                 + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD--------------WKEKK 223

Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKA 335
               P   +     L L    L     +R T+    +  W   K  ++ A
Sbjct: 224 TYLNPWKKID-SAPLALLHKILVENPSARITIPDIKKDRW-YNKPLKKGA 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (453), Expect = 6e-54
 Identities = 64/279 (22%), Positives = 104/279 (37%), Gaps = 33/279 (11%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKN-KHDKCLLLEFKNEILTWSKIE 104
            + FS   +IG G  G VY  + +++  +VA+K+   + K       +   E+    K+ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H N ++  G         +V+EY            +    L+  E   +       L YL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H      +IHRDVKA NIL++E    K+ DFG A +          +    GT  ++ P+
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSFVGTPYWMAPE 181

Query: 225 YLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV 281
            +      Q   K DV+S G+  +E+   + P+ +   +     I               
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQN 229

Query: 282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
             P L+    S           D CL    Q RPT +  
Sbjct: 230 ESPALQSGHWSEYFRN----FVDSCLQKIPQDRPTSEVL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-53
 Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 43/306 (14%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
              S    +G G  G V +              VAVK  + + H         +E+   S
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE-ALMSELKVLS 81

Query: 102 KIE-HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGN----------------G 144
            +  H+N+V L G    G   +++ EY   G L   L  +  +                 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 145 LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
           L+L + L  +  VA  + +L        IHRD+ A NIL+T     K+ DFG AR  + D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
           S    +    +    ++ P+ +     T +SDV+S+G+ L E+ +         P+    
Sbjct: 199 SN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255

Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
                 + +K G           R  +   A  ++  +   C       RPT K+  +++
Sbjct: 256 ---KFYKMIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

Query: 325 WKIRKD 330
            K   +
Sbjct: 303 EKQISE 308

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-52
 Identities = 64/295 (21%), Positives = 116/295 (39%), Gaps = 33/295 (11%)

Query: 40  FEEIYK---ATENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKN 95
           +E + +     + +    ++G+G  G VYK + K+   + A K       ++  L ++  
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMV 58

Query: 96  EILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           EI   +  +H N+VKL     + +   I++E+   G +   +       L  ++   +  
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCK 117

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
               AL YLH   D  IIHRD+KA NIL T     K+ DFG +  +              
Sbjct: 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---IQRRDSFI 171

Query: 216 GTAGYLDPDYLRTYQL-----TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM 270
           GT  ++ P+ +            K+DV+S G+ L+EM     P     P++        +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LL 225

Query: 271 QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW 325
           +  K+    L    R      S+   + +      CL     +R T  +  +  +
Sbjct: 226 KIAKSEPPTLAQPSRW-----SSNFKDFLKK----CLEKNVDARWTTSQLLQHPF 271

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-52
 Identities = 72/323 (22%), Positives = 120/323 (37%), Gaps = 46/323 (14%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS---IVAVKRARKNKHDKCLLLEFKNEILTWSKIE 104
            +    + IGEG  G V K ++K        A+KR ++         +F  E+    K+ 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLCKLG 68

Query: 105 -HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGR--------------GGNGLELAE 149
            H N++ L G  EH     + +EY  +G L + L                   + L   +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 150 RLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSH 209
            L  A DVA  + YL        IHRD+ A NIL+ E   AK+ DFG +R  E       
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 182

Query: 210 ISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA 269
             T  +    ++  + L     T  SDV+S+GVLL E+++            E       
Sbjct: 183 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------- 234

Query: 270 MQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK 329
                    +    P+  R        +++  L   C       RP+  +    L ++ +
Sbjct: 235 ---------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

Query: 330 DFREKAPSS----FSSSSSPASA 348
           + +    ++    F+ +    SA
Sbjct: 286 ERKTYVNTTLYEKFTYAGIDCSA 308

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 5e-52
 Identities = 69/292 (23%), Positives = 123/292 (42%), Gaps = 28/292 (9%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH 105
            + ++   KIG+G SGTVY    +  G  VA+++    +  K       NEIL   + ++
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKN 76

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
            N+V        GDE  +V+EY+  G+L + +     +     +   +  +   AL +LH
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH 133

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 +IHRD+K+ NIL+      K+TDFGF      +       + + GT  ++ P+ 
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEV 187

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           +       K D++S G++ +EM+ G  P  ++ P++    I                 P 
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------ATNGTPE 235

Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW-KIRKDFREKAP 336
           L+     +      L   + CL    + R + K+  +  + KI K      P
Sbjct: 236 LQNPEKLSAIFRDFL---NRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 6e-52
 Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 17/267 (6%)

Query: 45  KATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSK 102
           K  E+F     +GEG   TV   + L      A+K   K     +  +     E    S+
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
           ++H   VKL+   +  ++    + Y  NG L +++   G    +         ++  AL 
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALE 122

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           YLH      IIHRD+K  NIL+ E +  ++TDFG A++   +S     +    GTA Y+ 
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-QARANSFVGTAQYVS 178

Query: 223 PDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI---------RWAMQCL 273
           P+ L      + SD+++ G ++ +++ G  P  +         I         ++  +  
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238

Query: 274 KAGDAILVMDPRLRRTPASNMAVEKIL 300
              + +LV+D   R           + 
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLK 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 30/292 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI 103
           E       IGEG  G V++G           VA+K  +    D  +  +F  E LT  + 
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS-VREKFLQEALTMRQF 65

Query: 104 EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
           +H ++VKL G +   +   I++E    G LR  L  R    L+LA  +  A  ++ AL Y
Sbjct: 66  DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAY 123

Query: 164 LHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDP 223
           L        +HRD+ A N+L++     K+ DFG +R  E+ +   + +++ K    ++ P
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPIKWMAP 178

Query: 224 DYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVM 282
           + +   + T  SDV+ FGV + E++  G  P +  K           +  ++ G+     
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGE----- 226

Query: 283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREK 334
                R P        +  L   C A     RP   +    L  I ++ + +
Sbjct: 227 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-51
 Identities = 68/305 (22%), Positives = 107/305 (35%), Gaps = 48/305 (15%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGS------IVAVKRARKNKHDKCLLLEFKNEILTWS 101
           EN      +G G  G V        S       VAVK  ++ K D        +E+   +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMT 95

Query: 102 KIE-HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGG------------------ 142
           ++  H N+V L G         ++ EY   G L  +L  +                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 143 ---NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR 199
              N L   + L  A  VA  + +L        +HRD+ A N+L+T     K+ DFG AR
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP 259
               DS    +    +    ++ P+ L     T KSDV+S+G+LL E+ +         P
Sbjct: 213 DIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----P 266

Query: 260 IKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKK 319
                      + ++ G           +      A E+I  +   C A   + RP+   
Sbjct: 267 YPGIPVDANFYKLIQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 320 CAEIL 324
               L
Sbjct: 317 LTSFL 321

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 9e-49
 Identities = 69/325 (21%), Positives = 130/325 (40%), Gaps = 44/325 (13%)

Query: 38  FSFEEIYKATE------NFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKH 85
           FS  ++Y   E        + + ++G+G  G VY+G  K        + VA+K   +   
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 86  DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNG- 144
            +   +EF NE     +    ++V+L G +  G   ++++E +  G L+ +L        
Sbjct: 64  MR-ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 145 -------LELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF 197
                    L++ + +A ++A  + YL+       +HRD+ A N ++ E    K+ DFG 
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179

Query: 198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESK 257
            R   E         +      ++ P+ L+    T  SDV+SFGV+L E+ T        
Sbjct: 180 TRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238

Query: 258 KPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTM 317
              ++ +                VM+  L   P +    + +  L  +C     + RP+ 
Sbjct: 239 LSNEQVLR--------------FVMEGGLLDKPDN--CPDMLFELMRMCWQYNPKMRPSF 282

Query: 318 KKCAEILWK-IRKDFREKAPSSFSS 341
            +    + + +   FRE   S + S
Sbjct: 283 LEIISSIKEEMEPGFRE--VSFYYS 305

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 3e-48
 Identities = 59/340 (17%), Positives = 122/340 (35%), Gaps = 42/340 (12%)

Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           +E+Y   E +  A  +G G  G V++            K  +    D+ L    K EI  
Sbjct: 1   KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISI 54

Query: 100 WSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAH 159
            +   H N++ L    E  +E +++ E++    + E ++      L   E +     V  
Sbjct: 55  LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCE 113

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEK--LRAKVTDFGFARMSEEDSAVSHISTQVKGT 217
           AL +LH      I H D++  NI+   +     K+ +FG AR  +           +   
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG----DNFRLLFTA 166

Query: 218 AGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD 277
             Y  P+  +   ++  +D++S G L+  +++G  P  ++   +               +
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-------------E 213

Query: 278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAE----------ILWKI 327
            I+  +          +++E  +   D  L   R+SR T  +  +          +  K+
Sbjct: 214 NIMNAEYTFDEEAFKEISIE-AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272

Query: 328 RKDF-REKAPSSFSSSSSPASASESHYPIGDAKKKSRHIS 366
            +     +   +          S +    G A +  + +S
Sbjct: 273 IRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVS 312

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (410), Expect = 5e-48
 Identities = 79/289 (27%), Positives = 122/289 (42%), Gaps = 26/289 (8%)

Query: 47  TENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIE 104
           ++ +     +G GG   V+  + L+    VAVK  R +   D    L F+ E    + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 105 HLNLVKLFGFLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
           H  +V ++   E     G    IV+EYV   TLR+ +   G   +     +++  D   A
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           L + H      IIHRDVK +NI+I+     KV DFG AR   +       +  V GTA Y
Sbjct: 124 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 221 LDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL 280
           L P+  R   +  +SDVYS G +L E++TG  P     P      +  A Q ++      
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVRED---- 230

Query: 281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-TMKKCAEILWKIR 328
            + P  R    S      +L      LA   ++R  T  +    L ++ 
Sbjct: 231 PIPPSARHEGLSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVH 275

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (415), Expect = 5e-48
 Identities = 58/322 (18%), Positives = 108/322 (33%), Gaps = 28/322 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           +++    ++G G  G V++      G+  A K               + EI T S + H 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHP 83

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            LV L    E  +E +++ E++  G L E +       +   E ++    V   L ++H 
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH- 141

Query: 167 YSDPPIIHRDVKASNILITEKL--RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
             +   +H D+K  NI+ T K     K+ DFG     +             GTA +  P+
Sbjct: 142 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPE 195

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
                 +   +D++S GVL   +++G  P   +   +                 +   D 
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------------RNVKSCDW 242

Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSS 344
            +  +  S ++ E         L     +R T+ +  E  W +         S   SS  
Sbjct: 243 NMDDSAFSGIS-EDGKDFIRKLLLADPNTRMTIHQALEHPW-LTPGNAPGRDSQIPSSRY 300

Query: 345 PASASESHYPIGDAKKKSRHIS 366
                          +    + 
Sbjct: 301 TKIRDSIKTKYDAWPEPLPPLG 322

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  161 bits (409), Expect = 5e-47
 Identities = 54/300 (18%), Positives = 108/300 (36%), Gaps = 29/300 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + +    ++G G  G V++      G +   K               KNEI   +++ H 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHP 86

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
            L+ L    E   E ++++E++  G L + +       +  AE ++        L ++H 
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH- 144

Query: 167 YSDPPIIHRDVKASNILI--TEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
             +  I+H D+K  NI+    +    K+ DFG A     D     I      TA +  P+
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD----EIVKVTTATAEFAAPE 198

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP 284
            +    +   +D+++ GVL   +++G  P   +  ++                 +   D 
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------------QNVKRCDW 245

Query: 285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW--KIRKDFREKAPSSFSSS 342
                  S+++  +        L    + R T+    E  W      +   + PSS  + 
Sbjct: 246 EFDEDAFSSVS-PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 304

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 8e-47
 Identities = 77/303 (25%), Positives = 117/303 (38%), Gaps = 44/303 (14%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK--------DGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           +       +GEG  G V   +            + VAVK  + +  +K  L +  +E+  
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLISEMEM 71

Query: 100 WSKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELA---------- 148
              I +H N++ L G         ++VEY   G LRE+L  R   GLE +          
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 149 ----ERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED 204
               + +  A  VA  + YL        IHRD+ A N+L+TE    K+ DFG AR     
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERV 264
                 +T  +    ++ P+ L     T +SDV+SFGVLL E+ T              V
Sbjct: 189 DYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG------GSPYPGV 241

Query: 265 TIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEIL 324
            +    + LK G           R    +    ++  +   C       RPT K+  E L
Sbjct: 242 PVEELFKLLKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

Query: 325 WKI 327
            +I
Sbjct: 292 DRI 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-46
 Identities = 66/303 (21%), Positives = 107/303 (35%), Gaps = 40/303 (13%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWS 101
           +       +G G  G V +              VAVK  ++               +   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 102 KIEHLNLVKLFG-FLEHGDERIIVVEYVGNGTLREHLDGRGG--------------NGLE 146
              HLN+V L G   + G   +++VE+   G L  +L  +                + L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 147 LAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
           L   +  +  VA  + +L +      IHRD+ A NIL++EK   K+ DFG AR   +D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI 266
                   +    ++ P+ +     T +SDV+SFGVLL E+ +         P       
Sbjct: 190 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKID 243

Query: 267 RWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK 326
               + LK G           R  A +    ++      C       RPT  +  E L  
Sbjct: 244 EEFCRRLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

Query: 327 IRK 329
           + +
Sbjct: 294 LLQ 296

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 3e-46
 Identities = 52/282 (18%), Positives = 104/282 (36%), Gaps = 26/282 (9%)

Query: 44  YKATEN----FSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEIL 98
           +K  E+    +   + +G G    V   +  +   +VA+K   K   +       +NEI 
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIA 59

Query: 99  TWSKIEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
              KI+H N+V L    E G    ++++ V  G L + +  +G       +   +   V 
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVL 117

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
            A+ YLH         +        + E  +  ++DFG ++M +  S    + +   GT 
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTP 173

Query: 219 GYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA 278
           GY+ P+ L     ++  D +S GV+   ++ G  P   +   K               + 
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-------------EQ 220

Query: 279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
           IL  +         +++ +         +    + R T ++ 
Sbjct: 221 ILKAEYEFDSPYWDDIS-DSAKDFIRHLMEKDPEKRFTCEQA 261

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (403), Expect = 4e-46
 Identities = 57/268 (21%), Positives = 101/268 (37%), Gaps = 28/268 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARK----NKHDKCLLLEFKNEILTWSK 102
            +FS    IG GG G VY  +  D G + A+K   K     K  + L L  +  +   S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 103 IEHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALT 162
            +   +V +       D+   +++ +  G L  HL   G       +    A ++   L 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA--DMRFYAAEIILGLE 121

Query: 163 YLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
           ++H   +  +++RD+K +NIL+ E    +++D G A    +            GT GY+ 
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PHASVGTHGYMA 173

Query: 223 PDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL-------- 273
           P+ L+        +D +S G +L +++ G  P    K   +    R  +           
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 274 -KAGDAI---LVMDPRLRRTPASNMAVE 297
            +    +   L  D   R       A E
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQE 261

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-45
 Identities = 63/285 (22%), Positives = 103/285 (36%), Gaps = 18/285 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           ENF    KIGEG  G VYK + K  G +VA+K+ R +   + +      EI    ++ H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+VKL   +   ++  +V E++    L++ +D     G+ L         +   L + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                ++HRD+K  N+LI  +   K+ DFG AR           + +V           L
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILL 175

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI-----------RWAMQCLKA 275
                +   D++S G +  EM+T R        I +   I              +  +  
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
                    R   +       E    L    L      R + K  
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  155 bits (393), Expect = 2e-45
 Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 18/284 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           E +    KIGEG  G VYK +   G   A+K+ R  K D+ +      EI    +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +VKL+  +      ++V E++     +      G  GLE        + + + + Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH-- 117

Query: 168 SDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLR 227
            D  ++HRD+K  N+LI  +   K+ DFG AR           + ++           + 
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMG 174

Query: 228 TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC-----------LKAG 276
           + + +   D++S G +  EM+ G           + + I   +             L   
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
           D    +   L          E  + L    L      R T K+ 
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-45
 Identities = 59/252 (23%), Positives = 101/252 (40%), Gaps = 20/252 (7%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK--HDKCLLLEFKNEILTWSKIE 104
           E+F     +G+G  G V+  + K      A+K  +K+    D  +      + +     E
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 105 HLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYL 164
           H  L  +F   +  +    V+EY+  G L  H+        +L+     A ++   L +L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL 119

Query: 165 HTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPD 224
           H      I++RD+K  NIL+ +    K+ DFG  + +    A +       GT  Y+ P+
Sbjct: 120 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT---NTFCGTPDYIAPE 173

Query: 225 YLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG-------- 276
            L   +     D +SFGVLL EM+ G+ P   +   +   +IR                 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233

Query: 277 -DAILVMDPRLR 287
              + V +P  R
Sbjct: 234 LVKLFVREPEKR 245

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (395), Expect = 2e-45
 Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 22/261 (8%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEH 105
           ++F     +G G  G V+  + + +G   A+K  +K        +    +E L  S + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             +++++G  +   +  ++++Y+  G L   L         +A+    A +V  AL YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF--YAAEVCLALEYLH 121

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 II+RD+K  NIL+ +    K+TDFGFA+       V  ++  + GT  Y+ P+ 
Sbjct: 122 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY------VPDVTYTLCGTPDYIAPEV 172

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG--------- 276
           + T    +  D +SFG+L+ EM+ G  P      +K    I  A                
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232

Query: 277 DAILVMDPRLRRTPASNMAVE 297
             ++  D   R     N   +
Sbjct: 233 SRLITRDLSQRLGNLQNGTED 253

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (392), Expect = 2e-45
 Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 38/288 (13%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE-------FKNEILT 99
           EN+ P   +G G S  V +          AVK             E          E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 100 WSKI-EHLNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
             K+  H N+++L    E      +V + +  G L ++L  +    L   E   I   + 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTA 218
             +  LH      I+HRD+K  NIL+ + +  K+TDFGF+   +          +V GT 
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG----EKLREVCGTP 173

Query: 219 GYLDPDYLRTYQL------TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC 272
            YL P+ +            ++ D++S GV++  ++ G  P   +K +            
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--------- 224

Query: 273 LKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
                 I+  + +       + + + +  L    L    Q R T ++ 
Sbjct: 225 ----RMIMSGNYQFGSPEWDDYS-DTVKDLVSRFLVVQPQKRYTAEEA 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 4e-45
 Identities = 62/294 (21%), Positives = 103/294 (35%), Gaps = 25/294 (8%)

Query: 45  KATENFSPANKIGEGGSGTVYKGKLK--DGSIVAVKRARKNKHDKCLLLEFKNEILTWSK 102
           +A + +    +IGEG  G V+K +     G  VA+KR R    ++ + L    E+     
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 103 I---EHLNLVKLFGFLEHGDE----RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAI 155
           +   EH N+V+LF            ++ +V    +  L  +LD     G+      D+  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 156 DVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVK 215
            +   L +LH      ++HRD+K  NIL+T   + K+ DFG AR+           T V 
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----MALTSVV 176

Query: 216 GTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAM----- 270
            T  Y  P+ L         D++S G +  EM   +        + +   I   +     
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236

Query: 271 ----QCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
               + +                       E    L   CL      R +    
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (382), Expect = 9e-44
 Identities = 47/303 (15%), Positives = 103/303 (33%), Gaps = 30/303 (9%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
            ++    +IGEG  G +++G  L +   VA+K   +         + ++E  T+  +   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGC 60

Query: 107 N-LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             +  ++ F + G   ++V++ +G     E L    G    +      A  +   +  +H
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 166 TYSDPPIIHRDVKASNILITEKLR-----AKVTDFGFARMSEEDSAVSHI----STQVKG 216
              +  +++RD+K  N LI            V DFG  +   +     HI       + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 217 TAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG 276
           TA Y+  +     + + + D+ + G + +  + G  P +  K    +       +  ++ 
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS- 234

Query: 277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAP 336
                  P             K +            + P       +  K+ +       
Sbjct: 235 ------TPLRELCAGFPEEFYKYM---HYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

Query: 337 SSF 339
            +F
Sbjct: 286 ENF 288

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 56/282 (19%), Positives = 100/282 (35%), Gaps = 23/282 (8%)

Query: 54  NKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK---HDKCLLLEFKNEILTWSKIEHLNLV 109
           + +GEG   TVYK + K    IVA+K+ +          +      EI    ++ H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L     H     +V +++         D      L  +      +     L YLH    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLH---Q 118

Query: 170 PPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY 229
             I+HRD+K +N+L+ E    K+ DFG A+        +   T    T  Y  P+ L   
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP---NRAYTHQVVTRWYRAPELLFGA 175

Query: 230 QL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI----------RWAMQCLKAGDA 278
           ++     D+++ G +L E++     +     + +   I          +W   C      
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
                P +      + A + +L L          +R T  + 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 59/298 (19%), Positives = 111/298 (37%), Gaps = 26/298 (8%)

Query: 42  EIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTW 100
           +++     ++  + IGEG  G V       +   VA+K+    +H          EI   
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT-YCQRTLREIKIL 60

Query: 101 SKIEHLNLVKLFGFLEHGD----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAID 156
            +  H N++ +   +        + + +V ++    L + L  +    L           
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQ 117

Query: 157 VAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKG 216
           +   L Y+H      ++HRD+K SN+L+      K+ DFG AR+++ D   +   T+   
Sbjct: 118 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 217 TAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIR-------- 267
           T  Y  P+ +      T+  D++S G +L EM++ R     K  + +   I         
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 268 --WAMQCLKAGDAILVMDPRLRRTPASNM---AVEKILGLADVCLAPTRQSRPTMKKC 320
                         L+  P   + P + +   A  K L L D  L      R  +++ 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-41
 Identities = 58/249 (23%), Positives = 102/249 (40%), Gaps = 21/249 (8%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE----FKNEILTWSKI--EHLN 107
            +G GG G+VY G  + D   VA+K   K++      L        E++   K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 108 LVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY 167
           +++L  + E  D  ++++E               G  L+          V  A+ + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH-- 127

Query: 168 SDPPIIHRDVKASNILIT-EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
            +  ++HRD+K  NILI   +   K+ DFG   + ++      + T   GT  Y  P+++
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRVYSPPEWI 181

Query: 227 RTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI---RWAMQCLKAGDAILVM 282
           R ++     + V+S G+LL +M+ G  P E  + I         R + +C       L +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241

Query: 283 DPRLRRTPA 291
            P  R T  
Sbjct: 242 RPSDRPTFE 250

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 57/296 (19%), Positives = 112/296 (37%), Gaps = 32/296 (10%)

Query: 55  KIGEGGSGTVYKGKLK-DGSIVAVKRARKNK----HDKCLLLEFKNEILTWSKIEHLNLV 109
           ++G G    V K + K  G   A K  +K +           + + E+    +I+H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 110 KLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
            L    E+  + I+++E V  G L + L  +     E A        +   L  ++    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNGVYYLHS 131

Query: 170 PPIIHRDVKASNILITE----KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
             I H D+K  NI++ +    K R K+ DFG A   +  +        + GT  ++ P+ 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE----FKNIFGTPEFVAPEI 187

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
           +    L  ++D++S GV+   +++G  P       +                 +  ++  
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------------ANVSAVNYE 234

Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSS 341
                 SN +           L    + R T++   +  W   KD ++   S++S 
Sbjct: 235 FEDEYFSNTSAL-AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 50/282 (17%), Positives = 89/282 (31%), Gaps = 28/282 (9%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           KIG G  G +Y G  +  G  VA+K             +   E   +  ++    +    
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIR 69

Query: 114 -FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPI 172
                GD  ++V+E +G                 L   L +A  +   + Y+H       
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIH---SKNF 124

Query: 173 IHRDVKASNILITEK---LRAKVTDFGFARMSEEDSAVSHI----STQVKGTAGYLDPDY 225
           IHRDVK  N L+          + DFG A+   +     HI    +  + GTA Y   + 
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR 285
               + + + D+ S G +L+    G  P +  K   +R       +              
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----------KKMS 234

Query: 286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI 327
                       +     + C +     +P      ++   +
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 4e-41
 Identities = 65/325 (20%), Positives = 122/325 (37%), Gaps = 36/325 (11%)

Query: 56  IGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEI-LTWSKIEHLNLVKLFG 113
           +G G +G V +    +     A+K  +          + + E+ L W   +  ++V++  
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVD 72

Query: 114 FLEH----GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSD 169
             E+        +IV+E +  G L   +  RG       E  +I   +  A+ YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 129

Query: 170 PPIIHRDVKASNILIT---EKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
             I HRDVK  N+L T        K+TDFGFA+ +   ++++        T  Y+ P+ L
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT----PCYTPYYVAPEVL 185

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL 286
              +  +  D++S GV++  ++ G  P  S   +     ++           I +     
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---------TRIRMGQYEF 236

Query: 287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFREKAPSSFSSSSSPA 346
                S ++ E++  L    L      R T+ +     W I +    K P +   +S   
Sbjct: 237 PNPEWSEVS-EEVKMLIRNLLKTEPTQRMTITEFMNHPW-IMQST--KVPQTPLHTSRVL 292

Query: 347 SASESHYPIGDAKKKSRHISFGNDE 371
              +  +     +  S   +   D 
Sbjct: 293 KEDKERWEDVKEEMTSALATMRVDY 317

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 9e-41
 Identities = 61/292 (20%), Positives = 105/292 (35%), Gaps = 32/292 (10%)

Query: 49  NFSPANKIGEGGSGTVYKGKLKD-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLN 107
           +++    IG G  G VY+ KL D G +VA+K+  ++K           E+    K++H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCN 74

Query: 108 LVKLFGFLEHGDER------IIVVEYVGNGTLREHLD-GRGGNGLELAERLDIAIDVAHA 160
           +V+L  F     E+       +V++YV     R      R    L +         +  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
           L Y+H      I HRD+K  N+L+       K+ DFG A+            + +     
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYY 188

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKP-------IKERVTIRWAMQC 272
                       T   DV+S G +L E++ G+               IK   T       
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248

Query: 273 LKAGDAILVMDPRLRRTPASNMAVEKI----LGLADVCLAPTRQSRPTMKKC 320
               +      P+++  P + +   +     + L    L  T  +R T  + 
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (357), Expect = 3e-40
 Identities = 54/286 (18%), Positives = 96/286 (33%), Gaps = 20/286 (6%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
           + +    KIGEG  GTV+K K +    IVA+KR R +  D+ +      EI    +++H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 107 NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT 166
           N+V+L   L    +  +V E+      +      G    E          +   L + H+
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCHS 119

Query: 167 YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYL 226
                ++HRD+K  N+LI      K+ +FG AR           S +V            
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLF 174

Query: 227 RTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT------------IRWAMQCLK 274
                +   D++S G +  E+     P+     + +++                +M  L 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 275 AGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
                 +                    L    L      R + ++ 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 6e-40
 Identities = 56/298 (18%), Positives = 102/298 (34%), Gaps = 30/298 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHL 106
             +    KIG+G  G V+K +  K G  VA+K+       +   +    EI     ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 107 NLVKLFGFLEHGDERI--------IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVA 158
           N+V L                   +V ++  +       +      L   +R+     + 
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQ 124

Query: 159 HALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR-MSEEDSAVSHISTQVKGT 217
             L  L+      I+HRD+KA+N+LIT     K+ DFG AR  S   ++  +  T    T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 218 AGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL--- 273
             Y  P+ L   +      D++  G ++ EM T    ++      +   I      +   
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 274 -----------KAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKC 320
                      +  + +     +++    + +     L L D  L      R      
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 63/261 (24%), Positives = 94/261 (36%), Gaps = 19/261 (7%)

Query: 48  ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEH 105
            +F     +G+G  G V   + K  G   A+K  RK     K  +     E        H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             L  L    +  D    V+EY   G L  HL                  ++  AL YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLH 122

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 +++RD+K  N+++ +    K+TDFG  +    D A         GT  YL P+ 
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK---TFCGTPEYLAPEV 176

Query: 226 LRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIK-----ERVTIRWAMQCLKAG---- 276
           L         D +  GV++ EMM GR P  ++   +         IR+            
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236

Query: 277 DAILVMDPRLRRTPASNMAVE 297
             +L  DP+ R     + A E
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKE 257

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 66/300 (22%), Positives = 109/300 (36%), Gaps = 23/300 (7%)

Query: 10  SNTKSSRKSSRSYVSSSSPKSGQATTINFSFEEIYKAT-ENFSPANKIGEGGSGTVYKGK 68
           +   + + S +  V     K+ +     +       A  + F     +G G  G V   K
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 69  -LKDGSIVAVKRARKNK-HDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE 126
             + G+  A+K   K K      +    NE      +    LVKL    +      +V+E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE 186
           YV  G +  HL   G            A  +     YLH      +I+RD+K  N+LI +
Sbjct: 122 YVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176

Query: 187 KLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVE 246
           +   +VTDFGFA+  +        +  + GT   L P+ + +    +  D ++ GVL+ E
Sbjct: 177 QGYIQVTDFGFAKRVK------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 247 MMTGRYPIESKKPIKERVTIRWAM---------QCLKAGDAILVMDPRLRRTPASNMAVE 297
           M  G  P  + +PI+    I                     +L +D   R     N   +
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVND 290

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-37
 Identities = 54/307 (17%), Positives = 107/307 (34%), Gaps = 36/307 (11%)

Query: 38  FSFEEIYKAT----ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLE 92
           F  +E+ K        +     +G G  G V      + G+ VA+K+  +    +     
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 93  FKNEILTWSKIEHLNLVKLFGFLEHGD------ERIIVVEYVGNGTLREHLDGRGGNGLE 146
              E+     + H N++ L       +      +  +V+ ++G    +     +    L 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LG 119

Query: 147 LAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA 206
                 +   +   L Y+H      IIHRD+K  N+ + E    K+ DFG AR ++    
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---- 172

Query: 207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI 266
            S ++  V           L   + T+  D++S G ++ EM+TG+   +    + +   I
Sbjct: 173 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231

Query: 267 R----------WAMQCLKAGDAILVMDPRLRRTPASNM---AVEKILGLADVCLAPTRQS 313
                                  +   P L +   +++   A    + L +  L    + 
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291

Query: 314 RPTMKKC 320
           R T  + 
Sbjct: 292 RVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-33
 Identities = 63/272 (23%), Positives = 100/272 (36%), Gaps = 29/272 (10%)

Query: 48  ENFSPANKIGEGGSGTVYKGKL----KDGSIVAVKRARKNK--HDKCLLLEFKNEILTWS 101
           ENF     +G G  G V+  +       G + A+K  +K             + E     
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 102 KIEHL-NLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHA 160
            I     LV L    +   +  ++++Y+  G L  HL  R           ++ I V   
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGEI 138

Query: 161 LTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGY 220
           +  L       II+RD+K  NIL+       +TDFG ++    D   +  +    GT  Y
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE--TERAYDFCGTIEY 196

Query: 221 LDPDYLRT--YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLK---- 274
           + PD +R       +  D +S GVL+ E++TG  P         +  I   +   +    
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256

Query: 275 ------AGDAI---LVMDPRLRRTPASNMAVE 297
                 A D I   L+ DP+ R       A E
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 60/311 (19%), Positives = 110/311 (35%), Gaps = 45/311 (14%)

Query: 48  ENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EH 105
           +++    K+G G    V++   + +   V VK  +  K  K      K EI     +   
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREIKILENLRGG 89

Query: 106 LNLVKLFGFLEHGDER--IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTY 163
            N++ L   ++    R   +V E+V N   ++         L   +      ++  AL Y
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDY 144

Query: 164 LHTYSDPPIIHRDVKASNILITEK-LRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLD 222
            H      I+HRDVK  N++I  +  + ++ D+G A         +        +  +  
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR----VASRYFKG 197

Query: 223 PDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPI-ESKKPIKERVTIRWAMQCLKAGDAIL 280
           P+ L  YQ+     D++S G +L  M+  + P         + V I   +      D I 
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257

Query: 281 VMD-------------------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCA 321
             +                    R   +   ++   + L   D  L    QSR T ++  
Sbjct: 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317

Query: 322 E--ILWKIRKD 330
           E    + + KD
Sbjct: 318 EHPYFYTVVKD 328

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-32
 Identities = 44/233 (18%), Positives = 86/233 (36%), Gaps = 19/233 (8%)

Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           +  +   + +     IG G  G V           VA+K+  +   ++        E++ 
Sbjct: 10  DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 100 WSKIEHLNLVKLFGF------LEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDI 153
              + H N++ L         LE   +  +V+E +     +           +      +
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYL 124

Query: 154 AIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQ 213
              +   + +LH+     IIHRD+K SNI++      K+ DFG AR +        + T 
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP 177

Query: 214 VKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTI 266
              T  Y  P+ +      E  D++S G ++ EM+  +     +  I +   +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-31
 Identities = 58/323 (17%), Positives = 110/323 (34%), Gaps = 32/323 (9%)

Query: 41  EEIYKATENFSPANKIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILT 99
           + I++  E +   + +G G  G+V      K G  VAVK+  +             E+  
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 100 WSKIEHLNLVKLFGFLEHGD-----ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIA 154
              ++H N++ L               + +V ++    L   +  +    L       + 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLI 127

Query: 155 IDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQV 214
             +   L Y+H      IIHRD+K SN+ + E    K+ DFG AR +++      ++  V
Sbjct: 128 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYV 179

Query: 215 KGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIES-------KKPIKERVTIR 267
                      L      +  D++S G ++ E++TGR            K  ++   T  
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239

Query: 268 WAMQCLKAGDAILVMDPRLRRTPASNM------AVEKILGLADVCLAPTRQSRPTMKKCA 321
             +    + ++       L + P  N       A    + L +  L      R T  +  
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

Query: 322 EILW--KIRKDFREKAPSSFSSS 342
              +  +      E     +  S
Sbjct: 300 AHAYFAQYHDPDDEPVADPYDQS 322

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 1e-25
 Identities = 47/293 (16%), Positives = 93/293 (31%), Gaps = 21/293 (7%)

Query: 55  KIGEGGSGTVYKGK-LKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG 113
           K+G G   TV+  K + + + VA+K  R +K         ++EI    ++   +  K   
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---EAAEDEIKLLQRVNDADNTKEDS 76

Query: 114 FLEHGDERIIVVEYVGNGTLR--------------EHLDGRGGNGLELAERLDIAIDVAH 159
              +   +++                           +      G+ L     I+  +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 160 ALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAG 219
            L Y+H      IIH D+K  N+L+      +                    T    T  
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 220 YLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA-GDA 278
           Y  P+ L        +D++S   L+ E++TG +  E  +            Q ++  G+ 
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF 331
              +    + T     +   +  ++ +   P         K ++   K   DF
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 94.1 bits (233), Expect = 2e-23
 Identities = 35/201 (17%), Positives = 69/201 (34%), Gaps = 23/201 (11%)

Query: 54  NKIGEGGSGTVYKGKLKDGSIVAVKRARKNK--------HDKCLLLEFKNEILTWSKIEH 105
             +GEG    V+    +      VK  +                 L F    +  ++ E 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 106 LNLVKLFGFLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLH 165
             L KL G          V  + GN  L E +D +    + +    ++   +   +   +
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 166 TYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDY 225
                 I+H D+   N+L++E+    + DF  +    E+     +   V+    Y    +
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITY----F 172

Query: 226 LRTYQLTEKSDVYSFGVLLVE 246
            RTY    + D+ S    +++
Sbjct: 173 SRTY--RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	380
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.97
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.38
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.11

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=411.19  Aligned_cols=252  Identities=25%  Similarity=0.428  Sum_probs=213.7

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||+||+|.++ +|+.||+|++...... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999997 5899999998754322 223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus        86 Ey~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             eecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            99999999999987554  899999999999999999999999   9999999999999999999999999997654321


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+...       .+..+.        
T Consensus       161 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------~i~~~~--------  220 (263)
T d2j4za1         161 -----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVE--------  220 (263)
T ss_dssp             -----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHTTC--------
T ss_pred             -----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH-------HHHcCC--------
Confidence                 234679999999999999999999999999999999999999998655432211       111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ...+..+++++.+||.+||+.||.+|||++|+++|+|-.
T Consensus       221 ---~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         221 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence               112223557899999999999999999999999999854

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-58  Score=415.55  Aligned_cols=266  Identities=30%  Similarity=0.483  Sum_probs=212.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++.+.||+|+||+||+|+++  ..||||+++...........|.+|+.+|++++|||||++++++.. +..++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            4578999999999999999999875  359999998766656667789999999999999999999998754 5689999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++..... .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             ecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999976543 4999999999999999999999988   9999999999999999999999999998765422


Q ss_pred             cceeeeecccCCccccChhhhhhc---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTY---QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      . ........||+.|||||++.+.   .|+.++|||||||+||||+||+.||............      ...+..    
T Consensus       159 ~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~~~~~~----  227 (276)
T d1uwha_         159 G-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGRGYL----  227 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHHTSC----
T ss_pred             C-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------HhcCCC----
Confidence            2 1223456799999999999753   5789999999999999999999999876543321111      111110    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .+..  ......+++.+.+||.+||+.+|.+|||+++|+++|+.+.+.+
T Consensus       228 ~p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         228 SPDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CCCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCcc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            0110  1123345678999999999999999999999999999887644

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=413.66  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=211.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||+||+|.++ +|+.||||++....... ....+.+|+.+|++++||||+++++++.+.+..||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            367999999999999999999987 59999999997654322 2346889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.++|....  .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 Ey~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          83 EYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             ECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             eccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            9999999999997654  4999999999999999999999999   9999999999999999999999999998765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      . ........||+.|||||++.+..+ +.++|||||||++|+|++|+.||.............     ....        
T Consensus       158 ~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~~--------  223 (271)
T d1nvra_         158 R-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKK--------  223 (271)
T ss_dssp             E-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTTC--------
T ss_pred             c-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcCC--------
Confidence            1 223345789999999999998886 578999999999999999999997655432211110     0000        


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        .........+.++.+||.+||+.||.+|||++|+++|.|-
T Consensus       224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence              0011123345778899999999999999999999999883

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-57  Score=413.19  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=214.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.......  ...+.+|+.+|++++||||+++++++.+.+..|+|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            47999999999999999999986 69999999997654332  4568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |++||+|.+++....   +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++.......
T Consensus        98 y~~gg~L~~~~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          98 YLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CCTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            999999999887643   999999999999999999999999   99999999999999999999999999987654321


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........   ...   .+         .
T Consensus       172 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~---~~---------~  233 (293)
T d1yhwa1         172 ---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT---NG---------T  233 (293)
T ss_dssp             ---CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH---HC---------S
T ss_pred             ---cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH---HHh---CC---------C
Confidence               23456799999999999999999999999999999999999999976554332111   111   10         0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .....+..++..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            1112233456789999999999999999999999999885

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=412.73  Aligned_cols=258  Identities=23%  Similarity=0.330  Sum_probs=203.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--CCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--GDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  124 (380)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++......+.....+.+|+.+|++++||||+++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999987 59999999998776666667778999999999999999999999864  4568999


Q ss_pred             EEeCCCCCHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          125 VEYVGNGTLREHLDGR--GGNGLELAERLDIAIDVAHALTYLHTYS--DPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      |||+++|+|.+++...  ....+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643  2345999999999999999999999864  23599999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....   .......||+.|||||++.+..|+.++|||||||++|||++|+.||......+...       .+..+..  
T Consensus       164 ~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~-------~i~~~~~--  231 (269)
T d2java1         164 LNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKF--  231 (269)
T ss_dssp             C--------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHHTCC--
T ss_pred             cccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH-------HHHcCCC--
Confidence            65432   12345679999999999999999999999999999999999999998655432211       1111111  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                              ...+..+++++.+||.+||+.||.+|||++|+++|+|
T Consensus       232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence                    1122235578999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-57  Score=404.11  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|++.+.||+|+||+||+|.+.+++.||||+++.....   ..++.+|+.++++++||||++++|++...+..++|||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            3578899999999999999999988889999999865443   3568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|.+++.... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             CCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             ecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999987654 34889999999999999999999998   99999999999999999999999999987654321


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG-RYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                        .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||......+.   +.    .+..+..       
T Consensus       157 --~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~----~i~~~~~-------  220 (263)
T d1sm2a_         157 --TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VE----DISTGFR-------  220 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HH----HHHHTCC-------
T ss_pred             --eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHhcCC-------
Confidence              122345689999999999999999999999999999999995 555544332211   11    1111110       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         ...+..++.++.+||.+||+.||++|||+++|+++|+++.+
T Consensus       221 ---~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 ---LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence               11223345778999999999999999999999999998865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=401.68  Aligned_cols=252  Identities=26%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             CCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe----CCEEEEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH----GDERIIV  124 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv  124 (380)
                      |++.++||+|+||+||+|.+. +++.||+|++............+.+|+.+|++++|||||++++++..    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            367778999999999999987 58999999998766555566779999999999999999999999865    4568999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC-CCCceEEccccccccccC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT-EKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||+++|+|.+++.+...  +++..++.++.||+.||.|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus        91 mE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999987543  899999999999999999999864 5599999999999997 578999999999986443


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      .     ......||+.|||||++.+ .++.++|||||||++|||++|+.||.........      ...+..+...    
T Consensus       168 ~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~------~~~i~~~~~~----  231 (270)
T d1t4ha_         168 S-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKP----  231 (270)
T ss_dssp             T-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH------HHHHTTTCCC----
T ss_pred             C-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH------HHHHHcCCCC----
Confidence            2     1245679999999999876 6999999999999999999999999765433221      1111111110    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                           .......++++.+||.+||+.||++|||++|+++|.|
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         232 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             -----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence                 1112223456889999999999999999999999987

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=409.26  Aligned_cols=255  Identities=23%  Similarity=0.333  Sum_probs=212.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      +.|++.+.||+|+||+||+|.++ +|+.||||++......  ....+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            56899999999999999999987 5999999999765433  24568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|.+++.+.. .++++..+..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        90 y~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          90 FCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            999999999987643 34999999999999999999999999   9999999999999999999999999987543211 


Q ss_pred             ceeeeecccCCccccChhhhh-----hcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          207 VSHISTQVKGTAGYLDPDYLR-----TYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                        .......||+.|+|||++.     +..|+.++|||||||++|+|++|+.||....+.+....+.   .    +.    
T Consensus       165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~---~----~~----  231 (288)
T d2jfla1         165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA---K----SE----  231 (288)
T ss_dssp             --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH---H----SC----
T ss_pred             --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH---c----CC----
Confidence              1123567999999999984     5568899999999999999999999998766544322111   1    10    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ......+..++.++.+||.+||+.||.+|||++|+++|.|-
T Consensus       232 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         232 ----PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             ----CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                01112233456789999999999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-57  Score=407.77  Aligned_cols=256  Identities=22%  Similarity=0.284  Sum_probs=210.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++..... .......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999986 699999999975432 2223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++...+.  +++..++.++.|++.||.|||++|   |+||||||+|||+++++.+||+|||+++.+....
T Consensus        88 Ey~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999999887654  899999999999999999999999   9999999999999999999999999998765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      . ........||+.|+|||++.+..++.++|||||||++|+|++|..||..........       .+..+.        
T Consensus       163 ~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-------~i~~~~--------  226 (288)
T d1uu3a_         163 K-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ-------KIIKLE--------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHTTC--------
T ss_pred             c-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH-------HHHcCC--------
Confidence            2 122345679999999999999999999999999999999999999998755432211       111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ...+...+.++.+||.+||+.||.+|||++|++++.|-+
T Consensus       227 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~  265 (288)
T d1uu3a_         227 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK  265 (288)
T ss_dssp             ---CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH
Confidence               011223456789999999999999999999987766543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-57  Score=407.68  Aligned_cols=263  Identities=26%  Similarity=0.366  Sum_probs=219.0

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ++...++|++.+.||+|+||+||+|.++ +|+.||||+++.+...   .+++.+|+.+|++++|||||++++++.+.+..
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3345678999999999999999999987 4889999999765443   45688999999999999999999999999999


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++|+|.+++.......+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence            99999999999999998776667999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....  .......||+.|+|||++.+..|+.++|||||||++|||++|..||.........      ...+..+.    
T Consensus       166 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~------~~~i~~~~----  233 (287)
T d1opja_         166 TGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDY----  233 (287)
T ss_dssp             CSSSS--EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------HHHHHTTC----
T ss_pred             CCCCc--eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH------HHHHhcCC----
Confidence            54322  2234456899999999999999999999999999999999987776543332221      11111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                            ..+.+..++..+.+||.+||+.||.+|||+++|++.|..+.+
T Consensus       234 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         234 ------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  112233456789999999999999999999999998876643

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-57  Score=414.48  Aligned_cols=272  Identities=25%  Similarity=0.389  Sum_probs=212.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|++.+.||+|+||+||+|.+. +|+.||+|+++..... .....+.+|+.+|++++|||||++++++.+.+..++|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3578999999999999999999986 5899999999765332 3456788999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||+++|+|.+++.+.+.  +++..++.++.||+.||.|||+ +|   |+||||||+|||++.++.+||+|||+|+....
T Consensus        83 mEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999999987654  8999999999999999999997 48   99999999999999999999999999986543


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc--------
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA--------  275 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  275 (380)
                      .     ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....................        
T Consensus       158 ~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         158 S-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             H-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             C-----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            2     123567999999999999999999999999999999999999999765433211110000000000        


Q ss_pred             -CCcc--------------cccc---cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          276 -GDAI--------------LVMD---PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       276 -~~~~--------------~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                       ....              ...+   ............+.++.+||.+||+.||.+|||++|+++|.|-.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence             0000              0000   000000011123467889999999999999999999999998654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=403.35  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=213.3

Q ss_pred             HHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           44 YKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        44 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ....++|++.+.||+|+||.||+|.+++++.||||+++.....   ...+.+|+.++++++|||||++++++.+ +..++
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            3345789999999999999999999988889999999765443   3568899999999999999999998855 56799


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence            999999999999887766556999999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..  ........||+.|+|||++.++.++.++|||||||++|||+||..|+........      ....+..+.      
T Consensus       162 ~~--~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~~~~------  227 (272)
T d1qpca_         162 NE--YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGY------  227 (272)
T ss_dssp             SC--EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTC------
T ss_pred             Cc--cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcC------
Confidence            32  2223456799999999999999999999999999999999996655543322211      111111111      


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                          ....+..++.++.+|+.+||+.+|++|||+++|++.|+.+.
T Consensus       228 ----~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         228 ----RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                11122345678999999999999999999999999888664

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=398.71  Aligned_cols=264  Identities=21%  Similarity=0.375  Sum_probs=216.6

Q ss_pred             hcCCCCCC-eeeccCceEEEEEEeC---CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPAN-KIGEGGSGTVYKGKLK---DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|.+.+ +||+|+||+||+|.++   ++..||||+++.... .....+|.+|+.+|++++|||||++++++.. +..+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            35666667 4999999999999875   355799999976543 3456779999999999999999999999875 4679


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999999986554 34899999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .............||+.|+|||++.++.++.++|||||||++|||+| |+.||......+..       ..+..+..   
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-------~~i~~~~~---  230 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKR---  230 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-------HHHHTTCC---
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCCC---
Confidence            54443333445679999999999999999999999999999999998 99999876543221       11112211   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhhc
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFRE  333 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~~  333 (380)
                             .+.+..++.++.+||.+||+.+|++|||+.+|++.|......+..
T Consensus       231 -------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~  275 (285)
T d1u59a_         231 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  275 (285)
T ss_dssp             -------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence                   122334667899999999999999999999999998877665543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-56  Score=398.79  Aligned_cols=254  Identities=25%  Similarity=0.407  Sum_probs=205.9

Q ss_pred             CeeeccCceEEEEEEeCC---CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeCCC
Q 041907           54 NKIGEGGSGTVYKGKLKD---GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYVGN  130 (380)
Q Consensus        54 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  130 (380)
                      ++||+|+||+||+|.+++   ++.||||+++..........++.+|+.+|++++|||||++++++..+ ..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            469999999999998752   56899999976655555567799999999999999999999999654 57899999999


Q ss_pred             CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcceee
Q 041907          131 GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHI  210 (380)
Q Consensus       131 ~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  210 (380)
                      |+|.+++.....  +++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...........
T Consensus        92 g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            999999987543  899999999999999999999998   999999999999999999999999999877654443444


Q ss_pred             eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCC
Q 041907          211 STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRT  289 (380)
Q Consensus       211 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                      .....||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..       ..+..+.          ..
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~~~----------~~  229 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGE----------RM  229 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTC----------CC
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH-------HHHHcCC----------CC
Confidence            445679999999999999999999999999999999998 89999875543211       1111111          12


Q ss_pred             CCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          290 PASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       290 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      +.+..++.++.+||.+||+.||.+|||+++|++.|.....+
T Consensus       230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            23334567899999999999999999999998877765443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.2e-56  Score=403.52  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=203.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-CC---EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-GS---IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (380)
                      ++|++.+.||+|+||+||+|.++. |+   .||||.+...... ...+.|.+|+.+|++++|||||++++++...+..++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            457778899999999999999863 33   5899988765433 345679999999999999999999999999999999


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccC
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  203 (380)
                      ||||+++|+|.+++..... .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            9999999999998876543 4899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcceee--eecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          204 DSAVSHI--STQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       204 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .......  .....||+.|||||++.++.++.++|||||||++|||+| |..||......+..       ..+..+.   
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~-------~~i~~~~---  250 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI-------NAIEQDY---  250 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHHHTTC---
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---
Confidence            3222111  223468999999999999999999999999999999998 89999865543211       1111111   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                             ..+.+..++..+.+||.+||+.+|.+|||+++|++.|+.+.+
T Consensus       251 -------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 -------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                   122333466789999999999999999999999999988765

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=392.78  Aligned_cols=254  Identities=27%  Similarity=0.413  Sum_probs=214.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      .++|++.++||+|+||+||+|++++++.||||+++.....   ..++.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            3689999999999999999999988889999999876544   3568899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+++|+|..++..... .+++..+++++.|+++||.|||++|   |+||||||+|||++.++.+||+|||+++.......
T Consensus        80 y~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          80 YMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             CCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             ccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            9999999999766543 3889999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .  ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+..       ..+..+.        
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~-------~~i~~~~--------  218 (258)
T d1k2pa_         156 T--SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGL--------  218 (258)
T ss_dssp             C--CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-------HHHHTTC--------
T ss_pred             e--eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH-------HHHHhCC--------
Confidence            1  2234669999999999999999999999999999999998 89999876543221       1111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ..+.+..++..+.+||.+||+.||++|||+++|+++|.+
T Consensus       219 --~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         219 --RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             --CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence              112233455789999999999999999999999999854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-56  Score=406.56  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..+.|++.+.||+|+||+||+|.++ +|+.||||++....... ....+.+|+.+|++++||||+++++++.+.+..|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4577999999999999999999987 59999999997654332 234578999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC---CCCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT---EKLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~  201 (380)
                      |||++||+|.++|...+  .+++..+..++.||+.||.|||++|   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        86 mE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999997754  3999999999999999999999999   99999999999995   5789999999999865


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....    ......||+.|||||++.+..|+.++|||||||++|+|++|..||..........       .+..+..   
T Consensus       161 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-------~i~~~~~---  226 (307)
T d1a06a_         161 DPGS----VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-------QILKAEY---  226 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-------HHHTTCC---
T ss_pred             cCCC----eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHH-------HHhccCC---
Confidence            5432    2345679999999999999999999999999999999999999998655432211       1111110   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                          ....+....+++++.+||.+||+.||.+|||++|+++|.|-
T Consensus       227 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  267 (307)
T d1a06a_         227 ----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI  267 (307)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred             ----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence                01112233456789999999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-56  Score=403.53  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=209.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      +.|++.+.||+|+||+||+|.+. +|+.||||++..... .......+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35899999999999999999986 588999999976643 3344567899999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      |||.+|+|..++....  ++++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++....  
T Consensus        95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            9999999987766543  3999999999999999999999999   99999999999999999999999999986543  


Q ss_pred             cceeeeecccCCccccChhhhhh---cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRT---YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                           .....||+.|||||++.+   ..|+.++|||||||++|||++|..||......+....   ..    .+..    
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~---i~----~~~~----  231 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IA----QNES----  231 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HH----HSCC----
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---HH----hCCC----
Confidence                 234569999999999964   4589999999999999999999999976554322111   11    1110    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                       +    ......+++.+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       232 -~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         232 -P----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             -C----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             -C----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence             0    111223457899999999999999999999999998864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-55  Score=408.30  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=213.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      -++|++.+.||+|+||.||+|.++ +|+.||||++......  ....+.+|+.+|++++|||||++++++.+.+..||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            468999999999999999999986 6999999999765433  3456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC--CCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE--KLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~  203 (380)
                      ||++||+|.+++....+ .+++..++.++.||+.||.|||++|   |+||||||+|||++.  ++.+||+|||+++....
T Consensus       103 E~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         103 EFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             EcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            99999999999965543 3999999999999999999999999   999999999999964  57899999999987654


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..    ......||+.|||||++.+..++.++|||||||++|+|++|..||.+....+....+.   .    ...     
T Consensus       179 ~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---~----~~~-----  242 (350)
T d1koaa2         179 KQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK---S----CDW-----  242 (350)
T ss_dssp             TS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----TCC-----
T ss_pred             cc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---h----CCC-----
Confidence            32    2345679999999999999999999999999999999999999998765433221111   1    100     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                       . ........+++.+.+||.+||+.||.+|||++|+++|.|-
T Consensus       243 -~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~  283 (350)
T d1koaa2         243 -N-MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL  283 (350)
T ss_dssp             -C-SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred             -C-CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence             0 0011122345778999999999999999999999999884

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.5e-55  Score=404.82  Aligned_cols=256  Identities=21%  Similarity=0.310  Sum_probs=214.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++......  ....+.+|+.+|++++|||||++++++.+.+.+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            467999999999999999999986 6999999998765432  2456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeC--CCCceEEccccccccccC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILIT--EKLRAKVTDFGFARMSEE  203 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~--~~~~~kl~Dfg~~~~~~~  203 (380)
                      |||+||+|.+++...+ .++++.+++.++.||+.||.|||++|   |+||||||+|||++  .++.+||+|||+++....
T Consensus       106 E~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         106 EFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             ECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence            9999999999887654 34999999999999999999999999   99999999999998  568999999999988765


Q ss_pred             CCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc
Q 041907          204 DSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD  283 (380)
Q Consensus       204 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+       ..+..     
T Consensus       182 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i-------~~~~~-----  245 (352)
T d1koba_         182 DE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------KRCDW-----  245 (352)
T ss_dssp             TS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------HHCCC-----
T ss_pred             CC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCC-----
Confidence            32    234567999999999999999999999999999999999999999876543321111       11110     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                       . ........++.++.+||.+||+.||.+|||++|+++|.|-
T Consensus       246 -~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~  286 (352)
T d1koba_         246 -E-FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL  286 (352)
T ss_dssp             -C-CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             -C-CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence             0 0111223455778999999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=392.29  Aligned_cols=261  Identities=27%  Similarity=0.420  Sum_probs=205.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCC-C----CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKD-G----SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      +.|++.+.||+|+||.||+|.++. +    ..||||++...... ....+|.+|+.+|++++|||||+++|++.+.+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            568889999999999999999763 2    36999999765443 34557899999999999999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||+.+++|.+++.... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        86 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999887654 34999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      .............||+.|+|||++.++.++.++|||||||++|||++|..|+........      ....+..+.     
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~~-----  230 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGF-----  230 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTC-----
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHhccC-----
Confidence            543333333456789999999999999999999999999999999997666544332211      111111111     


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                           ..+.+..++..+.+||.+||+.+|.+|||+.+|++.|+.+.+
T Consensus       231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                 122333466789999999999999999999999999988765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=398.95  Aligned_cols=259  Identities=20%  Similarity=0.331  Sum_probs=213.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDE  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  120 (380)
                      ..++|++.+.||+|+||+||+|.++ +|+.||||++.......    .....+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3478999999999999999999986 69999999987543221    235678899999999999999999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC----ceEEcccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL----RAKVTDFG  196 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~----~~kl~Dfg  196 (380)
                      .||||||+++|+|.++|...+.  +++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999999987653  999999999999999999999999   99999999999998776    49999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++.......    ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+....       +..+
T Consensus       163 ~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~-------i~~~  231 (293)
T d1jksa_         163 LAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN-------VSAV  231 (293)
T ss_dssp             TCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHTT
T ss_pred             hhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH-------HHhc
Confidence            998765432    12445799999999999999999999999999999999999999987554332111       1111


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                      ..      .. ........+..+.+||.+||+.||.+|||++|+++|.|-.
T Consensus       232 ~~------~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  275 (293)
T d1jksa_         232 NY------EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK  275 (293)
T ss_dssp             CC------CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred             CC------CC-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            00      00 0001112346788999999999999999999999998853

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-54  Score=397.31  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=212.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||+||+|.++ +|+.||||+++.... .......+.+|+.+|++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57899999999999999999986 599999999975432 1223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++||+|..++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++..... 
T Consensus        84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            99999999999987654  788899999999999999999998   999999999999999999999999999876542 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||......+....+       ..+.        
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-------~~~~--------  217 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-------LNAE--------  217 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHCC--------
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH-------HcCC--------
Confidence                 23567999999999999999999999999999999999999999876543321111       1111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                         ...+...+.++.+++.+||+.||.+|+     |++++++|+|-
T Consensus       218 ---~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f  260 (316)
T d1fota_         218 ---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  260 (316)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             ---CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence               111223456789999999999999996     99999999884

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=398.48  Aligned_cols=253  Identities=23%  Similarity=0.283  Sum_probs=213.6

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|.+.+.||+|+||.||+|+++ +|+.||||++..... .......+.+|+.+|++++||||+++++++.+...+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999986 699999999975432 1223456789999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||++||+|.+++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++......
T Consensus        85 ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999987654  899999999999999999999999   9999999999999999999999999998654322


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                         ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........       ....+.        
T Consensus       160 ---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-------~i~~~~--------  221 (337)
T d1o6la_         160 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------LILMEE--------  221 (337)
T ss_dssp             ---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHCC--------
T ss_pred             ---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH-------HHhcCC--------
Confidence               12345679999999999999999999999999999999999999998765432111       111111        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                         ...+..++.++.+||.+||+.||.+||+     ++++++|.|-
T Consensus       222 ---~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f  264 (337)
T d1o6la_         222 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             ---CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence               1122335577899999999999999994     8999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=399.98  Aligned_cols=259  Identities=26%  Similarity=0.350  Sum_probs=210.0

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC-C-----CEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD-G-----SIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||+||+|.+.. +     ..||+|.+...... .....+.+|+.+|.++ +|||||++++++.+.
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            34689999999999999999999753 2     36999998654332 2345688999999998 899999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGG---------------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDV  177 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl  177 (380)
                      +..++||||+++|+|.++|.....                     ..+++..++.++.||+.||.|||+++   |+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            999999999999999999976532                     24889999999999999999999998   999999


Q ss_pred             CCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 041907          178 KASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIES  256 (380)
Q Consensus       178 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~  256 (380)
                      ||+|||++.++.+||+|||+++....... ........||+.|||||++.++.++.++|||||||++|||++ |..||.+
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTT-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             chhccccccCCeEEEeeccccccccCCCc-eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            99999999999999999999987654332 223345678999999999999999999999999999999998 8999986


Q ss_pred             CCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          257 KKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .........      ....+.          ..+.+..+++++.+||.+||+.+|.+|||++||+++|.
T Consensus       270 ~~~~~~~~~------~~~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVDANFYK------LIQNGF----------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCSHHHHH------HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHHHHHHH------HHhcCC----------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            554332111      111111          11223345678999999999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-54  Score=389.31  Aligned_cols=258  Identities=29%  Similarity=0.433  Sum_probs=206.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ..++|++++.||+|+||.||+|.+++++.||||++......   ...|.+|+.++++++|||||++++++.+ +..++||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            35789999999999999999999998888999999766544   3568899999999999999999999854 5678999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|..++.......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999999998765555999999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                      .  .......||+.|+|||++.++.++.++|||||||++|||++|..||.........  +    ..+..+.        
T Consensus       168 ~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~--~----~~i~~~~--------  231 (285)
T d1fmka3         168 Y--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--L----DQVERGY--------  231 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H----HHHHTTC--------
T ss_pred             c--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH--H----HHHHhcC--------
Confidence            2  2233466999999999999999999999999999999999976666543332211  1    1111110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                        ..+.+..+++++.+||.+||+.||++||++++|++.|+...
T Consensus       232 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         232 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             --CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence              12233445678999999999999999999999998777543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.9e-54  Score=386.99  Aligned_cols=263  Identities=27%  Similarity=0.392  Sum_probs=207.0

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----E
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----E  120 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  120 (380)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++.... .......+.+|+.++++++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            478999999999999999999986 699999999986644 3344567899999999999999999999987643    4


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .|+||||++|++|.+++...+.  +++.+++.++.||+.||.|||++|   |+||||||+|||++.++.++|+|||.+..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence            7999999999999999977654  899999999999999999999999   99999999999999999999999999876


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ...............||+.|+|||++.+..++.++|||||||++|+|+||+.||....+.+...      .....+..  
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~--  232 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI--  232 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC--
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcCCC--
Confidence            5543333333456779999999999999999999999999999999999999998765433211      11111100  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-ChHHHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-TMKKCAEILWKIR  328 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~eil~~l~~~~  328 (380)
                            ........++..+.+||.+||+.||.+|| |++++++.|.+++
T Consensus       233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                  00111223457799999999999999999 8999988887664

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-54  Score=398.54  Aligned_cols=250  Identities=26%  Similarity=0.327  Sum_probs=212.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVV  125 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (380)
                      ++|++.+.||+|+||.||+|.++ +|+.||||++..... .......+.+|+.+|+.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999986 699999999865432 1223456889999999999999999999999999999999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+.+|+|..++...+.  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++..... 
T Consensus       121 e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            99999999999987654  899999999999999999999999   999999999999999999999999999876532 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccC
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPR  285 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (380)
                           .....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.........+       ..+.        
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i-------~~~~--------  254 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI-------VSGK--------  254 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC--------
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH-------hcCC--------
Confidence                 23467999999999999999999999999999999999999999876543221111       1110        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          286 LRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       286 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                         ...+..++.++.+||.+||+.||.+|+     |++++++|.|-
T Consensus       255 ---~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f  297 (350)
T d1rdqe_         255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF  297 (350)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             ---CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence               111223557789999999999999994     99999999885

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=386.94  Aligned_cols=260  Identities=27%  Similarity=0.411  Sum_probs=204.3

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC----CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD----GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      ..++|++.+.||+|+||.||+|.+..    +..||||.++.... ......+.+|+.+|++++||||+++++++. .+..
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            35789999999999999999998752    35689999865443 344567899999999999999999999996 4678


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence            99999999999999887654 34899999999999999999999999   999999999999999999999999999876


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++ |..||......+....       +..+.   
T Consensus       159 ~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-------i~~~~---  226 (273)
T d1mp8a_         159 EDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------IENGE---  226 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTC---
T ss_pred             cCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCC---
Confidence            54321  22344568999999999999999999999999999999998 8999987665432211       11111   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                             ..+.+..+++.+.+||.+||+.||.+|||++||+++|..+.++
T Consensus       227 -------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                   1123334567899999999999999999999999999988664

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-53  Score=382.88  Aligned_cols=257  Identities=24%  Similarity=0.312  Sum_probs=212.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc-------hHHHHHHHHHHHHHhcCC-CCceeceEEEEEe
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD-------KCLLLEFKNEILTWSKIE-HLNLVKLFGFLEH  117 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  117 (380)
                      .++|++.+.||+|+||+||+|++. +|+.||||++......       ......+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            378999999999999999999986 6899999999765432       122345789999999997 9999999999999


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      ++..||||||+++|+|.++|...+.  +++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999987653  999999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhc------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTY------QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQ  271 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  271 (380)
                      ++......    ......||..|+|||++.+.      .++.++|||||||++|+|++|+.||...........      
T Consensus       157 a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~------  226 (277)
T d1phka_         157 SCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM------  226 (277)
T ss_dssp             CEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------
T ss_pred             eeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH------
Confidence            98765432    12456799999999999743      467899999999999999999999987654322111      


Q ss_pred             hhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          272 CLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                       +..+..       ....+....+++++.+|+.+||+.+|.+|||++|+++|.|-
T Consensus       227 -i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~  273 (277)
T d1phka_         227 -IMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  273 (277)
T ss_dssp             -HHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             -HHhCCC-------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence             111110       01122233466789999999999999999999999999873

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.1e-53  Score=396.68  Aligned_cols=254  Identities=21%  Similarity=0.296  Sum_probs=207.4

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcc----hHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHD----KCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++......    ........+++.+++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            67999999999999999999987 5999999998643221    111222335577888889999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      +||||++||+|.++|.....  +++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++...
T Consensus        84 ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999987654  889999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ...     .....||+.|+|||++.+ ..|+.++|||||||+||||++|+.||............    ......     
T Consensus       159 ~~~-----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~-----  224 (364)
T d1omwa3         159 KKK-----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM-----  224 (364)
T ss_dssp             SSC-----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSC-----
T ss_pred             CCc-----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccC-----
Confidence            432     234579999999999964 56899999999999999999999999876543322111    111100     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCC-----hHHHHHHHHH
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPT-----MKKCAEILWK  326 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~~l~~  326 (380)
                            ....+..++.++.+||.+||+.||.+|||     ++|+++|.|-
T Consensus       225 ------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f  268 (364)
T d1omwa3         225 ------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF  268 (364)
T ss_dssp             ------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence                  11122235577999999999999999999     7999999885

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=389.61  Aligned_cols=260  Identities=22%  Similarity=0.374  Sum_probs=207.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCC----EEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGS----IVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  122 (380)
                      .+|++.+.||+|+||+||+|.+. +|+    +||+|.++.... ....+++.+|+.++++++|||||++++++.++ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            46999999999999999999976 354    588888865432 23456789999999999999999999999875 567


Q ss_pred             EEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccccc
Q 041907          123 IVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSE  202 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  202 (380)
                      ++||++.+|+|.+.+.... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8889999999999887654 34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCcccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILV  281 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .... ........||+.|+|||++.++.++.++|||||||++|||+| |..||......+....+       ..+.    
T Consensus       163 ~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-------~~~~----  230 (317)
T d1xkka_         163 AEEK-EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGE----  230 (317)
T ss_dssp             TTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------HHTC----
T ss_pred             cccc-cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC----
Confidence            4332 122234568999999999999999999999999999999998 88999766543321111       1111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          282 MDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       282 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                            ..+.+..++..+.+|+.+||+.+|.+|||+.+|+++++.+....
T Consensus       231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence                  11223345678999999999999999999999999999886543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=387.73  Aligned_cols=257  Identities=20%  Similarity=0.279  Sum_probs=212.6

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ..++|.+.+.||+|+||+||+|.++ +|+.||||+++.....   ...+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH---HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3578999999999999999999987 5889999999765433   34577999999999999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCC--CceEEcccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEK--LRAKVTDFGFARMSE  202 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~--~~~kl~Dfg~~~~~~  202 (380)
                      ||||+||+|.++|...+ ..+++.+++.++.||+.||.|||++|   |+||||||+|||++.+  +.+||+|||+++...
T Consensus        80 mE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999998754 24899999999999999999999999   9999999999999854  479999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM  282 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ...    ......||+.|+|||.+.+..++.++|||||||++|+|++|..||......+....+       ..+...  +
T Consensus       156 ~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i-------~~~~~~--~  222 (321)
T d1tkia_         156 PGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-------MNAEYT--F  222 (321)
T ss_dssp             TTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HHTCCC--C
T ss_pred             cCC----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhCCCC--C
Confidence            432    234456999999999999999999999999999999999999999876543321111       111000  0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          283 DPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       283 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                           .......++.++.+||.+||+.||.+|||++|+++|.|-.
T Consensus       223 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~  262 (321)
T d1tkia_         223 -----DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             -----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             -----ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence                 0000112356789999999999999999999999999853

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-54  Score=381.96  Aligned_cols=252  Identities=29%  Similarity=0.445  Sum_probs=203.3

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CCEEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GDERIIVV  125 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  125 (380)
                      .++|++.+.||+|+||.||+|.++ |..||||+++.+..    .+.+.+|+.++++++||||++++|++.+ .+.+++||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            467888999999999999999996 78899999976432    3568899999999999999999999854 45689999


Q ss_pred             EeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCC
Q 041907          126 EYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDS  205 (380)
Q Consensus       126 e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  205 (380)
                      ||+++|+|.+++.......+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++..... 
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999997665445899999999999999999999988   999999999999999999999999999864432 


Q ss_pred             cceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          206 AVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       206 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                           .....+|..|+|||++.++.++.++|||||||++|||+| |..||......+....       +..+.       
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-------i~~~~-------  217 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGY-------  217 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------HTTTC-------
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCC-------
Confidence                 233458999999999999999999999999999999998 7888876544332111       11111       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                         ..+.+..++.++.+||.+||+.||.+|||+.+++++|+.++.
T Consensus       218 ---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         218 ---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence               122333455789999999999999999999999999988753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-53  Score=387.80  Aligned_cols=267  Identities=24%  Similarity=0.366  Sum_probs=216.8

Q ss_pred             HHHHHHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEE
Q 041907           40 FEEIYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFG  113 (380)
Q Consensus        40 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  113 (380)
                      +.+++...++|++.+.||+|+||+||+|+++      +++.||||++..... .....++.+|+.+|++++||||+++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-hHHHHHHHHHHHHHHhcCCCCccccee
Confidence            3445556688999999999999999999864      357899999976543 345667999999999999999999999


Q ss_pred             EEEeCCEEEEEEEeCCCCCHHHHhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 041907          114 FLEHGDERIIVVEYVGNGTLREHLDGRG----------------------GNGLELAERLDIAIDVAHALTYLHTYSDPP  171 (380)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  171 (380)
                      ++......+++|||+++|+|.+++....                      ...+++..++.++.||+.||+|||+++   
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence            9999999999999999999999996432                      223789999999999999999999998   


Q ss_pred             eeeccCCCCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCC
Q 041907          172 IIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR  251 (380)
Q Consensus       172 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~  251 (380)
                      ++||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCcc-ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            99999999999999999999999999986644322 22334567899999999999999999999999999999999986


Q ss_pred             -CCCCCCCCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHH
Q 041907          252 -YPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIR  328 (380)
Q Consensus       252 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~  328 (380)
                       .||......+...       .+..+..          .+.+..++.++.+|+.+||+.+|.+|||+.||++.|+++.
T Consensus       240 ~~p~~~~~~~e~~~-------~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHEEVIY-------YVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHHHHHH-------HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHHHH-------HHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             5676654432211       1111111          1223345578999999999999999999999999998764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=391.28  Aligned_cols=253  Identities=23%  Similarity=0.317  Sum_probs=209.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCc-chHHHHHHHHHHHHHh-cCCCCceeceEEEEEeCCEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKH-DKCLLLEFKNEILTWS-KIEHLNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  124 (380)
                      ++|.+.+.||+|+||+||+|.++ +|+.||||+++.... .......+..|..++. .++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            67999999999999999999987 599999999975421 1122344556666654 68999999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCC
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEED  204 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  204 (380)
                      |||+++|+|.+++.....  +++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999999987654  889999999999999999999999   999999999999999999999999999865432


Q ss_pred             CcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccccc
Q 041907          205 SAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDP  284 (380)
Q Consensus       205 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+       ..+.       
T Consensus       157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~~-------  219 (320)
T d1xjda_         157 D---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMDN-------  219 (320)
T ss_dssp             T---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC-------
T ss_pred             c---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCC-------
Confidence            2   1234567999999999999999999999999999999999999999876543321111       1110       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChH-HHHHHHHH
Q 041907          285 RLRRTPASNMAVEKILGLADVCLAPTRQSRPTMK-KCAEILWK  326 (380)
Q Consensus       285 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~l~~  326 (380)
                          ...+..++.++.+||.+||+.||.+||++. ++++|.|-
T Consensus       220 ----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         220 ----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             ----CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence                112223457799999999999999999996 89988774

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-54  Score=383.95  Aligned_cols=260  Identities=26%  Similarity=0.400  Sum_probs=202.5

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC--CC--CEEEEEEccccCc-chHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK--DG--SIVAVKRARKNKH-DKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDER  121 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  121 (380)
                      .++|++.+.||+|+||.||+|.+.  ++  ..||||++..... .....++|.+|+.+|++++||||+++++++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            467999999999999999999864  23  3689999876543 23345679999999999999999999999965 467


Q ss_pred             EEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccc
Q 041907          122 IIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMS  201 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  201 (380)
                      ++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            899999999999998876543 3999999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhccCCccc
Q 041907          202 EEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIKERVTIRWAMQCLKAGDAIL  280 (380)
Q Consensus       202 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..............|+..|+|||++.+..++.++|||||||++|||+| |..||......+...      .....+    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~------~i~~~~----  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEG----  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSC----
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH------HHHhCC----
Confidence            655444444455678999999999999999999999999999999998 899998655433211      111111    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          281 VMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ...+.+..++..+.+||.+||+.||.+|||+.+|++.|.+.
T Consensus       232 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  11123334567899999999999999999999999988764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=391.98  Aligned_cols=256  Identities=23%  Similarity=0.336  Sum_probs=206.5

Q ss_pred             hcCCCCCC-eeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhc-CCCCceeceEEEEEe----CC
Q 041907           47 TENFSPAN-KIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSK-IEHLNLVKLFGFLEH----GD  119 (380)
Q Consensus        47 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~  119 (380)
                      .++|.+.+ .||+|+||+||+|.+. +|+.||||+++..       ..+.+|+.++.+ .+||||+++++++.+    ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            46888875 5999999999999986 6999999998642       235688888665 489999999999875    46


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEcccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAKVTDFG  196 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg  196 (380)
                      .+|+|||||+||+|.++|...+...+++..++.++.||+.||.|||++|   |+||||||+|||++.   .+.+||+|||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence            7899999999999999998876667999999999999999999999999   999999999999985   4579999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      +++.......    .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+   .....  
T Consensus       160 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~--  230 (335)
T d2ozaa1         160 FAKETTSHNS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIR--  230 (335)
T ss_dssp             TCEECCCCCC----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC--
T ss_pred             eeeeccCCCc----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHh--
Confidence            9987654322    34567999999999999999999999999999999999999999765543221111   00000  


Q ss_pred             CcccccccCCC-CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          277 DAILVMDPRLR-RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       277 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                            ..... ..+....+++++.+||.+||+.||.+|||+.|+++|.|-.
T Consensus       231 ------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  276 (335)
T d2ozaa1         231 ------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  276 (335)
T ss_dssp             ------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred             ------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence                  00101 1112235667899999999999999999999999999854

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-53  Score=384.03  Aligned_cols=272  Identities=25%  Similarity=0.326  Sum_probs=207.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++...........+.+|+.+|++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999986 69999999997655444445678899999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      |+.+ .+..++.......+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9965 6666665555556999999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             ceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccccc---
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVM---  282 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  282 (380)
                        .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..+....+................   
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              1233457999999999987766 4789999999999999999999998765443222211111000000000000   


Q ss_pred             --ccCCCCCC------CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          283 --DPRLRRTP------ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       283 --~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                        ........      .....+.++.+|+.+||+.||.+|||++|+++|.|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence              00000000      011234678899999999999999999999999873

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=382.85  Aligned_cols=266  Identities=20%  Similarity=0.226  Sum_probs=201.4

Q ss_pred             CCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch---HHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEeC
Q 041907           53 ANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK---CLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEYV  128 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  128 (380)
                      ++.||+|+||+||+|.++ +|+.||||+++......   .....+.+|+.+|++++|||||++++++...+..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999986 59999999997553321   12345789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcce
Q 041907          129 GNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAVS  208 (380)
Q Consensus       129 ~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  208 (380)
                      .++++..++....  .+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 ~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          83 ETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             SEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             cchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            8877766655433  3888999999999999999999999   99999999999999999999999999986654321  


Q ss_pred             eeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccc----
Q 041907          209 HISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMD----  283 (380)
Q Consensus       209 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  283 (380)
                       ......||+.|+|||++.+. .|+.++|||||||++|||++|..||......+....+.................    
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh
Confidence             22345799999999998754 579999999999999999999999987665543333221111000100000000    


Q ss_pred             cCCCC-CCCC-----HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          284 PRLRR-TPAS-----NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       284 ~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ..... ....     ...++++.+||.+||+.||++|||++|+++|.|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f  283 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  283 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence            00000 0000     1234678999999999999999999999999883

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-52  Score=380.08  Aligned_cols=268  Identities=25%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEE
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFG  113 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~  113 (380)
                      ..+....++|++.+.||+|+||.||+|.+.      +++.||||+++...... ....+.+|...+.++ +|+||+.+++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-HHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            444445688999999999999999999864      24689999997654433 345677788877776 6899999999


Q ss_pred             EEEeC-CEEEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 041907          114 FLEHG-DERIIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVK  178 (380)
Q Consensus       114 ~~~~~-~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk  178 (380)
                      ++... ...++||||+++|+|.++|....              ...+++..++.++.||+.||.|||+++   |+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCC
Confidence            87654 56899999999999999997542              224889999999999999999999998   9999999


Q ss_pred             CCceeeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhC-CCCCCCC
Q 041907          179 ASNILITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTG-RYPIESK  257 (380)
Q Consensus       179 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg-~~p~~~~  257 (380)
                      |+|||++.++.+||+|||+++........ .......||+.|+|||++.++.++.++|||||||++|||++| ..||...
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999865543221 223456799999999999999999999999999999999986 5677655


Q ss_pred             CCcchhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          258 KPIKERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .......      ..+..+..          ...+..++.++.+||.+||+.||.+|||++||+++|+.+.+
T Consensus       241 ~~~~~~~------~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         241 KIDEEFC------RRLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCSHHHH------HHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHH------HHHhcCCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            4332211      11111111          11223355779999999999999999999999999998754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.5e-52  Score=377.21  Aligned_cols=270  Identities=24%  Similarity=0.314  Sum_probs=209.0

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEEe
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVEY  127 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (380)
                      ++|++.+.||+|+||+||+|.+++|+.||||++............+.+|+.+|++++||||+++++++...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            68999999999999999999999999999999977655444456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +.++.+..+....+  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus        82 ~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            98876666665443  3999999999999999999999998   99999999999999999999999999987653221 


Q ss_pred             eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCccc-----c
Q 041907          208 SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAIL-----V  281 (380)
Q Consensus       208 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~  281 (380)
                        ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+..............     .
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence              12344689999999998764 468999999999999999999999987654443222211110000000000     0


Q ss_pred             cccCCC------CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHH
Q 041907          282 MDPRLR------RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILW  325 (380)
Q Consensus       282 ~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~  325 (380)
                      .+....      ........+..+.+||.+||+.||++|||++|+++|+|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            000000      00111234467889999999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=380.51  Aligned_cols=246  Identities=25%  Similarity=0.422  Sum_probs=202.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcch----HHHHHHHHHHHHHhcCC--CCceeceEEEEEeCC
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDK----CLLLEFKNEILTWSKIE--HLNLVKLFGFLEHGD  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  119 (380)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.......    .....+.+|+.+|++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            468999999999999999999986 69999999987543221    11123568999999886  899999999999999


Q ss_pred             EEEEEEEeCCC-CCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-CCceEEccccc
Q 041907          120 ERIIVVEYVGN-GTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-KLRAKVTDFGF  197 (380)
Q Consensus       120 ~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~  197 (380)
                      ..++||||+.+ +++.+++.....  +++..++.++.||+.||.|||++|   |+||||||+|||++. ++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            99999999976 688888876543  899999999999999999999999   999999999999985 47999999999


Q ss_pred             cccccCCCcceeeeecccCCccccChhhhhhcCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          198 ARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQL-TEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ++.....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....      +   .    .+
T Consensus       158 a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i---~----~~  219 (273)
T d1xwsa_         158 GALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I---I----RG  219 (273)
T ss_dssp             CEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H---H----HC
T ss_pred             ceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H---h----hc
Confidence            9865432     2345679999999999998776 4678999999999999999999975321      0   0    00


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          277 DAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      .           ......++.++.+||.+||+.||++|||++|+++|.|-
T Consensus       220 ~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         220 Q-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             C-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             c-----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            0           00111245678999999999999999999999999884

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=376.63  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=207.7

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeCC-CC--EEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeCCEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLKD-GS--IVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHGDERI  122 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  122 (380)
                      .++|++.+.||+|+||+||+|.+++ |.  .||||.+...... .....+.+|+.+|.++ +||||+++++++.+.+..+
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            3789999999999999999999863 44  4778887544332 2355689999999998 7999999999999999999


Q ss_pred             EEEEeCCCCCHHHHhccC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          123 IVVEYVGNGTLREHLDGR--------------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       123 lv~e~~~~~~L~~~i~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      +||||+++|+|.++|+..              ....+++..++.++.||+.||.|||+++   ++||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCC
Confidence            999999999999999754              2345899999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcchhhHHH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR-YPIESKKPIKERVTIR  267 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~-~p~~~~~~~~~~~~~~  267 (380)
                      .+||+|||+++......    ......||..|+|||.+.+..++.++|||||||++|||++|. .||......+      
T Consensus       165 ~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------  234 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------  234 (309)
T ss_dssp             CEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred             ceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------
Confidence            99999999998644321    123456899999999999999999999999999999999975 5676543222      


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                       ....+..+.          ..+.+..+++++.+||.+||+.||++|||++||+++|..+.+.
T Consensus       235 -~~~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         235 -LYEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -HHHHGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -HHHHHHhcC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             111121111          1222334567899999999999999999999999999988653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-51  Score=372.64  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=207.3

Q ss_pred             CCeeeccCceEEEEEEeCC--C--CEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe-CCEEEEEEEe
Q 041907           53 ANKIGEGGSGTVYKGKLKD--G--SIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH-GDERIIVVEY  127 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  127 (380)
                      .+.||+|+||+||+|.+.+  +  ..||||+++... ......+|.+|+.+|++++||||++++|++.. .+..++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            5689999999999999763  2  258999987533 34456779999999999999999999999875 5689999999


Q ss_pred             CCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCcc
Q 041907          128 VGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSAV  207 (380)
Q Consensus       128 ~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  207 (380)
                      +++|+|.+++..... .+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++........
T Consensus       111 ~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             eecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            999999999886653 4788889999999999999999998   999999999999999999999999999876543222


Q ss_pred             e-eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcccccccCC
Q 041907          208 S-HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAILVMDPRL  286 (380)
Q Consensus       208 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (380)
                      . .......||..|+|||.+.+..++.++||||||+++|||++|..||.........      ...+..+..        
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~------~~~i~~g~~--------  252 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQGRR--------  252 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C------HHHHHTTCC--------
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH------HHHHHcCCC--------
Confidence            1 1223457899999999999999999999999999999999988887653322110      111111111        


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhhh
Q 041907          287 RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDFR  332 (380)
Q Consensus       287 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~~  332 (380)
                        ...+..++..+.+||.+||+.||++||++.||+++|+.+...+.
T Consensus       253 --~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         253 --LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence              11223355789999999999999999999999999999977543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=379.29  Aligned_cols=272  Identities=20%  Similarity=0.293  Sum_probs=204.8

Q ss_pred             cCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----EEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----ERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~l  123 (380)
                      +.|.+.+.||+|+||.||+|++. |+.||||++......   ......|+..+.+++||||+++++++.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~---~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh---HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            56778899999999999999975 889999998654321   222345666667889999999999997654    6899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS-----DPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                      ||||+++|+|.++|++..   +++..++.++.+++.||.|||+..     .++|+||||||+||||+.++.+||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999998753   899999999999999999999731     134999999999999999999999999999


Q ss_pred             ccccCCCccee-eeecccCCccccChhhhhhcC------CCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--------
Q 041907          199 RMSEEDSAVSH-ISTQVKGTAGYLDPDYLRTYQ------LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER--------  263 (380)
Q Consensus       199 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~--------  263 (380)
                      +.......... ......||+.|+|||++.+..      ++.++|||||||+||||+||..||.........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            87755433222 234577999999999987643      567899999999999999999887543221110        


Q ss_pred             hHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhh
Q 041907          264 VTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKD  330 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~  330 (380)
                      ............+    .+++.+............+.+|+.+||+.||++|||+.||++.|.++..+
T Consensus       236 ~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0111111111111    11222222222345667899999999999999999999999999988654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=375.77  Aligned_cols=262  Identities=28%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeCC--------CCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEE
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLE  116 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  116 (380)
                      ..++|.+.+.||+|+||.||+|+...        +..||||+++..... ....++.+|...+.++ +|||||++++++.
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-HHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            45789999999999999999998642        247999999776543 3456788899999888 8999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGRG--------------GNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      +.+..++||||+++|+|.++|....              ...+++..++.++.||+.||+|||+++   |+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            9999999999999999999997653              234899999999999999999999999   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      |++.++.+||+|||+++........ .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||.......
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             eecCCCCeEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999999876543222 22344678999999999999999999999999999999998 788887544322


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .       ...+..+..          .+.+..++..+.+||.+||+.||.+|||+.||++.|+.+.+
T Consensus       246 ~-------~~~i~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 L-------FKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             H-------HHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-------HHHHHcCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1       111111111          12223355779999999999999999999999999988865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-52  Score=378.65  Aligned_cols=272  Identities=22%  Similarity=0.266  Sum_probs=203.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-C-CCEEEEEEccccCcchHHHHHHHHHHHHHhcC---CCCceeceEEEEEe----
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-D-GSIVAVKRARKNKHDKCLLLEFKNEILTWSKI---EHLNLVKLFGFLEH----  117 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  117 (380)
                      .++|++.+.||+|+||+||+|.+. + ++.||||+++...........+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999985 4 66799999976543322222345666666555   89999999998853    


Q ss_pred             -CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccc
Q 041907          118 -GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFG  196 (380)
Q Consensus       118 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  196 (380)
                       ....+++|||+.++.+..... .....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence             346899999998865544433 33445899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC
Q 041907          197 FARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG  276 (380)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      +++......    ......||+.|+|||++.+..|+.++|||||||++|||++|+.||......+....+..........
T Consensus       162 ~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         162 LARIYSFQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCCCCGGG----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhcccc----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            987654322    2345679999999999999999999999999999999999999998776544333322211110000


Q ss_pred             Ccc-------ccc-ccC-CCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          277 DAI-------LVM-DPR-LRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       277 ~~~-------~~~-~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ...       ... ... ..........++.+.+||.+||+.||.+|||++|+++|+|-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence            000       000 000 00001122345678899999999999999999999999883

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-51  Score=373.14  Aligned_cols=263  Identities=25%  Similarity=0.391  Sum_probs=214.9

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcC-CCCceeceEEEEEeC
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKI-EHLNLVKLFGFLEHG  118 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  118 (380)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||+++..... .....+.+|+.+++++ +|||||++++++...
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-HHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            4578999999999999999999862      3568999999765543 3456788999999998 699999999999999


Q ss_pred             CEEEEEEEeCCCCCHHHHhccCCC----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCce
Q 041907          119 DERIIVVEYVGNGTLREHLDGRGG----------------NGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNI  182 (380)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~i~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Ni  182 (380)
                      +..++||||+++|+|.+++.....                ..+++..++.++.||+.||+|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            999999999999999999976432                24889999999999999999999998   99999999999


Q ss_pred             eeCCCCceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 041907          183 LITEKLRAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMT-GRYPIESKKPIK  261 (380)
Q Consensus       183 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~  261 (380)
                      |++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.......
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             cccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999987664332 233455789999999999999999999999999999999999 555555444332


Q ss_pred             hhhHHHHHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          262 ERVTIRWAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      ....      ....+.          ....+..++..+.+||.+||+.||.+|||+.+|++.|+++..
T Consensus       256 ~~~~------~i~~~~----------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         256 KFYK------MIKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHH------HHHHTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH------HHhcCC----------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            2111      111110          111223355789999999999999999999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=374.93  Aligned_cols=263  Identities=23%  Similarity=0.354  Sum_probs=214.2

Q ss_pred             HHHHhcCCCCCCeeeccCceEEEEEEeC------CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEE
Q 041907           43 IYKATENFSPANKIGEGGSGTVYKGKLK------DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLE  116 (380)
Q Consensus        43 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  116 (380)
                      +....++|++.+.||+|+||+||+|.++      .++.||||+++.... ......+.+|+.++++++||||+++++++.
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-hHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            3345688999999999999999999874      257899999976543 334556899999999999999999999999


Q ss_pred             eCCEEEEEEEeCCCCCHHHHhccC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC
Q 041907          117 HGDERIIVVEYVGNGTLREHLDGR--------GGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL  188 (380)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~i~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~  188 (380)
                      .....++||||+++|+|.+++...        ....+++..+..++.++++||.|||+++   |+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence            999999999999999999998643        1234788999999999999999999988   99999999999999999


Q ss_pred             ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcchhhHHH
Q 041907          189 RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGR-YPIESKKPIKERVTIR  267 (380)
Q Consensus       189 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~-~p~~~~~~~~~~~~~~  267 (380)
                      .+||+|||+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||. .||......+..    
T Consensus       171 ~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----  245 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----  245 (308)
T ss_dssp             CEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----
T ss_pred             eEEEeecccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence            999999999987654322 22234456899999999999999999999999999999999984 777654432211    


Q ss_pred             HHHHhhccCCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          268 WAMQCLKAGDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                         ..+..+.          ..+.+..++..+.+||.+||+.+|.+|||+++|+++|...
T Consensus       246 ---~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         246 ---RFVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---HHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---HHHHhCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence               1111111          1122334557899999999999999999999999998765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=371.13  Aligned_cols=275  Identities=20%  Similarity=0.220  Sum_probs=204.8

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe--------
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH--------  117 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  117 (380)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++......+.....+.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            378999999999999999999986 69999999987665544445668899999999999999999998754        


Q ss_pred             CCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccc
Q 041907          118 GDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGF  197 (380)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  197 (380)
                      .+..++||||+.++.+.......  ..++...++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            34689999999876655444433  34899999999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCCcc-eeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          198 ARMSEEDSAV-SHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       198 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ++........ ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9866532211 1122345799999999999765 6899999999999999999999999876554433333222211111


Q ss_pred             CCcccc--------cccCCCCCCCC------HHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          276 GDAILV--------MDPRLRRTPAS------NMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       276 ~~~~~~--------~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ......        +..........      ......+.+||.+||+.||++|||++|+++|.|-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            110000        00000000000      1113467789999999999999999999999984

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=360.05  Aligned_cols=271  Identities=21%  Similarity=0.263  Sum_probs=213.5

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCCEEEEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGDERIIVVE  126 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  126 (380)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++...........+.+|+.+|+.++||||+++++++......+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999986 68999999997766555567788999999999999999999999999999999999


Q ss_pred             eCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccccccCCCc
Q 041907          127 YVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARMSEEDSA  206 (380)
Q Consensus       127 ~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  206 (380)
                      ++.+++|..++...+.  +++..++.++.|++.||+|||++|   |+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            9999998888876543  889999999999999999999999   99999999999999999999999999987654321


Q ss_pred             ceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHhhccCCcc-----
Q 041907          207 VSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVT-IRWAMQCLKAGDAI-----  279 (380)
Q Consensus       207 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~-----  279 (380)
                         ......++..|+|||++.+.. ++.++|||||||++|||++|+.||........... +.............     
T Consensus       157 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         157 ---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence               223445788999999988765 68999999999999999999999765443332211 11111100000000     


Q ss_pred             ------cccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 ------LVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                            ...................+.+|+.+||+.||.+|||++|+++|.|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence                  00000111111223345678899999999999999999999999873

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-50  Score=372.75  Aligned_cols=268  Identities=19%  Similarity=0.277  Sum_probs=203.8

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC-----
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD-----  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  119 (380)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||+++.....+.....+.+|+.+|++++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999986 5999999999876666566677899999999999999999999997654     


Q ss_pred             -EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccc
Q 041907          120 -ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFA  198 (380)
Q Consensus       120 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  198 (380)
                       .+|+||||+ +.+|..++....   +++..++.++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecc-cccHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence             469999999 568888876543   999999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCcceeeeecccCCccccChhhhhhc-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh----
Q 041907          199 RMSEEDSAVSHISTQVKGTAGYLDPDYLRTY-QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCL----  273 (380)
Q Consensus       199 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----  273 (380)
                      +.....      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.......    
T Consensus       169 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         169 RQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             EECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eccCCc------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            865432      2446799999999998764 56899999999999999999999998765433222211100000    


Q ss_pred             -ccCCcc---c--ccccCCC---CCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          274 -KAGDAI---L--VMDPRLR---RTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       274 -~~~~~~---~--~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                       ......   .  ...+...   ...........+.+||.+||+.||.+|||++|+++|.|-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f  304 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  304 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence             000000   0  0000000   001112334678899999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=373.53  Aligned_cols=274  Identities=22%  Similarity=0.286  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeCC----E
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHGD----E  120 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  120 (380)
                      .+++|++.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.+|++++||||+++++++....    .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC-hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            4568999999999999999999986 699999999975443 344567889999999999999999999986543    2


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++++++.+|+|.+++....   +++..++.++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++..
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~~---l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCchhhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            244456677899999997643   999999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCcc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDAI  279 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ...............||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+..................
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            6544333333355679999999999854 457889999999999999999999998765433222211110000000000


Q ss_pred             --------c-c-cccCCCCCC---CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          280 --------L-V-MDPRLRRTP---ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       280 --------~-~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                              . . ..+.....+   .......++.+|+.+||+.||.+|||++|+++|.|-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~  298 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  298 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence                    0 0 000000000   011223568899999999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1e-48  Score=355.20  Aligned_cols=266  Identities=16%  Similarity=0.260  Sum_probs=213.2

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC-CceeceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-LNLVKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.......    .+.+|++.++.++| +|++.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC----CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH----HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            578999999999999999999987 58999999986544332    35678888888865 8999999999999999999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC-----CCceEEccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE-----KLRAKVTDFGFAR  199 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~-----~~~~kl~Dfg~~~  199 (380)
                      |||+ +++|.+++...+ ..++...+..++.|++.||.|||++|   |+||||||+|||++.     .+.+||+|||+++
T Consensus        80 me~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9999 679999987654 34899999999999999999999998   999999999999974     5689999999998


Q ss_pred             cccCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhcc
Q 041907          200 MSEEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKA  275 (380)
Q Consensus       200 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .+.......    .......||+.|||||++.+..++.++|||||||++|||++|..||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            765432211    1233567999999999999999999999999999999999999999876655443333222221111


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHhhh
Q 041907          276 GDAILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRKDF  331 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~~~  331 (380)
                      .....          ....+++++.+++..|++.+|.+||+++.+.+.+..+....
T Consensus       235 ~~~~~----------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         235 TPLRE----------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             SCHHH----------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CChHH----------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            10000          01123467899999999999999999999999888876654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-48  Score=355.75  Aligned_cols=264  Identities=18%  Similarity=0.241  Sum_probs=202.1

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEEE
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERIIV  124 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  124 (380)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.......    ++..|+.++++++|+|+ +.+.+++...+..++|
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC----CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH----HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            367999999999999999999986 58999999987654332    46789999999987765 4555666888899999


Q ss_pred             EEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCC---CCceEEccccccccc
Q 041907          125 VEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITE---KLRAKVTDFGFARMS  201 (380)
Q Consensus       125 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~---~~~~kl~Dfg~~~~~  201 (380)
                      |||+ +++|.+.+.... ..+++..++.++.|++.||+|||++|   |+||||||+|||++.   +..++|+|||+++.+
T Consensus        82 me~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          82 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9999 457777665543 34999999999999999999999999   999999999999863   457999999999977


Q ss_pred             cCCCcce----eeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCC
Q 041907          202 EEDSAVS----HISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGD  277 (380)
Q Consensus       202 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .......    .......||+.|+|||++.+..++.++|||||||++|||++|..||...........+...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            5432221    123456799999999999999999999999999999999999999987654433222221111111000


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHHHh
Q 041907          278 AILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKIRK  329 (380)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~~~  329 (380)
                      .          ......++.++.+++.+||+.+|.+||++.++.+.|+.+..
T Consensus       237 ~----------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         237 I----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             H----------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             h----------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0          00111245678999999999999999999999888876644

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=364.00  Aligned_cols=258  Identities=24%  Similarity=0.303  Sum_probs=210.1

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC----CCCEEEEEEccccCc--chHHHHHHHHHHHHHhcCCC-CceeceEEEEEeCCE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK----DGSIVAVKRARKNKH--DKCLLLEFKNEILTWSKIEH-LNLVKLFGFLEHGDE  120 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  120 (380)
                      ++|++.+.||+|+||+||+|...    +|+.||||+++....  .......+.+|+.+|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999862    488999999865432  11123457799999999977 899999999999999


Q ss_pred             EEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEcccccccc
Q 041907          121 RIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFARM  200 (380)
Q Consensus       121 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  200 (380)
                      .+++|||+.+|+|.+++...+.  +....++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999987654  778899999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcceeeeecccCCccccChhhhhhc--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccCCc
Q 041907          201 SEEDSAVSHISTQVKGTAGYLDPDYLRTY--QLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAGDA  278 (380)
Q Consensus       201 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      +.....  .......|++.|+|||.+.+.  .++.++|||||||+||+|++|..||...........+.......     
T Consensus       179 ~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-----  251 (322)
T d1vzoa_         179 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----  251 (322)
T ss_dssp             CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred             hccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----
Confidence            653322  123456799999999999765  46789999999999999999999998776555433332211110     


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCC-----ChHHHHHHHHH
Q 041907          279 ILVMDPRLRRTPASNMAVEKILGLADVCLAPTRQSRP-----TMKKCAEILWK  326 (380)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~~l~~  326 (380)
                               ..+.+...+.++.+|+.+||+.||.+||     |++|+++|.|-
T Consensus       252 ---------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         252 ---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             ---------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence                     0112234567899999999999999999     58999999884

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=365.88  Aligned_cols=269  Identities=18%  Similarity=0.242  Sum_probs=201.9

Q ss_pred             hcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEe------CC
Q 041907           47 TENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEH------GD  119 (380)
Q Consensus        47 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~  119 (380)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++...........+.+|+.+|++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            478999999999999999999987 59999999998776666566778999999999999999999999863      36


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      .+|+||||+.+ ++.+.+..    .+++..++.++.||+.||.|||+.|   |+||||||+|||++.++.++++|||+++
T Consensus        96 ~~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eeEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            88999999976 45555532    3899999999999999999999999   9999999999999999999999999988


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh-------
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQC-------  272 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------  272 (380)
                      ......    ......||+.|+|||++.+..+++++||||+||++|+|++|..||.+.........+......       
T Consensus       168 ~~~~~~----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         168 TAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccccc----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            654322    234567999999999999999999999999999999999999999876543332222110000       


Q ss_pred             ---------hccC-Cc-----ccccccCC--CCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHHH
Q 041907          273 ---------LKAG-DA-----ILVMDPRL--RRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWKI  327 (380)
Q Consensus       273 ---------~~~~-~~-----~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~~  327 (380)
                               .... ..     ........  .........+..+.+||.+||+.||++|||++|+++|+|--
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~  315 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  315 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence                     0000 00     00000000  00112234577899999999999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=364.78  Aligned_cols=264  Identities=22%  Similarity=0.319  Sum_probs=198.3

Q ss_pred             CCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC------CEE
Q 041907           49 NFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG------DER  121 (380)
Q Consensus        49 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~  121 (380)
                      .|+..+.||+|+||+||+|++. +|+.||||++......      ..+|+.+|++++||||+++++++...      .++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            5788899999999999999987 5999999999765432      24799999999999999999998543      357


Q ss_pred             EEEEEeCCCCCHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEccccccc
Q 041907          122 IIVVEYVGNGTLREHLD-GRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFAR  199 (380)
Q Consensus       122 ~lv~e~~~~~~L~~~i~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  199 (380)
                      ++||||++++.+..+.. ......+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .+||+|||+++
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchh
Confidence            99999997754333332 122345999999999999999999999988   99999999999999775 89999999998


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhh-cCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH--------H
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRT-YQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWA--------M  270 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~--------~  270 (380)
                      ......    ......||..|+|||.+.+ ..++.++|||||||++|||++|..||......+....+...        .
T Consensus       172 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         172 QLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             ECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence            765432    1234579999999998875 56899999999999999999999999876544332222110        0


Q ss_pred             HhhccCCcccccccCCCC----CCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          271 QCLKAGDAILVMDPRLRR----TPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ...........+ +....    .......+..+.+|+.+||+.||.+|||++|+++|.|-
T Consensus       248 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         248 REMNPNYTEFKF-PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HHHCC---CCCC-CCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhhccchhhccc-cccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            000000000000 00000    00112345678999999999999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4e-48  Score=357.22  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=202.2

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEe--CCEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEH--GDERII  123 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~l  123 (380)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...     ...+.+|+.+|++++ ||||+++++++..  ....++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            67999999999999999999986 69999999987543     345789999999995 9999999999975  456899


Q ss_pred             EEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCC-ceEEcccccccccc
Q 041907          124 VVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKL-RAKVTDFGFARMSE  202 (380)
Q Consensus       124 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~  202 (380)
                      ||||+.+++|..+..     .+++..++.++.||+.||.|||++|   |+||||||+|||++.++ .+||+|||+++...
T Consensus       110 v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            999999999877643     3899999999999999999999999   99999999999998654 69999999998765


Q ss_pred             CCCcceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHH------HHhhc
Q 041907          203 EDSAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKER-VTIRWA------MQCLK  274 (380)
Q Consensus       203 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~-~~~~~~------~~~~~  274 (380)
                      ....    .....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||......... ..+...      .....
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         182 PGQE----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TTCC----CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCCc----ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            4321    24556899999999988754 789999999999999999999999765543211 111000      00000


Q ss_pred             cCCc--c----cccc-------cCCCCCCCCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          275 AGDA--I----LVMD-------PRLRRTPASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       275 ~~~~--~----~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                      ....  .    ....       ...........++.++.+||.+||+.||.+|||++|+++|+|-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F  322 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  322 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            0000  0    0000       0001111223345678999999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-49  Score=365.37  Aligned_cols=269  Identities=20%  Similarity=0.264  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCceeceEEEEEeC-----C
Q 041907           46 ATENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNLVKLFGFLEHG-----D  119 (380)
Q Consensus        46 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  119 (380)
                      +.++|++.+.||+|+||+||+|.+. +|+.||||++............+.+|+.+|++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3578999999999999999999986 699999999987766655666788999999999999999999998643     3


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..+++|+++.+|+|.+++...   .+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+|++|||++.
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             ceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            346667788899999999654   3999999999999999999999999   9999999999999999999999999987


Q ss_pred             cccCCCcceeeeecccCCccccChhhhhhcC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhccC--
Q 041907          200 MSEEDSAVSHISTQVKGTAGYLDPDYLRTYQ-LTEKSDVYSFGVLLVEMMTGRYPIESKKPIKERVTIRWAMQCLKAG--  276 (380)
Q Consensus       200 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  276 (380)
                      .....      .....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+..........  
T Consensus       170 ~~~~~------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         170 HTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             CCTGG------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccCcc------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            64432      23456899999999877754 5789999999999999999999998765443332221111000000  


Q ss_pred             ---Cc---ccccccCCCCCC-----CCHHHHHHHHHHHHHhcCCCCCCCCChHHHHHHHHH
Q 041907          277 ---DA---ILVMDPRLRRTP-----ASNMAVEKILGLADVCLAPTRQSRPTMKKCAEILWK  326 (380)
Q Consensus       277 ---~~---~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~l~~  326 (380)
                         ..   ............     .....+..+.+||.+||+.||.+|||++|+++|.|-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f  304 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  304 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence               00   000000000000     011234678899999999999999999999999884

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-42  Score=321.06  Aligned_cols=268  Identities=21%  Similarity=0.268  Sum_probs=194.9

Q ss_pred             cCCCCCCeeeccCceEEEEEEeC-CCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-----------CCceeceEEEE
Q 041907           48 ENFSPANKIGEGGSGTVYKGKLK-DGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-----------HLNLVKLFGFL  115 (380)
Q Consensus        48 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~  115 (380)
                      ++|++++.||+|+||+||+|++. +|+.||||+++...   .....+.+|+.++++++           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            46999999999999999999986 69999999997643   22345678888887764           57899999887


Q ss_pred             Ee--CCEEEEEEEeCCCCC-HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeccCCCCceeeCCCC---
Q 041907          116 EH--GDERIIVVEYVGNGT-LREHLDGRGGNGLELAERLDIAIDVAHALTYLHT-YSDPPIIHRDVKASNILITEKL---  188 (380)
Q Consensus       116 ~~--~~~~~lv~e~~~~~~-L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlkp~Nil~~~~~---  188 (380)
                      ..  ....+++|+++..+. ............+.+..+..++.||+.||.|||+ .|   |+||||||+|||++.++   
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence            54  456667777665543 3344444444568999999999999999999997 77   99999999999998665   


Q ss_pred             ---ceEEccccccccccCCCcceeeeecccCCccccChhhhhhcCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch---
Q 041907          189 ---RAKVTDFGFARMSEEDSAVSHISTQVKGTAGYLDPDYLRTYQLTEKSDVYSFGVLLVEMMTGRYPIESKKPIKE---  262 (380)
Q Consensus       189 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~---  262 (380)
                         .++++|||.+......      .....||+.|+|||++.+..++.++|||||||++++|++|+.||........   
T Consensus       167 ~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             ccceeeEeecccccccccc------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence               3999999998754432      2345699999999999999999999999999999999999999975432211   


Q ss_pred             hhHHHHHHHhhcc--------CC----------cccccccC---------CCCCCCCHHHHHHHHHHHHHhcCCCCCCCC
Q 041907          263 RVTIRWAMQCLKA--------GD----------AILVMDPR---------LRRTPASNMAVEKILGLADVCLAPTRQSRP  315 (380)
Q Consensus       263 ~~~~~~~~~~~~~--------~~----------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  315 (380)
                      ...+......+..        ..          ....+...         ..........+..+.+|+.+||+.||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence            1111100110000        00          00000000         001223466788999999999999999999


Q ss_pred             ChHHHHHHHHHH
Q 041907          316 TMKKCAEILWKI  327 (380)
Q Consensus       316 t~~eil~~l~~~  327 (380)
                      |++|+++|.|-.
T Consensus       321 ta~e~L~Hp~f~  332 (362)
T d1q8ya_         321 DAGGLVNHPWLK  332 (362)
T ss_dssp             CHHHHHTCGGGT
T ss_pred             CHHHHhcCcccC
Confidence            999999998844

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=6.3e-27  Score=197.65  Aligned_cols=166  Identities=16%  Similarity=0.206  Sum_probs=121.9

Q ss_pred             CCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcc----------------hHHHHHHHHHHHHHhcCCCCceeceEE
Q 041907           50 FSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHD----------------KCLLLEFKNEILTWSKIEHLNLVKLFG  113 (380)
Q Consensus        50 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~niv~~~~  113 (380)
                      +.+.++||+|+||+||+|.+.+|+.||||+++.....                .........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            3467899999999999999988999999987642110                111233557888999999999999886


Q ss_pred             EEEeCCEEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCceeeCCCCceEEc
Q 041907          114 FLEHGDERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYSDPPIIHRDVKASNILITEKLRAKVT  193 (380)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlkp~Nil~~~~~~~kl~  193 (380)
                      +..    .+++|||+++..+.+         ++...+..++.|++.+|.|||++|   |+||||||+|||++++ .++|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            642    279999998865433         333445678999999999999999   9999999999999965 48999


Q ss_pred             cccccccccCCCcceeeeecccCCccccC------hhhhhhcCCCCccchhhHHHHH
Q 041907          194 DFGFARMSEEDSAVSHISTQVKGTAGYLD------PDYLRTYQLTEKSDVYSFGVLL  244 (380)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DiwSlGvil  244 (380)
                      |||++.........           .|..      .+.+ ...|+.++|+||+.--+
T Consensus       145 DFG~a~~~~~~~~~-----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR-----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH-----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH-----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            99998765432211           1111      1222 35678899999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=2.9e-08  Score=85.82  Aligned_cols=149  Identities=16%  Similarity=0.154  Sum_probs=100.9

Q ss_pred             HHHHHHhcCCCCCCeeeccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC-CCceeceEEEEEeCC
Q 041907           41 EEIYKATENFSPANKIGEGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE-HLNLVKLFGFLEHGD  119 (380)
Q Consensus        41 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  119 (380)
                      .++....+.|++.+..+-+..+.||+.... ++.+++|+........  ...+.+|...+..+. +--+.+++.+....+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~   83 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence            455555677776665444445789988754 6667888875443221  223557777776653 444678888888899


Q ss_pred             EEEEEEEeCCCCCHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-------------------------------
Q 041907          120 ERIIVVEYVGNGTLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTYS-------------------------------  168 (380)
Q Consensus       120 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  168 (380)
                      ..++||++++|.++.+.....    ..   ...++.++...+..||+..                               
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             ceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999999998887665321    11   2234556666666666421                               


Q ss_pred             -------------------------CCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          169 -------------------------DPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       169 -------------------------~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                                               ...++|+|+.|.||++++++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                     1137999999999999987666799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.36  E-value=5.4e-07  Score=77.13  Aligned_cols=130  Identities=18%  Similarity=0.199  Sum_probs=85.3

Q ss_pred             eeeccCc-eEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCC--CCceeceEEEEEeCCEEEEEEEeCCCC
Q 041907           55 KIGEGGS-GTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIE--HLNLVKLFGFLEHGDERIIVVEYVGNG  131 (380)
Q Consensus        55 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~  131 (380)
                      .+..|.. +.||+....++..+++|........     .+..|...++.+.  .-.+.+++.+..+.+..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3444543 6799999887888999987654332     2456777766553  234677888888888899999999886


Q ss_pred             CHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHhhC--------------------------------------------
Q 041907          132 TLREHLDGRGGNGLELAERLDIAIDVAHALTYLHTY--------------------------------------------  167 (380)
Q Consensus       132 ~L~~~i~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  167 (380)
                      ++.+..       ....   .++.++...|..||..                                            
T Consensus        92 ~~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          92 DLLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             ETTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            653311       1111   1122333333444421                                            


Q ss_pred             -----------CCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          168 -----------SDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       168 -----------~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                                 ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       01237999999999999987667899999765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.97  E-value=9.9e-06  Score=73.80  Aligned_cols=79  Identities=14%  Similarity=0.131  Sum_probs=47.0

Q ss_pred             CCeeeccCceEEEEEEeCC-CCEEEEEEcccc-----CcchHHHHHHHHHHHHHhcCC-C--CceeceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKD-GSIVAVKRARKN-----KHDKCLLLEFKNEILTWSKIE-H--LNLVKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l  123 (380)
                      .+.||.|....||++...+ |+.|+||.-...     ...+........|...|+.+. +  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4478999999999998764 778999964321     001111223345676666552 2  345566654  3445678


Q ss_pred             EEEeCCCCCH
Q 041907          124 VVEYVGNGTL  133 (380)
Q Consensus       124 v~e~~~~~~L  133 (380)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.38  E-value=0.00067  Score=59.14  Aligned_cols=158  Identities=12%  Similarity=0.062  Sum_probs=84.5

Q ss_pred             cccHHHHHHHhcCCCCCCeee-----ccCceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCC-----C
Q 041907           37 NFSFEEIYKATENFSPANKIG-----EGGSGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEH-----L  106 (380)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~  106 (380)
                      ..+.+++...-.+|.+++...     .|--.+.|+....+|+ |++|+.......    .++..|+.++..+..     |
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH----HHHHHHHHHHHhhhhcccccc
Confidence            456788888889998866554     4445788999887665 899998654222    123345555554422     2


Q ss_pred             ceeceEE---EEEeCCEEEEEEEeCCCCCHHHH--------------hc----cCCC---CCC-----------------
Q 041907          107 NLVKLFG---FLEHGDERIIVVEYVGNGTLREH--------------LD----GRGG---NGL-----------------  145 (380)
Q Consensus       107 niv~~~~---~~~~~~~~~lv~e~~~~~~L~~~--------------i~----~~~~---~~~-----------------  145 (380)
                      ..+...+   +.........++.++.+......              ++    ....   ...                 
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            2222111   22334566677777655332110              00    0000   000                 


Q ss_pred             -CHHHHHHHHHHHHHHHHHHhhC-CCCCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          146 -ELAERLDIAIDVAHALTYLHTY-SDPPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       146 -~~~~~~~i~~~i~~~l~~LH~~-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                       ........+..+...+...+.. -..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             0011112222233333333321 13459999999999999988777899999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00092  Score=58.62  Aligned_cols=134  Identities=21%  Similarity=0.146  Sum_probs=76.6

Q ss_pred             ceEEEEEEeCCCCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-----eceE--EEEEeCCEEEEEEEeCCCCCH
Q 041907           61 SGTVYKGKLKDGSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-----VKLF--GFLEHGDERIIVVEYVGNGTL  133 (380)
Q Consensus        61 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~--~~~~~~~~~~lv~e~~~~~~L  133 (380)
                      ...||++...+|+.|++|+.+.....   ..++..|...+..|...++     +..-  ..+...+..+.++++++|..+
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            46899999999999999998766443   3446667777766632211     1111  134557778899999876433


Q ss_pred             H-----HH------h-------ccCC---CCCCCH----------------------HHHHHHHHHHHHHHHHHh-hCCC
Q 041907          134 R-----EH------L-------DGRG---GNGLEL----------------------AERLDIAIDVAHALTYLH-TYSD  169 (380)
Q Consensus       134 ~-----~~------i-------~~~~---~~~~~~----------------------~~~~~i~~~i~~~l~~LH-~~~~  169 (380)
                      .     .+      +       ....   ....+.                      .....++..+...+.-+- ....
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            1     00      0       0000   001111                      111222333333333221 1123


Q ss_pred             CCeeeccCCCCceeeCCCCceEEccccccc
Q 041907          170 PPIIHRDVKASNILITEKLRAKVTDFGFAR  199 (380)
Q Consensus       170 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  199 (380)
                      ..+||+|+.+.|||++++  ..++||+.+.
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence            458999999999999754  4589999775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.11  E-value=0.00053  Score=61.99  Aligned_cols=73  Identities=18%  Similarity=0.258  Sum_probs=47.9

Q ss_pred             CCeeeccCceEEEEEEeCC--------CCEEEEEEccccCcchHHHHHHHHHHHHHhcCCCCce-eceEEEEEeCCEEEE
Q 041907           53 ANKIGEGGSGTVYKGKLKD--------GSIVAVKRARKNKHDKCLLLEFKNEILTWSKIEHLNL-VKLFGFLEHGDERII  123 (380)
Q Consensus        53 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l  123 (380)
                      .+.|+.|-.-.+|++...+        ++.|.+++.-. ...   .....+|..+++.+.-.++ .++++++.+    ++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            3568888888999998653        35677777652 222   2244578888887743344 567776632    68


Q ss_pred             EEEeCCCCCH
Q 041907          124 VVEYVGNGTL  133 (380)
Q Consensus       124 v~e~~~~~~L  133 (380)
                      |+||++|..|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987544